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NOTICE TO READERS

This AICPA Audit and Accounting Guide has been prepared by the AICPA
Health Care Committee to assist preparers of financial statements in preparing
financial statements in conformity with generally accepted accounting princi
ples and to assist auditors in auditing and reporting on such financial state
ments in accordance with generally accepted auditing standards.
Descriptions of accounting principles and financial reporting practices in Audit
and Accounting Guides are approved by the affirmative vote of at least twothirds of the members of the Accounting Standards Executive Committee,
which is the senior technical body of the AICPA authorized to speak for the
AICPA in the areas of financial accounting and reporting. SAS No. 69, The
Meaning of Present Fairly in Conformity With Generally Accepted Accounting
Principles, identifies AICPA Audit and Accounting Guides that have been
cleared by the Financial Accounting Standards Board (for financial statements
of entities other than governmental entities) or Governmental Accounting
Standards Board (for financial statements of Governmental entities) as sources
of accounting principles in category b of the hierarchy of generally accepted
accounting principles that it establishes. This Audit and Accounting Guide has
been cleared by the Financial Accounting Standards Board and the Govern
mental Accounting Standards Board. AICPA members should consider the
accounting principles described in this Audit and Accounting Guide if the
accounting treatment of a transaction or event is not specified by a pronounce
ment covered by rule 203 of the AICPA Code of Professional Conduct. In such
circumstances, the accounting treatments specified by this Audit and Account
ing Guide should be used, or the member should be prepared to justify another
treatment, as discussed in paragraph 7 of SAS No. 69.
This AICPA Audit and Accounting Guide, which contains auditing guidance,
is an interpretive publication pursuant to SAS No. 95, Generally Accepted
Auditing Standards. Interpretive publications are recommendations on the
application of SASs in specific circumstances, including engagements for enti
ties in specialized industries. Interpretive publications are issued under the
authority of the Auditing Standards Board. The members of the Auditing
Standards Board have found this Guide to be consistent with existing SASs.
The auditor should be aware of and consider interpretive publications applica
ble to his or her audit. If the auditor does not apply the auditing guidance
included in an applicable interpretive publication, the auditor should be pre
pared to explain how he or she complied with the SAS provisions addressed by
such auditing guidance.
Public Accounting Firms Registered With the PCAOB

Subject to the Securities and Exchange Commission (SEC) oversight, Section
103 of the Sarbanes-Oxley Act (Act) authorizes the Public Company Accounting
Oversight Board (PCAOB) to establish auditing and related attestation, quality
control, ethics, and independence standards to be used by registered public
accounting firms in the preparation and issuance of audit reports as required
by the Act or the rules of the SEC. Accordingly, public accounting firms
registered with the PCAOB are required to adhere to all PCAOB standards in
the audits of issuers, as defined by the Act, and other entities when prescribed
by the rules of the SEC.
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This edition of the Audit and Accounting Guide Health Care Organizations,
has been modified by the AICPA staff to include certain changes necessary
due to the issuance of authoritative pronouncements since the Guide was
originally issued. This Guide reflects relevant guidance contained in
authoritative pronouncements through May 1, 2004:
• FASB Statement No. 150, Accounting for Certain Financial Instruments
with Characteristics of both Liabilities and Equity, and Revised FASB
Statements issued through May 1,2004, including FASB Statement No.
132 (revised 2003), Employers’ Disclosures about Pensions and Other
Postretirement Benefits
• FASB Interpretation No. 46 (revised December 2003), Consolidation of
Variable Interest Entities
• FASB Technical Bulletin 01-1, Effective Date for Certain Financial
Institutions of Certain Provisions ofStatement 140 Related to the Isolation
of Transferred Financial Assets
• FASB Staff Positions issued through May 1, 2004
• FASB Emerging Issues Task Force (EITF) consensus positions adopted
at meetings of the EITF held through March 2004
• GASB StatementNo. 43, Financial Reporting for Postemployment Benefit
Plans Other Than Pension Plans
• GASB Interpretation No. 6, Recognition and Measurement of Certain
Liabilities and Expenditures in Governmental Fund Financial
Statements
• GASB Technical Bulletin 03-1, Disclosure Requirements for Derivatives
Not Reported at Fair Value on the Statement of Net Assets
• SOP 03-5, Financial Highlights of Separate Accounts: An Amendment to
the Audit and Accounting Guide Audits of Investment Companies
• Practice Bulletin No. 15, Accounting by the Issuer of Surplus Notes
• SAS No. 101, Auditing Fair Value Measurements and Disclosures
• PCAOB Auditing Standards approved by the SEC through Auditing
Standard No. 1, References in Auditors’Reports to the Standards of the
Public Company Accounting Oversight Board (approved by the SEC May
14,2004)
Users of this Guide should consider pronouncements issued subsequent to
those listed above to determine their effect on entities covered by this Guide.
The changes made for the current year are identified in a schedule in appendix
H of the Guide. The changes do not include all those that might be considered
necessary if the Guide were subjected to a comprehensive review and revision.
This edition includes Statement of Position 98-2, Accounting for Costs of
Activities of Not-for-Profi t Organizations and State and Local Governmental
Entities That Include Fund Raising (Appendix C), Statement of Position 99-1,
Guidance to Practitioners in Conducting and Reporting on an Agreed-Upon
Procedures Engagement to Assist Management in Evaluating the Effectiveness
of Its Corporate Compliance Program (Appendix D), and Statement of Position
00-1, Auditing Health Care Third-Party Revenues and Related Receivables
(Appendix E), and Statement of Position 02-2, Accounting for Derivative
Instruments and Hedging Activities by Not-for-Profit Health Care Organiza
tions, and Clarification of the Performance Indicator (Appendix F). In using this
Guide, readers should refer to the material in these Statements of Position.
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Preface
Purpose

This Guide has been prepared to assist providers of health care services in
preparing financial statements in conformity with generally accepted account
ing principles (GAAP) and to assist independent auditors1 in auditing and
reporting on those financial statements.
Applicability

This Guide applies to health care organizations that are either (a) investorowned businesses or (b) not-for-profit enterprises that have no ownership
interest and are essentially self-sustaining from fees charged for goods and
services, as defined in Financial Accounting Standards Board (FASB) State
ment of Financial Accounting Concepts No. 4, Objectives of Financial Report
ing by Nonbusiness Organizations, paragraph 8,12 or (c) governmental. This
Guide applies to organizations whose principal operations consist of providing
or agreeing to provide health care services and that derive all or almost all of
their revenues from the sale of goods or services; it also applies to organizations
whose primary activities are the planning, organization, and oversight of such
organizations, such as parent or holding companies of health care providers.
This Guide applies to the following types of health care organizations:
• Clinics, medical group practices, individual practice associations, in
dividual practitioners, emergency care facilities, laboratories, surgery
centers, and other ambulatory care organizations
• Continuing care retirement communities (CCRCs)
• Health maintenance organizations (HMOs) and similar prepaid
health care plans
• Home health agencies
• Hospitals
• Nursing homes that provide skilled, intermediate, and less intensive
levels of health care
• Drug and alcohol rehabilitation centers and other rehabilitation facilities
This Guide also applies to integrated delivery systems that include one or
more of the above types of organizations.
This Guide does not apply to voluntary health and welfare organizations, as
defined in FASB Statement No. 117, Financial Statements of Not-for-Profit
Organizations. These organizations should follow the American Institute of
Certified Public Accountants (AICPA) Audit and Accounting Guide Not-forProfit Organizations. Related fund-raising foundations that meet the definition
of a not-for-profit organization given in FASB Statement No. 117 also should
follow the AICPA Audit and Accounting Guide Not-for-Profit Organizations.
When separate financial statements are issued for a state or local governmen
tal health care organization that uses enterprise fund accounting and reporting,
1 A member performing an attest engagement must be independent pursuant to Rule 101 of the
AICPA Code of Professional Conduct. Other applicable independence rules/regulations may also
apply to members and accountants while performing attest engagements (e.g. Securities and Ex
change Commission (SEC), Public Company Accounting Oversight Board (PCAOB), Government
Accountability Office (GAO), state licensing boards, etc.).
2 See paragraph 1.03 of this Guide.
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the accounting, reporting, and disclosure requirements set forth in this Guide
and by pronouncements of the Governmental Accounting Standards Board
(GASB) apply. (See chapter 1 for a discussion of the application of GAAP.)
GASB Statement No. 34, Basic Financial Statements—and Management’s
Discussion and Analysis—for State and Local Governments, replaces the pre
vious definition with a new definition of enterprise funds. Based on paragraph
67 of GASB Statement No. 34, as amended, any activity that charges a fee to
external users for goods or services may be reported as an enterprise fund. In
addition, paragraph 67 requires governments to report activities in enterprise
funds if any one of the following three criteria, as summarized below, is met:
(a) The activity is financed with debt that is secured solely by a pledge
of the net revenues from fees and charges of the activity.
(b) Laws or regulations require the activity’s costs of providing services,
including capital costs, to be recovered with fees and charges rather
than with taxes or similar revenues.
(c) The pricing policies of the activity establish fees and charges that are
designed to recover the activity’s costs of providing services, includ
ing capital costs.
The primary focus of these criteria is on fees charged to external users. Also,
paragraph 67 of GASB Statement No. 34 requires that these criteria should be
applied in the context of the activity’s principal revenue sources.
This Guide is not the only industry-specific AICPA Audit and Accounting
Guide that auditors should consider when performing an audit of a governmen
tal health care entity. The Audit and Accounting Guide State and Local
Governments, includes governmental health care entities in its scope and was
cleared by the GASB. Therefore, certain accounting and financial reporting
guidance in that Guide constitutes category (b) guidance for governmental
health care entities, and the auditing guidance in that Guide should also be
considered during an audit of a governmental health care entity that is included
in the scope of this Guide. In practice, auditors of governmental health care
entities that issue separate financial statements using enterprise fund account
ing and reporting may use this Guide as the primary source of guidance because
this Guide addresses transactions that are unique to or prevalent in the health
care industry. The Audit and Accounting Guide State and Local Governments,
however, contains information about governmental accounting and financial
reporting standards and other matters that are unique to or prevalent in
government and not included in this Guide.3
Many governmental health care entities are considered to be special-purpose
governments as defined in GASB Statement No. 34, paragraph 134.4 Specialpurpose governments are legally separate entities, as that term is described in
paragraph 15 of GASB Statement No. 14, The Financial Reporting Entity. They
3 See paragraphs 1.21 and 12.11 through 12.13 in the Audit and Accounting Guide State and
Local Governments.
4 GASB Statement No. 34, Basic Financial Statements—and Management’s Discussion and
Analysis—for State and Local Governments, does not provide guidance on separate reporting by
individual enterprise funds of a government. Although this discussion of the guidance in GASB
Statement No. 34 is written in terms of special-purpose business-type activities that are governmen
tal health care entities, the accounting, financial reporting, and auditing considerations are usually
equally applicable when the health care activity is conducted as a function or program of a generalpurpose government and reported in an enterprise fund. See footnote 7 to the section heading
“Specific Guidance for Special-Purpose Governments” in Chapter 12 of the Audit and Accounting
Guide State and Local Governments. Reporting guidance on separate reporting by individual enter
prise funds of a government is provided in the Audit and Accounting Guide State and Local
Governments.
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may be component units of another governmental entity or they may be other
stand-alone governments. (Both terms component units and other stand-alone
governments are also defined by GASB Statement No. 14) Because GASB
Statement No. 34 is written from the perspective of general-purpose govern
ments, paragraph 138 of GASB Statement No. 34 discusses how those require
ments apply to special-purpose governments engaged only in business-type
activities, such as certain governmental health care entities. Governmental
health care entities that are special-purpose governments engaged only in
business-type activities should present only the financial statements required
for enterprise funds. These financial statements are discussed further in
paragraph 1.13 of this Guide.
Limitations

This Guide does not discuss the application of all GAAP and all generally
accepted auditing standards (GAAS) that are relevant to the preparation and
audit of financial statements of health care organizations. The Guide is directed
primarily to those aspects of the preparation and audit of health care organi
zations’ financial statements that may be unique to those organizations or
areas considered particularly significant to them.
Other Literature

This Guide incorporates certain provisions of FASB Statements No. 116,
Accounting for Contributions Received and Contributions Made, No. 117, No.
124, Accounting for Certain Investments Held by a Not-for-Profit Organizations,
No. 136, Transfers of Assets to a Not-for-Profit Organization or Charitable Trust
That Raises or Holds Contributions for Others, GASB Statement No. 33,
Accounting and Financial Reporting for Nonexchange Transactions, as
amended, and GASB Statement No. 34 and related pronouncements. Not all
guidance included in those Statements, however, is incorporated, repeated, or
summarized in this Guide. Accordingly, those Statements, and all authoritative
guidance,5 should be read in conjunction with this Guide.
This Guide supersedes the AICPA Audit and Accounting Guide Audits of
Providers of Health Care Services. This Guide also incorporates and supersedes
AICPA Statements of Position (SOP) 89-5, Financial Accounting and Reporting
by Providers of Prepaid Health Care Services, 90-8, Financial Accounting and
Reporting by Continuing Care Retirement Communities, and 94-2, The Appli
cation of the Requirements of Accounting Research Bulletins, Opinions of the
Accounting Principles Board, and Statements and Interpretations of the Finan
cial Accounting Standards Board to Not-for-Profit Organizations.
Office of Management and Budget (OMB) Circular A-133, Audits of States,
Local Governments, and Non-Profit Organizations, sets forth audit require
ments for health care organizations expending federal awards. Institutions
covered by OMB Circular A-133 include not-for-profit hospitals, public hospi
tals and institutions of higher education, and their affiliated hospitals, voluntary
5
Other professional literature and authoritative guidance includes statements issued by the
AICPA Accounting Standards Executive Committee (AcSEC) and the FASB—including its Emerging
Issues Task Force (EITF). Authoritative literature for governmental health care entities includes
GASB pronouncements, FASB and AICPA pronouncements specifically made applicable to state and
local governmental entities by the GASB, and AICPA Audit and Accounting Guides, Industry Audit
Guides, Statements of Position, and Practice Bulletins made applicable to governmental entities and
cleared by the GASB.
AAG-HCO
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health and welfare organizations and other community-based organiza
tions.6 Auditors of health care organizations that are subject to the audit
requirements of OMB Circular A-133 should refer to the Audit Guide Govern
ment Auditing Standards and Circular A-133 Audits.
Effective Date and Transition

The provisions of this Guide, other than those included in paragraphs 1.40
through 1.51, which are discussed below, are effective for financial statements
for periods beginning after June 15, 1996.7 Earlier application is permitted.
The provisions included in paragraphs 1.40 through 1.51 are effective for
financial statements issued for fiscal years beginning after December 15, 1994,
except for organizations with less than $5 million in total assets and less than
$1 million in annual expenses. For those organizations, the effective date is fiscal
years beginning after December 15, 1995. Earlier application is permitted.
Unless the provisions of this Guide, other than those included in paragraphs
1.40 through 1.51, are applied retroactively under the provisions of the follow
ing paragraph, the effect of initially applying this Guide shall be reported as
the effect of a change in accounting principle, in a manner similar to the
cumulative effect of a change in accounting principle (Accounting Principles
Board [APB] Opinion No. 20, Accounting Changes, paragraph 19). The amount
of the cumulative effect should be based on a retroactive computation. A
not-for-profit organization should report the cumulative effect of a change in
accounting on each class of net assets in the statement of activities between the
captions extraordinary items, if any, and change in unrestricted net assets,
change in temporarily restricted net assets, and change in permanently re
stricted net assets. The cumulative effect on temporary and permanently
restricted net assets should be reflected in the statement of changes in net
assets. An investor-owned business should report the amount of the cumulative
effect in the income statement between the captions extraordinary items and
net income (APB Opinion No. 20, paragraph 20).
This Guide, other than the guidance in paragraphs 1.40 through 1.51, may
be applied retroactively by restating the opening net assets for the earliest year
presented or for the year this Guide is first applied if no prior years are
presented. In the period in which this Guide is first applied, that organization
should disclose the nature of any restatement and its effect on the change in
net assets for each period presented. An investor-owned business should
account for any restatement as a change in accounting principle applied
retroactively (APB Opinion No. 20, paragraphs 27 and 28).
In implementing the guidance in paragraphs 1.40 through 1.51, which incor
porates the provisions of SOP 94-2 into this Guide, the transition rules of the
APB Opinions and FASB Statements adopted, other than their effective dates,
should be followed. However, if there is more than one change in accounting
principle as a result of applying the guidance in paragraphs 1.40 through 1.51,
organizations have the option of including the cumulative effect of adopting
6 The Codification of Office of Management and Budget (OMB) Circular A-133 by the U.S.
Department of Health and Human Services (HHS) also includes audit requirements for commercial
organizations (including for-profit hospitals) that receive federal awards under HHS programs.
Generally, the organization has two options regarding audits: (1) a financial-related audit of a
particular award in accordance with Government Auditing Standards, or (2) an audit that meets the
requirements of OMB Circular A-133. See title 45 of the Code of Federal Regulations section 74.26(d)
for further information.
7 This Guide does not defer the effective date of any pronouncements that cover not-for-profit
organizations.
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those accounting principles in the statement of activity or similar statement in
the year this Guide is adopted, regardless of the transition rules of the APB
Opinions and FASB Statements adopted,8 and the financial statements should
disclose the nature of the cumulative adjustment. (Paragraphs 19 and 20 of
APB Opinion No. 20 discuss reporting the cumulative effects of changes in
accounting principles.) In circumstances in which there is more than one
change in accounting principle resulting from applying this Guide and the
cumulative effect of adopting those accounting principles is included in the
statement of activity or similar statement in the year the guidance in para
graphs 1.40 through 1.51 is adopted, this Guide does not require the pro forma
disclosures required by paragraphs 19(d) and 21 of APB Opinion No. 20.
Substantial Changes to Audit Process Proposed

(Note: This discussion is not applicable to public accounting firms registered
with the Public Company Accounting Oversight Board and their associated
persons in connection with their audits of issuers as defined by the SarbanesOxley Act, and other entities when prescribed by the rules of the Securities and
Exchange Commission.)
In December 2002, the AICPA’s Auditing Standards Board (ASB) issued an
exposure draft proposing seven new Statements on Auditing Standards (SASs)
relating to the auditor’s risk assessment process. The ASB believes that the
requirements and guidance provided in the proposed SASs, if adopted, would
result in a substantial change in audit practice and in more effective audits.
The primary objective of the proposed SASs is to enhance auditors’ application
of the audit risk model in practice by requiring:
• More in-depth understanding of the entity and its environment, in
cluding its internal control, to identify the risks of material misstate
ment in the financial statements and what the entity is doing to
mitigate them.
• More rigorous assessment of the risks of material misstatement of the
financial statements based on that understanding.
• Improved linkage between the assessed risks and the nature, timing
and extent of audit procedures performed in response to those risks.
The exposure draft consists of the following proposed SASs:
• Amendment to Statement on Auditing Standards No. 95, Generally
Accepted Auditing Standards
• Audit Evidence
• Audit Risk and Materiality in Conducting an Audit
• Planning and Supervision
• Understanding the Entity and Its Environment and Assessing the
Risks of Material Misstatement
• Performing Audit Procedures in Response to Assessed Risks and Evalu
ating the Audit Evidence Obtained
• Amendment to Statement on Auditing Standards No. 39, Audit Sampling
Organizations that adopt the guidance in paragraphs 1.40 through 1.51 of this Guide in the
same year in which they adopt FASB Statement No. 116 are permitted to apply the provisions of
paragraph 17 of that Statement, concerning recognition of expirations of restrictions, prospectively,
as specified in that Statement, regardless of whether they report the cumulative effect of adopting
other accounting principles as a result of applying the guidance in paragraphs 1.40 through 1.51 of
this Guide.
AAG-HCO
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The proposed SASs establish standards and provide guidance concerning the
auditor’s assessment of the risks of material misstatement in a financial
statement audit, and the design and performance of audit procedures whose
nature, timing, and extent are responsive to the assessed risks. Additionally,
the proposed SASs establish standards and provide guidance on planning and
supervision, the nature of audit evidence, and evaluating whether the audit
evidence obtained affords a reasonable basis for an opinion regarding the
financial statements under audit.
Readers can access the proposed standards at AICPA Online (www.aicpa.org)
and should be alert to future progress on this project.
Applicability of Requirements of the Sarbanes-Oxley
Act of 2002, Related Securities and Exchange
Commission Regulations, and Standards of the Public
Company Accounting Oversight Board

Publicly-held companies and other “issuers” (see definition below) are subject
to the provisions of the Sarbanes-Oxley Act of 2002 (Act) and related Securities
and Exchange Commission (SEC) regulations implementing the Act. Their
outside auditors are also subject to the provisions of the Act and to the rules
and standards issued by the Public Company Accounting Oversight Board
(PCAOB).
Presented below is a summary of certain key areas addressed by the Act, the
SEC, and the PCAOB that are particularly relevant to the preparation and
issuance of an issuer’s financial statements and the preparation and issuance
of an audit report on those financial statements. However, the provisions of the
Act, the regulations of the SEC, and the rules and standards of the PCAOB are
numerous and are not all addressed in this section or in this Guide. Issuers and
their auditors should understand the provisions of the Act, the SEC regulations
implementing the Act, and the rules and standards of the PCAOB, as applicable
to their circumstances.
Definition of an Issuer
The Act states that the term “issuer” means an issuer (as defined in section
3 of the Securities Exchange Act of 1934 (15 U.S.C. 78c)), the securities of
which are registered under section 12 of that Act (15 U.S.C. 781), or that is
required to file reports under section 15(d) (15 U.S.C. 78o(d)), or that files
or has filed a registration statement that has not yet become effective under
the Securities Act of 1933 (15 U.S.C. 77a et seq.), and that it has not
withdrawn.
Issuers, as defined by the Act, and other entities when prescribed by the
rules of the SEC (collectively referred to in this Guide as “issuers” or
“issuer”) and their public accounting firms (who must be registered with
the PCAOB) are subject to the provisions of the Act, implementing SEC
regulations, and the rules and standards of the PCAOB, as appropriate.
Non-issuers are those entities not subject to the Act or the rules of the SEC.
Guidance for Issuers
Management Assessment of Internal Control

As directed by Section 404 of the Act, the SEC adopted final rules requiring
companies subject to the reporting requirements of the Securities Exchange
Act of 1934, other than registered investment companies and certain other
AAG-HCO
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entities (e.g., 11-K filers), to include in their annual reports a report of man
agement on the company’s internal control over financial reporting. See the
SEC Web site at www.sec.gov/rules/final/33-8238.htm for the full text of the
regulation.
The SEC rules clarify that management’s assessment and report is limited to
internal control over financial reporting. The SEC’s definition of internal
control encompasses the Committee of Sponsoring Organizations of the Tread
way Commission (COSO) definition but the SEC does not mandate that the
entity use COSO as its criteria forjudging effectiveness.
Under the SEC rules, the company’s annual 10-K must include:
1. Management’s Annual Report on Internal Control Over Financial
Reporting
2. Attestation Report of the Registered Public Accounting Firm
3. Changes in Internal Control Over Financial Reporting
The SEC rules also require management to evaluate any change in the entity’s
internal control that occurred during a fiscal quarter and that has materially
affected, or is reasonably likely to materially affect, the entity’s internal control
over financial reporting.
Audit Committees and Corporate Governance

Section 301 of the Act establishes requirements related to the makeup and
the responsibilities of an issuer’s audit committee. Among those require
ments—
• Each member of the audit committee must be a member of the board
of directors of the issuer, and otherwise be independent.
• The audit committee of an issuer is directly responsible for the ap
pointment, compensation, and oversight of the work of any registered
public accounting firm employed by that issuer.
• The audit committee shall establish procedures for the “receipt, reten
tion, and treatment of complaints” received by the issuer regarding
accounting, internal controls, and auditing.
In April 2003, the SEC adopted a rule to direct the national securities
exchanges and national securities associations to prohibit the listing of any
security of an issuer that is not in compliance with the audit committee
requirements mandated by the Act.
Disclosure of Audit Committee Financial Expert and
Code of Ethics

In January 2003, the SEC adopted amendments requiring issuers, other than
registered investment companies, to include two new types of disclosures in
their annual reports filed pursuant to the Securities Exchange Act of 1934.
These amendments conform to Sections 406 and 407 of the Act and relate to
disclosures concerning the audit committee’s financial expert and code of ethics
relating to the companies’ officers. An amendment specifies that these disclo
sures are only required for annual reports.
Certification of Disclosure in an Issuer's Quarterly and
Annual Reports

Section 302 of the Act requires the Chief Executive Officer (CEO) and Chief
Financial Officer (CFO) of each issuer to prepare a statement to accompany the
audit report to certify the “appropriateness of the financial statements and
AAG-HCO
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disclosures contained in the periodic report, and that those financial state
ments and disclosures fairly present, in all material respects, the operations
and financial condition of the issuer.”
In August 2002, the SEC adopted final rules for Certification of Disclosure in
Companies’ Quarterly and Annual Reports in response to Section 302 of the
Act. CEOs and CFOs are now required to certify the financial and other
information contained in quarterly and annual reports.
Improper Influence on Conduct of Audits

Section 303 of the Act makes it unlawful for any officer or director of an issuer
to take any action to fraudulently influence, coerce, manipulate, or mislead any
auditor engaged in the performance of an audit for the purpose of rendering
the financial statements materially misleading. In April 2003, the SEC adopted
rules implementing these provisions of the Act.
Disclosures in Periodic Reports

Section 401(a) of the Act requires that each financial report of an issuer that
is required to be prepared in accordance with generally accepted accounting
principles (GAAP) shall “reflect all material correcting adjustments . . . that
have been identified by a registered accounting firm . . . .” In addition, “each
annual and quarterly financial report... shall disclose all material off-balance
sheet transactions” and “other relationships” with “unconsolidated entities”
that may have a material current or future effect on the financial condition of
the issuer.
In January 2003, the SEC adopted rules that require disclosure of material
off-balance sheet transactions, arrangements, obligations, and other relation
ships of the issuer with unconsolidated entities or other persons, that may have
a material current or future effect on financial condition, changes in financial
condition, results of operations, liquidity, capital expenditures, capital re
sources, or significant components of revenues or expenses. The rules require
an issuer to provide an explanation of its off-balance sheet arrangements in a
separately captioned subsection of the Management’s Discussion and Analysis
section of an issuer’s disclosure documents.
Guidance for Auditors

The Act mandates a number of requirements concerning auditors of issuers,
including mandatory registration with the PCAOB, the setting of auditing
standards, inspections, investigations, disciplinary proceedings, prohibited
activities, partner rotation, and reports to audit committees, among others.
Auditors of issuers should familiarize themselves with applicable provisions of
the Act and the standards of the PCAOB. The PCAOB continues to establish
rules and standards implementing provisions of the Act concerning the auditors
of issuers.
Applicability and Integration of Generally Accepted
Auditing Standards and Public Company Accounting
Oversight Board Standards

AICPA members who perform auditing and other related professional serv
ices have been required to comply with Statements on Auditing Standards
(SASs) promulgated by the AICPA Auditing Standards Board (ASB). These
standards constitute what is known as “generally accepted auditing standards”
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(GAAS). In the past, the ASB’s auditing standards have applied to audits of all
entities. However, as a result of the passage of the Act, auditing and related
professional practice standards to be used in the performance of and reporting
on audits of the financial statements of issuers are now established by the
PCAOB.
Specifically, the Act authorizes the PCAOB to establish auditing and related
attestation, quality control, ethics, and independence standards to be used by
registered public accounting firms in the preparation and issuance of audit
reports for entities subject to the Act or the rules of the SEC. Accordingly, public
accounting firms registered with the PCAOB are required to adhere to all
PCAOB standards in the audits of "issuers,” as defined by the Act, and other
entities when prescribed by the rules of the SEC.
For those entities not subject to the Act or the rules of the SEC, the prepara
tion and issuance of audit reports remain governed by GAAS as issued by the
ASB.
Extensive Guidance Available in AICPA Professional Standards

The AICPA Professional Standards and Codification of Auditing Standards
contains a thorough section that provides important information and guidance
about:
• The applicability and integration of GAAS and PCAOB standards;
• Standards applicable to the audits of non-issuers;
• Standards applicable to the audits of issuers;
• The PCAOB’s adoption of interim standards;
• Standards applicable if a non-issuer’s financial statements are audited
in accordance with PCAOB standards; and,
• Applicability of GAAS to audits of issuers
GAAS and PCAOB Standards Included in This Guide

As the ASB and the PCAOB move forward in establishing auditing standards
for entities within their respective jurisdictions, this Guide will present both
GAAS and PCAOB standards, as applicable depending on the auditing guid
ance presented in this Guide. Moreover, if differences between GAAS and
PCAOB standards emerge, the auditing guidance in this Guide will integrate
both sets of standards, as applicable, in order to offer practitioners a seamless
source of auditing standards applicable to non-issuers and those applicable to
issuers.
Major Existing Differences Between GAAS and
PCAOB Standards

At the time of development of this Guide, the major differences between GAAS
and final PCAOB Standards approved by the SEC are as follows:
• Audit of Internal Control. In connection with the requirement of
Section 404(b) of the Sarbanes-Oxley Act that an issuer’s independent
auditor attest to and report on management’s assessment of the
effectiveness of internal control, PCAOB Auditing Standard No. 2, An
Audit of Internal Control Over Financial Reporting Performed in
Conjunction With an Audit of Financial Statements, establishes re
quirements and provides direction that apply when an auditor is engaged
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•

•
•

•
•
•
•

to audit the internal control over financial reporting and to perform
that audit in conjunction with the audit of an issuer’s financial state
ments.
References in Auditor’s Reports. PCAOB Auditing Standard No. 1
requires registered public accounting firms to include in their reports
on engagements performed pursuant to the PCAOB’s auditing and
related professional practice standards, including audits and reviews
of financial statements, a reference to the standards of the Public
Company Accounting Oversight Board (United States).
Concurring Partner—PCAOB Rule 3400T requires the establishment
of policies and procedures for a concurring review (generally the
SECPS membership rule)9
Communication of Firm Policy—PCAOB Rule 3400T requires regis
tered firms to communicate through a written statement to all profes
sional firm personnel the broad principles that influence the firm’s
quality control and operating policies and procedures on, at a mini
mum, matters that relate to the recommendation and approval of
accounting principles, present and potential client relationships, and
the types of services provided, and inform professional firm personnel
periodically that compliance with those principles is mandatory (gen
erally the SECPS membership rule).
Affiliated Firms—PCAOB Rule 3400T requires registered firms that
are part of an international association to seek adoption of policies and
procedures by the international organization or individual foreign
associated firms consistent with PCAOB Standards.
Partner Rotation—PCAOB Rule 3600T requires compliance with the
SEC’s independence rules which include partner rotation.
Continuing Professional Education (CPE) Requirements—PCAOB
Rule 3400T requires registered accounting firms to ensure that all of
their professionals participate in at least 20 hours of qualifying CPE
every year (generally the SECPS membership rule).
Independence Matters—PCAOB Rule 3600T requires compliance with
the SEC’s independence rules and Standards No. 1, 2 and 3, and
Interpretations 99-1, 00-1, and 00-2 of the Independence Standards
Board.

Proposed PCAOB Auditing Standards and Proposed Changes to
the PCAOB Interim Auditing Standards

As of the publication of this Guide, certain PCAOB Standards and rules have
been issued as final pronouncements, but are awaiting SEC approval. As such,
these Standards and rules are not yet effective. In addition, the PCAOB has
issued exposure drafts of proposed standards and rules. Presented below is a
table presenting certain key PCAOB proposed standards and rules that are
particularly relevant to the audit of financial statements and how they may
significantly affect the audits of issuers.
Auditors of issuers should be alert to the final resolution of these matters. If
these Standards are approved by the SEC, auditors of issuers will be required
to comply with additional responsibilities and procedures. Furthermore, sec
tions of the existing PCAOB interim auditing standards will be amended and
superseded.
9 Firms that were not members of the AICPA’s SECPS as of April 16, 2003 do not have to comply
with this requirement.
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PCAOB Standard
or Exposure Draft

Status

Auditing Standard
No. 2, An A udit of
Internal Control
Over Financial Re
porting Performed in
Conjunction With an
Audit of Financial
Statements

Issued as a
final
standard by
the PCAOB;
approved by
the SEC

Proposed Auditing
Standard,
Conforming
Amendments to
PCAOB Interim
Standards Resulting
From the Adoption of
PCAOB Auditing
Standard No. 2

Issued as an
exposure
draft by the
PCAOB

Explanation and Affect on
Existing PCAOB Standards

PCAOB
Website Link

This standard establishes re
quirements and provides direc
tions that apply when an auditor
is engaged to audit both an
issuer’s financial statements and
management’s assessment of the
effectiveness of internal control
over financial reporting. This stan
dard is the standard on attesta
tion engagements referred to in
Section 404(b) of the Act. Amend
ments to the PCAOB’s Interim
Standards as a result of the issu
ance of this standard are handled
in the proposed auditing standard
below.
This standard proposes conform
ing amendments to the PCAOB
interim auditing standards as a
result of the issuance of PCAOB
Auditing Standard No. 2. Sections
of the PCAOB Interim Auditing
Standards that would be affected
include:
AU sec. 310, Appointment of the
Independent A uditor; AU sec.
311, Planning and Supervision;
AU sec. 312, A u dit R isk and
M ateria lity in Conducting an
Audit; AU sec. 313, Substantive
Tests Prior to the Balance-Sheet
Date; AU sec. 316, Consideration
of Fraud in a Financial Statement
Audit; AU sec. 319, Consideration
of Internal Control in a Financial
Statement Audit; AU sec. 322, The
A u ditor’s Consideration of the
Internal A u dit Function in an
A udit of Financial Statements;
AU sec. 324, Service Organiz
tions; AU sec. 325, Communica
tion of Internal Control Related
Matters Noted in an Audit; AU
sec. 326, Evidential Matter; AU
sec. 329, Analytical Procedures;
AU sec. 332, Auditing Derivative
Instruments, Hedging Activities,
and Investments in Securities; AU
sec. 333, Management Represen
tations; AU sec. 339, A udit Docu
mentation; AU sec. 342, Auditing
Accounting Estimates; AU sec.
508, Reports on Audited Finan
cial Statements; AU sec. 530,
Dating of the Independent A udi
tor’s Report; AU sec. 543, Part of
A u d it P erform ed by O ther
Independent Auditors; AU sec.
560, Subsequent Events; AU sec.

www.pcaobus.org/
rules/Release20040308-la.pdf

www.pcaobus.org/
rules/Release20040308-2.pdf

(continued)
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PCAOB Standard
or Exposure Draft

Auditing Standard
No. , References in
Auditors’ Reports to
the Standards of the
Public Company
Accounting Oversight
Board
1

Auditing Standard
No. 3, Audit
Documentation

Status

Explanation and Affect on
Existing PCAOB Standards

561, Subsequent D iscovery o f
Facts Existing at the Date of the
Auditor’s Report, AU sec. 711, Fil
ings Under Federal Securities
Statutes', AU sec. 722, Interim Fi
nancial Information; AT sec. 501,
Reporting on an E ntity’s Internal
Control Over Financial Report
ing; ET sec. 101, Independence
This standard requires registered
Issued as a
public accounting firms to infinal
standard by clude in their reports on engagethe PCAOB; ments performed pursuant to the
approved by PCAOB’s auditing and related
professional practice standards, a
the SEC,
May 14, 2004 reference to the standards of the
PCAOB (United States).
This standard establishes general
Issued as a
requirements for documentation
final
standard by the auditor should prepare and
the PCAOB; retain in connection with any
approved by engagement conducted in accord
ance with auditing and related
the SEC,
professional practice standards of
August 25,
the PCAOB. This standard does
2004
not supplant specific documenta
tion req uirem en ts of other
PCAOB auditing and related
professional practice standards.
This standard would supersede
AU sec. 339, A udit Documenta
tion, and amend AU sec. 543, Part
of Audit Performed by Other Inde
pendent Auditors, of the PCAOB
Interim Auditing Standards.

PCAOB
Website Link

www.pcaobus.org/
rules/Release2003025.pdf

www.pcaobus.org/
rules/Release2003023.pdf

Auditor Reports to Audit Committees

Section 204 of the Act requires the accounting firm to report to the issuer’s
audit committee all “critical accounting policies and practices to be used ... all
alternative treatments of financial information within [GAAP] that have been
discussed with management. . . ramifications of the use of such alternative
disclosures and treatments, and the treatment preferred” by the firm.
Audit Documentation

Section 103 of the Act instructs the PCAOB to require registered public
accounting firms to “prepare, and maintain for a period of not less than 7 years,
audit work papers, and other information related to any audit report, in
sufficient detail to support the conclusions reached in such report.” The PCAOB
has issued a proposed auditing standard (see the table above) that responds to
this directive. Also, in January 2003, the SEC adopted rules to require account
ing firms to retain for seven years certain records relevant to their audits and
reviews of issuers’ financial statements.
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Other Requirements

The Act contains requirements in a number of other important areas, and the
SEC has issued implementing regulations in certain of those areas as well. For
example,
• The Act prohibits auditors from performing certain non-audit or
non-attest services. The SEC adopted amendments to its existing
requirements regarding auditor independence to enhance the inde
pendence of accountants that audit and review financial statements
and prepare attestation reports filed with the SEC. This rule conforms
the SEC’s regulations to Section 208(a) of the Act and, importantly,
addresses the performance of non-audit services.
• The Act requires the lead audit or coordinating partner and the
reviewing partner to rotate off of the audit every 5 years. (See SEC
Releases 33-8183 and 33-8183A for SEC implementing rules.)
• The Act directs the PCAOB to require a second partner review and
approval of audit reports (concurring review).
• The Act states that an accounting firm will not be able to provide audit
services to an issuer if one of that issuer’s top officials (CEO, Control
ler, CFO, Chief Accounting Officer, etc.) was employed by the firm and
worked on the issuer’s audit during the previous year.
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Unique Considerations of Health Care Organizations

1

Chapter 1
Unique Considerations o f Health
Care Organizations
Overview

1.01 Financial statements of health care organizations should be prepared
in conformity with generally accepted accounting principles (GAAP). AICPA
Statement on Auditing Standards (SAS) No. 69, The Meaning of Present Fairly in
Conformity With Generally Accepted Accounting Principles (AICPA, Professional
Standards, vol. 1, AU sec. 411), provides the GAAP hierarchy summary for both
nongovernmental and governmental organizations.1
Classification of Health Care Organizations

1.02 Health care enterprises usually can be classified into the following
categories on the basis of their operating characteristics:
a. Investor-Owned Health Care Enterprises. These are owned by in
vestors or others with a private equity interest and provide goods or
services with the objective of making a profit.
b. Not-for-Profit, Business-Oriented Organizations. These are charac
terized by no ownership interests and essentially are self-sustaining
from fees charged for goods and services. The fees charged by such
organizations generally are intended to help the organization main
tain its self-sustaining status rather than to maximize profits for the
owner’s benefit. Such organizations often are exempt from federal
income taxes and may receive contributions of relatively small
amounts from resource providers that do not expect commensurate
or proportionate pecuniary return.

1
GASB Statement No. 34, Basic Financial Statements—and Management’s Discussion and
Analysis—for State and Local Governments, paragraphs 93 through 95, indefinitely extend the
provisions of GASB Statement No. 20, Accounting and Financial Reporting for Proprietary Funds
and Other Governmental Entities That Use Proprietary Fund Accounting. GASB Statement No. 20,
paragraph 6, as amended, requires that proprietary funds should apply all applicable GASB pro
nouncements as well as any Financial Accounting Standards Board (FASB) Statements and Interpre
tations, Accounting Principles Board (APB) Opinions, and Accounting Research Bulletins (ARBs)
issued on or before November 30, 1989, that do not conflict with or contradict GASB pronouncements.
Furthermore, paragraph 7, as amended, of GASB Statement No. 20 provides that governmental
enterprise funds and activities reported using enterprise fund accounting and financial reporting
may apply all FASB Statements and Interpretations issued after November 30, 1989, that do not
conflict with or contradict GASB pronouncements. Entities that choose to apply these “new” FASB
pronouncements must apply them on an “all or none” basis (that is, they may not select which
pronouncements to apply). In addition, GASB Statement No. 29, The Use of Not-for-Profit Accounting
and Financial Reporting Principles by Governmental Entities, provides that governmental enterprise
funds and activities reported using enterprise fund accounting and financial reporting that apply the
provisions of paragraph 7, as amended, of GASB Statement No. 20 should apply only those FASB
Statements and Interpretations issued after November 30, 1989 that are developed for business
enterprises (see paragraph 1.53 in this Guide). They should not apply FASB Statements and
Interpretations whose provisions are limited to not-for-profit organizations, such as FASB Statement
No. 117, Financial Statements of Not-for-Profit Organizations, or address issues concerning primarily
such organizations, such as FASB Statement No. 116, Accounting for Contributions Received and
Contributions Made. The requirements set forth in this Guide for governmental health care enter
prises generally apply to such enterprises that apply paragraph 7, as amended, of GASB Statement
No. 20.
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Health Care Organizations

c. Governmental Health Care Organizations. These are public corpor
ations2 and bodies corporate and politic. Other organizations are gov
ernmental organizations if they have one or more of the following
characteristics:
• Popular election of officers or appointment (or approval) of a
controlling majority of the members of the organization’s gov
erning body by officials of one or more state or local governments;
• The potential for unilateral dissolution by a government with
the net assets reverting to a government; or
• The power to enact and enforce a tax levy.
Furthermore, organizations are presumed to be governmental if they
have the ability to issue directly (rather than through a state or
municipal authority) debt that pays interest exempt from federal
taxation. However, organizations possessing only that ability (to
issue tax-exempt debt) and none of the other governmental charac
teristics may rebut the presumption that they are governmental if
their determination is supported by compelling, relevant evidence.
d. Not-for-Profit, Nonbusiness-Oriented Organizations. These are vol
untary health and welfare organizations (see the Glossary) as de
fined in FASB Statement No. 117, Financial Statements of
Not-for-Profit Organizations. Such organizations are within the
scope of the AICPA Audit and Accounting Guide Not-for-Profit Or
ganizations rather than this Guide.
Financial Reporting of Nongovernmental Health
Care Organizations

1.03 The nature of the organization and its operating structure have a
significant effect on the needs of financial statement users. According to FASB
Statement of Financial Accounting Concepts (Concepts Statement) No. 4, Ob
jectives of Financial Reporting by Nonbusiness Organizations, paragraph 8:
Some organizations have no ownership interests but are essentially self-sustain
ing from fees they charge for goods and services. Examples are those private
nonprofit hospitals . . . that may receive relatively small amounts of contributions
and grants but finance their capital needs largely from the proceeds of debt issues
and their operating needs largely from service charges rather than from private
philanthropy or governmental grants. As a result, assessment of amounts, timing,
and uncertainty of cash flows becomes the dominant interest of their creditors and
other resource providers and profitability becomes an important indicator of
performance. Consequently, the objectives of FASB Concepts Statement No. 1
[Objectives of Financial Reporting by Business Enterprises] may be more appro
priate for those organizations. [Footnote reference omitted.]

1.04 The financial reporting for not-for-profit, business-oriented or
ganizations and investor-owned health care enterprises generally is consistent
2
Black’s Law Dictionary defines a public corporation as: An artificial person (e.g., [a] municipal
ity or a governmental corporation) created for the administration of public affairs. Unlike a private
corporation it has no protection against legislative acts altering or even repealing its charter.
Instrumentalities created by [the] state, formed and owned by it in [the] public interest, supported in
whole or part by public funds, and governed by managers deriving their authority from [the] state.
Sharon Realty Co. v. Westlake, Ohio Com.Pl., 188 N.E.2d 318, 323, 25, O.O.2d 322. A public
corporation is an instrumentality of the state, founded and owned in the public interest, supported by
public funds and governed by those deriving their authority from the state. York County Fair Ass’n v.
South Carolina Tax Commission, 249 S.C. 337, 154 S.E.2d 361, 362.
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except for transactions that clearly are not applicable. For example, not-forprofit, business organizations would have nothing to report for shareholders’
equity. On the other hand, investor-owned health care enterprises typically
would not have anything to report for contributions.
1.05 The basic financial statements of health care organizations generally
consist of a balance sheet, a statement of operations, a statement of changes in
equity (or net assets), a statement of cash flows, and notes to the financial
statements.3 The statement of operations for not-for-profit organizations should
report a performance indicator (see paragraph 10.19) as well as all other changes
in unrestricted net assets for the period. The statement of operations may be
combined with the statement of changes in equity (net assets). Illustrative finan
cial statements are included in the Appendix A of this Guide.
1.06 FASB Statement No. 117 requires not-for-profit organizations to
provide information about the liquidity of assets and liabilities in the balance
sheet. Health care organizations should classify assets and liabilities as cur
rent and noncurrent. However, rather than presenting a classified balance
sheet, a continuing care retirement community (CCRC) instead may sequence
assets according to their nearness of conversion to cash and may sequence
liabilities according to the nearness of the maturity and resulting use of cash.
1.07 FASB Statement No. 95, Statement of Cash Flows, established
standards for cash flow reporting for investor-owned organizations. FASB
Statement No. 95 was amended by FASB Statement No. 117 to include
not-for-profit organizations. The statement of cash flows may be prepared
using the direct or indirect method of reporting cash flows.
1.08 A health care organization may be a part of another organization,
such as a medical school or a university, or a subsidiary of a corporation. The
recommendations in this Guide apply to the separate financial statements of
these organizations as defined above.
Financial Reporting of Governmental Health
Care Organizations

1.09 This section of the Guide discusses the financial reporting require
ments applicable to governmental health care entities within the scope of this
Guide, including the financial reporting requirements of GASB Statement No.
34, as amended, and GASB Statement No. 38, Certain Financial Statement
Note Disclosures.
1.10 A health care organization may be a part of another organization,
such as a general-purpose-government or medical school or a university. The
recommendations in this Guide apply to the separate financial statements of
these organizations. Therefore, when separate financial statements are pre
pared for a governmental health care organization that uses enterprise fund
accounting and reporting, the accounting and disclosure requirements set forth
by GASB pronouncements and this Guide apply. The requirements in this
Guide presume that governmental health care organizations apply paragraph
7 of GASB Statement No. 20 (see footnote 1 to this chapter).
3
The terms balance sheet and statement of operations indicate the content and purpose of the
respective statements and serve as possible titles for those statements. Other appropriately descrip
tive titles may also be used. For example, a statement reporting financial position could be called a
statement of financial position as well as a balance sheet. Current practice and purpose suggest,
however, that a statement of cash flows only be titled “Statement of Cash Flows.”
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1.11
This Guide makes various references to implementation guides pub
lished by the GASB staff. Those implementation guides are category (d)
guidance in the hierarchy of GAAP applicable to state and local governments,
as discussed in SAS No. 69 and in paragraph 1.61 in this chapter. References
to the guidance in GASB staff implementation guides in this Guide do not
elevate that guidance to category (b) guidance. Similarly, references in this
Guide to discussions or examples in the nonauthoritative appendixes of GASB
pronouncements or its staff's implementation guides do not elevate that guid
ance from “other accounting literature.”
GASB Statement No. 34 and Related Pronouncements

1.12
Briefly, GASB Statement No. 34 and related pronouncements re
quire that the separately issued financial reports of governmental health care
entities that are special-purpose governments engaged only in business-type
activities:
• Present a management’s discussion and analysis (MD&A) before the
basic financial statements as required supplementary information
(RSI).
• Present a classified statement of net assets/balance sheet.
• Report three categories of net assets—(a) net assets invested in capital
assets net of related debt, (b) restricted net assets, and (c) unrestricted
net assets.
• Apply the definition of restricted provided in GASB Statement No. 34
in determining restricted assets and restricted net assets.
• Present a statement of revenues, expenses, and changes in net assets/
equity that reports on changes in net assets, including permanent
endowments. The focus of this statement is to present all changes in
net assets.
• Report transfers as interfund transfers after nonoperating revenues
and expenses. Under GASB Statement No. 34, there is no distinction
as to the type of transfer.
• Report revenues by major source and separately identify revenue used
as security for revenue bonds.
• Distinguish between operating and nonoperating revenues and ex
penses and provide an intermediate total for operating income or loss.
• Separately report capital contributions and contributions to term and
permanent endowments as components of the all-inclusive statement
of revenues, expenses, and changes in net assets/equity.
• Separately report special items and extraordinary items at the bottom
of the statement of revenues, expenses, and changes in net assets/equity.
• Report operating cash flows using the direct method in the statement
of cash flows.
• Present certain note disclosures, including the entity’s policy for
defining operating revenues and expenses, policy regarding the use of
restricted resources, schedules of changes in capital assets and long
term liabilities, disaggregated information about accounts receivable
and payable, and short-term debt activity during the year. (Disclosure
of disaggregated information about accounts receivable and payable
is required by GASB Statement No. 38.)
• If the entity has segments, present segment information based on the
definition of a segment in GASB Statement No. 34.
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The requirements in this paragraph do not apply to health care units that are
not legally separate entities.
1.13 GASB Statement No. 34 requires governmental health care entities
that are special-purpose governments engaged only in business-type activities
to present three basic financial statements, notes to the financial statements,
and RSI:4
a. MD&A as RSI.
b. A statement of net assets or balance sheet.
c. A statement of revenues, expenses, and changes in net assets/equity.
d. A statement of cash flows.
e. Notes to financial statements.
f. RSI other than MD&A, as established by GAAP, such as GASB
Statement No. 27, Accounting for Pensions by State and Local Gov
ernmental Employers.
Management's Discussion and Analysis

1.14 GASB Statement No. 34, paragraphs 8 through 11, as amended,
establish eight required elements of MD&A for general-purpose governments.
However, certain of those elements are not applicable to governmental health
care entities that are special-purpose governments engaged only in businesstype activities. These governmental health care entities should limit their discus
sion in MD&A to the elements that are applicable to their entity. Because it is
RSI, no additional information should be presented within MD&A.
1.15 Many health care entities that are special-purpose governments
engaged only in business-type activities present comparative financial state
ments. When comparative financial statements are presented, MD&A should
present an analysis of both current- and prior-year net assets and changes in
them, as discussed in the GASB staff document, Comprehensive Implementa
tion Guide—2003 (GASB Q&A 2003 Edition), item 7.14. (See paragraph 1.11
in this chapter regarding references in this Guide to discussions in GASB staff
implementation guides.) Two completely separate MD&As are not required.
When comparative financial statements are presented, the MD&A should
present the current year, prior year, and preceding year financial information
summarized in the MD&A, and discuss the fluctuations. If comparative finan
cial data is presented, as distinguished from a complete set of comparative
statements, notes, and RSI, the requirements for MD&A in paragraph 11 of
GASB Statement No. 34 should be met for the current year with comparisons
to the prior year, as discussed in the GASB Q&A—2003 Edition, item 7.15.
Measurement Focus and Basis of Accounting

1.16 GASB Statement No. 34, paragraph 92, requires activities reported
using enterprise fund accounting and reporting to use the accrual basis of account
ing and the economic resources measurement focus. GASB Statement No. 34,

4
GASB Statement No. 34 does not provide guidance on separate reporting by individual
enterprise funds of a government. Although this discussion of the guidance in GASB Statement No.
34 is written in terms of special-purpose business-type activities that are governmental health care
entities, the accounting, financial reporting, and auditing considerations are usually equally applica
ble when the health care activity is conducted as a function or program of a general-purpose
government and reported in an enterprise fund. See footnote 7 to the section heading “Specific
Guidance for Special-Purpose Governments” in Chapter 12 of the Audit and Accounting Guide State
and Local Governments. Reporting guidance on separate reporting by individual enterprise funds of
a government is provided in the Audit and Accounting Guide State and Local Governments.
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paragraphs 93 through 95, indefinitely extend the provisions of GASB State
ment No. 20, Accounting and Financial Reporting for Proprietary Funds and
Other Governmental Entities That Use Proprietary Fund Accounting (see foot
note 1 to paragraph 1.01 in this chapter). GASB Statement No. 20, as amended,
requires governmental health care entities that use enterprise fund accounting
and reporting to apply all GASB pronouncements as well as FASB pronounce
ments issued on or before November 30, 1989 that do not conflict with or
contradict GASB pronouncements. In addition, those entities may also apply
all FASB Statements and Interpretations issued after November 30, 1989,
except for those that conflict with or contradict GASB pronouncements. Only
those FASB Statements and Interpretations issued after November 30, 1989
that are developed for business enterprises should be applied, as discussed in
GASB Statement No. 29, The Use of Not-for-Profit Accounting and Financial
Reporting Principles by Governmental Entities, paragraph 7, as amended.
GASB Statement No. 34, paragraph 115, requires disclosure in the summary
of significant accounting policies of the policy for applying FASB pronounce
ments issued after November 30, 1989, to business-type activities and to
enterprise funds. The requirements in this Guide presume that governmental
health care entities apply paragraph 7 of GASB Statement No. 20.
Statement of Net Assets or Balance Sheet

1.17 GASB Statement No. 34, paragraphs 97 through 99, provide guid
ance on the statement of net assets or balance sheet. Governmental health care
entities that are special-purpose governments engaged only in business-type
activities may use either a balance sheet format—assets equal liabilities plus
net assets/equity—or a net assets format—assets less liabilities equal net
assets/equity. Assets and liabilities are required to be presented in a classified
format.5
1.18 Either term net assets or equity may be used to refer to the difference
between assets and liabilities. Regardless of the label, net assets/equity is
required to be reported in three broad components: (a) invested in capital
assets, net of related debt; (b) restricted, and (c) unrestricted. When permanent
endowments are reported in restricted net assets, two additional components—
expendable and nonexpendable are required, as discussed in paragraph 35 of
GASB Statement No. 34.
1.19 The term restricted is defined by GASB Statement No. 34, paragraphs
34 and 99. A restriction is a constraint placed on the use of assets or net assets that
is either externally imposed (such as by creditors through debt covenants) or
imposed by law through constitutional provisions or enabling legislation. Inter
nally designated net assets should be reported as unrestricted net assets and
should not be displayed separately in the net assets section of the statement of
net assets/balance sheet, as discussed in paragraph 37 of GASB Statement No.
34. (Designated assets, however, may be reported in the statement of net
assets/balance sheet, as discussed in paragraph 3.01 in this Guide.)
Statement of Revenues, Expenses, and Changes in
Net Assets/Equity

1.20 The operating statement of governmental health care entities that
are special-purpose governments engaged only in business-type activities is the
5
Guidance regarding the classification of certain specific assets or liabilities can be found in the
chapters of the Guide. For example, see paragraph 4.16 in this Guide regarding the reporting of
securities as current and noncurrent.
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statement of revenues, expenses, and changes in net assets/equity. Changes in
both restricted and unrestricted net assets should be reported in this state
ment using an all inclusive format, illustrated in GASB Statement No. 34,
paragraph 101:
Operating revenues (detailed)
Total operating revenues
Operating expenses (detailed)
Total operating expenses
Operating income (loss)
Nonoperating revenues and expenses (detailed)
Income before other revenues, expenses, gains, losses, and transfers
Capital contributions (grant, developer, and other), additions to permanent and
term endowments, special and extraordinary items (detailed) and transfers
Increase (decrease) in net assets
Net assets—beginning of period
Net assets—end of period

In a change in net assets approach, the increase or decrease in net assets for
the period and net income are not necessarily the same amount (for example,
because of capital contributions), as noted in GASB Statement No. 34, para
graph 433. However, GASB Statement No. 34, paragraph 434, indicates that
this required format does not preclude governments from presenting different
subtotals before the comprehensive performance measure—increase (decrease)
in net assets. (See paragraph 1.11 in this chapter regarding references in this
Guide to discussions in the nonauthoritative appendixes in GASB pronounce
ments.) The subtotals required by GASB Statement No. 34 must be presented.
1.21 As discussed in paragraph 100 and footnote 41 in GASB Statement
No. 34, governmental health care entities are required to report revenues (net
of discounts and allowances) by major source and separately identify revenues
that provide security for revenue bonds. (See further discussion in Chapter 10
of this Guide.) As illustrated in paragraph 1.20 of this Guide, separate subto
tals are required for operating revenues, operating expenses and operating
income (loss). Governmental health care entities are required by GASB State
ment No. 34, paragraph 102, to establish a policy that defines operating
revenues and expenses that is appropriate to the nature of the activity being
reported and to disclose that policy in the notes to the financial statements.
Factors that may be considered in establishing that policy are discussed in
Chapter 10 of this Guide.
1.22 Revenues from capital contributions as well as contributions to the
principal of permanent and term endowments should be reported after nonop
erating revenues and expenses, as discussed in GASB Statement No. 34,
paragraph 100. Income from permanent or term endowments should be re
corded as nonoperating revenue, as discussed in the GASB Q&A 2003 Edition,
item 7.334. (See paragraph 1.11 in this chapter regarding references in this
Guide to discussions in GASB staff implementation guides.)
1.23 Governmental health care entities that apply paragraph 7 of GASB
Statement No. 20 should be aware that FASB Statement No. 130, Reporting
Comprehensive Income, conflicts with the all-inclusive format required by GASB
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Statement No. 34, as discussed in the GASB Q&A 2003 Edition, item 7.315.
(See paragraph 1.11 in this chapter regarding references in this Guide to
discussions in GASB staff implementation guides.)
Statement of Cash Flows

1.24 GASB Statement No. 9, Reporting Cash Flows of Proprietary and
Nonexpendable Trust Funds and Governmental Entities, established stand
ards for cash flow reporting for governmental entities. GASB Statement No.
34, paragraph 105, requires governmental health care entities that are specialpurpose governments engaged only in business-type activities to present a
statement of cash flows using the direct method, discussed in GASB Statement
No. 9, paragraph 31, as amended. A reconciliation of operating income (loss) to
operating cash flows also should be presented.
Revenue From Health Care Services

1.25 In general, gross service revenue is recorded in the accounting
records on an accrual basis at the provider’s established rates, regardless of
whether the health care organization expects to collect that amount. Provisions
recognizing contractual adjustments and other adjustments (see examples in
paragraph 5.02) are recorded on an accrual basis and deducted from gross
service revenue to determine net service revenue. For financial reporting
purposes, gross revenue does not include charity care (see discussion in para
graph 10.03) and service revenue is reported net of contractual and other
adjustments in the statement of operations. Accounting and auditing issues
related to receivables and revenue from health care services are discussed in
Chapters 5 and 10.
1.26 In many cases, revenues are generated as a result of an agreement
to provide health care rather than from the actual provision of services. For
example, an integrated delivery system may agree to provide all health-related
services for a specified group residing within its primary service area for an
agreed-upon amount per member per month (PMPM). These revenues are
premium revenues, not patient service revenues, since they are earned by
agreeing to provide care, regardless of whether services actually are rendered.
Third-Party Payor Considerations

1.27 Some third-party payors retrospectively determine final amounts
reimbursable for services rendered to their beneficiaries based on allowable
costs. These payors reimburse the health care organization on the basis of
interim payment rates until the retrospective determination of allowable costs
can be made. In most instances, the accumulation and allocation of allowable
costs and other factors result in final settlements different from the interim
payment rates. Final settlements are determined after the close of the fiscal
periods to which they apply and may affect materially the health care organi
zation’s financial position and results of operations. Consequently, a reason
able estimate of the amount receivable from or payable to these payors should
be made in the same period that the related services are rendered. Accounting
and auditing issues related to receivables from third parties are discussed in
Chapter 5.

Classification and Reporting of Net Assets

1.28 Currently, many not-for-profit health care organizations use fund
accounting for purposes of internal recordkeeping and managerial control. Many
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individual funds may be established by an organization to help in monitoring
compliance with donor or grantor restrictions due to the fiduciary account
ability associated with these resources. Each fund consists of a self-balancing
group of accounts composed of assets, liabilities, and net assets. Consistent
with FASB Concepts Statement No. 6, Elements of Financial Statements,
FASB Statement No. 117 concluded that although some not-for-profit organi
zations may choose to classify assets and liabilities into fund groups, informa
tion about those groupings is not a necessary part of general-purpose external
financial reporting. Although FASB Statement No. 117 does not preclude
not-for-profit organizations from using fund accounting for internal record
keeping and reporting, for purposes of external financial reporting each of the
individual internal funds must be classified into one or more of the three broad
classes of net assets: unrestricted net assets, temporarily restricted net assets,
and permanently restricted net assets. These classifications are related to the
existence or absence of donor-imposed restrictions and are discussed in more
detail in paragraphs 1.29 through 1.33 and also Chapter 9.
1.29 Unrestricted Net Assets. These represent the part of net assets that
have not been externally restricted for identified purposes by donors and
grantors. Unrestricted net assets also include assets whose use is contractually
limited, such as—
• Proceeds of debt issues and funds of the health care organization
deposited with a trustee and limited to use in accordance with the
requirements of an indenture or a similar agreement. (See paragraph
7.18.)
• Other assets limited to use for identified purposes through an agree
ment between the health care organization and an outside party other
than a donor or grantor. Examples include assets set aside under debt
agreements, assets set aside under self-insurance (risk-retention)
funding arrangements, and assets set aside to meet statutory reserve
requirements (such as those required under state law for many health
maintenance organizations [HMOs]). (See paragraph 8.20.)
1.30 Information about significant contractual limits (for example, debt
covenants and self-insurance trusts) generally is disclosed in the notes to the
financial statements. Similarly, internally designated funds should be re
ported separately from externally designated funds either on the face of the
balance sheet or in the notes to the financial statements.
1.31 Temporarily Restricted and Permanently Restricted Net Assets.
FASB Statement No. 117 defines two classes of donor-restricted net assets:
temporarily restricted and permanently restricted. The distinction between
these two types of restricted net assets is based on the nature of the donor’s
restriction. Temporarily restricted net assets are those donor-restricted net
assets that can be used by the not-for-profit organization for their specified
purpose once the donor’s restriction is met. Generally, these restrictions are
met either by the passage of time or by actions taken by the entity, such as use
of the funds for the purpose intended. Permanently restricted net assets (for
example, endowment funds) are those with donor restrictions that do not
expire with the passage of time and cannot be removed by any actions taken
by the entity. All donor-restricted net assets must be classified into one of these
two broad categories for external reporting. Not-for-profit organizations may
want to further classify temporarily and permanently restricted net assets into
distinct groups that distinguish the nature or purpose of the donor’s restriction.
Accounting and reporting considerations pertaining to gifts and grants that are
externally restricted for identified purposes by donors and grantors are dis
cussed in paragraphs 9.04 through 9.06 and 10.08 through 10.14.
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1.32 It should be noted that donor restrictions generally relate to limita
tions on the use of net assets rather than the use of specific assets. According
to FASB Concepts Statement No. 6, paragraphs 101 and 102:
Restrictions impose responsibilities on management to ensure that the organi
zation uses donated resources in the manner stipulated by resource providers.
Sometimes donor-imposed restrictions limit an organization’s ability to sell or
exchange the particular asset received. For example, a donor may give a
painting to a museum stipulating that it must be publicly displayed, properly
maintained, and never sold.
More commonly, donors’ stipulations permit the organization to pool the
donated assets with other assets and to sell or exchange the donated assets for
other suitable assets as long as the economic benefits of the donated assets are
not consumed or used for a purpose that does not comply with the stipulation.
For example, a donor may contribute 100 shares of Security A to an organiza
tion’s endowment, thereby requiring that the amount of the gift be retained
permanently but not requiring that the specified shares be held indefinitely.
Thus, permanently restricted net assets and temporarily restricted net assets
generally refer to amounts of net assets that are restricted by donor-imposed
limits, not to specific assets.

1.33 A not-for-profit organization can report separate line items within
any of the three classes of net assets either on the face of the balance sheet or
in the notes to the financial statements to further distinguish the nature of
donor restrictions within that category of net assets. For example, a health care
organization may want to disclose the amount of temporarily restricted net
assets restricted for a specific purpose such as indigent care. Further examples
are provided in paragraph 15 of FASB Statement No. 117. An organization’s
internal fund accounting can be used to account for these different types of
resources within a specific class of net assets.
Health Care Contracting

1.34 Contracts between a health care provider and a payor based on
anything other than full charges requires the provider to accept some financial
risk. The nature and degree of risk for the provider varies depending on the
contract terms (for example, the definition of the unit of service or the basis for
payment). In planning the audit of the health care provider, the auditor
considers the audit risk associated with the entity’s health care contracts. For
example, contracts with payments for services based on a discount from the
provider’s established rates may have different risks than contracts with
payments for services based on a capitated arrangement.
1.35 Generally, capitation payments are made at the beginning of each
month and obligate the provider to render covered services during the month.
Revenue is earned as a result of agreeing to provide services to qualified
beneficiaries and not as a result of actually providing the care. If the provider’s
accounting system records patient charges and establishes patient receivables
as services are rendered, appropriate valuation allowances or adjustments
should be recorded so only the amount of contract revenue is recorded.
1.36 A capitation contract may obligate the provider to assume the risk of
physician referrals and other outside services. In this case, a liability for
unpaid claims, including incurred but not reported claims, should be estab
lished. A lag analysis may be helpful in estimating the liability.
1.37 In addition to the capitation payments, the amount of contract
revenue may be affected by factors such as reinsurance recoveries, deductibles,
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coinsurance, and risk pool adjustments. Risk pool adjustments may be based
on factors such as utilization or cost targets.
1.38 Sometimes health care providers enter preferred provider arrange
ments with self-insured employers whereby the provider guarantees that the
employer’s health care cost will not increase over a specified amount or
percentage. In substance, these providers may have provided aggregate stoploss insurance to the self-insured employer, and a material liability to the
provider may exist. FASB Statement No. 5, Accounting for Contingencies,
provides guidance on accounting for these contingencies. GASB Statement No.
10, Accounting and Financial Reporting for Risk Financing and Related Insurance
Issues, provides guidance on accounting for contingencies by governmental
enterprises.
GAAP Hierarchy for Not-for-Profit Organizations

1.39 SAS No. 69 states that the guidance provided by FASB Statements
and Interpretations, Opinions of the APB, and ARBs shall be considered
established accounting principles pursuant to Rule 203 of the AICPA Code of
Professional Conduct. (Appendix G [paragraph 1.61] of this chapter discusses
SAS No. 69 and the hierarchy of sources of GAAP.)
1.40 Not-for-profit organizations should follow the guidance in effective
provisions of ARBs, APB Opinions, and FASB Statements and Interpretations
unless the specific pronouncement explicitly exempts not-for-profit organiza
tions or their subject matter precludes such applicability. (As noted in para
graphs 1.45 and 1.46, not-for-profit organizations should follow the guidance
in FASB Statements No. 116, Accounting for Contributions Received and
Contributions Made, No. 117, No. 124, Accounting for Certain Investments Held
by Not-for-Profit Organizations, and No. 136, Transfers of Assets to a Not-forProfit Organization or Charitable Trust That Raises or Holds Contributions for
Others, and this Guide in applying the guidance in pronouncements listed in
Appendixes C and D [paragraphs 1.57 and 1.58] of this chapter.)
1.41 The appendixes [paragraphs 1.55 through 1.61] of this chapter are
aids to the implementation of the guidance in this chapter.
1.42 Pronouncements issued by the FASB subsequent to this Guide’s
effective date apply to not-for-profit organizations unless those pronounce
ments explicitly exempt not-for-profit organizations or their subject matter
precludes such applicability.6
1.43 Not-for-profit organizations may follow and are not prohibited from
following the guidance in effective provisions of the APB Opinions and the
FASB Statements and Interpretations listed in Appendix A [paragraph 1.55]
of this chapter, which specifically exempt not-for-profit organizations from
their application, unless FASB Statements No. 116 or No. 117 or this Guide
provide different guidance. (However, the guidance included in the effective
provisions of pronouncements listed in Appendix A [paragraph 1.55] applies to
all for-profit entities owned, whether owned all or in part, by not-for-profit
entities.) The discussion in paragraphs 1.45 through 1.51 should be considered
6
The guidance in paragraphs 1.39 through 1.51 addresses only the pronouncements listed in
paragraph 1.40. However, not-for-profit organizations are also subject to other pronouncements
included in categories (b)—(d) of paragraph 5 of SAS No. 69 and should apply AICPA Audit and
Accounting Guides, Statements of Position (SOPs), and Practice Bulletins and FASB Technical
Bulletins and the consensus positions of the FASB Emerging Issues Task Force (EITF) that apply to
them. (Appendix G [paragraph 1.61] of this chapter discusses SAS No. 69 and the GAAP hierarchy.)
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in determining the hierarchy of such guidance and of guidance issued by the
AICPA.
1.44 Certain financial reporting guidance listed in Appendix B [para
graph 1.56] of this chapter, such as that concerning common stock and convertible
debt, generally does not apply to the kinds of not-for-profit entities covered by
this Guide, because such entities do not enter into the kinds of transactions
covered by that guidance. (However, the guidance included in the effective
provisions of pronouncements included in Appendix B [paragraph 1.56] applies
to all for-profit entities owned, whether owned all or in part, by not-for-profit
entities. Also, not-for-profit organizations should follow the effective provisions
of pronouncements in Appendix B [paragraph 1.56] if they enter into the kinds
of transactions covered by that guidance.)
1.45 Other pronouncements, which are listed in Appendix C [paragraph
1.57] of this chapter (ARB No. 51, Consolidated Financial Statements, and APB
Opinion No. 29, Accounting for Nonmonetary Transactions), do not exempt not-forprofit organizations from their scope, but the transactions they contemplate also
are covered by FASB Statement No. 116 and this Guide. FASB Statements No.
116, No. 117, No. 124, and No. 136 and this Guide provide guidance for applying
the pronouncements to circumstances unique to not-for-profit organizations and
not contemplated by the pronouncements and therefore should be followed to
apply the guidance in those pronouncements to not-for-profit organizations. (How
ever, the guidance included in the effective provisions of pronouncements included
in Appendix C [paragraph 1.57] should be followed by all for-profit entities owned,
whether owned all or in part, by not-for-profit entities.)
1.46 Some pronouncements (listed in Appendix D [paragraph 1.58] of this
chapter), which may include guidance concerning the recognition and measure
ment of assets, liabilities, revenues, expenses, gains and losses, and financial
statement display, state that their provisions apply only to entities operating
in certain industries. Such entities generally are business enterprises. An
example of such guidance is FASB Statement No. 63, Financial Reporting by
Broadcasters. However, some not-for-profit organizations conduct activities7 in
some of those industries and should apply the guidance in the pronouncements
concerning the recognition and measurement of assets, liabilities, revenues,
expenses, and gains and losses to the transactions unique to those industries.
However, such not-for-profit organizations should follow the financial state
ment display guidance in FASB Statement No. 117 and this Guide, even
though it may conflict with display that would result from applying the
guidance in the pronouncements listed in Appendix D [paragraph 1.58].
1.47 Financial reporting pronouncements that have not been superseded
and are not included in Appendixes A through D [paragraphs 1.55 through
1.58] of this chapter are listed in Appendix E [paragraph 1.59] of this chapter.
Not-for-profit organizations should follow the effective provisions of the pro
nouncements listed in Appendix E [paragraph 1.59].8
1.48 Certain other pronouncements, although they do not exempt notfor-profit organizations and do cover transactions conducted by not-for-profit
organizations, include some provisions whose application by not-for-profit
organizations may be unclear. Nevertheless, not-for-profit organizations are
required to follow the effective provisions of those pronouncements. These
provisions and their applicability are discussed below.
7 Such activities may be conducted by (a) for-profit entities owned and consolidated by not-for-profit
organizations, (b) divisions of not-for-profit organizations, or (c) entire not-for-profit organizations.
8 See footnote 6.
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APB Opinion No. 16, Business Combinations*

1.49 Because the conditions for applying the pooling of interests method of
accounting for a business combination generally include an exchange of common
stock of the combining entities, not-for-profit organizations generally would not
meet the conditions for applying that method. The AICPA Accounting Standards
Executive Committee (AcSEC) believes that circumstances exist under which
reporting on the combination of two or more not-for-profit organizations (or that of
a not-for-profit organization with a formerly for-profit entity) by the pooling of
interests method better reflects the substance of the transaction than reporting by
the purchase method. Therefore, not-for-profit organizations are, under certain
circumstances, permitted to report by the pooling of interests method, even though
they generally do not issue common stock. Such circumstances include the combi
nation of two or more entities to form a new entity without the exchange of
consideration. See paragraph 11.38 for further guidance.
1.50 An example of acceptable practice, in some circumstances, for report
ing business combinations by not-for-profit organizations if there has been no
exchange of consideration is to report the (a) assets, (b) liabilities, and (c) net
asset balances of the combined entities as of the beginning of the year and
disclose the information that would be required to be disclosed for a pooling of
interests under APB Opinion No. 16.
Provisions of Certain Pronouncements Concerning Financial
Statement Display

1.51 The following pronouncements include provisions specifying the fi
nancial statement display of certain financial statement elements or items
such as gains and losses, extraordinary items, translation adjustments, income
tax expense, and prepaid or deferred income taxes:
• APB Opinion No. 9, Reporting the Results of Operations
• APB Opinion No. 26, Early Extinguishment of Debt, as amended by
APB Opinion No. 30, Reporting the Results of Operations—Reporting
the Effects of Disposal of a Segment of a Business, and Extraordinary,
Unusual and Infrequently Occurring Events and Transactions; FASB
In June 2001, the FASB issued FASB Statement No. 141, Business Combinations, which
supersedes several pronouncements including APB Opinion No. 16, Business Combinations.
However, FASB Statement No. 141 does not apply to certain combinations, including a combination
involving two or more not-for-profit organizations or the acquisition of a for-profit business entity by
a not-for-profit organization. For those combinations, the guidance in APB Opinion No. 16 still
applies. Thus, GAAP does not change for those types of combinations. Not-for-profit health care
organizations should continue to follow the guidance in this Guide and in APB Opinion No. 16, as
amended by pronouncements prior to the issuance of FASB Statement No. 141. Pronouncements that
were amended by FASB Statement No. 141 should be applied by those entities as though that
Statement had not amended them. In addition, in applying the guidance included in APB Opinion No.
16, not-for-profit health care organizations should continue to apply the amendments to that Opinion
that were included in FASB Statement No. 121, Accounting for the Impairment of Long-Lived Assets
and for Long-Lived Assets to Be Disposed Of, even though FASB Statement No. 121 was superseded
by FASB Statement No. 144, Accounting for the Impairment or Disposal of Long-Lived Assets. (FASB
Statement No. 144 did not carry forward those amendments to APB Opinion No. 16 because APB
Opinion No. 16 had been superseded.) The FASB has on its agenda a project on accounting for
combinations of not-for-profit organizations, the scope of which also will include the acquisition of a
for-profit business entity by a not-for-profit organization. Readers should be alert to the issuance of a
final standard. Also, FASB Statement No. 142, Goodwill and Other Intangible Assets, is not
applicable to goodwill and other intangible assets arising from combinations between not-for-profit
organizations or arising from the acquisition of a for-profit business entity by a not-for-profit
organization until the FASB completes its deliberation with respect to application of the purchase
method by those entities.
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Statement No. 145, Rescission of FASB Statements No. 4, 44, and 64,
Amendment of FASB Statement No. 13, and Technical Corrections);
and FASB Statement No. 140, Accounting for Transfers and Servicing
of Financial Assets and Extinguishments of Liabilities
• APB Opinion No. 30, as amended by FASB Statement No. 128, Earn
ings per Share, FASB Statement No. 144, Accounting for the Impair
ment or Disposal of Long-Lived Assets, and FASB Statement No. 145
• FASB Statement No. 52, Foreign Currency Translation
• FASB Statement No. 109, Accounting for Income Taxes
None of the preceding pronouncements considers the net asset reporting model
included in FASB Statement No. 117 and this Guide. Therefore, preparers of
financial statements of not-for-profit organizations should consider the report
ing objectives of these APB Opinions and FASB Statements when exercising
judgment about how to best display elements, such as in which net asset class.
GAAP Hierarchy for Governmental Organizations

1.52 SAS No. 69 provides that, for state or local governmental entities,
officially established accounting principles consist of GASB Statements and
Interpretations as well as AICPA and FASB pronouncements specifically made
applicable to state and local governmental entities by GASB Statements or
Interpretations. (Appendix G [paragraph 1.61] of this chapter discusses SAS
No. 69 and the hierarchy of sources of GAAP for governmental entities.) GASB
Statements No. 20 and No. 29, The Use of Not-for-Profit Accounting and
Financial Reporting Principles by Governmental Entities, provide guidance on
the applicability of FASB and AICPA pronouncements to governmental health
care enterprises that use enterprise fund accounting and financial reporting.
Footnote 1 and paragraph 1.16 of this chapter discusses the guidance in GASB
Statement No. 20.
1.53 GASB Statement No. 29 provides that governmental enterprise
funds and activities reported using enterprise fund accounting and financial
reporting that apply the provisions of paragraph 7, as amended, of GASB
Statement No. 20 should apply only those “new” (issued after November 30,
1989) FASB Statements and Interpretations that are developed for business
enterprises, rather than those whose provisions are limited to not-for-profit
organizations or address issues primarily concerning such organizations (such
as FASB Statements No. 116, No. 117, No. 124, and No. 136). (See paragraph
1.16 of this chapter.)
1.54 Paragraph 33 in the “Basis for Conclusions” of GASB Statement No.
20 also provides that AICPA pronouncements issued after November 30, 1989
and not specifically made applicable to governmental entities should be applied
using the same logic used in the application of FASB standards. That is, AICPA
pronouncements that do not conflict with or contradict GASB pronouncements
should be applied on an “all or none” basis and constitute level “b” in the GAAP
hierarchy. (See Appendix G [paragraph 1.61] of this chapter.) Many of the
AICPA pronouncements issued after November 30, 1989 provide guidance on
specialized industries, including this Guide. However, users of this Guide
should note the provisions of SOP 94-6, Disclosure of Certain Significant Risks
and Uncertainties, discussed in paragraph 8.30 of this Guide.
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1.55
Appendix A— Financial Reporting Pronouncements
That Specifically Exempt Not-for-Profit Organizations
From Their Application

Note regarding effective dates of recently issued pronouncements that are
listed in this appendix, or that amend pronouncements listed in this appen
dix; the applicability of FASB Statement No. 141, Business Combinations,
FASB Statement No. 142, Goodwill and Other Intangible Assets, and FASB
Interpretation No. 46 (revised December 2003), Consolidation of Variable
Interest Entities; and outstanding FASB exposure drafts of proposed state
ments of financial accounting standards:
• FASB Statement No. 132 (revised 2003), Employers’ Disclosures about
Pensions and Other Postretirement Benefits, amends APB Opinion No.
28. FASB Statement No. 132 (revised 2003) is effective for fiscal years
ending after December 15,2003, with certain exceptions. Interim-period
disclosures are effective for interim periods beginning after December
15, 2003. The provisions of FASB Statement No. 132 remain in effect
until the provisions of FASB Statement No. 132 (revised 2003) are
adopted.
• FASB Statement No. 150, Accounting for Certain Financial Instruments
with Characteristics of both Liabilities and Equity, amends FASB
Statement No. 128. FASB Statement No. 150 is effective for financial
instruments entered into or modified after May 31, 2003 and otherwise
at the beginning of the first interim period beginning after June 15,2003,
except for mandatorily redeemable financial instruments of a nonpublic
entity. See FASB Staff Position (FSP) No. 150-3, Effective Date,
Disclosures, and Transition for Mandatorily Redeemable Financial
Instruments of Certain Nonpublic Entities and Certain Mandatorily
Redeemable Noncontrolling Interests under FASB Statement No. 150,
Accounting for Certain Financial Instruments with Characteristics of
both Liabilities and Equity, issued November 7, 2003, for additional
effective date information.
• FASB Interpretation No. 46 (revised December 2003). In 2003, the FASB
issued FASB Interpretation No. 46, Consolidation of Variable Interest
Entities, and FASB Interpretation No. 46 (revised December 2003),
which replaced FASB Interpretation No. 46, to address consolidation by
business enterprises of variable interest entities. Special effective date
provisions apply to enterprises that have fully or partially applied FASB
Interpretation No. 46 prior to the issuance of the revised Interpretation.
Otherwise, application of FASB Interpretation No. 46 (revised December
2003) or FASB Interpretation No. 46 is required in financial statements
of public entities that have interests in variable interest entities or
potential variable interest entities commonly referred to as specialpurpose entities for periods ending after December 15,2003. Application
by public entities, other than small business issuers, for all other types
of entities is required in financial statements for periods ending after
March 15, 2004. Application by small business issuers to entities other
(continued)
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than special-purpose entities and by nonpublic entities to all types of
entities is required at various dates in 2004 and 2005. In some instances,
enterprises have the option of applying or continuing to apply FASB
Interpretation No. 46 for a short period of time before applying the revised
Interpretation. Not-for-profit organizations are not subject to FASB
Interpretation No. 46 (revised December 2003), except that they may be
related parties for purposes of applying paragraphs 16 and 17 of that
Interpretation. Also, if a not-for-profit entity is used by business enter
prises in a manner similar to a variable interest entity in an effort to
circumvent the provisions of FASB Interpretation No. 46 (revised De
cember 2003), that not-for-profit entity is subject to that Interpretation.
• FASB Statement No. 141, among other matters, amends APB Opinion
No. 28 and FASB Statement No. 128. FASB Statement No. 141 applies
to business combinations initiated after June 30, 2001 and prescribes
the use of the purchase method for those business combinations. FASB
Statement No. 141, however, does not apply to certain combinations,
including a combination involving two or more not-for-profit organiza
tions, or the acquisition of a for-profit business entity by a not-for-profit
organization. For those combinations, pronouncements that are amended
by FASB Statement No. 141 should be applied as though FASB State
ment No. 141 had not amended them, and this appendix does not reflect
those amendments.
• The provisions of FASB Statement No. 142 shall be applied in fiscal years
beginning after December 15, 2001, to all goodwill and other intangible
assets recognized in an entity’s statement of financial position at the
beginning of that fiscal year. Early application is permitted in certain
circumstances. Certain provisions of FASB Statement No. 142 shall be
applied to goodwill and other acquired intangible assets for which the
acquisition date is after June 30, 2001, even if an entity has not adopted
FASB Statement No. 142 in its entirety. The provisions of FASB
Statement No. 141 and FASB Statement No. 142 should not be applied
to goodwill and intangible assets arising from a combination between
two or more not-for-profit organizations or acquired in the acquisition of
a for-profit business entity by a not-for-profit organization until the
FASB completes its project on those types of combinations and
acquisitions. Thus, the guidance in APB Opinions No. 16 and No. 17
remains in effect for such assets. In addition, when applying APB
Opinions No. 16 and No. 17, not-for-profit organizations should continue
to apply the amendments to those Opinions found in other literature
even though that other literature may have been superseded by FASB
Statements No. 141, No. 142, and No. 144. For example, when applying
APB Opinion No. 17, not-for-profit organizations should continue to
apply the amendments to that Opinion found in FASB Statement No.
121, even though that Statement was superseded by FASB Statement
No. 144. Readers should be alert to the issuance of a final Standard on
combinations of not-for-profit organizations.
• FASB exposure drafts. The FASB has released exposure drafts of pro
posed statements of financial accounting standards that would amend
or replace certain pronouncements that are listed in this appendix.
Readers should be alert to the issuance of final Standards.
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Pronouncement______
APB Opinion No. 18, The
Equity Method of Accounting
for Investments in Common
Stock, as amended by APB
Opinions No. 23 and No. 30
and FASB Statements No.
13, No. 58, No. 94, No. 115,
No. 128, No. 142, and No.
144, and including FASB
Interpretation No. 35
APB Opinion No. 28, Interim
Financial Reporting, as
amended by FASB
Statements No. 3, No. 95,
No. 109, No. 128, No. 130,
No. 131, No. 132 (revised
2003), No. 135, No. 144,
No. 145, and No. 148 and
including FASB
Interpretation No. 18
FASB Statement No. 3,
Reporting Accounting
Changes in Interim Financial
Statements, as amended by
FASB Statement No. 135
FASB Statement No. 89,
Financial Reporting and
Changing Prices, as
amended by FASB
Statements No. 109,
No. 135, and No. 139
FASB Statement No. 115,
Accounting for Certain
Investments in Debt and
Equity Securities, as
amended by FASB State
ments No. 124, No. 130, No.
133, No. 134, No. 135, No.
140, No. 144, and No. 145
FASB Statement No. 128,
Earnings per Share, as
amended by FASB
Statements No. 135, No.
145, and No. 150
FASB Statement No. 130,
Reporting Comprehensive
Income, as amended by
FASB Statement No. 135
FASB Statement No. 131,
Disclosures about Segments
of an Enterprise and Related
Information
FASB Statement No. 141,
Business Combinations,
as amended by FASB
Statements No. 144, No.
145, and No. 147

Other References, if Any *
This Guide

Status of Other References
Chapter 11 of this Guide
provides guidance concerning
the equity method of
accounting for investments
in common stock

None

None

None

None

None

None

FASB Statement No. 124,
Accounting for Certain
Investments Held by
Not-for-Profit
Organizations;
Chapter 4 of this Guide

Currently effective

None

None

FASB Statement No. 117

Currently effective

None

None

Chapter 1 and Chapter 11
of this Guide

Currently effective

(continued)
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Pronouncement______
FASB Interpretation
No. 18, Accounting for
Income Taxes in Interim
Periods, as amended by
FASB Statements No. 71,
No. 109, No. 111, No. 135,
and No. 144
FASB Interpretation
No. 35, Criteria for Applying
the Equity Method of
Accounting for Investments
in Common Stock
FASB Interpretation No. 46
(revised December 2003),
Consolidation of Variable
Interest Entities

Other References, if Any *
None

Status of Other References
None

See APB Opinion No. 18

See APB Opinion No. 18

None

None

References in this column are provided as a guide to other sources of information about the
topic covered by the listed pronouncement.
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1.56
Appendix B— Financial Reporting Pronouncements
That, by the Nature of Their Subject Matter, Generally
Do Not Apply to Not-for-Profit Organizations•

Note regarding effective dates of recently issued pronouncements that are
listed in this appendix, or that amend pronouncements listed in this appen
dix; the applicability of FASB Statement No. 141, Business Combinations;
and outstanding FASB exposure drafts of proposed statements of financial
accounting standards:
• FASB Statement No. 150, Accounting for Certain Financial Instruments
with Characteristics of both Liabilities and Equity, is effective for
financial instruments entered into or modified after May 31, 2003 and
otherwise at the beginning of the first interim period beginning after
June 15, 2003 except for mandatorily redeemable financial instruments
of a nonpublic entity. See FSP No. 150-3, Effective Date, Disclosures, and
Transition for Mandatorily Redeemable Financial Instruments of
Certain Nonpublic Entities and Certain Mandatorily Redeemable
Noncontrolling Interests under FASB Statement No. 150, Accounting for
Certain Financial Instruments with Characteristics of both Liabilities
and Equity, issued November 7, 2003, for additional effective date
information.
• FASB Statement No. 141, an amendment of FASB Statement No. 123,
applies to business combinations initiated after June 30, 2001, and
prescribes the use of the purchase method for those combinations. FASB
Statement No. 141, however, does not apply to certain combinations,
including a combination involving two or more not-for-profit organiza
tions, or the acquisition of a for-profit business entity by a not-for-profit
organization.
• FASB exposure drafts. The FASB has released exposure drafts of pro
posed statements of financial accounting standards that would amend
or supersede pronouncements that are listed in this appendix. Readers
should be alert to the issuance of final standards.
• APB Opinion No. 14, Accounting for Convertible Debt and Debt Issued
with Stock Purchase Warrants
• APB Opinion No. 25, Accounting for Stock Issued to Employees, as
amended by FASB Statements No. 109 and No. 123, and including
FASB Interpretations No. 28, No. 38, and No. 44
• FASB Statement No. 84, Induced Conversions of Convertible Debt
• FASB Statement No. 123, Accounting for Stock-Based Compensation,
as amended by FASB Statements No. 128, No. 135, No. 141, No. 144,
and No. 148
• FASB Statement No. 148, Accounting for Stock-Based Compensation—
Transition and Disclosure
• FASB Statement No. 150, Accounting for Certain Financial Instru
ments with Characteristics of both Liabilities and Equity
AAG-HCO 1.56
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• FASB Interpretation No. 28, Accounting for Stock Appreciation Rights
and Other Variable Stock Option or Award Plans, as amended by
FASB Statements No. 123 and No. 128
• FASB Interpretation No. 38, Determining the Measurement Date for
Stock Option, Purchase, and Award Plans Involving Junior Stock, as
amended by FASB Statements No. 123 and No. 128
• FASB Interpretation No. 44, Accounting for Certain Transactions
involving Stock Compensation, as amended by FASB Statement No.
141
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1.57
Appendix C— Financial Reporting Pronouncements
Whose Application to Not-for-Profit Organizations Is
Subject to Additional FASB or AICPA Guidance

Note regarding the applicability of FASB Statement No. 141, Business
Combinations and FASB Interpretation No. 46 (revised December 2003),
Consolidation of Variable Interest Entities; and outstanding FASB exposure
drafts of proposed statements of financial accounting standards:
• FASB Statement No. 141, among other matters, amends APB Opinion
No. 29. FASB Statement No. 141 applies to business combinations
initiated after June 30, 2001 and prescribes the use of the purchase
method for those business combinations. FASB Statement No. 141,
however, does not apply to certain combinations, including a combi
nation involving two or more not-for-profit organizations, or the
acquisition of a for-profit business entity by a not-for-profit organization.
For those combinations, pronouncements that are amended by FASB
Statement No. 141 should be applied as though FASB Statement No.
141 had not amended them, and this appendix does not reflect those
amendments.
• FASB Interpretation No. 46 (revised December 2003), an interpretation
of ARB No. 51, Consolidated Financial Statements, exempts not-forprofit organizations from its scope, except that they may be related
parties for purposes of applying paragraphs 16 and 17 of that Interpre
tation. Also, if a not-for-profit entity is used by business enterprises in a
manner similar to a variable interest entity in an effort to circumvent
the provisions of FASB Interpretation No. 46 (revised December 2003),
that not-for-profit entity is subject to that Interpretation. For informa
tion about FASB Interpretation No. 46, Consolidation of Variable
Interest Entities, which was replaced by FASB Interpretation No. 46
(revised 2003) and information about the effective date of FASB
Interpretation No. 46 (revised December 2003), see paragraph 1.55 in
this chapter.
• FASB exposure drafts. The FASB has released exposure drafts of pro
posed statements of financial accounting standards that would amend
or supersede certain pronouncements that are listed in this appendix.
Readers should be alert to the issuance of final Standards.
_________ Pronouncement_________ ______Additional Guidance
ARB No. 51, Consolidated Financial This Guide
Statements, as amended by APB Opin
ions No. 10, No. 16, No. 18, and No. 23,
and FASB Statements No. 58, No. 71,
No. 94, No. 111, No. 131, and No. 144
APB Opinion No. 29, Accounting for FASB Statement No. 116 and Chap
Nonmonetary Transactions, as ters 5 and 10 of this Guide provide
amended by FASB Statements No. 71, accounting guidance for contribu
No. 109, No. 123, and No. 144 and tions
including FASB Interpretation No. 30
(continued)
AAG-HCO 1.57

22

Health Care Organizations

Additional Guidance
Pronouncement
FASB Statement No. 94, Consolida See ARB No. 51
tion of All Majority-Owned Subsidiar
ies, as amended by FASB Statement
No. 131
FASB Statement No. 116, Accounting FASB Statement No. 136, this Guide
for Contributions Received and Con and the AICPA Audit and Accounting
tributions Made
Guide Not-for-Profit Organizations
FASB Statement No. 117, Financial This Guide
Statements of Not-for-Profit Organiza
tions, as amended by FASB Statements
No. 124, and No. 144
FASB Statement No. 124, Accounting This Guide
for Certain Investments Held by Notfor-Profit Organizations, as amended
by FASB Statement No. 133, Account
ing for Derivative Instruments and
Hedging Activities, as amended by
FASB Statement No. 138, Accounting
for Certain Derivative Instruments
and Certain Hedging Activities
FASB Statement No. 136, Transfers of This Guide and the AICPA Audit and
Assets to a Not-for-Profit Organization Accounting Guide Not-for-Profit Or
or Charitable Trust That Raises or ganizations
Holds Contributions for Others, as
amended by FASB Statement No. 140
FASB Interpretation No. 30, Accounting See APB Opinion 29
for Involuntary Conversions of Non
monetary Assets to Monetary Assets, as
amended by FASB Statement No. 109
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1.58
Appendix D— Financial Reporting Pronouncements
Pertaining to Specialized Industry Practices of
Business Enterprises

Note regarding effective dates of recently issued pronouncements that are
listed in this appendix, or that amend pronouncements listed in this appen
dix; the applicability of FASB Statement No. 141, Business Combinations,
and FASB Statement No. 142, Goodwill and Other Intangible Assets; and
outstanding FASB exposure drafts of proposed statements of financial ac
counting standards:
• FASB Statement No. 149, Amendment of Statement 133 on Derivative
Instruments and Hedging Activities, amends FASB Statements No. 35,
No. 60, No. 65, and No. 91. FASB Statement No. 149 is effective for
contracts entered into or modified after June 30, 2003, with certain
exceptions, and for hedging relationships designated after June 30,2003,
with certain exceptions.
• FASB Statement No. 141, among other matters, amends FASB State
ments No. 44, No. 45, and No. 72 and FASB Interpretation No. 9. FASB
Statement No. 141 applies to business combinations initiated after June
30, 2001 and prescribes the use of the purchase method for those
business combinations. FASB Statement No. 141, however, does not
apply to certain combinations, including a combination involving two or
more not-for-profit organizations, or the acquisition of a for-profit bus
iness entity by a not-for-profit organization. For those combinations,
pronouncements that are amended by FASB Statement No. 141 should
be applied as though FASB Statement No. 141 had not amended them,
and this appendix does not reflect those amendments.
• The provisions of FASB Statement No. 142 shall be applied in fiscal years
beginning after December 15, 2001, to all goodwill and other intangible
assets recognized in an entity’s statement of financial position at the
beginning of that fiscal year. Early application is permitted in certain
circumstances. Certain provisions of FASB Statement No. 142 shall be
applied to goodwill and other acquired intangible assets for which the
acquisition date is after June 30, 2001, even if an entity has not adopted
FASB Statement No. 142 in its entirety. The provisions of FASB
Statement No. 141 and FASB Statement No. 142 should not be applied
to goodwill and intangible assets arising from a combination between
two or more not-for-profit organizations or acquired in the acquisition of
a for-profit business entity by a not-for-profit organization until the
FASB completes its project on those types of combinations and
acquisitions. Thus, the guidance in APB Opinions No. 16 and No. 17
remains in effect for such assets. In addition, when applying APB
Opinions No. 16 and No. 17, not-for-profit organizations should continue
to apply the amendments to those Opinions found in other literature
even though that other literature may have been superseded by FASB
Statements No. 141, No. 142, and No. 144. For example, when applying
APB Opinion No. 17, not-for-profit organizations should continue to
apply the amendments to that Opinion found in FASB Statement No. 121,
(continued)
AAG-HCO 1.58

Health Care Organizations

24

even though that Statement was superseded by FASB Statement No. 144.
Readers should be alert to the issuance of a final Standard on combina
tions of not-for-profit organizations.
• FASB exposure drafts. The FASB has released exposure drafts of pro
posed statements of financial accounting standards that would amend or
supersede certain pronouncements that are listed in this appendix.
Readers should be alert to the issuance of final Standards.
This appendix includes pronouncements that apply only to entities operating
in certain industries, generally business enterprises. However, some not-forprofit organizations conduct activities in some of those industries and should
apply the guidance concerning recognition and measurement of assets, liabili
ties, revenues, expenses, and gains and losses in those pronouncements to the
transactions unique to those industries. In addition, those not-for-profit organi
zations should follow the financial statement display guidance in FASB State
ment No. 117, Financial Statements of Not-for-Profit Organizations, and this
Guide, although it may conflict with display that would result from applying
the guidance in the pronouncements included in this appendix.
• APB Opinion No. 12, Omnibus Opinion—1967 (guidance under the
heading “Capital Changes”)
• APB Opinion No. 13, Amending Paragraph 6 of APB Opinion No. 9,
Application to Commercial Banks
• FASB Statement No. 7, Accounting and Reporting by Development
Stage Enterprises, as amended by FASB Statements No. 71 and No.
95, and including FASB Interpretation No. 7
• FASB Statement No. 19, Financial Accounting and Reporting by Oil
and Gas Producing Companies, as amended by FASB Statements No.
25, No. 69, No. 71, No. 109, No. 143, No. 144, and No. 145, and including
FASB Interpretations No. 33 and No. 36
• FASB Statement No. 25, Suspension of Certain Accounting Require
ments for Oil and Gas Producing Companies (an amendment of FASB
Statement No. 19), as amended by FASB Statement No. 111
• FASB Statement No. 35, Accounting and Reporting by Defined Benefit
Pension Plans, as amended by FASB Statements No. 75, No. 110, No.
135, and No. 149
• FASB Statement No. 45, Accounting for Franchise Fee Revenue
• FASB Statement No. 50, Financial Reporting in the Record and Music
Industry
• FASB Statement No. 51, Financial Reporting by Cable Television
Companies, as amended by FASB Statements No. 71, No. 131, No. 142,
and No. 144
• FASB Statement No. 60, Accounting and Reporting by Insurance
Enterprises, as amended by FASB Statements No. 91, No. 97, No. 109,
No. 113, No. 114, No. 115, No. 120, No. 124, No. 133, No. 135, No. 144,
No. 145, and No. 149, and including FASB Interpretation No. 40
• FASB Statement No. 61, Accounting for Title Plant, as amended by
FASB Statement No. 144
• FASB Statement No. 63, Financial Reporting by Broadcasters, as
amended by FASB Statement No. 139
• FASB Statement No. 65, Accounting for Certain Mortgage Banking
Activities, as amended by FASB Statements No. 91, No. 115, No. 124,
No. 133, No. 134, No. 140, and No. 149
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• FASB Statement No. 67, Accounting for Costs and Initial Rental
Operations of Real Estate Projects, as amended by FASB Statements
No. 111 and No. 144
• FASB Statement No. 69, Disclosures about Oil and Gas Producing
Activities (an amendment of FASB Statements 19, 25, 33, and 39), as
amended by FASB Statements No. 89, No. 95, No. 109, and No. 131
• FASB Statement No. 71, Accounting for the Effects of Certain Types of
Regulation, as amended by FASB Statements No. 90, No. 92, No. 109,
No. 135, No. 142, and No. 144
• FASB Statement No. 72, Accounting for Certain Acquisitions of Bank
ing or Thrift Institutions (an amendment of APB Opinion No. 17, an
interpretation of APB Opinions 16 and 17, and an amendment ofFASB
Interpretation No. 9), as amended by FASB Statements No. 142 and
No. 147
• FASB Statement No. 73, Reporting a Change in Accounting for Rail
road Track Structures (an amendment of APB Opinion No. 20)
• FASB Statement No. 90, Regulated Enterprises—Accounting for
Abandonments and Disallowances of Plant Costs (an amendment of
FASB Statement No. 71), as amended by FASB Statements No. 92 and
No. 109
• FASB StatementNo. 91,Accounting for Nonrefundable Fees and Costs
Associated with Originating or Acquiring Loans and Initial Direct
Costs of Leases (an amendment of FASB Statements No. 13, 60, and
65 and a rescission of FASB Statement No. 17), as amended by FASB
Statements No. 98, No. 114, No. 115, No. 124, and No. 149
• FASB Statement No. 92, Regulated Enterprises—Accounting for
Phase-in Plans (an amendment of FASB Statement No. 71)
• FASB Statement No. 97, Accounting and Reporting by Insurance
Enterprises for Certain Long-Duration Contracts and for Realized
Gains and Losses from the Sale of Investments, as amended by FASB
Statements No. 113, No. 115, and No. 120
• FASB Statement No. 101, Regulated Enterprises—Accounting for the
Discontinuation ofApplication of FASB Statement No. 71, as amended
by FASB Statements No. 109 and No. 144
• FASB Statement No. 110, Reporting by Defined Benefit Pension Plans
of Investment Contracts (an amendment of FASB Statement No. 35)
• FASB Statement No. 113, Accounting and Reporting for Reinsurance
of Short-Duration and Long-Duration Contracts, as amended by FASB
Statements No. 120 and No. 133, and including FASB Interpretation
No. 40
• FASB Statement No. 120, Accounting and Reporting by Mutual Life
Insurance Enterprises and by Insurance Enterprises for Certain LongDuration Participating Contracts (an amendment of FASB Statement
Nos. 60, 97, and 113 and Interpretation No. 40)
• FASB Statement No. 134, Accounting for Mortgage-Backed Securities
Retained after the Securitization of Mortgage Loans Held for Sale by a
Mortgage Banking Enterprise (an amendment of FASB Statement No.
65)
• FASB Statement No. 139, Rescission of FASB Statement No. 53 and
amendments to FASB Statements No. 63, 89, and 121
• FASB Statement No. 147, Acquisitions of Certain Financial Institutions
• FASB Interpretation No. 7, Applying FASB Statement No. 7 in Finan
cial Statements of Established Operating Enterprises
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• FASB Interpretation No. 9, Applying APB Opinions No. 16 and 17
When a Savings and Loan Association or a Similar Institution Is
Acquired in a Business Combination Accounted for by the Purchase
Method, as amended by FASB Statements No. 72, No. 142, and No. 147
• FASB Interpretation No. 33, Applying FASB Statement No. 34 to Oil
and Gas Producing Operations Accounted for by the Full Cost Method
• FASB Interpretation No. 36, Accounting for Exploratory Wells in
Progress at the End of a Period
• FASB Interpretation No. 40, Applicability of Generally Accepted Ac
counting Principles to Mutual Life Insurance and Other Enterprises,
as amended by FASB Statements No. 115, No. 120, and No. 135
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1.59
Appendix E— Financial Reporting Pronouncements
Not Subsequently Superseded and Not Included
in Appendixes A through D of This Chapter

Note regarding effective dates of recently issued pronouncements that are
listed in this appendix, or that amend pronouncements listed in this appen
dix; the applicability of FASB Statement No. 141, Business Combinations,
and FASB Statement No. 142, Goodwill and Other Intangible Assets; and
outstanding FASB exposure drafts of proposed statements of financial ac
counting standards:
• FASB Statement No. 149, Amendment of Statement 133 on Derivative
Instruments and Hedging Activities, amends FASB Statements No. 15,
No. 87, No. 95, No. 106, and No. 126. FASB Statement No. 149 is effective
for contracts entered into or modified after June 30, 2003, with certain
exceptions, and for hedging relationships designated after June 30,2003,
with certain exceptions.
• FASB Statement No. 150, Accounting for Certain Financial Instruments
with Characteristics of both Liabilities and Equity, amends FASB State
ment No. 133. FASB Statement No. 150 is effective for financial
instruments entered into or modified after May 31, 2003 and otherwise
at the beginning of the first interim period beginning after June 15,2003
except for mandatorily redeemable financial instruments of a nonpublic
entity. See FSP No. 150-3, Effective Date, Disclosures, and Transition for
Mandatorily Redeemable Financial Instruments of Certain Nonpublic
Entities and Certain Mandatorily Redeemable Noncontrolling Interests
under FASB Statement No. 150, Accounting for Certain Financial
Instruments with Characteristics of both Liabilities and Equity, issued
November 7, 2003, for additional effective date information.
• FASB Statement No. 132 (revised 2003), Employers’Disclosures about
Pensions and Other Postretirement Benefits, supersedes FASB State
ment No. 132 and carries forward the amendments made by FASB
Statement No. 132 to FASB Statements No. 87, No. 88, and No. 106, with
minor changes. FASB Statement No. 132 (revised 2003) is effective for
fiscal years ending after December 15, 2003, with certain exceptions.
Interim-period disclosures are effective for interim periods beginning
after December 15, 2003. The provisions of FASB Statement No. 132
remain in effect until the provisions of FASB Statement No. 132 (revised
2003) are adopted.
• FASB Statement No. 141, among other matters, supersedes APB
Opinion No. 16 and FASB Statements No. 10, No. 38, and No. 79; and
amends APB Opinions No. 20 and No. 30, FASB Statements No. 15, No.
16, No. 68, No. 87, No. 95, No. 106, No. 109, and No. 133 and FASB
Interpretations No. 4 and No. 21. (The amendment of FASB Statement
No. 68 was subsequently deleted by the technical corrections in FASB
Statement No. 145). FASB Statement No. 141 applies to business
combinations initiated after June 30, 2001 and prescribes the use of
the purchase method for those business combinations. FASB Statement
No. 141, however, does not apply to certain combinations, including a
combination involving two or more not-for-profit organizations, or the
(continued)
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acquisition of a for-profit business entity by a not-for-profit organization.
For those combinations, pronouncements that are superseded or amend
ed by FASB Statement No. 141 should be applied as though FASB
Statement No. 141 had not superseded or amended them, and this
appendix does not reflect those amendments or supersessions.
• The provisions of FASB Statement No. 142 shall be applied in fiscal years
beginning after December 15, 2001, to all goodwill and other intangible
assets recognized in an entity’s statement of financial position at the
beginning of that fiscal year. Early application is permitted in certain
circumstances. Certain provisions of FASB Statement No. 142 shall be
applied to goodwill and other acquired intangible assets for which the
acquisition date is after June 30, 2001, even if an entity has not adopted
FASB Statement No. 142 in its entirety. The provisions of FASB
Statement No. 141 and FASB Statement No. 142 should not be applied
to goodwill and intangible assets arising from a combination between
two or more not-for-profit organizations or acquired in the acquisition of
a for-profit business entity by a not-for-profit organization until the FASB
completes its project on those types of combinations and acquisitions.
Thus, the guidance in APB Opinions No. 16 and No. 17 remains in effect
for such assets. In addition, when applying APB Opinions No. 16 and
No. 17, not-for-profit organizations should continue to apply the
amendments to those Opinions found in other literature even though
that other literature may have been superseded by FASB Statements
No. 141, No. 142, and No. 144. For example, when applying APB Opinion
No. 17, not-for-profit organizations should continue to apply the
amendments to that Opinion found in FASB Statement No. 121 even
though that Statement was superseded by FASB Statement No. 144.
Readers should be alert to the issuance of a final Standard on
combinations of not-for-profit organizations.
• FASB exposure drafts. The FASB has released exposure drafts of pro
posed statements of financial accounting standards that would amend
or replace certain pronouncements that are listed in this appendix.
Readers should be alert to the issuance of final Standards.
As stated in paragraph 1.40 of this Guide, not-for-profit organizations should
follow the guidance in effective provisions of ARBs, APB Opinions, and FASB
Statements and Interpretations, except for specific pronouncements that ex
plicitly exempt not-for-profit organizations and pronouncements for which this
Guide provides guidance. This appendix includes pronouncements, not sub
sequently superseded, that (a) do not exempt not-for-profit organizations from
their application, (b) by the nature of their subject matter, apply to the kinds
of transactions not-for-profit organizations engage in, (c) are subject to no
additional FASB or AICPA guidance, and (d) do not pertain to specialized
industry practices of business enterprises. Not-for-profit organizations should
follow the guidance in the effective provisions of the pronouncements included
in this appendix.
• ARB No. 43, Restatement and Revision of Accounting Research Bulle
tins, as amended by APB Opinions No. 6, No. 9, No. 10, No. 16, No. 17,
No. 20, No. 21, No. 25, and No. 26, and FASB Statements No. 5, No.
6, No. 52, No. 78, No. 94, No. 109, No. 111, No. 115, No. 123, No. 131,
No. 133, No. 135, and No. 142
• ARB No. 45, Long-Term Construction-Type Contracts
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• ARB No. 46, Discontinuance of Dating Earned Surplus
• APB Opinion No. 2, Accounting for the “Investment Credit,” as
amended by APB Opinion No. 4 and FASB Statements No. 71 and No.
109
• APB Opinion No. 4 (amending Opinion No. 2), Accounting for the
“Investment Credit”
• APB Opinion No. 6, Status of Accounting Research Bulletins, as
amended by APB Opinions No. 16, No. 17, and No. 26, and FASB
Statements No. 52, No. 71, No. 109, No. 111, and No. 135
• APB Opinion No. 9, Reporting the Results of Operations (paragraph
1.51 of this Guide discusses this pronouncement), as amended by APB
Opinions No. 13, No. 15, No. 20, and No. 30, and FASB Statement No.
16
• APB Opinion 10, Omnibus Opinion—1966, as amended by APB Opin
ions No. 12, No. 14, No. 16, and No. 18, and FASB Statements No. 111
and No. 129, and including FASB Interpretations No. 39 and No. 41
• APB Opinion No. 12, Omnibus Opinion—1967 (except guidance under
the heading, “Capital Changes”), as amended by APB Opinion No. 14
and FASB Statements No. 87, No. 106, and No. 111
• APB Opinion No. 16, Business Combinations (paragraph 1.49 of this
Guide discusses this pronouncement), as amended by FASB State
ments No. 10, No. 38, No. 71, No. 79, No. 87, No. 106, No. 109, No. 121,
and No. 135, and including FASB Interpretations No. 4, No. 9, and No.
21
• APB Opinion 17, Intangible Assets, as amended by APB Opinion No.
30 and FASB Statements No. 2, No. 71, No. 72, No. 109, No. 121, and
No. 135, and including FASB Interpretation No. 9
• APB Opinion No. 20, Accounting Changes, as amended by FASB
Statements No. 16, No. 58, No. 71, No. 73, No. 95, No. 111, and No.
128, and including FASB Interpretations No. 1 and No. 20
• APB Opinion No. 21, Interest on Receivables and Payables, as amended
by FASB Statements No. 34 and No. 109
• APB Opinion No. 22, Disclosure of Accounting Policies, as amended by
FASB Statements No. 2, No. 52, No. 95, and No. 111
• APB Opinion No. 23, Accounting for Income Taxes—Special Areas, as
amended by FASB Statements No. 60, No. 71, No. 94, and No. 109
• APB Opinion No. 26, Early Extinguishment of Debt (paragraph 1.51
of this Guide discusses this pronouncement), as amended by APB
Opinion No. 30 and FASB Statements No. 15, No. 71, No. 84, and No.
140
• APB Opinion No. 30, Reporting the Results of Operations—Reporting
the Effects of Disposal of a Segment of a Business, and Extraordinary,
Unusual and Infrequently Occurring Events and Transactions (para
graph 1.51 of this Guide discusses this pronouncement), as amended
by FASB Statements No. 16, No. 60, No. 97, No. 101, No. 109, No. 128,
No. 144, and No. 145, and including FASB Interpretation No. 27
• FASB Statement No. 2, Accounting for Research and Development
Costs, as amended by FASB Statements No. 71, No. 86, and No. 142,
and including FASB Interpretations No. 4 and No. 6
• FASB Statement No. 5, Accounting for Contingencies, as amended by
FASB Statements No. 11, No. 16, No. 60, No. 71, No. 87, No. 111, No.
112, No. 113, No. 114, and No. 123, and including FASB Interpreta
tions No. 14, No. 34, and No. 45
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• FASB Statement No. 6, Classification of Short-Term Obligations Ex
pected to Be Refinanced (an amendment of ARB No. 43, Chapter 3A),
and including FASB Interpretation No. 8
• FASB Statement No. 10, Extension of “Grandfather” Provisions for
Business Combinations (an amendment of APB Opinion No. 16)
• FASB Statement No. 11, Accounting for Contingencies—Transition
Method (an amendment of FASB Statement No. 5)
• FASB Statement No. 13, Accounting for Leases, as amended by FASB
Statements No. 22, No. 23, No. 27, No. 28, No. 29, No. 34, No. 71, No.
91, No. 94, No. 98, No. 109, No. 135, No. 140, and No. 145, and including
FASB Interpretations No. 19, No. 21, No. 23, No. 24, No. 26, and No. 27
• FASB Statement No. 15, Accounting by Debtors and Creditors for
Troubled Debt Restructurings, as amended by FASB Statements No.
71, No. 111, No. 114, No. 135, No. 144, No. 145, and No. 149
• FASB Statement No. 16, Prior Period Adjustments, as amended by
FASB Statements No. 71 and No. 109
• FASB Statement No. 22, Changes in the Provisions of Lease Agree
ments Resulting from Refundings of Tax-Exempt Debt (an amendment
of FASB Statement No. 13), as amended by FASB Statements No. 71,
No. 140, and No. 145
• FASB Statement No. 23, Inception of the Lease (an amendment of
FASB Statement No. 13)
• FASB Statement No. 27, Classification of Renewals or Extensions of
Existing Sales-Type or Direct Financing Leases (an amendment of
FASB Statement No. 13)
• FASB Statement No. 28, Accounting for Sales with Leasebacks (an
amendment of FASB Statement No. 13), as amended by FASB State
ment No. 66
• FASB Statement No. 29, Determining Contingent Rentals (an
amendment of FASB Statement No. 13), as amended by FASB State
ment No. 98
• FASB Statement No. 34, Capitalization of Interest Cost, as amended
by FASB Statements No. 42, No. 58, No. 62, No. 71, and No. 144, and
including FASB Interpretation No. 33
• FASB Statement No. 37, Balance Sheet Classification of Deferred
Income Taxes (an amendment of APB Opinion No. 11), as amended by
FASB Statement No. 109
• FASB Statement No. 38, Accounting for Preacquisition Contingencies
of Purchased Enterprises (an amendment of APB Opinion No. 16), as
amended by FASB Statement No. 109
• FASB Statement No. 42, Determining Materiality for Capitalization
of Interest Cost (an amendment of FASB Statement No. 34)
• FASB Statement No. 43, Accounting for Compensated Absences, as
amended by FASB Statements No. 71, No. 112, No. 123, No. 135, and
No. 144
• FASB Statement No. 47, Disclosure of Long-Term Obligations
• FASB Statement No. 48, Revenue Recognition When Right of Return
Exists
• FASB Statement No. 49, Accounting for Product Financing Arrange
ments, as amended by FASB Statement No. 71
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• FASB Statement No. 52, Foreign Currency Translation (paragraph
1.51 of this Guide discusses this pronouncement), as amended by
FASB Statements No. 95, No. 109, No. 130, No. 133, No. 135, and No.
142, and including FASB Interpretation No. 37
• FASB Statement No. 57, Related Party Disclosures, as amended by
FASB Statements No. 95 and No. 109, and including FASB Interpre
tation No. 45
• FASB Statement No. 58, Capitalization of Interest in Financial State
ments That Include Investments Accounted for by the Equity Method
(an amendment of FASB Statement No. 34)
• FASB Statement No. 62, Capitalization of Interest Cost in Situations
Involving Certain Tax-Exempt Borrowings and Certain Gifts and
Grants (an amendment of FASB Statement No. 34)
• FASB Statement No. 66, Accounting for Sales of Real Estate, as
amended by FASB Statements No. 98, No. 135, and No. 144
• FASB Statement No. 68, Research and Development Arrangements, as
amended by FASB Statement No. 142
• FASB Statement No. 78, Classification of Obligations That Are Call
able by the Creditor (an amendment of ARB No. 43, Chapter 3A)
• FASB Statement No. 79, Elimination of Certain Disclosures for Busi
ness Combinations by Nonpublic Enterprises (an amendment of APB
Opinion No. 16)
• FASB Statement No. 86, Accounting for the Costs of Computer Soft
ware to Be Sold, Leased, or Otherwise Marketed
• FASB Statement No. 87, Employers’ Accounting for Pensions, as
amended by FASB Statements No. 106, No. 109, No. 130, No. 132
(revised 2003), No. 135, and No. 149
• FASB Statement No. 88, Employers’ Accounting for Settlements and
Curtailments of Defined Benefit Pension Plans and for Termination
Benefits, as amended by FASB Statements No. 132 (revised 2003) and
No. 144
• FASB Statement No. 93, Recognition of Depreciation by Not-for-Profit
Organizations, as amended by FASB Statements No. 99 and No. 135
• FASB Statement No. 95, Statement of Cash Flows, as amended by
FASB Statements No. 102, No. 104, No. 117, No. 133, No. 145, and No.
149
• FASB Statement No. 98, Accounting for Leases:
— Sale-Leaseback Transactions Involving Real Estate
— Sales-Type Leases of Real Estate
— Definition of the Lease Term
— Initial Direct Costs of Direct Financing Leases
(an amendment of FASB Statements No. 13,66, and 91 and a rescission
of FASB Statement No. 26 and Technical Bulletin No. 79-11)
• FASB Statement No. 99, Deferral of the Effective Date of Recognition
of Depreciation by Not-for-Profit Organizations (an amendment of
FASB Statement No. 93)
• FASB Statement No. 102, Statement of Cash Flows—Exemption of
Certain Enterprises and Classification of Cash Flows from Certain
Securities Acquired for Resale (an amendment of FASB Statement No.
95), as amended by FASB Statements No. 115, No. 135, and No. 145
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• FASB Statement No. 104, Statement of Cash Flows—Net Reporting of
Certain Cash Receipts and Cash Payments and Classification of Cash
Flows from Hedging Transactions (an amendment of FASB Statement
No. 95)
• FASB Statement No. 106, Employers’ Accounting for Postretirement
Benefits Other Than Pensions, as amended by FASB Statements No.
132 (revised 2003), No. 135, No. 144, and No. 149
• FASB Statement No. 107, Disclosures about Fair Value of Financial
Instruments, as amended by FASB Statements No. 112, No. 123, No.
126, No. 133, and No. 140, and including FASB Interpretation No. 45
• FASB Statement No. 109, Accounting for Income Taxes (paragraph
1.51 of this Guide discusses this pronouncement), as amended by
FASB Statements No. 115, No. 123, No. 130, and No. 135
• FASB Statement No. 111, Rescission of FASB Statement No. 32 and
Technical Corrections
• FASB Statement No. 112, Employers’Accounting for Postemployment
Benefits (an amendment of FASB Statements No. 5 and 43), as
amended by FASB Statement No. 123
• FASB Statement No. 114, Accounting by Creditors for Impairment of
a Loan (an amendment of FASB Statements No. 5 and 15), as amended
by FASB Statement No. 118
• FASB Statement No. 118, Accounting by Creditors for Impairment of
a Loan—Income Recognition and Disclosures (an amendment of FASB
Statement No. 114)
• FASB Statement No. 121, Accounting for the Impairment of LongLived Assets and for Long-Lived Assets to Be Disposed Of, as amended
by FASB Statements No. 139 and No. 142 (FASB Statement No. 121
was superseded by FASB Statement No. 144)
• FASB Statement No. 126, Exemption from Certain Required Disclo
sures about Financial Instruments for Certain Nonpublic Entities, as
amended by FASB Statements No. 133 and No. 149
• FASB Statement No. 129, Disclosure of Information about Capital
Structure
• FASB Statement No. 132 (revised 2003), Employers’Disclosures about
Pensions and Other Postretirement Benefits (supersedes FASB State
ment No. 132)
• FASB Statement No. 133, Accounting for Derivative Instruments and
Hedging Activities, as amended by FASB Statements No. 137, No. 138,
No. 140, No. 145, No. 149, and No. 150
• FASB Statement No. 135, Rescission of FASB Statement No. 75 and
Technical Corrections, as amended by FASB Statement No. 145
• FASB Statement No. 137, Accounting for Derivative Instruments and
Hedging Activities—Deferral of the Effective Date of FASB Statement
No. 133
• FASB Statement No. 138, Accounting for Certain Derivative Instru
ments and Certain Hedging Activities
• FASB Statement No. 140, Accounting for Transfers and Servicing of
Financial Assets and Extinguishments of Liabilities
• FASB Statement No. 142, Goodwill and Other Intangible Assets, as
amended by FASB Statements No. 144, No. 145, and No. 147
• FASB Statement No. 143, Accounting for Asset Retirement Obliga
tions, as amended by FASB Statement No. 144
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• FASB Statement No. 144, Accounting for the Impairment or Disposal
of Long-Lived Assets, as amended by FASB Statements No. 145 and
No. 147
• FASB Statement No. 145, Rescission of FASB Statements No. 4, 44,
and 64, Amendment of FASB Statement No. 13, and Technical Correc
tions
• FASB Statement No. 146, Accounting for Costs Associated With Exit
or Disposal Activities
• FASB Statement No. 149,Amendment of Statement No. 133 onDerivative Instruments and Hedging Activities
• FASB Interpretation No. 1, Accounting Changes Related to the Cost of
Inventory
• FASB Interpretation No. 4, Applicability of FASB Statement No. 2 to
Business Combinations Accounted for by the Purchase Method
• FASB Interpretation No. 6, Applicability of FASB Statement No. 2 to
Computer Software, as amended by FASB Statement No. 86
• FASB Interpretation No. 8, Classification of a Short-Term Obligation
Repaid Prior to Being Replaced by a Long-Term Security
• FASB Interpretation No. 14, Reasonable Estimation of the Amount of
a Loss
• FASB Interpretation No. 19, Lessee Guarantee of the Residual Value
of Leased Property
• FASB Interpretation No. 20, Reporting Accounting Changes under
AICPA Statements of Position, as amended by FASB Statement No.
111
• FASB Interpretation No. 21, Accounting for Leases in a Business
Combination, as amended by FASB Statement No. 145
• FASB Interpretation No. 23, Leases of Certain Property Owned by a
Governmental Unit or Authority
• FASB Interpretation No. 24, Leases Involving Only Part of a Building
• FASB Interpretation No. 26, Accounting for Purchase of a Leased Asset
by the Lessee during the Term of the Lease
• FASB Interpretation No. 27, Accounting for a Loss on a Sublease, as
amended by FASB Statements No. 135 and No. 144
• FASB Interpretation No. 37, Accounting for Translation Adjustments
upon Sale of Part of an Investment in a Foreign Entity
• FASB Interpretation No. 39, Offsetting of Amounts Related to Certain
Contracts, as amended by FASB Statements No. 113, No. 135, and No.
144 and FASB Interpretation No. 41
• FASB Interpretation No. 41, Offsetting of Amounts Related to Certain
Repurchase and Reverse Repurchase Agreements
• FASB Interpretation No. 43, Real Estate Sales, as amended by FASB
Statement No. 140
• FASB Interpretation No. 45, Guarantor’s Accounting and Disclosure
Requirements for Guarantees, Including Indirect Guarantees of In
debtedness of Others
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1.60
Appendix F— All Financial Reporting Pronouncements,
Cross-Referenced by Appendix

Note regarding effective dates of pronouncements and the applicability of
FASB Statement No. 141, Business Combinations, and FASB Statement No.
142, Goodwill and Other Intangible Assets:
• See Appendixes A through E of this chapter for effective date information
for recently issued pronouncements.
• FASB Statement No. 141 supersedes or amends certain pronouncements
that are listed in this appendix. FASB Statement No. 141 applies to
business combinations initiated after June 30, 2001 and prescribes the
use of the purchase method for those business combinations. FASB
Statement No. 141, however, does not apply to certain combinations,
including a combination involving two or more not-for-profit organizations,
or the acquisition of a for-profit business entity by a not-for-profit
organization. For those combinations, pronouncements that are super
seded or amended by FASB Statement No. 141 should be applied as
though FASB Statement No. 141 had not superseded or amended them.
• The provisions of FASB Statement No. 142 shall be applied in fiscal years
beginning after December 15, 2001, to all goodwill and other intangible
assets recognized in an entity’s statement of financial position at the
beginning of that fiscal year. Early application is permitted in certain
circumstances. Certain provisions of FASB Statement No. 142 shall be
applied to goodwill and other acquired intangible assets for which the
acquisition date is after June 30, 2001, even if an entity has not adopted
FASB Statement No. 142 in its entirety. The provisions of FASB
Statement No. 141 and FASB Statement No. 142 should not be applied
to goodwill and intangible assets arising from a combination between
two or more not-for-profit organizations or acquired in the acquisition of
a for-profit business entity by a not-for-profit organization until the
FASB completes its project on those types of combinations and
acquisitions. Thus, the guidance in APB Opinions No. 16 and No. 17
remains in effect for such assets. In addition, when applying APB
Opinions No. 16 and No. 17, not-for-profit organizations should continue
to apply the amendments to those Opinions found in other literature
even though that other literature may have been superseded by FASB
Statements No. 141, No. 142, and No. 144. For example, when applying
APB Opinion No. 17, not-for-profit organizations should continue to
apply the amendments to that Opinion found in FASB Statement No.
121, even though that Statement was superseded by FASB Statement
No. 144. Readers should be alert to the issuance of a final Standard on
combinations of not-for-profit organizations.
Pronouncement_______
ARB No. 1 to ARB No. 42
ARB No. 43
ARB No. 44
ARB No. 44 (Revised)
ARB No. 45
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1.61
Appendix G— The Hierarchy of GAAP

SAS No. 69, The Meaning of Present Fairly in Conformity With Generally
Accepted Accounting Principles, establishes the hierarchy of GAAP.
For financial statements of entities other than governmental entities, the
hierarchy is summarized as follows:
Category (a). Rule 203 literature consists of officially established ac
counting principles, which are FASB Statements and
Interpretations, APB Opinions, and ARBs.
Category (b). This consists of FASB Technical Bulletins and, if clear
ed by the FASB, AICPA Industry Audit and Account
ing Guides, and AICPA SOPs.
Category (c). This consists of AICPA AcSEC Practice Bulletins that
have been cleared by the FASB and consensus positions
of the FASB EITF.
Category (d). This consists ofAICPA accounting interpretations and
implementation guides (“Qs and As”) published by the
FASB staff, and practices that are widely recognized
and prevalent either generally or in the industry.
If the accounting treatment of a transaction or event is not specified by Rule
203 literature, the auditor should consider whether the accounting treatment
is specified by another source of established accounting principles. If an
established accounting principle from one or more sources in category (b), (c),
or (d) is relevant to the circumstances, the auditor should be prepared to justify
a conclusion that another treatment is generally accepted. If there is a conflict
between accounting principles relevant to the circumstances from one or more
sources in category (b), (c), or (d), the auditor should follow the treatment
specified by the source in the higher category—for example, follow category (b)
treatment over category (c)—or be prepared to justify a conclusion that a
treatment specified by a source in the lower category better presents the
substance of the transaction in the circumstances.
For financial statements of State and Local governmental entities,1 the
hierarchy is summarized as follows:
Category (a). Officially established accounting principles, consists
of GASB Statements and Interpretations, as well as
AICPA and FASB pronouncements specifically made
applicable to state and local governmental entities by
GASB Statements or Interpretations. GASB Statements
and Interpretations are periodically incorporated in the
Codification of Governmental Accounting and Finan
cial Reporting Standards.1
1
State and local governmental entities include public benefit corporations and authorities;
public employee retirement systems; and governmental utilities, hospitals and other health care
providers, and colleges and universities. SAS No. 91, Federal GAAP Hierarchy, amends SAS No. 69
to establish a hierarchy for federal governmental entities. Federal health care organizations are not
included in the scope of this Guide.
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Category (b). This consists of GASB Technical Bulletins and, if spe
cifically made applicable to state and local governmen
tal entities by the AICPA and cleared2 by the GASB,
AICPA Industry Audit and Accounting Guides and
AICPA SOPs.
Category (c). This consists of AICPA AcSEC Practice Bulletins if
specifically made applicable to state and local govern
mental entities and cleared3 by the GASB, as well as
consensus positions of a group of accountants organ
ized by the GASB that attempts to reach consensus
positions on accounting issues applicable to state and
local governmental entities.4
Category (d). Includes implementation guides (“Qs and As”) publish
ed by the GASB staff, as well as practices that are widely
recognized and prevalent in state and local government.
In the absence of a pronouncement covered by Rule 203 or another source of
established accounting principles, the auditor of financial statements of state
and local governmental entities may consider other accounting literature,
depending on its relevance in the circumstances. Other accounting literature
includes, for example, GASB Concepts Statements; the pronouncements re
ferred to in categories (a) through (d) above that relate to other than govern
mental entities when not specifically made applicable to state and local
governmental entities either by the GASB or by the organization issuing them;
FASB Concepts Statements; Federal Accounting Standards Advisory Board
(FASAB) Statements, Interpretations, Technical Bulletins, and Concepts
Statements; AICPA Issues Papers; International Accounting Standards of the
International Accounting Standards Committee; pronouncements of other pro
fessional associations or regulatory agencies; Technical Information Service
Inquiries and Replies included in AICPA Technical Practice Aids; and account
ing textbooks, handbooks, and articles. The appropriateness of other account
ing literature depends on its relevance to particular circumstances, the
specificity of the guidance, and the general recognition of the issuer or author
as an authority. For example, GASB Concepts Statements would normally be
more influential than other sources in this category.

2 The auditor should assume that such pronouncements specifically made applicable to state and
local governments have been cleared by the GASB unless the pronouncement indicates otherwise.
3 See footnote 2.
4 As of the date of this Guide, the GASB had not organized such a group.
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Chapter 2
General Auditing Considerations
Auditing Guidance in the Audit and Accounting Guide
State and Local Governments

2.01 This Guide is not the only industry-specific AICPA Audit and Ac
counting Guide that auditors should consider when performing an audit of a
governmental health care entity. The Audit and Accounting Guide State and
Local Governments, includes governmental health care entities in its scope and
the auditing guidance in that Guide should also be considered during an audit
of a governmental health care entity that is included in the scope of this Guide.
Registered Public Accounting Firms

2.02 Registered public accounting firms must comply with the standards
of the Public Company Accounting Oversight Board (PCAOB) in connection
with the preparation or issuance of any audit report on the financial state
ments of an issuer, as defined by the Sarbanes-Oxley Act, and other entities
when prescribed by the rules of the SEC (collectively referred to as “issuers”).
Scope of the Engagement

2.03 SAS No. 83, Establishing an Understanding With the Client, as
amended by SAS No. 89, Audit Adjustments (AICPA, Professional Stand
ards, vol. 1, AU sec. 310), provides that, for each audit engagement, the
independent auditor and the health care organization should establish a
clear understanding regarding the services to be performed. The under
standing should include the objectives of the engagement, management’s
responsibilities, the auditor’s responsibilities, and limitations of the en
gagement. Such an understanding should be documented in the audit docu
mentation preferably through a written communication with the client. If the
auditor believes an understanding with the client has not been established, he
or she should decline to accept or perform the engagement. In addition to
reporting on the entity’s basic financial statements, the independent auditor
may be asked to report on the following special reports: (a) cost-reimbursement
reports; (b) cost reports related to research grants; (c) reports for contribu
tors; (d) reports for local, state, or federal authorities; (e) reports related to
bond indentures and other debt instruments; and (f ) other special-purpose
reports. The nature, timing, and extent of auditing procedures to be performed
and the type of reports to be issued are based on the scope of services required
by the entity. Chapter 4 in the Audit and Accounting Guide State and Local
Governments (see paragraph 2.01 in this chapter of the Guide), also discusses
the need to establish an understanding with the client. That discussion states
that the auditor should consider holding a preaudit conference with the auditee
to discuss the responsibilities of both the auditee and the auditor. That discus
sion also provides a listing of topics for the preaudit conference that have
elements that are unique to or significant in a governmental audit.
Planning the Audit

2.04 The nature, timing, and extent of planning usually vary with the size
and complexity of the entity, as well as with the independent auditor’s experience
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with the entity and with the industry. SAS No. 22, Planning and Supervision
(AICPA, Professional Standards, vol. 1, AU sec. 311), contains guidance on
planning an audit in accordance with generally accepted auditing standards
(GAAS).
2.05 The independent auditor’s work in forming an opinion on financial
statements consists of obtaining and evaluating evidential matter regarding
management’s assertions. Assertions are representations by management that
are embodied in the financial statements. They can be either explicit or implicit
and can be classified according to the following broad categories: existence and
occurrence, completeness, rights and obligations, valuation and allocation, and
presentation and disclosure.
2.06 The purpose of specific audit objectives and examples of control
activities in the auditing sections of the following chapters is to illustrate how
the independent auditor might obtain an understanding of internal control,
assess control risk, and perform audit procedures. There is not necessarily a
one-to-one relationship between audit objectives and procedures. Some proce
dures may relate to more than one objective. On the other hand, a combination
of procedures may be needed to achieve a single objective. The illustrations are
not intended to be all-inclusive or to suggest that specific audit objectives,
control activities, and audit procedures should be applied. Some of the objec
tives may not be relevant to a particular entity because of the nature of its
operations or the absence of certain types of transactions. The absence of one
or more of the illustrative controls would not necessarily indicate a deficiency
in internal control. The auditor performs procedures that are responsive to the
auditor’s risk assessment.
2.07 The illustrations are arranged by broad audit objectives. These
classifications may be useful in the evaluation process, but the classifications
are of secondary importance. Some specific objectives may serve to achieve
more than one broad objective.
2.08 Many of the illustrative control activities are premised on the exist
ence of certain essential characteristics of internal control (for example,
authorization of transactions, segregation of duties, documentation, supervi
sion and review, and timeliness of procedures). To avoid repetition, these
characteristics have not been emphasized in the illustrations.
Inherent Risk

2.09 In determining the scope of audit procedures to be performed, the
independent auditor should be aware of certain aspects of the health care
organization’s operations that are usually subject to higher or lower levels of
inherent risk. SAS No. 47, Audit Risk and Materiality in Conducting an Audit
(AICPA, Professional Standards, vol. 1, AU sec. 312), provides guidance on the
consideration of audit risk and materiality when planning and performing an
audit of financial statements. SAS No. 96, Audit Documentation, amends SAS
No. 47 (AICPA, Professional Standards, vol. 1, AU sec. 312.40), to require that
the auditor should document the nature and effect of aggregated misstate
ments, and his or her conclusion as to whether the aggregated misstatements
cause the financial statements to be materially misstated. SAS No. 98, Omni
bus Statement on Auditing Standards—2002 (AICPA, Professional Standards,
vol. 1, AU sec. 312.34—.41), amends the section “Evaluating Audit Findings” of
SAS No. 47, to clarify the auditor’s responsibility with respect to evaluating
auditing adjustments. SOP 00-1, Auditing Health Care Third-Party Revenues
and Related Receivables, provides guidance to auditors regarding uncertainties
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inherent in health care third-party revenue recognition. SOP 00-1 is included
as Appendix E to this Guide. The Audit and Accounting Guide State and Local
Governments (see paragraph 2.01 in this chapter of the Guide), provides
additional guidance on audit materiality determinations, including opinion
units, as that term is described in State and Local Governments.
2.10 In many health care organizations, certain accounts typically (a)
will have a low volume of transactions, (b) will consist of transactions that
are not complex, and (c) do not require the use of significant accounting
estimates. Accounts such as inventories, marketable securities, assets
whose use is limited, property and equipment, long-term debt, and equity
frequently have these characteristics and may allow the auditor to assess
inherent risk as being at a relatively low level. However, in certain circum
stances, such as investments in complex derivative financial instruments,
inherent risk may be higher. The auditor should use professional judgment
in evaluating the factors relevant to assessments of inherent risk. SAS No.
92, Auditing Derivative Instruments, Hedging Activities, and Investments in
Securities (AICPA, Professional Standards, vol. 1, AU sec. 332), among other
matters, provides guidance to auditors in planning and performing auditing
procedures for assertions about derivative instruments that are made in an
entity’s financial statements, and presents examples of factors that affect
inherent risk for assertions about derivatives. In addition, a companion Audit
Guide, Auditing Derivative Instruments, Hedging Activities, and Investments
in Securities, provides practical guidance for implementing SAS No. 92.
2.11 Because of the large monetary amounts and the complexity of deter
mining health care service revenue and receivables, there are risks associated
with health care service revenue recognition and the valuation of the related
receivables. A significant portion of services usually is paid for by third parties
such as Medicare, Medicaid, and various health insurance carriers under
statutory provisions or other arrangements in amounts that can be significantly
different from, and frequently less than, the entity’s established rates.
2.12 Risks are associated with recognizing the liability for costs incurred
by providers of prepaid health care services (for example, HMOs) because such
costs may have been incurred but not yet reported to the providers. It is
therefore necessary to estimate the liability for those costs. These estimates
often require a high degree of management judgment. Management must
consider historical experience as well as the effects of any changes in conditions
such as seasonality trends and changes in subscriber population and in the
services and benefits provided.
2.13 Risks also are associated with contingencies for uninsured medical
malpractice losses and obligations under continuing care contracts. A high
degree of management judgment and complex analyses usually are involved in
evaluating the related financial statement assertions.
2.14 The risk of material misstatements, whether caused by error or
fraud, and illegal acts by clients is present in all audit engagements. SAS No. 54,
Illegal Acts by Clients (AICPA, Professional Standards, vol. 1, AU sec. 317),
describes the auditor’s responsibilities for detecting illegal acts in an audit of
financial statements and the auditor’s responsibilities for communicating de
tected illegal acts to parties within and external to the entity.
Consideration of Fraud in a Financial Statement Audit

2.15 SAS No. 99, Consideration of Fraud in a Financial Statement Audit
(AICPA, Professional Standards, vol. 1, AU sec. 316), is the primary source of
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authoritative guidance about an auditor’s responsibilities concerning the con
sideration of fraud in a financial statement audit. SAS No. 99 supersedes SAS
No. 82, Consideration of Fraud in a Financial Statement Audit, and amends
SAS No. 1, section 230, Due Professional Care in the Performance of Work
(AICPA, Professional Standards, vol. 1, AU sec. 230). SAS No. 99 establishes
standards and provides guidance to auditors in fulfilling their responsibility to
plan and perform the audit to obtain reasonable assurance about whether the
financial statements are free of material misstatement, whether caused by
error or fraud as stated in SAS No. 1, section 110, Responsibilities and
Functions of the Independent Auditor (AICPA, Professional Standards, vol. 1,
AU sec. 110.02). SAS No. 99 also amends SAS No. 85, Management Repre
sentations (AICPA, Professional Standards, vol. 1, AU sec. 333), as amended.
2.16 There are two types of misstatements relevant to the auditor’s
consideration of fraud in a financial statement audit:
• Misstatements arising from fraudulent financial reporting
• Misstatements arising from misappropriation of assets
2.17 Three conditions generally are present when fraud occurs. First,
management or other employees have an incentive or are under pressure,
which provides a reason to commit fraud. Second, circumstances exist—for
example, the absence of controls, ineffective controls, or the ability of manage
ment to override controls—that provide an opportunity for a fraud to be
perpetrated. Third, those involved are able to rationalize committing a fraudu
lent act.
The Importance of Exercising Professional Skepticism
2.18
Because of the characteristics of fraud, the auditor’s exercise of
professional skepticism is important when considering the risk of material
misstatement due to fraud. Professional skepticism is an attitude that includes
a questioning mind and a critical assessment of audit evidence. The auditor
should conduct the engagement with a mindset that recognizes the possibility
that a material misstatement due to fraud could be present, regardless of any
past experience with the entity and regardless of the auditor’s belief about
management’s honesty and integrity. Furthermore, professional skepticism
requires an ongoing questioning of whether the information and evidence
obtained suggests that a material misstatement due to fraud has occurred.
Discussion Among Engagement Personnel Regarding the Risks
of Material Misstatement Due to Fraud
2.19
Members of the audit team should discuss the potential for mate
rial misstatement due to fraud in accordance with the requirements of
paragraphs 14 through 18 of SAS No. 99 (AU sec. 316.14—.18). The discus
sion among the audit team members about the susceptibility of the entity’s
financial statements to material misstatement due to fraud should include
a consideration of the known external and internal factors affecting the entity
that might (a) create incentives/pressures for management and others to
commit fraud, (b) provide the opportunity for fraud to be perpetrated, and
(c) indicate a culture or environment that enables management to rational
ize committing fraud. Communication among the audit team members about
the risks of material misstatement due to fraud also should continue
throughout the audit.
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Obtaining the Information Needed to Identify the Risks of
Material Misstatement Due to Fraud

2.20 SAS No. 22 (AICPA, Professional Standards, vol. 1, AU sec. 311.06.08), provides guidance about how the auditor obtains knowledge about the
entity’s business and the industry in which it operates. In performing that
work, information may come to the auditor’s attention that should be consid
ered in identifying risks of material misstatement due to fraud. As part of this
work, the auditor should perform the following procedures to obtain informa
tion that is used (as described in paragraphs 35 through 42 of SAS No. 99 [AU
sec. 316.35-.42]) to identify the risks of material misstatement due to fraud:
a. Make inquiries of management and others within the entity to obtain
their views about the risks of fraud and how they are addressed. (See
paragraphs 20 through 27 of SAS No. 99 [AU sec. 316.20-27].)
b. Consider any unusual or unexpected relationships that have been
identified in performing analytical procedures in planning the audit.
(See paragraphs 28 through 30 of SAS No. 99 [AU sec. 316.28-.30].)
c. Consider whether one or more fraud risk factors exist. (See para
graphs 31 through 33 of SAS No. 99 [AU sec. 316.31-.33], the
Appendix to SAS No. 99, and paragraph 2.22 in this chapter.)
d. Consider other information that may be helpful in the identification
of risks of material misstatement due to fraud. (See paragraph 34 of
SAS No. 99 [AU sec. 316.34].)
2.21 In planning the audit, the auditor also should perform analytical
procedures relating to revenue with the objective of identifying unusual or
unexpected relationships involving revenue accounts that may indicate a
material misstatement due to fraudulent financial reporting.
2.22 Considering Fraud Risk Factors. As indicated in paragraph 2.20(c)
in this chapter, the auditor may identify events or conditions that indicate
incentives/pressures to perpetrate fraud, opportunities to carry out the fraud,
or attitudes/rationalizations to justify a fraudulent action. Such events or
conditions are referred to as “fraud risk factors.” Fraud risk factors do not
necessarily indicate the existence of fraud; however, they often are present in
circumstances where fraud exists.
2.23 SAS No. 99 provides fraud risk factor examples that have been
written to apply to most enterprises. Remember that fraud risk factors are only
one of several sources of information an auditor considers when identifying and
assessing risk of material misstatement due to fraud.
Identifying Risks That May Result in a Material Misstatement
Due to Fraud

2.24
In identifying risks of material misstatement due to fraud, it is
helpful for the auditor to consider the information that has been gathered in
accordance with the requirements of paragraphs 19 through 34 of SAS No. 99
(AU sec. 316.19-.34). The auditor’s identification of fraud risks may be influenced
by characteristics such as the size, complexity, and ownership attributes of the
entity. In addition, the auditor should evaluate whether identified risks of
material misstatement due to fraud can be related to specific financial-statement
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account balances or classes of transactions and related assertions, or whether
they relate more pervasively to the financial statements as a whole. Certain
accounts, classes of transactions, and assertions that have high inherent risk
because they involve a high degree of management judgment and subjectivity
also may present risks of material misstatement due to fraud because they are
susceptible to manipulation by management.
A Presumption That Improper Revenue Recognition Is a Fraud Risk

2.25 Material misstatements due to fraudulent financial reporting often
result from an overstatement of revenues (for example, through premature
revenue recognition or recording fictitious revenues) or an understatement of
revenues (for example, through improperly shifting revenues to a later period).
Therefore, the auditor should ordinarily presume that there is a risk of mate
rial misstatement due to fraud relating to revenue recognition (see paragraph
41 of SAS No. 99 [AU sec. 316.41]).
A Consideration of the Risk o f Management Override of Controls

2.26 Even if specific risks of material misstatement due to fraud are not
identified by the auditor, there is a possibility that management override of
controls could occur, and accordingly, the auditor should address that risk (see
paragraph 57 of SAS No. 99 [AU sec. 316.57]) apart from any conclusions
regarding the existence of more specifically identifiable risks. Specifically, the
procedures described in paragraphs 58 through 67 of SAS No. 99 (AU sec.
316.58-.67) should be performed to further address the risk of management
override of controls. These procedures include (1) examining journal entries
and other adjustments for evidence of possible material misstatement due to
fraud, (2) reviewing accounting estimates for biases that could result in mate
rial misstatement due to fraud, and (3) evaluating the business rationale for
significant unusual transactions.
Assessing the Identified Risks After Taking Into Account an
Evaluation of the Entity's Programs and Controls That
Address the Risks*
2.27 Auditors should comply with the requirements of paragraphs 43
through 45 of SAS No. 99 (AU sec. 316.43-.45) concerning an entity’s programs
and controls that address identified risks of material misstatement due to
fraud.
2.28 The auditor should consider whether such programs and controls
mitigate the identified risks of material misstatement due to fraud or whether
specific control deficiencies exacerbate the risks. After the auditor has evalu
ated whether the entity’s programs and controls have been suitably designed

*In March 2004, the Public Company Accounting Oversight Board (PCAOB) issued Auditing
Standard No. 2, An Audit of Internal Control Over Financial Reporting Performed in Conjunction
With an Audit of Financial Statements, which was subsequently approved by the Securities and
Exchange Commission (SEC). This Standard applies to audits of issuers, as defined by the SarbanesOxley Act, and other entities when prescribed by the rules of the SEC (collectively referred to as
“issuers”). PCAOB Auditing Standard No. 2 establishes requirements that apply when an auditor is
engaged to audit both an issuer’s financial statements and management’s assessment of the
effectiveness of internal control over financial reporting. Auditing Standard No. 2 specifically
addresses and emphasizes the importance of controls over possible fraud and requires the auditor to
test controls specifically intended to prevent or detect fraud that is reasonably likely to result in
material misstatement of the financial statements. See the Preface to this Guide for more detailed
information, and paragraph 2.02 of this chapter.
AAG-HCO 2.2 5

49

General Auditing Considerations

and placed in operation, the auditor should assess these risks taking into account
that evaluation. The assessment should be considered when developing the
auditor’s response to the identified risks of material misstatement due to fraud.
Responding to the Results of the Assessment

2.29 Paragraphs 46 through 67 of SAS No. 99 (AU sec. 316.46-.67)
provide requirements and guidance about an auditor’s response to the results
of the assessment of the risks of material misstatement due to fraud. The
auditor responds to risks of material misstatement due to fraud in the follow
ing three ways:
a. A response that has an overall effect on how the audit is conducted—
that is, a response involving more general considerations apart from
the specific procedures otherwise planned (see paragraph 50 of SAS
No. 99 [AU sec. 316.50]).
b. A response to identified risks involving the nature, timing, and
extent of the auditing procedures to be performed (see paragraphs
51 through 56 of SAS No. 99 [AU sec. 316.51-.56]).
c. A response involving the performance of certain procedures to fur
ther address the risk of material misstatement due to fraud involving
management override of controls, given the unpredictable ways in
which such override could occur (see paragraphs 57 through 67 of
SAS No. 99 [AU sec. 316.57-.67] and paragraph 2.26 in this chapter).
Evaluating Audit Evidence

2.30 Paragraphs 68 through 78 of SAS No. 99 (AU sec. 316.68-.78) provide
requirements and guidance for evaluating audit evidence. The auditor should
evaluate whether analytical procedures that were performed as substantive
tests or in the overall review stage of the audit indicate a previously unrecog
nized risk of material misstatement due to fraud. The auditor also should
consider whether responses to inquiries throughout the audit about analytical
relationships have been vague or implausible, or have produced evidence that
is inconsistent with other evidential matter accumulated during the audit.
2.31 At or near the completion of fieldwork, the auditor should evaluate
whether the accumulated results of auditing procedures and other observa
tions affect the assessment of the risks of material misstatement due to fraud
made earlier in the audit. As part of this evaluation, the auditor with final
responsibility for the audit should ascertain that there has been appropriate
communication with the other audit team members throughout the audit
regarding information or conditions indicative of risks of material misstate
ment due to fraud.
Responding to Misstatements That May Be the Result of Fraud

2.32 When audit test results identify misstatements in the financial
statements, the auditor should consider whether such misstatements may be
indicative of fraud. See paragraphs 75 through 78 of SAS No. 99 (AU sec.
316.75-.78) for requirements and guidance about an auditor’s response to
misstatements that may be the result of fraud. If the auditor believes that
misstatements are or may be the result of fraud, but the effect of the misstate
ments is not material to the financial statements, the auditor nevertheless
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should evaluate the implications, especially those dealing with the organiza
tional position of the person(s) involved.
2.33 If the auditor believes that the misstatement is or may be the result
of fraud, and either has determined that the effect could be material to the
financial statements or has been unable to evaluate whether the effect is
material, the auditor should:
a. Attempt to obtain additional evidential matter to determine whether
material fraud has occurred or is likely to have occurred, and, if so,
its effect on the financial statements and the auditor’s report
thereon.1
b. Consider the implications for other aspects of the audit (see para
graph 76 of SAS No. 99 [AU sec. 316.76]).
c. Discuss the matter and the approach for further investigation with
an appropriate level of management that is at least one level above
those involved, and with senior management and the audit commit
tee.12
d. If appropriate, suggest that the client consult with legal counsel.
2.34 The auditor’s consideration of the risks of material misstatement
and the results of audit tests may indicate such a significant risk of material
misstatement due to fraud that the auditor should consider withdrawing from
the engagement and communicating the reasons for withdrawal to the audit
committee or others with equivalent authority and responsibility. The auditor
may wish to consult with legal counsel when considering withdrawal from an
engagement.
Communicating About Possible Fraud to Management, the Audit
Committee, and Others

2.35 Whenever the auditor has determined that there is evidence that
fraud may exist, that matter should be brought to the attention of an appropri
ate level of management. See paragraphs 79 through 82 of SAS No. 99 (AU sec.
316.79-.82) for further requirements and guidance about communications with
management, the audit committee, and others.
Documenting the Auditor's Consideration of Fraud

2.36 Paragraph 83 of SAS No. 99 (AU sec. 316.83) requires certain items
and events to be documented by the auditor. Auditors should comply with those
requirements.
Practical Guidance

2.37 The AICPA Practice Aid Fraud Detection in a GAAS Audit—Revised
Edition, provides a wealth of information and help on complying with the
provisions of SAS No. 99. Moreover, this Practice Aid will assist auditors in
understanding the requirements of SAS No. 99 and whether current audit
practices effectively incorporate these requirements. This Practice Aid is an
1 See Statement on Auditing Standards (SAS) No. 58, Reports on Audited Financial Statements
(AICPA, Professional Standards, vol. 1, AU sec. 508), for guidance on auditor’s reports issued in
connection with audits of financial statements.
2 If the auditor believes senior management may be involved, discussion of the matter directly
with the audit committee may be appropriate.
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Other Auditing Publication as defined in SAS No. 95, Generally Accepted
Auditing Standards (AICPA, Professional Standards, vol. 1, AU sec. 150).
Other Auditing Publications have no authoritative status; however, they may
help the auditor understand and apply SASs.
Infernal Control†

2.38 SAS No. 55, Consideration of Internal Control in a Financial State
ment Audit, as amended by SAS No. 78, Consideration of Internal Control in a
Financial Statement Audit: An Amendment to SAS No. 55, and SAS No. 94, The
Effect of Information Technology on the Auditor’s Consideration of Internal
Control in a Financial Statement Audit (AICPA, Professional Standards, vol. 1,
AU sec. 319), describes the components of internal control and explains how an
independent auditor should consider internal control in planning and perform
ing an audit. Internal control is a process—effected by an entity’s board of
directors, management, and other personnel—designed to provide reasonable
assurance regarding the achievement of objectives in the following categories:
(a) reliability of financial reporting, (b) effectiveness and efficiency of opera
tions, and (c) compliance with applicable laws and regulations. Internal control
consists of the following five interrelated components:
a. Control environment
b. Risk assessment
c. Control activities
d. Information and communication
e. Monitoring
2.39 The auditor should obtain an understanding of each of the five compo
nents of internal control sufficient to plan the audit. A sufficient understanding is
obtained by performing procedures to understand the design of controls relevant
to an audit of financial statements and whether the controls have been placed in
operation. In obtaining this understanding, the auditor considers how an entity’s
use of information technology (IT) and manual procedures may affect controls
relevant to the audit. IT encompasses automated means of originating, processing,
storing, and communicating information, and includes recording devices, commu
nication systems, computer systems, and other electronic devices. The auditor is
primarily interested in the entity’s use of IT to initiate, record, process, and report
transactions or other financial data.
2.40 After obtaining an understanding of the components of internal control,
the independent auditor assesses control risk for the assertions embodied in the
account balance, transaction class, and disclosure components of the financial
statements. The independent auditor uses the understanding of internal control
and the assessed level of control risk in determining the nature, timing, and extent
of substantive tests for financial statement assertions.†
† In March 2004, the PCAOB issued Auditing Standard No. 2, which was subsequently
approved by the SEC. This Standard applies to audits of the financial statements of issuers, as
defined by the Sarbanes-Oxley Act, and other entities when prescribed by the rules of the SEC
(collectively referred to as “issuers”). PCAOB Auditing Standard No. 2 establishes requirements that
apply when an auditor is engaged to audit both an issuer’s financial statements and management’s
assessment of the effectiveness of internal control over financial reporting. Due to the issuance of
PCAOB Auditing Standard No. 2, a related proposed Standard (PCAOB Release No. 2004-002),
would amend and supersede certain sections of the PCAOB Interim Standards. See the Preface to
this Guide for more detailed information, and paragraph 2.02 of this chapter. Registered public
accounting firms auditing the financial statements of issuers should keep alert to final SEC approval
of this PCAOB Standard.
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Analytical Procedures

2.41 SAS No. 56, Analytical Procedures (AICPA, Professional Standards,
vol. 1, AU sec. 329), provides guidance on the use of analytical procedures and
requires their use in the planning and overall review stages of all audits. The
AICPA Audit Guide Analytical Procedures, provides practical guidance to
auditors on the effective use of analytical procedures. That Audit Guide in
cludes a discussion of SAS No. 56; concepts and definitions; a series of ques
tions and answers; and a case study illustrating trend analysis, ratio analysis,
reasonableness testing, and regression analysis. For planning purposes, these
procedures should focus on (a) enhancing the independent auditor’s under
standing of the client’s business and the transactions and events that have
occurred since the last audit date and (b) identifying areas that may represent
specific risks relevant to the audit. Thus, the objective of the procedures is to
identify such things as the existence of unusual transactions and events, as
well as amounts, ratios, and trends that might indicate matters that have
financial statement and audit planning ramifications. For overall review pur
poses, these procedures should focus on considering the adequacy of the
evidence gathered in response to unusual or unexpected balances or relation
ships. The objective of the procedures is to assist the auditor in assessing the
conclusions reached and evaluating the overall financial statement presenta
tion. Analytical procedures also may be used as substantive tests to identify
potential misstatements. These procedures focus on comparing actual balances
with expected balances and investigating and evaluating significant differ
ences from the balances expected. SAS No. 96 amends SAS No. 56 (AICPA,
Professional Standards, vol. 1, AU sec. 329.22), to add a requirement that the
auditor document all of the following when an analytical procedure is used as
the principal substantive test of a significant financial statement assertion:
a. The expectation, where that expectation is not otherwise readily
determinable from the documentation of the work performed, and
factors considered in its development
b. Results of the comparison of the expectation to the recorded amounts
or ratios developed from recorded amounts
c. Any additional auditing procedures performed in response to signifi
cant unexpected differences arising from the analytical procedure
and the results of such additional procedures
2.42 Examples of sources of information for developing expectations in
clude prior-period financial information, budgets, and health care financial
and statistical ratios. Additional information is available from the Center for
Healthcare Industry Performance Studies’ (CHIPS) Financial Analysis Service,
which is published annually, as well as other health care industry associations.
2.43 Following are examples of analytical procedures the independent
auditor may find useful:
• Comparison of account balances with budget and prior-period amounts
• Analysis of changes in revenues during the current period based on
statistical data (for example, admissions, patient days, visits, and
professional service procedure counts for laboratory, radiology, and
surgery) and information concerning price changes
• Comparison between periods of the number of days of revenue in
receivables
• Relationship between periods of the allowance for uncollectible ac
counts to the balance of patient accounts receivable in the aggregate,
AAG-HCO 2.41

53

General Auditing Considerations

based on known changes in the accounts receivable’s aging and com
position by payor
• Relationship between periods of the liability for claims incurred but
not reported (IBNR) to the related expense
Accounting Estimates

2.44 In determining the scope of audit procedures to be performed, the
independent auditor should recognize that certain areas of health care organi
zation operations require accounting estimates that may be material in the
preparation and presentation of financial statements. SOP 94-6, Disclosure of
Certain Significant Risks and Uncertainties,3 requires entities to include in
their financial statements information about the use of estimates in the
preparation of financial statements. In addition, if certain specified disclosure
criteria are met, the SOP requires entities to include disclosures about certain
significant estimates in their financial statements. SAS No. 57, Auditing
Accounting Estimates (AICPA, Professional Standards, vol. 1, AU sec. 342),
provides guidance on obtaining and evaluating sufficient competent evidential
matter to support significant accounting estimates in an audit of financial
statements in accordance with GAAS. SOP 00-1 provides guidance for auditors
regarding the sufficiency of evidential matter supporting accounting estimates
recorded for the proper valuation of health care third-party revenues and
related receivables. SOP 00-1 is included as Appendix E to this Guide.
2.45 Although management is responsible for making estimates, the inde
pendent auditor is responsible for evaluating the reasonableness of estimates and
should consider appropriate procedures in planning and performing the audit.
These procedures should include both subjective and objective factors.
2.46 The independent auditor should acquire an understanding of the
relevance of internal control to the accumulation of data and the preparation
of accounting estimates. Internal control should also provide for adequate
review and approval of accounting estimates by appropriate levels of authority.
2.47 Although significant accounting estimates may affect many ele
ments of a health care organization’s financial statements, they most often
affect the following:
a. The provision for third-party payor contractual adjustments and
allowances and the provision for estimated receivables and payables
for final settlements with those payors
b. The provision for uncollectible accounts
c. Accruals for uninsured medical malpractice claims
d. Accruals for obligations under continuing care contracts
e. Accruals by providers of prepaid health care services for IBNR costs
Individual Practice Associations

2.48 In planning the audit of an individual practice association (IPA), the
auditor usually considers the following matters:
• The size of a typical IPA accounting department and business office
often is not large enough to result in effective segregation of duties.

3
SOP 94-6 does not pertain to governmental entities, unless the entity has elected to follow all
FASB pronouncements under paragraph 7 of GASB Statement No. 20, Accounting and Financial
Reporting for Proprietary Funds and Other Governmental Entities That Use Proprietary Fund
Accounting. (See Chapter 1, footnote 1.)
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However, most IPAs have an active office manager who can exercise
a high degree of influence and control over the operations.
• Physician compensation arrangements often use incentives or other
features with complicated methodologies and formulas.
• Contracts with managed care plans, often with capitated payment and
risk pool settlement terms, frequently represent a significant amount
of revenue for the IPA.
2.49 IPAs with capitated contracts accrue costs when the services are
rendered, including cost estimates of IBNR claims. The IBNR accrual includes
an estimate of the costs of services for which the IPA is responsible, including
referrals outside the IPA. Risk pool settlements should be accrued during the
contract period based on relevant factors, such as experience to date.
Other Planning Considerations

2.50 In planning the audit, the independent auditor also should consider—
• Matters relating to the entity’s business and the health care industry.
• Financial statement items likely to require adjustment.
• Conditions that might require extension or modification of audit tests
(such as the existence of related party transactions or the existence of
uninsured malpractice risks).
• The entity’s experience with payment denials and other matters
subject to review by medical review organizations.
• The nature of reports expected to be rendered. Examples include
reports on consolidated or consolidating financial statements, reports
on financial statements filed with the Securities and Exchange Com
mission (SEC), reports filed with third-party payors or other regula
tory bodies, and other special reports.
2.51 Planning procedures usually include reviewing the independent
auditor’s files relating to the entity and holding discussions with audit person
nel and the personnel of the entity. Examples of these procedures include the
following:
• Review correspondence files, the prior year’s audit documentation,
permanent files, financial statements, and independent auditors’ re
ports.
• Review the minutes of meetings of the governing board of directors
and board committees.
• Review the relationship of affiliated organizations to the health care
organization and determine the extent to which their financial infor
mation should be included in the financial statements of the entity.
(See the related discussion in Chapter 11.)
• Review the status of unsettled cost (reimbursement) reports for prior
periods filed with third-party payors.
• Discuss matters that may affect the audit with the firm’s personnel
responsible for any nonaudit services to the entity.
• Identify situations for which accounting estimates are required and
relevant factors that may affect those estimates.
• Inquire about current business developments affecting the entity.
• Read the current year’s interim financial statements and 10-Q forms.
• Review periodic reports to third-party payors or other regulatory
bodies.
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• Discuss the nature, scope, and timing of the engagement with the
entity’s management, board of directors, or audit committee.
• Consider the effects of all applicable accounting and auditing pro
nouncements, particularly recent pronouncements.
• Coordinate the assistance of entity personnel in data preparation.
• Determine the extent of involvement, if any, of consultants, special
ists, and internal auditors.
• Establish the timing of the audit work.
2.52 SAS No. 96 (AICPA, Professional Standards, vol. 1, AU sec. 339),
provides guidance regarding the content, ownership, and confidentiality of
audit documentation. Audit documentation should include abstracts or copies
of significant contracts or agreements that were examined to evaluate the
accounting for significant transactions.‡
2.53 The independent auditor may find it helpful to maintain a perma
nent file that includes copies of the following documents relating to the health
care organization:
a. Articles of incorporation
b. Bylaws
c. Chart of accounts
d. Organization chart
e. Specific documents concerning restrictions on donor gifts and bequests
f. Contracts and agreements, including leases, agreements with phy
sicians, agreements with third-party payors, and agreements with
affiliated organizations
g. Description of internal control
h. Loan agreements, bond indentures, and other debt instruments
2.54 The independent auditor should understand the specific cost-finding
or other rate-setting methods used by third-party payors to determine final
amounts reimbursable to the health care organization. These payment meth
ods may require that a health care organization accumulate and report various
statistical data, such as admissions, discharges, patient days, visits, beds,
square footage, and pounds of laundry.
2.55 The independent auditor intending to use audit-sampling proce
dures should refer to SAS No. 39, Audit Sampling (AICPA, Professional Stand
ards, vol. 1, AU sec. 350), when planning the work to be done. The AICPA Audit
Guide Audit Sampling presents recommendations on the application of gener
ally accepted auditing standards to audits involving the use of audit sampling‡
‡ The PCAOB has issued 1) Auditing Standard No. 3, Audit Documentation, and an amendment
to their Interim Auditing Standards, and 2) Auditing Standard No. 2. These Standards apply to
audits of financial statements of issuers, as defined by the Sarbanes-Oxley Act, and other entities
when prescribed by the rules of the SEC (collectively referred to as “issuers”).
The Audit Documentation Standard supersedes AU sec. 339 of the PCAOB’s Interim Standards.
The Standard establishes general requirements for documentation the auditor should prepare and
retain in connection with any engagement conducted in accordance with auditing and related
professional practice Standards of the PCAOB.
PCAOB Auditing Standard No. 2 establishes requirements that apply when an auditor is
engaged to audit both an issuer’s financial statements and management’s assessment of the effective
ness of internal control over financial reporting. PCAOB Auditing Standard No. 2 provides that in
addition to the documentation requirements contained in AU sec. 339 of the PCAOB’s Interim
Standards, the auditor should document certain items related to their audit of internal control over
financial reporting.
See the Preface to this Guide for more detailed information, and paragraph 2.02 of this chapter.
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methods, and guidance on applying audit sampling in accordance with SAS No.
39.
2.56 If the health care organization has an internal audit function, the
independent auditor should also refer to SAS No. 65, The Auditor’s Considera
tion of the Internal Audit Function in an Audit of Financial Statements
(AICPA, Professional Standards, vol. 1, AU sec. 322).
Transactions Processed by Service Organizations

2.57 Health care organizations may engage outside service organizations
to perform services that are part of the health care provider’s information
system. A service organization’s services are part of an entity’s information
system if they affect any of the following—
• The classes of transactions in the entity’s operations that are signifi
cant to the entity’s financial statements
• The procedures, both automated and manual, by which the entity’s
transactions are initiated, recorded, processed, and reported from
their occurrence to their inclusion in the financial statements
• The related accounting records, whether electronic or manual, sup
porting information, and specific accounts in the entity’s financial
statements involved in initiating, recording, processing and reporting
the entity’s transactions
• How the entity’s information system captures other events and condi
tions that are significant to the financial statements
• The financial reporting process used to prepare the entity’s financial
statements, including significant accounting estimates and disclo
sures
Examples of service organizations used by health care organizations include
the following:
• Bank trust departments that invest and service assets for health care
organizations
• Service organizations that process payroll
• Billing entities that prepare reimbursement claims to insurers and
other third parties
• Administrators of employee benefit plans who process and pay benefit
claims and maintain participant records
2.58 SAS No. 55, as amended by SAS No. 78, and SAS No. 94 states that
the auditor should obtain an understanding of an entity’s internal control
sufficient to plan the audit. This understanding may encompass controls
placed in operation by the health care organization and service organizations
whose services are part of the health care organization’s information system.
In planning the audit, such information should be used to—
• Identify types of potential misstatements.
• Consider factors that affect the risk of material misstatement.
• Design tests of controls, when applicable.
• Design substantive tests.
2.59 SAS No. 70, Service Organizations, as amended (AICPA, Profes
sional Standards, vol. 1, AU sec. 324), explains the considerations an auditor
should make in obtaining an understanding of internal control and assessing
control risk for entities that use a service organization to process transactions.
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The AICPA Audit Guide Service Organizations: Applying SAS No. 70, as
Amended, provides additional guidance for user auditors engaged to audit the
financial statements of entities that use service organizations.
2.60 The auditor of a health care organization should determine whether
the health care organization uses a service organization. Information about the
nature of the services provided by the service organization and the service
organization’s controls over those services may be available from sources such
as user manuals, system overviews, technical manuals, the contract between
the health care organization and the service organization, and reports by
service auditors, internal auditors, or regulatory authorities on the service
organization’s controls.
2.61 After considering the available information, the auditor of the health
care organization may conclude that he or she has the means to obtain a
sufficient understanding of internal control to plan the audit. If the auditor of
the health care organization concludes that information is not available to
obtain a sufficient understanding to plan the audit, he or she may consider
contacting the service organization, through the health care organization, to
obtain specific information or request that a service auditor be engaged to
perform procedures that will supply the necessary information, or the auditor
of the health care organization may visit the service organization and perform
such procedures. If the auditor of the health care organization is unable to
obtain sufficient evidence to achieve his or her audit objectives, the auditor of
the health care organization should qualify his or her opinion or disclaim an
opinion on the financial statements because of a scope limitation.
2.62 After obtaining an understanding of internal control, the auditor
may assess control risk at the maximum level for some or all financial state
ment assertions related to the service organization’s processing because, he or
she believes controls are unlikely to pertain to an assertion, are unlikely to be
effective, or because evaluating their effectiveness would be inefficient. Proce
dures to evaluate operating effectiveness include one or any combination of the
following:
a. Performing tests of controls over the activities of the service organi
zation at the health care organization
b. Performing tests of controls at the service organization
c. Obtaining a service auditor’s report that describes the results of tests
of the operating effectiveness of controls performed by the service
auditor
Other Audit Considerations
Illegal Acts

2.63 The Social Security Act provides for criminal penalties for individu
als or entities that offer, pay, solicit, or receive remuneration to induce busi
ness that is reimbursed under Medicare or state health care programs. The
types of remuneration covered by the Medicare Anti-Kickback Statute include,
with certain exceptions, kickbacks, bribes, and rebates made directly or indi
rectly, overtly or covertly, and in cash or in kind. In addition, prohibited
conduct includes not only remuneration intended to induce referrals or pa
tients but also remuneration intended to induce the purchasing, leasing,
ordering, or arranging for any good, facility, service, or item paid for by
Medicare or state health care programs. In addition, fraudulent activities may
exist that are unrelated to Medicare or state programs, such as fraudulent
billing and admitting practices.
AAG-HCO 2 .6 3

58

Health Care Organizations

2.64 The auditor’s procedures will vary based on his or her assessment of
the risk of material misstatement resulting from such illegal acts. SAS No. 54
states that the auditor should plan and perform the audit to provide reasonable
assurance of detecting illegal acts having a direct and material effect on the
determination of financial statement amounts. SAS No. 54 also notes that an
audit in accordance with GAAS does not include audit procedures specifically
designed to detect illegal acts that have only an indirect effect on the financial
statements (for example, illegal acts that have a material effect as the result
of fines or penalties that may be imposed on the entity) and provides guidance
on the auditor’s responsibilities when specific information concerning the
possible existence of this type of illegal act comes to the auditor’s attention.
2.65 Examples of laws and regulations that are generally recognized by
auditors to have a direct and material effect on the determination of amounts
in financial statements of health care organizations include tax laws affecting
tax accruals and tax expense as well as Medicare and Medicaid laws directly
affecting the amount of revenue recognized during the accounting period (such
as those concerning the submission of bills for fictitious patients).
2.66 Health care organizations also may be affected by many other laws
and regulations such as those related to Medicare and Medicaid fraud and
abuse, securities trading, occupational safety and health, food and drug ad
ministration, environmental protection, equal employment opportunities, and
price-fixing or other antitrust violations. Generally, these laws and regulations
relate more to an entity’s operating aspects than to its financial and accounting
aspects, and their financial statement effect is only indirect. An auditor ordi
narily does not have sufficient basis for recognizing possible violations of such
laws and regulations. Their indirect effect is normally the result of the need to
disclose a contingent liability because of the allegation or determination of
illegality. For example, patients may be obtained based on illegal arrange
ments with physicians or other providers. While the direct effects of the
services rendered may be recorded appropriately, their indirect effects, the
possible contingent liability for violating Medicare and Medicaid fraud and
abuse statutes, may not be appropriately disclosed. Even when violations of
such laws and regulations can have consequences material to the financial
statements, auditors may not become aware of the existence of the illegal act
unless he or she is informed by the client, or there is evidence of a governmental
agency investigation or enforcement proceeding in the records, documents, or
other information normally inspected in an audit of financial statements.
2.67 Whether an act is, in fact, illegal is a determination that is normally
beyond the auditor’s professional competence. The auditor’s training, experi
ence, and understanding of the client and the industry may provide a basis for
recognizing that some acts coming to the auditor’s attention may be illegal.
However, determining whether a particular client act is illegal generally would
be based on the advice of an informed expert qualified to practice law or may
have to await final determination by a court of law. For example, determining
whether admitting a patient or providing a service is medically necessary or
whether a particular procedure or device was properly approved is not within
the auditor’s professional competence.
Use of a Specialist

2.68 SAS No. 73, Using the Work of a Specialist (AICPA, Professional
Standards, vol. 1, AU sec. 336), provides guidance to the auditor who uses the
work of a specialist in performing the audit of a health care organization’s
financial statements. Guidance is provided on deciding when to use a special
ist, the auditor’s responsibilities for evaluating the qualifications and the work
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of the specialist, and using the findings of the specialist. The Statement
requires the auditor to evaluate the relationship of the specialist to the client
and states that the auditor should perform additional procedures if the auditor
concludes that the objectivity of the specialist may be impaired by such a
relationship.
Clinical Coding Validations

2.69 Typically, a number of clinicians (e.g., the attending physician,
consulting physicians, radiologists, pathologists, therapists, and nurses) add
documentation to a patient’s medical record. Provider personnel generally
review the medical record and assign a code (ICD-9-CM or CPT-4 code) to the
record. The provider prepares and submits a bill that includes, among other
things, the assigned ICD-9-CM or CPT-4 code. The Medicare Fiscal Intermedi
ary or other third-party payor typically reviews the bill and assigns it a specific
payment code, such as a Diagnostic Related Group (DRG) number. Payment is
based on the DRG or other payment code assigned. The provider may check the
payment code assigned and follow up on any discrepancies identified. However,
since the assignment of the payment code is made by the third-party payor,
responsibility for correct assignment rests with that payor.
2.70 Errors can occur throughout this process. Physicians or other clini
cians may not document the appropriate procedure. Coding personnel may not
notice or interpret certain items in the medical record correctly. Accordingly,
an incorrect code may be assigned and an erroneous amount may be paid.
2.71 An auditor ordinarily would not find it necessary to consider the
process of assigning codes in planning and performing an audit of the
provider’s financial statements. However, the auditor should be alert for
indications of potential material misstatements of the financial statements
resulting indirectly from such matters. For example, the auditor may become
aware that a retrospective review has been performed or that an investigation
has been completed or is in process. In such circumstances, the auditor should
consider whether performance of additional substantive audit procedures is
necessary to reduce audit risk to an acceptable level.

Going-Concern Considerations

2.72 SAS No. 59, The Auditor’s Consideration of an Entity’s Ability to
Continue as a Going Concern (AICPA, Professional Standards, vol. 1, AU sec.
341), provides guidance to the independent auditor conducting an audit on how
to evaluate whether there is substantial doubt about the entity’s ability to
continue as a going concern. Continuation of an entity as a going concern is
assumed in financial reporting in the absence of significant information to the
contrary. Ordinarily, information that significantly contradicts the going-con
cern assumption relates to the entity’s inability to continue to meet its obliga
tions as they become due without substantial disposition of assets outside the
ordinary course of business, restructuring of debt, externally forced revision of
its operations, or similar actions. SAS No. 59 states that the independent
auditor has a responsibility to evaluate whether there is substantial doubt
about the entity’s ability to continue as a going concern for a reasonable period
of time, not to exceed one year beyond the date of the financial statements
being audited. SAS No. 96 amends SAS No. 59 (AICPA, Professional Stand
ards, vol. 1, AU sec. 341.17), to add a requirement that the auditor document
certain matters if, after considering the identified conditions and events in the
aggregate, the auditor believes there is substantial doubt about the ability of
the entity to continue as a going concern for a reasonable period of time, not to
exceed one year beyond the date of the financial statements being audited.
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2.73 Noncompliance with donor-imposed restrictions should be disclosed
if there is a reasonable possibility that a material contingent liability has been
incurred at the date of the financial statements or there is at least a reasonable
possibility that the noncompliance could lead to a material loss of revenue or
could cause an entity to be unable to continue as a going concern. If the
noncompliance results from an organization’s failure to maintain an appropri
ate composition of assets in amounts needed to comply with all donor restric
tions, the amounts and circumstances should be disclosed.
Communication
Communication of Matters Related to Internal Control

2.74 SAS No. 60, Communication of Internal Control Related Matters
Noted in an Audit (AICPA, Professional Standards, vol. 1, AU sec. 325),
provides guidance in identifying and reporting conditions related to an entity’s
internal control that are observed during an audit of the financial state
ments.|| It is contemplated that the communication generally would be to the
audit committee or, in organizations that do not have an audit committee, to
those with an equivalent level of authority and responsibility such as the board
of directors, the owner in an owner-managed enterprise, or the individuals who
engaged the independent auditor. Conditions noted by the independent auditor
that are considered reportable under SAS No. 60 should be reported, preferably
in writing. If information is communicated orally, the independent auditor
should document the communication by appropriate memoranda or notations
in the audit documentation.
Communication With Audit Committees

2.75 SAS No. 61, Communication With Audit Committees, as amended by
SAS No. 89, Audit Adjustments, and SAS No. 90, Audit Committee Communi
cations (AICPA, Professional Standards, vol. 1, AU sec. 380), establishes a
requirement for the independent auditor to determine that certain matters
related to the conduct of an audit are communicated to those with responsibil
ity for oversight of the financial reporting process. The communications re
quired by SAS No. 61 are applicable to (a) entities that either have an audit
committee or otherwise have formally designated oversight of the financial
reporting process to a group equivalent to an audit committee (such as a
finance committee or a budget committee) and (b) all SEC engagements as
defined in SAS No. 61. In addition, communication with the audit committee
or its equivalent by the independent auditor on certain specified matters when
they arise in the conduct of an audit is required by other standards, including
SAS No. 99 and SAS No. 54.
Management Representations

2.76 SAS No. 85, Management Representations, as amended by SAS No.
89, Audit Adjustments, and SAS No. 99 (AICPA, Professional Standards, vol.
1, AU sec. 333), establishes a requirement that an auditor performing an audit
in accordance with GAAS, obtain written representations from management for
| See footnote t to paragraph 2.38. Also, the ASB has released an exposure draft of a proposed
Statement on Auditing Standards (SAS), Communication of Internal Control Related Matters Noted
in an Audit. Among other matters, the proposed SAS would supersede SAS No. 60. This proposed
SAS is not applicable to public accounting firms registered with the PCAOB and their associated
persons in connection with their audits of issuers, as defined by the Sarbanes-Oxley Act, and other
entities when prescribed by the rules of the SEC.
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all financial statements and periods covered by the auditor’s report. The
specific written representations to be obtained depend on the circumstances of
the engagement and the nature and basis of presentation of the financial
statements. Paragraph 6 of SAS No. 85, as amended by SAS No. 89 and SAS
No. 99, lists matters ordinarily included in management’s representation
letter. SAS No. 85, as amended by SAS No. 89 and SAS No. 99, includes several
examples as well. Appendix A of the SAS, as amended by SAS No. 89 and SAS
No. 99, includes an illustrative management representation letter, Appendix
B provides illustrative wording for additional representations that may be
appropriate in certain situations, and Appendix C provides an illustrative
updating management representation letter. Auditors of governmental health
care entities also should consider obtaining representations concerning the
information provided in MD&A, as provided in SAS No. 52, Required Supple
mentary Information (AICPA, Professional Standards, vol. 1, AU sec. 558.07c).
Independent auditors of health care organizations also might obtain repre
sentations, if applicable, of the following:
• The health care organization is in compliance with the provisions of
Internal Revenue Code (IRC) sec. 501(c)(3) and is exempt from federal
income tax under IRC sec. 501(a), as evidenced by a determination
letter.
• Information returns have been filed on a timely basis.
• Provision has been made, when material, for estimated retroactive
adjustments by third-party payors under reimbursement agreements.
• The health care organization is in compliance with bond indentures or
other debt instruments.
• Pending changes in the organizational structure, financing arrange
ments, or other matters that could have a material effect on the
financial statements of the entity are properly disclosed.
• The health care organization is in compliance with contractual agree
ments, grants, and donor restrictions.
• The health care organization has maintained an appropriate compo
sition of assets in amounts needed to comply with all donor restrictions.
• All assets and liabilities under the entity’s control have been included
in the financial statements.
• The internal controls over the receipt and recording of contributions
received are adequate.
• Reclassifications between net asset classes is proper.
2.77
SOP 00-1 provides the following examples of specific representations
for receivables, cost reports filed with third parties, and contingencies related
to health care third-party revenue recognition:
• Receivables
— Adequate consideration has been given to, and appropriate provi
sion made for, estimated adjustments to revenue, such as for
denied claims and changes to diagnosis-related group (DRG)
assignments.
— Recorded valuation allowances are necessary, appropriate, and
properly supported.
— All peer review organizations, fiscal intermediary, and thirdparty payor reports and information have been made available.
• Cost reports filed with third parties
— All required Medicare, Medicaid, and similar reports have been
properly filed.
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— Management is responsible for the accuracy and propriety of all
cost reports filed.
— All costs reflected on such reports are appropriate and allowable
under applicable reimbursement rules and regulations and are
patient-related and properly allocated to applicable payors.
— The reimbursement methodologies and principles employed are
in accordance with applicable rules and regulations.
— Adequate consideration has been given to, and appropriate provi
sion made for, audit adjustments by intermediaries, third-party
payors, or other regulatory agencies.
— All items required to be disclosed, including disputed costs that
are being claimed to establish a basis for a subsequent appeal,
have been fully disclosed in the cost report.
— Recorded third-party settlements include differences between
filed (and to be filed) cost reports and calculated settlements,
which are necessary based on historical experience or new or
ambiguous regulations that may be subject to differing interpre
tations. While management believes the entity is entitled to all
amounts claimed on the cost reports, management also believes
the amounts of these differences are appropriate.
• Contingencies
— There are no violations or possible violations of laws or regula
tions, such as those related to the Medicare and Medicaid antifraud
and abuse statutes, including but not limited to the Medicare and
Medicaid Anti-Kickback Statute, Limitations on Certain Physi
cian Referrals (the Stark law), and the False Claims Act, in any
jurisdiction, whose effects should be considered for disclosure in
the financial statements or as a basis for recording a loss contin
gency other than those disclosed or accrued in the financial
statements.
— Billings to third-party payors comply in all material respects with
applicable coding guidelines (for example, ICD-9-CM and CPT-4)
and laws and regulations (including those dealing with Medicare
and Medicaid antifraud and abuse), and billings reflect only
charges for goods and services that were medically necessary;
properly approved by regulatory bodies (for example, the Food and
Drug Administration), if required; and properly rendered.
— There have been no communications (oral or written) from regu
latory agencies, governmental representatives, employees, or oth
ers concerning investigations or allegations of noncompliance
with laws and regulations in any jurisdiction (including those
related to the Medicare and Medicaid antifraud and abuse stat
utes), deficiencies in financial reporting practices, or other mat
ters that could have a material adverse effect on the financial
statements.
Single Audit Act and Related Audit Considerations

2.78
An independent auditor may be engaged to audit the financial
statements of a health care organization that expends federal awards from a
governmental agency in accordance with the Single Audit Act Amendments of
1996 and Office of Management and Budget (OMB) Circular A-133, Audits of
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States, Local Governments, and Non-Profit Organizations. Federal awards may
take the form of grants, contracts, loans, loan guarantees, property, coopera
tive agreements, interest subsidies, and insurance or direct appropriations.
2.79 OMB Circular A-133 prescribes policies, procedures, and guidelines
to implement the Single Audit Act Amendments of 1996 and requires state and
local governments and not-for-profit organizations that expend total federal
awards equal to or in excess of $500,000 in a fiscal year to have an audit
performed in accordance with the Act and OMB Circular A-133.#
2.80 Institutions covered by OMB Circular A-133 include not-for-profit
hospitals and public hospitals and institutions of higher education, and their
affiliated hospitals, voluntary health and welfare organizations and other
community-based organizations.*4 Medicare payments to a non-federal entity
for providing patient care services to Medicare eligible individuals are not
considered federal awards expended under OMB Circular A-133. Medicaid
payments to a subrecipient for providing patient care services to Medicaid
eligible individuals are not considered federal awards expended under OMB
Circular A-133 unless a state requires the funds to be treated as federal awards
expended because reimbursement is on a cost-reimbursement basis.
2.81 OMB Circular A-110 establishes standard requirements (such as
insurance, record retention, and banking) for obtaining consistency and uni
formity among federal agencies in the administration of grants to and agree
ments with public and private hospitals and other entities. OMB Circular A-87,
Cost Principles for State and Local Governments, establishes principles and
standards for determining allowable costs incurred by state and local govern
ments under grants, contracts, and other agreements. OMB Circular A-21,
Cost Principles for Educational Institutions, and OMB Circular A-122, Cost
Principles for Nonprofit Organizations, establish principles and standards for
determining allowable costs incurred by educational institutions and not-forprofit organizations under grants, contracts, and other agreements. Federal
research and development awards under grants and contracts administered by
hospitals are exempt from OMB’s cost principles circulars A-87, A-21 and
A-122, but are subject to requirements provided in the U.S. Department of
Health and Human Services regulations at 45 CFR part 74, Appendix E,
“Principles for Determining Costs Applicable to Research and Development
Under Grants and Contracts with Hospitals.”
2.82 SAS No. 74, Compliance Auditing Considerations in Audits of Gov
ernmental Entities and Recipients of Governmental Financial Assistance
(AICPA, Professional Standards, vol. 1, AU sec. 801), provides general guid
ance for audits of governmental entities and entities that receive federal
awards. The Statement explains the requirements of the financial audit stand
ards contained in Government Auditing Standards, as amended (the Yellow
Book) issued by the Comptroller General of the United States and their
relationship to GAAS. It also provides general guidance on testing compliance
with requirements applicable to federal awards. The Statement clarifies that
the entity, rather than the independent auditor, is responsible for arranging
* This threshold was changed to $500,000 from $300,000, effective for fiscal years ending after
December 31, 2003. Early implementation is not permitted.
4 The Codification of Office of Management and Budget (OMB) Circular A-133 by the U.S.
Department of Health and Human Services also includes audit requirements for commercial organi
zations (including for-profit hospitals) that receive federal awards under HHS programs. Generally,
the organization has two options regarding audits: (1) a financial-related audit of a particular award
in accordance with Government Auditing Standards, or (2) an audit that meets the requirements of
OMB Circular A-133. See title 45 of the Code of Federal Regulations (CFR) section 74.26(d) for
further information.
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for audits that meet all applicable requirements and provides guidance on
communications the auditor should make upon becoming aware that the entity
may be subject to an audit requirement that may not be satisfied by his or her
engagement.
2.83 The Audit Guide Government Auditing Standards and Circular
A-133 Audits, provides guidance on the auditor’s responsibilities when con
ducting a single audit or program-specific audit in accordance with the Single
Audit Act Amendments of 1996 and OMB Circular A-133. It discusses the
auditor’s responsibility for considering internal control and for performing
tests of compliance with applicable laws, regulations, and program compliance
requirements. Further, it provides reporting guidance including examples of
the reports required by Government Auditing Standards and OMB Circular
A-133.
Statutory Reporting Considerations for Managed
Care Organizations
Risk-based Capital Requirements

2.84 Many managed care organizations (MCO) that bear financial risk
are regulated by state departments of insurance. The risk-based capital (RBC)
formula is one of the tools used by regulators to evaluate the financial health
of regulated entities.
2.85 The National Association of Insurance Commissioners (NAIC) for
mula for the RBC of managed care organizations became effective in the filing
of 1998 annual statements. Five principal risk elements to the MCO RBC
formula are: affiliated investment risk, asset risk, underwriting risk, credit
risk, and general business risk. Four action levels (in order of increasingly
stringent level of regulatory response) are: company action level, regulatory
action level, authorized control level, and mandatory control level. At a mini
mum, the company action-level event requires the filing with the respective
state insurance commissioner an RBC plan detailing conditions leading to the
event and proposals of corrective action. State laws vary as to whether appli
cable legislation pertaining to compliance with the RBC formula has been passed.
Additional information can be found on the NAIC Web site at www.naic.org.
Codification of Statutory Accounting Practices for Managed
Care Organizations

2.86 Generally speaking, regulated insurers have been required by their
state of domicile to submit annually a set of audited financial statements that were
prepared using that state’s prescribed or permitted statutory accounting practices.
These statutory accounting practices are considered to be an “other comprehensive
basis of accounting” (OCBOA) under SAS No. 62, Special Reports.
2.87 In 1999, the NAIC completed a process to codify statutory accounting
practices for certain insurance entities (including regulated MCO), resulting in
a revised Accounting Practices and Procedures Manual effective January 1,
2001 (the “revised Manual”). This Manual has also been updated on an annual
basis and a new Accounting Practices and Procedure Manual (Manual) reflect
ing revisions or additions to SAP is published in March of each year. It is
expected that most states will require insurers to comply with most, if not all,
provisions of the Manual. States may adopt the Manual in whole, or in part, as
an element of prescribed statutory accounting practices in those states. If,
however, the requirements of state laws, regulations, and administrative rules
differ from guidance provided in the Manual those state laws, regulations, and
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administrative rules will take precedence. Preparers of financial statements
and auditors should monitor the status of the adoption of the Manual by the
domiciliary state insurance regulatory authority.
2.88 Practitioners should consider whether going-concern issues exist as
a result of the financial statement effect of adoption. This includes considera
tion of the effect on RBC.
2.89 Nine of the Statements of Statutory Accounting Principles (SSAPs)
included in the revised Manual have been specifically modified or written to address
issues related to managed care. These include SSAP No. 25, Accounting for and
Disclosures about Transactions with Affiliates and Other Related Parties, No. 35,
Guaranty Fund and Other Assessments, No. 47, Uninsured Plans, No. 50, Classi
fications and Definitions of Insurance or Managed Care Contracts in Force, No. 54,
Individual and Group Accident and Health Contracts, No. 55, Unpaid Claims,
Losses and Loss Adjustment Expenses, No. 66, Retrospectively Rated Insurance
Contracts, No. 73, Health Care Delivery Assets—Supplies, Pharmaceuticals and
Surgical Supplies, Durable Medical Equipment, Furniture, Medical Equipment and
Fixtures, and Leasehold Improvements in Health Care Facilities and SSAP No. 84,
Health Care Receivables. All other SSAPs will apply if applicable to the entity.
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Chapter 3
Cash and Cash Equivalents
Accounting and Financial Reporting

3.01
Cash and cash equivalents should include all cash and highly liquid
investments that are both (a) readily convertible to cash and (b) so near to
maturity that they present insignificant risk of changes in value because of
changes in interest rates, in accordance with paragraph 8 of FASB Statement
No. 95, Statement of Cash Flows, and paragraph 9 of GASB Statement No. 9,
Reporting Cash Flows of Proprietary and Nonexpendable Trust Funds and
Governmental Entities That Use Proprietary Fund Accounting. For fiduciary
purposes, separate checking or savings accounts may be maintained for re
stricted donations. Such accounts, however, are not reported on a line separate
from other cash and cash equivalents because donor restrictions generally
relate to limitations on the use of net assets rather than on the use of specific
assets.1 However, cash and claims to cash that (a) are restricted as to with
drawal or use for other than current operations, (b) are designated for expen
diture in the acquisition or construction of noncurrent assets, (c) are required
to be segregated for the liquidation of long-term debts, or (d) are required by a
donor-imposed restriction that limits their use to long-term purposes are
reported separately and are excluded from current assets. (See paragraph
10.10.) Internally designated funds should be reported separately from exter
nally designated funds either on the face of the balance sheet or in the notes to
the financial statements. If the form of the assets is not evident from the
description on the balance sheet, the form of the assets should be disclosed in
the notes to the financial statements. GASB Statement No. 9, paragraph 8,
provides that a governmental health care enterprise’s statement of cash flows
should explain the change in all cash and cash equivalents, regardless of any
restrictions on their use. For governmental health care entities, restricted cash
and cash equivalents should be reported when restrictions on the use of those
assets change the nature or normal understanding of those assets, as discussed
in GASB Statement No. 34, Basic Financial Statements and Management’s
Discussion and Analysis for State and Local Governments, paragraph 99. For
example, cash and investments that can only be used to pay debt principal and
interest would be reported as restricted cash and investments or as cash and
investments held by trustee for debt service. The term restricted is defined by
GASB Statement No. 34, paragraphs 34 and 99. A restriction is a constraint
placed on the use of assets or net assets that is either externally imposed (such
as by creditors through debt covenants) or imposed by law through constitu
tional provisions or enabling legislation.
Agency Funds

3.02
Health care organizations may receive and hold assets owned by
others under agency relationships; for example, they may perform billing and
1
A columnar presentation that highlights the three classes of net assets (that is, permanently
restricted, temporarily restricted, and unrestricted) is not precluded if the totals for the reporting
entity as a whole are displayed.
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collection services for physicians. In accepting responsibility for those assets,
an organization incurs a liability to the principal under the agency relationship
to return the assets in the future or, if authorized, to disburse them to another
party on behalf of the principal. Such agency funds are reported as unrestricted
assets.
3.03
In other cases, not-for-profit health care organizations may act as
agents, trustees, or intermediaries helping donors to make a contribution to
another entity or individual. When acting in that capacity, those organizations
do not receive a contribution when they receive the assets, nor do they make a
contribution when they disburse the assets to the other entity or individual.
Instead, they act as go-betweens, passing the assets from the donor through
their organization to the specified entity or individual. FASB Statement No.
136, Transfers of Assets to a Not-for-Profit Organization or Charitable Trust
That Raises or Holds Contributions for Others,2 establishes standards for
transactions in which a donor makes a contribution by transferring assets to a
recipient organization—a not-for-profit organization or a charitable trust—
that accepts the assets from the donor and agrees to use the assets on behalf
of or transfer the assets, their investment return, or both to another entity—
the beneficiary—named by the donor.3 In general, if a donor specifies a
beneficiary, the recipient organization should not recognize a contribution.
(For exceptions, see the discussion of variance power at paragraph 10.05 in
this Guide and financially interrelated organizations at paragraphs 11.29
through 11.33 in this Guide.) Instead, as discussed in paragraph 11 of FASB
Statement No. 136, the recipient organization should recognize its liability to
the specified beneficiary concurrent with its recognition of cash or other
financial assets received from the donor. Both the asset and the liability
recognized should be measured at the fair value of the assets received. If the
assets received from the donor are donated materials, supplies, or other
nonfinancial assets, the recipient organization may choose either to (a) report
the receipt of the assets as a liability to the beneficiary concurrent with
recognition of the assets received or (b) not report the transaction at all. The
choice is an accounting policy that should be applied consistently from period
to period. An entity should consider the need for disclosure in the notes to the
financial statements pursuant to APB Opinion No. 22, Disclosure of Accounting
Policies, and paragraph 11 of FASB Statement No. 136. Standards for not-forprofit organizations that act as agents, trustees, or intermediaries are de
scribed further in Chapters 5 and 6 of the Audit and Accounting Guide
Not-for-Profit Organizations.
Disclosures

3.04
If the provider has concentrations of credit risk related to financial
instruments such as certificates of deposit or money market mutual funds,
the disclosure requirements of FASB Statement No. 107, Disclosures about
Fair Value of Financial Instruments, as amended by FASB Statement No. 133,
2 This pronouncement is not applicable to governmental health care enterprises. (See footnote 1
in Chapter 1.)
3 FASB Statement No. 136 also establishes standards for transactions that take place in a
similar manner but are not contributions because the transfers are revocable, repayable, or recipro
cal. For example, if a resource provider transfers assets to a recipient organization and names itself
or its affiliate as beneficiary, that transaction is reciprocal even if the resource provider grants
variance power. Those standards and transactions are discussed in paragraphs 4.14, 4.15, 11.21,
11.23 and 11.24 in this Guide. This Guide does not use the word donor in discussing those transac
tions because they are not contributions.
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Accounting for Derivative Instruments and Hedging Activities,4 should be
followed. Examples of potential exposure to credit risk include funds deposited
with a single financial institution in excess of Federal Deposit Insurance
Corporation (FDIC) limits and investments in obligations that are not insured or
guaranteed by the government. For governmental health care enterprises,
GASB Statement No. 3, Deposits with Financial Institutions, Investments (in
cluding Repurchase Agreements), and Reverse Repurchase Agreements, requires
certain disclosures about deposits, including credit risk classification of bank
balances that are not entirely insured.**
Auditing

3.05
There are no unique auditing considerations with respect to cash and
cash equivalents recorded by health care organizations.

4
This pronouncement is not applicable to governmental health care enterprises that do not
apply paragraph 7 of GASB Statement No. 20, Accounting and Financial Reporting for Proprietary
Funds and Other Governmental Entities That Use Proprietary Fund Accounting. (See footnote 1 in
Chapter 1.)
*In March 2003, the GASB issued GASB Statement No. 40, Deposit and Investment Risk
Disclosures, an amendment of GASB Statement No. 3, Deposits with Financial Institutions, Invest
ments (including Repurchase Agreements), and Reverse Repurchase Agreements. Among other mat
ters, GASB Statement No. 40 establishes and modifies disclosure requirements for deposit risks. The
provisions of GASB Statement No. 40 are effective for financial statements for periods beginning
after June 15, 2004. Earlier application is encouraged. Conforming changes to reflect the issuance of
GASB Statement No. 40 will be made in a future edition of this Guide.
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Chapter 4
Investments
Accounting

4.01 This chapter discusses the accounting and reporting for investments
of health care entities other than (a) equity investments accounted for under
the equity method or (b) investments in consolidated subsidiaries. Discussions
pertaining to those two types of investments are included in Chapter 11. In
some cases, nongovernmental health care organizations may transfer assets to
a not-for-profit organization (such as a community foundation or a financially
interrelated organization) or a trust for investment and management. Para
graphs 4.14 and 4.15 discuss a nongovernmental health care organization’s
reporting of investments held on its behalf by unrelated foundations and trusts
or by related organizations that are not financially interrelated. Paragraphs
11.21 through 11.24 and 11.29 through 11.33 discuss the reporting by a
nongovernmental health care organization of investments held on its behalf by
financially interrelated organizations.
4.02 The accounting for investments in equity securities that have readily
determinable fair values and all investments in debt securities is discussed in
paragraphs 4.03 through 4.13. Other types of investments that are not finan
cial instruments (such as real estate or certain oil and gas interests) are
reported at amortized cost and are subject to impairment considerations
consistent with FASB Statement No. 144, Accounting for the Impairment or
Disposal of Long-Lived Assets.1
Investments in Debt Securities and Certain Equity Securities

4.03 This section discusses the accounting and reporting for investments
in equity securities that have readily determinable fair values and all invest
ments in debt securities held by (a) investor-owned entities, (b) not-for-profit
organizations, and (c) governmental entities.
Investor-Owned Entities

4.04 Investor-owned providers are subject to the accounting and report
ing requirements of FASB Statement No. 115, Accounting for Certain Invest
ments in Debt and Equity Securities. FASB Statement No. 115 defines three
categories into which an enterprise classifies investments. The accounting and
reporting differ by category. Investments in debt securities that the enterprise
has the positive intent and ability to hold to maturity are classified as held-tomaturity securities and are reported at amortized cost. Debt and equity securi
ties that are bought and held principally for the purpose of selling them in the
near term are classified as trading securities and reported at fair value, with
unrealized holding gains and losses included in income. However, an enter
prise is not precluded from classifying at acquisition a security it plans to hold
for a longer period as a trading security. Investments in debt securities that
1
This pronouncement is not applicable to governmental health care enterprises that do not
apply paragraph 7 of GASB Statement No. 20, Accounting and Financial Reporting for Proprietary
Funds and Other Governmental Entities That Use Proprietary Fund Accounting. (See footnote 1 in
Chapter 1.)
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are not classified as held-to-maturity or trading and equity securities that are
not classified as trading are classified as available-for-sale securities and re
ported at fair value, with unrealized holding gains and losses excluded from
income and reported in a separate component of other comprehensive income
until realized, except all or a portion of the unrealized holding gain and loss of
an available-for-sale security that is designated as being hedged in a fair value
hedge shall be recognized in earnings during the period of the hedge.2
4.05 Investor-owned entities should follow the disclosure requirements of
FASB Statement No. 115, as amended by FASB Statement No. 133, Account
ing for Derivative Instruments and Hedging Activities.3
Not-for-Profit Organizations

4.06 Not-for-profit organizations should report investments in equity
securities with readily determinable fair values and all debt securities at fair
value on the balance sheet consistent with FASB Statement No. 124, Account
ing for Certain Investments Held by Not-for-Profit Organizations. FASB State
ment No. 124 does not apply to investments in derivative instruments that are
subject to the requirements of FASB Statement No. 133. FASB Statement No.
133 establishes accounting and reporting standards for derivative instru
ments, including certain derivative instruments embedded in other contracts
and for hedging activities. Investment return, including realized and unreal
ized gains and losses, should be included as changes in net assets consistent
with paragraphs 4.07 through 4.10.
4.07 Investment return (including realized and unrealized gains and
losses) not restricted by donors or by law should be classified as changes in
unrestricted net assets as follows:
a. Included in the performance indicator (see paragraphs 10.19 and
10. 20 ):
• Dividend, interest, and other similar investment income
• Realized gains and losses
• Unrealized gains and losses on trading securities4
• Other than temporary impairment losses5
b. Excluded from the performance indicator:
2 Emerging Issues Task Force (EITF) Issue No. 03-1, The Meaning of Other-Than-Temporary
Impairment and Its Application to Certain Investments, provides guidance to determine when an
investment is considered impaired, whether that impairment is other-than-temporary, and the
measurement of an impairment loss. EITF Issue No. 03-1 also provides guidance regarding account
ing considerations subsequent to the recognition of an other-than-temporary impairment, and re
quires certain disclosures about unrealized losses that have not been recognized as
other-than-temporary impairments. EITF No. 03-1 applies to debt and equity securities within the
scope of FASB Statement No. 115, Accounting for Certain Investments in Debt and Equity Securities,
and FASB Statement No. 124, Accounting for Certain Investments Held by Not-for-Profit Organiza
tions, (applicable to investments held by a not-for-profit health care organization in the scope of this
Guide). See EITF Issue No. 03-1 for further information regarding investments within the scope of
this Issue. The recognition and measurement guidance is effective for reporting periods beginning
after June 15, 2004. For investments accounted for under FASB Statements No. 115 and No. 124, the
disclosure requirements are effective for annual financial statements for fiscal years ending after
December 15, 2003. The disclosures for other investments within the scope of this Issue are effective
for annual financial statements for fiscal years ending after June 15, 2004.
3 See footnote 2 in paragraph 4.04.
4 Trading securities are defined in FASB Statement No. 115, including any interpretations
thereof.
5 See footnote 2 in paragraph 4.04.
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• Unrealized gains and losses on other than trading securities
4.08 Except as described in paragraphs 4.09 and 4.10, investment return
(including realized and unrealized gains and losses) restricted by donors or by
law, should be classified as changes in temporarily or permanently restricted
net assets consistent with the applicable restrictions.
4.09 Gains and investment income that are limited to specific uses by
donor-imposed restrictions may be reported as increases in unrestricted net
assets if the restrictions are met in the same reporting period as the gains and
income are recognized, provided that the organization has a similar policy for
reporting contributions received, applies the policy consistently from period to
period, and discloses its accounting policy. The classification of these gains and
investment income in unrestricted net assets should be consistent with para
graph 4.07.
4.10 In the absence of donor stipulations or law to the contrary, losses on
the investments of a donor-restricted endowment fund6 shall reduce temporar
ily restricted net assets to the extent that donor-imposed temporary restric
tions on net appreciation of the fund have not been met before the loss occurs.
Any remaining loss shall reduce unrestricted net assets and shall be excluded
from the determination of the performance indicator. If losses reduce the assets
of a donor-restricted endowment fund below the level required by the donor
stipulations or law, gains that restore the fair value of the assets of the
endowment fund to the required level shall be classified as increases in
unrestricted net assets and shall be excluded from the determination of the
performance indicator.
4.11 Not-for-profit organizations should follow the disclosure require
ments of FASB Statement No. 124.7
Governmental Entities

4.12 Governmental health care entities are subject to the accounting and
reporting requirements of GASB Statement No. 31, Accounting and Financial
Reporting for Certain Investments and for External Investment Pools. Govern
mental health care entities should report investments in (a) participating
interest-earning investment contracts, (b) external investment pools, (c) openended mutual funds, (d) debt securities, and (e) equity securities, option contracts,
stock warrants, and stock rights that have readily determinable fair values at
fair value on the balance sheet. Governmental entities are permitted to report
certain money market investments and participating interest-earning invest
ment contracts at amortized cost, provided that the investment has a remain
ing maturity of one year or less at time of purchase. All investment income,
including changes in the fair value of investments, shall be recognized as
revenue in the statement of revenues, expenses, and changes in net assets/
equity. Governmental health care entities are required to distinguish between
operating revenues and expenses and nonoperating revenues and expenses.
(See further discussion in paragraph 10.23 of this Guide.) Governmental health
*Donors that create endowment funds can require that their gifts be invested in perpetuity or
for a specified term. Some donors may require that a portion of income, gains, or both be added to the
gift and invested subject to similar restrictions. It is generally understood that at least the amount of
the original gifit(s) and any required accumulations are not expendable, although the value of the
investments purchased may occasionally fall below that amount. Future appreciation of the invest
ments generally restores the value to the required level. In states that have enacted its provisions,
the Uniform Management of Institutional Funds Act describes “historic dollar value” as the amount
that is not expendable.
7 See footnote 2 in paragraph 4.04.
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care entities should follow the disclosure requirements of GASB Statement No.
31. Also, GASB Statement No. 34, paragraph 121, requires that governmental
health care entities that receive donor-restricted endowments make certain
disclosures about their use of investment income generated by those endow
ments.
4.13 GASB Statements No. 3, Deposits with Financial Institutions, In
vestments (Including Repurchase Agreements), and Reverse Repurchase
Agreements, No. 28, Accounting and Financial Reporting for Securities Lend
ing Transactions, and GASB Interpretation No. 3, Financial Reporting for
Reverse Repurchase Agreements, provide guidance on investment-related
disclosures required by governmental entities as well as accounting for secu
rities lending and reverse repurchase agreements.
Transfers of Assets to a Not-for-Profit Organization or
Charitable Trust for Investment

4.14 If a nongovernmental health care organization transfers assets to a
not-for-profit organization or charitable trust (called a recipient organization)
that accepts those assets and agrees to use them on behalf of or transfer them,
their investment return, or both back to the health care organization or its
affiliate, the transfer is reciprocal and thus is not a contribution (see para
graphs 4, 17 and 18 of FASB Statement No. 136, Transfers of Assets to a
Not-for-Profit Organization or Charitable Trust That Raises or Holds Contri
butions for Others).8 Examples of that type of reciprocal transfer include (a) a
nongovernmental health care organization transfers assets to a community
foundation to establish an endowment for the benefit of the nongovernmental
health care organization (or its affiliate) and (b) a nongovernmental health care
organization transfers assets to a foundation it creates to hold those assets.
Paragraphs 17 and 18 of FASB Statement No. 136 describe two types of
reciprocal transfers, which are:
• An equity transaction—The nongovernmental health care organiza
tion (a) specifies itself or its affiliate as the beneficiary, (b) the health
care organization and the recipient organization are financially inter
related organizations (paragraph 11.22 discusses financially interre
lated organizations), and (c) neither the health care organization nor
its affiliate expects payment of the transferred assets, although pay
ment of investment return on the transferred assets may be expected.
(All three criteria must be met.)
• The nongovernmental health care organization specifies itself or its
affiliate as the beneficiary and the transfer is not an equity transaction.
(The three criteria (a), (b), and (c) in the previous bullet are not
met.)
4.15 If the reciprocal transaction is not an equity transaction, the nongov
ernmental health care organization reports an asset, in exchange for the assets
transferred, as discussed in paragraph 17 ofFASB Statement No. 136. (Accounting
* In March 2003, the GASB issued GASB Statement No. 40, Deposit and Investment Risk
Disclosures, an amendment of GASB Statement No. 3, Deposits with Financial Institutions, Invest
ments (including Repurchase Agreements), and Reverse Repurchase Agreements. Among other mat
ters, GASB Statement No. 40 establishes and modifies disclosure requirements related to investment
risks. The provisions of GASB Statement No. 40 are effective for financial statements for periods
beginning after June 15, 2004. Earlier application is encouraged. Conforming changes to reflect the
issuance of GASB Statement No. 40 will be made in a future edition of this Guide.
8
This pronouncement is not applicable to governmental health care enterprises. (See footnote 1
in Chapter 1).
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for equity transactions is discussed in paragraphs 11.21 through 11.24 of this
Guide.) The nongovernmental health care organization should disclose the
following information for each period for which a statement of financial posi
tion is presented, in accordance with paragraph 19 of FASB Statement No.
136:
• The identity of the recipient organization to which the transfer was
made
• Whether variance power was granted to the recipient organization
and, if so, a description of the terms of the variance power9
• The terms under which amounts will be distributed to the health care
organization or its affiliate
• The aggregate amount recognized in the statement of financial posi
tion for those transfers and whether that amount is recorded as an
interest in the net assets of the recipient organization or as another
asset (for example, as a beneficial interest in assets held by others or
a refundable advance).
Financial Statement Presentation
Entities Subject to FASB Statement No. 115, FASB
Statement No. 124, or GASB Statement No. 31

4.16 Securities should be reported as either current or noncurrent, as
appropriate, under the provisions of ARB No. 43, Restatement and Revision of
Accounting Research Bulletins, Chapter 3A.10
4.17 For cash flow reporting purposes by nongovernmental entities, pur
chases, sales, and maturities of trading securities should be classified as cash
flows from operating activities; governmental entities should classify these
items as investing activities. Cash flows from purchases, sales, and maturities
of all other securities should be classified as cash flows from investing activi
ties. If investments in debt securities are reported as cash equivalents in
accordance with FASB Statement No. 95, Statement of Cash Flows, or GASB
Statement No. 9, Reporting Cash Flows of Proprietary and Nonexpendable
Trust Funds and Governmental Entities That Use Proprietary Fund Account
ing, the notes to the financial statements should reconcile the reporting classi
fications used in the statement of financial position.
4.18 All health care organizations with investments that meet the defini
tion of financial instruments set forth in FASB Statement No. 107 are subject
9 Because of their reciprocal nature, those transfers were presumed by the FASB not to be
contributions received or made—even if the health care organization granted variance power at the
time of the transfer. See paragraph 96 of FASB Statement No. 136.
10 Chapter 3A of ARB No. 43 indicates in paragraph 4 that “the term current assets is used to
designate cash and other assets or resources commonly identified as those which are reasonably
expected to be realized in cash or sold or consumed during the normal operating cycle of the
business.” That paragraph further indicates that the term also comprehends “marketable securities
representing the investment of cash available for current operations.” Paragraph 5 indicates that “a
one-year time period is to be used as a basis for the segregation of current assets in cases where there
are several operating cycles occurring within a year.” Paragraph 6 says that the “concept of the
nature of current assets contemplates the exclusion from that classification o f. . . cash and claims to
cash which are restricted as to withdrawal or use for other than current operations, are designated
for expenditure in the acquisition or construction of noncurrent assets, or are segregated for the
liquidation of long-term debts.” Cash and cash equivalents of permanent endowment funds held
temporarily until suitable long-term investment opportunities are identified are included in the
classification “long-term investments.”
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to the disclosure requirements of FASB Statement No. 107, Disclosures about
Fair Value of Financial Instruments.11 Organizations with derivative instru
ments that meet the definition of derivative instruments set forth in FASB
Statement No. 133, as amended by FASB Statement No. 149, Amendment of
Statement 133 on Derivative Instruments and Hedging Activities, are subject to
the disclosure requirements in FASB Statement No. 133.1112 SOP 02-2, Account
ing for Derivative Instruments and Hedging Activities by Not-for-Profit Health
Care Organizations and Clarification of the Performance Indicator, requires
that not-for-profit health care organizations that are within the scope of this
Guide provide disclosures that are analogous to those required by paragraph
45 of FASB Statement No. 133 for for-profit enterprises, including the disclo
sure of anticipated reclassifications into the performance indicator of gains and
losses that have been excluded from that measure and reported in accumulated
derivative gain or loss as of the reporting date. SOP 02-2 does not apply to
governmental entities that are within the scope of this Guide. SOP 02-2 is
included as Appendix F to this Guide. Governmental health care entities are
also required to disclose information about their investments in accordance
with GASB Statements No. 3, No. 28,†and No. 31, GASB Technical Bulletin
No. 87-1, Applying Paragraph 68 of GASB Statement No. 3, No. 03-1, Disclo
sure Requirements for Derivatives Not Reported at Fair Value on the Statement
of Net Assets,† No. 97-1, Classifications of Deposits and Investments into
Custodial Credit Risk Categories for Certain Bank Holding Company Transac
tions, and GASB Interpretation No. 3.
4.19
The following example illustrates the accounting treatment and
financial statement presentation for other-than-trading securities of a not-forprofit health care organization:
Facts

Other than trading securities are purchased in year 1 at a cost of $100. At the
end of year 1, the fair value of the securities is $300. In year 2, the securities
are sold for $400.
Journal Entries

• Entry at the end of year 1 to adjust the recorded value of the securities
to fair value:
Valuation allowance
200
Change in net unrealized gains and losses on investments
200

11 Disclosures about the fair value of financial instruments prescribed in FASB Statement No.
107 are optional for an entity that meets the criteria of FASB Statement No. 126, Exemption from
Certain Required Disclosures about Financial Instruments for Certain Nonpublic Entities, as
amended by FASB Statement No. 133, Accounting for Derivative Instruments and Hedging Activities,
and FASB Statement No. 149, Amendment of Statement 133 on Derivative Instruments and Hedging
Activities.
12 FASB Statements No. 107 and No. 133 are not applicable to governmental health care
enterprises that do not apply paragraph 7 of GASB Statement No. 20. (See footnote 1 in Chapter 1.)
† See footnote * to paragraph 4.13 in this chapter.
In June 2003, the GASB issued Technical Bulletin (TB) No. 03-1, Disclosure Requirements for
Derivatives Not Reported at Fair Value on the Statement of Net Assets. Among other matters, GASB
TB No. 03-1 supersedes GASB TB No. 94-1, Disclosures about Derivatives and Similar Debt and
Investment Transactions. GASB TB No. 03-1 is effective for financial statements for periods ending
after June 15, 2003. Earlier application is encouraged.
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• Entry at the end of year 2 to record the sale of the securities:
Cash
400
Realized gain
300
Investments
100
Change in net unrealized gains and losses on investments
200
Valuation allowance
200
As discussed in paragraph 4.07, unrealized gains and losses on other than
trading securities are reported in the statement of operations below the per
formance indicator and realized gains and losses are reported in the statement
of operations above the performance indicator.
Auditing

4.20
Auditing objectives and procedures for investments of health care
organizations generally are similar to those of other organizations. SAS No. 92,
Auditing Derivative Instruments, Hedging Activities, and Investments in Securi
ties (AICPA, Professional Standards, vol. 1, AU sec. 332), among other matters,
provides guidance to auditors in planning and performing auditing procedures
for assertions about investments in securities that are made in an entity’s
financial statements. The guidance in SAS No. 92 applies to all debt and equity
securities. SAS No. 92 uses the definitions of debt security and equity security
that are in FASB Statement No. 115, but applies to debt and equity securities
without regard to whether they are subject to the requirements of FASB
Statement No. 115, such as, for example, assertions about securities accounted
for under the equity method following the requirements of APB Opinion No.
18, The Equity Method of Accounting for Investments in Common Stock. A
companion Audit Guide Auditing Derivative Instruments, Hedging Activities,
and Investments in Securities, provides practical guidance for implementing
SAS No. 92. In addition, the independent auditor may need to consider the
examples of specific auditing objectives, selected control activities, and audit
ing procedures that are presented in Exhibit 4-1.
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Exhibit 4-1

Auditing Considerations

Financial Statement Specific Auditing
Assertions
Objectives
Existence and
Marketable
completeness;
securities are
rights and
fairly stated,
obligations; and properly
valuation
classified,
described, and
disclosed.

Selected Control
Activities
An independent
trustee manages
the investments.
The trustee’s
reports are
reviewed by a
responsible
employee.

Auditing
Procedures
Verify existence
through
confirmation.
Test the valuation
of equity and debt
securities not
intended to be
held to maturity
by comparing the
recorded values
with the fair
market values
reported by the
trustee or another
independent
source. For fair
value estimates
obtained from
third-party
sources, the
auditor should
consider the
applicability of
the guidance in
SAS No. 73, Using
the Work of a
Specialist
(AICPA,
Professional
Standards, vol. 1,
AU sec. 336) or
SAS No. 70,
Service
Organizations
(AICPA,
Professional
Standards, vol. 1,
AU sec. 324).13

13
Paragraphs 35 through 46 of SAS No. 92, Auditing Derivative Instruments, Hedging
Activities, and Investments in Securities (AICPA, Professional Standards, vol. 1, AU sec. 332), and
paragraphs 6.16 through 6.38 in the companion Audit Guide Auditing Derivative Instruments,
Hedging Activities, and Investments in Securities, provide guidance to auditors on audit evidence that
may be used to support assertions about the fair value of securities. That guidance should be
considered in the context of specific accounting requirements. SAS No. 101, Auditing Fair Value
Measurements and Disclosures (AICPA, Professional Standards, vol. 1, AU sec. 328), provides
additional guidance on auditing fair value measurements and disclosures contained in financial
statements. SAS No. 101 does not address specific types of assets, liabilities, components of equity,
transactions, or industry-specific practices.
AAG-HCO 4 .2 0

Investments

79

Financial Statement Specific Auditing
Assertions
Objectives
Valuation, rights, Endowment
and obligations funds are
properly stated at
their required
value and related
gains and losses
are properly
classified.

Selected Control
Activities
Value of
endowment
funds are
reviewed
periodically to
ensure that the
balance is at its
required level.

Auditing
Procedures
Verified that
value of
endowments are
at required levels
through
confirmation.
Review treatment
of gains and
losses on
endowment funds
to ensure that
they are properly
classified.

Accuracy and
completeness

Review of
investment
transactions to
ensure they are
recorded in
compliance with
donor restrictions.

Test the recording
of selected
transactions to
ensure amounts
are properly
classified in
accordance with
donor restrictions.

Investment
income and
gains/losses are
recorded in
accordance with
donor restrictions.

Presentation and Securities are
properly
disclosure
classified.

Classification is
monitored
periodically and
is based on
management’s
intent or ability
to dispose of
excess funds that
are available for
operations within
an operating
cycle.

AAG-HCO 4 .2 0

81

Receivables

Chapter 5
Receivables

5.01 Receivables may include amounts due for (a) health care services
from patients, residents, third-party payors, and employers; (b) premiums and
stop-loss insurance recoveries; (c) intercompany transactions; (d) promises to
give in future periods (pledges); and (e) amounts due from employees, physi
cians, or others. All loans, such as loans to physicians, should be evaluated
periodically for impairment. Loans that are included in the scope of FASB State
ment No. 114, Accounting by Creditors for Impairments of a Loan,1 should be
evaluated based on the provisions of that statement. A loan is impaired when,
based on current information and events, it is probable that the provider will
be unable to collect all amounts due, including principal and interest, according
to the contractual terms of the loan agreement. If the provider measures an
impaired loan using a present value amount, the creditor should calculate that
present value based on an estimate of the expected future cash flows of the
impaired loan, discounted at the loan’s effective interest rate.
5.02 Amounts realizable from third-party payors for health care services
are usually less than the provider’s full established rates for those services. The
realizable amounts may be determined by (a) contractual agreement with
others (such as Blue Cross plans, Medicare, Medicaid, or HMOs), (b) legislation
or regulation (such as workers’ compensation or no-fault insurance), or (c)
provider policy or practice (such as courtesy discounts to medical staff mem
bers and employees or other administrative adjustments).
5.03 Revenue and the related receivables for health care services usually
are recorded in the accounting records on an accrual basis at the provider’s full
established rates. The provision for contractual adjustments (that is, the
difference between established rates and third-party payor payments) and
discounts (that is, the difference between established rates and the amount
collectible) are recognized on an accrual basis and deducted from gross service
revenue to determine net service revenue. Contractual adjustments, discounts,
and an allowance for uncollectibles are recorded to report the receivables for
health care services at net realizable value. Estimates of contractual adjust
ments, other adjustments, and the allowance for uncollectibles are reported in
the period during which the services are provided even though the actual
amounts may become known at a later date. This later date may be (a) when
the person is discharged, (b) subsequent to discharge or completion of service,
(c) when the third party is billed, or (d) when payment or partial payment is
received. As discussed in paragraph 10.03, the provision of charity care does
not qualify for recognition as receivables or revenue in the financial statements.
5.04 Nongovernmental health care organizations with loans and trade
receivables should follow the recognition and measurement guidance in para
graph 8 of Statement of Position (SOP) 01-6, Accounting by Certain Entities
(Including Entities With Trade Receivables) That Lend to or Finance the
Activities of Others, to the extent that that guidance is applicable.1
1
This pronouncement is not applicable to governmental health care enterprises that do not
apply paragraph 7 of GASB Statement No. 20, Accounting and Financial Reporting for Proprietary
Funds and Other Governmental Entities That Use Proprietary Fund Accounting. (See footnote 1 in
Chapter 1.)
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Rate Setting

5.05 The independent auditor should be familiar with the rate-setting
environment in which the entity operates and the regulations and contractual
agreements that determine payments to be received for health care services.
Payment rates established by regulations or contractual agreements may be
determined either prospectively or retrospectively.
5.06 Prospective rate setting is a method used to set payment rates in
advance of the delivery of health care services. Such payment rates determine
what third parties will pay for health care services during the rate period
(generally one year). Prospective rate setting may result from a contractual
agreement with a third party, such as a Blue Cross plan, or it may be mandated
through legislation. The intent of prospective rate setting is to establish
payment rates before the period to which they will apply and that are not
subject to change. The independent auditor should be aware, however, that
some rate-setting methods described as prospective may include provision for
retrospective adjustments and that some third parties pay prospective rates
for certain services and retrospective rates for other services.
5.07 Under retrospective rate setting, third parties usually determine an
interim payment rate and, during the rate period (generally one year), pay the
health care organization for services rendered using that rate. After the rate
period has ended, a final settlement is made in accordance with federal or state
regulations or contractual agreements.
Estimated Final Settlements

5.08 Under a retrospective system, an entity may be entitled to receive
additional payments or may be required to refund amounts received in excess
of amounts earned under the system. Although final settlements are not made
until a subsequent period, they are usually subject to reasonable estimations
and are reported in the financial statements in the period in which services are
rendered. Differences between original estimates and subsequent revisions
(including final settlements) are included in the statement of operations in the
period in which the revisions are made and disclosed, if material. Those
differences are not treated as prior period adjustments unless they meet the
criteria for prior period adjustments as set forth in FASB Statement No. 16,
Prior Period Adjustments.2
5.09 Rate-setting methods that are described as prospective but provide
for retrospective adjustments are accounted for as retrospective rate-setting
systems for the services to which they apply (see paragraph 5.08).
State Waiver Contingencies Under Medicare

5.10 Certain states (referred to as waiver states) have received permis
sion to determine rates of payment for Medicare patients in accordance with a
statewide rate-setting method different from the method used by the federal
program. A condition for Medicare participation in a state waiver program
typically requires that Medicare expenditures in that state not exceed pre
scribed limits. If Medicare expenditures exceed prescribed limits, the excess,
depending on the conditions of the waiver, may be recoverable by the federal2
2
Paragraph 37 of SOP 00-1, Auditing Health Care Third-Party Revenues and Related Receiv
ables, provides a sample disclosure for material differences between an original estimate and
subsequent revisions. SOP 00-1 is included in Appendix E to this Guide.
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government. FASB Statement No. 5, Accounting for Contingencies, provides
guidance with respect to accounting for loss contingencies, such as those arising
under state Medicare waivers. GASB Statement No. 10, Accounting and Finan
cial Reporting for Risk Financing and Related Insurance Issues, provides
guidance with respect to accounting for contingencies by governmental entities.
Premiums and Stop-Loss Insurance Receivables

5.11 Some health care organizations contract to provide comprehensive
health care services for a fixed period in return for fixed periodic premiums.
Many of those organizations may transfer a portion of their financial risks
under the contract to another organization by purchasing stop-loss insurance.
Receivables of those organizations may include uncollected premiums and
amounts recoverable from stop-loss insurers reduced by appropriate valuation
allowances. Chapter 13 provides guidance on applying GAAP for stop-loss
insurance costs of providers of prepaid health care services. FASB Statement
No. 113, Accounting and Reporting for Reinsurance of Short-Duration and
Long-Duration Contracts, also provides guidance on accounting for reinsur
ance contracts. Governmental entities should comply with the provisions of
GASB Statement No. 10 which provides different guidance on accounting for
reinsurance contracts than FASB Statement No. 113.

Promises to Give in Future Periods (Pledges)

5.12 Providers involved in fund-raising campaigns frequently are the
recipients of promises to give3 with payments due in future periods; pledge
drives are a common example. FASB Statement No. 116, Accounting for
Contributions Received and Contributions Made,4 establishes the accounting
and financial reporting guidance for pledges and similar promises to pay. Provid
ers may also be the beneficiaries of fund-raising campaigns conducted by others.
FASB Statement No. 136, Transfers of Assets to a Not-for-Profit Organization
or Charitable Trust That Raises or Holds Contributions for Others,5 estab
lishes standards for transactions in which a donor makes a contribution by
transferring assets to a recipient organization—a not-for-profit organization or
a charitable trust—that accepts the assets from the donor and agrees to use the
assets on behalf of or transfer the assets, their investment return, or both to
another entity—the beneficiary—named by the donor.6 In general, a nongov
ernmental health care organization that is specified as a beneficiary recognizes
its rights to the assets held by a recipient organization as an asset: either a
beneficial interest or a receivable. (See paragraph 15 of FASB Statement No.
136.) (For exceptions, see the discussion of variance power at paragraph 10.05 and
financially interrelated organizations at paragraphs 11.29 through 11.33 of this
Guide.) If the beneficiary has an unconditional right to receive all or a portion of
the specified cash flows from a charitable trust or other identifiable pool of assets,
the beneficiary has a beneficial interest. The beneficiary recognizes that beneficial

3 To be recognized in financial statements there must be sufficient evidence in the form of
verifiable documentation that a promise was made and received (FASB Statement No. 116, para
graph 6).
4 This pronouncement is not applicable to governmental health care enterprises. (See footnote 1
in Chapter 1.)
5 See footnote 4.
6 FASB Statement No. 136 also establishes standards for transactions that take place in a
similar manner but are not contributions because the transfers are revocable, repayable, or recipro
cal. Those standards and transactions are discussed in paragraphs 4.14, 4.15, 11.21, 11.23, and 11.24
of this Guide. This Guide does not use the word donor in discussing those transactions because they
are not contributions.
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interest as an asset and a contribution received, measuring and subse- quently
remeasuring it at fair value, using a valuation technique such as the present
value of the estimated expected future cash flows. If the beneficiary has uncon
ditional rights to receive the value of the transferred assets at a future date,
the beneficiary has a receivable that should be recognized in accordance with
the provisions of FASB Statement No. 116 for unconditional promises to give.
5.13 A general summary of the provisions of FASB Statement No. 116 for
promises to give is presented below. Specific guidance is provided in chapter 5
of the AICPA Audit and Accounting Guide Not-for-Profit Organizations. By
specifying that they will adhere to future payment dates, donors implicitly
indicate that their gift is to support activities in each period in which a
payment is scheduled. Therefore, in any promise to give with payments due in
future periods, a time restriction is implicit unless the donor explicitly states
that the gift is to support current activities or other circumstances clearly point
to that intent.
5.14 Promises to give fall into two broad categories: conditional and
unconditional. Conditional promises to give depend on the occurrence of a
specified future and uncertain event (for example, a stipulation that the
provider must meet a matching requirement) whose occurrence or failure of
occurrence gives the donor the right of return of the assets or releases the donor
from the obligation to transfer assets in the future. Conditional promises to
give are not recognized in financial statements until the conditions on which
they depend are substantially met (that is, until the period in which the
conditional promise becomes an unconditional promise). A transfer of assets in
partial fulfillment of a conditional promise shall be accounted for as a refund
able advance (that is, as a liability) until such time as the conditional promise
becomes unconditional.7
5.15 Unconditional promises to give with payments due in future periods
should be reported as receivables and as restricted support in the period the
promise is received (unless explicit donor stipulations or circumstances sur
rounding the receipt of the promise make clear that the donor intended the
promise to be used to support activities of the current period). The expiration
of those restrictions (or the expiration of a portion of the restriction) is recog
nized as the donor makes the future payment or payments. If the promise is to
be paid in one future payment, the related temporarily restricted net assets
will be transferred to unrestricted net assets in the period in which the
payment is received. If the donor sets forth a schedule of future payments, a
transfer from temporarily restricted net assets to unrestricted net assets is
made in each period a payment is received. If other explicit donor restrictions
are attached to the promise, such as that the gift be used for a specific purpose,
the expiration of the restriction is recognized in the time period(s) when the
donor makes the future payment(s) and when the stipulated purpose for which
the assets were restricted has been fulfilled. In the period (or periods) that the
restrictions expire, the temporarily restricted net assets (or the portion of the
temporarily restricted net assets that relate to the particular payment install
ment) are reclassified as unrestricted net assets and reported in the statement
of operations as net assets released from restriction.
7
For accounting purposes, a conditional promise to give is considered unconditional if the
possibility that the condition will not be met is remote. In the case of ambiguous donor stipulations,
if a promise contains stipulations that are not clearly unconditional (that is, if the donor’s stipula
tions are ambiguous), the promise is presumed to be a conditional promise. Additional guidance on
distinguishing conditional promises from unconditional promises is provided in FASB Statement No.
116, paragraphs 22 and 23.
AAG-HCO 5 .1 3

85

Receivables

5.16 In the year that unconditional promises to give cash are received,
they should be measured at the present value8 of their estimated future cash
flows. (Unconditional promises to give cash that are expected to be collected
within one year of the financial statement date may be measured at their net
realizable value.) In determining the estimated future cash flows of uncondi
tional promises to give cash, not-for-profit organizations should consider when
the receivable is expected to be collected, the creditworthiness of the other
parties, the organization’s past collection experience and its policies concerning
the enforcement of promises to give, and other factors concerning the receiv
able’s collectibility. If the present value of unconditional promises to give cash
decreases after initial measurement because of decreases in estimated future
cash flows, the decrease should be recognized in the period(s) in which the
expectation changes. Such decreases should be reported as expenses or
losses (bad debt) in the net asset class in which the net assets are repre
sented.9 Accretion of the discount element of the unconditional promise to give
is accounted for as contribution income, which increases unrestricted, tempo
rarily, or permanently restricted net assets, as appropriate.
5.17 With regard to pledges and other promises to pay in future periods, if a
provider routinely conducts fund drives, an estimate of the future cash flows of a
portfolio of short-term promises resulting from a mass fund-raising appeal may be
made based on experience gained from similar appeals in prior years.
5.18 Chapter 5 of the Audit and Accounting Guide Not-for-Profit Organi
zations provides further guidance regarding accounting for promises to give in
future periods and for assets held by not-for-profit organizations or charitable
trusts that raise or hold contributions for others.
5.19 GASB Statement No. 33, Accounting and Financial Reporting for
Nonexchange Transactions, as amended by GASB Statement No. 36, Recipient
Reporting for Certain Shared Nonexchange Revenues, provides guidance on
accounting and reporting contributions to governmental health care entities.
Promises of cash or other assets that nongovernmental entities, including indi
viduals, voluntarily make to governments may be referred to in practice as
“pledges,” “promises to give,” or “promised donations” or by some other term.
Promised assets may include permanently nonexpendable additions to endow
ments and other trusts; term endowments; contributions of works of art and
similar assets to capitalized collections; or other kinds of capital or financial
assets, with or without purpose restrictions or time requirements. For purposes of
reporting under GASB Statement No. 33, these are classifed as “voluntary
nonexchange transactions.” Governmental health care enterprises that receive
promises to give from nongovernmental entities to provide cash or other assets
should recognize receivables and revenues (net of estimated uncollectible
amounts) when all eligibility requirements are met, provided that the promise
is verifiable and the resources are measurable and probable of collection. Trans
actions that are not recognizable because they are not measureable should be
disclosed.
5.20 As discussed in GASB Statement No. 33, paragraph 20, eligibility
requirements comprise one or more of the following:
8 FASB Statement No. 116 states that present value should be calculated using a discount rate
commensurate with the risks involved.
9 As discussed in FASB Statement No. 116, all expenses should be reported as decreases in
unrestricted net assets. Therefore, decreases in contributions because of changes in the estimated
future cash flows should be reported as losses if they are decreases in temporarily restricted net
assets or permanently restricted net assets.
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a. Required characteristics of recipients.
b. Time requirements.
c. Reimbursements.
d. Contingencies.
Detailed guidance on the application of eligibility requirements is provided in
GASB Statement No. 33, paragraphs 21 through 26.
Financial Statement Presentation
Accounts Receivable

5.21 Receivables are reported net of an allowance for doubtful accounts.
Although the aggregate amount of receivables may include balances due from
patients and third-party payors (including final settlements and appeals), the
amounts due from third-party payors for retroactive adjustments of items such
as final settlements or appeals shall be reported separately in the financial
statements.
5.22 Accounts receivable of health care organizations generally are sub
ject to the same financial disclosure requirements as other business organiza
tions.101 Nongovernmental health care organizations with loans and trade
receivables should follow the presentation and disclosure guidance in para
graph 13 of SOP 01-6 to the extent that guidance is applicable. FASB State
ment No. 107, Disclosures about Fair Value of Financial Instruments,11 sets
forth disclosure requirements regarding the carrying amount of patient ac
counts receivable.
5.23 GASB Statement No. 38, Certain Financial Statement Note Disclo
sures, paragraph 13, requires that governmental health care entities provide
details in the notes to their financial statements about receivable balances
when significant components of those receivables have been obscured by
aggregation.
5.24 FASB Statement No. 107, Disclosures about Fair Value of Financial
Instruments, as amended by FASB Statement No. 133, Accounting for Deriva
tive Instruments and Hedging Activities,12 provides guidance on the required
disclosures about significant concentrations of credit risk arising from all
financial instruments, including trade accounts receivable. Concentration of
credit risk frequently is an issue because most health care organizations
generally tend to treat patients from their local or surrounding communities.
Accordingly, disclosure should be made of the primary geographic sources of
patients. It should be noted that concentration of credit risk may be a signifi
cant issue in stand-alone financial statements issued for a member hospital of
a large national multi hospital system but may not be an issue for financial
statements prepared for the hospital system. When the individual facilities’
financial statements are consolidated into statements prepared for the entire
system, the credit risk is dispersed over a much larger base of health plans,
patients, and geographies and, therefore, is not as concentrated. Health care
organizations with significant concentrations of credit risk should comply with
10 See discussion of SOP 00-1 in paragraph 5.32.
11 This pronouncement is not applicable to governmental health care enterprises that do not
apply paragraph 7 of GASB Statement No. 20. (See footnote 1 in Chapter 1.)
12 See footnote 11.
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the disclosure provisions of FASB Statement No. 107, as amended by FASB
Statement No. 133.
5.25 Off-balance-sheet risk exists when the possible accounting loss from
a financial instrument is not reflected on the balance sheet. Health care organiza
tions (most notably hospitals) may enter into arrangements where they will
finance their patient accounts receivable as a cash flow management strategy.
Nongovernmental health care organizations should follow the presentation
and disclosure guidance in paragraph 13 of SOP 01-6 regarding credit losses
on off-balance-sheet instruments to the extent that guidance is applicable.
5.26 FASB Statement No. 133, as amended, provides guidance on
the required disclosures by entities that hold or issue derivative instru
ments.13 SOP 02-2, Accounting for Derivative Instruments and Hedging Activi
ties by Not-for-Profit Health Care Organizations and Clarification of the
Performance Indicator, requires that not-for-profit health care organizations
that are within the scope of this Guide provide disclosures that are analogous
to those required by paragraph 45 of FASB Statement No. 133 for for-profit
enterprises, including the disclosure of anticipated reclassifications into the
performance indicator of gains and losses that have been excluded from that
measure and reported in accumulated derivative gain or loss as of the reporting
date. SOP 02-2 does not apply to governmental entities that are within the
scope of this Guide. SOP 02-2 is included as Appendix F to this Guide. GASB
Technical Bulletin No. 03-1, Disclosure Requirements for Derivatives Not Re
ported at Fair Value on the Statement of Net Assets applies to governmental
health care enterprises.
Interfund Receivables
5.27 Interfund receivables (or payables) may exist in internal records.
However, since general-purpose financial statements of not-for-profit health
care organizations do not classify assets and liabilities into fund groups,
interfund receivables (or payables) are eliminated. Such interfund balances
and transactions are different from interfund transactions between a govern
mental health care enterprise fund and another fund, such as the general fund
or a special revenue fund of a primary government, when the two funds are
included in the same financial reporting entity. Governmental health care
entities that are funds or component units of another governmental entity may
report receivables (or payables) from other funds or from the primary govern
ment or other component units. (The term primary government is defined in
GASB Statement No. 14, The Financial Reporting Entity.) Interfund balances
are eliminated in the government-wide financial statements of the financial
reporting entity, when presented.14 Discretely presented component units that
report amounts receivable (or payable) from the primary government or from
other component units should report those assets on a separate line from other
receivables (payables), as discussed in GASB Statement No. 34, Basic Finan
cial Statements—and Management’s Discussion and Analysis—for State and

13 See footnote 11.
In June 2003, the GASB issued Technical Bulletin (TB) No. 03-1, Disclosure Requirements for
Derivatives Not Reported at Fair Value on the Statement of Net Assets. Among other matters, GASB
TB No. 03-1 supersedes GASB TB No. 94-1, Disclosures about Derivatives and Similar Debt and
Investment Transactions. GASB TB No. 03-1 is effective for financial statements for periods ending
after June 15, 2003. Earlier application is encouraged.
14 If a governmental health care entity reports using multiple enterprise funds, interfund
balances between those funds are eliminated in the total enterprise fund column.
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Local Governments, paragraph 61. GASB Statement No. 38, paragraph 14, also
requires disclosures about interfund balances and transfers.
Promises to Give in Future Periods (Pledges)

5.28 Contributions receivable should be reported net of an allowance for
uncollectible amounts. That allowance may be based on the receivable’s age, the
creditworthiness of the parties, the organization’s past collection experience
and its policies concerning the enforcement of promises to give, and other
factors concerning the receivable’s collectibility. After the date of initial meas
urement, bad debt expense should be reported for the amount of promises to
give that are expected to be uncollectible (see paragraphs 5.14 and 5.19).
5.29 Investor owned health care enterprises and not-for-profit health care
organizations that are recipients of unconditional pledges (promises to give in
future periods) shall disclose—
a. The amounts of promises receivable in less than one year, in one to
five years, and in more than five years.
b. The amount of the allowance for uncollectible promises receivable.
5.30 Investor owned health care enterprises and not-for-profit health care
organizations that are recipients of conditional pledges (promises to give in
future periods) shall disclose—
a. The total of the amounts promised.
b. A description and amount for each group of promises having similar
characteristics, such as amounts of promises conditioned on estab
lishing new programs, completing a new building, or raising match
ing gifts by a specified date.
Auditing

5.31 In general, receivables, particularly those arising from health care
services, are material to the financial position of health care organizations.
Examples of specific auditing objectives, selected control activities, and audit
ing procedures that may be considered by the independent auditor as they
relate to the major components of receivables of health care organizations are
presented in Exhibit 5-1 at the end of this chapter.
5.32 SOP 00-1, Auditing Health Care Third-Party Revenues and Related
Receivables, provides guidance to auditors in evaluating the reasonableness of
management’s estimates regarding the proper valuation of health care thirdparty revenues and receivables embodied in the financial statements.
Accounts Receivable Confirmations

5.33 Direct confirmation of amounts due from discharged patients and
third-party payors may be an appropriate audit procedure for obtaining evi
dence about the existence and accuracy of amounts due. However, many
patients whose accounts are expected to be paid by a third-party payor may not
have received bills, and many third-party payors may be unable to respond to
confirmation requests on specific account balances. In addition, obtaining
confirmation of receivables from patients who are not discharged may be
impracticable because those patients may not know the amount of their
indebtedness until they are discharged.
5.34 If confirmation of amounts due from patients and third-party payors
is impracticable or determined not to be effective, the independent auditor
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should document this decision in accordance with SAS No. 67, The Confirma
tion Process (AICPA, Professional Standards, vol. 1, AU sec. 330), and should
use alternate procedures such as—
• Performing an analytical procedure or testing the details of sub
sequent receipts.
• Reviewing third-party contracts or payment agreements.
• Comparing billings with documentation in medical records.
• Reviewing the results of third-party payor audits and, if available,
peer review organization (PRO) reports.
• Examining or confirming interim payments with third-party payors.
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Exhibit 5-1

Auditing Considerations

Financial Statement Specific Auditing
Assertions
Objectives
Receivables for Health Care Services
Existence
Amounts reported
in the financial
statements
represent valid
receivables, which
do not include
charity care
balances.

Completeness

AAG-HCO 5 .3 4

Amounts reported
in the financial
statements are
complete and are

Selected Control
Activities

Auditing
Procedures

Charges are
generated
automatically
when services are
performed.

Review and test
subsequent
receipts.

A medical record
is prepared.

Compare billing
information to the
documentation
contained in the
medical records.

Procedures
ensure that
amounts due
from third-party
payors for
individual
accounts are
supported
properly.

Review the
results of PRO, if
available, and
insurance
company reviews
for evidence that
might indicate
receivables may
not be realized.

Procedures
ensure the
proper recording
of cash receipts.

Trace the receipts
applicable to
patient accounts
to the accounts
receivable records.

Procedures
ensure charity
care balances are
identified and
excluded from
gross receivables.

Review the
management
policy for
determining
charity care.
Review policy and
reasonableness of
charity care
measurement.
Compare detailed
accounts
receivable records
with control

Procedures
ensure that (a)
detailed accounts
receivable
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Financial Statement Specific Auditing
Assertions
Objectives
calculated and
accumulated
properly.

Selected Control
Activities
records are
compared
routinely with
control accounts
and third-party
payor logs, (b)
differences are
investigated and
reconciled, and
(c) adjustments,
if necessary, are
made promptly.

Auditing
Procedures
accounts and
third-party payor
logs, and
investigate
reconciling items.

Valuation

Allowances for
uncollectibles
and contractual
adjustments are
reviewed
periodically by
management to
ensure that
receivables are
reported at
estimated net
realizable value.

Review
third-party
contracts and
recompute patient
receivables.
Examine
contracts or
confirm interim
third-party
payments with
third-party payors.

Write-offs and
allowances for
uncollectibles are
identified and
approved in
accordance with
the entity’s
established policy.

Review and test
the method used
to determine the
allowances for
uncollectible
accounts.

Receivables are
reported in the
financial
statements at net
realizable value.

Determine that
patient accounts
are classified
appropriately by
payor (for
example,
Medicare or
self-pay) to
evaluate
collectibility.
Test Medicare
logs for accuracy
and completeness.
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Financial Statement Specific Auditing Selected Control
Activities
Assertions
Objectives

Auditing
Procedures
Test and analyze
aged accounts
receivable trial
balances,
collection trends,
delinquent
accounts,
subsequent period
write-offs and
economic or other
factors used to
determine
allowance for
uncollectible
accounts.
Review pledges
and other
receivables for
collectibility.

Presentation and Significant
disclosure
contractual
arrangements
with third parties
are disclosed.
Estimated Third-Party Settlements
Existence
Amounts reported
in the financial
statements
represent valid
receivables and/or
payables.

Completeness and Amounts included
valuation
in the financial
statements are
accurate and
complete.
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Determine that
significant
contractual
arrangements
with third parties
are disclosed.
Procedures
ensure that
estimated
third-party
settlements
are determined
in accordance
with the
reimbursement
and rate-setting
methodologies
applicable to the
entity.
Procedures
ensure that
estimated
third-party
settlements are
reasonably

Review
correspondence
from significant
third-party payors
related to (a)
interim payment
rates applicable to
periods for which
final settlements
have not been
made and (b) the
amount of interim
or final
settlements made
during the period.
Test the
reasonableness of
settlement
amounts,
including specific
and unallocated
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Financial Statement Specific Auditing Selected Control
Assertions
Objectives
Activities
calculated and
reported.

Auditing
Procedures
reserves, in light
of the payors
involved, the
nature of the
payment
mechanism, the
risks associated
with future
audits, and other
relevant factors.
Review
third-party payor
audit reports and
adjustments for
prior years’ cost
reports or
settlements to
consider whether
(a) the effect of
such adjustments
has been reported
properly in the
financial
statements and
(b) adjustments of
a similar nature
apply to the
current period.
Obtain a
representation
from management
that provisions for
estimated
retroactive
adjustments by
third-party payors
under
reimbursement
agreements for
open years are
adequate.

Presentation and Amounts reported
disclosure
in the financial
statements are
presented
properly and all

Determine that
the tentative
nature of
third-party
settlement
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Financial Statement Specific Auditing Selected Control
Activities
Assertions
Objectives
required
disclosures are
made.
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Auditing
Procedures
amounts is
disclosed properly.
Determine that
differences
between original
estimates and
subsequent
revisions
(including final
settlements) are
included in the
statement of
operations in the
period in which
the revisions are
made and
disclosed, if
material.
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Chapter 6
Property and Equipment, Supplies, and
O ther Assets
Overview

6.01 Health care organizations use various types of property and equip
ment. Those assets may be material to the financial position of institutional
health care organizations, such as hospitals and nursing homes. Typical ac
counts used to record property and equipment transactions are land, land
improvements, buildings and improvements, leasehold improvements, equip
ment (fixed and movable), leased property and equipment, accumulated depre
ciation and amortization, and construction in progress.
6.02 Supplies usually are not material to the financial position of health
care organizations. However, because of the volume of supply transactions,
they may materially affect operations. Supplies typically include medical and
surgical supplies; pharmaceuticals; linens, uniforms, and garments; food and
other commodities; and housekeeping, maintenance, and office supplies.
6.03 Other assets may include prepaid expenses, deposits, and deferred
expenses. Prepaid costs, such as amounts paid to physicians for future services
(for example, administering a hospital department or providing community
services that further the organization’s mission) may be deferred and amor
tized over the period benefited. Such assets are classified as current or noncur
rent as appropriate.
Accounting

6.04 Accounting for property and equipment, supplies, and other assets of
health care organizations is similar to that used by other business organizations.
6.05 Depreciation and amortization of property and equipment are recorded
in conformity with GAAP. Useful lives assigned to depreciable assets should be
reasonable, based on the circumstances. The American Hospital Association
publishes useful guidelines for classifications and estimated useful lives for
property and equipment used by hospitals. Those guidelines also may be useful to
other health care organizations. If there is a potential that an asset is impaired,
health care organizations should consider the guidance in FASB Statement No.
144, Accounting for the Impairment or Disposal of Long-Lived Assets.1,*1

1
This pronouncement is not applicable to governmental health care enterprises that do not
apply paragraph 7 of GASB Statement No. 20, Accounting and Financial Reporting for Proprietary
Funds and Other Governmental Entities That Use Proprietary Fund Accounting. (See footnote 1 in
Chapter 1.)
*In November 2003, the GASB issued GASB Statement No. 42, Accounting and Financial
Reporting for Impairment of Capital Assets and for Insurance Recoveries. GASB Statement No. 42
establishes accounting and financial reporting standards for impairment of capital assets (capital
assets are defined in paragraph 19 of GASB Statement No. 34, Basic Financial Statements—and
Management’s Discussion and Analysis—for State and Local Governments), including standards for
the assessment of impairment of capital assets and for the measurement of impairment. GASB
Statement No. 42 also provides accounting and reporting guidance for insurance recoveries, and
requires disclosures about impaired capital assets that are idle at year-end. GASB Statement No. 42
is effective for financial statements for periods beginning after December 15, 2004. Earlier applica
tion is encouraged. Conforming changes to reflect the issuance of GASB Statement No. 42 will be
made in a future edition of this Guide.
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6.06
The recognition of contribution income related to donated long-lived
assets (or assets recognized to be acquired with donated funds) is discussed in
Chapter 10 of this Guide.
Financial Statement Presentation

6.07 Financial statement presentation of property and equipment of
health care organizations is similar to that of other business organizations.
Property held for investment purposes should be presented as part of invest
ments. Donor or legal restrictions on the proceeds from the disposition of
donated property and equipment (or of property and equipment purchased
with cash restricted for acquisition of long-lived assets) are disclosed.
6.08 Financial statement presentation of supplies and other assets of
health care organizations is similar to that of other business organizations.
6.09 Capital assets that are not being depreciated, if significant, should
be reported separately in the statement of net assets from capital assets being
depreciated, as discussed in GASB Statement No. 34, Basic Financial
Statements—and Management’s Discussion and Analysis—for State and Local
Governments, paragraph 20. GASB Statement No. 34 also establishes two
capital-asset related-disclosure requirements for governmental health care
entities. First, GASB Statement No. 34, paragraph 115e, requires entities to
disclose their policy for capitalizing assets and for estimating the useful lives
of those assets in their summary of significant accounting policies. Second,
GASB Statement No. 34, paragraphs 116 and 117, require certain information
to be presented about major classes of capital assets, including beginning and
ending balances, capital acquisitions, sales or other dispositions, current pe
riod depreciation expense, and accumulated depreciation. Capital assets that
are not being depreciated should be disclosed separately from those that are
being depreciated.
Auditing

6.10 Auditing objectives for property and equipment, supplies, and other
assets of health care organizations are similar to those in audits of other
business organizations. The auditor may be able to assess inherent risk for
these accounts as being relatively low because the transactions therein are
generally small in number, relatively simple in nature, and do not involve the
use of complex estimates. The auditor should consider the characteristics of the
entity and of the transactions occurring during the period when assessing
inherent risk for these accounts.
6.11 A health care organization may have access to the use of property
and equipment under a variety of arrangements. It may (a) own property and
equipment, (b) rent property and equipment from an independent or related
organization, (c) use property and equipment provided by a related organiza
tion (such as a religious order) or by an unrelated organization under an
affiliation program, or (d) use property and equipment provided by a govern
ment agency or unit or a government-related hospital district. The inde
pendent auditor should inquire into (and the financial statements should
disclose) the nature of any relationship between the health care organization
and lessors, bailors, or other owners of property. With respect to leases, FASB
Statement No. 13, Accounting for Leases, as amended and interpreted, provides
AAG-HCO 6 .0 6
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accounting guidance.2 GASB Statement No. 13, Accounting for Operating
Leases with Scheduled Rent Increases, provides additional guidance for oper
ating leases of governmental health care enterprises.
6.12 In evaluating capitalization policies, the independent auditor should
consider whether interest has been capitalized in accordance with the provisions
of FASB Statement No. 34, Capitalization of Interest Cost, and related amend
ments and FASB Statement No. 62, Capitalization of Interest Cost in Situations
Involving Certain Tax-Exempt Borrowings and Certain Gifts and Grants.
6.13 In evaluating the entity’s depreciation policies, the auditor may wish
to refer to the American Hospital Association’s Estimated Useful Lives of
Depreciable Hospital Assets, which is revised periodically and sets forth plant
asset classifications and the estimated useful lives of depreciable assets. The
auditor also should be aware that social, economic, and scientific advances in
the health care industry make obsolescence an important factor to be consid
ered when evaluating depreciation policies and methods.
6.14 FASB Statement No. 144 requires that health care organizations
review long-lived assets for impairment whenever events or changes in circum
stances indicate that the carrying amount of the asset may not be recoverable.
In considering a health care organization’s application of FASB Statement No.
144, auditors should obtain an understanding of the policies and procedures
used by management to determine whether all impaired assets have been
properly identified. In addition to evaluating the entity’s procedures for iden
tifying indicators of impairment, the auditor should consider information
obtained during the audit in determining whether the health care organization
has identified appropriate indicators of impairment. For example, a change in
the use of a facility from an acute-care hospital to an ambulatory surgery
center may require that the asset be reviewed for impairment using the
method prescribed by FASB Statement No. 144.**
6.15 The independent auditor may need to consider the examples of
specific auditing objectives, selected control activities, and auditing procedures
relating to property and equipment that are presented in Exhibit 6-1.

2
For governmental health care enterprises, National Council on Governmental Accounting
(NCGA) Statement No. 5, Accounting and Financial Reporting Principles for Lease Agreements of
State and Local Governments, requires the application of FASB Statement No. 13 for proprietary
activities and provides additional guidance on specific matters unique to governmental entities.
*In November 2003, the GASB issued GASB Statement No. 42, Accounting and Financial
Reporting for Impairment of Capital Assets and for Insurance Recoveries. GASB Statement No. 42
establishes accounting and financial reporting standards for impairment of capital assets (capital
assets are defined in paragraph 19 of GASB Statement No. 34, Basic Financial Statements—and
Management’s Discussion and Analysis—for State and Local Governments), including standards for
the assessment of impairment of capital assets and for the measurement of impairment. GASB
Statement No. 42 also provides accounting and reporting guidance for insurance recoveries, and
requires disclosures about impaired capital assets that are idle at year-end. GASB Statement No. 42
is effective for financial statements for periods beginning after December 15, 2004. Earlier applica
tion is encouraged. Conforming changes to reflect the issuance of GASB Statement No. 42 will be
made in a future edition of this Guide.
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Auditing Considerations

Financial Statement Specific Auditing
Assertions
Objectives
Donated Property Equipment
Valuation
Donated property
and equipment is
reported at fair
market value at
the date of
donation.

Selected Control
Activities

Auditing
Procedures

Procedures
ensure that the
donation of
property and
equipment is
known and
recorded and
that documenta
tion supports the
determination of
the fair market
value.

Review the
documentation
supporting the
determination of
the fair market
value.3

Presentation and The receipt of
disclosure
donated property
and equipment is
properly reported.
Property and Equipment Not Held for Use in Operations
Presentation and Property and
Property records
disclosure
equipment not segregate prop
used for
erty and equip
ment not used for
operations is
operating pur
reported
poses.
separately.
Property and Equipment Additions
Rights and
The appropriate Management
obligations
health care plan regularly moni
ning agency or tors compliance
other regulatory with health care
agency approvals, planning agency
if required, have regulations re
been obtained for lated to additions
of property and
property and
equipment.
equipment
additions.

Review material
donated property
and equipment
transactions to
ensure the
propriety of the
reporting.
Determine that
property held for
nonoperating
purposes is
reported
separately.
For material new
construction,
determine com
pliance with
health care
planning agency
or other regula
tory agency
requirements.

3
SAS No. 101, Auditing Fair Value Measurements and Disclosures (AICPA, Professional
Standards, vol. 1 AU sec. 328), provides guidance on auditing fair value measurements and
disclosures contained in financial statements. SAS No. 101 does not address specific types of assets,
liabilities, components of equity, transactions, or industry-specific practices.
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Financial Statement Specific Auditing Selected Control
Assertions
Objectives
Activities
Additions are
authorized in the
capital budget.
Existence and
valuation

Recorded
property and
equipment are
owned by the
entity and are
carried at the
appropriate
amounts.

Inventory of fixed
assets is taken
periodically.
Detailed property
records
periodically are
reconciled to the
recorded
amounts.

Auditing
Procedures

Review a
summary of
property and
equipment (cost
and accumulated
depreciation)
including
additions,
deletions, and
transfers.
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Chapter 7
Current Liabilities, Tax Considerations, and
Long-Term Obligations
Overview

7.01 Current liabilities may include notes payable to banks; the current
portion of long-term debt; accounts payable; advances from and amounts
payable to third-party payors for estimated and final reimbursement settle
ments; refunds to and deposits from patients and others; deferred revenue;
accrued salaries and payroll taxes; and other accruals such as pension or
profit-sharing contributions, compensated absences, and income and other
taxes. In addition, there may be a current portion of estimated malpractice
costs and risk-contract recognized losses (see Chapter 8).
7.02 Long-term obligations may include notes, mortgages, capital leases,
bonds, and obligations under continuing care contracts. They also may include
estimated malpractice cost and risk-contract recognized losses.

Accounting for Current Liabilities

7.03 Accounting for current liabilities of health care organizations is
similar to that of other business enterprises. Health care organizations are
usually labor-intensive and provide employees with compensated absences,
such as for holidays, vacations, and illnesses. Liabilities related to such ab
sences are accounted for in accordance with FASB Statement No. 43, Account
ing for Compensated Absences. Governmental health care entities should
follow the guidance in GASB Statement No. 16, Accounting for Compensated
Absences.
7.04 Liabilities related to postretirement benefits other than pensions
should be accounted for in accordance with FASB Statement No. 106, Employ
ers’Accounting for Postretirement Benefits Other Than Pensions, and postem
ployment benefits should be accounted for in accordance with FASB Statement
No. 112, Employers’Accounting for Postemployment Benefits. These two pro
nouncements are not required to be applied by governmental health care
enterprises. GASB Statement No. 12, Disclosure of Information on Postemploy
ment Benefits Other Than Pension Benefits by State and Local Governmental
Employers, however, does require certain disclosures about postemployment
benefits.
7.05 Governmental health care enterprises sometimes report govern
ment-mandated or voluntary nonexchange revenues, such as expendituredriven grants. These revenues are recognized when all eligibility requirements
The GASB released a revised exposure draft of a proposed statement Accounting and Finan
cial Reporting by Employers for Postemployment Benefits Other Than Pensions that addresses how
state and local governments should account for and report their costs and obligations related to
postemployment health care and other non-pension benefits provided to retirees. A final pronounce
ment, GASB Statement No. 45, Accounting and Financial Reporting by Employers for Postemploy
ment Benefits Other Than Pensions, was issued in the third quarter of 2004. Conforming changes to
reflect the issuance of GASB Statement No. 45 will be made in a future edition of this Guide.
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have been met, as discussed in GASB Statement No. 33, Accounting and
Financial Reporting for Nonexchange Transactions. In some cases, it may
become apparent after revenue has been recognized in the financial statements
that the eligibility requirements are no longer met, for example, because an
audit of a particular grant program determined that certain expenses did not
meet purpose restrictions. GASB Statement No. 33 provides that, if it is
probable that the recipient must return all or part of the resources, a liability
(or reduction of receivables) and an expense should be recognized for the
amount that the resource provider (grantor) is expected to cancel or reclaim.
(See paragraphs 5.19, 5.20, 10.05 and 10.12 for further discussion of GASB
Statement No. 33.)
Tax Considerations for Not-for-Profit Health
Care Organizations

7.06
Health care organizations that are owned and operated by a state or
local government are exempt from federal income tax pursuant to IRC sec. 115
and also are exempt from the federal income tax filing requirements. Such
organizations are exempt not only from regular federal income tax but also
from the tax on unrelated business income. If a health care entity is owned and
operated by a separately constituted authority or other legal entity, the entity’s
management should consider whether such authority or other legal entity is
organized properly to preserve qualification of the tax exemption pursuant to
IRC sec. 115. In some cases, state or local governmental entities will secure
tax-exempt status as an IRC sec. 501(c)(3) organization. If such an exemption
is secured, the entity may become subject to federal income tax and the related
filing requirements on the same basis as other tax-exempt entities.

Tax-Exempt Entities

7.07
Nongovernmental not-for-profit health care organizations usually
seek exemption from federal income tax under IRC sec. 501(a). Under IRC sec.
501(a), entities organized and operated exclusively for religious, charitable, or
educational purposes, as described in IRC sec. 501(c)(3), are exempt from
federal income taxes. The following are additional requirements for such
entities:
a. No part of the entity’s net earnings, either directly or indirectly,
inures to any private shareholder or individual.
b. No substantial part of the entity’s activities consists of carrying on
propaganda or otherwise attempting to influence legislation. (IRC
sec. 501(h) provides a limited exception to the general rule that public
charities may not incur expenditures to influence legislation.)
c. The entity does not participate in, or intervene in, any political
campaign on behalf of any candidate for public office.
7.08
The term charitable is used in IRC sec. 501(c)(3) in its generally
accepted legal sense. Providing health care to the community is considered a
charitable activity. Therefore, provided a health care entity is not organized or
operated for the benefit of private interests (such as designated individuals,
the founder or the founder’s family, shareholders of the entity, or persons
controlled directly or indirectly by such private interests), it generally would
qualify as an IRC sec. 501(c)(3) organization.
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7.09 The Internal Revenue Service (IRS) has ruled that in order for a
nursing home to establish its exemption as a public charitable organization
under IRC sec. 501(c)(3), it must be operated to meet the primary needs of the
elderly for housing, health care, and financial security. Operating for financial
security generally means that an individual will be maintained in residence
even if such individual can no longer pay residence fees.
Private Inurement

7.10 Under IRC sec. 501(c)(3) no part of the net earnings of the charitable
organization shall inure to the benefit of any private shareholder or individual.
A private shareholder or individual refers to a person or persons having a
private or personal interest in the activities of the organization. The IRS has
stated that physicians have a personal or private interest in the activities of a
hospital and could be subject to the private inurement proscription.
Unrelated Business Income Tax

7.11 Although not-for-profit organizations may be exempt from federal
income tax, they nevertheless may be subject to tax on unrelated business
income. The objective of the tax on unrelated business is to place such activities
on the same basis as that of taxable entities. Unrelated business income is the
income from any regularly carried-on trade or business, the conduct of which
is not substantially related to the exercise or performance of the organization’s
tax-exempt purpose or function. The fact that proceeds from an activity are
used exclusively for the entity’s tax-exempt purpose does not make the activity
substantially related to its tax-exempt purpose or function. As is the case with
most tax-related definitions, there are qualifications and exceptions. Some of
the more significant exclusions from this tax include—
• An annual specific deduction for certain limited activities.
• Income from activities of which substantially all the work is performed
by unpaid volunteers.
• Income from activities carried on for the convenience of the entity’s
patients, officers, or employees.
• Dividends, interest, annuities, royalties, capital gains and losses, and
rents from real property—with two major exceptions. The first excep
tion is that income from investments that are debt-financed and
otherwise not functionally related to the tax-exempt purpose is tax
able. The second major exception makes taxable the interest, annui
ties, royalties, and rents received from a controlled (80-percent-owned)
taxable corporation or partnership unless this entity is engaged in an
activity that would have been exempt if it were carried on directly by
the not-for-profit organization.
Financial Statement Presentation

7.12 Financial reporting and disclosure requirements for current liabili
ties and long-term obligations of health care organizations are the same as for
other business organizations. In addition, with respect to CCRCs, the method
of accounting for advance fees, the method of calculating the obligation to
provide future services and use of facilities, and the refund policy for refund
able fees are disclosed in the financial statements. Chapter 14 describes other
disclosure requirements applicable to CCRCs. Taxable entities have the same
financial reporting and disclosure requirements as other commercial enter
prises. Tax-exempt entities should disclose their tax-exempt status.
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7.13 GASB Statement No. 34, Basic Financial Statements—and Manage
ment’s Discussion and Analysis—for State and Local Governments, and GASB
Statement No. 38, Certain Financial Statement Note Disclosures, provide
guidance about required disclosures for governmental health care entities
about current and long-term liabilities, including the following:
• GASB Statement No. 38, paragraph 13, requires disclosures about
accounts payable balances when significant components of those bal
ances have been obscured by aggregation.
• GASB Statement No. 38, paragraph 12, requires disclosures about
short-term debt activity during the year, even if no short-term debt is
outstanding at year-end. For this purpose, short-term debt consists of
anticipation notes, use of lines of credit, and similar loans. Disclosures
should include a schedule of changes in short-term debt as well as a
discussion of the purposes for which short-term debt was issued.
• GASB Statement No. 34, paragraphs 116, 119, and 120, requires
information to be presented about both long-term debt, such as bonds
payable, and about long-term liabilities, such as compensated ab
sences and claims and judgments. Required disclosures include begin
ning and ending balances, increases, decreases, and the portions of
each item that are due within one year.
• GASB Statement No. 38, paragraphs 10 and 11, requires disclosure of
debt service requirements to maturity for each of the five subsequent
years and in five-year increments thereafter. Principal and interest
requirements are required to be disclosed separately. Similar require
ments apply to obligations under capital leases and noncancelable
operating leases.
• GASB Statement No. 38, paragraph 9, requires disclosure of actions
taken to remedy significant violations of finance-related legal or con
tractual provisions.
Long-Term Debt

7.14 Significant sums of money are required to replace and upgrade
buildings and expand the facilities of health care organizations. As a result,
health care organizations are dependent on external sources of funds to satisfy
their capital needs. Many health care organizations finance acquisitions, addi
tions, and renovations with long-term debt.
7.15 In addition to serving as a financing source for government opera
tions, tax-exempt debt frequently is issued by state and local governments on
behalf of nongovernmental organizations (for example, not-for-profit organiza
tions) to foster private-sector participation in certain desirable community
activities such as the provision of health care services. Tax-exempt bonds
usually can be issued to obtain a higher ratio of project financing (up to 100
percent), a longer maturity period (up to thirty years), and a lower interest cost
than taxable bonds. The majority of tax-exempt bonds issued by health care
organizations are revenue bonds, which are bonds secured by a pledge of the
entity’s revenues. General obligation bonds are secured by the revenues of the
issuing authority.
Financing Authorities

7.16 Because most providers legally cannot issue tax-exempt revenue
bonds directly, a significant number of states have enacted legislation permit
ting health care organizations to borrow funds for capital projects by issuing
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bonds through financing authorities. Financing authorities are authorized to
issue tax-exempt bonds or other obligations and use the proceeds for the
benefit of the health care organization. To obtain project financing, a health
care organization sometimes is required by a financing authority to enter into
a lease arrangement, a sublease arrangement, or both. At other times, a lease
or sublease arrangement is not required.
7.17 When a financing authority issues tax-exempt bonds or similar debt
instruments and uses the proceeds for the benefit of a health care organization,
the obligation is reported as a liability in the organization’s balance sheet if the
health care organization is responsible for repayment. In some cases, this
obligation may take the form of a liability arising from a capital lease. If a
health care organization has no obligation to make payments of principal and
interest on the debt or capital or operating lease payments on related buildings
or equipment, the organization should not reflect the liability on its balance
sheet. In such circumstances, proceeds from the bond issue are reported as
contributions from the sponsoring organization.
Assets Whose Use Is Limited

7.18 Among the many provisions normally included in the bond inden
tures of tax-exempt issues are the requirements to set aside funds annually
from operations to ensure that bond principal, interest payments, and other
requirements are met. The treatment of funds established under the terms of
debt-financing instruments is discussed in paragraphs 1.29 and 1.30.

Advance Refundings

7.19 In an advance refunding, new debt is issued for the purpose of replacing
an existing debt issue. Advance refundings enable providers to restructure
their long-term liabilities, take advantage of reduced interest rates, or termi
nate restrictive bond covenants. The terms by which the debt may be satisfied
legally and the related lien released without the debt necessarily being retired
are spelled out in the debt instrument. Under the Tax Reform Act of 1986,
bonds issued before January 1, 1986, may be advance refunded only twice.
Bonds issued on or after that date may be advance refunded only once.
7.20 The accounting, financial reporting, and disclosure requirements for
advance refundings entered into by health care organizations other than
governmental entities are described in APB Opinion No. 30, Reporting the
Results of Operations—Reporting the Effects of Disposal of a Segment of a
Business, and Extraordinary, Unusual and Infrequently Occurring Events and
Transactions, FASB Statement No. 140, Accounting for Transfers and Servic
ing of Financial Assets and Extinguishments of Liabilities, and FASB Interpre
tation No. 39, Offsetting of Amounts Related to Certain Contracts.1 Generally
speaking, these entities are required to report any gain or loss resulting from an *16

1 Emerging Issues Task Force (EITF) Issue No. 96-19, Debtor’s Accounting for a Modification or
Exchange of Debt Instruments, addresses accounting for modifications or exchanges of debt instru
ments. EITF Issue No. 96-19 requires that (1) an exchange of debt instruments with substantially
different terms is a debt extinguishment and should be accounted for in accordance with paragraph
16 of FASB Statement No. 125; and (2) a substantial modification of terms should be accounted for
like, and reported in the same manner as an extinguishment. Also, transactions involving the
modification or exchange of debt instruments can only result in gain or loss recognition by the debtor
if the conditions for extinguishment of debt described in paragraph 16 of FASB Statement No. 125 are
satisfied or if the consensus in Issue No. 96-19 requires that accounting. FASB Statement No. 140,
among other matters, replaces FASB Statement No. 125. FASB Statement No. 140 does not change
the guidance dealing with accounting for extinguishments of liabilities.
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advance refunding as an extraordinary item in the financial statements of the
period in which the refunding occurred only if the criteria in APB Opinion No.
30 for classification as an extraordinary item are met. The accounting, finan
cial reporting, and disclosure requirements for advance refundings (and for
current refundings) entered into by governmental health care entities are set
forth in GASB Statements No. 23, Accounting and Financial Reporting for
Refundings of Debt Reported by Proprietary Activities, and No. 7, Advance
Refundings Resulting in Defeasance of Debt. Generally speaking, governmen
tal entities are required to amortize any gain or loss resulting from a current
or advance refunding to interest expense over the shorter of the life of the new
bonds or the remaining life of the old bonds.
7.21 There are several types of advance refundings, including net ad
vance refundings, full cash advance refundings, and crossover refundings (see
the Glossary). In a crossover refunding, because the old bonds are not defeased
until the crossover date, no immediate gain or loss should be recognized. If the
retirement dates of the old debt have been established, the call premium,
unamortized premium or discount, and initial issue costs should be recognized
systematically in the income statement over the remaining life of the old debt
as an adjustment of the cost of borrowing related to the old debt. In addition,
the income earned on the funds used to consummate the advance refunding
and the interest expense on both the old and new debts should be recognized
in the statement of operations. The funds used to consummate the advance
refunding should be reported as an asset and both the old and new debts should
be reported as liabilities. The assets and liabilities should not be offset.†
7.22 FASB Statement No. 140 provides accounting and reporting stand
ards for extinguishments of liabilities. Paragraph 16 of FASB Statement No.
140 says a debtor should derecognize a liability if and only if it has been
extinguished. Paragraph 16 says a liability has been extinguished if either of
the following conditions is met:
a. The debtor pays the creditor and is relieved of its obligation for the
liability. Paying the creditor includes delivery of cash, other financial
assets, goods, or services or reacquisition by the debtor of its out
standing debt securities whether the securities are canceled or held
as so-called treasury bonds.
b. The debtor is legally released from being the primary obligor under
the liability, either judicially or by the creditor [footnote omitted].
Paragraph 114 of FASB Statement No. 140 provides related guidance.
7.23 Paragraph 17b of FASB Statement No. 140 requires that, if an entity
had debt that was considered to be extinguished by an in-substance defeasance
under the provisions of FASB Statement No. 76 prior to the effective date of
FASB Statement No. 125, the entity should provide a general description of the
transaction and the amount of debt that is considered extinguished at the end
of the period so long as that debt remains outstanding.
Arbitrage Rebate Liabilities

7.24 Advance refundings involving tax-exempt debt are subject to arbi
trage rules under the IRC sec. 103(c) and related regulations that, in general,†

† Public companies may also refer to the interpretations in Securities and Exchange Commission
(SEC) Staff Accounting Bulletin (SAB) No. 94. This SAB expresses the views of the SEC staff regarding
the period in which a gain or loss is recognized on early extinguishments of debt and the periods over
which deferred debt issue costs and debt premium or discount should be amortized. SABs represent
interpretations and practices followed by the staff of the Office of the Chief Accountant and the Division
of Corporation Finance in administering the disclosure requirements of federal securities laws.
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prohibit the yield realized from the investment of the proceeds of the new debt
from exceeding the yield on the debt itself. Compliance with those rules is
necessary for the interest on the debt to be exempt from federal income tax and,
possibly, from state and local tax.
7.25 Whenever a provider invests tax-exempt bond proceeds and the
ultimate yield is higher than the interest rate on the bonds, the provider may
be subject to an arbitrage rebate liability. The arbitrage determination is made
as of the date of the issue; however, intentional acts undertaken after the date
of the issue can disqualify the issue retroactively. The earnings in excess of
interest expense represent a liability that must be paid to the U.S. Treasury in
order for the bonds to maintain their tax-exempt status. The arbitrage rebate
liability may be a substantial amount if the bond proceeds are not spent as
quickly as planned. For example, this may occur if a provider encounters a
delay in a major construction project.
Auditing

7.26 Auditing objectives and procedures for long-term debt issued by
health care organizations generally are similar to those of other organizations.
In addition, the independent auditor may need to consider the examples of
specific auditing objectives, selected control activities, and auditing procedures
that are presented in Exhibit 7-1.
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Exhibit 7-1

Auditing Considerations

Financial Statement Specific Auditing
Assertions
Objectives
Tax-Exempt Debt
Presentation and Amounts related
disclosure
to tax-exempt
debt are properly
classified in the
financial
statements and
related
disclosures are
adequate.
Income Taxes
Rights and
The not-for-profit
obligations
organization has
obtained a
qualifying income
tax exemption
from the
governmental
authority.
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Selected Control
Activities

Auditing
Procedures

Procedures
ensure that the
providers
monitor their
compliance with
restrictive debt
covenants.

Review the debt
instruments for
the presence of
any restrictive
debt covenants.
Test compliance
with restrictive
debt covenants.

Management
monitors
compliance with
applicable tax
regulations.
Transactions are
reviewed for
their effect on tax
status and tax
liabilities.

Determine that
the not-for-profit
organization has
obtained a
determination of
its tax-exempt
status.
Inquire if tax
returns have been
filed on a timely
basis.
Determine the
status of the tax
returns under
examination.
Read the prior
years’ tax returns.
Read the minutes
and the
accounting for
evidence of
significant
unrelated
business activities.
Review for
reasonableness
the unrelated
business income
tax liability.
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Financial Statement Specific Auditing Selected Control
Activities
Assertions
Objectives
Presentation and The entity’s
tax-exempt status
disclosure
and its tax
contingencies are
disclosed in the
notes to the
financial
statements.
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Auditing
Procedures
Determine that
the entity’s
tax-exempt status
is disclosed in the
notes to the
financial
statements.
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Chapter 8
Commitments and Contingencies
Overview

8.01 Commitments and contingencies may include (a) losses arising from
litigation, including malpractice and other claims; (b) contingencies related to
risk contracting; (c) third-party payment and rate-setting programs; (d) con
struction contract commitments; (e) the Hill-Burton Act obligation to provide
uncompensated care; (f ) commitments and guarantees that include contractual
agreements with physicians, specialists, and others who perform services by
arrangement with health care organizations; and (g) commitments and contin
gent liabilities related to pension plans, operating leases, purchase commit
ments, and loan guarantees.
8.02 FASB Statement No. 5, Accounting for Contingencies, as amended,
and interpreted by FASB Interpretation No. 14, Reasonable Estimation of the
Amount of a Loss, and FASB Interpretation No. 45, Guarantor’s Accounting
and Disclosure Requirements for Guarantees, Including Indirect Guarantees of
Indebtedness of Others, provides guidance on accounting for contingencies.
FASB Statement No. 60, Accounting and Reporting by Insurance Enterprises,
discusses accounting for claims costs, including estimates of costs relating to
IBNR claims. Governmental health care entities should consider the account
ing and disclosure requirements of GASB Statement No. 10, Accounting and
Financial Reporting for Risk Financing and Related Insurance Issues, as
amended by GASB Statement No. 30, Risk Financing Omnibus, and Interpre
tation No. 4, Accounting and Financial Reporting for Capitalization Contribu
tions to Public Entity Risk Pools.
Medical Malpractice Claims

8.03 The extent of risk transfer is key in determining whether a liability
should be recognized in a provider’s financial statements pertaining to mal
practice claims. The existence of an insurance policy, by itself, is no assurance
that the risk of financial loss is transferred.
8.04 If the entity has purchased a claims-made insurance policy (see
paragraph 8.13), there is no transfer of risk for claims not reported to the
insurance carrier within the policy term. With regard to retrospectively rated
insurance policies (see paragraphs 8.14 and 8.15) and policies by captive
insurance companies (see paragraphs 8.16 through 8.19), the economic sub
stance of the terms of the insurance policy may more closely resemble a claims
funding mechanism than an instrument that transfers risk of loss to an
external third party. If the health care organization has not transferred risk to
an external third party, it should evaluate its exposure to losses arising from
malpractice claims and record a liability, if appropriate.

Accruing Malpractice Liabilities

8.05 The ultimate costs of malpractice claims, which include costs associ
ated with litigating or settling claims, are accrued when the incidents that give
AAG-HCO 8 .0 5

112

Health Care Organizations

rise to the claims occur. Estimated losses from asserted and unasserted claims
are accrued either individually or on a group basis, based on the best estimates
of the ultimate costs of the claims and the relationship of past reported
incidents to eventual claims payments. All relevant information, including
industry experience, the entity’s own historical experience, the entity’s existing
asserted claims, and reported incidents, is used in estimating the expected
amount of claims. The accrual includes an estimate of the losses that will result
from unreported incidents, which are probable of having occurred before the
end of the reporting period.
8.06 In estimating the probability that unreported incidents have oc
curred, some health care organizations may develop a range of possible esti
mates of the number of unreported incidents, including zero. However, the
greater the volume of a health care organization’s operations, the greater the
likelihood that the organization’s minimum estimate of the number of probable
unreported incidents will be greater than zero.
8.07 If it is probable that a loss has been incurred and the information
available indicates the loss is within a range of amounts, the most likely amount
of loss in the range is accrued. If no amount in the range is more likely than any
other, the minimum amount in the range is accrued. The potential additional loss
is disclosed if there is at least a reasonable possibility of a loss in excess of the
amount accrued.
8.08 In estimating losses from malpractice claims, a health care organi
zation may need to modify data drawn from industry experience so it is relevant
to developing an estimate that is specific to the organization. Various factors
(such as the nature of operations, size, and the provider’s past experience) are
considered in assessing comparability. Further, industry data that are not
current may not be relevant.
8.09 Estimated losses are reviewed and changed, if necessary, at each
reporting date. The amounts of the changes are recognized currently as addi
tional expense or as a reduction of expense.
8.10 Accrued unpaid claims and expenses that are expected to be paid
during the normal operating cycle (generally within one year of the date of the
financial statements) are classified as current liabilities. All other accrued
unpaid claims and expenses are classified as noncurrent liabilities.
8.11 A health care organization discloses its program of medical malprac
tice insurance coverages and the basis for any related loss accruals. If the
organization cannot estimate losses relating to a particular category ofmalpractice
claims (for example, asserted claims, reported incidents, or unreported incidents)
in accordance with paragraphs 8.03 through 8.10, the potential losses related
to that category of claims are not accrued. However, the contingency is disclosed
in the notes to the financial statements, as required by FASB Statement No. 5.
8.12 Health care organizations that discount accrued malpractice claims
should disclose in the notes to the financial statements the carrying amount of
accrued malpractice claims that are discounted in the financial statements and
the interest rate or rates used to discount those claims. Also, the FASB has issued
FASB Concepts Statement No. 7, Using Cash Flow Information and Present
Value in Accounting Measurements. This Concepts Statement provides
useful discussion of general principles governing the use of present value, and of
the objective of present value in accounting measurements. Statements of Finan
cial Accounting Concepts are not sources of established accounting principles
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as described in SAS No. 69, The Meaning of Present Fairly in Conformity with
Generally Accepted Accounting Principles, and, thus, do not amend, modify, or
justify a change from generally accepted accounting principles currently in effect.
Accounting (or Claims-Made Insurance Policies and
Tail Coverage

8.13
A claims-made insurance policy represents a transfer of risk within
the policy limits to the insurance carrier for asserted claims and incidents
reported to the insurance carrier. The policy, however, does not represent a
transfer of risk for claims and incidents not reported to the insurance carrier
during the policy period. Consequently, a health care organization that is
insured under a claims-made insurance policy recognizes the estimated cost of
those claims and incidents not reported to the insurance carrier, in accordance
with paragraphs 8.03 through 8.10. This estimation is done unless the health
care organization has bought tail coverage (see the Glossary) and included the
cost of the premium as an expense in the financial statements for that period.
Accounting for Retrospectively Rated Premiums

8.14 A health care organization with a retrospectively rated insurance
policy whose ultimate premium is based primarily on the health care organi
zation’s loss experience accounts for the minimum premium as an expense over
the period of coverage under the policy and accrues estimated losses from
asserted and unasserted claims in excess of the minimum premium, as indi
cated in paragraphs 8.03 through 8.10. Such estimated losses, however, are not
accrued in excess of a stipulated maximum premium. If the health care
organization cannot estimate losses from asserted or unasserted malpractice
claims, as indicated in paragraphs 8.03 through 8.10, the health care organi
zation should disclose the existing contingency in the notes to the financial
statements, as required by FASB Statement No. 5.
8.15 A health care organization insured under a retrospectively rated
policy whose ultimate premium is based primarily on the experience of a group
of health care organizations amortizes the initial premium to expense on a pro
rata basis over the policy term. The organization also accrues additional
premiums or refunds on the basis of the group’s experience to date, which
includes a provision for the ultimate cost of asserted and unasserted claims
before the financial statement date, whether reported or unreported. The
health care organization discloses that (a) it is insured under a retrospectively
rated policy and (b) premiums are accrued based on the ultimate cost of the
experience to date of a group of organizations. If the health care organization
cannot estimate losses from asserted or unasserted malpractice claims, as
indicated in paragraphs 8.03 through 8.10, it should disclose the existing
contingency in the notes to the financial statements, as required by FASB
Statement No. 5.
Accounting for Medical Malpractice Claims Insured by
Captive Insurance Companies

8.16 A majority-owned captive insurance company (for example, a wholly
owned captive) is consolidated in accordance with FASB Statement No. 94,
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Consolidation of All Majority-Owned Subsidiaries. Multi provider captives, in
which the ownership percentage is 50 percent or less, are accounted for in
accordance with APB Opinion No. 18, The Equity Method of Accounting for
Investments in Common Stock. (See Chapter 11 of the Guide for additional
discussion of considerations related to consolidation and the use of the equity
method.)
8.17 A health care organization insured by an unconsolidated multi
provider captive insurance company for medical malpractice claims under a
retrospectively rated insurance policy whose ultimate premium is based pri
marily on the health care organization’s experience up to a maximum pre
mium, if any, accounts for such insurance as indicated in paragraph 8.14.
8.18 A health care organization insured by an unconsolidated multi
provider captive insurance company for medical malpractice claims under a
retrospectively rated policy based primarily on the experience of a group of
health care organizations accounts for such insurance as indicated in para
graph 8.15. However, the health care organization considers whether the
economic substance of the multi provider captive insurance company is suffi
cient to relieve the health care organization from further liability. The health
care organization should disclose that (a) it is insured under a retrospectively
rated policy of a multi provider captive insurance company and (b) the premi
ums are accrued based on the captive insurance company’s experience to date.
8.19 A health care organization that is insured by a multi provider captive
insurance company discloses in its financial statements that it is insured by
such a company, and it should disclose its ownership percentage, if significant,
in the captive company as well as the method of accounting for its investment
in, and the operations of, the captive company. In addition, if the health care
organization cannot make the necessary estimates of losses from asserted or
unasserted claims, as indicated in paragraphs 8.03 through 8.10, the health
care organization discloses the existing contingency in the notes to the finan
cial statements, as required by FASB Statement No. 5.
Accounting for Trust Funds

8.20 In general, a trust fund, whether legally revocable or irrevocable, is
included in the financial statements of the health care organization. A portion of

On February 23, 1999, the FASB released an exposure draft (revised) of a proposed FASB
Statement, Consolidated Financial Statements: Purpose and Policy—Revision of Exposure Draft issued
October 15, 1995, that, in addition to other matters, would supersede FASB Statement No. 94 and amend
APB Opinion No. 18. The FASB temporarily suspended work on consolidation policy issues and focused
its efforts on developing interpretive guidance for variable interest entities. In 2003, the FASB issued
FASB Interpretation No. 46, Consolidation of Variable Interest Entities, and FASB Interpretation No. 46,
Consolidation of Variable Interest Entities (revised December 2003), to address consolidation by business
enterprises of variable interest entities. Special effective date provisions apply to enterprises that have
fully or partially applied FASB Interpretation No. 46 prior to the issuance of the revised Interpretation.
Otherwise, application of FASB Interpretation No. 46 (revised December 2003) or FASB Interpretation
No. 46 is required in financial statements of public entities that have interests in variable interest
entities or potential variable interest entities commonly referred to as special-purpose entities for periods
ending after December 15, 2003. Application by public entities, other than small business issuers, for all
other types of entities is required in financial statements for periods ending after March 15, 2004.
Application by small business issuers to entities other than special-purpose entities and by nonpublic
entities to all types of entities is required at various dates in 2004 and 2005. In some instances,
enterprises have the option of applying or continuing to apply FASB Interpretation No. 46 for a short
period of time before applying the revised Interpretation. Not-for-profit organizations are not subject to
FASB Interpretation No. 46 (revised December 2003), except that they may be related parties for
purposes of applying paragraphs 16 and 17 of that Interpretation. Also, if a not-for-profit entity is used by
business enterprises in a manner similar to a variable interest entity in an effort to circumvent the
provisions of FASB Interpretation No. 46 (revised December 2003), that not-for-profit entity is subject to
that Interpretation.
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the fund equal to the amount of assets expected to be liquidated to pay
malpractice claims classified as current liabilities is classified as a current
asset; the balance of the fund, if any, is classified as a noncurrent asset.
Revenues and administrative expenses of the trust fund are included in the
statement of operations (see Chapter 10). In some circumstances, the foregoing
may not be possible (for example, if a common trust fund exists for a group of
health care organizations; if the health care organization is part of a common
municipality risk-financing internal service fund; or if the legal, regulatory, or
indenture restrictions prevent the inclusion of a trust fund in a health care
organization’s financial statements). In those circumstances, the provisions of
paragraphs 8.21 and 8.22 apply.
8.21 In general, estimated losses from asserted and unasserted claims are
accrued and reported, as indicated in paragraphs 8.03 through 8.12. The estimated
losses are not based on payments to the trust fund. However, accounting for a
health care organization that participates in a pooled fund depends on the
extent to which the associated risks and rewards have been transferred to another
party. An organization that transfers its risk of loss to the common trust fund and
forfeits its rights to any excess funding should expense its contributions and
account for its participation in the trust fund based on the type of coverage
obtained (for example, occurrence basis, claims-made, or retrospectively rated).
Governmental health care entities that are component units of a state or local
government reporting entity and that participate in that entity’s risk-financing
internal service fund should report claims expenses equal to the charges from the
internal service fund if those charges meet the requirements of paragraphs 65
through 68, as amended, of GASB Statement No. 10.
8.22 The existence of the trust fund and whether it is irrevocable is
disclosed in the financial statements.
Governmental Health Care Enterprises

8.23 Governmental health care enterprises that are component units of a
state or local governmental reporting entity and that participate in that entity’s
risk-financing internal service fund should report claims expenses equal to the
charges from the internal service fund if those charges meet the requirements
of paragraphs 65 through 68, as amended, of GASB Statement No. 10. A govern
mental health care enterprise that participates in a public entity risk pool with
transfer or pooling of risk should present its premium or required contribution
as insurance expense, as discussed in GASB Statement No. 10, paragraphs 69,
as amended, and 70. Enterprises participating in public entity risk pools without
transfer or pooling of risk should report payments to pools as deposits and
recognize and measure claims liabilities in accordance with GASB Statement
No. 10, paragraphs 53 through 58, as amended. GASB Statement No. 34, Basic
Financial Statements—and Management’s Discussion and Analysis—for State
and Local Governments, paragraphs 116, 119, and 120, requires disclosures
about long-term liabilities (such as claims and judgments). Information to be
presented includes beginning and ending balances, increases, decreases, and
the portions of each item that are due within one year.
Auditing Commitments and Contingencies

8.24 Auditing objectives and procedures for commitments and contingen
cies generally are similar to those of other organizations. The independent
auditor may need to consider the specific auditing objectives, selected control
activities, and auditing procedures presented in Exhibit 8-1 at the end of this
chapter.
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Auditing Medical Malpractice Loss Contingencies

8.25 The existence of an insurance policy, by itself, is no assurance that
malpractice contingencies are assumed by others. The auditor should review
the insurance contracts and determine the extent of the risk retained by the
provider. Specific auditing procedures to consider include the following:
• Determine the type (such as occurrence basis or claims-made) and
level (per occurrence or in the aggregate) of insurance protection the
provider has obtained.
• Determine if the coverage actually transfers the malpractice risks. Is
the insurance with a related party (for example, a captive insurance
company)? Does it provide for retrospective premiums or similar
adjustments?
Once the extent of the risk retained is understood, the auditor will be able to
determine the nature, extent, and timing of other auditing procedures.
8.26 If a health care organization has transferred the risk of loss to a
financially viable third party by purchasing insurance coverage of sufficient
limits on an occurrence basis, no additional auditing procedures are necessary.
If the organization retains all or a portion of the risk through self-insurance or
has purchased a claims-made policy, the independent auditor should perform
additional auditing procedures to obtain reasonable assurance that the organi
zation’s accounting for medical malpractice losses is in accordance with GAAP.
8.27 The independent auditor should consider the extent to which the
renewal of a claims-made policy or the purchase of tail coverage after the
balance-sheet date but prior to the issuance of the financial statements limits
the entity’s liability exposure as of the balance-sheet date. If an entity either
renews a claims-made policy or purchases tail coverage, and the new policy
covers claims asserted during the new policy term (regardless of when the
incident occurred), the entity has transferred to the insurer the risk for that
portion of the entity’s claims that is expected to be reported during the new
policy term (up to the new policy limits). Accordingly, the entity’s liability for
the IBNR claims transferred would not exceed the premium on the new policy,
except for anticipated claims in excess of the new policy limits.
8.28 Management’s intent to renew a claims-made policy is not sufficient
to constitute a limit on IBNR claims as of the balance-sheet date unless
management contractually obligates itself for renewal before the issuance date
of the financial statements and the cost is expensed in the period covered by
the financial statements. The requirement to renew a claims-made policy or to
purchase and expense tail coverage applies even if state regulations require
that renewal of claims-made coverage be offered continually.
8.29 If the insured has the unilateral option to purchase tail coverage at
a premium that may not exceed a stipulated maximum, and the provider
intends to purchase that coverage, the amount of IBNR loss to be accrued may
effectively be limited to the maximum tail-coverage premium stated in the
policy. However, providers in these circumstances that do not intend to pur
chase tail coverage may not accrue the cost of obtaining that coverage as a
substitute for the IBNR accrual.
Auditing Accounting Estimates

8.30 Management is responsible for making the accounting estimates
that are included in the financial statements. Management is also responsible
for providing proper disclosure of (1) the use of estimates in the preparation of
financial statements and (2) certain significant estimates (SOP 94-6, Disclosure of
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Certain Significant Risks and Uncertainties).1 The auditor is responsible for
evaluating the reasonableness of management’s estimates and the adequacy of
the related disclosures. The auditor does this using one or more of the following
approaches:
a. Test the process used by management to develop the estimate.
b. Develop an independent expectation of the estimate to corroborate
the reasonableness of management’s estimate.
c. Review subsequent events or transactions occurring prior to comple
tion of fieldwork.
8.31 In evaluating management’s estimates of asserted and unasserted
claims, the auditor should consider factors such as management’s description
and evaluation of asserted claims and unasserted claims arising from reported
incidents; the lawyer’s (and, if appropriate, the outside risk manager’s) assess
ment of asserted claims and reported incidents not covered by insurers; and
the actuary’s evaluations of the aggregate liability covering asserted claims
and unasserted claims arising from reported and unreported incidents.
8.32 Written assurances should be obtained from management that it has
disclosed all such matters required to be disclosed by FASB Statement No. 5.
8.33 In evaluating the information provided by legal counsel, it may be
necessary to supplement the written representations with inquiries if the
representations are not clear regarding the probability of the litigation out
come or the potential range of loss.12
8.34 The auditor should consider the frequency of losses due to unre
ported incidents and the magnitude of prior losses and underlying causes for
the IBNR claims. If there is a basis for an accrual, the auditor should then
determine whether the entity’s prior history supports the estimation of the
number of claims and the probable settlement value.
Use of Actuaries and Actuarial Methods

8.35 An actuary may be engaged to provide or review the estimate of the
medical malpractice loss amount or range of amounts or to assist in developing
certain factors and assumptions used in estimating the malpractice liability.
The decision to use an actuary should be based on a consideration of whether
(a) the estimated claim liability is potentially material to the fair presentation
of financial statements in conformity with GAAP and (b) special knowledge is
required to estimate the claim liability.
8.36 If an actuary is involved in a substantial way in determining the
amount of a provider’s malpractice self-insurance liability, the independent
auditor should follow the requirements of SAS No. 73, Using the Work of a
Specialist (AICPA, Professional Standards, vol. 1, AU sec. 336). The independent
1 See paragraphs 8.40 through 8.43. SOP 94-6 does not pertain to governmental entities unless
the entity has elected to follow all FASB pronouncements under paragraph 7 of GASB Statement No.
20, Accounting and Financial Reporting for Proprietary Funds and Other Governmental Entities That
Use Proprietary Fund Accounting. (See footnote 1 in Chapter 1.)
2 According to SAS No. 12, Inquiry of a Client’s Lawyer Concerning Litigation, Claims, and
Assessments (AICPA, Professional Standards, vol. 1, AU sec. 337), a letter of audit inquiry to the
lawyer handling the claims is the auditor’s primary means of obtaining corroboration of the informa
tion furnished by management concerning claims made and known incidents for which claims have
not been made that are either uninsured or in excess of the insurance coverage. Audit inquiry letters
generally would not be required with respect to reported contingencies that were not considered to
have a material potential loss. The inability or unwillingness of counsel to evaluate asserted claims
and or reported incidents would give rise to a modification of the auditor’s opinion.
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auditor should consider the actuary’s professional qualifications, reputation,
prior experience in estimating malpractice claim losses, and relationship to the
client. There should be an understanding among the auditor, the client, and
the actuary of the objectives and scope of the analysis and the methods and
assumptions used. The independent auditor should be aware of (a) the limita
tions of assurances in actuarial calculations due to uncertainties and (b)
restrictions as to the use of the actuarial reports. The independent auditor is
responsible for determining the adequacy of the actuary’s report for purposes
of corroborating the representations in the financial statements. The inde
pendent auditor should perform an appropriate test of the accounting data
provided by the client to the actuary. Such accounting data may include
historical claim experience, policy terms (such as coverage, expiration, deduct
ibles, presence of retrospectively determined premiums, and indemnity limita
tions), exposure data (such as the number of beds, high-risk medical
specialties, outpatient visits, and emergency room visits), and information
about risk management systems, personnel, and procedures.
8.37 An accrual for malpractice losses should be based on estimated
ultimate losses and costs associated with settling claims. Accruals should not
be based on recommended funding amounts, which in addition to a provision
for the actuarially determined liability also includes a provision for (a) credit
for investment income and (b) a margin for risk of adverse deviation. The
following are examples of factors to consider and adjustments that may be
required to convert actuarially determined malpractice funding amounts to an
appropriate loss accrual to be reported in the financial statements:
• The risk of adverse deviation is an additional cost factor applied to
bring a funding requirement to a selected confidence level. This factor
does not meet the criteria for recognition as a liability in accordance
with FASB Statement No. 5.
• An evaluation should be made of the extent and validity of industry
data when the credibility factor actuarial technique is used. The lower
the credibility factor, the greater the blending of industry data. This
may create an unacceptable level of industry data at lower confidence
levels. Further, a low credibility factor may indicate that provider-spe
cific data is not sufficient to support the claims liability estimation
process.
• A review of the discounting approach used is necessary to develop the
required disclosure. The impact on the discounting calculation of any
other adjustment made to the actuarially determined amounts (such
as risk of adverse deviation or the credibility of the risk management
system) has to be evaluated.
• A review of the expenses included in the loss estimation process should
be made. Such expenses include the expense of settlement and litiga
tion (that is, allocated loss adjustment expenses).
8.38 Limitations on the availability of provider-specific data, lack of a suffi
cient patient population for claims projection purposes, a very low credibility
factor, and a variety of other factors may cause the actuary's estimate of loss to be
of limited value in developing an estimate of the liability under GAAP.
Risks and Uncertainties

8.39 Uncertainties arise when the evidence available is insufficient for a
reasonable estimation of the effects of the outcome of a particular future event
on the current financial statements. Normally, the resolution of the uncertainty is
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prospective, and sufficient evidence cannot be expected to exist at the time of
the audit. In these situations, it cannot be determined what adjustments, if
any, to the financial statements may be appropriate. The existence of such an
uncertainty, if material, ordinarily should result in the inclusion of an explana
tory paragraph in the auditor’s report. In certain circumstances, the possi
ble effects of the uncertainty on the financial statements may be so pervasive
that the balance of the financial statements has little meaning. In these cases,
a disclaimer of opinion may be appropriate.
8.40 SOP 94-6 requires entities to include in their financial statements
information about—
a. The nature of their operations.
b. Use of estimates in the preparation of financial estimates.
In addition, if certain specified disclosure criteria are met, it requires entities
to include in their financial statements disclosures about—
a. Certain significant estimates.
b. Current vulnerability due to certain concentrations.
8.41 Paragraph 18 of SOP 94-6 gives examples of items that may be based
on estimates that are particularly sensitive to changes in the near term.
Examples of similar estimates that may be included in financial statements of
health care organizations include, but are not limited to, the following:
• Third-party revenue and related receivables
• Assets subject to impairment, for example, goodwill
• Environmental remediation-related obligations
• Litigation-related contingencies, for example, fraud and abuse actions
by regulators
• Estimated risk pool settlements arising from managed care contracting
• Amounts reported for long-term obligations such as amount reported
for pensions and postemployment benefits
• Estimated net proceeds recoverable, the provisions for expected loss
to be incurred, or both, on disposition of a business or assets
8.42 SOP 00-1 provides guidance to auditors regarding uncertainties
inherent in health care revenue recognition. Examples of risks unique to the
government-contracting environment are presented in paragraph 7 of the SOP.
Also, in the health care environment, it is almost always at least reasonably
possible that estimates regarding third-party payments could change in the
near term as a result of one or more future confirming events (for example,
regulatory action reflecting local or national audit or enforcement initiatives).
For most entities with significant third-party revenues, the effect of the change
could be material to the financial statements. Where material exposure exists,
the uncertainty regarding revenue realization is disclosed in the notes to the
financial statements.3
8.43 Examples of concentrations that may meet the criteria that require
disclosure in the financial statements of health care organizations in accord
ance with paragraph 21 of the SOP include the following:
• Concentrations in the volume of business transacted with a particular
payor, supplier, lender, grantor, or contributor
3
A sample disclosure is provided in SOP 00-1 that among other things indicates laws and
regulations governing the Medicare and Medicaid programs are extremely complex and subject to
interpretation. As a result, there is at least a reasonable possibility that recorded estimates will
change by a material amount in the near term. SOP 00-1 is included as Appendix E to this Guide.
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• Concentrations in revenue from particular products, services, or fund
raising events
• Concentrations in the available sources of supply of material, labor, or
services, or of licenses or other rights used in the entity’s operations
• Concentrations in the market or geographic area in which an entity
conducts its operations
Evaluating Lawyers' Responses

8.44 Determining the outcome of pending or threatened litigation, claims
and assessments (including unasserted claims and assessments) normally is
beyond the auditor’s professional competence. Accordingly, the auditor’s evalu
ation of the need for disclosures or report modifications is based primarily on
the opinion of the lawyer handling the matter. The American Bar Association
(ABA) has adopted a Statement of Policy Regarding Lawyers’ Responses to
Auditors’Requests for Information under which lawyers accept certain respon
sibility for responses to auditors’ inquiries. However, the ABA Statement of
Policy is not enforceable by the ABA in the same way the AICPA is able to
enforce its standards under the accounting profession’s Code of Professional
Conduct. As a result, lawyers’ responses may vary widely.
8.45 Interpretation No. 7 of SAS No. 12, entitled “Assessment of a Law
yer’s Evaluation of the Outcome of Litigation” (AICPA, Professional Stand
ards, vol. 1, AU sec. 9337.18-.22) includes the following examples of
evaluations of litigation, which may be considered to communicate in a suffi
ciently clear manner a remote likelihood of an unfavorable outcome:
• “We are of the opinion that this action will not result in any liability
to the company.”
• “It is our opinion that the possible liability to the company in this
proceeding is nominal in amount.”
• “We believe the company will be able to defend this action successfully.”
• “We believe that the plaintiff's case against the company is without
merit.”
• “Based on the facts known to us, after a full investigation, it is our
opinion that no liability will be established against the company in
these suits.”
8.46 On the other hand, the lawyer may use terms, such as meritorious
defenses, that have different meanings to different lawyers. The Interpretation
includes the following examples of lawyers’ evaluations that are unclear re
garding the likelihood of an unfavorable outcome:
• “This action involves unique characteristics wherein authoritative
legal precedents do not seem to exist. We believe that the plaintiff will
have serious problems establishing the company’s liability under the
act; nevertheless, if the plaintiff is successful, the award may be
substantial.”
• “It is our opinion that the company will be able to assert meritorious
defenses to this action.” (The term “meritorious defenses” indicates
that the company’s defenses will not be summarily dismissed by the
court; it does not necessarily indicate the lawyer’s opinion that the
company will prevail.)
• “We believe the action can be settled for less than the damages
claimed.”
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• “We are unable to express an opinion as to the merits of the litigation
at this time. The company believes there is absolutely no merit to the
litigation.” (If the company’s lawyer, with the benefit of all relevant
information, is unable to conclude that the likelihood of an unfavorable
outcome is “remote”, it is unlikely that management would be able to
form a judgment to that effect.)
• “In our opinion, the company has a substantial chance of prevailing in
this action.” (A “substantial chance”, a “reasonable opportunity”, or
similar terms indicate more uncertainty than an opinion that the
company will prevail.)
8.47
When the lawyer’s response is unclear, the auditor may request a
conference to clarify the lawyer’s opinion. If the response is still unclear or the
materiality of the uncertainty cannot be determined, the auditor should con
sider the guidance in paragraphs 29 through 32 of SAS No. 58, Reports on
Audited Financial Statements, as amended by SAS No. 79, Amendment to
Statement on Auditing Standards No. 58, Reports on Audited Financial State
ments (AICPA, Professional Standards, vol. 1, AU sec. 508).
Auditing
8.48
The independent auditor may need to consider the examples of
specific auditing objectives, selected control activities, and auditing procedures
for commitments and contingencies that are presented in Exhibit 8-1.
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Exhibit 8-1

Auditing Considerations

Financial Statement Specific Auditing
Assertions
Objectives
Malpractice Loss Contingencies
Existence and
The liability for
occurrence,
malpractice
completeness,
claims is reported
properly in the
rights and
obligations, and balance sheet.
valuation
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Selected Control
Activities

Auditing
Procedures

Insurance
coverage is
reviewed
regularly,
including the
financial viability
of the insurer.
The risk
management
system identifies
and monitors
malpractice
incidents and
evaluates
associated losses.
Outside legal
counsel and
insurance
carriers review
and monitor all
claims.
The adequacy of
malpractice
accruals is
reviewed
regularly by
management,
including
information
obtained from
qualified
specialists.
Information
supplied to
specialists is
reviewed for
accuracy and
completeness.
Actuarial
assumptions are
reviewed for
compliance with
GAAP.

Review the
amount of
insurance
coverage, the type
of coverage
(claims-made or
occurrence), the
deductible
provisions, and so
forth, to
determine the
level of risk that
is retained by the
entity. Consider
the financial
viability of the
insurance carrier.
Send letters of
inquiry to
malpractice
insurance carriers
and legal counsel
(in accordance
with SAS No. 12).
Review and test
the method of
estimating
accruals (for
example, review
actuarial reports
and prior
historical loss
experience).
Determine that
additional
premiums
charged by
insurers for
retrospectively
related policies
are reported as a
liability.
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Financial Statement Specific Auditing Selected Control
Assertions
Objectives
Activities
Changes in the
risk management
system are
communicated on
a timely basis.
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Auditing
Procedures
Review prior
estimates and
historical loss
experience.
Determine
whether
uncertainties
related to medical
malpractice
claims need to be
disclosed in the
auditor’s report.

Presentation and The program of
disclosure
medical
malpractice
insurance
coverage and the
basis for any loss
accruals are
disclosed
adequately in the
financial
statements.
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Chapter 9
Net Assets (Equity)
Investor-Owned Health Care Organizations

9.01 The equity accounts of investor-owned health care entities are simi
lar to those of other investor-owned businesses.
Not-for-Profit Health Care Organizations

9.02 The balance sheets of not-for-profit health care organizations should
report separate amounts for each of three classes of net assets:1 (a) perma
nently restricted net assets, (b) temporarily restricted net assets, and (c)
unrestricted net assets. This is based on the existence or absence of donor-im
posed restrictions.
9.03 Unrestricted net assets generally result from revenues from provid
ing or agreeing to provide health care services, receiving unrestricted contribu
tions and grants, or receiving dividends or interest from investing in
income-producing assets minus expenses incurred in providing or agreeing to
provide health care services, providing other community benefits, and perform
ing administrative functions. The only limits on the use of unrestricted net
assets are the broad limits resulting from the nature of the provider’s organi
zation; the environment in which the organization operates; the purposes
specified in its articles of incorporation or in its bylaws; or limits resulting from
contractual agreements with suppliers, creditors, and others entered into in
the course of business. Information about significant contractual limits, includ
ing the existence of restrictive debt covenants, generally is provided in the
notes to the financial statements. Similarly, information about self-imposed
limits may be provided either on the face of the balance sheet or in the notes to
the financial statements. Such specifics include information about voluntary
resolutions by the entity’s governing board to designate a portion of its unre
stricted net assets for identified purposes (for example, funded depreciation).
9.04 Information about the nature and amounts of different types of
permanent restrictions or temporary restrictions should be provided either by
reporting their amounts on the face of the financial statements or by including
relevant details in the notes to the financial statements. Separate line items
may be reported within permanently restricted net assets (or in the notes to
the financial statements) to distinguish between permanent restrictions for
holdings of (a) assets, such as land or works of art, donated with stipulations
that they be used for a specified purpose, be preserved, and not be sold, or (b)
assets donated with stipulations that they be invested to provide a permanent
source of income (that is, permanent endowment funds).
9.05 Similarly, separate line items may be reported within temporarily
restricted net assets (or in the notes to the financial statements) to distinguish
between temporary restrictions for (a) support of particular operating activi
ties, (b) investment for a specified term, (c) use in a specified future period, or
(d) acquisition of long-lived assets. Donors’ temporary restrictions may require
1
Though some health care organizations may use other terms, such as equity, this Guide uses
the term net assets to describe residual interest.
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that resources be used in a later period or after a specified date (time restric
tions) or that resources be used for a specified purpose (purpose restrictions) or
both. For example, gifts of cash and other assets with stipulations that they be
invested to provide a source of income for a specified term and that the income
be used for a specified purpose are restricted both as to time and purpose.
9.06
The nature of the restrictions on donor-restricted resources should
be disclosed in the financial statements.
Governmental Health Care Organizations*

9.07 The statements of net assets/balance sheets of governmental health
care entities should report net assets/equity in three components: (1) invested
in capital assets, net of related debt; (2) restricted, and (3) unrestricted. Either
term net assets or equity may be used to refer to the difference between assets
and liabilities. The term fund balance should not be reported on the face of the
statement. When governmental health care entities first apply GASB State
ment No. 34, Basic Financial Statements—and Management’s Discussion and
Analysis—for State and Local Governments, classifying net assets into the
three required categories should begin by adding together all previously re
ported fund balance amounts. Calculating each of the three required compo
nents is described in paragraphs 9.08 through 9.10.
9.08 As discussed in GASB Statement No. 34, paragraph 33, the net asset
component, invested in capital assets, net of related debt should be the sum of
capital assets (capital assets are defined in paragraph 19 of GASB Statement
No. 34), net of accumulated depreciation less any debt issued to finance those
assets. Invested in capital assets, net of related debt should not include any
restricted resources that must be used to acquire capital assets, (such as
unexpended debt proceeds, or capital grants and contributions), or debt attrib
utable to significant amounts of unexpended debt proceeds. Capitalized costs
of issuance are included with the same category as the related debt, as
discussed in the GASB staff document Comprehensive Implementation
Guide—2003 (GASB Q&A 2003 Edition), item 7.130 (see paragraph 1.11 in this
Guide).
9.09 The term restricted is defined by GASB Statement No. 34, para
graphs 34 and 99. A restriction is a constraint placed on the use of assets or net
assets that is either externally imposed (such as by creditors through debt
covenants) or imposed by law through constitutional provisions or enabling
legislation. Restricted net assets should be reported based on this definition of
restricted. As discussed in paragraph 98 of GASB Statement No. 34, major
categories of restrictions should be reported on the face of the statement of net
assets/balance sheet, for example, net assets restricted for capital acquisitions.
As discussed in the GASB Q&A 2003 Edition, item 7.129, (see paragraph 1.11
in this Guide) unexpended debt proceeds that must be used to acquire or
construct capital assets and the portion of the debt attributable to the unex
pended proceeds should be included in restricted net assets. When a govern
mental health care entity reports restricted net assets arising from permanent
endowments, restricted net assets should be reported in two additional compo
nents—expendable and nonexpendable, as discussed in paragraph 35 of GASB
Statement No. 34. As discussed in Appendix 7-3, Exercise 3 in the GASB Q&A
*This section contains guidance that is limited to governmental health care organizations that
report as proprietary activities. This section does not apply to governmental health care
organizations that report using governmental funds.
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2003 Edition (see paragraph 1.11 in this Guide), no category of restricted net
assets can be negative. If liabilities that relate to restricted assets exceed those
assets, no balance should be reported. The negative amount should be reported
as a reduction of unrestricted net assets.
9.10 GASB Statement No. 34, paragraph 98, prohibits governmental
entities from reporting internal designations in the net assets section of their
statements of net assets/balance sheets. Designations are management’s plans
for the use of resources. They should not be afforded the same status as
restrictions. Internally designated net assets should be reported as unre
stricted net assets and should not be displayed separately in the net assets
section of the statement of net assets/balance sheet, as discussed in paragraph
37 of GASB Statement No. 34. (Designated assets, however, may be reported
in the statement of net assets/balance sheet, as discussed in paragraph 3.01 in
this Guide.)
9.11 The nature of the restrictions on donor-restricted resources should
be disclosed in the financial statements.
Auditing

9.12 The independent auditor may need to consider the examples of
specific auditing objectives, selected control activities, and auditing procedures
relating to net assets (equity) that are presented in Exhibit 9-1.
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Exhibit 9-1

Auditing Considerations

Financial Statement Specific Auditing
Assertions
Objectives
Net Assets (Equity)
Rights and
Resources are
obligations
used and
accounted for in
accordance with
donor and grantor
restrictions.

Selected Control
Activities

Auditing
Procedures

Management
monitors
compliance with
these restrictions.

Review the
minutes of board
and board
committee
meetings for
evidence of donor
restrictions.
Determine
compliance with
donor and grantor
restrictions.

Presentation and Net assets are
disclosure
presented and
disclosed properly
in the financial
statements.
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Procedures
ensure proper
authorization,
recording, and
presentation.

Test significant
net asset
transactions to
determine that
they are properly
authorized and
recorded.
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Chapter 10
Revenue/ Expenses, Gains, and Losses
Conceptual Framework for Reporting Revenue,
Expenses, Gains, and Losses

10.01 FASB Concepts Statement No. 6, Elements of Financial State
ments, provides a useful conceptual framework for preparers of financial
statements to distinguish among elements of financial statements for purposes
of display. Additionally, not-for-profit organizations are subject to the require
ments of FASB Statement No. 117, Financial Statements of Not-for-profit
Organizations.1 This chapter draws on the concepts contained in FASB
Concepts Statement No. 6 and FASB Statement No. 117 in discussing revenue,
expenses, gains, and losses with respect to health care organizations. Expenses
are not generally netted against revenues, whereas gains and losses may be
displayed as net amounts. The application of these concepts to the classifica
tion of revenue, expenses, gains, and losses in the statement of operations of
health care organizations is discussed in paragraphs 10.02 through 10.10.
10.02 FASB Concepts Statement No. 6, paragraph 78, defines revenues
as “inflows or other enhancements of assets of an entity or settlements of its
liabilities (or a combination of both) from delivering or producing goods,
rendering services, or other activities that constitute the entity’s ongoing major
or central operations.” Similarly, paragraph 80 defines expenses as “outflows
or other using up of assets or incurrences of liabilities (or a combination of both)
from delivering or producing goods, rendering services, or carrying out other
activities that constitute the entity’s ongoing major or central operations.”
Distinguishing Charity Care From Bad Debt Expense
or Allowance

10.03
Charity care represents health care services that are provided but
are never expected to result in cash flows. As a result, charity care does not
qualify for recognition as receivables or revenue in the financial statements.
Distinguishing charity care from bad-debt expense (or allowance, for govern
mental health care entities12) requires the exercise of judgment. Charity care
is provided to a patient with demonstrated inability to pay. Each organization
establishes its own criteria for charity care consistent with its mission state
ment and financial ability. Only the portion of a patient’s account that meets
the organization’s charity care criteria is recognized as charity. Although it is
not necessary for the entity to make this determination upon admission or
registration of an individual, at some point the entity must determine that the
individual meets the established criteria for charity care. (See paragraph 10.26
for disclosure requirements relating to charity care.)
1 This pronouncement is not applicable to governmental health care enterprises. (See footnote 1
in Chapter 1.)
2 See paragraph 10.26 in this chapter for a discussion about the reporting of allowances by
governmental health care entities.
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10.04 Revenue usually is recorded when coverage is provided to an en
rollee or the service is provided to a patient or resident. Revenue is classified
based on the type of service rendered or contracted to be rendered. Examples
of revenue include—
• Patient service revenue, which is derived from fees charged for patient
care. This may be based on diagnosis related group (DRG) payments,
resource-based relative value scales (RBRVS) payments, per diems,
discounts, or other fee-for-service arrangements.
• Premium revenue, which is derived from capitation arrangements.
• Resident service revenue, which may be related to maintenance fees,
rental fees, or amortization of advance fees.
10.05 Some not-for-profit health care enterprises may receive relatively
small amounts of contributions, grants, or tax support. Such amounts, whether
temporarily restricted, permanently restricted, or unrestricted, are recognized
as revenue or gains when they are received. Special considerations pertaining
to revenue recognition of promises to give in future periods (pledges) are
discussed in Chapter 5 and in paragraphs 10.07 through 10.10 in this Guide.
FASB Statement No. 136, Transfers of Assets to a Not-for-Profit Organization
or Charitable Trust That Raises or Holds Contributions for Others,3 estab
lishes standards for transactions in which a donor makes a contribution by
transferring assets to a recipient organization—a not-for-profit organization or
a charitable trust—that accepts the assets from the donor and agrees to use
the assets on behalf of or transfer the assets, their investment return, or both
to another entity—the beneficiary—named by the donor.34 If a donor transfers
assets to an agent, trustee, or intermediary (recipient organization) and speci
fies a nongovernmental health care organization as the ultimate recipient (the
specified beneficiary) of the contribution or grant, that specified health care
organization should recognize its rights to the assets held by a recipient
organization as an asset and contribution revenue unless the recipient organi
zation is explicitly granted variance power. (See paragraph 15 of FASB State
ment No. 136.) Variance power is the unilateral power to redirect the use of the
transferred assets to an entity or individual other than the specified benefici
ary. Explicitly grants means that the donor should explicitly refer to the
recipient organization’s ability to exercise variance power in the instrument
that transfers the assets. Unilateral power means that the recipient organiza
tion can override the donor’s instructions without approval from the donor, the
specified beneficiary, or any other interested party. (See paragraph 12 of FASB
Statement No. 136.) If the recipient organization is explicitly granted variance
power, the specified health care organization (beneficiary) should not recognize
its potential for future distributions from the assets held by the recipient
organization. (See paragraph 16 of FASB Statement No. 136.) Those distribu
tions, if they occur, should be recognized as contributions by the specified health
care organization (beneficiary) when received or unconditionally promised.

3 This pronouncement is not applicable to governmental health care enterprises. (See footnote 1
in Chapter 1.)
4 FASB Statement No. 136 also established standards for transactions that take place in a
similar manner but are not contributions because the transfers are revocable, repayable, or recipro
cal. For example, if a resource provider transfers assets to a recipient organization and names itself
or its affiliate as beneficiary, that transaction is reciprocal even if the resource provider grants
variance power. Those standards and transactions are discussed in paragraphs 4.14, 4.15, 11.21,
11.23, and 11.24 of this Guide. This Guide does not use the word donor in discussing those transac
tions because they are not contributions.
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(See further discussion at paragraph 5.11 in this Guide. Also, special consid
erations pertaining to transfers between related entities are discussed in
paragraphs 10.07,11.21 through 11.24 and 11.29 through 11.33 in this Guide.)
Governmental health care enterprises may also receive contributions, grants,
or tax support. Governmental health care enterprises classify these transac
tions into one of four classes of nonexchange transactions based on their
principal characteristics, as discussed in GASB Statement No. 33, Accounting
and Financial Reporting for Nonexchange Transactions, paragraph 7, as
amended by GASB Statement No. 36, Recipient Reporting for Certain Shared
Nonexchange Revenues. (GASB Statement No. 33, as amended, applies to
transactions involving financial and capital resources. GASB Statement No.
33, as amended, does not apply to other resources, such as contributed serv
ices.) Transactions that are not recognizable because they are not measurable
should be disclosed.
10.06 Other revenue, gains, or losses are derived from services other than
providing health care services or coverage to patients, residents, or enrollees.
These typically include—
• Interest and dividends from all funds held by a trustee, malpractice
funds, or other miscellaneous investment activities.
• Certain realized changes in market values of marketable securities
(see Chapter 4).
• Fees from educational programs, which include tuition for schools
(such as nursing) or laboratory and X-ray technology.
• Rental of health care facility space.
• Sales of medical and pharmaceutical supplies to employees, physi
cians, and others.
• Fees charged for transcripts for lawyers, insurance companies, and
others.
• Proceeds from sale of cafeteria meals and guest trays to employees,
medical staff, and visitors.
• Proceeds from sale of scrap, used X-ray film, etc.
• Proceeds from sales at gift shops, snack bars, newsstands, parking
lots, vending machines, or other service facilities operated by the
health care organization.
10.07 Interest earned and gains and losses on investments and other
assets (or liabilities) are reported by not-for-profit organizations as increases
or decreases in unrestricted net assets, unless their use is temporarily or
permanently restricted by explicit donor stipulation or by law. Net assets
released from restriction, such as those related to the fulfillment of time or
purpose restrictions, should be reported separately in the financial statements
or disclosed in the notes. Additional guidance on accounting for investments
can be found in Chapter 4. Occasionally, nongovernmental health care organi
zations may receive funds from (or transfer funds to) a not-for-profit organiza
tion or a charitable trust. If the not-for-profit organization is an affiliate, those
transfers generally are either: (a) an equity transfer, (b) an equity transaction,
or (c) a loan or advance. Equity transfers are discussed in paragraph 11.20.
Equity transactions are discussed in paragraphs 11.21 through 11.24. Loans
and advances to related entities are discussed in paragraph 11.26. In limited
circumstances, those transfers are contributions. The circumstances in which a
distribution from a not-for-profit organization or charitable trust to an affili
ated nongovernmental health care organization is a contribution are described
in paragraphs 11.32 and 11.33. If the not-for-profit organization or charitable
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trust is not an affiliate, the transaction is either (a) an investment transaction,
(b) a refundable advance, or (c) a contribution. Investment transactions are
discussed in paragraphs 4.14 and 4.15. The transfer is a refundable advance if
it is revocable or repayable. The transfer is a contribution only if it meets the
definition of a contribution in FASB Statement No. 116; that is, it is an
unconditional, voluntary, nonreciprocal transfer by an entity acting other than
as an owner.
10.08 Contributions of noncash assets that are not long-lived assets are
recognized as revenue or gains in the period received and as assets or a
reduction of liabilities or expenses, depending on the form of the benefits
received. (For example, a donation of supplies would be reflected as revenue or
gains and as an increase in inventory or supply expense.) The donations are
measured at fair value.5 Donations received with no restrictions attached are
reported as unrestricted support in the statement of operations. Donations
with explicit donor restrictions attached (other than permanent restrictions)
are reported as temporarily restricted support. The expiration of these restric
tions is recognized in the period when the time stipulated by the donor has elapsed,
when the stipulated purpose for which the asset was restricted has been fulfilled,
or both. When the restriction expires, the temporarily restricted net assets are
reclassified to unrestricted net assets and reported in the statement of operations
as “net assets released from restriction.” Donor-restricted contributions whose
restrictions are met in the same reporting period may be reported as unrestricted
support provided that an organization discloses its accounting policy and applies
the policy consistently from period to period. Donations with explicit donor restric
tions attached that permanently limit the health care organization’s use of the
contributed assets (for example, permanent endowments) are reported as in
creases in permanently restricted net assets.
10.09 Contributions of long-lived assets, including the use of long-lived
assets such as land, buildings, and equipment, are reported as support or gains
in the period received. The donation is measured at its fair value. If the donor
places no restrictions on the use of the asset, the contribution is reported as
unrestricted support. Contributions of long-lived assets with explicit donor
restrictions are reported as temporarily or permanently restricted support.
The provider reports expirations of donor restrictions when the stipulation is
fulfilled and the assets are placed in service. At that time, temporarily re
stricted net assets are reclassified to unrestricted net assets and reported in
the statement of operations as “net assets released from restriction.”
10.10 Donations of cash or other assets that must be used to acquire longlived assets are reported as temporarily restricted support in the period received.
Expirations of donor restrictions are reported when the acquired long-lived
assets are placed in service and donor-imposed restrictions are satisfied. The
temporarily restricted net assets are reclassified to unrestricted net assets and
reported in the statement of operations as “net assets released from restric
tion.” For providers that prepare classified balance sheets, assets that are
restricted by donors for acquisition of long-lived assets (such as cash or contri
butions receivable) are not included in “cash and cash equivalents” or with
other “contributions receivable.” Rather, those assets are reported in a sepa
rate section, such as “assets restricted to investment in property and equip
ment,” and are sequenced near the “property and equipment” section of the
balance sheet (see paragraph 3.01).
5
Information necessary to estimate the fair value of a donated asset may be obtained from
various sources as described in FASB Statement No. 116, Accounting for Contributions Received and
Contributions Made, paragraph 19.
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10.11 The nature and extent of donated services received by health care
organizations varies and can range from the limited participation of many
people in fund-raising activities to active participation in the entity’s service
programs; their values usually are not recorded. Contributed services should
be reported as contribution revenue and as assets or expenses if the services
create or enhance a nonfinancial (that is, nonmonetary) asset (for example,
property and equipment) or meet all of the following criteria:
a. Require specialized skills
b. Are provided by individuals with those skills (such as accounting,
financial, construction, educational, electrical, legal, medical, and
other services provided by accountants, investment advisers, con
tractors, teachers, electricians, lawyers, doctors, and other profes
sionals and craftspeople)
c. Would typically need to be purchased by the organization if they had
not been provided by contribution
Additional guidance with regard to the accounting for and the reporting of
donated services is provided in FASB Statement No. 116.
10.12 Contributions to governmental health care enterprises are gov
erned by GASB Statement No. 33, discussed in paragraph 10.05. GASB State
ment No. 33 applies to external transactions involving financial and capital
resources. As discussed in GASB Statement No. 33, paragraph 14, purpose
restrictions on nonexchange revenues (such as grants, contributions, and
endowments) do not affect when revenues are recognized. Rather, resulting net
assets should be reported as restricted until the resources have been used for
the specified purpose (see paragraph 9.08 of this Guide) or for as long as the
resource provider requires (for example, for endowments). Unlike not-for-profit
health care entities, the statement of revenues, expenses, and changes in net
assets/equity does not require disaggregation of transactions based on the
types of restrictions that may exist (such as unrestricted, temporarily re
stricted, or permanently restricted revenues). Disaggregations such as net
assets released from restrictions, changes in temporarily restricted net assets,
and changes in permanently restricted net assets should not be reported in
either the statement of revenues, expenses, and changes in net assets/equity
or in the net assets section of the statement of net assets/balance sheet of
governmental health care entities. Interfund transfers are reported after
nonoperating revenues and expenses in the statement of revenues, expenses,
and changes in net assets/equity as discussed in paragraphs 101 and 112 of
GASB Statement No. 34, Basic Financial Statements—and Management’s
Discussion and Analysis—for State and Local Governments (see paragraph
1.20 of this Guide). Intra-entity activity between a primary government and its
component units are accounted for in accordance with paragraph 61 of GASB
Statement No. 34.
10.13 Additional guidance regarding accounting for contributions dis
cussed above can be found in Chapters 5 and 6 of the Audit and Accounting
Guide Not-for-Profit Organizations, which also addresses the following:
• Permanent endowments
• Split-interest agreements
• Gifts in kind
• Contributed utilities, facilities, or use of long-lived assets
• Transfers to a not-for-profit organization or charitable trust that
raises or holds contributions for others (refer to Chapter 5 in the Audit
and Accounting Guide Not-for-Profit Organizations under the heading
“Agency Transactions”)
AAG-HCO 1 0.13

134

Health Care Organizations

10.14 Foundations, business organizations, and other types of entities
may provide resources to health care organizations under programs referred to
as grants, awards, or sponsorships. Those asset transfers are contributions if the
resource providers receive no value in exchange for the assets transferred or if
the value received by the resource provider is incidental to the potential public
benefit from using the assets transferred. For governmental health-care or
ganizations, these transactions are referred to as nonexchange transactions,
addressed in GASB Statement No. 33. The asset transfers are exchange or
exchange-like transactions if the potential public benefit is secondary to the
resource providers’ potential direct benefits. For example, a research grant
made by a foundation to a hospital would likely be a contribution if the research
program is to be planned and carried out by the hospital and the hospital has
the right to publish the results. If, however, the grant is made by a pharmaceu
tical manufacturer that provides potential new medications to be tested in the
hospital’s research facilities and retains the right to any patents or other
results, the grant would likely be an exchange transaction.
10.15 For governmental health care entities, capital contributions and
contributions to term and permanent endowments are reported as a compo
nent of the all-inclusive statement of revenues, expenses, and changes in net
assets/equity. Contributions of capital assets or of financial resources required
to be used to acquire capital assets are required to be reported as revenues
separately after nonoperating revenues and expenses, in the statement of
revenues, expenses, and changes in net assets/equity, as illustrated in para
graph 1.18 of this Guide. Contributions to term and permanent endowments
should be reported in the same manner as capital contributions. Capital
contributions received from other funds of the same financial reporting entity
should be reported last as interfund transfers, after nonoperating revenues and
expenses in the statement of revenues, expenses, and changes in net assets/
equity, as discussed in paragraph 101 of GASB Statement No. 34 and para
graph 10.12 in this chapter.
10.16 Revenues from capital contributions as well as contributions to the
principal of permanent and term endowments should be reported after nonop
erating revenues and expenses, as discussed in GASB Statement No. 34, para
graph 100. Income from permanent or term endowments should be recorded as
nonoperating revenue, as discussed in the GASB staff document Comprehen
sive Implementation Guide—2003 (GASB Q&A 2003 Edition), item 7.334 (see
paragraph 1.11 in this Guide).
Expenses

10.17 The basis and timing of the recognition of expenses for health care
organizations generally are the same as for other business enterprises. Ex
penses arising from nonexchange transactions (such as grants, taxes, and
contributions) reported by governmental health care enterprises are recog
nized based on their appropriate class of nonexchange transactions, as dis
cussed in paragraph 10.05. Not-for-profit organizations report expenses as
decreases in unrestricted net assets.
10.18 Statement of Position (SOP) 98-2, Accounting for Costs of Activities
of Not-for-Profit Organizations and Local Governmental Entities That Include
Fund Raising, provides guidance for not-for-profit and state and local govern
mental entities (including health care organizations) that conduct fund-raising
activities with activities related to other functions, such as program activities
or supporting services (joint activities). This SOP establishes financial accounting
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standards for accounting for costs of joint activities, and requires financial
statement disclosures about the nature of the activities for which joint costs
have been allocated and the amounts of joint costs. SOP 98-2 is included as
Appendix C to this Guide.
Financial Statement Presentation

10.19 The statement of operations for not-for-profit organizations should
include a performance indicator that reports results of operations. This per
formance indicator and the income from continuing operations reported by
for-profit health care enterprises generally are consistent, except for transac
tions that clearly are not applicable to one kind of entity (for example, for-profit
health care enterprises typically would not receive contributions, and not-forprofit health care organizations would not award stock compensation). That is,
the performance indicator is analogous to income from continuing operations
of a for-profit enterprise. Because of the importance of the performance indica
tor, it should be clearly labeled with a descriptive term such as revenues over
expenses, revenues and gains over expenses and losses, earned income, or perform
ance earnings. The notes to the financial statements should include a descrip
tion of the nature and composition of the performance indicator. Not-for-profit
organizations should report the performance indicator in a statement that also
presents the total changes in unrestricted net assets. Other changes in net
assets may be presented separately or in the same statement.
10.20 Health care organizations should report the following items sepa
rately from the performance indicator—
a. Transactions with owners acting in that capacity.
b. Equity transfers involving other entities that control the reporting
entity, are controlled by the reporting entity, or are under common
control with the reporting entity.
c. Receipt of restricted contributions, including temporary restrictions
(such as time or purpose) or permanent restrictions.
d. Contributions of (and assets released from donor restrictions related
to) long-lived assets.
e. Items that are required to be reported in or reclassified from other
comprehensive income, such as a minimum pension liabilities in
accordance with paragraph 37 of FASB Statement No. 87, Employers’
Accounting for Pensions; foreign currency translation adjustments
and the effective portion of the gain or loss on derivative instruments
designated and qualifying as cash flow hedging instruments.
f. Items that are required to be reported separately under specialized
not-for-profit standards. These include extraordinary items, the ef
fect of discontinued operations, and the cumulative effect of account
ing changes pursuant to the provisions of FASB Statement No. 117;
and unrealized gains and losses on investments not restricted by
donors or by law (except for those investments classified as trading
securities) and investment returns restricted by donors or by law, as
required by paragraphs 4.07 through 4.10 of this Guide.
10.21 Classifying revenues, expenses, gains, and losses within classes of
net assets does not preclude incorporating additional classifications within the
performance indicator. For example, within a class or classes of changes in net
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assets, a not-for-profit organization may classify items as operating and non
operating, expendable and nonexpendable, earned and unearned, recurring and
nonrecurring, or in other ways. This Guide neither requires nor precludes
reporting such intermediate measures or subtotals. However, because terms
such as operating income are used with different meanings, if an intermediate
measure of operations is reported and its use is not apparent from the details
provided on the face of the statement, a note to the financial statements should
describe the nature of the reported measure of operations or the items excluded
from operations.
10.22 Governmental health care entities should separately report special
items and extraordinary items at the bottom of the statement of revenues,
expenses, and changes in net assets/equity, as illustrated in GASB Statement
No. 34, paragraph 101. Governmental health care entities should report spe
cial items separately after capital contributions and contributions to perma
nent and term endowments but before extraordinary items, if any. GASB
Statement No. 34, paragraph 56, defines a special item as a significant trans
action or other event that is within the control of management and that is
either unusual in nature or infrequent in occurrence.
10.23 Governmental health care entities are required to distinguish be
tween operating revenues and expenses and nonoperating revenues and ex
penses and provide an intermediate total for operating income or loss. GASB
Statement No. 34, paragraph 102, does not establish a definition of operating.
Rather, governments are required to establish their own policy defining oper
ating revenues and expenses that is appropriate to the nature of the activity
being reported. Once established, an entity’s policy should be applied consis
tently and disclosed in the notes to the financial statements. GASB Statement
No. 34, paragraph 102, notes that a consideration for determining which
revenues and expenses should be reported as operating is how those transac
tions would be classified in the statement of cash flows. Using this approach,
transactions that are considered investing, capital and related financing, and
noncapital financing activities would normally not be reported as operating
revenues and expenses. This would include investment revenues and interest
expense as well as most nonexchange transactions, including most grants,
taxes, and contributions.
10.24 For governmental health care entities, changes in accounting prin
ciples, addressed in APB Opinion No. 20, Accounting Changes, as amended,
should be reported as restatements of beginning net assets/equity, as discussed
in footnote 13 to paragraph 17 of GASB Statement No. 34.
10.25 For financial reporting purposes, patient service revenue is re
ported net of provisions for contractual and other adjustments in the operating
statement. Significant revenue earned under capitation arrangements is re
ported separately. The notes to the financial statements disclose the methods
of revenue recognition (for example, policies related to capitation revenue,
patient service revenue, or contributions). In addition, with regard to contrac
tual adjustments and third-party settlements, identification and explanation
of the estimated amounts that are payable or receivable by the entity are
disclosed.
10.26 GASB Statement No. 34, paragraph 100, requires revenues to be
reported by major source, net of discounts and allowances, and separately
identify pledged revenues. The amount of discounts and allowances, including
the increase or decrease in the estimate of uncollectible accounts, should be
reported parenthetically on the face of the financial statements, as a separate line
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directly below the revenue amount, or in the notes, as required by GASB
Statement No. 34, footnote 41 to paragraph 100. Paragraph 10.04 in this chapter
provides additional discussion on classification of revenue, and examples of
revenue, including patient service revenue. As discussed in paragraph 10.25 in
this chapter, patient service revenue is reported net of contractual and other
adjustments in the operating statement.
10.27 As discussed in paragraph 10.03, patient service revenue does not
include charity care. Management’s policy for providing charity care, as well as
the level of charity care provided, should be disclosed in the financial state
ments. Such disclosure generally is made in the notes to the financial state
ments and is measured based on the provider’s rates, costs, units of service, or
other statistical measure.
10.28 Expenses may be reported on the face of the financial statements
using either a natural classification or a functional presentation. Public com
panies (that is, registrants with the SEC) are required to disclose segment
information in accordance with FASB Statement No. 131, Disclosure about
Segments of an Enterprise and Related Information. Not-for-profit organiza
tions that report using a natural classification of expenses are required to
disclose expenses by functional classification. For governmental health care
entities, GASB Statement No. 34, paragraph 122, as amended by GASB
Statement No. 37, paragraph 17, defines a segment as an identifiable activity
(or grouping of activities) reported as or within an enterprise fund or an other
stand-alone entity that:
• Has one or more bonds or other debt instruments outstanding with a
revenue stream pledged in support of that debt, and
• Is required by an external party (such as through a bond indenture)
to account separately for its assets, liabilities, revenues, and expenses.
GASB Statement No. 34, paragraph 122, also details the disclosure required
for segments.
10.29 Governmental health care entities that receive restricted resources
are required to disclose whether, when both restricted and unrestricted re
sources are available, it is their policy to use restricted or unrestricted re
sources first, as discussed in GASB Statement No. 34, paragraph 115(h).
10.30 GASB Statement No. 34, paragraph 121, requires governmental
health care entities that receive donor-restricted endowments to make certain
disclosures about their policy for use of investment income generated by those
endowments.
10.31 As noted in paragraph 10.23 of this chapter, governmental health
care entities should disclose their policy for defining operating revenues and
expenses.
10.32 The extent of classification and subclassification of expenses de
pends on many factors, such as the nature and complexity of the health care
organization. For example, some entities may present only two categories: (a)
health services (including inpatient services, outpatient procedures, home
health services, etc.) and (b) general and administrative. Others may present
additional distinctions such as physician services, research, and teaching.
Functional allocations should be based on full cost allocations. If a not-forprofit health care organization includes a ratio of fund-raising expenses to
amounts raised in its financial statements, it should disclose how that ratio is
computed (See paragraph 20 of FASB Statement No. 136).
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Auditing6

10.33
The independent auditor may need to consider the examples of
specific auditing objectives, selected control activities, and auditing procedures
to audit revenue, expenses, gains, and losses that are presented in Exhibit 10-1.

6 SOP 00-1, Auditing Health Care Third-Party Revenues and Related Receivables, discusses
matters for auditors to consider in testing third-party revenues and related receivables, and provides
guidance to auditors regarding the sufficiency of evidential matter and reporting on financial
statements of health care entities exposed to material uncertainties. SOP 00-1 is included as
Appendix E to this Guide.
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Auditing Considerations

Financial Statement Specific Auditing Selected Control
Assertions
Objectives
Activities
Revenue and Gains for Health Care Services
Existence and
Revenue and
Procedures help
gains are
occurrence,
ensure that
completeness, and reported in the revenue is
presentation and proper period
accrued as
disclosure
using the accrual services are
basis of
performed or as
accounting and contractual
are classified
obligations are
properly by the satisfied.
type of service
rendered.

In the statement
of operations,
revenue from
health care
services is
reported, net of
contractual
adjustments and
other
adjustments, in
the proper period
and is classified
properly.

Auditing
Procedures
Perform a
walk-through of
the revenue
system.
Compare the
current period’s
revenue with
prior periods’
revenue and/or
budgets and
obtain
explanations for
large or unusual
variances.

Management
establishes and
monitors controls
over the
recognition of
revenue.

Consider the
adequacy of the
controls over the
revenue
recognition
process.

Controls ensure
that deductions
from revenue are
recorded in the
proper period
and are classified
properly.
Contractual and
other
adjustments are
authorized,
controlled, and
recorded properly.

Review the
financial
statements to
determine that
revenue is
reported net of
contractual
adjustments and
other adjustments.
Test contractual
adjustments,
other
adjustments, and
bad debts to
determine that
they are
accounted for both
in accordance
with the
respective
contracts and the
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Financial Statement Specific Auditing Selected Control
Activities
Assertions
Objectives
Charity care,
bad-debt
writeoffs, and
courtesy and
policy discounts
are authorized,
controlled, and
recorded properly.
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Auditing
Procedures
entity’s policy.
Determine that
specific and
unallocated
reserves appear
reasonable and
comparable to
prior year.
Review
third-party payor
contracts and
methods of
payment and test
the entity’s
computation of
estimated
adjustments to
revenue as
required under
such contracts.
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Chapter 11
The Reporting Entity and Related
Organizations
Overview

11.01 Networks among health care organizations, both vertical and hori
zontal, are being formed continually and new organizational structures are
being developed. The dynamics of change in the health care industry and their
impact on evolving organizational structures must be considered in defining
the reporting entity.
11.02 An integrated health care system typically consists of multiple
related entities, operating both for-profit and not-for-profit organizations. A
not-for-profit parent corporation may be the sole corporate member or, through
other means, it may control other entities such as a not-for-profit hospital, a
not-for-profit medical foundation that contracts with a for-profit physician
group, or other not-for-profit providers such as a long-term care center, a
substance abuse center, a surgery center, or an outpatient clinic. The system
also may own stock in various for-profit ventures such as HMOs or insurance
companies that may or may not provide patient care. Fund-raising typically is
accomplished through a separate foundation. Foundations, auxiliaries, guilds,
and similar organizations frequently assist and, in many instances, are related
to the health care organization.
Financial Reporting of Governmental Health Care Entities

11.03 The GASB has issued GASB Statement No. 14, The Financial
Reporting Entity, which addresses issues related to consolidations, application
of the equity method of accounting, and accounting for various types of joint
ventures for governmental entities. GASB Statement No. 14 establishes stand
ards for defining and reporting for the financial reporting entity and for
reporting its participation in joint ventures. GASB Statement No. 39, Deter
mining Whether Certain Organizations Are Component Units, amended GASB
Statement No. 14 to provide additional guidance for assessing potential com
ponent units in determining the financial reporting entity. GASB Statement
No. 39 may require the reporting of certain hospital foundations in the finan
cial statements of governmental health care entities, regardless of whether the
foundations follow FASB or GASB Standards.
Financial Reporting of Nongovernmental Health
Care Entities

11.04 The guidance which follows in this chapter relates to for-profit and
not-for-profit consolidations of parent-subsidiary relationships, whether through

On February 23, 1999, the FASB released an exposure draft (revised) of a proposed FASB
Statement, Consolidated Financial Statements: Purpose and Policy—Revision of Exposure Draft
issued October 16, 1995, that, in addition to other matters, would supersede FASB Statement No. 94
and paragraphs 1-3 and 5 of ARB No. 51, add a sentence to endnote three of ARB No. 51, and amend
APB Opinions No. 16 and No. 18 and FASB Statements No. 15, No. 57, and No. 65. The FASB
temporarily suspended work on consolidation policy issues and focused its efforts on developing
interpretive guidance for variable interest entities. In 2003, the FASB issued FASB Interpretation
(continued)
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stock ownership or other means of control. Other circumstances may exist in the
health care industry where combined financial statements involving commonly
controlled entities are more meaningful than their separate financial statements.
More specific guidance related to combined financial statements can be found
in ARB No. 51, Consolidated Financial Statements, paragraphs 22 and 23.*1
11.05 Whether the financial statements of a reporting health care organi
zation and those of one or more other for-profit or not-for-profit entities should
be consolidated, whether those other entities should be reported using the
equity method, and the extent of disclosure that should be required (if any) if
consolidated financial statements are not presented, should be based on the
nature of the relationship between the entities.
11.06 Health care organizations may be related to one or more other
entities in numerous ways, including ownership, control, and/or economic
interest.
11.07 As discussed in paragraphs 11.10 through 11.17, the existence of
various forms of control and economic interests result in various financial
reporting. Certain kinds of control result in consolidation (see paragraph
11.10). Other kinds of control result in consolidation only if coupled with an
economic interest (see paragraph 11.11). Still other kinds of control result in
consolidation being permitted but not required, if coupled with an economic
interest (see paragraph 11.12). The existence of either control or an economic
interest, but not both, is discussed in paragraph 11.13; consolidation of vari
able interest entities is discussed in paragraph 11.14; disclosures concerning
restrictions on distributions are discussed in paragraph 11.15; and reporting
under the equity method of accounting is discussed in paragraph 11.17.
11.08 Control is the direct or indirect ability to determine the direction of
management and policies through ownership, contract, or otherwise. However, the
rights and powers of the controlling entity may vary depending on the legal
structure of the controlled entity and the nature of control. The majority owner of
a for-profit entity’s voting stock or the sole corporate member of a not-for-profit
entity may not only have the ability to determine the direction of the controlled
entity but also have the proportionate right to (or the responsibility for) operating
No. 46, Consolidation of Variable Interest Entities, and FASB Interpretation No. 46 (revised December
2003), to address consolidation by business enterprises of variable interest entities. Special effective
date provisions apply to enterprises that have fully or partially applied FASB Interpretation No. 46
prior to the issuance of the revised Interpretation. Otherwise, application of FASB Interpretation No.
46 (revised December 2003) (or FASB Interpretation No. 46), is required in financial statements of
public entities that have interests in variable interest entities or potential variable interest entities
commonly referred to as special-purpose entities for periods ending after December 15, 2003.
Application by public entities, other than small business issuers, for all other types of entities is
required in financial statements for periods ending after March 15, 2004. Application by small
business issuers to entities other than special-purpose entities and by nonpublic entities to all types
of entities is required at various dates in 2004 and 2005. In some instances, enterprises have the
option of applying or continuing to apply FASB Interpretation No. 46 for a short period of time before
applying the revised Interpretation. Not-for-profit organizations are not subject to FASB
Interpretation No. 46 (revised December 2003), except that they may be related parties for purposes
of applying paragraphs 16 and 17 of that Interpretation. Also, if a not-for-profit entity is used by
business enterprises in a manner similar to a variable interest entity in an effort to circumvent the
provisions of FASB Interpretation No. 46 (revised December 2003), that not-for-profit entity is subject
to that Interpretation.
1
In some situations, debt agreements may require combined financial statements of affiliated
entities, the assets or revenues of which serve as collateral for the related debt (sometimes called an
“obligated group”). ARB No. 51 applies to those situations. However, if debt or other agreements
prescribe a financial presentation that varies from GAAP (for example, exclusion of entities otherwise
required to be consolidated), the auditor should consider SAS No. 62, Special Reports (AICPA,
Professional Standards, vol. 1, AU sec. 623), for reporting guidance.
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results and a residual interest in the net assets upon dissolution. However, in
other situations, the rights of the controlling party may be more limited. For
example, in the case of a sole general partner in a limited partnership, the limited
partners—and not the general partner—may be entitled to the net assets upon
dissolution. Further, the existence of “super-majority” voting rights can entitle the
holder to disproportionate voting powers, and could affect the determination of the
“controlling entity.” As a result, whether the financial statements of a controlled
entity should be consolidated with the reporting entity depends on the nature of
control and whether an economic interest exists.2
11.09 An economic interest in another entity exists if (a) the other entity
holds or utilizes significant resources that must be used for the unrestricted or
restricted purposes of the reporting entity—either directly or indirectly—for
producing income or providing services or (b) the reporting entity is responsible
for the liabilities of the other entity. The following are examples of economic
interests:
• Other entities solicit funds in the name of, and with the expressed or
implied approval of, the reporting entity. In addition, substantially all
of the funds solicited are intended by the contributor or are otherwise
required to be transferred to the reporting entity or used at its
discretion or direction.
• The reporting entity transfers significant resources to another entity
whose resources are held for the benefit of the reporting entity.
• The reporting entity assigns certain significant functions to another
entity.
• The reporting entity provides or is committed to provide funds for
another entity or the reporting entity guarantees significant debt of
another entity.
• The reporting entity has a right to, or the responsibility for, the
operating results of another entity. Or, upon dissolution, the reporting
entity is entitled to the net assets, or is responsible for any deficit, of
another entity.
11.10 Health care organizations with a controlling financial interest in other
entities through direct or indirect ownership of a majority voting interest3 in
2 Emerging Issues Task Force (EITF) Issue No. 97-2, Application of FASB Statement No. 94 and
APB Opinion No. 16 to Physician Practice Management Entities and Certain Other Entities with
Contractual Management Arrangements, addresses the issue of consolidation and business combina
tions among physician practice management entities, and other situations in which one entity
manages another under similar circumstances and arrangements. If a physician practice is a variable
interest entity as described in FASB Interpretation No. 46 and FASB Interpretation No. 46 (revised
December 2003), that entity is subject to the requirements of those Interpretations, and the consen
sus in EITF Issue No. 97-2 does not apply. Not-for-profit organizations are not subject to FASB
Interpretation No. 46 (revised December 2003), except that they may be related parties for purposes
of applying paragraphs 16 and 17 of that Interpretation. Also, if a not-for-profit entity is used by
business enterprises in a manner similar to a variable interest entity in an effort to circumvent the
provisions of FASB Interpretation No. 46 (revised December 2003), that not-for-profit entity is subject
to that Interpretation. See footnote * to the heading to paragraph 11.04 in this chapter for informa
tion regarding the effective date of FASB Interpretation No. 46 and FASB Interpretation No. 46
(revised December 2003).
3 Because not-for-profit organizations may exist in various legal forms, ownership of not-forprofit organizations may be evidenced in various ways. Examples include corporations issuing stock,
corporations issuing ownership certificates, membership corporations issuing membership certifi
cates, joint ventures, and partnerships. A parent corporation typically owns stock in a for-profit
entity, whereas a sole corporate member holds membership rights in a not-for-profit entity. As it
relates to health care consolidations, sole corporate membership in a not-for-profit entity is consid
ered to be equivalent to ownership of a majority voting interest in a for-profit entity, unless the sole
corporate member’s economic interest in the controlled entity is limited by state law or contractual
agreement.
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those other entities should consolidate those other entities, unless control
does not rest directly or indirectly with the majority owner or sole corporate
member (for example, if the subsidiary is in legal reorganization or in bank
ruptcy).4, † In such situations consolidation is prohibited, as discussed in
paragraph 2 of ARB No. 51, as amended by FASB Statement No. 94, Consoli
dation of All Majority Owned Subsidiaries and FASB Statement No. 144,
Accounting for the Impairment or Disposal of Long-Lived Assets.45
11.11 In the case of (a) control through a majority voting interest in the
board of another entity by means other than ownership or sole corporate
membership6 and (b) an economic interest in such entities, consolidation is
required, unless control is likely to be temporary or does not rest with the
majority owner. In this situation consolidation is prohibited.7
11.12 Control of a separate not-for-profit organization in which the re
porting entity has an economic interest may take forms other than majority
ownership or voting interest; for example, control may be through contract or
affiliation agreement.8 In circumstances such as these, consolidation is
permitted but not required, unless control is likely to be temporary.9 In this
situation consolidation is prohibited.10 If the reporting entity controls a sepa
rate not-for-profit entity through a form other than majority ownership (para
graph 11.10) or voting interest (paragraph 11.11), has an economic interest in
that other entity, and consolidated financial statements are not presented, the
notes to the financial statements should include the following disclosures:
a. Identification of the other entity and the nature of its relationship
with the reporting entity that results in control
b. Summarized financial data of the other entity, including total assets,
liabilities, net assets, revenue, and expenses; and resources that are
held for the benefit of the reporting entity or that are under its control
4 See footnote 2 in this chapter.
† AcSEC has released an exposure draft of a proposed Statement of Position (SOP), Clarification
of the Scope of the Audit and Accounting Guide Audits of Investment Companies and Accounting by
Parent Companies and Equity Method Investors for Investments in Investment Companies. Among
other matters, this proposed SOP may modify this paragraph in this Guide. Readers should be alert
for the issuance of a final Standard.
5 FASB Statement No. 144, among other matters, amends ARB No. 51 to eliminate the excep
tion to consolidation for a subsidiary for which control is likely to be temporary. This Guide has been
conformed to FASB Statement No. 144 to eliminate the exception to consolidation for a temporarily
controlled subsidiary in circumstances in which this Guide requires consolidation based on a control
ling financial interest (paragraph 11.10 of this Guide). No such conforming change to this Guide is
appropriate in circumstances in which consolidation is required or permitted based on control
through other than a controlling financial interest (paragraphs 11.11 and 11.12 of this Guide).
Accordingly, this Guide retains the exception to consolidation for a temporarily controlled subsidiary
in circumstances in which consolidation is required or permitted based on control through other than
a controlling financial interest.
6 For purposes of this Guide, a majority voting interest in the board of another entity by means
other than ownership or sole corporate membership is illustrated by the following example. Entity B
has a five-member board, and a simple voting majority is required to approve board actions. Entity A
will have a majority voting interest in the board of entity B if three or more of its board members,
officers, or employees serve on (or may be appointed at entity A’s discretion to) the board of entity B.
However, if three of entity A’s board members serve on the board of entity B but entity A does not have
the ability to require that those members serve on entity B’s board, entity A does not have a majority
voting interest in the board of entity B.
7 See footnote 5 in this chapter.
8 Evidence of control may include authority to amend articles of incorporation and bylaws or
authority to approve operating, capital, and construction budgets; capital acquisitions; strategic
plans, goals, and objectives; and mergers or dissolutions.
9 See footnote 2 in this chapter.
10 See footnote 7 in this chapter.
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c. The disclosures set forth in FASB Statement No. 57, Related Party
Disclosures
11.13 In some cases, one entity may have an economic interest in another
entity without controlling it (for example, a noncontrolled entity may solicit funds
in the name of, and with the expressed or implied approval of, the reporting entity
and substantially all of the funds solicited are intended by the contributor to
benefit the reporting entity). The existence of control (other than through owner
ship or sole corporate membership) or an economic interest, but not both, precludes
consolidation but requires the disclosures set forth in FASB Statement No. 57.11
11.14 FASB Interpretation No. 46, Consolidation of Variable Interest
Entities (revised December 2003), clarifies the application of ARB No. 51 to
certain entities in which equity investors do not have the characteristics of a
controlling financial interest or do not have sufficient equity at risk for the
entity to finance its activities without additional subordinated financial sup
port.‡ An entity subject to consolidation according to the provisions of FASB
Interpretation No. 46 (revised December 2003) is referred to in that Interpre
tation as a variable interest entity. An entity shall be subject to consolidation
according to the provisions of FASB Interpretation No. 46 (revised December
2003) if, by design, the conditions in paragraph 5 of that Interpretation exist.
Paragraph 14 of FASB Interpretation No. 46 (revised December 2003) provides
guidance for consolidation based on variable interests. FASB Interpretation
No. 46 (revised December 2003), also requires certain disclosures. Not-forprofit organizations are not subject to FASB Interpretation No. 46 (revised
December 2003), except that they may be related parties for purposes of applying
paragraphs 16 and 17 of that Interpretation. Also, if a not-for-profit entity is used
by business enterprises in a manner similar to a variable interest entity in an
effort to circumvent the provisions of FASB Interpretation No. 46 (revised
December 2003), that not-for-profit entity is subject to that Interpretation.
11.15 If consolidated financial statements are presented and they include
a controlled not-for-profit organization, they should disclose any restrictions
made by entities outside of the reporting entity on distributions from the
controlled not-for-profit organization to the reporting entity and any resulting
unavailability of the net assets of the controlled not-for-profit organization for
use by the reporting entity.
11.16 When consolidated financial statements are required or permitted,
a minority interest should be provided if such interest is represented by an
economic interest whereby the minority interest would share in the operating
results or residual interest upon dissolution.
11.17 Investments in common stock of for-profit entities in which the
reporting entity has 50 percent or less of the voting stock in the investee should
be reported under the equity method in conformity with APB Opinion No. 18,
The Equity Method of Accounting for Investments in Common Stock, if the
guidance in that opinion requires use of the equity method.†The equity method*†
11
The existence of an economic interest does not necessarily cause the entities to be related
parties, as defined in FASB Statement No. 57. However, the disclosures required by that statement
are required under this Guide if an economic interest exists.
‡ For information about FASB Interpretation No. 46, which was replaced by FASB Interpreta
tion No. 46 (revised December 2003), and the effective date of FASB Interpretation No. 46 (revised
December 2003), see footnote * to the heading to paragraph 11.04 in this chapter.
† AcSEC has released an exposure draft of a proposed Statement of Position, Clarification of the
Scope of the Audit and Accounting Guide Audits of Investment Companies and Accounting by Parent
Companies and Equity Method Investors for Investments in Investment Companies. Among other
matters, this proposed SOP may modify this paragraph in this Guide. Readers should be alert for the
issuance of a final Standard.
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should be followed by an investor whose investment in voting stock gives it the
ability to exercise significant influence over operating and financial policies of
an investee. Determining the ability of an investor to exercise significant
influence is not always clear, and applying judgment is necessary to assess the
status of each investment. However, to achieve a reasonable degree of uniform
ity, the ownership of 20 percent or more of the voting stock leads to a presump
tion that the investor can exercise significant influence and, therefore, the
investment should be accounted for under the equity method in accordance
with APB Opinion No. 18. However, this presumption can be overcome in
certain instances. FASB Interpretation No. 35, Criteria for Applying the Equity
Method of Accounting for Investments in Common Stock, paragraph 4, provides
examples of indications that an investor may be unable to exercise significant
influence. Health care organizations that report investments on the equity
method should make the financial statement disclosures required by APB
Opinion No. 18.
11.18 This Guide provides guidance concerning consolidated financial
statements. Consolidation of a parent or subsidiary organization requires the
presentation of a single set of amounts for the entire reporting entity. Combi
nation, as discussed in paragraphs 22 and 23 of ARB No. 51, refers to financial
statements prepared for organizations between which common control exists
but for which the parent-subsidiary relationship does not exist. Both consoli
dation and combination require elimination of interorganization transactions
and balances. Paragraph 22 of ARB No. 51 states that “there are circum
stances, however, where combined financial statements (as distinguished from
consolidated statements) of commonly controlled companies are likely to be
more meaningful than their separate statements.” This Guide prohibits con
solidated financial statements in certain circumstances. However, it provides
no guidance concerning combined financial statements of commonly controlled
entities, which may be presented in certain circumstances in conformity with
the guidance in ARB No. 51.
11.19 Paragraph 15 of FASB Statement No. 94 precludes the use of the
parent company’s financial statements as the general-purpose financial state
ments of the primary reporting entity. Similarly, where consolidation is re
quired, this Guide precludes the issuance of parent company financial
statements as the general-purpose financial statements of the primary report
ing entity. However, neither FASB Statement No. 94 nor this Guide discuss
the use of the parent company’s financial statements as other than the generalpurpose financial statements for the primary reporting entity.12 GAAP does
not preclude the issuance of financial statements for the subsidiary only.
However, care should be taken to include all disclosures required by FASB
Statement No. 57 and other relevant pronouncements.
Transfers
Equity Transfers

11.20 Equity transfers are similar to ownership transactions between a
for-profit parent and its owned subsidiary (for example, additional paid-in capital
or dividends).13 However, equity transfers can occur only between related not12 Contractual agreements or regulatory provisions may require parent company only financial
statements. SAS No. 62 provides guidance for reporting on financial presentations to comply with
contractual agreements or regulatory provisions.
13 See paragraphs 1.12 and 10.12 in this Guide regarding the reporting of transfers by govern
mental health care entities.
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for-profit entities when one controls the other or both are under common
control. An equity transfer embodies no expectation of repayment, nor does the
transferor receive anything of immediate economic value (such as a financial
interest or ownership). Equity transfers are reported separately as changes in
net assets, are excluded from the performance indicator, and do not result in
any step-up in basis of the underlying assets transferred. (Certain transfers
from a foundation to a related nongovernmental health care organization are
discussed in paragraphs 11.32 and 11.33.)
Equity Transactions
11.21 Transfers from

a nongovernmental health care organization to a
not-for-profit organization or charitable trust are equity transactions, as de
scribed in FASB Statement No. 136, Transfers of Assets to a Not-for-Profit
Organization or Charitable Trust That Raises or Holds Contributions for
Others, (see paragraphs 4 and 18), if the transfer meets all of the following
criteria:
• A nongovernmental health care organization transfers assets to a
not-for-profit organization or charitable trust (called a recipient or
ganization) that accepts those assets and agrees to use them on behalf
of or transfer them, their investment return, or both back to the health
care organization or its affiliate.
• The nongovernmental health care organization and the recipient
organization are financially interrelated organizations.
• Neither the nongovernmental health care organization nor its affiliate
expects payment of the transferred assets, although payment of in
vestment return on the transferred assets may be expected.
11.22 Paragraph 13 of FASB Statement No. 136 provides that organiza
tions are financially interrelated if the relationship between them has both of
the following characteristics: (a) one organization has the ability to influence
the operating and financial decisions of the other and (b) one organization has
an ongoing economic interest in the net assets of the other. The ability to
influence the operating and financial decisions of the other can be demon
strated in several ways:
a. The organizations are affiliates as defined in FASB Statement No. 57.
b. One organization has considerable representation on the governing
board of the other organization.
c. The charter or bylaws of one organization limit its activities to those
that are beneficial to the other organization.
d. An agreement between the organizations allows one organization to
actively participate in the policymaking processes of the other, such
as setting organizational priorities, budgets, and management
compensation.
An ongoing economic interest in the net assets of another is a residual right to
the other organization’s net assets that results from an ongoing relationship.
The value of those rights increases or decreases as a result of the investment,
fundraising, operating, and other activities of the other organization.14
14
Paragraph 104 of FASB Statement No. 136 notes that although most of the relationships
described in the definition of economic interest in the glossary of SOP 94-3, Reporting of Related
Entities by Not-for-Profit Organizations, are potentially ongoing economic interests in the net assets
of the other, some are not. (The guidance in SOP 94-3 is incorporated in paragraph 11.09 of this
Guide). Only economic interests that are both ongoing and residual interests in the net assets meet
the criterion of paragraph 13(b) of FASB Statement No. 136.
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11.23 An equity transaction differs from an equity transfer in that an
equity transaction, as described in FASB Statement No. 136, involves a finan
cially interrelated party either as a third party in a transfer from an entity to
one of its affiliates or as a counterparty in a transfer from an entity to itself.
An equity transfer, as described in the Guide, is a transaction directly between
a transferor and a transferee. In addition, an equity transaction is reciprocal;
the health care organization or its affiliate named as the beneficiary receives
an ongoing economic interest in the assets held by the recipient organization.
(See paragraphs 18 and 95 of FASB Statement No. 136). An equity transfer is
nonreciprocal; there is no expectation of repayment and the transferor does not
receive a financial interest or ownership. (See paragraph 11.20 of this Guide).
11.24 The reporting of an equity transaction depends upon whether the
resource provider or its affiliate is the specified beneficiary. As discussed in
paragraph 18 of FASB Statement No. 136, if the resource provider specifies
itself as the beneficiary, the resource provider reports an asset—interest in the
net assets of the recipient organization (or an increase in a previously recog
nized interest),15 and the recipient organization reports an equity transaction
as a separate line in its statement of activities. If the resource provider specifies
its affiliate as the beneficiary, the resource provider and the recipient organization
report an equity transaction as separate lines in their statements of activities, and
the affiliate named as beneficiary reports an interest in the net assets of the
recipient organization.16 The resource provider should disclose the information
described in paragraph 4.15 of this Guide for each period for which a statement
of financial position is presented.
Other Transfers

11.25 Other transfers may occur among related entities. If the entities are
consolidated or combined, such transfers are eliminated in consolidation and/or
combination. If the entities are not consolidated or combined (for example,
in separate subsidiaries or obligated group financial statements),17 the method
of accounting for such transfers is dictated by the substance of the transaction
as well as the legal form. For example, certain transfers by a foundation to a
related nongovernmental health care organization are reported as contribu
tions, as discussed in paragraphs 11.32 and 11.33. In other situations, pay
ments may be made for services provided between not-for-profit entities under
common control, which should be accounted for as revenues and expenses
depending on the types of services provided.
11.26 A health care organization may loan or advance resources to a
related entity. If repayment is reasonably assured, a receivable or payable
should be recorded by the entities. Subsequent to the time a receivable is
recorded, the ability of the receiving entity to repay the receivable should be
considered. If the receivable is not to be repaid, or if the receiving entity is
perceived as unable to repay, it may be accounted for as an equity transfer with
the transferor reducing net assets and the transferee increasing net assets at
the date such determination is made (see paragraph 11.20).
15 That interest would be eliminated if the beneficiary (resource provider) and the recipient
organization were included in consolidated financial statements. See footnote 6 to paragraph 15 of
FASB Statement No. 136.
16 That interest would be eliminated if the beneficiary (affiliate) and the recipient organization
were included in consolidated financial statements. See footnote 6 to paragraph 15 of FASB State
ment No. 136.
17 See paragraph 12.10 for additional discussion regarding obligated group financial state
ments.
AAG-HCO 11.23

The Reporting Entity and Related Organizations

149

11.27 Transfers that result in changes in ownership interest are ac
counted for as investments in accordance with APB Opinion No. 18 and FASB
Statement No. 94.
11.28 Assets transferred from one commonly controlled entity to another
should be recorded by the transferee at the carrying value of the transferring
entity. This treatment is consistent with the guidance prescribed by Appendix
D of FASB Statement No. 141, Business Combinations.||
Related Fund-Raising Organizations

11.29 A related entity may act as an agent, trustee, or intermediary for
contributions to the reporting entity. FASB Statement No. 136 establishes
standards for transactions in which a donor makes a contribution by transferring
assets to a recipient organization—a not-for-profit organization or a charitable
trust—that accepts the assets from the donor and agrees to use the assets on
behalf of or transfer the assets, their investment return, or both to another
entity—the beneficiary—named by the donor.18,19 Paragraph 68 of FASB State
ment No. 136 states that a donor may specify the beneficiary (a) by name,
(b) by stating that all entities that meet a set of donor-defined criteria are
beneficiaries, or (c) by actions surrounding the transfer that made clear the
identity of the beneficiary, such as by responding to a request from an organi
zation that exists to raise assets for the beneficiary. Paragraphs 69 through 72
and Appendix A of FASB Statement No. 136 provide examples of donor
stipulations and discuss whether those stipulations specify a beneficiary.
11.30 If a recipient organization and a specified beneficiary are finan
cially interrelated organizations (as defined in paragraph 13 of FASB State
ment No. 136 and described in paragraph 11.22 of this Guide) and the recipient
organization is not a trustee, the recipient organization should recognize the
fair value of any assets it receives from the donor that are specified by the
beneficiary as a contribution received, rather than as a liability to the benefi
ciary, as discussed in paragraph 14 of FASB Statement No. 136. For example,
a foundation that exists to raise, hold, and invest assets for a specified health
care organization or for a group of affiliates of which the specified health care
organization is a member generally is financially interrelated with the organiza
tion or organizations it supports. A financially interrelated foundation should
recognize contribution revenue when it receives assets from the donor.181920 The
specified health care organization should recognize its interest in the net assets
of the foundation (the recipient organization) and adjust that interest for its
share of the change in net assets of the recipient organization using a method
|| FASB Statement No. 141, Business Combinations, supersedes AICPA Accounting Interpreta
tion No. 39 of APB Opinion No. 16, Business Combinations. However, the guidance in that Interpre
tation, used in past practice to account for transfers of net assets between entities under common
control, is carried forward without reconsideration in Appendix D, Continuing Authoritative Guid
ance, of FASB Statement No. 141.
18 FASB Statement No. 136 also establishes standards for transactions that take place in a
similar manner but are not contributions because the transfers are revocable, repayable, or recipro
cal. For example, if a resource provider transfers assets to a recipient organization and names itself
or its affiliate as beneficiary, that transaction is reciprocal even if the resource provider grants
variance power. Those standards and transactions are discussed in paragraphs 4.14, 4.15, 11.21,
11.23, and 11.24 of this Guide. This Guide does not use the word donor in discussing those transac
tions because they are not contributions.
19 This pronouncement is not applicable to governmental health care enterprises. (See footnote
1 in Chapter 1.)
20 Foundations that are not providers of health care services are not covered by this Guide and
should follow the AICPA Audit and Accounting Guide Not-for-Profit Organizations.
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similar to the equity method of accounting for investments in common stock
(see paragraph 15 of FASB Statement No. 136).21
11.31 When measuring its interest in the recipient organization, the
specified health care organization would include the net assets of the recipient
organization that are restricted to use by that health care organization. If the
recipient organization supports more than one beneficiary and an agreement
with the recipient organization specifies how unrestricted gifts to the recipient
organization should be divided between the organizations supported, the speci
fied health care organization would also include its share of the recipient
organization’s unrestricted assets, computed in accordance with that agree
ment. Similarly, if a parent organization controls both the recipient organiza
tion and the specified health care organization and the parent directed that
unrestricted gifts would be distributed to affiliates in accordance with a
specified formula, each affiliate would include in its interest its share of
unrestricted net assets, computed in accordance with that formula. (See para
graphs 41 through 45 of FASB Statement No. 136).
11.32 Distributions from a financially interrelated recipient organization
to a nongovernmental health care organization that it supports are generally
reported by the health care organization as a reduction of its interest in the
recipient organization. However, if the distribution is made from net assets that
are not includable in that interest because the health care organization does
not have rights to them (that is, the recipient organization can determine to
whom the assets will be distributed), the health care organization reports a
contribution from the related recipient organization. For example, assume a
foundation’s mission is to raise contributions for two financially interrelated
health care organizations, Hospital A and Hospital B. The foundation receives
$10,000 in contributions from donors that do not specify which of the two
hospitals should benefit from their gifts. There is no agreement between the
foundation and Hospitals A and B that specifies how gifts to the foundation
should be divided between the hospitals if the donor does not specify a benefi
ciary. Hospital A would report contribution revenue for any portion of the
$10,000 that it receives from the foundation. Likewise, Hospital B would report
contribution revenue for any portion of the $10,000 that it receives, but neither
Hospital A nor Hospital B would record an interest in those assets before the
foundation either distributes them or unconditionally promises them.
11.33 As discussed in paragraphs 11 and 12 of FASB Statement No. 136,
if the recipient organization and the specified health care organization are not
financially interrelated organizations as defined in paragraph 13 of FASB
Statement No. 136 (see paragraph 11.22 in this Guide), and the donor specifies
a beneficiary, the recipient organization should recognize a liability to the
specified beneficiary unless the recipient is explicitly granted variance power.
(See discussion of variance power at paragraph 10.05 of this Guide). If the
assets received from the donor are donated materials, supplies, or other
nonfinancial assets, the recipient organization may choose either to (a) report
the receipt of the assets as a liability to the beneficiary concurrent with
recognition of the assets received or (b) not to report the transaction at all. The
choice is an accounting policy that should be applied consistently from period
to period and disclosed in the notes to the financial statements. The specified
health care organization recognizes its rights to the assets (financial or nonfi
nancial) held by a recipient organization as an asset and contribution revenue
21
That interest would be eliminated if the beneficiary and the recipient organization were
included in consolidated financial statements. See footnote 6 to paragraph 15 of FASB Statement No.
136 .
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unless the recipient organization is explicitly granted variance power. (See
further discussion at paragraphs 5.11 and 10.05.) In contrast, if the donor does
not specify a beneficiary (see further discussion at paragraph 11.29) and the
foundation and a hospital are under common control, but they are not finan
cially interrelated, the recipient organization should recognize contribution
revenue when it receives the gift. The gift should be accounted for as contribu
tions received by the hospital, consistent with FASB Statement No. 116,
Accounting for Contributions Received and Contributions Made, and Chapter
10 of this Guide, provided that the foundation is acting other than as an owner.
11.34 Additional guidance regarding accounting for contributions re
ceived by agents, trustees, and intermediaries can be found in Chapter 5 of the
Audit and Accounting Guide Not-for-Profit Organizations.
Disclosure

11.35 Significant relationships and transactions not in the ordinary course
of business with directors, management, medical staff, or other related parties
(including unconsolidated related organizations) should be disclosed in accordance
with FASB Statement No. 57. SAS No. 45, Omnibus Statement on Auditing
Standards—1983, “Related Parties” (AICPA, Professional Standards, vol. 1, AU
sec. 334), sets forth procedures for the auditor to consider in determining the
existence of transactions with related parties and identifying them.
11.36 Hospital boards may contract with management companies to operate
their facilities. Frequently, the management company will employ the admin
istrator as well as other key personnel. Further, services may be acquired
from entities related to the management company.22 The auditor should
evaluate the impact of these arrangements on the hospital’s internal controls
and disclose related party transactions as required by FASB Statement No. 57.
11.37 The reporting and disclosure requirements of the nongovernmental
health care organization under the circumstances noted in paragraphs 11.10
through 11.19 are summarized as follows:23
Circumstances
The entity owns a majority of a
for-profit entity’s voting stock.
The entity is the sole corporate
member of a not-for-profit entity.
(See paragraph 11.10, footnote 3.)
The entity controls another
through a majority voting interest
in the board and an economic
interest exists.

Requirements
Consolidate unless control does not
rest with the majority owner or the
interest is limited by state law or
contractual agreement.
Consolidate unless control does not
rest with the majority owner or the
sole corporate member’s interest is
limited by state law or contractual
agreement.
Consolidate unless control is likely
to be temporary or does not rest
with the majority owner or the sole
corporate member; or the interest
is limited by state law or
contractual agreement.
(continued)

22 See footnote 2 in this chapter.
23 See footnote 5 in this chapter.
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Circumstances
The reporting entity owns 50
percent or less of the common
voting stock of an investee and can
exercise significant influence over
operating and financial policies.
There have been material
transactions between the health
care entity and the related
organization. (This could be present
in any of the foregoing
circumstances.)
An entity has control over another
not-for-profit organization or has
an economic interest in the other,
but not both.
The reporting entity controls a
separate not-for-profit entity
through a form other than majority
ownership or voting interest and
has an economic interest in that
other entity.

The entity is a variable interest
entity subject to the provisions of
FASB Interpretation No. 46
(revised December 2003).

Requirements
The investment should be
accounted for under the equity
method in accordance with APB
Opinion No. 18.
In the notes to the financial
statements (a) disclose the
existence and nature of the
relationship and (b) describe and
quantify the transactions.
In the notes to the financial
statements (a) disclose the
existence and nature of the
relationship and (b) describe and
quantify the transactions.
Consolidation is prohibited.
Consolidation permitted but not
required. If consolidated
statements are not presented, the
notes to the financial statements
should disclose (a) the
identification of the other entity
and the nature of its relationship
with the reporting entity, (b)
summarized financial data of the
other entity, and (c) the disclosures
set forth in FASB Statement No. 57.
Apply the guidance in FASB
Interpretation No. 46 (revised
December 2003), including the
disclosure requirements in that
Interpretation.#

Business Combinations

11.38
As discussed in paragraph 11.02, the dynamics of change in the
health care industry have resulted in increased business combinations as
new organizational structures are being formed. FASB Statement No. 141
addresses financial accounting and reporting for business combinations. FASB
Statement No. 141 applies to business combinations initiated after June 30,
2001 and prescribes the use of the purchase method for those business
combinations.*** FASB Statement No. 141, however, does not apply to certain
combinations, including a combination involving two or more not-for-profit
# For information about FASB Interpretation No. 46, which was replaced by FASB Interpreta
tion No. 46 (revised December 2003), the effective date of FASB Interpretation No. 46 (revised
December 2003), and the applicability of that revised Interpretation’s requirements for not-for-profit
organizations, see footnote * to the heading to paragraph 11.04 in this chapter.
*FASB Statement No. 141 supersedes APB Opinion No. 16. If FASB Statement No. 141 has not
been adopted, see APB Opinion No. 16 for guidance concerning business combinations.
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organizations, or the acquisition of a for-profit business by a not-for-profit
organization. For those combinations, the guidance in APB Opinion Nos. 16
and 17 still apply and APB Opinion No. 16 provides a useful framework when
evaluating similar transactions entered into by not-for-profit health care busi
ness organizations.††A list of possible factors to be considered when evaluating
these transactions in relation to APB Opinion No. 16 is summarized as follows:
Accounting and Disclosure Guidance
Circumstances
Monetary consideration received or This is similar to a purchase under
paid, change in legal title to assets, APB Opinion No. 16.*24
and/or assumption of liabilities.
This is similar to a pooling of
Change in control (for example,
interests transaction under APB
change in sole corporate member).
Opinion No. 16. No step-up in basis.
See paragraphs 1.47 and 1.48 for additional guidance regarding the application
of APB Opinion No. 16 to not-for-profit organizations. Also see footnote * in the
section “APB Opinion No. 16, Business Combinations” in Chapter 1 in this
Guide regarding pronouncements that were superseded by FASB Statement
No. 141, including APB Opinion No. 16.
Auditing

11.39
The independent auditor may need to consider the examples of
specific auditing objectives, control activities, and auditing procedures for
related party organizations, balances, and transactions that are presented in
Exhibit 11-1.

†heT FASB has on its agenda a project on accounting for combinations of not-for-profit
organizations. Readers should be alert to the issuance of a final Standard.
24
FASB Statement No. 141 supersedes AICPA Accounting Interpretation No. 39 of APB Opinion
No. 16. Appendix D of FASB Statement No. 141 carries forward without reconsideration guidance in
APB Opinion No. 16 and an interpretation that has been used in past practice to account for transfers
of net assets or exchanges of shares between entities under common control. Paragraph D12 of FASB
Statement No. 141 discusses the accounting for a transfer of assets or exchange of shares between
entities under common control.
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Exhibit 11-1

Auditing Considerations

Financial Statement Specific Auditing Selected Control
Assertions
Objectives
Activities
Reporting Entity and Related Organizations
Existence and
Procedures
The reporting
occurrence,
ensure that
entity is
completeness, and appropriate.
investees,
presentation and
affiliates, and
disclosure
other related
entities are
accounted for
appropriately.

Auditing
Procedures

Review the
articles of
incorporation,
bylaws, and
minutes of
directors’
meetings,
shareholder lists,
and filings with
regulatory
authorities to
determine the
existence of
related parties.
Obtain
representations
from management
as to whether all
investees,
affiliates, and
related entities
have been
accounted for
properly or
disclosed.
Review
transactions with
investees,
affiliates, and
other related
entities to
determine that
they are reported
properly.
Test significant
Relationships and Procedures
related party
transactions with ensure that
conflict-of-interest transactions as
related
follows:
organizations are policies,
procedures, and
identified and
disclosure
• Determine
disclosed, if
requirements are
substance.
appropriate,
because of
met.
• Examine
economic
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Financial Statement Specific Auditing Selected Control
Activities
Assertions
Objectives
dependence of the
entity.

Presentation and Related party
disclosure
transactions and
organizations are
reported properly.
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Auditing
Procedures
documents
(invoices,
contracts, and
agreements).
• Determine the
basis of pricing.
• Determine the
collectibility of
receivables and
advances.
Review related
party transactions
for completeness
by• Considering
previously
identified
transactions or
relationships.
• Reviewing the
minutes of
directors’ and
other meetings.
• Discussing
related-party
transactions
with entity
personnel.
• Reviewing
unusual
transactions.
• Reviewing the
responses to
related party
(conflict-ofinterest)
questionnaires.
Review the
presentation and
disclosure of
related party
information for
completeness.
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Chapter 12
Independent Auditor's Reports
Overview

12.01 The guidance in SAS No. 58, Reports on Audited Financial State
ments, as amended (AICPA, Professional Standards, vol. 1, AU sec. 508),
applies to audit reports on the financial statements of health care organiza
tions. Such a report may contain an unqualified opinion, an unqualified
opinion with an explanatory paragraph, a qualified opinion, a disclaimer of
opinion, or an adverse opinion. The facts and circumstances of each particular
audit govern the appropriate form of the report.*1 Report examples appearing
in this chapter illustrate the form of certain auditor’s reports issued by the
independent auditor in auditing the financial statements of a health care
organization. The Audit and Accounting Guide State and Local Governments,
provides guidance on audit reports for state and local governments as well as
on assessing materiality (opinion units). See paragraph 2.01 of this Guide.
Registered Public Accounting Firms

12.02 As discussed in paragraph 2.02 in this Guide, registered public
accounting firms must comply with the standards of the Public Company
Accounting Oversight Board (PCAOB) in connection with the preparation or
issuance of any audit report on the financial statements of an issuer, as defined
by the Sarbanes-Oxley Act, and other entities when prescribed by the rules of
the Securities and Exchange Commission (SEC) (collectively referred to as
“issuers”). On May 14,2004, the SEC approved PCAOB Auditing Standard No.
1, References in Auditors’ Reports to the Standards of the Public Company
Accounting Oversight Board, effective for auditors’ reports issued or reissued
on or after May 24, 2004. PCAOB Standard No. 1 replaces in auditors’ reports
the sentence “We conducted our audits in accordance with auditing standards
generally accepted in the United States of America.” with the following sen
tence: “We conducted our audits in accordance with the standards of the Public
Company Accounting Oversight Board (United States).” The SEC simultane
ously issued interpretive guidance in Release No. 33-8422 under the Securities
Act of 1933 (1933 Act) (Release No. 34-49708 under the Securities Act of 1934)
(1934 Act) to address certain implementation issues relating to the Standard.
See the “Preface” of this Guide for additional information about the SarbanesOxley Act and the PCAOB.
Unqualified Opinion

12.03 The independent auditor’s standard report states that the financial
statements present fairly, in all material respects, an entity’s financial position,
The AICPA Auditing Standards Board (ASB) plans to issue in the second quarter in 2004 a
series of new audit interpretations of SAS No. 58, Reports on Audited Financial Statements (AICPA,
Professional Standards, vol. 1, AU sec. 508). Readers should be alert for the issuance of these
Interpretations.
1
SAS No. 79, Amendment to Statement on Auditing Standards No. 58, Reports on Audited
Financial Statements (AICPA, Professional Standards, vol. 1, AU sec. 508), amends SAS No. 58 to
eliminate the requirement that when certain criteria are met, the auditor add an uncertainties
explanatory paragraph to the auditor’s report. It also clarifies and reorganizes the guidance in SAS
No. 58 concerning emphasis paragraphs, uncertainties, and disclaimers of opinion.
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results of operations, changes in net assets, and cash flows in conformity with
GAAP. The opinion should include an identification of the United States of
America as the country of origin of those accounting principles. This conclusion
may be expressed only when the independent auditor has formed such an
opinion on the basis of an audit performed in accordance with GAAS and an
identification of the United States of America as the country of origin of those
standards. An example of the independent auditor’s standard report is pre
sented in Exhibit 12-1 at the end of this chapter.
Qualified Opinion

12.04 SAS No. 58 states that certain circumstances may require a quali
fied opinion. A qualified opinion states that except for the effects of the matter
to which the qualification relates, the financial statements present fairly, in all
material respects, the financial position, results of operations, and cash flows
in conformity with GAAP. Such an opinion is expressed when—
a. There is a lack of sufficient competent evidential matter or there are
restrictions on the scope of the audit that have led the independent
auditor to conclude that an unqualified opinion cannot be expressed
and the independent auditor has concluded not to disclaim an opinion
(see Exhibit 12-2).
b. The independent auditor believes, on the basis of the audit, that the
financial statements contain a departure from GAAP, the effect of
which is material, and has concluded not to express an adverse
opinion (see Exhibit 12-3).
Additional Information

12.05 SAS No. 29, Reporting on Information Accompanying the Basic Finan
cial Statements in Auditor-Submitted Documents (AICPA, Professional Stand
ards, vol. 1, AU sec. 551), contains useful guidance on reporting on additional
information. The information covered by SAS No. 29 is presented to accompany
the basic financial statements in an independent auditor-submitted document and
is not considered necessary for a fair presentation of financial position, results of
operations, changes in net assets, and cash flows in conformity with GAAP. Such
information includes additional details or explanations of items in, or related to,
the basic financial statements, consolidating/combining information, historical
summaries of items extracted from the basic financial statements, statistical data,
and other material, some of which may be from sources outside the accounting
system or outside the health care organization.
12.06 With respect to supplementary and other information, guidance is
contained in SAS No. 8, Other Information in Documents Containing Audited
Financial Statements (AICPA, Professional Standards, vol. 1, AU sec. 550),
and SAS No. 52, Omnibus Statement on Auditing Standards—1987, “Required
Supplementary Information” (AICPA, Professional Standards, vol. 1, AU sec.
558). Among other changes, SAS No. 52 amends SAS No. 29 regarding required
supplementary information. SAS No. 8 (AICPA, Professional Standards, vol.
1, AU sec. 550.07), SAS No. 29 (AICPA, Professional Standards, vol. 1, AU secs.
551.12 and .15), and SAS No. 52 (AICPA, Professional Standards, vol. 1, AU
secs. 558.08 and .10), were also amended by SAS No. 98, Omnibus Statement
on Auditing Standards—2002, to address the appropriate reporting for supple
mentary information and other information. The amendments to SAS No. 8 and
SAS No. 52, among other matters, clarify that an auditor may issue a report
providing an opinion, in relation to the basic financial statements taken as a whole,
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on supplementary information and other information that has been subjected
to the auditing procedures applied in the audit of those basic financial state
ments. The amendments to SAS No. 29, among other matters, clarify the
reporting guidance with respect to required supplementary information in an
auditor-submitted document. In addition, SAS No. 42, Reporting on Condensed
Financial Statements and Selected Financial Data (AICPA, Professional
Standards, vol. 1, AU sec. 552), contains guidance on reporting in a client-pre
pared document when condensed financial statements or selected financial
data are presented by a public entity.
12.07 GASB Statement No. 34, Basic Financial Statements—and Man
agement’s Discussion and Analysis—for State and Local Governments, para
graphs 8 through 11, require presentation of management’s discussion and
analysis as required supplementary information. Paragraph 8 of SAS No. 52
(AU sec. 558.08), as amended, and paragraph 16 of SAS No. 29 (AU sec.
551.16), as amended, require auditor reporting on required supplementary
information if (a) the supplementary information that GAAP requires to be
presented in the circumstances is omitted; (b) the auditor has concluded that
the measurement or presentation of the supplementary information departs
materially from prescribed guidelines; (c) the auditor is unable to complete the
prescribed procedures; or (d) the auditor is unable to remove substantial
doubts about whether the supplementary information conforms to prescribed
guidelines. Paragraph 8 of SAS No. 52 (AU sec. 558.08), as amended, provides
example language for explanatory paragraphs that, except for an explanatory
paragraph because all required supplementary information is omitted, include
a disclaimer on the information.
12.08 When an auditor-submitted document contains required supple
mentary information and the conditions listed in paragraph 12.06 in this
chapter do not exist, the auditor should (a) express an opinion on the informa
tion if engaged to examine the information; (b) report on such information
using the guidance in AU sec. 551.12 and .14, provided such information has
been subjected to the auditing procedures applied in the audit of the basic
financial statements; or (c) disclaim an opinion on the information, as dis
cussed in paragraph 15 of SAS No. 29 (AU sec. 551.15).
12.09 When a client-prepared document contains required supplemen
tary information and the conditions listed in paragraph 12.07 in this chapter
do not exist, the auditor has no reporting requirement but may voluntarily
disclaim an opinion on the required supplementary information.2 Paragraph 7
of SAS No. 8 (AICPA, Professional Standards, vol. 1, AU sec. 550.07), as
amended, permits an auditor to issue a report providing an opinion, in relation
to the financial statements taken as a whole, when required supplementary
information has been subjected to auditing procedures applied in the audit of
the basic financial statements.
Special Reports

12.10 If a health care organization is required to follow reporting require
ments of a regulatory agency, to report under a cash receipts and disburse
ments basis of accounting, or to report on another comprehensive basis of
accounting other than GAAP, the auditor should follow the guidance in SAS No.
62, Special Reports (AICPA, Professional Standards, vol. 1, AU sec. 623). SAS
No. 62 also provides reporting guidance when reporting on specified elements,
2
Some auditors voluntarily disclaim an opinion on required supplementary information to
inform the report user of the extent of auditor responsibility for the information.
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accounts, or items of a financial statement; compliance with aspects of contrac
tual agreements or regulatory requirements related to audited financial state
ments; financial presentations to comply with contractual agreements or
regulatory provisions; and financial information presented in prescribed forms
(see Exhibit 12-4). Accountants’ reports on regulatory basis financial state
ments generally are prescribed by professional standards as restricted-use
reports as described in SAS No. 87, Restricting the Use of an Auditor’s Report
(AICPA, Professional Standards, vol. 1, AU sec. 532). Where obligated group
financial statements exclude entities that are required under GAAP to be
consolidated in order to comply with loan agreements, the accountants’ report
should restrict the use to specified parties (see Exhibit 12-4).3 Use should be
restricted to the company and other parties to the agreement. Health care
providers that receive federal financial assistance should also refer to the
Audit Guide Government Auditing Standards and Circular A-133 Audits.

3
Obligated group is a term used to denote a group of entities, sometimes a parent corporation
and several of its subsidiaries, that is liable for the repayment of obligations, such as tax-exempt
bonds.
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Exhibit 12-1

Unqualified Opinion—Comparative Financial Statements

Independent Auditor’s Report
To the Board of Trustees
XYZ Health Care Organization
We have audited the accompanying balance sheets of XYZ Health Care Organi
zation as of September 30, 20X2, and 20X1, and the related statements of
operations, changes in net assets, and cash flows for the years then ended.
These financial statements are the responsibility of XYZ Health Care Organi
zation’s management. Our responsibility is to express an opinion on these
financial statements based on our audits.
We conducted our audits in accordance with auditing standards generally
accepted in the United States of America. These standards require that we plan
and perform the audit to obtain reasonable assurance about whether the
financial statements are free of material misstatement. An audit includes
examining, on a test basis, evidence supporting the amounts and disclosures
in the financial statements. An audit also includes assessing the accounting
principles used and significant estimates made by management, as well as
evaluating the overall financial statement presentation. We believe that our
audits provide a reasonable basis for our opinion.
In our opinion, the financial statements referred to above present fairly, in all
material respects, the financial position of XYZ Health Care Organization as
of September 30, 20X2, and 20X1, and the results of its operations, changes in
net assets, and cash flows for the years then ended in conformity with account
ing principles generally accepted in the United States of America.
[Signature]
[Date]
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Exhibit 12-2

Qualified Opinion—Scope Limitation

Independent Auditor’s Report
To the Board of Trustees
XYZ Health Care Organization
[Include same first paragraph as the standard report—see Exhibit 12-1]
Except as discussed in the following paragraph, we conducted our audits in
accordance with auditing standards generally accepted in the United States of
America. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of
material misstatement. An audit includes examining, on a test basis, evidence
supporting the amounts and disclosures in the financial statements. An audit
also includes assessing the accounting principles used and significant esti
mates made by management, as well as evaluating the overall financial
statement presentation. We believe that our audits provide a reasonable basis
for our opinion.
We were unable to obtain audited financial statements supporting XYZ’s
investment in an affiliate stated at $XXX,XXX and $XXX,XXX at September
30, 20X2, and 20X1, respectively, or its equity in earnings of that affiliate of
$XXX,XXX and $XXX,XXX, which is included in the statement of operations
for the years then ended as described in Note X to the financial statements; nor
were we able to satisfy ourselves as to the carrying value of the investment in
the affiliate or the equity in its earnings by other auditing procedures.
In our opinion, except for the effects of such adjustments, if any, as might have
been determined to be necessary had we been able to examine evidence
regarding the affiliate investment and earnings, the financial statements
referred to in the first paragraph present fairly, in all material respects, the
financial position of XYZ Health Care Organization as of September 30, 20X2,
and 20X1, and the results of its operations, changes in net assets, and cash
flows for the years then ended in conformity with accounting principles gener
ally accepted in the United States of America.
[Signature]
[Date]
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Exhibit 12-3

Qualified Opinion—Departure From
Generally Accepted Accounting Principles
That Have a Material Effect on the Financial Statements

Independent Auditor’s Report
To the Board of Trustees
XYZ Health Care Organization
[Include same first and second paragraphs as the
standard report—see Exhibit 12-1]
XYZ Health Care Organization has excluded, from property and debt in the
accompanying balance sheets, certain lease obligations that, in our opinion,
should be capitalized to conform with accounting principles generally accepted
in the United States of America. If these lease obligations were capitalized,
property would be increased by $XXX,XXX and $XXX,XXX, long-term debt
would be increased by $XXX,XXX and $XXX,XXX, and unrestricted net assets
would be increased by $XXX,XXX and $XXX,XXX as of September 31, 20X2,
and 20X1, respectively. In addition, earnings would be increased by $XXX,XXX
and $XXX,XXX, respectively, for the years then ended.
In our opinion, except for the effects of not capitalizing certain lease obligations
as discussed in the preceding paragraph, the financial statements referred to
in the first paragraph present fairly, in all material respects, the financial
position of XYZ Health Care Organization as of September 30, 20X2, and 20X1,
and the results of its operations, changes in net assets, and cash flows for the
years then ended in conformity with accounting principles generally accepted
in the United States of America.
[Signature]
[Date]
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Exhibit 12-4

Report on Financial Statements Prepared Pursuant to a
Master Trust Indenture That Results in a Presentation Not
in Conformity With Generally Accepted Accounting Principles
or Other Comprehensive Basis of Accounting

Independent Auditor’s Report
To the Board of Directors
Sample Health Care Corporation
We have audited the accompanying special-purpose combined balance sheets
of the Obligated Group (as defined in the Master Trust Indenture dated
December X, 20X0, between Sample Health Care Corporation and Any Bank
as Trustee) of Sample Health Care Corporation and Affiliates as of December
31, 20X2, and 20X1, and the related special-purpose combined statements of
operations, changes in net assets, and cash flows for the years then ended.
These financial statements are the responsibility of management. Our respon
sibility is to express an opinion on these financial statements based on our
audits.
We conducted our audits in accordance with auditing standards generally
accepted in the United States of America. Those standards require that we plan
and perform the audit to obtain reasonable assurance about whether the
financial statements are free of material misstatement. An audit includes
examining, on a test basis, evidence supporting the amounts and disclosures
in the financial statements. An audit also includes assessing the accounting
principles used and significant estimates made by management, as well as
evaluating the overall financial statement presentation. We believe that our
audits provide a reasonable basis for our opinion.
As described in Note 1, these special-purpose financial statements were pre
pared in accordance with the accounting requirements set forth in the Master
Trust Indenture and are not intended to be a presentation in conformity with
generally accepted accounting principles.
In our opinion, the special-purpose financial statements of the Obligated Group
as of and for the years ended December 31,20X2, and 20X1, are fairly presented,
in all material respects, on the basis of accounting described in Note 1.
This report is intended solely for the information and use of the board of
directors and management of Sample Health Care Corporation, the Trustee
under the Master Trust Indenture, and bondholders, and is not intended to be
and should not be used by anyone other than these specified parties.
[Signature]
[Date]
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Corporate Compliance Programs

12.11
SOP 99-1, Guidance to Practitioners in Conducting and Reporting
on an Agreed-Upon Procedures Engagement to Assist Management in Evaluat
ing the Effectiveness of Its Corporate Compliance Program, provides guidance
to practitioners in conducting and reporting on an agreed-upon procedures
engagement performed pursuant to the AICPA Statements on Standards for
Attestation Engagements to assist a health care provider in evaluating the
effectiveness of its corporate compliance program consistent with the require
ments of a Corporate Integrity Agreement entered into with the Office of the
Inspector General of the U.S. Department of Health and Human Services. SOP
99-1 is included as Appendix D to this Guide.
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Chapter 13
Financial Accounting and Reporting b y
Providers o f Prepaid Health Care Services
Overview

13.01
This chapter provides guidance on applying GAAP to providers of
prepaid health care services for the accounting and reporting of health care
costs, contract losses (premium deficiencies), stop-loss insurance (reinsur
ance), and contract acquisition costs.
Accounting for Health Care Costs

13.02 Health care costs should be accrued as services are rendered,
including estimates of the costs of services rendered but not yet reported.
Furthermore, if a provider of prepaid health care services is obligated to render
services to specific members beyond the premium period due to provisions in
the contract or regulatory requirements, the costs of such services to be
incurred also should be accrued currently. Costs that will be incurred after a
contract is terminated, such as guaranteed salaries, rent, and depreciation, net
of any anticipated revenues, should be accrued when it is determined that a
contract with a sponsoring employer or other group will be terminated. FASB
Statement No. 146, Accounting for Costs Associated with Exit or Disposal
Activities, provides accounting and reporting guidance for certain contract
termination costs associated with an exit or disposal activity.1
13.03 Amounts payable to hospitals, physicians, or other health care provid
ers under risk-retention, bonus, or similar programs should be accrued during
the contract period based on relevant factors, such as experience to date.
13.04 The basis for accruing health care costs and significant business
and contractual arrangements with hospitals, physicians, or other associated
entities should be disclosed in the notes to the financial statements.
Accounting for Loss Contracts

13.05
A prepaid health care provider enters into contracts to provide
members with specified health care services for specified periods in return for
fixed periodic premiums. The premium revenue is expected to cover health care
costs and other costs over the terms of the contracts. Only in unusual circum
stances would a provider be able to increase premiums on contracts in force to
cover expected losses. A provider may be able to control or reduce future health
care delivery costs to avoid anticipated losses, but the ability to avoid losses
under existing contracts may be difficult to measure or to demonstrate. Associated
entities such as hospitals, medical groups, and individual practice associations
1
This pronouncement is not applicable to governmental health care entities that do not apply
paragraph 7 of GASB Statement No. 20, Accounting and Financial Reporting for Proprietary Funds
and Other Governmental Entities That Use Proprietary Fund Accounting. (See Chapter 1, footnote 1.)
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(IPAs) may enter into similar contracts with prepaid health care providers in
which they agree to deliver identified health care services to the providers’
members for specified periods in return for fixed fees.
13.06
FASB Statement No. 5, Accounting for Contingencies, states that a
loss should be accrued in financial statements when it is probable that a loss
has been incurred and the amount of the loss can be reasonably estimated.
Accordingly, losses should be recognized when it is probable that expected
future health care costs and maintenance costs under a group of existing
contracts will exceed anticipated future premiums and stop-loss insurance
recoveries on those contracts. The estimated future health care costs and
maintenance costs to be considered in determining whether a loss has been
incurred should include fixed and variable, direct and allocable indirect costs.
Contracts should be grouped in a manner consistent with the provider’s
method of establishing premium rates, for example, by community rating
practices, geographical area, or statutory requirements, to determine whether
a loss has been incurred.
Accounting for Stop-Loss Insurance

13.07 In stop-loss insurance, prepaid health care providers or associated
entities transfer portions of their financial risks to other companies. A provider
typically contracts to recover health care costs in excess of stated amounts
during the contract periods.
13.08 Stop-loss insurance premiums should be included in reported
health care costs. Stop-loss insurance recoveries should be reported as reduc
tions of related health care costs. Receivables representing amounts recover
able from insurers should be reported as assets, reduced by appropriate
valuation allowances. In addition, the nature, amounts, and effects of signifi
cant stop-loss insurance contracts should be disclosed.
Accounting for Contract Acquisition Costs

13.09
Many prepaid health care providers incur costs that vary with, and
are primarily related to, the marketing of subscriber contracts and member
enrollment. These costs, sometimes referred to as acquisition costs, consist
mainly of commissions paid to agents or brokers and incentive compensation
based on new enrollments. Commissions and incentive compensation may be
paid when the contracts are written, at later dates, or over the terms of the
contracts as premiums are received. Some providers incur additional costs
directly related to the acquisition of specific contracts, such as the costs of
specialized brochures, marketing, and advertising. Providers also incur costs
that are related to the acquisition of new members but that do not relate to
specific contracts and are not considered acquisition costs. These costs include
salaries of the marketing director and staff, general marketing brochures, and
general advertising and promotion expenses.
* In November 2003, the GASB issued GASB Statement No. 42, Accounting and Financial
Reporting for Impairment of Capital Assets and for Insurance Recoveries. Among other matters,
GASB Statement No. 42 clarifies and establishes accounting requirements for insurance recoveries.
GASB Statement No. 42 is effective for financial statements for periods beginning after December 15,
2004. Earlier application is encouraged.
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13.10
Although there is theoretical support for deferring certain acquisi
tion costs, acquisition costs of providers of prepaid health care services—other
than costs of advertising—should be expensed as incurred.2 Advertising costs
should be accounted for in conformity with the guidance in SOP 93-7, Reporting
on Advertising Costs.3

2 In accordance with existing practice, as mandated by SOP 89-5, Financial Accounting and
Reporting by Providers of Prepaid Health Care Services. Although SOP 89-5 has been superseded
with the issuance of this Audit and Accounting Guide, its provisions have been adopted in this
chapter.
3 This pronouncement is not applicable to governmental health care enterprises that do not
apply paragraph 7 of GASB Statement No. 20, Accounting and Financial Reporting for Proprietary
Funds and Other Governmental Entities That Use Proprietary Fund Accounting. (See Chapter 1,
footnote 1.)
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Chapter 14
Financial Accounting and Reporting by
Continuing Care Retirement Communities
Overview

14.01 This chapter provides guidance on applying GAAP to continuing
care retirement communities (CCRCs) for refundable and nonrefundable ad
vance fees, for obligations to provide future services and the use of facilities to
current residents, and for the costs of acquiring initial care contracts.1
14.02 The United States has over one thousand CCRCs. Most CCRCs are
operated by not-for-profit organizations, and many are affiliated with religious
organizations.
14.03 CCRC facilities may be independent or they may be affiliated with
other health care facilities. They usually provide less intensive care than do
hospitals. They generally supply required continuous nursing service or appro
priate assistance to residents who have a wide range of medical conditions and
needs.
14.04 Some states regulate CCRCs, although most states currently do
not. There is, however, a growing trend toward regulation in this rapidly
developing industry. States that do require some form of regulation specify
that the CCRCs be certified by a state authority, such as a department of
insurance or a department of social services. In addition, some states mandate
that escrow or reserve funds be maintained for the protection of residents.
Types of Contracts

14.05 CCRCs use three basic types of contracts. They include all-inclusive
(type A), modified (type B), and fee-for-service (type C) contracts.
Type A Contracts

14.06 An all-inclusive continuing-care contract includes residential facili
ties, meals, and other amenities. It also provides long-term nursing care for
little or no increase in periodic fees, except to cover normal operating costs and
inflation.
Type B Contracts

14.07 A modified continuing-care contract also includes residential facili
ties, meals, and other amenities. However, only a specified amount of long
term nursing care is provided for little or no increase in periodic fees, except to
1 The provisions of this chapter do not apply to governmental health care enterprises, unless the
entity has elected to follow all FASB pronouncements under paragraph 7 of GASB Statement No. 20,
Accounting and Financial Reporting for Proprietary Funds and Other Governmental Entities That
Use Proprietary Fund Accounting. (See Chapter 1, footnote 1.)
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cover normal operating costs and inflation. After the specified amount of
nursing care is used, residents pay either a discounted rate or the full per diem
rates for required nursing care.
Type C Contracts

14.08 A fee-for-service continuing-care contract includes residential fa
cilities, meals, and other amenities as well as emergency and infirmary nurs
ing care. Access to long-term nursing care is guaranteed, but it may be required
at full per diem rates.

Types of Living Accommodations

14.09 CCRCs offer different types of living accommodations to residents,
such as single or shared apartment units or individual homes. They also
provide a variety of amenities, including social, recreational, dining, and
laundry services.
14.10 CCRCs may provide long-term nursing-care services, either at the
same location or, by agreement, with another facility. Residents are trans
ferred to or from a nursing center as medical care is required. As the health of
a resident declines, he or she may be transferred permanently to a nursing
center.
Fees and Payment Methods

14.11 Continuing-care contracts contain a number of different ap
proaches to providing delivery of services. Contract provisions, for example,
may stipulate the amount of the advance fee, whether periodic fees will be
required, and, if so, whether they can be adjusted. In addition, contracts
generally do the following: detail the future services that will be provided to
residents; explain how a resident will be charged for services; describe the
CCRC’s refund policies and the formula for calculating the amount of the
refund, which may be simple or complex; and describe the obligations of the
CCRC and the resident if a contract is terminated or a residential unit is
reoccupied.
14.12 A CCRC may require several different payment methods for serv
ices and the use of facilities. Paragraphs 14.13 through 14.19 discuss three of
the most prevalent methods.
Advance Fee Only

14.13 Under this method, a resident pays an advance fee in return for
future services and the use of facilities. Such services generally include CCRC
housing-related services (for example, meals, laundry, housekeeping, and so
cial services) and health care. These services usually are provided to the
resident for the remainder of his or her life or until the contract is terminated.
Additional periodic fees are not paid, regardless of how long a resident lives or
if the resident requires more services than anticipated. Generally, the resident
receives no ownership interest in the facility.
Advance Fee With Periodic Fees

14.14 Under this method, a resident pays an advance fee and periodic fees
for services and the use of facilities. Such periodic fees may be fixed, or they
may be subject to adjustment for increases in operating costs or inflation or for
other economic reasons.
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14.15 Under this method, a resident pays a fee at periodic intervals for
services and the use of the facilities provided by the CCRC. Such fees may be
either fixed or adjustable.
14.16 An advance fee may be met by transferring a resident’s personal
assets (which may include rights to future income) or by paying a lump sum of
cash to the CCRC.
14.17 Advance fees received for future services may be refunded at the
occurrence of some future event, such as death, withdrawal from the CCRC,
termination of the contract, or reoccupancy of a residential unit. The amount
of the refund generally is based on contractual provisions or statutory require
ments.
14.18 Many continuing-care contracts are similar to annuity contracts.
Under those contracts, the CCRC assumes the risks associated with (a) esti
mating the amount of the advance fee and other fees to be paid by a resident
and (b) determining whether such fees will be sufficient to cover the cost of
providing a resident’s required services and the use of facilities. For some
contracts, residents may share the future costs without limit.
14.19 The CCRC has an obligation to provide future services for the
length of the contract or the life of the resident. In certain circumstances, this
obligation continues regardless of whether advance fees or periodic fees are
sufficient to meet the costs of providing services to a resident.
Accounting for Refundable Advance Fees

14.20 Payment of an advance fee generally is required before a resident
acquires a right to reside in an apartment or residential unit for life. A portion
of advance fees may be refundable by rescission within a legally set time period
or if a certain future event occurs, such as the death or withdrawal of a resident
or termination of the contract. Some refunds are paid only if a residential unit
is reoccupied.
14.21 CCRC refund policies vary either by region or according to statu
tory requirements, but generally the amount of the refund is based on provi
sions specified in a contract. For example, some contracts require a refund of
the advance fee, less a reasonable processing fee. Amounts refunded may be
based on a fixed amount or percentage, an amount that declines to a fixed
amount over time, an amount that declines to zero, or an amount based on the
resale amount. Refunds may be contingent on vacating the unit, resale of the
unit, or passage of a fixed period of time if the unit is not resold.
14.22 The estimated amount of advance fees that is expected to be re
funded to current residents under the terms of the contracts should be ac
counted for and reported as a liability. The estimated amount should be based
on the individual facility’s own experience or, if records are not available, on
the experience of comparable facilities. The remaining amount of advance fees
should be accounted for as deferred revenue within the liability section of the
balance sheet. Adjustments to the estimated liability should be accounted for
as deferred revenue and amortized together with nonrefundable advance fees
as discussed in paragraph 14.23. The gross amount of contractual refund
obligations under existing contracts and the CCRC’s refund policy should be
disclosed in the notes to the financial statements. Amounts refunded should be
disclosed in the statement of cash flows as a financing transaction.
AAG-HCO 14.22

174

Health Care Organizations

14.23
The deferred revenue should be amortized to income over future
periods based on the estimated life of the resident or on the contract term, if
shorter. The period of amortization should be adjusted annually based on the
actuarially determined, estimated, remaining life expectancy of each individ
ual or on the joint and last survivor life expectancy of each pair of residents
occupying the same unit. The straight-line method should be used to amortize
deferred revenue except in certain circumstances when costs are expected to
increase at a significantly higher rate than future revenues in the later years
of residence. In those situations, deferred revenue may be amortized to income
using a method that reflects the disproportionate ratio between the costs of the
expected services and the expected revenues. The amortized amount should
not exceed the amount available to the CCRC under state regulations, contract
provisions, or management policy. Unamortized deferred revenue from nonre
fundable advance fees should be recorded as revenue upon a resident’s death
or the termination of the contract. The method of amortization should be
disclosed in the notes to the financial statements.
Accounting for Fees Refundable to Residents
Only From Reoccupancy Proceeds of a Contract
Holder's Unit

14.24 Some contracts between a CCRC and a resident stipulate that all
or a portion of the advance fee may be refundable if the contract holder’s unit
is reoccupied by another person. The source of money for the payment is from
the proceeds of the advance fees collected by the CCRC from the next resident
of the reoccupied unit. The terms governing how the proceeds from the next
resident are to be paid to the previous resident vary from contract to contract.
In effect, the CCRC acts as if it were an agent for present and future residents.
14.25 The portion of the fees that will be paid to current residents or their
designees, only to the extent of the proceeds of reoccupancy of a contract
holder’s unit, should be accounted for as deferred revenue, provided that legal
and management policy and practice support the withholding of refunds under
this condition. Similar amounts received from new residents in excess of the
amount to be paid to previous residents or their designees also should be
deferred. The deferred revenue should be amortized to income over future
periods based on the remaining useful life of the facility. The basis and method
of amortization should be consistent with the method for calculating deprecia
tion and should be disclosed in the notes to the financial statements.
Accounting for Nonrefundable Advance Fees

14.26 Under provisions of continuing-care contracts entered into by a
CCRC and residents, nonrefundable advance fees represent payment for fu
ture services and should be accounted for as deferred revenue. If a CCRC has
sufficient historical experience and relevant statistical data about life expec
tancies, it should consider that information when determining the remaining
life of residents. A CCRC with insufficient historical experience or reliable
actuarial data may use relevant data of similar communities within that area,
relevant national industry statistics, or other appropriate data. Nonrefundable
advance fees should be amortized in the manner discussed in paragraph 14.23.
14.27 The application of the conclusions in paragraphs 14.25 and 14.26 is
presented in Exhibit 14-1 at the end of this chapter.
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Accounting for the Obligation to Provide Future
Services and the Use of Facilities to Current Residents

14.28 A CCRC expects to provide services and the use of facilities to
individuals over their remaining lives under continuing-care contract agree
ments. The nature and extent of such services depend on such variables as the
individual’s age, health, sex, and economic status upon entering the CCRC.
Thus, the CCRC assumes a risk in estimating the cost of future services and
the use of facilities. Although many CCRCs are allowed contractually to
increase periodic fees, some contracts may restrict increases in periodic fees
and require continuing services without additional compensation. If the ad
vance fees and periodic fees charged are insufficient to meet the costs of
providing future services and the use of facilities, the CCRC has a liability to
provide future services and the use of facilities that is equal to the estimated
cost of providing future services and the use of facilities (defined as amounts
that are expected to be incurred to provide services and the use of facilities to
individuals over their remaining lives under continuing care contracts, includ
ing resident-care, dietary, health care, facility, interest, depreciation, and
amortization costs) in excess of the related anticipated revenues. The liability
is based on actuarial assumptions (such as mortality and morbidity rates), on
estimates of future costs and revenues, and on the specific CCRC’s historical
experience and statistical data.
14.29 The obligation to provide future services and the use of facilities to
current residents should be calculated annually in order to determine whether
a liability should be reported in the financial statements. The liability related
to continuing-care contracts is the present value of future net cash flows, minus
the balance of unamortized deferred revenue, plus depreciation of facilities to
be charged related to the contracts, plus unamortized costs of acquiring the
related initial continuing-care contracts, if applicable. The calculation should
be made by grouping contracts by type, such as all contracts with a limit on
annual increases in fees, contracts with unlimited fee increases, and so forth.
14.30 Cash inflows include revenue contractually committed to support
the residents and inflows resulting from monthly fees including anticipated
increases in accordance with contract terms. This includes third-party pay
ments, contractually or statutorily committed investment income from services
related to CCRC activities, contributions pledged by donors to support CCRC
activities, and the volume of deferred nonrefundable advance fees. Cash out
flows are composed of operating expenses, including interest expense and
excluding selling, and general and administrative expenses. Anticipated cost
increases affecting these operating expenses should be considered in determin
ing cash outflows. The expected inflation rate as well as other factors should
be considered in determining the discount rate. In calculating the liability, the
specific CCRC’s historical experience or statistical data relating to the residents’
life spans should be used. The life spans used should be the same as those used
to amortize deferred revenue (see paragraph 14.23). For a new CCRC, either
relevant data of similar communities in the area or relevant national industry
statistics may be used if they are deemed to be representative.
14.31 A CCRC should disclose in its notes to the financial statements (1)
the carrying amount of the liability to provide future services and the use of
facilities related to continuing-care contracts that is presented at present value
in the financial statements (if not separately disclosed in the balance sheet)
and (2) the interest rate used to discount that liability. Also, the FASB has
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issued FASB Concepts Statement No. 7, Using Cash Flow Information and
Present Value in Accounting Measurements. This Concepts Statement provides
useful discussion of general principles governing the use of present value, and
of the objective of present value in accounting measurements. Statements of
Financial Accounting Concepts are not sources of established accounting prin
ciples as described in SAS No. 69, The Meaning of Present Fairly in Conformity
with Generally Accepted Accounting Principles, and, thus, do not amend,
modify, or justify a change from generally accepted accounting principles
currently in effect.
14.32
The application of the conclusions in paragraph 14.30 is presented
in Exhibit 14-2 at the end of this chapter.
Accounting for the Costs of Acquiring Initial
Continuing-Care Contracts

14.33
Advertising costs incurred in connection with acquiring initial con
tinuing-care contracts should be accounted for in conformity with the guidance
in SOP 93-7, Reporting on Advertising Costs. Start-up costs should be expensed
as incurred in accordance with SOP 98-5, Reporting on the Costs of Start-Up
Activities. However, costs of acquiring initial continuing-care contracts that are
within the scope of FASB Statement No. 67, Accounting for Costs and Initial
Rental Operations of Real Estate Projects, should be expensed or capitalized in
accordance with that Statement. Capitalized costs should be amortized to
expenses on a straight-line basis over the average expected remaining lives of
the residents under the contract or the contract term, if shorter. The costs of
acquiring continuing-care contracts after a CCRC is substantially occupied or
one year following completion should be expensed when incurred.2
Financial Statements

14.34 A complete set of illustrative financial statements for a CCRC is
included in Appendix A.
14.35 The notes to the financial statements for each year presented
should include—
• A description of the CCRC and the nature of the related continuingcare contracts entered into by the CCRC.
• The statutory escrow or similar requirements.
• The refund policy of the CCRC and the general amount of refund
obligation under the existing contracts.
• The interest rate used to discount the liability to provide future services.
Auditing

14.36
When auditing a CCRC, the independent auditor may need to
consider the examples of specific auditing objectives, selected control activities,
and auditing procedures that are presented in Exhibit 14-3 at the end of this
chapter.

2 In accordance with existing practice, as mandated by SOP 90-8, Financial Accounting and
Reporting by Continuing Care Retirement Communities. Although SOP 90-8 is superseded with the
issuance of this Audit and Accounting Guide, its provisions have been adopted in this chapter.
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Accounting for Refundable and Nonrefundable Advance Fees

Assumptions:
a. The unit is occupied for twenty years.
b. The facility has an estimated thirty-year life.
c. The resident is admitted on the first day of the year indicated and
dies on the last day of year indicated.
d. The estimated remaining life expectancy is taken from an appropri
ate actuarial table.
e. The cost of providing future services is expected to be incurred
equally over the remaining life.
Example:
__________ Advance Fees__________

Year
Entry
Admitted Dies Resident Age

1

5
9
14

4
8
13
—

A
B
C
D

Refunded to
Nonrefundable Refundable the Previous
25%
75%
Total
Occupant*

68 $100,000
82 120,000
79 150,000
80 130,000

$25,000
30,000
37,500
32,500

__

$ 75,000
90,000
112,500
97,500

$75,000
90,000
97,500

Amortization of Nonrefundable Advance Fees:
Unamortized Estimated
Deferred
Remaining
Revenue
Life (in Years)
Resident A
Year 1
$25,000
12.1 =
2
22,934
11.5 =
3
20,940
11.1 =
4
19,054
10.6 =
Unamortized deferred revenue
recognized upon the death of the resident
Total

Income
$ 2,066
1,994
1,886
1,798
17,256
$25,000

Per contact, the amount is limited to 75% of proceeds of reoccupancy up to amount originally
paid by previous occupant.
Amortization of Advance Fees Refundable to Residents
$75,000/30 years = $2,500 per year for years 1 through 4
15,000/26 years = $577 additional or $3,077 per year for years 5 through 8
22,500/22 years = $1,023 additional or $4,100 per year for years 9 through next change in occupancy
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Unamortized Estimated
Remaining
Deferred
Resident B
Life (in Years)
Revenue
Year 5
6.1 =
$30,000
5.8 =
6
25,082
7
5.5 =
20,758
5.3 =
8
16,984
Unamortized deferred revenue
recognized upon the death of the resident
Total
Unamortized Estimated
Remaining
Deferred
Life (in Years)
Resident C
Revenue
Year 9
7.0 =
$37,500
6.7 =
10
32,143
6.4 =
11
27,346
6.1 =
12
23,073
5.8 =
13
19,290
Unamortized deferred revenue
recognized upon the death of the resident
Total
Unamortized Estimated
Remaining
Deferred
Life (in Years)
Resident D
Revenue
6.7 =
Year 14
$32,500
6.4 =
15
27,649
6.1 =
16
23,328
5.8 =
17
19,504
5.5 =
18
16,141
5.3 =
19
13,206
5.1 =
20
10,714

Income
$ 4,918
4,324
3,774
3,205
13,779
$30,000

Income
$ 5,357
4,797
4,273
3,783
3,324
15,966
$37,500

Income
$4,851
4,321
3,824
3,363
2,935
2,492
2,100

Amortization continues until the death of the resident.
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Accounting for the Obligation to Provide Future Services
and the Use of Facilities to Current Residents

Assumptions:
a. All residents pay a $ 50,000 fee, which is refundable less 2 percent
per month for the first 36 months. After that period, none of the fee
is refundable. The CCRC opened on 1/1/X4. (See Exhibit 14-1 for an
illustration of how to compute refundable and deferred revenue.)
b. An additional periodic fee of $1,000 is payable monthly with a 5
percent increase annually.
c. The unamortized (deferred) costs of acquiring related initial con
tracts on 12/31/X6 are assumed to be $17,000.
d. The unamortized deferred revenue on 12/31/X6 is assumed to be
$27,027.
Present value of net cash flow on 12/31/X6:
Cash inflows:

Estimated
Remaining Life
(in Months)
on 12/31/X 6
Resident
A
36
B
22
C
27
D
38
Estimated cash inflows

Estimated Cash Inflows
19X7
$12,000
12,000
12,000
12,000
$48,000

19X8
$12,600
10,500
12,600
12,600
$48,300

19X9
$13,230
—

20X0
—
—

3,308
13,230
$29,768

—

$2,315
$2,315

Cash outflows:
Estimated
Remaining Life
(in Months)
on 12/ 31/X 6
Resident
A
36
B
22
C
27
D
38
Estimated cash outflows
Recapitulation
Cash inflows
Cash outflows

Estimated Cash Outflows
19X7
$10,000
15,000
14,000
8,000
$47,000

19X8
$12,000
11,000
17,000
12,000
$52,000

19X7
$ 48,000
(47,000)
$ 1,000

19X8
$ 48,300
(52,000)
$ (3,700)

Present value of net cash flows discounted at 10 percent

19X9
$15,000
—

20X0
—
—

5,000
14,000
$34,000

—

$4,000
$4,000

19X9
20X0
$ 29,768 $ 2,315
(34,000)
(4,000)
$ (4,232) $(1,685)
$(7,137)
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Depreciation of facilities to be charged to current residents:
Original cost of facility
Cost of facility allocable to revenue-producing service
areas
Cost of facility to be allocated to residents (including
common areas)
Useful life
Annual depreciation using straight-line method
Number of residents expected to occupy the facility
Annual depreciation per resident
Monthly depreciation per resident
Estimated
Remaining Life
(in Months)
on 12/ 31/X6
Resident
A
36
22
B
27
C
D
38
Yearly estimated depreciation of
facilities to be charged to current
residents

$17,000,000
$(2,000,000)
40 years
200

$15,000,000
$ 375,000
$
$

1,875
156

19X7
$1,875
1,875
1,875
1,875

19X8
$1,875
1,560
1,875
1,875

19X9
$1,875
468
1,875

—
$ 312

$7,500

$7,185

$4,218

$ 312

Total estimated depreciation of the use of facilities to be
charged to the current residents

—

20X0
—
—

$19,215

Liability for providing future services and the use of facilities to current resi
dents:
Present value of future net cash outflows
Minus:
Unamortized deferred revenue on 12/31/X6
Plus:
Depreciation to be charged to current residents
Unamortized costs of acquiring initial
contracts—see assumption c above
Liability for providing future services and the use of
facilities to current residents on 12/31/X6

$ 7,137
(27,027)
19,215
17,000†
$16,325

† These numbers are for illustrative purposes only and no inference has been made as to the
recoverability of the $17,000.
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Auditing Considerations

Financial Statement Specific Auditing Selected Control
Assertions
Objectives
Activities
Continuing Care Retirement Communities
Existence,
Liabilities
Written
documentation is
completeness, and relating to
prepared for
presentation and refundable fee
arrangements are refundable fee
maturity
accounted for and arrangements.
reported properly.

Liabilities are
All liabilities are
accounted for and classified,
reported properly. described, and
disclosed
properly in the
financial
statements.
Management
monitors
compliance with
restrictive
covenants.
Deferred Revenue
Completeness,
rights and
obligations, and
presentation and
disclosure

Deferred revenue
and the obligation
to provide future
services to, and
the use of
facilities by,
current residents
of CCRCs are
recognized and
reported properly.

Long-Term Obligations
Existence,
Liabilities
completeness, and relating to

Auditing
Procedures
Review the
refundable fee
arrangements
regarding
stipulations for
repayments and
determine that
such
arrangements are
classified and
disclosed properly
in the financial
statements.
Compare the
account balances
with the prior
periods’ balance
and the
amortization
schedules.
Confirm any
significant new
obligations.

Procedures
ensure that
amounts received
as advance fees
are recognized in
the proper period
and that the
obligation to
provide future
services and the
use of facilities is
reported.

Test the
procedures
related to the
recognition of
advance fees and
determine that
the obligation to
provide future
services and the
use of facilities is
properly reported.

Written
documentation is

Review the
refundable fee
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Financial Statement Specific Auditing
Assertions
Objectives
presentation and refundable fee
maturity
arrangements are
accounted for and
reported properly.
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Selected Control
Activities
prepared for
refundable fee
arrangements.

Auditing
Procedures
arrangements
regarding
stipulations for
repayments and
determine that
such
arrangements are
classified and
disclosed properly
in the financial
statements.
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Appendix A
Illustrative Financial Statements

The following illustrative financial statements illustrate the applications of
the reporting practices discussed in this Guide. Specific types of health care
organizations have been selected to illustrate a wide diversity of reporting
practices. It is not intended that these illustrations represent either the only
types of disclosure nor the only statement formats that would be appropriate.
For example, the reporting of revenue, expenses, gains, and losses vary depend
ing on the relationship of the underlying transaction to the entity’s operations.
More or less detail should appear either in the financial statements or in the
notes to the financial statements, depending on the circumstances.
Governmental health care entities are required to follow the accounting and
reporting requirements of the GASB. GASB pronouncements may require govern
mental health care entities to present information beyond or different from that
presented by not-for-profit and investor-owned entities. For example, GASB State
ment No. 3, Deposits with Financial Institutions, Investments (including Repur
chase Agreements), and Reverse Repurchase Agreements, requires governmental
entities to make certain disclosures about the credit and market risks of their
investments. GASB Statement No. 27, Accounting for Pensions by State and Local
Governmental Employers, requires certain accounting for and disclosures about
pension benefits provided to employees ofgovernmental health care entities. GASB
Statement No. 9, Reporting Cash Flows of Proprietary and Nonexpendable Trust
Funds and Governmental Entities That Use Proprietary Fund Accounting, requires
governmental health care entities to present a statement of cash flows using a
format that differs in some respects from that required by FASB Statement No.
95, Statement of Cash Flows, and that requires the reporting of cash flow informa
tion on both restricted and unrestricted funds. GASB Statement No. 12, Disclosure
of Information on Postemployment Benefits Other Than Pension Benefits by State
and Local Governmental Employers, requires certain disclosures about other
postemployment benefits (OPEB) provided to employees of governmental health
care entities. GASB Statement No. 12 also provides that governmental health care
entities are not required to change their recognition and measurement of OPEB
to comply with FASB Statement No. 106, Accounting for Postretirement Benefits
Other Than Pensions, or FASB Statement No. 112, Employer’s Accounting for
Postemployment Benefits. GASB Statement No. 34, Basic Financial Statements—
and Management’s Discussion and Analysis—for State and Local Governments,
establishes new financial reporting requirements for state and local governments,
and amends or supersedes various existing GASB and NCGA Statements and
Interpretations.
Other GASB pronouncements may also have implications for governmental
health care entities. For example, GASB Statement No. 13, Accounting for
Operating Leases with Scheduled Rent Increases (paragraph 6.11), may affect
the accounting for and financial reporting of certain lease transactions. Dis
cussed elsewhere in this Audit and Accounting Guide are GASB Statement No.
7, Advance Refundings Resulting in Defeasance ofDebt (paragraph 7.20), GASB
Statement No. 10, Accounting and Financial Reporting for Risk Financing and
Related Insurance Issues (paragraph 8.02), GASB Statement No. 14, The
Financial Reporting Entity (paragraph 11.03), GASB Statement No. 16, Ac
counting for Compensated Absences (paragraph 7.03), GASB Statement No. 20,
AAG-HCO APP A

184

Health Care Organizations

Accounting and Financial Reporting for Proprietary Funds and Other Govern
mental Entities That Use Proprietary Fund Accounting (Chapter 1, footnote 1),
GASB Statement No. 23, Accounting and Financial Reporting for Refundings
of Debt Reported by Proprietary Activities (paragraph 7.20), GASB Statement
No. 28, Accounting and Financial Reporting for Securities Lending Transac
tions (paragraph 4.13), GASB Statement No. 29, The Use of Not-for-Profit
Accounting and Financial Reporting Principles by Governmental Entities
(Chapter 1, footnote 1), GASB Statement No. 30, Risk Financing Omnibus
(paragraph 8.02), GASB Statement No. 31, Accounting and Financial Report
ing for Certain Investments and for External Investment Pools (paragraph 4.12),
GASB Statement No. 33, Accounting and Financial Reporting for Nonexchange
Transactions, as amended by GASB Statement No. 36, Recipient Reporting for
Certain Shared Nonexchange Revenues, (paragraphs 5.19,5.20, 7.05,10.05, and
10.12), GASB Statement No. 39, Determining Whether Certain Organizations
Are Component Units (paragraph 11.03), GASB Interpretation No. 3, Financial
Reporting for Reverse Repurchase Agreements (paragraph 4.13), GASB Inter
pretation No. 4, Accounting and Financial Reporting for Capitalization Contri
butions to Public Entity Risk Pools (paragraph 8.02), and GASB Technical
Bulletin 03-1, Disclosure Requirements for Derivatives Not Reported at Fair
Value on the Statement of Net Assets (paragraphs 4.18 and 5.26).
These illustrative financial statements are not intended to include items that
should be accounted for under the requirements of FASB Statement No. 133,
Accounting for Derivative Instruments and Hedging Activities, as amended, and
do not reflect the requirements of FASB Statement No. 133. FASB Statement
No. 133, among other matters, amends the disclosure requirements for securi
ties in FASB Statement No. 115, Accounting for Certain Investments in Debt
and Equity Securities (see paragraph 534 of FASB Statement No. 133). In
reporting disclosures about investments in securities, investor-owned enti
ties should comply primarily with the requirements of paragraphs 6, 17, 19,
20, 21, and 22 of FASB Statement No. 115, as amended. Other disclosure
requirements for investments in securities may also be applicable. For example,
Emerging Issues Task Force (EITF) Issue No. 03-1, The Meaning of OtherThan-Temporary Impairment and Its Application to Certain Investments,
requires certain disclosures for investments that are in an unrealized loss
position but for which other-than-temporary impairments have not been rec
ognized. Practitioners should refer to FASB Statement No. 133, as amended,
for guidance on reporting derivative instruments and hedging activities.
This appendix contains illustrative financial statements for the following types
of health care organizations:
1. Not-for-profit hospital
2. Governmental hospital authority (includes illustrative manage
ment’s discussion and analysis)
3. Nursing home
4. Continuing care retirement community (CCRC)
5. Home health agency
6. Health maintenance organization (HMO)
7. Ambulatory care organization
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ILLUSTRATIVE FINANCIAL STATEMENTS FOR A NOT-FOR-PROFIT HOSPITAL
Sample Not-for-Profit Hospital
Balance Sheets
December 31, 20X7 and 20X6
(in thousands)*1

20X7

20X6

$ 4,758
15,836
970

$ 5,877
10,740
1,300

15,100
2,670
39,334

14,194
2,856
34,967

510
12,000
6,949
18,949
(970)
17,979

462
12,500
7,341
19,841
(1,300)
18,541
(continued)

Assets

Current assets:
Cash and cash equivalents
Short-term investments
Assets limited as to use
Patient accounts receivable, net of
allowance for doubtful accounts of $2,500
in 20X7 and $2,400 in 20X6
Other current assets
Total current assets
Interest in net assets of Sample Hospital
Foundation
Assets limited as to use:
Internally designated for capital acquisition
Held by trustee
Less amount required to meet current
obligations

These illustrative financial statements include a presentation of an interest in the net assets
of a financially interrelated foundation that is based on the particular fact pattern described in Note
11 to the illustrative financial statements and the following additional facts:
• Sample Not-for-Profit Hospital can influence the financial decisions of Sample Hospital Foun
dation to such an extent that it can determine the timing and amount of distributions from
the Foundation. Thus, it is inappropriate for the Hospital to imply a time restriction on amounts
held by the Foundation.
• Contributions to Foundation are restricted by donors for property acquisitions. Those restrictions
have been met by the Hospital even though the net assets remain at the Foundation. Thus,
the net assets related to the interest in the Foundation are classified as unrestricted in the
Hospital’s financial statements.
• The Hospital’s policy is to report restricted revenues as unrestricted if the restriction is met
in the same period as the revenues are recognized.
Because the change in the interest in net assets of the foundation results from contributions restricted to
property acquisitions, this presentation shows the change in that interest reported separately from the
performance indicator, in the spirit of the guidance in paragraph 10.20 for contributions restricted to
property acquisitions. Readers should be aware that FASB Statement No. 136 is silent on this
classification. The AICPA has released a group of Technical Practice Aids (TPAs) (6400.36 through
6400.42) that address recognition of the interests in the net assets of financially interrelated
organizations and the classification of the changes in those interests. TPAs are nonauthoritative and are
not sources of established accounting principles as described in SAS No. 69, The Meaning of Present
Fairly in Conformity With Generally Accepted Accounting Principles.
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Sample Not-for-Profit Hospital
Balance Sheets
(continued)
December 31, 20X7 and 20X6
(in thousands)

Long-term investments
Long-term investments restricted for capital
acquisition
Property and equipment, net
Other assets
Total assets

20X7
4,680
320
51,038
1,185
$115,046

20X6
4,680
520
50,492
908
$110,570

Liabilities and Net Assets

Current liabilities:
$ 1,470
Current portion of long-term debt
5,818
Accounts payable and accrued expenses
2,143
Estimated third-party payor settlements
1,969
Other current liabilities
11,400
Total current liabilities
23,144
Long-term debt, net of current portion
3,953
Other liabilities
Total liabilities
38,497
Net assets:
70,846
Unrestricted
2,115
Temporarily restricted
Permanently restricted
3,588
76,549
Total net assets
Total liabilities and net assets
$115,046
See accompanying notes to financial statements.
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5,382
1,942
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24,014
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66,199
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FORMAT A
Sample Not-for-Profit Hospital
Statements of Operations
Years Ended December 31, 20X7 and 20X6
(in thousands)

Unrestricted revenues, gains and other support:
Net patient service revenue
Premium revenue
Other revenue
Net assets released from restrictions used for operations
Total revenues, gains and other support
Expenses:
Operating expenses
Depreciation and amortization
Interest
Provision for bad debts
Other
Total expenses
Operating income
Other income:
Investment income
Other expense:
Loss from extinguishment of debt
Excess of revenues over expenses
Change in net unrealized gains and losses on other
than trading securities
Net assets released from restrictions used for purchase
of property and equipment
Change in interest in net assets of Sample
Hospital Foundation**
Transfers to parent
Increase in unrestricted net assets
See accompanying notes to financial statements.

20X7
$85,156
11,150
2,601
300
99,207
88,521
4,782
1,752
1,000
2,000
98,055
1,152
3,900
(500)
4,552
300
200
283
(688)
$ 4,647

20X6
$78,942
10,950
5,212
95,104
80,585
4,280
1,825
1,300
1,300
89,290
5,814
3,025
8,839
375
536
(3,051)
$ 6,699

These illustrative financial statements include a presentation of an interest in the net assets
of a financially interrelated foundation that is based on the particular fact pattern described in Note
11 to the illustrative financial statements and the following additional facts:
• Sample Not-for-Profit Hospital can influence the financial decisions of Sample Hospital Foun
dation to such an extent that it can determine the timing and amount of distributions from
the Foundation. Thus, it is inappropriate for the Hospital to imply a time restriction on amounts
held by the Foundation.
• Contributions to Foundation are restricted by donors for property acquisitions. Those restrictions
have been met by the Hospital even though the net assets remain at the Foundation. Thus,
the net assets related to the interest in the Foundation are classified as unrestricted in the
Hospital’s financial statements.
• The Hospital’s policy is to report restricted revenues as unrestricted if the restriction is met
in the same period as the revenues are recognized.
Because the change in the interest in net assets of the foundation results from contributions restricted to
property acquisitions, this presentation shows the change in that interest reported separately from the
performance indicator, in the spirit of the guidance in paragraph 10.20 for contributions restricted to
property acquisitions. Readers should be aware that FASB Statement No. 136 is silent on this
classification. The AICPA has released a group of Technical Practice Aids (TPAs) (6400.36 through
6400.42) that address recognition of the interests in the net assets of financially interrelated
organizations and the classification of the changes in those interests. TPAs are nonauthoritative and are
not sources of established accounting principles as described in SAS No. 69, The Meaning of Present
Fairly in Conformity With Generally Accepted Accounting Principles.
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FORMAT B
Sample Not-for-Profit Hospital
Statements of Operations
Years Ended December 31, 20X7 and 20X6
(in thousands)

20X7
20X6
Unrestricted revenues, gains and other support:
$ 85,156 $78,942
Net patient service revenue
Premium revenue
11,150 10,950
Other, primarily investment income
6,501
8,237
Net assets released from restrictions used for operations
300
103,107 98,129
Total revenues, gains and other support
Expenses:
53,900 49,938
Salaries and benefits
26,532 22,121
Medical supplies and drugs
Insurance
8,089
8,526
4,782
Depreciation and amortization
4,280
Interest
1,752
1,825
Allowance for bad debts
1,000
1,300
(500)
Loss from extinguishment of debt
Other
2,000
1,300
98,555 89,290
Total expenses
8,839
Excess of revenues, gains, and other support over expenses 4,552
Change in net unrealized gains and losses on
300
375
other than trading securities
Net assets released from restrictions used for
200
purchase of property and equipment
Change in interest in net assets of Sample
283
536
Hospital Foundation**
Transfers to parent
(688) (3,051)
$ 4,647 $ 6,699
Increase in unrestricted net assets
See accompanying notes to financial statements.
These illustrative financial statements include a presentation of an interest in the net assets
of a financially interrelated foundation that is based on the particular fact pattern described in Note
11 to the illustrative financial statements and the following additional facts:
• Sample Not-for-Profit Hospital can influence the financial decisions of Sample Hospital Foun
dation to such an extent that it can determine the timing and amount of distributions from
the Foundation. Thus, it is inappropriate for the Hospital to imply a time restriction on amounts
held by the Foundation.
• Contributions to Foundation are restricted by donors for property acquisitions. Those restrictions
have been met by the Hospital even though the net assets remain at the Foundation. Thus,
the net assets related to the interest in the Foundation are classified as unrestricted in the
Hospital’s financial statements.
• The Hospital’s policy is to report restricted revenues as unrestricted if the restriction is met
in the same period as the revenues are recognized.
Because the change in the interest in net assets of the foundation results from contributions restricted to
property acquisitions, this presentation shows the change in that interest reported separately from the
performance indicator, in the spirit of the guidance in paragraph 10.20 for contributions restricted to
property acquisitions. Readers should be aware that FASB Statement No. 136 is silent on this
classification. The AICPA has released a group of Technical Practice Aids (TPAs) (6400.36 through
6400.42) that address recognition of the interests in the net assets of financially interrelated
organizations and the classification of the changes in those interests. TPAs are nonauthoritative and are
not sources of established accounting principles as described in SAS No. 69, The Meaning of Present
Fairly in Conformity With Generally Accepted Accounting Principles.
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Sample Not-for-Profit Hospital
Statements of Changes in Net Assets
Years Ended December 31, 20X7 and 20X6
(in thousands)

20X7

20X6
Unrestricted net assets:
Excess of revenues over expenses
$ 4,552 $ 8,839
Net unrealized gains on investments, other
than trading securities
300
375
Change in interest in net assets of Sample
Hospital Foundation**
283
536
Transfers to parent
(688) (3,051)
Net assets released from restrictions used for
purchase of property and equipment
200
Increase in unrestricted net assets
4,647
6,699
Temporarily restricted net assets:
Contributions for charity care
140
996
Net realized and unrealized gains on investments
5
8
Net assets released from restrictions
(500)
Increase (decrease) in temporarily restricted net assets
(355) 1,004
Permanently restricted net assets:
Contributions for endowment funds
50
411
Net realized and unrealized gains on investments
5
2
Increase in permanently restricted net assets
55
413
Increase in net assets
4,347
8,116
Net assets, beginning of year
72,202 64,086
Net assets, end of year
$76,549 $72,202
See accompanying notes to financial statements.
These illustrative financial statements include a presentation of an interest in the net assets
of a financially interrelated foundation that is based on the particular fact pattern described in Note
11 to the illustrative financial statements and the following additional facts:
• Sample Not-for-Profit Hospital can influence the financial decisions of Sample Hospital Foun
dation to such an extent that it can determine the timing and amount of distributions from
the Foundation. Thus, it is inappropriate for the Hospital to imply a time restriction on amounts
held by the Foundation.
• Contributions to Foundation are restricted by donors for property acquisitions. Those restrictions
have been met by the Hospital even though the net assets remain at the Foundation. Thus,
the net assets related to the interest in the Foundation are classified as unrestricted in the
Hospital’s financial statements.
• The Hospital’s policy is to report restricted revenues as unrestricted if the restriction is met
in the same period as the revenues are recognized.
Because the change in the interest in net assets of the foundation results from contributions restricted to
property acquisitions, this presentation shows the change in that interest reported separately from the
performance indicator, in the spirit of the guidance in paragraph 10.20 for contributions restricted to
property acquisitions. Readers should be aware that FASB Statement No. 136 is silent on this
classification. The AICPA has released a group of Technical Practice Aids (TPAs) (6400.36 through
6400.42) that address recognition of the interests in the net assets of financially interrelated
organizations and the classification of the changes in those interests. TPAs are nonauthoritative and are
not sources of established accounting principles as described in SAS No. 69, The Meaning of Present
Fairly in Conformity With Generally Accepted Accounting Principles.
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Sample Not-for-Profit Hospital
Statements of Cash Flows (Indirect Method)
Years Ended December 31, 20X7 and 20X6
(in thousands)

20X 7

20X 6

Cash flows from operating activities:
Change in net assets
$ 4,347 $ 8,116
Adjustments to reconcile change in net assets to net
cash provided by operating activities:
500
Loss from extinguishment of debt
4,782
Depreciation and amortization
4,280
Net realized and unrealized gains on investments,
other than trading
(450)
(575)
Undistributed portion of change in interest in net
assets of Sample Hospital Foundation
(48)
(51)
688
Transfers to parent
3,051
Allowance for bad debts
1,000
1,300
Restricted contributions and investment
(290)
income received
(413)
(Increase) decrease in:
Patient accounts receivable
(1,906) (2,036)
Trading securities
215
186 (2,481)
Other current assets
Other assets
(277)
(190)
Increase (decrease) in:
436
Accounts payable and accrued expenses
679
Estimated third-party payor settlements
201
305
(145)
Other current liabilities
(257)
Other liabilities
787
(128)
10,026 11,600
Net cash provided by operating activities
Cash flows from investing activities:
Purchase of investments
(3,769) (2,150)
(4,728) (5,860)
Capital expenditures
Net cash used in investing activities
(8,497) (8,010)
Cash flows from financing activities:
(688) (3,051)
Transfers to parent
Proceeds from restricted contributions and
290
restricted investment income
413
(24,700)
(804)
Payments on long-term debt
(150)
Payments on capital lease obligations
(100)
22,600
Proceeds from issuance of long-term debt
500
(2,648) (3,042)
Net cash used in financing activities
Net (decrease) increase in cash and cash equivalents
(1,119)
548
Cash and cash equivalents, beginning of year
5,877
5,329
Cash and cash equivalents, end of year
$ 4,758 $ 5,877
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Supplemental Disclosures of Cash Flow Information:
The Hospital entered into capital lease obligations in the amount of $600,000
for new equipment in 20X7.
Cash paid for interest (net of amount capitalized) in 20X7 and 20X6 was
$1,780,000 and $1,856,000, respectively.
See accompanying notes to financial statements.
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Sample Not-for-Profit Hospital
Notes to Financial Statements
December 31, 20X7 and 20X6
1. Description of Organization and Summary of Significant Accounting
Policies1

Organization. The Sample Not-for-Profit Hospital (the Hospital), located in Tulsa,
Oklahoma, is a not-for-profit acute care hospital. The Hospital provides inpatient,
outpatient and emergency care services for residents of northeastern Oklahoma.
Admitting physicians are primarily practitioners in the local area. The Hospital was
incorporated in Oklahoma in 20X1 and is affiliated with the Sample Health System.
Use of estimates. The preparation of financial statements in conformity with
generally accepted accounting principles requires management to make esti
mates and assumptions that affect the reported amounts of assets and liabili
ties and disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of revenues and expenses during the
reporting period. Actual results could differ from those estimates.
Cash and cash equivalents. Cash and cash equivalents include certain in
vestments in highly liquid debt instruments with original maturities of three
months or less.
The Hospital routinely invests its surplus operating funds in money market
mutual funds. These funds generally invest in highly liquid U.S. government
and agency obligations.
Investments. Investments in equity securities with readily determinable fair
values and all investments in debt securities are measured at fair value in the
balance sheet. Investment income or loss (including realized gains and losses
on investments, interest and dividends) is included in the excess of revenues
over expenses unless the income or loss is restricted by donor or law. Unrealized
gains and losses on investments are excluded from the excess of revenues over
expenses unless the investments are trading securities.
Assets limited as to use. Assets limited as to use primarily include assets held
by trustees under indenture agreements and designated assets set aside by the
Board of Trustees for future capital improvements, over which the Board
retains control and may at its discretion subsequently use for other purposes.
Amounts required to meet current liabilities of the Hospital have been reclas
sified in the balance sheet at December 31, 20X7 and 20X6.
Property and equipment. Property and equipment acquisitions are recorded at
cost. Depreciation is provided over the estimated useful life of each class of
depreciable asset and is computed using the straight-line method. Equipment
under capital lease obligations is amortized on the straight-line method over the
shorter period of the lease term or the estimated useful life of the equipment. Such
amortization is included in depreciation and amortization in the financial state
ments. Interest cost incurred on borrowed funds during the period of construction
of capital assets is capitalized as a component of the cost of acquiring those assets.
Gifts of long-lived assets such as land, buildings, or equipment are reported
as unrestricted support, and are excluded from the excess of revenues over
expenses, unless explicit donor stipulations specify how the donated assets
1 Paragraph 13 of SOP 01-6, Accounting by Certain Entities (Including Entities With Trade
Receivables) That Lend to or Finance the Activities of Others, provides guidance on disclosures that
should be included in the summary of significant accounting policies, including accounting policies for
loans, trade receivables, and doubtful accounts.
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must be used. Gifts of long-lived assets with explicit restrictions that specify
how the assets are to be used and gifts of cash or other assets that must be used
to acquire long-lived assets are reported as restricted support. Absent explicit
donor stipulations about how long those long-lived assets must be maintained,
expirations of donor restrictions are reported when the donated or acquired
long-lived assets are placed in service.
Temporarily and permanently restricted net assets. Temporarily restricted
net assets are those whose use by the Hospital has been limited by donors to a
specific time period or purpose. Permanently restricted net assets have been
restricted by donors to be maintained by the Hospital in perpetuity.
Excess of revenues over expenses. The statement of operations includes excess
of revenues over expenses. Changes in unrestricted net assets which are excluded
from excess of revenues over expenses, consistent with industry practice, include
unrealized gains and losses on investments other than trading securities, perma
nent transfers of assets to and from affiliates for other than goods and services, and
contributions of long-lived assets (including assets acquired using contributions
which by donor restriction were to be used for the purposes of acquiring such assets).
Net patient service revenue. The Hospital has agreements with third-party
payors that provide for payments to the Hospital at amounts different from its
established rates. Payment arrangements include prospectively determined
rates per discharge, reimbursed costs, discounted charges, and per diem pay
ments. Net patient service revenue is reported at the estimated net realizable
amounts from patients, third-party payors, and others for services rendered,
including estimated retroactive adjustments under reimbursement agree
ments with third-party payors. Retroactive adjustments are accrued on an
estimated basis in the period the related services are rendered and adjusted in
future periods as final settlements are determined.
Premium revenue. The Hospital has agreements with various Health Main
tenance Organizations (HMOs) to provide medical services to subscribing par
ticipants. Under these agreements, the Hospital receives monthly capitation
payments based on the number of each HMO’s participants, regardless of
services actually performed by the Hospital. In addition, the HMOs make
fee-for-service payments to the Hospital for certain covered services based upon
discounted fee schedules.
Charity care. The Hospital provides care to patients who meet certain
criteria under its charity care policy without charge or at amounts less than its
established rates. Because the Hospital does not pursue collection of amounts
determined to qualify as charity care, they are not reported as revenue.
Donor-restricted gifts. Unconditional promises to give cash and other assets
to the Hospital are reported at fair value at the date the promise is received.
Conditional promises to give and indications of intentions to give are reported
at fair value at the date the gift is received. The gifts are reported as either
temporarily or permanently restricted support if they are received with donor
stipulations that limit the use of the donated assets. When a donor restriction
expires, that is, when a stipulated time restriction ends or purpose restriction
is accomplished, temporarily restricted net assets are reclassified as unre
stricted net assets and reported in the statement of operations as net assets
released from restrictions. Donor-restricted contributions whose restrictions
are met within the same year as received are reported as unrestricted contri
butions in the accompanying financial statements.
Estimated malpractice costs. The provision for estimated medical malprac
tice claims includes estimates of the ultimate costs for both reported claims and
claims incurred but not reported.
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Income taxes. The Hospital is a not-for-profit corporation and has been
recognized as tax-exempt pursuant to Sec. 501(c)(3) of the Internal Revenue Code.
2. Net Patient Service Revenue

The Hospital has agreements with third-party payors that provide for pay
ments to the Hospital at amounts different from its established rates. A
summary of the payment arrangements with major third-party payors follows:
• Medicare. Inpatient acute care services and outpatient services ren
dered to Medicare program beneficiaries are paid at prospectively deter
mined rates. These rates vary according to a patient classification system
that is based on clinical, diagnostic, and other factors. Inpatient nonacute
services and defined capital and medical education costs related to
Medicare beneficiaries are paid based on a cost reimbursement method
ology. The Hospital is reimbursed for cost reimbursable items at a
tentative rate with final settlement determined after submission of
annual cost reports by the Hospital and audits thereof by the Medicare
fiscal intermediary. Beginning in 20X3, the Hospital claimed Medicare
payments based on an interpretation of certain “disproportionate share”
rules. The intermediary disagreed and declined to pay the excess reim
bursement claimed under that interpretation. Through 1996, the Hospi
tal has not included the claimed excess in net patient revenues pending
resolution of the matter. In 20X7, the intermediary accepted the claims
and paid the outstanding claims, including $950,000 applicable to 20X6
and $300,000 applicable to 20X5 and prior, which has been included in
20X7 net revenues.
• Medicaid. Inpatient and outpatient services rendered to Medicaid
program beneficiaries are reimbursed under a cost reimbursement
methodology. The Hospital is reimbursed at a tentative rate with final
settlement determined after submission of annual cost reports by the
Hospital and audits thereof by the Medicaid fiscal intermediary.
Revenue from the Medicare and Medicaid programs accounted for approxi
mately XX percent and XX percent, respectively, of the Hospital’s net patient
revenue for the year ended 20X7, and XX percent and XX percent, respectively,
of the Hospital’s net patient revenue, for the year ended 20X6. Laws and
regulations governing the Medicare and Medicaid programs are extremely
complex and subject to interpretation. As a result, there is at least a reasonable
possibility that recorded estimates will change by a material amount in the
near term. The 20X6 net patient service revenue increased approximately
$XXX due to removal of allowances previously estimated that are no longer
necessary as a result of final settlements and years that are no longer subject
to audits, reviews, and investigations. The 20X7 net patient service revenue
decreased approximately $XXX due to prior-year retroactive adjustments in
excess of amounts previously estimated.
The Hospital also has entered into payment agreements with certain com
mercial insurance carriers, health maintenance organizations, and preferred
provider organizations. The basis for payment to the Hospital under these
agreements includes prospectively determined rates per discharge, discounts
from established charges, and prospectively determined daily rates.
3. Investments

Assets Limited as to Use
The composition of assets limited as to use at December 31, 20X7 and 20X6,
is set forth in the following table. Investments are stated at fair value.
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Internally designated for capital acquisition:
Cash
U.S. Treasury obligations
Interest receivable
Held by trustee under indenture agreement:
Cash and short-term investments
U.S. Treasury obligation
Interest receivable

20X7

20X6

$ 545,000 $ 350,000
11,435,000 12,115,000
20,000
35,000
12,000,000 12,500,000
352,000
260,000
6,505,000 7,007,000
92,000
74,000
6,949,000 7,341,000
$18,949,000 $19,841,000

Other Investments
Other investments, stated at fair value, at December 31, 20X7 and 20X6,
include:4
Trading:
U.S. Corporate Bonds
Other:
U.S. Treasury obligations
Interest receivable

20X7

20X6

$ 1,260,000 $ 1,475,000

$19,266,000 $14,233,000
310,000
232,000
20,836,000 15,940,000
Less:
Long-term investments
4,680,000 4,680,000
Long-term investments restricted for capital
acquisitions
320,000
520,000
Short-term investments
$15,836,000 $10,740,000
Investment income and gains for assets limited as to use, cash equivalents,
and other investments are comprised of the following for the years ending
December 31, 20X7 and 20X6:
Income:
Interest income
Realized gains on sales of securities
Unrealized gains on trading securities
Other Changes in Unrestricted Net Assets:
Unrealized gains on other than trading
securities

20X7

20X6

$3,585,000
150,000
165,000
$3,900,000

$2,725,000
200,000
100,000
$3,025,000

$ 300,000

$ 375,000

4. Property and Equipment

A summary of property and equipment at December 31, 20X7 and 20X6,
follows:
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20X7
20X6
$ 3,000,000 $ 3,000,000
472,000
472,000
46,852,000 46,636,000
29,190,000 26,260,000
2,851,000 2,752,000
82,365,000 79,120,000
Less accumulated depreciation and
34,928,000 30,661,000
amortization
47,437,000 48,459,000
3,601,000 2,033,000
Construction in progress
$51,038,000 $50,492,000
Property and equipment, net
Depreciation expense for the years ended December 31, 20X7 and 20X6
amounted to approximately $4,782,000 and $4,280,000. Accumulated amorti
zation for equipment under capital lease obligations was $689,000 and $453,000
at December 31, 20X7 and 20X6, respectively. Construction contracts of ap
proximately $7,885,000 exist for the remodeling of Hospital facilities. At
December 31, 20X7, the remaining commitment on these contracts approxi
mated $4,625,000.
Land
Land improvements
Buildings and improvements
Equipment
Equipment under capital lease obligations

5. Long-Term Debt

A summary of long-term debt and capital lease obligations at December 31,
20X7 and 20X6, follows:
20X7
20X6
7.25 percent 20X7 Tax-Exempt Revenue
Bonds, principal maturing in varying annual
amounts, due November 1, 20XX,
collateralized by a pledge of the Hospital’s
$21,479,000
gross receipts
8.50 percent 20X2 Tax-Exempt Revenue
Bonds, principal maturing in varying annual
$22,016,000
amounts, due June 1, 20XX
7.75 percent mortgage loan, principal
maturing in varying annual amounts, due
January 20XX, collateralized by a mortgage
2,010,000 2,127,000
on certain property and equipment
7.75 percent note payable, payable in monthly
installments of $12,000, including interest,
125,000
671,000
due March 20XX, unsecured
Capital lease obligations, at varying rates of
imputed interest from 6.8 percent to 9.3
950,000
1,000,000
percent collateralized by leased equipment
24,614,000 25,764,000
1,470,000 1,750,000
Less current portion
$23,144,000 $24,014,000
Under the terms of the 20X7 and 20X2 revenue bond indentures, the Hospital is
required to maintain certain deposits with a trustee. Such deposits are included
with assets limited as to use. The revenue note indenture also places limits on the
incurrence of additional borrowings and requires that the Hospital satisfy certain
measures of financial performance as long as the notes are outstanding.
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Scheduled principal repayments on long-term debt and payments on capital
lease obligations are as follows:
Long-Term Capital Leases
Year Ending
Obligations
Debt
December 31,
$ 970,000 $ 550,000
20X8
260,000
912,000
20X9
260,000
983,000
20Y0
45,000
1,060,000
20Y1
1,143,000
20Y2
18,546,000
Thereafter
—
$23,614,000
1,115,000
Less amount representing interest
115,000
under capital leases obligations
$1,000,000
—

A summary of interest cost and investment income on borrowed funds held
by the trustee under the 20X7 and 20X2 revenue bond indentures during the
years ended December 31, 20X7 and 20X6, follows:
20X7
20X6
Interest cost:
$ 740,000 $ 700,000
Capitalized
1,752,000 1,825,000
Charged to operations
$2,492,000 $2,525,000
Total
Investment income:
$ 505,000 $ 663,000
Capitalized
330,000
386,000
Credited to other revenue
$ 835,000 $1,049,000
Total
6. Temporarily and Perm anently Restricted Net Assets
Temporarily restricted net assets are available for the following purposes or
periods at December 31, 20X7 and 20X6:
20X6
20X7
Health care services
$ 320,000 $ 520,000
Purchase of equipment
950,000
840,000
Indigent care
350,000
400,000
Health education
605,000
600,000
For periods after December 31, 20X9
$2,115,000 $2,470,000
Permanently restricted net assets at December 31, 20X7 and 20X6, are
restricted to:
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Investments to be held in perpetuity, the income
from which is expendable to support health
care services (reported as operating income)
Endowment requiring income to be added to
original gift until fund value is $1,500,000

20X 7

20X 6

$2,973,000 $2,923,000
615,000
610,000
$3,588,000 $3,533,000
During 20X7, net assets were released from donor restrictions by incurring
expenses satisfying the restricted purposes of indigent care and health care
education in the amounts of $250,000 and $50,000, respectively.
7. Medical M alpractice Claims
The Hospital purchases professional and general liability insurance to cover
medical malpractice claims. There are known claims and incidents that may
result in the assertion of additional claims, as well as claims from unknown
incidents that may be asserted arising from services provided to patients. The
Hospital has employed independent actuaries to estimate the ultimate costs, if
any, of the settlement of such claims. Accrued malpractice losses have been
discounted at 7 percent and in management’s opinion provide an adequate
reserve for loss contingencies.
On March 15,20X7, a patient filed a suit against the Hospital for malpractice
during care received as an inpatient. The Hospital believes it has meritorious
defenses against the suit; however, the ultimate resolution of the matter could
result in a loss. The patient has claimed $16 million in actual damages. Under
state law, punitive damages are determined at trial. The Hospital maintains
insurance coverage for malpractice claims. The coverage does not include
punitive damages awards. Trial is scheduled to occur within the next year.
8. Pension and O ther Postretirem ent Benefit Plans2, †
[The follow in g p a ra g ra p h is encouraged bu t not required.]

The Hospital has a defined benefit pension plan covering substantially all of
its employees. The plan benefits are based on years of service and the employees’
2 The disclosures for pensions and other postretirement benefits in this note to the illustrative
financial statements have been modified to reflect the requirements of FASB Statement No. 132,
Employers’ Disclosures about Pensions and Other Postretirement Benefits (revised 2003). FASB
Statement No. 132 (revised 2003), is effective for fiscal years ending after December 15, 2003, with
certain exceptions. Interim-period disclosures are effective for interim periods beginning after De
cember 15, 2003. The provisions of FASB Statement No. 132 remain in effect until the provisions of
FASB Statement No. 132 (revised 2003), are adopted. This note to the financial statements illustrates
the financial statement disclosures about pension and postretirement benefit plans for a public
entity. Readers should refer to FASB Statement No. 132 (revised), when considering disclosure
requirements for nonpublic entities.
† Readers may also need to consider the accounting and disclosure requirements of FASB Staff
Position (FSP) No, 106-1, Accounting and Disclosure Requirements Related to the Medicare Prescrip
tion Drug, Improvement and Modernization Act of 2003, and FSP No. 106-2, Accounting and Disclo
sure Requirements Related to the Medicare Prescription Drug, Improvement and Modernization Act of
2003, when an employer provides postretirement prescription drug coverage. FSP No. 106-2, which
supersedes FSP No. 106-1, is effective, with exception for certain nonpublic entities, for the first
interim or annual period beginning after June 15, 2004. For a nonpublic entity, as defined in FASB
Statement No. 87, Employers’ Accounting for Pensions, that sponsors one or more defined benefit
postretirement health care plans that provide prescription drug coverage but of which no plan has
more than 100 participants, FSP No. 106-2 is effective for fiscal years beginning after December 15,
2004. Earlier application is encouraged.
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compensation during the last five years of covered employment. Contributions
are intended to provide not only for benefits attributed to service to date but
also for those expected to be earned in the future.
The Hospital also sponsors two defined benefit postretirement plans that
cover both salaried and nonsalaried employees. One plan provides medical and
dental benefits, and the other provides for the payment of life insurance
premiums. The postretirement health care plan is contributory, with retiree
contributions adjusted annually; the life insurance plan is noncontributory. The
accounting for the health care plan anticipates future cost-sharing changes to
the written plan that are consistent with the Hospital’s expressed intent to
increase retiree contributions each year to 50 percent of the excess of the
expected general inflation rate over 6 percent. Beginning in 20X7, the Hospital
adopted a funding policy for its postretirement health care plan similar to its
funding policy for its life insurance plan—an amount equal to a level percentage
of the employees’ salaries is contributed to the plan annually. For 20X7, that
percentage was 4.25, and the aggregate contribution for both plans was
$34,000. The Hospital uses a December 31 measurement date for its plans.
The following table sets forth the changes in benefit obligations, changes in
plan assets and components of net periodic benefit cost for both the pension
plan and the other postretirement benefit plans:
Pension Benefits Other Benefits
20X7
20X6 20X7 20X6
Change in benefit obligation:
Benefit obligation at beginning
$ 9,710 $ 9,700 $ 585 $ 500
of year
Service cost
905
770
14
15
Interest cost
700
650
50
44
Plan participants’ contributions
34
34
Actuarial gain
(20)
(7)
Benefits paid
(375) (1,410) (66)
(8)
Benefit obligation at end of year
9,710 610
10,920
585
Change in plan assets:
Fair value of plan assets at
beginning of year
9,610
89
40
9,800
Actual return on plan assets
4
759
810
4
Employer contribution
866
790
39
19
Plan participants’ contributions
34
34
Benefits paid
(375) (1,410) (66)
(8)
Fair value of plan assets at end
of year
11,050
9,800 100
89
Funded status
130
90 (510) (496)
Unrecognized net actuarial gain
(30)
(40) (30)
(40)
Unrecognized prior service cost
50
55
16
19
Unrecognized transition obligation
445
470
Unrecognized transition asset
(20)
(15)
Prepaid (accrued) benefit cost
$ 135 $ 85 $ (79) $ (47)
The accumulated benefit obligation for the defined benefit pension plan was
$XXX and $XXX at December 31, 20X7, and 20X6, respectively.
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Pension Benefits
Other Benefits
20X6 20X7
20X7
20X6
Components of net periodic
benefit cost:
$905
Service cost
700
Interest cost
(784)
Expected return on plan assets
5
Amortization of prior service cost
Recognized net actuarial (gain)
(5)
Amortization of transition
obligation
Amortization of transition asset
(5)
Net periodic benefit cost
$816

$ 770
650
(769)
7
(2)
(1)
$655

$14
50
(6)
3
(15)
25

$15
44
(3)
2
(1)
25

$71

$82

Additional Inform ation
Assumptions
W eighted-average assum ptions
used to determ ine benefit
obligations at December 31
7.00% 7.00%
7.00%
7.00%
Discount rate
6.00%
6.00%
Rate of compensation increase
W eighted-average assum ptions
used to determ ine net periodic
benefit cost for years ended
December 31
7.00% 7.00%
7.00%
7.00%
Discount rate
Expected long-term return on
8.00% 6.60%
6.60%
8.00%
plan assets
6.00%
6.00%
Rate of compensation increase
(Entity specific narrative description of the basis used to determine the overall
expected long-term rate of return on assets, as described in paragraph 5(d)(3) of
FASB Statement No. 132, Employers’ Disclosures about Pensions and Other
Postretirement Benefits (revised 2003), would be included here.)
Assumed health care cost trend
rates at December 31
Health care cost trend rate
7%
7%
assumed for next year
Rate to which the cost trend rate
is assumed to decline (the
5%
5%
ultimate trend rate)
Year that the rate reaches the
20Y2
20Y2
ultimate trend rate
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Assumed health care cost trend rates have a significant effect on the amounts
reported for the health care plans. A one-percentage-point change in assumed
health care cost trend rates would have the following effects:
1-Percentage- 1-PercentagePoint Increase Point Decrease
Effect on total of service and interest
cost
$13
$(11)
Effect on postretirement benefit obligation
73
(67)
Plan Assets

The composition of plan assets at December 31, 20X7, and 20X6, is as follows:
Pension Benefits Other Benefits
20X6
20X7
20X6 20X7
XX%
xx% xx%
xx%
Asset Category
XX
XX
XX
Equity securities
XX
XX
XX
XX
XX
Debt securities
XX
XX
XX
XX
Real estate
XX
XX
Other
XX
XX
100%
Total
100%
100% 100%
(Entity specific narrative description of investment policies and strategies for
plan assets, including weighted-average target asset allocations [if used as part
of those policies and strategies] as described in paragraph 5(d)(2) of FASB
Statement No. 132 (revised), would be included here.)
Cash Flows
Contributions

The Hospital expects to contribute $XXX to its pension plan and $XXX to its
other postretirement benefit plan in 20X8.
Estimated Future Benefit Payments

The following benefit payments, which reflect expected future service, as
appropriate, are expected to be paid:
Other
Pension
Benefits
Benefits
$xxx
$xxx
20X8
XXX
XXX
20X9
XXX
XXX
20Y0
XXX
XXX
20Y1
XXX
XXX
20Y2
XXX
XXX
Years 20Y3-20Y7
9. Concentrations of Credit Risk

The Hospital grants credit without collateral to its patients, most of whom
are local residents and are insured under third-party payor agreements. The
mix of receivables from patients and third-party payors at December 31, 20X7
and 20X6, was as follows:
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Medicare
Medicaid
Blue Cross
Other third-party payors
Patients

20X7
51%
17
18
7
7
100%

20X6
53%
14
17
9
7
100%

10. Commitments and Contingencies

Operating leases. The Hospital leases various equipment and facilities under
operating leases expiring at various dates through April 20Y2. Total rental
expense in 20X7 and 20X6 for all operating leases was approximately $859,000
and $770,000, respectively.
The following is a schedule by year of future minimum lease payments under
operating leases as of December 31, 20X7, that have initial or remaining lease
terms in excess of one year.
Year Ending
December 31,
Amount
$517,000
20X8
506,000
20X9
20Y0
459,000
20Y1
375,000
343,000
20Y2
Litigation. The Hospital is involved in litigation and regulatory investigations
arising in the course of business. After consultation with legal counsel, manage
ment estimates that these matters will be resolved without material adverse effect
on the Hospital’s future financial position or results from operations.
Allowance for doubtful accounts. Beginning in 20X5, the Hospital has provided
care under an agreement with Associated HMO. The HMO currently owes the
Hospital $950,000, substantially all of which is overdue. The Hospital has notified
the HMO that further services under the contract cannot be provided without
payment on the outstanding balance. The HMO has assured the Hospital that
additional funds are being obtained in order to pay the overdue balance and
continue service under the agreement, however, if the HMO is unable to make
payments, additional allowances for bad debts would need to be accrued.
11. Related Party Transactions

During the years ended December 31, 20X7 and 20X6, the Hospital contributed
capital to Sample Health System, an affiliate with some board members in common
with the Hospital, in the amounts of $688,000 and $3,051,000, respectively.
The Sample Hospital Foundation (the Foundation), which is controlled by
Sample Health System, was established to solicit contributions from the general
public solely for the funding of capital acquisitions by the Hospital. Funds are
distributed to the Hospital as determined by the Foundation’s Board of Directors.
A summary of the foundation’s assets, liabilities, net assets, results of operations,
and changes in net assets follows. The Hospital’s interest in the net assets of the
Foundation is reported as a non-current asset in the balance sheets.
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At December 31,
20X6
20X7
$521,000
$472,000
10,000
11,000
462,000
510,000
$472,000
$521,000
$535,000
$269,000

Assets, principally cash and cash equivalents
Liabilities
Unrestricted net assets
Total liabilities and net assets
Support and revenue
Expenses
Distributions to Sample Hospital for property
235,000
485,000
acquisitions
13,000
16,000
Other
501,000
248,000
Total expenses
34,000
21,000
Excess of support and revenue over expenses
17,000
27,000
Other changes in net assets
411,000
462,000
Unrestricted net assets, beginning of year
$462,000
$510,000
Unrestricted net assets, end of year
Liabilities include $10,000 payable at the end of each year to Sample Hospital.
These amounts were paid after the end of each year.
12. Functional Expenses

The Hospital provides general health care services to residents within its
geographic location. Expenses related to providing these services are as follows
(in thousands):13
At December 31,
20X7
20X6
$78,647
$86,000
Health care services
10,643
12,055
General and administrative
$89,290
$98,055
13. Fair Value of Financial Instruments

The following methods and assumptions were used by the Hospital in esti
mating the fair value of its financial instruments:
Cash and cash equivalents: The carrying amount reported in the
balance sheet for cash and cash equivalents approximates its fair value.
Investments: Fair values, which are the amounts reported in the
balance sheet, are based on quoted market prices, if available, or
estimated using quoted market prices for similar securities.
Assets limited as to use: These assets consist primarily of cash and
short-term investments and interest receivable. The carrying
amount reported in the balance sheet is fair value.
Accounts payable and accrued expenses: The carrying amount re
ported in the balance sheet for accounts payable and accrued ex
penses approximates its fair value.
Estimated third-party payor settlements: The carrying amount re
ported in the balance sheet for estimated third-party payor settle
ments approximates its fair value.
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Long-term debt: Fair values of the Hospital’s revenue notes are
based on current traded value. The fair value of the Hospital’s
remaining long-term debt is estimated using discounted cash flow
analyses, based on the Hospital’s current incremental borrowing
rates for similar types of borrowing arrangements.
The carrying amounts and fair values of the Hospital’s financial instru
ments at December 31, 20X7 and 20X6, are as follows (In thousands):1456
20X7
20X6
Carrying
Carrying
Amount Fair Value Amount Fair Value
Cash and cash
equivalents
Short-term investments
Assets limited as to use
Long-term investments
Long-term investments
restricted for capital
acquisition
Accounts payable and
accrued expenses
Estimated third-party
payor settlements
Long-term debt

$ 4,758
15,836
18,949
4,680

$ 4,758
15,836
18,949
4,680

$ 5,877
10,740
19,841
4,680

$ 5,877
10,740
19,841
4,680

320
5,818
2,143
24,614

320
5,818
2,143
23,980

520
5,382
1,942
25,764

520
5,382
1,942
24,918

14. Promises to Contribute

At December 31, 20X7, the Hospital had received $1,500,000 of conditional
promises to contribute to the building of a new facility for outpatient services.
These contributions will be recorded as temporarily restricted support when
received. The Hospital had no material outstanding unconditional promises of
support at December 31, 20X7.
15. Charity Care

The amount of charges foregone for services and supplies furnished under the
Hospital’s charity care policy aggregated approximately $4,500,000 and
$4,100,000 in 20X7 and 20X6, respectively.
16. Subsequent Event

On February 9, 20X8, the Hospital signed a contract in the amount of
$1,050,000 for the purchase of certain real estate.
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Illustrative Management's Discussion and Analysis and
Financial Statements

Sample Governmental Hospital Authority
A Component Unit of Feeling County, State of Union
Management’s Discussion and Analysis
Our discussion and analysis of Sample Hospital Authority’s (Authority’s)
financial performance provides an overview of the Authority’s financial activi
ties for the fiscal years ended December 31, 20X7 and 20X6. Please read it in
conjunction with the Authority’s financial statements, which begin on page
XXX. Unless otherwise indicated, amounts are in thousands.
Financial Highlights

• The Authority’s net assets increased in each of the past two years with
a $4,225 or 6.6 percent increase in 20X7 and a $9,460 or 17.4 percent
increase in 20X6.
• The Authority reported increased operating losses in both 20X7
($24,403) and 20X6 ($13,365). Losses in 20X7 increased by $11,038 or
82.6 percent over the loss reported in 20X6. Operating losses in 20X6
increased by $4,020 or 43.0 percent.
• Nonoperating revenues increased by $7,890 or 39.6 percent in 20X7
compared to 20X6. Nonoperating revenues also increased in 20X6 by
$1,139 or 6 percent compared to 20X5.

Using This Annual Report

The Authority’s financial statements consist of three statements—a Bal
ance Sheet; a Statement of Revenues, Expenses, and Changes in Net Assets;
and a Statement of Cash Flows. These financial statements and related notes
provide information about the activities of the Authority, including resources
held by the Authority but restricted for specific purposes by contributors,
grantors, or enabling legislation.
The Balance Sheet and Statement of Revenues, Expenses, and
Changes in Net Assets

Our analysis of the Authority finances begins on page XXX. One of the most
important questions asked about the Authority’s finances is, “Is the Authority
as a whole better or worse off as a result of the year’s activities?” The Balance
Sheet and the Statement of Revenues, Expenses, and Changes in Net Assets
report information about the Authority’s resources and its activities in a way
that helps answer this question. These statements include all restricted and
unrestricted assets and all liabilities using the accrual basis of accounting. All
of the current year’s revenues and expenses are taken into account regardless
of when cash is received or paid.
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These two statements report the Authority’s net assets and changes in them.
You can think of the Authority’s net assets—the difference between assets and
liabilities—as one way to measure the Authority’s financial health, or financial
position. Over time, increases or decreases in the Authority’s net assets are one
indicator of whether its financial health is improving or deteriorating. You will
need to consider other nonfinancial factors, however, such as changes in the
Authority’s patient base and measures of the quality of service it provides to
the community, as well as local economic factors to assess the overall health of
the Authority.
The Statement of Cash Flows

The final required statement is the Statement of Cash Flows. The statement
reports cash receipts, cash payments, and net changes in cash resulting from
operations, investing, and financing activities. It provides answers to such
questions as “Where did cash come from?” “What was cash used for?” and “What
was the change in cash balance during the reporting period?”

The Authority's Net Assets

The Authority’s net assets are the difference between its assets and liabili
ties reported in the Balance Sheet on page X. The Authority’s net assets
increased in each of the past two years by $4,225 (6.6 percent) in 20X7 and
$9,460 (17.4 percent) in 20X6, as you can see from Table 1.

Table 1: Assets, Liabilities, and Net Assets

Assets:
Current assets
Capital assets, net
Other noncurrent assets
Total assets
Liabilities:
Long-term liabilities
Other liabilities
Total liabilities
Net assets:
Invested in capital assets, net of
related debt
Restricted for debt service
Restricted expendable net assets
Restricted nonexpendable net
assets
Unrestricted
Total net assets

20X7
$32,382
43,382
25,118

20X6
$30,135
42,918
23,494

20X5
$26,070
42,445
19,767

100,882

96,547

88,282

23,033
9,690

23,102
9,511

24,349
9,459

32,723

32,613

33,808

22,460
1,945
1,845
3,003
38,906

21,018
2,005
2,100
2,919
35,892

18,649
2,035
2,075
2,652
29,063

$68,159

$63,934

$54,474

A significant component of the change in the Authority’s assets is the
increase in patient accounts receivable. Although operating revenues decreased
in 20X7 by $3,445 (5.7 percent), patient accounts receivable, net of estimated
uncollectible amounts, increased by $3,107 or 18.6 percent in 20X7. In addition,
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patient service revenue decreased by $2,105 in 20X6 compared to 20X5, but
receivables increased by $2,114 or 14.5 percent. In both cases, the increase in
accounts receivable is primarily the result of overall slowdowns by health
insurers in making payments in attempting to cut costs by managing their cash
flows.
Operating Results and Changes in The Authority's
Net Assets

In 20X7, the Authority’s net assets increased by $4,225 or 6.6 percent, as
shown in Table 2. This increase is made up of very different components. And
it represents a decline of 55.3 percent compared with the increase in net assets
for 20X6 of $9,460.

Table 2: Operating Results and Changes in Net Assets

O perating Revenues:
Net patient service revenues
Premium revenues
Other operating revenues
Total operating revenues
O perating Expenses:
Salaries and benefits
Medical supplies and drugs
Depreciation and amortization
Other operating expenses
Total operating expenses
O perating loss
N onoperating Revenues and
Expenses
Property taxes
Investment income
Noncapital grants and contributions
Other nonoperating revenues and
expenses, net
Total nonoperating
revenues (expenses)
Excess of revenues over
expenses before capital grants,
contributions, and additions to
perm anent endowments
Grants, Contributions, and
Endowments
Capital grants and contributions
Additions to permanent endowments
Increase in net assets
Net assets end of year

20X7
$43,305
9,876
3,416
56,597

20X6
$43,736
13,058
3,248
60,042

20X5
$45,841
12,976
2,910
61,727

46,845
12,746
4,065
17,344
81,000
(24,403)

43,235
7,986
3,638
18,548
73,407
(13,365)

40,640
6,788
3,508
20,136
71,072
(9,345)

23,895
5,653
170
(1,914)

15,309
5,304
853
(1,552)

14,875
5,108
510
(1,718)

27,804

19,914

18,775

3,401

6,549

9,430

824

2,560
351
$ 9,460
$63,934

1,980

$ 4,225
$68,159

$11,410
$ 4,474
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Operating Losses

The first component of the overall change in the Authority’s net assets is its
operating income (loss)—generally, the difference between net patient service
and Premium revenues and the expenses incurred to perform those services.
In each of the past two years, the Authority has reported an operating loss. This
is consistent with the Authority’s entire operating history. The Authority’s
hospital operations were begun in 19XX as a municipal hospital, when it was
agreed that a portion of its costs would be subsidized by property tax revenues,
making the facility more affordable for the County’s lower income residents.
However, in each of the past two years, operating losses have increased. Losses
in 20X7 increased by $11,038 or 82.6 percent higher than the loss reported in
20X6. Operating losses in 20X6 increased by $4,020 or 43.0 percent.
The primary components of these increased operating losses are:
• A decrease in premium revenue of $3,182 or 24.4 percent in 20X7.
(Premium revenues in 20X6 were roughly the same as in the previous
year.)
• Increases in salary and benefit costs for the hospital’s employees
($3,610 or 8.4 percent in 20X7 and $2,595 or 6.4 percent in 20X6).
• Increases in medical supply and drug costs of $4,760 or 59.6 percent
in 20X7 and of $1,198 or 17.6 percent in 20X6.
• An increase in the level of uncompensated care provided. These are
services provided for which there is no expectation of payment.
Premium revenues from contracts with health maintenance organizations
decreased in 20X7 primarily because of changes in the fixed amount per
individual per month (capitation rate) paid by the Acme Health Maintenance
Group. Acme is the HMO for the County’s largest employer, the XYZ Motor
Company. The Authority, (with the assistance of the County), negotiated a new
4-year contract with Acme in 20X6. Those negotiations resulted in a 15 percent
reduction in capitation rates in 20X7. Under the contract, capitation rates
increase by 3 percent each year for the next three years. At the same time, the
Authority (with the County’s approval) agreed to increase its property tax levy
by 10 percent, as discussed below.
Employee salary and benefits costs increased in 20X6 and again in 20X7
based on rates established in labor contracts negotiated in 20X5 and 20X6.
Current labor contracts for all of the Authority’s unionized employees extend
until 20Yl.
The rate of healthcare inflation has a direct effect on the cost of services
provided by the Authority. A component of the Authority’s costs are expenses
for medical supplies and prescription drugs. In 20X5, medical supplies and
prescription drug costs totaled $6.8 million. In 20X6, they totaled $8.0 million
or 10.7 percent of total expenses and an increase of 17.6 percent over 20X5.
And, in 20X7, medical supplies and prescription drug costs totaled $12.7
million, representing 15.6 percent of total expenses and an increase of 59.6
percent over 20X6. Some of the major factors contributing to the increased
medical supply and drug costs include the introduction of new drugs that cannot
be obtained in generic form, and changes in therapeutic mix. In addition, in
20X7, the company that the Authority used as its major wholesale drug supplier
filed for bankruptcy. The Authority negotiated new contracts with other sup
pliers at substantially higher costs. At its August 20X7 meeting, the Authority’s
Board of Trustees authorized management to explore other supplier options.
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The Authority sometimes provides care for patients who have little or no
health insurance or other means of repayment. As discussed, this service to the
community is consistent with the goals established for the Authority when it
was established in 19XX. The level of services provided to these patients
increased by $1,200 in 20X6 compared to 20X5. In 20X7, the costs of uncom
pensated care increased by $255. Because there is no expectation of repayment,
charity care is not reported as patient service revenues of the Authority.
Nonoperating Revenues and Expenses

Nonoperating revenues consist primarily of property taxes levied by the
Authority and interest revenue and investment earnings. During its negotia
tions with Acme and XYZ, discussed earlier, the Authority agreed—with the
County’s approval—to increase its property tax levy to County residents by 10
percent. County voters approved this increase in November 20X6. In addition,
a 35 percent increase in the sales of new homes in the County in 20X6 and 20X5
as well as additions of new commercial and manufacturing facilities resulted
in an increase in the County’s grand list. The grand list is calculated as of July
1 each year and used as the basis for tax levies on January 1. As a result of both
of these factors, nonoperating tax revenues increased by $8,586 or 56.1 percent
in 20X7 compared to a $434 (2.9 percent) increase in 20X6.
Grants, Contributions, and Endowments

The Authority receives both capital and operating grants from various state
and federal agencies for specific programs. These are discussed in detail in Note
2 to the financial statements. Capital and operating grants received in 20X7
from the State of Union declined due to fiscal/budgetary issues at the state from
$3,085 in 20X6 ($2,300 capital and $785 operating) to $800 in 20X7 ($650
capital and $150 operating). Although $1,640 in grants have been budgeted by
the state for the Authority in 20X8, it is not clear whether monies to fund these
grants will be appropriated.
The Authority received $351 in permanent endowments in 20X6 from the
ALAFoundation. Earnings from investing the principal of this endowment must
be used to support expenditures for Program A research. This is in contrast to
an increase in state funding of $580 in 20X6 compared to 20X5. The Authority
has received other permanent endowments in the past. Restrictions established
by these endowments are detailed in Note 2 to the financial statements.
The Authority's Cash Flows

Changes in the Authority’s cash flows are consistent with changes in
operating losses and nonoperating revenues and expenses, discussed earlier,
with one exception. Cash flows used by operating activities increased slightly
more than operating losses in both 20X7 and 20X6 due to increases in the
Authority’s patient accounts receivable, discussed earlier.
Capital Asset and Debt Administration
Capital Assets

At the end of 20X7, the Authority had $43.3 million invested in capital
assets, net of accumulated depreciation, as detailed in Note 7 to the financial
statements. In 20X7, the Authority purchased new equipment costing $4,529.
Of this, $510 was acquired through capital leases. Nearly the same amount—
$4,111—was spent to acquire new equipment in 20X6. Both of these amounts
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are less than 20X5, when the Authority spent $7,308 for new equipment. The
Authority has recently found it more economical to lease much of its equipment.
This allows the Authority to avoid some of the costs of obsolescence caused by
technological changes.
In August 20X5, the Authority’s Board of Trustees approved a resolution
setting aside $15 million of its unrestricted net assets for future expansion of
the hospital and possible addition of a cancer care wing. The Board of Trustees
held a special meeting in September 20X7 to reconsider the feasibility of the
project and held initial meetings with several local architectural firms in
January 20X8. No decisions have been reached as of the date of this annual
report.
Debt

At year-end, the Authority had $20.9 in revenue notes, mortgage loans, and
capital lease obligations outstanding as detailed in Note 8 to the financial
statements. Except for capital leases of $510 initiated in 20X7, the Authority
issued no new debt in 20X7 or 20X6. The Authority’s formal debt issuances—
revenue notes—cannot be issued without approval of the Feeling County Board
of Commissioners. The amount of debt issued is subject to limitations that apply
to the County and its component units as a whole. There have been no changes
in the Authority’s debt ratings in the past two years.
Other Economic Factors

The County’s largest employer, the XYZ Motor Company, has a number of
operating plants throughout the country. In late 20X5, XYZ announced that it
would close its plant in New City, Ohio and move the majority of that plant’s
operations (including up to 2,000 full-time employees) to its Feeling County
plant. Work on that move began in May 20X6.
Contacting The Authority's Financial Management

This financial report is designed to provide our patients, suppliers, taxpay
ers, and creditors with a general overview of the Authority’s finances and to
show the Authority’s accountability for the money it receives. If you have
questions about this report or need additional financial information, contact
the Authority Controller’s Office, at Sample Hospital Authority, 92 Third
Street, Anytown, UN 01000.
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ILLUSTRATIVE FINANCIAL STATEMENTS
FOR A GOVERNMENTAL HOSPITAL AUTHORITY
Sample Governmental Hospital Authority
A Component Unit of Feeling County, State of Union
Balance SheetsA
December 31, 20X7 and 20X6
(in thousands)

Assets
Current assets:
Cash and cash equivalents
Short-term investments
Patient accounts receivable, net of estimated
uncollectibles of $2,125 (20X7) and $2,040
(20X6)
Supplies and other current assets
Total current assets
Noncurrent cash and investments:
Internally designated for capital acquisitions
Other long-term investments
Held by trustee for debt service
Restricted by contributors and grantors for
capital acquisitions and research
Principal of permanent endowments
Delinquent property taxes
Capital Assets:
Land
Depreciable capital assets, net of accumulated
depreciation
Total capital assets, net of accumulated
depreciation
Other assets
Total assets

20X7

20X6

$ 7,136
3,142

$ 7,557
3,423

19,834
2,270
32,382

16,727
2,428
30,135

15,000
2,605
1,945
1,124
3,003
385

15,000
1,327
2,005
1,078
2,919
229

3,590
39,792
43,382
1,056
$100,882

3,590
39,328
42,918
936
$96,547
(continued)

A As discussed in paragraph 1.17 in this Guide, either a balance sheet or a statement of net
assets format may be used.
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Liabilities and Net Assets
Current liabilities:
Current maturities of long-term debt
Accounts payable and accrued expenses
Estimated third-party payor settlements
Other current liabilities
Total current liabilities
Long-term debt, net of current maturities
Other long-term liabilities
Total liabilities
Net Assets:B
Invested in capital assets net of related debt
Restricted:
For debt service
Expendable for capital acquisitions
Expendable for research
Expendable for specific operating activities
Nonexpendable permanent endowments
Unrestricted
Total net assets
Total liabilities and net assets
See accompanying notes to financial statements.

20X7

20X6

$ 1,250
4,945
1,822
1,673
9,690
19,672
3,361
32,723

$ 1,488
4,575
1,651
1,797
9,511
20,412
2,690
32,613

22,460
1,945
733
781
331
3,003
38,906
68,159
$100,882

21,018
2,005
628
899
573
2,919
35,892
63,934
$96,547

B As discussed in paragraph 1.18 in this Guide, either “net assets” or “equity” may be used as
the label for the difference between assets and liabilities.
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Sample Governmental Hospital Authority
A Component Unit of Feeling County, State of Union
Statements of Revenues, Expenses, and Changes in Net Assetsc
Years Ended December 31, 20X7 and 20X6
(in thousands)

Operating revenues:
Net patient service revenue (net of provision
for bad debts of $859 in 20X7 and $938 in 20X6)
Premium revenue
Other
Total operating revenues
Operating expenses:
Salaries and benefits
Medical supplies and drugs
Insurance
Other supplies
Depreciation and amortization
Total operating expenses
Operating loss
Nonoperating revenues (expenses):
Property taxes
Investment income
Interest expense
Noncapital grants and contributions
Other
Total nonoperating revenues (expenses)
Excess of revenues over expenses before
capital grants, contributions, and
additions to permanent endowments
Capital grants and contributions
Additions to permanent endowments
Increase in net assets
Net assets beginning of the year
Net assets end of the year
See accompanying notes to financial statements.

20X7

20X6

$43,305
9,876
3,416
56,597

$43,736
13,058
3,248
60,042

46,845
12,746
7,030
10,314
4,065
81,000
(24,403)

43,235
7,986
7,382
11,166
3,638
74,407
(13,365)

23,895
5,653
(1,489)
170
(425)
27,804

15,309
5,304
(1,552)
853

3,401
824
—
4,225
63,934
$68,159

6,549
2,560
351
9,460
54,474
$63,934

—

19,914

c As discussed in paragraph 1.20 of this Guide, GASB Statement No. 34, paragraph 101,
requires proprietary funds and special purpose governments engaged only in business-type activities
to present an operating statement that uses an “all-inclusive” format, presenting all changes in both
restricted and unrestricted net assets and presenting a final total, “Increase (decrease) in net
assets/equity.” As discussed in paragraph 1.18 of this Guide, governmental healthcare entities may
use either the term “net assets” or “equity” as a label for the difference between assets and liabilities.
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Sample Governmental Hospital Authority
A Component Unit of Feeling County, State of Union
Statements of Cash Flows
Years Ended December 31, 20X7 and 20X6
(in thousands)

Cash flows from operating activities:
Receipts from and on behalf of patients
Payments to suppliers and contractors
Payments to employees
Other receipts and payments, net
Net cash provided by operating activities
Cash flows from noncapital financing
activities:
Property taxes
Noncapital grants and contributions
Contributions to permanent endowments
Other
Net cash provided by noncapital financing
activities
Cash flows from capital and related
financing activities:
Capital grants and contributions
Property taxes restricted to capital acquisitions
Principal paid on long-term debt
Interest paid on long-term debt
Purchase of capital assets
Net cash used by capital and related
financing activities
Cash flows from investing activities:
Interest and dividends on investments
Purchases of investments
Proceeds from sale of investments
Net cash provided by investing activities
Net increase (decrease) in cash and cash
equivalents

AAG-HCO APP A

20X7
$50,074
(30,029)
(46,955)
4,591
(22,319)

20X6
$54,680
(26,634)
(43,460)
3,597
(11,817)

20,739
170
(425)

12,224
853
351
—

20,484

13,428

824
3,000
(1,488)
(1,489)
(4,019)

2,560
3,000
(1,896)
(1,552)
(4,111)

(3,172)

(1,999)

2,737
(1,045)
2,327
4,019

2,124
(289)
683
2,518

(988)

2,130
(continued)

—

215

Illustrative Financial Statements

Cash and cash equivalents, beginning of year
Cash and cash equivalents, end of year
Reconciliation of cash and cash equivalents to
the statement of net assets:
Cash and cash equivalents in current assets
Restricted cash and cash equivalents
Total cash and cash equivalents
Reconciliation of operating income (loss) to net
cash provided (used) by operating activities:
Operating loss
Adjustments to reconcile operating income to
net cash flows used in operating activities:
Depreciation and amortization
Provision for bad debts
Changes in:
Patient accounts receivable
Supplies and other current assets
Other assets
Accounts payable, accrued expenses, and
other current liabilities
Estimated third-party payor settlements
Other liabilities related to operating activities
Net cash used in operating activities

20X7
9,101
$ 8,113

20X6
6,971
$ 9,101

7,136
977
$ 8,113

7,557
1,544
9,101
$

($24,403) ($13,365)
4,065
3,638
859
938
(3,966)
(2,909)
158
100
(120)
246
(225)
171
(235)
671
241
($22,319) ($11,817)
—

Noncash Investing, Capital, and Financing Activities:
The Authority entered into capital lease obligations of $510,000 for new
equipment in 20X7.
The Authority held investments at December 31, 20X7 with a fair value of
$XXX. During 20X7, the net increase in the fair value of these investments
was $XXX.
See accompanying notes to financial statements.
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Sample Governmental Hospital Authority
A Component Unit of Feeling County, State of Union
Notes to Financial StatementsD
December 3 1 ,20X7 and 20X6
(in thousands)
1. Description of Reporting Entity and Summary of Significant
Accounting Policies

Reporting entity. The Sample Hospital Authority (the Authority) is a public
corporation. It was created on January 1, 19XX, by the Board of County
Commissioners of Feeling County, State of Union, to operate, control, and
manage all matters concerning the County’s health care functions. The Board
of County Commissioners appoints the Board of Trustee members of the
Authority, and the Authority may not issue debt or levy taxes without the
county’s approval. For this reason, the Authority is considered to be a compo
nent unit of Feeling County and is included as a discretely presented component
unit in the basic financial statements of the County.
Use of estimates. The preparation of financial statements in conformity with
generally accepted accounting principles requires management to make esti
mates and assumptions that affect the reported amounts of assets and liabili
ties and disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of revenues and expenses during the
reporting period. Actual results could differ from those estimates.
Enterprise fund accounting. The Authority uses enterprise fund accounting.
Revenues and expenses are recognized on the accrual basis using the economic
resources measurement focus. Based on Governmental Accounting Standards
Board (GASB) Statement No. 20, Accounting and Financial Reporting for
Proprietary Funds and Other Governmental Entities That Use Proprietary
Fund Accounting, as amended, the Authority has elected to apply the provisions
of all relevant pronouncements of the Financial Accounting Standards Board
(FASB), including those issued after November 30, 1989, that do not conflict
with or contradict GASB pronouncements.
Cash and cash equivalents. Cash and cash equivalents include investments
in highly liquid debt instruments with an original maturity of three months or
less.
Capital assets. The Authority’s capital assets are reported at historical cost.
Contributed capital assets are reported at their estimated fair value at the time
of their donation. All capital assets other than land are depreciated or amor
tized (in the case of capital leases) using the straight-line method of deprecia
tion using these asset lives:
Land improvements
15 to 20 years
Buildings and building improvements
20 to 40 years
Equipment, computers, and furniture
3 to 7 years
Costs of borrowing. Except for capital assets acquired through gifts, contri
butions, or capital grants, interest cost on borrowed funds during the period of
D The notes to the financial statements in these illustrative financial statements generally
include only disclosures unique to a governmental hospital. The disclosures regarding the accounting
policies for the use of estimates and cost of borrowing in note 1; and charity care in note 5 are not
unique to a governmental hospital. Also, the notes to the financial statements include disclosures
that are not required.
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construction of capital assets is capitalized as a component of the cost of
acquiring those assets. None of the Authority’s interest cost was capitalized in
either 20X7 or 20X6.
Property taxes. The Authority received approximately 29 percent in 20X7
and 19 percent in 20X6 of its financial support from property taxes. These funds
were used as follows:
20X7
20X6
Used to support operations
$20,895 $12,309
Levied for debt service
3,000
3,000
Property taxes are levied by the County on the Authority’s behalf on January
1 and are intended to finance the Authority’s activities of the same calendar
year. Amounts levied are based on assessed property values as of the preceding
July 1.
Property taxes are considered delinquent on the day following each payment
due date.
Grants and contributions. From time to time, the Authority receives grants
from Feeling County and the State of Union as well as contributions from
individuals and private organizations. Revenues from grants and contributions
(including contributions of capital assets) are recognized when all eligibility
requirements, including time requirements are met. Grants and contributions
may be restricted for either specific operating purposes or for capital purposes.
Amounts that are unrestricted or that are restricted to a specific operating
purpose are reported as nonoperating revenues. Amounts restricted to capital
acquisitions are reported after nonoperating revenues and expenses.
Endowments. Endowments are provided to the Authority on a voluntary
basis by individuals and private organizations. Permanent endowments require
that the principal or corpus of the endowment be retained in perpetuity. If a
donor has not provided specific instructions, Union state law permits the
Authority’s Board of Trustees to authorize for expenditure the net appreciation
of the investments of endowment funds, as discussed in Note 2.
Restricted resources. When the Authority has both restricted and unre
stricted resources available to finance a particular program, it is the Authority’s
policy to use restricted resources before unrestricted resources.
Net assets. Net assets of the Authority are classified in four components. Net
assets invested in capital assets net of related debt consist of capital assets net
of accumulated depreciation and reduced by the current balances of any
outstanding borrowings used to finance the purchase or construction of those
assets. Restricted expendable net assets are noncapital net assets that must be
used for a particular purpose, as specified by creditors, grantors, or contributors
external to the Authority, including amounts deposited with trustees as re
quired by revenue bond indentures, discussed in Note 8. Restricted nonexpend
able net assets equal the principal portion of permanent endowments.
Unrestricted net assets are remaining net assets that do not meet the definition
of invested in capital assets net of related debt or restricted.
Operating revenues and expenses. The Authority’s statement of revenues,
expenses and changes in net assets distinguishes between operating and
nonoperating revenues and expenses. Operating revenues result from exchange
transactions associated with providing health care services—the Authority’s
AAG-HCO APP A

218

Health Care Organizations

principal activity. Nonexchange revenues, including taxes, grants, and contri
butions received for purposes other than capital asset acquisition, are reported
as nonoperating revenues. Operating expenses are all expenses incurred to
provide health care services, other than financing costs.
Compensated absences. The Authority’s employees earn vacation days at
varying rates depending on years of service. Vacation time does not accumulate.
Generally, any days not used at year-end expire. Employees also earn sick leave
benefits based on varying rates depending on years of service. Employees may
accumulate sick leave up to a specified maximum. Employees are not paid for
accumulated sick leave if they leave before retirement. However, employees
who retire from the Authority may convert accumulated sick leave to termina
tion payments at varying rates, depending on the employee’s contract. The
estimated amount of sick leave payable as termination payments is reported
as a noncurrent liability in both 20X7 and 20X6.
Risk management. The Authority is exposed to various risks of loss from
torts; theft of, damage to, and destruction of assets; business interruption;
errors and omissions; employee injuries and illnesses; natural disasters; medi
cal malpractice; and employee health, dental, and accident benefits. Commer
cial insurance coverage is purchased for claims arising from such matters.
Settled claims have not exceeded this commercial coverage in any of the three
preceding years.
Investments in debt and equity securities. Investments in debt and equity
securities are reported at fair value except for short-term highly liquid invest
ments that have a remaining maturity at the time they are purchased of one
year or less. These investments are carried at amortized cost. Interest, divi
dends, and gains and losses, both realized and unrealized, on investments in
debt and equity securities are included in nonoperating revenue when earned.
2. Endowments and Restricted Net Assets

Restricted, expendable net assets are available for the following purposes:
Program A activities:
Purchase of equipment
Research
General
Program B activities:
Purchase of equipment
Research
General
Program C activities:
General
Buildings and equipment
Research
Total expendable, restricted net assets

20X7

20X6

$ 404
553
46
235
184
79
206
94
44
$1,845

$ 321
683
63
235
151
110
400
72
65
$2,100

Unless the contributor provides specific instructions, Union state law permits
the Authority Board of Trustees to authorize for expenditure the net appre
ciation (realized and unrealized) of the investments in its endowments. When
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administering its power to spend net appreciation, the Board of Trustees is
required to consider the Authority’s “long- and short-term needs, present
and anticipated financial requirements, expected total return on its invest
ments, price-level trends, and general economic conditions.” Any net appre
ciation that is spent is required to be spent for the purposes designated by
the contributor.
The Board of Trustees chooses to spend only a portion of the investment
income (including changes in the value of investments) each year. Under the
policy established by the Board, 5 percent of the average market value of
endowment investments at the end of the previous three years has been
authorized for expenditure. The Authority retains the remaining amount, if
any, to be used in future years when the amount computed using the spending
policy exceeds investment income. At December 31, 20X7 and 20X6, net
appreciation of $864 and $953, respectively, is available to be spent, of which
$402 and $682, respectively, is reported as restricted expendable net assets,
and the balance is in unrestricted net assets.
Restricted nonexpendable net assets as of December 31, 20X7 and 20X6,
represent the principal amounts of permanent endowments, restricted to
investment in perpetuity. Investment earnings from the Authority’s permanent
endowments are expendable to support these programs as established by the
contributor:
20X7
20X6
Program A activities
$ 158
$ 158
Program B activities
176
176
Program C activities
423
423
854
854
Any activities of the Authority
1,611
1,611
Endowment requiring income to be
added to original gift until the fund’s
value is $2,125
1,392
1,308
Total restricted nonexpendable net assets 3,003
2,919
3. Designated Net Assets
Of the $40,851 and $37,897 of unrestricted net assets reported in 20X7 and
20X6, respectively, $15,000 has been designated by the Authority’s Board of
Trustees for capital acquisitions. Designated funds remain under the control
of the Board of Trustees, which may at its discretion later use the funds for
other purposes.
4. Deposits and Investm ents‡
State law requires collateralization of all deposits with federal depository
insurance and other acceptable collateral in specific amounts. The Authority’s
bylaws require that all bank balances be insured or collateralized by U.S.
government securities held by the pledging financial institution’s trust depart
ment in the name of the Authority.
‡ GASB Statement No. 40, Deposit and Investment Risk Disclosures, an amendment of GASB
Statement No. 3, Deposits with Financial Institutions, Investments (Including Repurchase Agree
ments), and Reverse Repurchase Agreements, establishes and modifies disclosure requirements for
deposit risks and investment risks. The provisions of GASB Statement No. 40 are effective for
financial statements for periods beginning after June 15, 2004. Earlier application is encouraged.
Conforming changes to reflect the issuance of GASB Statement No. 40 will be made in a future
edition of this Guide.
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At December 31, 20X7 and 20X6, the Authority had bank balances as follows:
20X7
20X6
Insured (FDIC)
$3,687
$5,677
Collateralized by securities held by the
pledging financial institution’s trust
1,153
300
department in the Authority’s name
Uninsured, uncollateralized or collateralized
by securities held by the pledging
institution or by its trust department or
agent in other than the Authority’s name
Total
$4,840
$5,977
Carrying amount
$5,021
$6,539
Statutes authorize the Authority to invest in obligations of the U.S. Treasury,
agencies, and instrumentalities, commercial paper rated A-1 by Standard &
Poor’s Corporation or P-1 by Moody’s Commercial Paper Record, and bankers’
acceptances. However, the Authority’s bylaws require that investments be
made only in U.S. government obligations held by the Authority’s third-party
agent.
The Authority’s investments generally are reported at fair value, as discussed
in Note 1. At December 31, 20X7 and 20X6, the Authority’s investments
consisted of the following, all of which were held in the Authority’s name by a
custodial bank that is an agent of the Authority:
20X7
20X6
$21,774 $20,039
U.S. Treasury Obligations
7,160
6,731
U.S. Government Agency Securities
$28,934 $26,770
The carrying amounts of deposits and investments shown above are included
in the Authority’s balance sheets as follows:
20X7
20X6
Carrying amount
$ 5,021 $ 6,539
Deposits
28,934
26,770
Investments
$33,955 $33,309
Included in the following balance sheet captions
$ 7,136 $ 7,557
Cash and cash equivalents
3,423
3,142
Short-term investments
Noncurrent cash and investments:
1,327
2,605
Other long-term investments
Restricted by contributors and grantors for
1,124
1,078
capital acquisitions and research
15,000
15,000
Internally designated for capital acquisitions
2,005
1,945
Held by trustee for debt service
2,919
3,003
Principal of permanent endowments
$33,955 $33,309
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5. Charity Care
Charges excluded from revenue under the Authority’s charity care policy were
$7,100 and $6,845 for 20X7 and 20X6, respectively.
6. Accounts Receivable and Payable
Patient accounts receivable and accounts payable (including accrued ex
penses) reported as current assets and liabilities by the Authority at December
31, 20X7 and 20X6 consisted of these amounts:
Patient Accounts Receivable
20X7
20X6
Receivable from patients and their
$13,976 $11,868
insurance carriers
3,002
4,286
Receivable from Medicare
3,697
3,897
Receivable from Medicaid
21,959
18,767
Total patient accounts receivable
2,040
Less allowance for uncollectibles amounts
2,125
$19,834 $16,727
Patient accounts receivable, net
Accounts Payable and Accrued Expenses
20X7
20X6
$2,437
$1,970
Payable to employees (including payroll taxes)
2,481
2,591
Payable to suppliers
Other
27
14
Total accounts payable and accrued
$4,945
$4,575
expenses
7. Capital Assets
Capital asset additions, retirements, and balances for the years ended De
cember 31, 20X7 and 20X6 were as follows:
Balance
December 31,
20X6
Additions
LandE
$ 3,590
Land improvements
17
645
Buildings and
improvements
29,265
965
Equipment
3,547
30,375
Totals at historical cost
$4,529
$63,875
Less accumulated
depreciation for:
(291)
Land improvements
(65)
Buildings and
improvements
(5,352)
(582)
Equipment
(15,314)
(3,418)
Total accumulated
depreciation
(20,957)
(4,065)
Capital assets, net
$42,918
$ 464

Balance
December 31,
20X7
$ 3,590
662
—
(810)
29,420
32,062
(1,860)
$65,734
($2,670)

Retire
ments

—
810
1,860
2,670
$ 0

(356)
(5,124)
(16,872)
(22,352)
$43,382

E When present, construction-in-progress should be reported in a separate line in this schedule.
(See the GASB staff document Comprehensive Implementation Guide—2003, item 7.353). See para
graph 1.11 in this Guide regarding references to GASB staff Implementation Guides. Also, GASB
Statement No. 34, paragraph 20, requires non-depreciable capital assets to be shown separately on
the face of the balance sheet when these balances are significant.
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Balance
December 31,
Additions
20X5
Land
Land improvements
Buildings and
improvements
Equipment
Totals at historical cost
Less accumulated
depreciation for:
Land improvements
Buildings and
improvements
Equipment
Total accumulated
depreciation
Capital assets, net

$ 3,590
608

112

29,187
26,710
$60,095

Balance
December 31,
20X6

Retire
ments
(75)

$ 3,590
645

78
3,921
$4,111

(256)
($331)

29,265
30,375
$63,875

(309)

(57)

75

(291)

(4,826)
(12,515)

(526)
(3,055)

(17,650)
$42,445

(3,638)
$ 473

_

__

$

256

(5,352)
(15,314)

331
0

(20,957)
$42,918

8. Long-Term Debt and O ther N oncurrent Liabilities
A schedule of changes in the Authority’s noncurrent liabilities for 20X7 and
20X6 follows:
Bonds and
Notes Payable:
Revenue notes
Mortgage loan
Note payable
Total long-term
debt
Capital lease
obligations
Other
Liabilities:
Compensated
absences
Net pension
obligation
Total other
liabilities
Total
noncurrent
liabilities
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Balance
Balance
December 31,
December 31,
20X7
20X6
Additions Reductions
$18,714
1,808
570

—
—

21,092

Amounts
Due Within
One Year

($457)
(99)
(464)

$18,257
1,709
106

$620
99
106

(1,020)

20,072

825
425

808

510

(468)

850

2,625

662

(6)

3,281

65

15

2,690

677

(6)

3,361

$24,590

$1,187

($1,494)

$24,283

_

80

See
Note 9

$1,250
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Bonds and
Notes Payable:
Revenue notes
Mortgage loan
Note payable
Total long-term
debt
Capital lease
obligations
Other
Liabilities:
Compensated
absences
Net pension
obligation
Total other
liabilities
Total
noncurrent
liabilities

Balance
Balance
December 31,
December 31,
20X6
Additions Reductions
20X5

Amounts
Due Within
One Year

18,714
1,808
570
21,092
808

457
99
464
1,020
468

19,568
1,907
1,045
22,520
1,276

—
—

__
__

2,400
49
2,449

236
16
252

$26,245

$ 252

(854)
(99)
(475)
(1,428)
(468)

( 11)

2,625
65
2,690

($1,907)

$24,590

( 11)

See
Note 9
$1,488

Long-term debt. The terms and due dates of the Authority’s long-term debt,
including capital lease obligations, at December 31, 20X7 and 20X6, follow:
• 7.25 percent Revenue Notes, due November 1, 20Z7, collateralized by
a pledge of the Authority’s gross receipts. Thus all operating and
nonoperating revenues of the authority are similarly pledged.
• 9.25 percent mortgage loan, due January 20Y4, collateralized by a
mortgage on property and equipment with a depreciated cost of $1,530
at December 31, 20X7
• 9.75 percent note payable, due March 20X8, unsecured
• Capital lease obligations, at varying rates of imputed interest from 9.8
percent to 12.3 percent collateralized by leased equipment with cost
of $1,275 at December 31, 20X7
Under the terms of the Revenue Note Indenture, the Authority is required to
maintain certain deposits with a trustee. Such deposits are included with
restricted cash and investments in the balance sheet. The Revenue Note
Indenture also places limits on the incurrence of additional borrowings and
requires that the Authority satisfy certain measures of financial performance
as long as the notes are outstanding.
Scheduled principal and interest repayments on long-term debt and pay
ments on capital lease obligations are as follows:
_____ Long-term Debt_____ Capital Lease Obligations
Year Ending
December 31:
Principal
Interest
Principal
Interest
20X8
$ 825
$ 553
$425
$58
20X9
775
487
213
27
20Y0
836
212
13
465
20Y1
900
448
20Y2
972
432
20Y3 to 20Y7
5,764
1,769
20Y8 to 20Z2
4,824
1,492
20Z3 to 20Z7
5,176
1,116
Total
$20,072
$6,762
$850
$98
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Commitments under Noncancelable Operating Leases

The Authority is committed under various noncancelable operating leases, all
of which are for equipment and computers. These expire in various years
through 20Y9. Future minimum operating lease payments are as follows:
Year ending December 31:
20X8
$3,109
20X9
2,898
20Y0
2,795
20Y1
2,780
20Y2
2,575
20Y3-20Y7
4,215
20Y8-20Y9
1,065
Total
$19,437
10. Pension PlanF

Plan description. Sample Hospital Pension Plan (SHPP) provides retirement
and disability benefits, annual cost-of-living adjustments, and death benefits
to plan members and beneficiaries. SHPP is affiliated with County Employees
Pension Plan (CEPP), an agent multiple-employer pension plan administered
by the Union Retirement System. Article 39 of the Regulations of the State of
Union assigns the authority to establish and amend the benefit provisions of
the plans that participate in CEPP to the respective employer entities; for
CEPP, that authority rests with the County of Feeling, Union. The Union
Retirement System issues a publicly available financial report that includes
financial statements and required supplementary information for SHPP. That
report may be obtained by writing to Union Retirement System, State Govern
ment Lane, Anytown, Union 01000 or by calling 1-800-555-PLAN.
Funding policy. The contribution requirements of plan members and the
Authority are established and may be amended by the CEPP Board of Trustees.
Plan members are required to contribute 7.8 percent oftheir annual covered salary.
The Authority is required to contribute at an actuarially determined rate; the
current rate for both 20X7 and 20X6 is 11.9 percent of annual covered payroll.
Annual pension cost and net pension obligation. The Authority’s annual
pension cost and net pension obligation to SHPP for 20X7 and 20X6 were as
follows:
20X7
20X6
Annual required contribution
$26
$23
Interest on net pension obligation
3
2
Adjustment to annual required contribution
(3)
(2)
Annual pension cost
26
23
Contributions made
(7)
(11)
15
Increase (decrease) in net pension obligation
16
Net pension obligation, beginning of year
65
49
Net pension obligation, end of year
$80
$65
F The preparer of the financial statements should consider the need for required supplementary
information (RSI) as required by GASB Statement No. 27, Accounting for Pensions by State and Local
Governmental Employers, paragraph 22.
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The annual required contribution for the current year was determined as part
of the December 31, 20X6, actuarial valuation using the entry age actuarial
cost method. The actuarial assumptions included (a) 7.5 percent investment
rate of return (net of administrative expenses) and (b) projected salary in
creases ranging from 5.5 percent to 9.5 percent per year. Both (a) and (b)
included an inflation component of 5.5 percent. The actuarial assumptions also
include a 2 percent per year cost-of-living adjustment. The actuarial value of
assets was determined using techniques that smooth the effects of short-term
volatility in the market value of investments over a four-year period. The same
actuarial assumptions were used to determine the actuarial required contribu
tions for 20X6. The unfunded actuarial accrued liability is being amortized as
a level percentage of projected payroll on an open basis. The remaining
amortization period at December 31, 20X6, was 23 years.
Fiscal Year
Ending
12/31/X5
12/31/X6
12/31/X7

Three-Year Trend Information
Percentage
Annual
of APC
Pension Cost
Contributed
(APC)
94%
$20
30
23
42
26

Net
Pension
Obligation
$49
65
80

11. Postretirement Plan||

In addition to the pension benefits described above, the Authority provides
postretirement health care benefits, in accordance with the Authority’s bylaws,
to all employees who retire from the Authority on or after attaining age 60 with
at least 15 years of service. Currently 250 retirees (245 in 20X6) meet these
eligibility requirements. The Authority reimburses 75 percent of the amount
of validated claims for medical, dental, and hospitalization costs incurred by
pre-Medicare retirees and their dependents. The Authority also reimburses a
fixed amount of $25 per month for a Medicare supplement for each retiree
eligible for Medicare. Expenses for postretirement health care benefits are
recognized as retirees report claims and include a provision for estimated
claims incurred but not yet reported to the Authority. Expenses of $764 were
recognized for postretirement health care in 20X7; expenses recognized in 20X6
were $636. Approximately $64 of the $128 increase in expenses over the
previous year was caused by the addition of dental benefits, effective July 1,
20X7.
NOTE—Although not presented in these sample illustrative financial state
ments, other disclosures required by GASB pronouncements may be applicable,
including the following:
• Short-term debt (GASB Statement No. 38, paragraph 12)
• Interfund balances and transfers (GASB Statement No. 38, paragraph
14, when a governmental health care entity reports multiple enterprise
|| The GASB published a revised exposure draft of a proposed statement, Accounting and
Financial Reporting by Employers for Postemployment Benefits Other Than Pensions, that addresses
how state and local governments should account for and report their costs and obligations related to
postemployment health care and other non-pension benefits provided to retirees. A final pronounce
ment, GASB Statement No. 45, Accounting and Financial Reporting by Employers for Postretirement
Benefits Other than Pensions, was issued in the third quarter of 2004. Conforming changes to reflect
the issuance of GASB Statement No. 45 will be made in a future edition of this Guide.
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funds or is reported as an enterprise fund of a general purpose
government. See Appendix F, footnote 5.)
• Segment information (GASB Statement No. 34. paragraphs 122 and
123, as amended by GASB Statement No. 37, paragraph 17)
• Violations of finance-related legal or contractual provisions (GASB
Statement No. 38, paragraph 9)
• Risk financing (Requirements for disclosures about claims and judg
ments and risk financing by governmental health care entities that
retain a portion of risk for claims and judgments (including malprac
tice claims and judgments) are provided in GASB Statement No. 10,
Accounting and Financial Reporting for Risk Financing and Related
Insurance Issues, as amended). Additionally, GASB Statement No. 34,
paragraph 119 requires disclosure of certain information about the
long-term portion of accrued claims and judgments, if applicable.
Other required disclosures, which may be applicable, and that would be similar
to the disclosures contained in the notes to the sample illustrative financial
statements for a not-for-profit hospital, are not repeated here. They include the
following:
• Off-Balance Sheet Risk and Concentration of Credit Risk
• Fair Value of Financial Instruments
• Commitments and Contingencies
• Subsequent Events
• Net patient service revenue
• Related party transactions
• Description of Reporting Entity and Summary of Significant Account
ing Policies—Supplies, Net Patient Service Revenue, Charity Care,
Premium Revenue
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ILLUSTRATIVE FINANCIAL STATEMENTS FOR A NURSING HOME
Sample For-Profit Nursing Home, Inc.
Balance Sheets
December 31, 20X5 and 20X4

20X5

20X4

Assets

Current assets:
$ 95,000
Cash and cash equivalents
150,000
Investments
50,000
Assets limited as to use
Patient accounts receivable, net of allowance
for doubtful accounts of $6,700 in 20X5 and
162,000
$5,300 in 20X4
71,000
Estimated third-party payor settlements
7,000
Interest receivable
47,000
Supplies
3,000
Prepaid expenses
12,000
Deferred tax asset
597,000
Total current assets
Assets limited as to use, net of amount required
for current liabilities
173,000
Property and equipment:
205,000
Land
37,000
Land improvements
1,399,000
Buildings
228,000
Furniture, fixtures, and equipment
1,869,000
Less accumulated depreciation
210,000
1,659,000
Property and equipment, net
Other assets
150,000
$2,579,000
Total assets

$ 129,000
50,000
152,000
62,000
43,000
2,000
14,000
452,000
150,000
205,000
32,000
1,399,000
189,000
1,825,000
141,000
1,684,000
127,000
$2,413,000
(continued)
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Sample For-Profit Nursing Home, Inc.
Balance Sheets
(continued)
December 3 1 , 20X5 and 20X4

20X5
20X4
Liabilities and Shareholders’ Equity
Current liabilities:
Current maturities of long-term debt
$ 50,000 $ 50,000
Accounts payable
78,000
52,000
Accrued expenses
175,000
188,000
Deposits from patients
50,000
45,000
Other current liabilities
74,000
15,000
Total current liabilities
427,000
350,000
Deferred tax liability
6,000
14,000
Long-term debt, net of current maturities
1,700,000 1,750,000
Shareholders’ equity:
Common stock, $20 par value; authorized
5,000 shares; issued and outstanding
3,500 shares
70,000
70,000
Retained earnings
376,000
229,000
446,000
Total shareholders’ equity
299,000
Total liabilities and shareholders’ equity $2,579,000 $2,413,000
See accompanying notes to financial statements.
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Sample For-Profit Nursing Home, Inc.
Statements of Income and Retained Earnings
Years Ended December 31, 20X5 and 20X4

20X5

Revenue:
Net patient service revenue
$2,163,000
67,000
Other revenue
Interest on investments held by trustee
13,000
Total revenue
2,243,000
Expenses:
Salaries and benefits
969,000
Medical supplies and drugs
511,000
Insurance and other
216,000
Provision for bad debts
92,000
Depreciation
69,000
Interest
164,000
Total expenses
2,021,000
Operating income
222,000
Nonoperating income:
Other interest income
5,000
Income before provision for income taxes
227,000
Provision for income taxes
80,000
Net income
147,000
Retained earnings, beginning of year
229,000
Retained earnings, end of year
$ 376,000
See accompanying notes to financial statements.

20X4
$1,949,000
22,000
7,000
1,978,000
919,000
499,000
176,000
83,000
57,000
172,000
1,906,000
72,000
72,000
29,000
43,000
186,000
$ 229,000

AAG-HCO APP A

230

Health Care Organizations

Sample For-Profit Nursing Home, Inc.
Statements of Cash Flows
Years Ended December 31, 20X5 and 20X4

Cash flows from operating activities:
Cash received from residents and
third-party payors
Cash received from others
Cash paid to employees and suppliers
Interest and dividends received
Interest paid
Taxes paid
Deposits received from patients
Deposits refunded to patients
Net cash provided by operating activities
Cash flows from investing activities:
Purchase of investments
Proceeds from sale of property
Capital expenditures
Purchase of assets limited as to use
Net cash used in investing activities
Cash flows from financing activities:
Repayment of long-term debt
Net cash used in financing activities
Net increase (decrease) in cash and cash
equivalents
Cash and cash equivalents, beginning of year
Cash and cash equivalents, end of year
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20X5

20X4

$2,019,000
67,000
(1,679,000)
10,000
(160,000)
(29,000)
35,000
(30,000)
233,000

$1,796,000
22,000
(1,495,000)
10,000
(170,000)
(30,000)
15,000
(20,000)
128,000

(150,000)
(44,000)
(23,000)
(217,000)

2,000
(79,000)

(50,000)
(50,000)

(50,000)
(50,000)

(34,000)
129,000
$ 95,000

1,000
128,000
$ 129,000
(continued)

(77,000)
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Sample For-Profit Nursing Home, Inc.
Statements of Cash Flows
(continued)
Years Ended December 31, 20X5 and 20X4

20X5
Reconciliation of net income to net cash
provided by operating activities:
Net income
$147,000
Adjustments to reconcile net income to net
cash provided by operating activities:
Depreciation
69,000
Provision for bad debts
92,000
Loss on sale of property
Change in deferred income taxes
(6,000)
(Increase) decrease in:
Patient accounts receivable
(102,000)
Other current assets
(21,000)
Estimated third-party payor settlements
(9,000)
Interest receivable
(7,000)
Other assets
(7,000)
Increase (decrease) in:
Accounts payable and accrued expenses
13,000
Deposits from patients
5,000
Other current liabilities
59,000
Net cash provided by operating activities
$233,000
See accompanying notes to financial statements.
—

20X4
$43,000
57,000
83,000
11,000
(14,000)
(41,000)
(15,000)
(10,000)
(3,000)
(10,000)
43,000
(5,000)
(11,000)
$128,000
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Sample For-Profit Nursing Home, Inc.
Notes to Financial Statements
December 31, 20X5 and 20X4
1. Description of Organization and Summary of Significant Account
ing Policies3

Organization. The Sample Nursing Home, Inc. (the Company) was incorpo
rated in New State in 20X1 and operates a 128-bed nursing home in Abacus,
New State. A summary of the Company’s significant accounting policies follows:
Use of estimates. The preparation of financial statements in conformity with
generally accepted accounting principles requires management to make esti
mates and assumptions that affect the reported amounts of assets and liabili
ties and disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of revenues and expenses during the
reporting period. Actual results could differ from those estimates.
Cash and cash equivalents. Cash and cash equivalents include investments
in highly liquid debt instruments with an original maturity of three months or
less, excluding amounts whose use is limited by note indenture.
Investments. Investments in debt instruments, including assets limited as
to use, are classified as held-to-maturity because the Company has the positive
intent and ability to hold the securities until maturity. Held-to-maturity
securities are carried at cost adjusted for amortization of premiums and
accretion of discounts.
Assets limited as to use. Assets deposited with a trustee under terms of the
note indenture and assets set aside by the Board of Directors for capital
improvements are classified as assets limited as to use. Amounts required to
meet current liabilities have been reclassified in the balance sheet.
Property and equipment. Property and equipment are recorded at cost.
Depreciation is calculated on the straight-line method over the estimated useful
lives of depreciable assets.
Bond issuance costs. Costs incurred in issuing the Series 20X1 bonds are
being amortized based on the effective interest method.
Net patient service revenue. Net patient service revenue is reported at the
estimated net realizable amounts from residents, third-party payors, and
others for service rendered.
Revenue under third-party payor agreements is subject to audit and retroac
tive adjustment. Provisions for estimated third-party payor settlements are
provided in the period the related services are rendered. Differences between
the estimated amounts accrued and interim and final settlements are reported
in operations in the year of settlement.
Income taxes. The provisions for income taxes are based on amounts esti
mated to be currently payable and those deferred because of temporary differ
ences between the financial statement and tax bases of assets and liabilities.
These differences consist principally of bad debts and depreciation.
3 Paragraph 13 of SOP 01-6, Accounting by Certain Entities (Including Entities With Trade
Receivables) That Lend to or Finance the Activities of Others, provides guidance on disclosures that
should be included in the summary of significant accounting policies, including accounting policies for
loans, trade receivables, and doubtful accounts.
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2. Assets Limited as to Use

Assets limited as to use include:
Assets held by trustee under the Series 20X1 note indenture
agreement at December 31, 20X5 and 20X4.
U.S. Government obligations
Cash
Accrued interest income
Internally designated by the Board of
Directors for capital improvements
Certificate of deposit
Accrued interest

20X5
$150,000
24,000
2,000
176,000

20X4
$130,000
21,000
2,000
153,000

$ 45,000
2,000
47,000
$223,000

$ 45,000
2,000
47,000
$200,000

3. Investments#
4. Long-Term Debt

Long-term debt at December 31, 20X5 and 20X4, was as follows:
20X5
20X4
9.5 percent bonds payable to the City of
Abacus, maturing $50,000 annually through
November 1, 20YY, with a final maturity of
$1,750,000 $1,800,000
$1 million on November 1, 20YY
50,000
50,000
Less current maturities
$1,700,000 $1,750,000

The notes are collateralized by a first-mortgage lien on all property and
equipment of the Company and a security interest in all of its receipts. The note
indenture requires the maintenance of certain deposits with a trustee, which
are included in assets limited as to use.
Future maturities of long-term debt as of December 31, 20X5, follow:
Year Ending December 31,
Amount
20X6
$ 50,000
20X7
50,000
20X8
50,000
20X9
50,000
20Y0
50,000
Thereafter
1,500,000
Total
$1,750,000
# In reporting disclosures about investments in securities, entities should comply primarily
with the requirements of paragraphs 6, 17, 19, 20, 21, and 22 of FASB Statement No. 115, as
amended. Other disclosure requirements may also be applicable.
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5. Income Taxes
The provisions for income taxes are as follows:
Current:
Federal
State
Total current
Deferred:
Federal
State
Total deferred
Total provision for income taxes

20X5

20X4

$72,000
2,000
74,000

$15,000

6,000

13,000
1,000
14,000
$29,000

6,000
$80,000

15,000

Deferred income taxes are provided for the temporary differences between
the financial reporting basis and the tax basis of the Company’s assets and
liabilities.
For the years ended December 31, 20X5 and 20X4, the effective tax rate
approximated the statutory rate of 34 percent and 40 percent, respectively.
The net current and noncurrent components of deferred income taxes recog
nized in the balance sheet at December 31, 20X5 and 20X4, follows:
Net current assets
Net noncurrent liabilities

20X5
$12,000
6,000
$

6,000

20X4
$14,000
14,000
$_____

0

Management has determined that no valuation allowance related to deferred
tax assets is necessary at December 31, 20X5 and 20X4, respectively.
6. Concentration in State M edicaid Program
The Company has 100 of its 128 beds designated for care of patients under
the state’s Medicaid program. The current funding of that program is 90 days
behind filed claims. The current state budget has no provision for reducing that
lag and, while the proposed budget for 20X6 includes additional funding, there
is no assurance that the final budget will include the needed additional funds.
7. Third P arty Rate Adjustments and Revenue
Revenue from the Medicaid program accounted for approximately XX percent
for the year ended 20X5, and XX percent for the year ended 20X4, of the
Company’s net patient revenue. Laws and regulations governing the Medicaid
program are extremely complex and subject to interpretation. As a result, there
is at least a reasonable possibility that recorded estimates will change by a
material amount in the near term. The 20X5 net patient service revenue
increased approximately $XXX due to removal of allowances previously esti
mated that are no longer necessary as a result of final settlements and years
that are no longer subject to audits, reviews, and investigations. The 20X4 net
patient service revenue decreased approximately $XXX due to prior-year ret
roactive adjustments in excess of amounts previously estimated.
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8. Risks and Uncertainties Disclosures**
9. Pension Plan**
10. Postretirement Benefits**
11. Fair Values of Financial Instruments**
12. Concentrations of Credit Risk**

*The disclosures contained in these notes would be similar to the disclosures contained in the
notes to the financial statements for not-for-profit hospital and, therefore, are not repeated here.
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ILLUSTRATIVE FINANCIAL STATEMENTS FOR A CONTINUING
CARE RETIREMENT COMMUNITY
Sample Not-for-Profit Continuing Care Retirement Community
Balance Sheets
December 31, 20X5 and 20X4

20X5
Assets
Current assets:
Cash
$ 375,000
Assets limited as to use
265,000
Accounts receivable, net of allowance for
doubtful accounts of $4,000 in 20X5 and
$5,000 in 20X4
187,000
Supplies
40,000
115,000
Prepaid expenses
982,000
Total current assets
Assets limited as to use, net of amount
required for current liabilities
1,865,000
Property and equipment, net
14,893,000
Deferred financing costs, net of accumulated
amortization of $28,000 in 20X5 and $21,000
in 20X4
83,000
$17,823,000
Total assets
Liabilities and Net Assets
Liabilities:
$ 90,000
Current maturities of long-term debt
180,000
Accounts payable
161,000
Accrued expenses
22,000
Deposits on unoccupied units
453,000
Total current liabilities
8,871,000
Long-term debt, less current maturities
59,000
Refundable fees
Estimated obligation to provide future
services, in excess of amounts received or to
88,000
be received
6,304,000
Deferred revenue from advance fees
15,775,000
Total liabilities
Net assets:
1,286,000
Unrestricted
311,000
Temporarily restricted
451,000
Permanently restricted
2,048,000
Total net assets
$17,823,000
Total liabilities and net assets
See accompanying notes to financial statements.
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20X4
$ 330,000
170,000
197,000
21,000
73,000
791,000
1,583,000
15,280,000
90,000
$17,744,000
$

77,000
174,000
178,000
40,000
469,000
8,935,000
144,000
100,000
6,585,000
16,233,000

833,000
294,000
384,000
1,511,000
$17,744,000
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Sample Not-for-Profit Continuing Care Retirement Community
Statements of Operations
Years Ended December 31, 20X5 and 20X4

Revenue, gains, and other support:
Resident services, including amortization of
advance fees of $935,000 in 20X5 and
$915,000 in 20X4
Patient revenue from nonresidents
Change in obligation to provide future
services
Contributions
Net assets released from restrictions used for
operations
Investment income
Other
Total revenue, gains, and other support
Expenses:
Salaries and benefits
Medical supplies and drugs
Insurance
Depreciation
Interest
Total expenses
Operating income (loss)
Net assets released from restriction—purchase
of equipment
Increase (decrease) in unrestricted net
assets
See accompanying notes to financial statements.

20X5

20X4

$3,946,000
249,000
12,000
54,000
24,000
29,000
75,000
4,389,000

$3,152,000
275,000
(82,000)
39,000
50,000
30,000
68,000
3,532,000

1,708,000
543,000
291,000
452,000
967,000
3,961,000
428,000

1,250,000
742,000
311,000
447,000
955,000
3,705,000
(173,000)

25,000

45,000

$ 453,000

$ (128,000)

AAG-HCO APP A

238

Health Care Organizations

Sample Not-for-Profit Continuing Care Retirement Community
Statements of Changes in Net Assets
Years Ended December 31, 20X5 and 20X4

20X5

Unrestricted net assets:
Operating income (loss)
$ 428,000
Net assets released from
25,000
restriction—purchase of equipment
Increase (decrease) in unrestricted net
453,000
assets
Temporarily restricted net assets:
40,000
Contributions
Net assets released from restrictions used
(24,000)
for operations
Net assets released from
(25,000)
restriction—purchase of equipment
26,000
Investment income
Increase (decrease) in temporarily
17,000
restricted net assets
Permanently restricted net assets:
67,000
Contributions
Increase in permanently restricted net
67,000
assets
537,000
Increase (decrease) in net assets
1,511,000
Net assets, beginning of year
$2,048,000
Net assets, end of year
See accompanying notes to financial statements.
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$ (173,000)
45,000
(128,000)
15,000
(50,000)
(45,000)
15,000
(65,000)
52,000
52,000
(141,000)
1,652,000
$1,511,000
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Sample Not-for-Profit Continuing Care Retirement Community
Statements of Cash Flows
Years Ended December 31, 20X5 and 20X4

20X5
20X4
Cash flows from operating activities:
Cash received from residents and
third-party payors
$ 3,252,000 $ 2,341,000
Advance fees received
654,000
857,000
Other receipts from operations
68,000
75,000
Investment income received
68,000
53,000
Contributions received
51,000
44,000
Cash paid to employees and suppliers
(2,576,000) (2,040,000)
Interest paid
(950,000)
(945,000)
Net cash provided by operating activities
574,000
378,000
Cash flows from investing activities:
Purchase of property and equipment
(65,000)
(250,000)
Purchase of assets limited as to use
(377,000)
229,000
Net cash used in investing activities
(442,000)
(21,000)
Cash flows from financing activities:
Permanently restricted funds received
67,000
52,000
Refunds of deposits and refundable fees
(103,000)
(52,000)
Proceeds from issuance of long-term debt
26,000
Principal payments of long-term debt
(77,000)
(307,000)
Net cash used in financing activities
(87,000)
(307,000)
Net increase in cash
45,000
50,000
Cash, beginning of year
330,000
280,000
Cash, end of year
$ 375,000 $ 330,000
(continued)
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Sample Not-for-Profit Continuing Care Retirement Community
Statements of Cash Flows
(continued)
Years Ended December 31, 20X5 and 20X4

20X5

Reconciliation of change in net assets to net
cash provided by operating activities:
$ 537,000
Change in net assets
Adjustments to reconcile change in net assets
to net cash provided by operating activities:
654,000
Advance fees received
(67,000)
Restricted net assets received
(935,000)
Amortization of advance fees
Loss (gain) on obligation to provide future
(12,000)
services
452,000
Depreciation
7,000
Amortization of deferred financing costs
3,000
Provision for bad debts
(Increase) decrease in:
7,000
Accounts receivable
(61,000)
Other assets
Increase (decrease) in:
(11,000)
Accounts payable and accrued expenses
Net cash provided by operating
$ 574,000
activities
See accompanying notes to financial statements.
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$(141,000)
857,000
(52,000)
(915,000)
82,000
447,000
34,000
3,000
(33,000)
(4,000)
100,000
$ 378,000
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Sample Not-for-Profit Continuing Care Retirement Community
Notes to Financial Statements4
December 31, 20X5 and 20X4
1. Description of Organization and Summary of Significant Account
ing Policies††,5

Organization. The Sample Continuing Care Retirement Community (the
CCRC) is a nonprofit organization that principally provides housing, health
care, and other related services to residents through the operation of a retire
ment facility containing 249 apartments and a 78-bed health care facility
located in Evergreen Park, Illinois. The CCRC was incorporated in Illinois in
20X1. A summary of significant accounting policies follows.
Use of estimates. The preparation of financial statements in conformity with
generally accepted accounting principles requires management to make esti
mates and assumptions that affect the reported amounts of assets and liabili
ties and disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of revenues and expenses during the
reporting period. Actual results could differ from those estimates.
Investments. Investments, which consist of U.S. Treasury obligations, are
measured at fair value in the balance sheet. Investment income (including
realized gains and losses on investments, interest, and dividends) is included
in operating income (loss) unless restricted by donor or law. Unrealized gains
and losses on investments, if any, are excluded from operating income (loss).
Deferred financing costs. Deferred financing costs are amortized using the
effective interest method over the term of the related financing agreement.
Advance fees. Fees paid by a resident upon entering into a continuing care
contract, net of the portion thereof that is refundable to the resident, are
recorded as deferred revenue and are amortized to income using the straightline method over the estimated remaining life expectancy of the resident.
Obligation to provide future services. The CCRC annually calculates the
present value ofthe net cost offuture services and the use offacilities to be provided
to current residents and compares that amount with the balance of deferred
revenue from advance fees. If the present value of the net cost of future services
and the use of facilities exceeds the deferred revenue from advance fees, a liability
is recorded (obligation to provide future services and use of facilities) with the
corresponding charge to income. The obligation is discounted at 9 percent, based
on the expected long-term rate of return on government obligations.
Donor restrictions. The CCRC reports gifts ofcash and other assets as restricted
support if they are received with donor stipulations that limit the use ofthe donated
assets. When a donor restriction expires (that is, when a stipulated time restriction
ends or a purpose restriction is accomplished), temporarily restricted net assets are
4 SOP 00-1 provides auditors with guidance regarding uncertainties in health care revenue
recognition and includes a sample disclosure in paragraph 37 of the SOP for material differences
between an original estimate and subsequent revisions regarding third-party payments. SOP 00-1 is
included in Appendix E to this Guide.
†Does not include all disclosures common to all health care entities.
5 Paragraph 13 of SOP 01-6, Accounting by Certain Entities (Including Entities With Trade
Receivables) That Lend to or Finance the Activities of Others, provides guidance on disclosures that
should be included in the summary of significant accounting policies, including accounting policies for
loans, trade receivables, and doubtful accounts.
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reclassified as unrestricted net assets and reported in the statement of opera
tions as net assets released from restrictions. Donor-restricted contributions
whose restrictions are met within the same year as received are reflected as
unrestricted contributions in the accompanying financial statements.
The CCRC reports gifts of property and equipment (or other long-lived assets)
as unrestricted support unless explicit donor stipulations specify how the
donated assets must be used. Gifts of long-lived assets with explicit restrictions
that specify how the assets are to be used and gifts of cash or other assets that
must be used to acquire long-lived assets are reported as restricted support.
Absent explicit donor stipulations about how long those long-lived assets must
be maintained, the CCRC reports expirations of donor restrictions when the
donated or acquired long-lived assets are placed in service.
Incom e taxes. The CCRC has been recognized by the Internal Revenue
Service as a not-for-profit corporation as described in Sec. 501(c)(3) of the
Internal Revenue Code (IRC) and is exempt from federal income taxes pursuant
to Sec. 501(a) of the IRC.
P roperty a n d equipm ent. Property and equipment are stated at cost. Donated
property is recorded at its estimated fair value at the date of receipt. Deprecia
tion is computed on the straight-line method based on the following estimated
useful lives:
Land improvements
20 years
Buildings and improvements
40 years
Furniture and equipment
5—15 years
O perating incom e (loss). The statement of operations includes operating in
come (loss). Changes in unrestricted net assets which are excluded from operating
income (loss), consistent with industry practice, include unrealized gains and losses
on investments other than trading securities, permanent transfers of assets to and
from affiliates for other than goods and services, and contributions of long-lived
assets (including assets acquired using contributions which by donor restriction
were to be used for the purposes of acquiring such assets).
2. Property and Equipment

A summary of property and equipment at December 31, 20X5 and 20X4,
follows:
Land
Land improvements
Buildings and improvements
Furniture and equipment
Less: accumulated depreciation

20X 5

20X 4

$ 557,000 $ 557,000
205,000
203,000
14,573,000 14,564,000
752,000
698,000
16,087,000 16,022,000
(1,194,000) (742,000)
$14,893,000 $15,280,000

3. Temporarily Restricted Net Assets

Temporarily restricted net assets are available for the following purposes:
Purchase of equipment
Charity care
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$169,000
142,000
$311,000

20X 4

$152,000
142,000
$294,000
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Net assets were released from donor restrictions by incurring expenses
satisfying the restricted purposes or by occurrence of other events specified by
donors:
Charity care
Purchase of equipment

20X5
$24,000
$25,000

20X4
$50,000
$45,000

4. Permanently Restricted Net Assets

Permanently restricted net assets are restricted to investment in perpetuity,
the income from which is expendable to support:
Charity care
Community activities

20X5
$168,000
283,000
$451,000

20X4
$168,000
216,000
$384,000

5. Long-Term Debt

Long-term debt at December 31, 20X5 and 20X4, is as follows:

10.75 percent mortgage note payable
Notes payable to bank—unsecured
Other
Less current maturities

20X5
$8,901,000
34,000
26,000
8,961,000
90,000
$8,871,000

20X4
$8,965,000
14,000
33,000
9,012,000
77,000
$8,935,000

The mortgage note is payable in consecutive monthly installments of principal
and interest of $85,425 to May 20XX. The note is collateralized by a first
mortgage on property and equipment with a depreciated cost at December 31,
20X5, of $14,893,000 and by a pledge of all operating revenue.
As required by the mortgage note agreement, the CCRC established an initial
debt service reserve fund of $1,000,000 at April 15, 20X3. All resident fees
received thereafter, net of resident fee refunds and debt service payments not
to exceed $300,000 annually in the first four years and $200,000 annually
thereafter, are to be added to the debt service reserve fund until the total sum
of $2,050,000 is accumulated. Since June 1, 20X4, the CCRC has been required
to deliver to the trustee $5,500 per month to establish maintenance reserves
until the aggregate of such payments equals a residential unit reserve and a
health care center reserve of $240,000 and $90,000, respectively. At December
31, 20X5 and 20X4, the trustee held investments aggregating $2,130,000 and
$1,753,000, respectively. Such amount has been classified as assets limited as
to use.
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Scheduled annual principal maturities of long-term debt for the next five
years are as follows:
Year Ending December 31,
Amount
$ 90,000
20X6
90,000
20X7
95,000
20X8
105,000
20X9
105,000
20Y0
6. Classification of Expenses

Program activities
General and administrative

20X5
3,368,000
593,000
$3,961,000

20X4
3,135,000
570,000
$3,705,000

7. Assets Limited as to Use‡‡
8. Risks and Uncertainties Disclosures‡‡
9. Pension Plan‡‡
10. Postretirement Benefits‡‡
11. Fair Values of Financial Instruments‡‡
12. Concentrations of Credit Risk‡‡
13. Investments‡‡‡‡

‡‡ The disclosures contained in these notes would be similar to the disclosures contained in the
notes to the financial statements for the not-for-profit hospital and, therefore, are not repeated here.
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ILLUSTRATIVE FINANCIAL STATEMENTS FOR A HOME HEALTH AGENCY
Sample Not-for-Profit Home Health Agency
Balance Sheets
December 31, 20X5 and 20X4

20X5

20X4

$ 74,000
147,000

$ 41,000
137,000

752,000
27,000
1,000,000
100,000

476,000
22,000
676,000
100,000

56,000
50,000
106,000
(45,000)
61,000

39,000
37,000
76,000
(24,000)
52,000

Assets

Current assets:
Cash and cash equivalents
Investments
Accounts receivable, net of allowance for
doubtful accounts of $61,000 in 20X5 and
$30,000 in 20X4
Other receivables
Total current assets
Investments
Equipment:
Medical and office equipment
Vehicles

Less accumulated depreciation
Equipment, net
Deferred finance charges, net of accumulated
amortization of $15,000 in 20X5 and $10,000
in 20X4
20,000
Total assets
$1,181,000

25,000
$853,000

Liabilities and Net Assets

Current liabilities:
Current maturities of long-term debt
$ 13,000
Accounts payable
40,000
Accrued payroll and vacation costs
496,000
Estimated third-party payor settlements
28,000
Advances from third-party payors
70,000
Total current liabilities
647,000
Long-term debt, less current maturities
105,000
Total liabilities
752,000
Net assets:
Unrestricted
330,000
Temporarily restricted
9,000
Permanently restricted
90,000
Total net assets
429,000
Total liabilities and net assets
$1,181,000
See accompanying notes to financial statements.

$ 13,000
21,000
352,000
31,000
66,000
483,000
118,000
601,000
167,000
5,000
80,000
252,000
$853,000
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FORMAT A
Sample Not-for-Profit Home Health Agency
Statements of Operations
Years Ended December 31, 20X5 and 20X4

Revenue, gains, and other support:
Net patient service revenue
Contributions
Net assets released from restrictions
Investment income
Other revenue
Total revenue, gains, and other support
Expenses:
Salaries and benefits
Medical supplies and drugs
Insurance and other
Provision for bad debts
Depreciation
Interest
Total expenses
Excess of revenue over expenses and change in
unrestricted net assets
See accompanying notes to financial statements.
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20X5

20X4

$4,042,000
5,000
5,000
13,000
27,000
4,092,000

$2,687,000
22,000
6,000
32,000
2,747,000

2,714,000
1,042,000
90,000
46,000
21,000
16,000
3,929,000

1,835,000
675,000
83,000
21,000
15,000
19,000
2,648,000

$ 163,000

$ 99,000

—
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FORMAT B
Sample Not-for-Profit Home Health Agency
Statements of Operations
Years Ended December 31, 20X5 and 20X4

20X 5

Revenue, gains, and other support:
Net patient service revenue
$4,042,000
5,000
Contributions
5,000
Net assets released from restrictions
27,000
Other revenue
4,079,000
Total revenue, gains, and other support
Expenses:
2,714,000
Salaries and benefits
Medical supplies and drugs
1,042,000
Insurance and other
90,000
Provision for bad debts
46,000
Depreciation
21,000
16,000
Interest
Total expenses
3,929,000
Operating income
150,000
Other income:
Investment income
13,000
Excess of revenue over expenses and change in
unrestricted net assets
$ 163,000
See accompanying notes to financial statements.

20X 4

$2,687,000
22,000
32,000
2,741,000
—

1,835,000
675,000
83,000
21,000
15,000
19,000
2,648,000
93,000
6,000
$ 99,000
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Sample Not-for-Profit Home Health Agency
Statements of Changes in Net Assets
Years Ended December 31, 20X5 and 20X4

Unrestricted net assets:
Excess of revenue over expenses
Increase in unrestricted net assets
Temporarily restricted net assets:
Contributions
Net assets released from restrictions
Increase in temporarily restricted net
assets
Permanently restricted net assets:
Contributions
Increase in permanently restricted net
assets
Increase in net assets
Net assets, beginning of year
Net assets, end of year
See accompanying notes to financial statements.
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20X5

20X4

$163,000
163,000

$ 99,000
99,000

9,000
(5,000)

5,000

4,000

5,000

10,000

6,000

10,000
177,000
252,000
$429,000

6,000
110,000
142,000
$252,000
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Sample Not-for-Profit Home Health Agency
Statements of Cash Flows
Years Ended December 31, 20X5 and 20X4

20X5

Cash flows from operating activities:
Cash received from patients and
third-party payors
$3,721,000
Other receipts from operations
22,000
Cash paid to employees and suppliers
(3,679,000)
Interest paid
(11,000)
Nonoperating revenue
23,000
Net cash provided by operating activities
76,000
Cash flows from investing activities:
Purchase of equipment
(30,000)
Purchase of investments
(10,000)
Net cash used in investing activities
(40,000)
Cash flows from financing activities:
Proceeds from contributions restricted for:
Endowment
10,000
Other financing activities:
Payment of long-term debt
(13,000)
Net cash provided by (used in) financing
activities
(3,000)
Net increase in cash and cash equivalents
33,000
Cash and cash equivalents, beginning of year
41,000
Cash and cash equivalents, end of year
$ 74,000

20X4
$2,542,000
32,000
(2,541,000)
(14,000)
22,000
41,000
(19,000)
(15,000)
(34,000)
6,000
6,000
13,000
28,000
$ 41,000
(continued)
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Sample Not-for-Profit Home Health Agency
Statements of Cash Flows
(continued)
Years Ended December 31, 20X5 and 20X4

20X5
Reconciliation of change in net assets to net
cash provided by operating activities:
$177,000
Change in net assets
Adjustments to reconcile change in net assets
to net cash provided by operating activities:
Increase in permanently restricted net
(10,000)
assets
46,000
Provision for bad debts
21,000
Depreciation
5,000
Amortization of deferred financing charges
(Increase) decrease in:
(322,000)
Accounts receivable
(5,000)
Other receivables
Increase (decrease) in:
Accounts payable, accrued payroll, and
163,000
vacation costs
1,000
Estimated third-party payor settlements
$ 76,000
Net cash provided by operating activities
See accompanying notes to financial statements.
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$110,000
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Sample Not-for-Profit Home Health Agency
Notes to Financial Statements
Years Ended December 31, 20X5 and 20X4
1. Description of Organization and Summary of Significant Accounting
Policies6

O rganization. The Sample Home Health Agency (the Agency) was incorpo
rated in 20X0 in New State as a not-for-profit corporation. The Agency provides
health and supportive services to individuals at their homes, primarily in the
New State area.
Use o f estim ates. The preparation of financial statements in conformity with
generally accepted accounting principles requires management to make esti
mates and assumptions that affect the reported amounts of assets and liabili
ties and disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of revenues and expenses during the
reporting period. Actual results could differ from those estimates.
C ash a n d cash equivalents. Cash and cash equivalents include investments in
highly liquid debt instruments with an original maturity of three months or less.
Investm en ts. Investments, which consist of U.S. Treasury obligations, are
measured at fair value in the balance sheet. Investment income (including
realized gains and losses on investments, interest and dividends) is included
in excess of revenues over expenses unless restricted by donor or law. Unreal
ized gains and losses on investments, if any, are excluded from excess of
revenues over expenses.
E qu ipm en t. Equipment is recorded at cost. Depreciation is computed using
the straight-line method over the estimated useful lives of the assets.
D eferred fin an cin g costs. Deferred financing costs are being amortized using
the effective interest method over the term of the related financing agreement.
D onor restrictions. The Agency reports gifts of cash and other assets as
restricted support if they are received with donor stipulations that limit the
use of the donated assets. When a donor restriction expires, that is, when a
stipulated time restriction ends or purpose restriction is accomplished, tempo
rarily restricted net assets are reclassified as unrestricted net assets and
reported in the statement of operations as net assets released from restrictions.
When long-lived assets are placed in service, thus satisfying purpose restric
tions, the amount is included as a change in net assets, restricted and unre
stricted. Donor-restricted contributions whose restrictions are met within the
same year as received are reflected as unrestricted contributions in the accom
panying financial statements.
The Agency reports gifts of equipment (or other long-lived assets) as unre
stricted support unless explicit donor stipulations specify how the donated
assets must be used. Gifts of long-lived assets with explicit restrictions that
specify how the assets are to be used and gifts of cash or other assets that must
be used to acquire long-lived assets are reported as restricted support. Absent
explicit donor stipulations about how long those long-lived assets must be
maintained, the Agency reports expirations of donor restrictions when the
donated or acquired long-lived assets are placed in service.
6 Paragraph 13 of SOP 01-6, Accounting by Certain Entities (Including Entities With Trade
Receivables) That Lend to or Finance the Activities of Others, provides guidance on disclosures that

should be included in the summary of significant accounting policies, including accounting policies for
loans, trade receivables, and doubtful accounts.
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N et p a tie n t service revenue. Net patient service revenue represents the
estimated net realizable amounts from patients, third-party payors, and others
for services rendered.
C h arity care. The Agency has a policy of providing charity care to patients
who are unable to pay. Such patients are identified based on financial information
obtained from the patient and subsequent analysis. Since the Agency does not
expect payment, estimated charges for charity care are not included in revenue.
Incom e taxes. The Agency has been recognized by the Internal Revenue
Service as a not-for-profit corporation as described in Sec. 501(c)(3) of the
Internal Revenue Code (IRC) and is exempt from federal income taxes on
related income pursuant to Sec. 501(a) of the IRC.
Excess o f revenue over expenses. The statement of operations includes excess
of revenue over expenses. Changes in unrestricted net assets which are excluded
from excess of revenue over expenses, consistent with industry practice, include
unrealized gains and losses on investments other than trading securities,
permanent transfers of assets to and from affiliates for other than goods and
services, and contributions of long-lived assets (including assets acquired using
contributions which by donor restriction were to be used for the purposes of
acquiring such assets).
2. Temporarily Restricted Net Assets

Temporarily restricted net assets are available for the following purposes:
20X5
20X4
$ —
$5,000
Charity care
9,000
—
Purchase of equipment
$9,000
$5,000
Net assets were released from donor restrictions by incurring expenses
satisfying the restricted purposes or by occurrence of other events specified by
donors:
20X5
20X4
Charity care expenditures
$5,000
$—

3. Permanently Restricted Net Assets

Permanently restricted net assets are restricted in perpetuity, the income
from which is expendable to support:
20X5
20X4
Program A activities
$10,000
$ —
Any activities of the Agency
80,000
80,000
$90,000
$80,000
4. Third-Party Rate Adjustments and Revenue

Approximately 38 percent in 20X5 and 37 percent in 20X4 of net patient
service revenue was derived under federal and state third-party reimburse
ment programs. These revenues are based, in part, on cost reimbursement
principles and are subject to audit and retroactive adjustment by the respective
third-party fiscal intermediaries. Laws and regulations governing these pro
grams are extremely complex and subject to interpretation. As a result, there
is at least a reasonable possibility that recorded estimates will change by a
material amount in the near term. The 20X5 net patient service revenue
increased approximately $XXX due to removal of allowances previously estimated
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that are no longer necessary as a result of final settlements and years that are
no longer subject to audits, reviews, and investigations. The 20X4 net patient
service revenue decreased approximately $XXX due to prior-year retroactive
adjustments in excess of amounts previously estimated.
5. Internally-Designated Assets

The Board of Directors has designated investments aggregating $100,000 to
be used for future major capital improvements. Those assets are classified in
the balance sheet as long-term investments.
6. Long-Term Debt

Long-term debt at December 31, 20X5 and 20X4, is as follows:
20X5
Note payable to bank, interest at 15 percent,
payable in monthly installments of $2,200 per
month, including interest, collateralized by
equipment with a depreciated cost of $42,000
$118,000
Less current maturities
13,000
$105,000

20X4
$131,000
13,000
$118,000

Scheduled maturities of long-term debt at December 31, 20X5, are as follows:
Year Ending December 31,
Amount
20X6
$ 13,000
20X7
13,000
20X8
13,000
20X9
13,000
20Y0
13,000
Thereafter
53,000
Total
$118,000
7. Classification of Expenses

Total
Expenses incurred
for the year
ended December
31, 20X5, were
for:
Salaries and
benefits
$2,714,000
Medical supplies
and drugs
1,042,000
Insurance and
other
90,000
Provision for bad
debts
46,000
Depreciation
21,000
Interest
16,000
Total expenses $3,929,000

____________ Program_____________
B
A
C

$1,363,000

$699,000

$363,000

511,000

246,000

285,000

58,000
16,000
5,000
10,000
$1,963,000

General and
Administrative

$289,000
32,000

30,000
3,000
$978,000

16,000
3,000
$648,000

$340,000
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Total
Expenses incurred
for the year
ended December
31, 20X4, were
for:
Salaries and
benefits
$1,835,000
Medical supplies
and drugs
675,000
Insurance and
other
83,000
Provision for bad
debts
21,000
Depreciation
15,000
Interest
19,000
Total expenses $2,648,000

A

Program
B

C

General and
Administrative

$241,000

$ 915,000

$463,000

$216,000

335,000

211,000

129,000

64,000

19,000

21,000
6,000
12,000

5,000

$1,353,000

$679,000

9,000
2,000
$345,000

$271,000

(The preparer of the financial statements may wish to include a brief descrip
tion of the types of programs.)
8. Charity Care

Charity care represented approximately 3 percent and 4 percent of visits in
20X5 and 20X4, respectively.
9. Risks and Uncertainties Disclosures||||
10. Pension Plan||||
11. Postretirement Benefits||||
12. Fair Value of Financial Statements||||
13. Concentrations of Credit Risk||||
14. Investments||||

|||| The disclosures contained in these notes would be similar to the disclosures contained in
the notes to the financial statements for the not-for-profit hospital and, therefore, are not repeated
here.
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ILLUSTRATIVE FINANCIAL STATEMENTS FOR A
HEALTH MAINTENANCE ORGANIZATION

Sample Not-for-Profit Health Maintenance Organization
Balance Sheets
June 30, 20X5 and 20X4

20X5

20X4

$2,937,000

$1,021,000

358,000
263,000
190,000
197,000
3,945,000
5,756,000
150,000

407,000
261,000
184,000
99,000
1,972,000
5,626,000
150,000

18,000
$9,869,000

21,000
$7,769,000

Current liabilities:
Unsecured 12 percent note payable to a bank $ —
Current maturities of long-term debt
241,000
Accounts payable—medical services
2,245,000
Other accounts payable and accrued expenses
829,000
Unearned premium revenue
141,000
Total current liabilities
3,456,000
Long-term debt, less current maturities
4,295,000
Total liabilities
7,751,000
Net assets—unrestricted
2,118,000
Total liabilities and net assets
$9,869,000
See accompanying notes to financial statements.

$ 44,000
109,000
1,471,000
661,000
202,000
2,487,000
2,382,000
4,869,000
2,900,000
$7,769,000

Assets

Current assets:
Cash and cash equivalents
Premiums receivable, net of allowance for
doubtful accounts of $36,000 in 20X5 and
$42,000 in 20X4
Other receivables
Supplies
Prepaid expenses
Total current assets
Property and equipment, net
State guaranty fund deposit
Debt issuance costs, net of accumulated
amortization of $42,000 in 20X5 and $39,000
in 20X4
Total assets

Liabilities and Net Assets
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Sample Not-for-Profit Health Maintenance Organization
Statements of Operations and Changes in Net Assets
Years Ended June 30, 20X5 and 20X4

20X5

20X4

Revenue:
$27,682,000 $22,500,000
Premiums earned
500,000
689,000
Coinsurance
100,000
242,000
Interest and other income
28,613,000 23,100,000
Total revenue
Expenses:
16,154,000 13,328,000
Salaries and benefits
8,507,000 5,988,000
Medical supplies and drugs
3,963,000 2,463,000
Insurance
20,000
19,000
Provision for bad debts
336,000
367,000
Depreciation
375,000
385,000
Interest
29,395,000 22,510,000
Total expenses
590,000
(782,000)
Operating income (loss)
2,900,000 2,310,000
Net assets, beginning of year
$ 2,118,000 $ 2,900,000
Net assets, end of year
See accompanying notes to financial statements.
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Sample Not-for-Profit Health Maintenance Organization
Statements of Cash Flows
Years Ended June 30, 20X5 and 20X4

20X5

20X4

Cash flows from operating activities:
Cash received from premiums, stop-loss
insurance recoveries, and coinsurance
$28,969,000 $24,410,000
Cash paid to employees and to providers of
health care services
(28,405,000) (22,818,000)
Interest and other income received
90,000
230,000
Interest paid
(372,000)
(382,000)
Net cash provided by operating activities
412,000
1,310,000
Cash flows from investing activities:
Capital expenditures
(497,000)
(121,000)
Net cash used in investing activities
(497,000)
(121,000)
Cash flows from financing activities:
Proceeds from long-term debt
2,300,000
Principal payments on long-term debt
(255,000) (1,000,000)
Principal payments on note payable
(44,000)
Net cash provided by (used in) financing
activities
2,001,000 (1,000,000)
Net increase in cash and cash equivalents
1,916,000
189,000
Cash and cash equivalents, beginning of year 1,021,000
832,000
Cash and cash equivalents, end of year
$ 2,937,000 $ 1,021,000
(continued)
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Sample Not-for-Profit Health Maintenance Organization
Statements of Cash Flows
(continued)
Years Ended June 30, 20X5 and 20X4

20X5

Reconciliation of change in net assets to net
cash provided by operating activities:
$(782,000)
Change in net assets
Adjustments to reconcile change in net
assets to net cash provided by operating
activities:
370,000
Depreciation and amortization
19,000
Provision for bad debts
(Increase) decrease in:
30,000
Premiums receivables
230,000
Other current assets
Increase (decrease) in:
774,000
Accounts payable—medical services
Other accounts payable and accrued
(168,000)
expenses
(61,000)
Unearned premium revenue
$
412,000
Net cash provided by operating activities
See accompanying notes to financial statements.
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$ 590,000
339,000
20,000
64,000
(93,000)
335,000
(60,000)
115,000
$1,310,000
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Sample Not-for-Profit Health Maintenance Organization
Notes to Financial Statements7
June 30, 20X5 and 20X4
1. Organization

The Sample Health Maintenance Organization (the HMO) was incorporated
in 20X0 in New State as a not-for-profit corporation for the purpose of providing
comprehensive health care services on a prepaid basis and for the purpose of
establishing and operating organized health maintenance and health care
delivery systems.
The HMO has been determined to be a qualified health maintenance organi
zation under Title XIII of the Public Health Service Act.
2. Summary of Significant Accounting Policies8

Use o f estim ates. The preparation of financial statements in conformity with
generally accepted accounting principles requires management to make esti
mates and assumptions that affect the reported amounts of assets and liabili
ties and disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of revenues and expenses during the
reporting period. Actual results could differ from those estimates.
C ash a n d cash equivalents. Cash and cash equivalents include investments in
highly liquid debt instruments with an original maturity of three months or less.
S u pplies. Inventories of drugs and other supplies are stated at the lower of
cost (first-in, first-out) or market.
P roperty a n d equipm ent. Property and equipment are recorded at cost.
Maintenance and repairs are charged to expense, and betterments are capital
ized. Property and equipment costing approximately $700,000 was financed by
health maintenance organization initial development grants received in 20X1
and 20X2 from the U.S. Department of Health and Human Services (HHS).
This property will be owned by the HMO as long as the equipment and facilities
are used for projects related to the objectives of the Public Health Service Act.
Depreciation is computed using the straight-line method over the estimated
useful lives of the related assets as follows:
Building
40 years
Improvements
20—25 years
Data processing and laboratory
equipment and automobiles
3—7 years
Medical equipment
10 years
Office equipment
5-10 years
A m ortization o f d eb t issuance costs. Debt issuance costs are deferred and
amortized using the effective interest method over the term of the related debt.
H ealth care service cost recognition. The HMO contracts with various health
care providers for the provision of certain medical care services to its members.
7 SOP 00-1 provides auditors with guidance regarding uncertainties in health care revenue
recognition and includes a sample disclosure in paragraph 37 of the SOP for material differences
between an original estimate and subsequent revisions regarding third-party payments. SOP 00-1 is
included in Appendix E to this Guide.
8 Paragraph 13 of SOP 01-6, Accounting by Certain Entities (Including Entities With Trade
Receivables) That Lend to or Finance the Activities of Others, provides guidance on disclosures that
should be included in the summary of significant accounting policies, including accounting policies for
loans, trade receivables, and doubtful accounts.
AAG-HCO APP A

260

Health Care Organizations

The HMO compensates these providers on a capitation basis. As part of a cost
control incentive program, the HMO retains up to 20 percent of the capitation
as a risk-sharing fund. In the event of hospital utilization in excess of budget,
those providers bear the risk to the extent of 15 percent of the capitation fee.
Operating expenses include all amounts incurred by the HMO under the
aforementioned contracts.
The cost of other health care services provided or contracted for is accrued in
the period in which it is provided to a member based in part on estimates,
including an accrual for medical services provided but not reported to the HMO.
P rem iu m s revenue. Membership contracts are on a yearly basis subject to
cancellation by the employer group or the HMO upon 30 days written notice.
Premiums are due monthly and are recognized as revenue during the period in
which the HMO is obligated to provide services to members.
R ein surance (stop-loss insurance). Reinsurance premiums are reported as
health care costs, and reinsurance recoveries are reported as a reduction of
related health care costs.
F ederal incom e tax. The HMO is exempt from federal income taxes under
Sec. 501(c)(4) of the Internal Revenue Code; accordingly, no provision for
federal income taxes has been made in the accompanying financial statements.
3. Property and Equipment

Property and equipment at June 30, 20X5 and 20X4, consists of the following:

Land
Buildings and improvements
Furniture and equipment
Less accumulated depreciation

20X 5

20X 4

$ 300,000
5,473,000
1,786,000
7,559,000
(1,803,000)
$5,756,000

$ 300,000
5,459,000
1,303,000
7,062,000
(1,436,000)
$5,626,0004

4. Long-Term Debt

Long-term debt is collateralized by assets with a depreciated cost of
$4,943,000. A summary of long-term debt at June 30, 20X5 and 20X4, follows.
HHS loan, interest at 7.5 percent, payable in
monthly installments of $50,000, including
interest
HHS loan, interest at 9.25 percent, payable
in monthly installments of $10,000,
including interest
Secured equipment loans, payable in
monthly installments of $15,000, including
interest
Less current maturities
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20X 4

$2,020,000

$ 111,000

1,658,000

1,694,000

858,000
4,536,000
241,000
$4,295,000

686,000
2,491,000
109,000
$2,382,000
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Scheduled principal payments on long-term debt are as follows:
Year Ending December 31,
20X6
20X7
20X8
20X9
20Y0

Amount
$ 241,000
259,000
280,000
800,000
2,956,000
$4,536,000

5. State Guarantee Fund Deposit

In August 20X4 the state in which the HMO is domiciled enacted legislation
specifically governing HMOs. Under this legislation, the corporation is required
to maintain a deposit of $150,000 with the director of the division of insurance
of the state.
6. Employee Retirement Plan

The HMO has a contributory defined contribution retirement plan covering
substantially all employees. Expense determined in accordance with the plan
formula (4 percent to 10 percent of eligible covered compensation) was $354,000
and $275,000 for the years ended June 30, 20X5 and 20X4, respectively.
7. Stop-Loss Insurance

The HMO entered into a stop-loss insurance agreement with an insurance
company to limit its losses on individual claims. Under the terms of this
agreement, the insurance company will reimburse the HMO approximately 25
percent of the cost of each member’s annual hospital services, in excess of a
$1,000 deductible, up to a lifetime limitation of $500,000 per member. In the
event the HMO ceases operations, (a) plan benefits will continue for members
who are confined in an acute care hospital on the date of insolvency until their
discharge, and (b) plan benefits will continue for any other member until the
end of the contract period for which premiums have been paid.
Stop-loss insurance premiums of approximately $700,000 and $500,000 are
included in insurance expense (Note 9) in 20X5 and 20X4, respectively. Ap
proximately $600,000 and $400,000 in stop-loss insurance recoveries are de
ducted from insurance expense in 20X5 and 20X4, respectively.
Included in other receivables is approximately $50,000 recoverable from
insurers.
8. Malpractice Claims

Malpractice claims have been asserted against the HMO by various claim
ants. The claims are in various stages of processing, and some may ultimately
be brought to trial. In the opinion of counsel, the outcome of these actions will
not have a significant effect on the financial position or the operating income
of the HMO. Incidents occurring through June 30, 20X5, may result in the
assertion of additional claims. Other claims may be asserted arising from past
services provided. Management believes that these claims, if asserted, would
be settled within the limits of insurance coverage.
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9. Classification of Expenses

Program activities
General and administrative
10.
11.
12.
13.
14.

20X 5

20X 4

26,921,000
2,474,000
$29,395,000

20,909,000
1,601,000
$22,510,000

Risks and Uncertainties Disclosures##
Pension Plan##
Postretirement Benefits##
Fair Value of Financial Instruments##
Concentrations of Credit Risk##

## The disclosures contained in these notes would be similar to the disclosures contained in the
notes to the financial statements for the not-for-profit hospital and, therefore, are not repeated here.
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ILLUSTRATIVE FINANCIAL STATEMENTS FOR AN
AMBULATORY CARE ORGANIZATION
Sample Not-for-Profit Ambulatory Care, Inc.
Balance Sheets
December 31, 20X5 and 20X4

20X5

20X4

$ 65,000

$ 76,000

290,000
19,000
13,000
21,000
5,000
413,000

278,000
32,000
8,000
18,000
9,000
421,000

100,000
322,000
682,000
1,390,000
2,494,000
217,000
2,277,000

100,000
322,000
682,000
1,389,000
2,493,000
100,000
2,393,000

14,000
$2,704,000

5,000
$2,819,000

Current liabilities:
Notes payable
$ 138,000
Accounts payable
42,000
Accrued payroll, benefits, and taxes
33,000
Estimated retroactive
adjustments—third-party payors
30,000
Financing advance from third-party payors
—
Total current liabilities
243,000
Guarantee liability
10,000
Total liabilities
253,000
Net assets—unrestricted
2,451,000
Total liabilities and net assets
$2,704,000
See accompanying notes to financial statements.

$ 144,000
77,000
22,000
24,000
1,000
268,000
10,000
278,000
2,541,000
$2,819,000

Assets

Current assets:
Cash
Patient accounts receivable, net of allowance
for doubtful accounts of $15,000 in 20X5 and
$5,000 in 20X4
Estimated retroactive
adjustments—third-party payors
Accounts receivable—other
Supplies
Prepaid expenses and deposits
Total current assets
Property and equipment, at cost:
Land
Land improvements
Buildings
Equipment
Less accumulated depreciation
Property and equipment, net
Other assets:
Advances receivable
Total assets

Liabilities and Net Assets
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Sample Not-for-Profit Ambulatory Care, Inc.
Statements of Operations and Changes
in Net Assets
Years Ended December 31, 20X5 and 20X4

20X5
Revenue and gains:
$ 860,000
Net patient service revenue
29,000
Other
889,000
Total revenue and gains
Expenses:
485,000
Salaries and benefits
189,000
Medical supplies and drugs
154,000
Insurance
14,000
Provision for bad debts
117,000
Depreciation
20,000
Interest
979,000
Total expenses
(90,000)
Operating loss
2,541,000
Net assets, beginning of year
$2,451,000
Net assets, end of year
See accompanying notes to financial statements.
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20X4
$ 357,000
15,000
372,000
243,000
66,000
98,000
4,000
100,000
18,000
529,000
(157,000)
2,698,000
$2,541,000
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Sample Not-for-Profit Ambulatory Care, Inc.
Statements of Cash Flows
Years Ended December 31, 20X5 and 20X4

Cash flows from operating activities:
Cash received from patients and third-party
payors
Cash received from others
Interest received
Interest paid
Cash paid to employees and suppliers
Net cash provided by (used in) operating
activities
Cash flows from investing activities:
Purchase of equipment
Advances made to XYZ Affiliate
Net cash used in investing activities
Cash flows from financing activities:
Proceeds from notes payable
Payments on notes payable
Net cash provided by (used in) financing
activities
Net increase (decrease) in cash
Cash, beginning of year
Cash, end of year

20X5

20X4

$866,000
21,000
3,000
(15,000)
(870,000)

$368,000
6,000
11,000
(16,000)
(432,000)

5,000

(63,000)

(1,000)
(9,000)
(10,000)

(4,000)
(5,000)
(9,000)

—
(6,000)

144,000

(6,000)
(11,000)
76,000
$ 65,000

144,000
72,000
4,000
$ 76,000
(continued)
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Sample Not-for-Profit Ambulatory Care, Inc.
Statements of Cash Flows
(continued)
Years Ended December 31, 20X5 and 20X4

20X5

Reconciliation of change in net assets to net
cash provided by (used in) operating
activities:
Change in net assets
$ (90,000)
Adjustments to reconcile change in net assets
to net cash provided by (used in) operating
activities:
Depreciation
117,000
Provision for bad debts
14,000
(Increase) decrease in:
Patient accounts receivable
(12,000)
Other current assets
1,000
Increase (decrease) in:
Accounts payable and accrued payroll,
benefits, and taxes
(24,000)
Other current liabilities
(1,000)
Net cash provided by (used in) operating
activities
$ 5,000
See accompanying notes to financial statements.
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Sample Not-for-Profit Ambulatory Care, Inc.
Notes to Financial Statements
December 31, 20X5 and 20X4
1. Description of Organization and Summary of Significant Accounting
Policies9

O rgan ization . Ambulatory Care, Inc. was incorporated on September 7,
20X3, in New State, to operate an ambulatory care health facility to treat or
prevent injury and disease, to provide funds or to expend funds to further the
treatment or prevention of injury or disease, and to develop and participate in
activities designed to promote the general health of the community.
Three area hospitals—ABC Hospital and Health Center, DEF Hospital, and
GHI Hospital—entered into a members’ agreement to develop this ambulatory
care center. In accordance with this agreement, each hospital contributed
capital of $947,000 to Ambulatory Care, Inc. Ambulatory Care, Inc. began
operations in October 20X3.
Use o f estim ates. The preparation of financial statements in conformity with
generally accepted accounting principles requires management to make esti
mates and assumptions that affect the reported amounts of assets and liabili
ties and disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of revenues and expenses during the
reporting period. Actual results could differ from those estimates.
S u pplies. Supplies are stated at the lower of cost (first-in, first-out) or net
realizable value.
D epreciation. Depreciation of property and equipment is computed on the
straight-line method over the estimated lives of depreciable assets.
T h ird-party contractual adju stm en ts. Retroactively calculated third-party
contractual adjustments are accrued on an estimated basis in the period the
related services are rendered. Net patient service revenue is adjusted as
required in subsequent periods based on final settlements.
N et p a tie n t service revenue. Patient service revenue is reported at the esti
mated net realizable amounts from patients, third-party payors, and others for
services rendered.
C h arity care. Ambulatory Care, Inc. has a policy of providing charity care to
patients who are unable to pay. Such patients are identified and related charges
are estimated, based on financial information obtained from the patient and
subsequent analysis. Since management does not expect payment for charity
care, the estimated charges are excluded from revenue.
Incom e taxes. Ambulatory Care, Inc. has been recognized by the Internal
Revenue Service as a not-for-profit corporation as described in Sec. 501(c)(3) of
the Internal Revenue Code (IRC) and is exempt from federal income taxes on
related income pursuant to Sec. 501(a) of the IRC.
9 Paragraph 13 of SOP 01-6, Accounting by Certain Entities (Including Entities With Trade
Receivables) That Lend to or Finance the Activities of Others, provides guidance on disclosures that

should be included in the summary of significant accounting policies, including accounting policies for
loans, trade receivables, and doubtful accounts.
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2. Advances Receivable

In May 20X4, Ambulatory Care, Inc. entered into a five-year agreement with
XYZ Affiliates (XYZ). Under this agreement, XYZ is to provide emergency
medical services as well as charge and bill each patient treated at Ambulatory
Care, Inc. Ambulatory Care, Inc. has guaranteed that XYZ will collect at least
$18,000 per month during the term of this agreement. In any month in which
XYZ does not collect the minimum guarantee, Ambulatory Care, Inc. advances
funds to XYZ to cover the deficiency. Such advances are to be repaid to the
extent XYZ’s net cash collections exceed the minimum guarantee amount.
Management estimates that the advances will be fully recovered in 20X8.
3. Related-Party Transactions

During 20X3, Ambulatory Care, Inc. entered into a contract with one of the
member hospitals (the managing hospital) for the management of the business
and affairs of Ambulatory Care, Inc. Under this agreement, Ambulatory Care,
Inc. pays $4,000 per month to the managing hospital. The agreement with the
managing hospital was to remain in effect through December 31, 20X5, but has
been extended on a month-to-month basis.
In addition, during 20X4 each hospital loaned $48,000 to Ambulatory Care,
Inc. in the form of promissory notes at an interest rate of prime rate plus 1
percent (effective rates of 10 percent and 9 percent in 20X5 and 20X4, respec
tively). Of the total $144,000 liability, $48,000 is payable on demand after
November 28, 20X5, to one member hospital, with the remaining portion
($96,000) payable on demand after December 8, 20X5, to the other two member
hospitals. During 20X5, Ambulatory Care, Inc. paid $2,000 to each member
hospital, thereby reducing the obligation to $138,000.
4. Revenue From Contracting Agencies

Ambulatory Care, Inc. participates as a provider of health care services to Blue
Cross, Medicare, and County Indigent Plan patients. Reimbursement for covered
services is based on tentative payment rates. Final reimbursement is determined
after submission of annual cost reports and audits thereof by the fiscal intermedi
aries. Provisions for estimated reimbursement adjustments are reported in the
financial statements in the period that the services are rendered.
Revenue from the Medicare program accounted for approximately XX percent
for the year ended 20X5, and XX percent for the year ended 20X4, of Ambulatory
Care, Inc.’s net patient revenue. Laws and regulations governing the Medicare
program are extremely complex and subject to interpretation. As a result, there
is at least a reasonable possibility that recorded estimates will change by a
material amount in the near term. The 20X5 net patient service revenue
increased approximately $XXX due to removal of allowances previously esti
mated that are no longer necessary as a result of final settlements and years
that are no longer subject to audits, reviews, and investigations. The 20X4 net
patient service revenue decreased approximately $XXX due to prior-year ret
roactive adjustments in excess of amounts previously estimated.
5. Charity Care

Ambulatory Care, Inc. has a policy of providing charity care to indigent
patients in emergency situations. These services, which are excluded from
revenues, amounted to $27,000 and $13,000 in 20X5 and 20X4, respectively,
when measured at Ambulatory Care, Inc.’s established rates.
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6.

Classification of Expenses

Expenses incurred
for the year
ended December
31, 20X5, were
for:
Salaries and
benefits
Medical supplies
and drugs
Insurance
Provision for bad
debts
Depreciation
Interest
Total expenses

Total

$485,000
189,000
154,000
14,000
117,000
20,000
$979,000

__ Total

Expenses incurred
for the year
ended December
31, 20X4, were
for:
Salaries and
benefits
$243,000
Medical supplies
and drugs
66,000
Insurance
98,000
Provision for
bad debts
4,000
Depreciation
100,000
Interest
18,000
Total expenses $529,000

____________ Program_____________
A
B
C

$216,000
98,000
79,000
9,000
100,000
9,000
$511,000

$102,000
43,000
45,000
—
—
—

$190,000

$121,000
48,000
14,000
5,000
17,000
—

$205,000

______________Program______________
A
B
C

$111,000
31,000
45,000
—
56,000
7,000
$250,000

$46,000
15,000
19,000
4,000
—
—
$84,000

$ 57,000
20,000
26,000
—
44,000
—
$147,000

General and
Administrative

$46,000
—

16,000
—

11,000
$73,000
General and
Adm inistrative

$29,000
—
8,000
—
—
11,000
$48,000

(The preparer of the financial statements may wish to include a brief descrip
tion of the types of programs.)
7. Risks and Uncertainties Disclosures***
8. Pension Plan***
9. Postretirement Benefits***
10. Fair Value of Financial Instruments***
11. Concentrations of Credit Risk***

*The disclosures contained in these notes would be similar to the disclosures contained in the
notes to the financial statements for the not-for-profit hospital and, therefore, are not repeated here.
AAG-HCO APP A

Background Information and Basis for Conclusions

271

Appendix B
Background Information and Basis
for Conclusions

1. This appendix provides background information and discusses the
comments received on the April 14, 1995 exposure draft that preceded this
Audit and Accounting Guide (Guide)— Proposed Audit and Accounting Guide
H ealth Care O rgan ization s and the basis for key conclusions in this Guide.
Background Information

2. In 1989, the AICPA Health Care Committee (“the Committee”) com
pleted a total rewrite of the Guide. Since then, conforming changes have been
made to update the Guide for newly issued technical pronouncements. In June
1993, the FASB issued FASB Statement No. 116, A ccounting for C ontributions
R eceived a n d C on tribution s M ade (“Contributions”), and FASB Statement No.
117, F in an cial S tatem en ts o f N ot-for-P rofit O rgan ization s (“Display”). These
Statements provide broad standards and introduce new concepts for which
there is no detailed implementation guidance. FASB Statement No. 117 per
mits the AICPA to provide more specific reporting guidance. Specifically,
paragraph 3 of FASB Statement No. 117 states:
“Within the parameters of the Statement, the AICPA or another appropriate
body, following the process described in AICPA Statement of Auditing Stand
ards (SAS) No. 69, The Meaning of Present Fairly in Conformity With Generally
Accepted Accounting Principles in the Independent Auditor’s Report, may
provide more specific reporting guidance for certain not-for-profit organiza
tions.”

The Guide provides this guidance as it relates to providers of health care
services.
3. In April 1995, the Committee released an exposure draft of a proposed
Audit and Accounting Guide H ealth Care O rgan ization s (ED) for public com
ment. The committees received 40 comment letters on the ED. The committees
redeliberated the issues based on the comments received. This appendix dis
cusses the key issues in the ED and comments received on those issues, as well
as the basis for AcSEC’s conclusions on those and certain other issues.
Basis for Conclusions
Contributions and Display

4.
FASB Statements No. 116 and No. 117 allow more flexibility in finan
cial reporting than currently exists within the health care industry. The most
prominent flexibility relates to the elimination of the requirements to present
a classified balance sheet and income statement as compared to the statement
of activities.
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5. FASB Statements No. 116 and No. 117 apply to all not-for-profit
enterprises, regardless of whether or not the entity is a business enterprise.
The majority of tax-exempt health care organizations, however, operate as
business enterprises (i.e., are essentially self-sustaining from fees charged for
goods and services). The Committee believes that the uniformity and useful
ness of financial reporting for business enterprise organizations would be
enhanced if the implementation guidance for FASB Statements No. 116 and
No. 117 were consistent with the objectives of business enterprise financial
reporting. The Committee points to the provisions in FASB Concept Statement
No. 4, paragraph 8, which clearly supports the use of business enterprise
financial reporting objectives for those organizations:
“Some organizations have no ownership interest but are essentially self-sus
taining from fees they charge for goods and services. Examples are those private
nonprofit hospitals...that may receive relatively small amounts of contributions
and grants, but finance their capital needs largely from the proceeds of debt
issues and their operating needs largely from service charges rather than from
private philanthropy or governmental grants. As a result, assessments of
amounts, timing, and uncertainty of cash flows become the dominate interest
of their creditors and other resource providers and profitability becomes an
important indicator of performance. Consequently, the objectives of Concepts
Statement 1 may be more appropriate for those organizations.”

6. Based on the theoretical support provided in FASB Concepts State
ment No. 4, as well as the FASB allowance for more specific guidance (see
paragraph 2 of this appendix), Chapter 1 of the Guide defines four types of
operating structures that are found within the industry: (1) not-for-profit
business-oriented organizations, (2) investor-owned health care enterprises,
(3) governmental health care organizations, and (4) not-for-profit, nonbusi
ness-oriented organizations. This Guide provides specific reporting guidance
for not-for-profit business-oriented organizations, investor-owned enterprises
and governmental entities. (Not-for-profit nonbusiness organizations follow
guidance for not-for-profit entities provided in the Audit and Accounting Guide
Not-for-Profit Organizations.) The Guide recommends that these entities pro
vide a classified balance sheet and a statement of operations. The Guide also
encourages natural class reporting on the face of the financial statements, with
disclosure of functional details in the footnotes.
7. A number of respondents to the ED were concerned that because the
exposure draft of the Guide did not require an entity to distinguish between
operating activities and nonoperating activities that such distinctions were no
longer permissible. In response to these concerns, the Guide was clarified to
incorporate paragraph 23 of FASB Statement No. 117. This paragraph specifi
cally allows additional classifications within a statement of operations. Like
FASB Statement No. 117, however, the Guide neither requires nor precludes
such classifications.
Assets W hose Use is Limited

8. Several comments were received on the ED requesting specific guid
ance to allow internally designated funds to be disclosed on the face of the
financial statements. In response to these comments, the Committee clarified
the Guide to require cash and claims to cash that meet one of the following
criteria to be reported separately and excluded from current assets:
a. restricted as to withdrawal or use for other than current operations,
b. designated for expenditure in the acquisition or construction of
noncurrent assets,
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required to be segregated for the liquidation of long-term debts, or
required by a donor-imposed restriction that limits their use to
long-term purposes.
Consistent with comments received from a rating agency, the Guide requires
internally designated funds to be reported separately from externally desig
nated funds either in the notes to or on the face of the financial statements. The
Committee believes this separation is beneficial due to the degree of control an
organization maintains over internally designated funds.
c.
d.

Investments

9. Chapter 4, as presented in the Exposure Draft, was re-drafted to
conform with the provisions of FASB Statement No. 124, C ertain Investm ents
H eld by N ot-F or-P rofit O rgan ization s. This Standard requires fair value ac
counting for marketable equity and debt securities. The majority of respon
dents to the ED favored an income recognition approach similar to FASB
Statement No. 115, A ccounting for C ertain Investm ents in D ebt a n d E qu ity
Securities. They believe such an approach is essential because it would foster
greater consistency among not-for-profit and for-profit entities. Accordingly,
an approach similar to FASB Statement No. 115 (i.e., the differentiation of
trading securities vs. available-for-sale securities) was incorporated into the
Guide. (The FASB specifically prohibited the use of a held-to-maturity category
by not-for-profit organizations.)
Accounting for Donor-Imposed Restricted Contributions on
Long-Lived Assets

10. The majority of comments received on accounting for donor-imposed
restrictions on contributions of long-lived assets concurred with the Health
Care Committee’s conclusion that the expiration of donor imposed restrictions
on long-lived assets should be recognized when the asset is placed in service
(rather than as depreciated as permitted by FASB Statement No. 116). Other
respondents disagreed with the Health Care Committee’s position for various
reasons. After considering each comment on the issue, the Committee con
cluded that it would maintain the position set forth in the ED. The Committee
believes this approach is easier to implement, it provides for uniformity in
reporting within the industry and, because the donations are excluded from
operating results, an appropriate matching of revenues and expenses occurs.
Use of a Performance Indicator

11. The Guide stresses the importance of the performance indicator and,
in an effort to ensure consistency within the industry, provides specific guid
ance on what the performance indicator should represent. This guidance is
consistent with performance criteria historically used in the health care indus
try, to the extent allowed under the provisions of FASB Statement No. 117.
Specifically, the Guide states that health care organizations should report the
results of their operations separately from—
a. Transactions with owners acting in that capacity.
b. Equity transfers involving other entities that control the reporting
entity, are controlled by the reporting entity, or are under common
control with the reporting entity.
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c. Receipt of restricted contributions, including temporary restrictions
(such as time or purpose) or permanent restrictions.
d. Contributions of (and assets released from donor restrictions related
to) long-lived assets.
e. Unrealized gains and losses on investments not restricted by donors
or by law, except for those investments classified as trading securi
ties.
f. Investment returns restricted by donors or by law.
g. Other items that are required by GAAP to be reported separately
(such as extraordinary items, the effect of discontinued operations,
or the cumulative effect of accounting changes).1
12. In its deliberations, the FASB discussed the use of the word net
income to describe the performance indicator of not-for-profit health care
organizations. The Board concluded that the term net income is an inappropri
ate term to describe the performance indicator of a not-for-profit organization
and that descriptive terms such as revenues over expenses, revenues and gains
over expenses and losses, earned income or performance earnings would be more
appropriate. Accordingly, this Guide requires the use of such descriptive terms
instead of net income to describe the performance indicator of not-for-profit
organizations.
Definition of a Governmental Entity

13. Subsequent to the release of the ED, the FASB and the GASB agreed
on the definition of a governmental entity. Paragraph 1.02 of the Guide
incorporates that definition.
Effective Date

14. Several comment letters were received expressing concern about the
effective date of the Guide. In response to these comments, the Committee
revised the effective date to fiscal years beginning after June 15, 1996, with
earlier application permitted.
Status of Audit and Accounting Guides in the
GAAP Hierarchy

15. In several instances the Guide provides more specific reporting re
quirements than FASB Statements No. 116 and No. 117 (see paragraphs 4
through 6, 8, 10, and 11). In the deliberation of the Guide, the question has
arisen regarding the status of the Guide in the GAAP hierarchy, given the fact
that AICPA Audit and Accounting Guides are “Level B” GAAP while FASB
Statements are “Level A”. In discussing the issue the Committee and the
Accounting Standards Executive Committee referred to paragraph 49 of FASB
Statement No. 117, which states that the AICPA:
“may provide more specific reporting guidance for certain not-for profit organi
zations. SAS 69 requires that an entity adopt cleared AICPA Industry Audit
and Accounting Guides, and cleared AICPA Statements of Position that become

1 Governmental enterprises should report extraordinary items and the effect of discontinued
operations in the statement of operations immediately preceding net income; the cumulative effect of
an accounting change should be reported as an adjustment to beginning fund balance in the period of
the change. Investor-owned enterprises should report extraordinary items, the effect of discontinued
operations and the cumulative effect of an accounting change in the statement of operations immedi
ately preceding net income.
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effective after March 15 , 1992. As used in SAS 69, cleared means that the FASB
has indicated that it does not object to the issuance of the proposed pronounce
ment.”

The FASB has indicated that it does not object to the more specific reporting
requirements contained in this Guide for health care organizations.
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Appendix C

Statement of
Position

98-2

Accounting for Costs of
Activities of Not-for-Profit
Organizations and State and
Local Governmental Entities
That Include Fund Raising
March 11,1998

Amendment to
AICPA Audit and Accounting Guides
Health Care Organizations,
Not-for-Profit Organizations, and
Audits of State and Local Governmental Units§
Issued by the Accounting
Standards Executive Committee
§ The AICPA Audit and Accounting Guide State and Local Governments, supersedes the 1994
AICPA Audit and Accounting Guide Audits of State and Local Governmental Units, and subsequent
editions of that Guide with conforming changes made by the AICPA staff. AICPA Audit and Account
ing Guide State and Local Governments, provides guidance on the application of this Statement of
Position (SOP) to state and local governments. [Footnote added, June 2004, to reflect conforming
changes due to the issuance of the AICPA Audit and Accounting Guide State and Local Governments.]
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NOTE

Statements of Position on accounting issues present the conclusions
of at least two-thirds of the Accounting Standards Executive Com
mittee, which is the senior technical body of the Institute authorized
to speak for the Institute in the areas of financial accounting and
reporting. Statement on Auditing Standards No. 69, The Meaning of
Present Fairly in Conformity With Generally Accepted Accounting
Principles, identifies AICPA Statements of Position that have been
cleared by either the Financial Accounting Standards Board (for
financial statements of nongovernmental entities) or the Govern
mental Accounting Standards Board (for financial statements of
state and local governmental entities), as sources of established
accounting principles in category b of the hierarchy of generally
accepted accounting principles that it establishes. AICPA members
should consider the accounting principles in this Statement of Posi
tion if a different accounting treatment of a transaction or event is
not specified by a pronouncement covered by Rule 203 of the AICPA
Code of Professional Conduct. In such circumstances, the accounting
treatment specified by this Statement of Position should be used, or
the member should be prepared to justify a conclusion that another
treatment better presents the substance of the transaction in the
circumstances.
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SUMMARY

This Statement of Position (SOP) applies to all nongovernmental not-for-profit
organizations (NPOs) and all state and local governmental entities that solicit
contributions.
This SOP requires—
• If the criteria of purpose, audience, and content as defined in this SOP
are met, the costs of joint activities that are identifiable with a
particular function should be charged to that function and joint costs
should be allocated between fund raising and the appropriate program
or management and general function.
• If any of the criteria of purpose, audience, and content are not met, all
costs of the activity should be reported as fund-raising costs, including
costs that otherwise might be considered program or management and
general costs if they had been incurred in a different activity, subject
to the exception in the following sentence. Costs of goods or services
provided in exchange transactions that are part ofjoint activities, such
as costs of direct donor benefits of a special event (for example, a meal),
should not be reported as fund raising.
• Certain financial statement disclosures if joint costs are allocated.
• Some commonly used and acceptable allocation methods are described
and illustrated although no methods are prescribed or prohibited.
This SOP amends existing guidance in AICPA Audit and Accounting Guides
Health Care Organizations, Not-for-Profit Organizations (which was issued in
August 1996 and supersedes SOP 87-2, Accounting for Joint Costs of Informa
tional Materials and Activities of Not-for-Profit Organizations That Include a
Fund-Raising Appeal, because the provisions of SOP 87-2 are incorporated into
the Guide), and Audits of State and Local Governmental Units.§
This SOP is effective for financial statements for years beginning on or after
December 15, 1998. Earlier application is encouraged in fiscal years for which
financial statements have not been issued. If comparative financial statements
are presented, retroactive application is permitted but not required.*

§ The AICPA Audit and Accounting Guide State and Local Governments, supersedes the 1994
AICPA Audit and Accounting Guide Audits of State and Local Governmental Units, and subsequent
editions of that Guide with conforming changes made by the AICPA staff. AICPA Audit and Account
ing Guide State and Local Governments, provides guidance on the application of this Statement of
Position (SOP) to state and local governments. [Footnote added, June 2004, to reflect conforming
changes due to the issuance of the AICPA Audit and Accounting Guide State and Local Governments.]
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FOREWORD
The accounting guidance contained in this document has been cleared by the
Financial Accounting Standards Board (FASB) and the Governmental Account
ing Standards Board (GASB). The procedure for clearing accounting guidance
in documents issued by the Accounting Standards Executive Committee (Ac
SEC) involves the FASB and the GASB reviewing and discussing in public
board meetings (1) a prospectus for a project to develop a document, (2) a
proposed exposure draft that has been approved by at least ten of AcSEC’s
fifteen members, and (3) a proposed final document that has been approved by
at least ten of AcSEC’s fifteen members. The document is cleared if at least five
of the seven FASB members and three of the five GASB members do not object
to AcSEC undertaking the project, issuing the proposed exposure draft or, after
considering the input received by AcSEC as a result of the issuance of the
exposure draft, issuing the final document.†
The criteria applied by the FASB and the GASB in their review of proposed
projects and proposed documents include the following:
1. The proposal does not conflict with current or proposed accounting
requirements, unless it is a limited circumstance, usually in special
ized industry accounting, and the proposal adequately justifies the
departure.
2. The proposal will result in an improvement in practice.
3. The AICPA demonstrates the need for the proposal.
4. The benefits of the proposal are expected to exceed the costs of
applying it.
In many situations, prior to clearance, the FASB and the GASB will propose
suggestions, many of which are included in the documents.

† This document was cleared prior to July 1, 1997. In July 1997, the GASB increased to seven
members. Documents considered by the GASB after July 1, 1997 are cleared if at least four of the
seven GASB members do not object. [Footnote renumbered, June 2004, to reflect conforming changes
necessary due to the issuance of the AICPA Auidt and Accounting Guide State and Local Govern
ments.]
AAG-HCO APP C

283

Statement of Position 98-2

Accounting for Costs of Activities of
Not-for-Profit Organizations and
State and Local Governmental Entities
That Include Fund Raising
Introduction

1. Some nongovernmental not-for-profit organizations (NPOs) and
some state and local governmental entities,1 such as governmental colleges
and universities and governmental health care providers, solicit support
through a variety of fund-raising activities.12 These activities include direct
mail, telephone solicitation, door-to-door canvassing, telethons, special events,
and others. Sometimes fund-raising activities are conducted with activities
related to other functions, such as program activities or supporting services,
such as management and general activities.34 Sometimes fund-raising
activities include components that would otherwise be associated with pro
gram or supporting services, but in fact support fund raising.
2. External users of financial statements—including contributors, credi
tors, accreditation agencies, and regulators—want assurance that fund-raising
costs, as well as program costs and management and general costs, are stated
fairly.
3. In 1987, the AICPA issued Statement of Position (SOP) 87-2, Account
ing for Joint Costs of Informational Materials and Activities of Not-for-Profit
Organizations That Include a Fund-Raising Appeal.4 SOP 87-2 required that
1 This Statement of Position (SOP) uses the term entity to refer to both nongovernmental
not-for-profit organizations (NPOs) and state and local governments.
2 Terms that appear in the Glossary are set in boldface type the first time they appear.
3 The functional classifications of fund raising, program, and management and general are
discussed throughout this SOP for purposes of illustrating how the guidance in this SOP would be
applied by entities that use those functional classifications. Some entities have a functional structure
that does not include fund raising, program, or management and general, or that includes other
functional classifications, such as membership development. This SOP is not intended to require
reporting the functional classifications of fund raising, program, and management and general. In
circumstances in which entities that have a functional structure that includes other functional
classifications conduct joint activities, all costs of those joint activities should be charged to fund
raising (or the category in which fund raising is reported—see the following two parenthetical
sentences), unless the purpose, audience, and content of those joint activities are appropriate for
achieving those other functions. (An example of an entity that reports fund raising in a category other
than fund raising is a state and local governmental entity applying the accounting and financial
reporting principles in the AICPA Industry Audit Guide Audits of Colleges and Universities, as
amended by SOP 74-8. As discussed in paragraph D.5 of this SOP, those entities are required to
report fund raising as part of the “institutional support” function. See also footnote ** to paragraph
D.5.) [Footnote revised, June 2004, to reflect conforming changes necessary due to the issuance of
GASB Statements No. 34 and No. 35.]
4 In August 1996, the AICPA issued the Audit and Accounting Guide Not-for-Profit Organiza
tions. The Guide supersedes SOP 87-2, Accounting for Joint Costs of Informational Materials and
Activities of Not-for-Profit Organizations That Include a Fund-Raising Appeal, because the provi
sions of SOP 87-2 are incorporated into paragraphs 13.36 to 13.45 of Not-for-Profit Organizations.
Not-for-Profit Organizations applies to all nongovernmental NPOs other than those required to
follow the Audit and Accounting Guide Health Care Organizations. The discussion in this SOP of SOP
87-2 refers to both SOP 87-2 and the guidance included in paragraphs 13.36 to 13.45 of Not-for-Profit
Organizations. Also, SOP 87-2 was not applicable to entities that are within the scope of Governmen
tal Accounting Standards Board (GASB) Statement No. 29, The Use of Not-for-Profit Accounting and
Financial Reporting Principles by Governmental Entities.
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all circumstances concerning informational materials and activities that in
clude a fund-raising appeal be considered in accounting for joint costs of those
materials and activities and that certain criteria be applied in determining
whether joint costs of those materials and activities should be charged to fund
raising or allocated to program or management and general. Those criteria
include requiring verifiable indications of the reasons for conducting the activ
ity, such as the content, audience, and action, if any, requested of the partici
pant, as well as other corroborating evidence. Further, SOP 87-2 required that
all joint costs of those materials and activities be charged to fund raising unless
the appeal is designed to motivate its audience to action other than providing
financial support to the organization.
4. The provisions of SOP 87-2 have been difficult to implement and have
been applied inconsistently in practice. (Appendix B, “Background,” discusses
this further.)
5. This SOP establishes financial accounting standards for accounting for
costs of joint activities. In addition, this SOP requires financial statement
disclosures about the nature of the activities for which joint costs have been
allocated and the amounts ofjoint costs. Appendix F provides explanations and
illustrations of some acceptable allocation methods.
Scope

6. This SOP applies to all nongovernmental NPOs and all state and local
governmental entities that solicit contributions.
Conclusions
Accounting for Joint Activities

7. If the criteria of purpose, audience, and content are met, the costs of a
that are identifiable with a particular function should be
charged to that function and joint costs should be allocated between fund
raising and the appropriate program or management and general function. If
any of the criteria are not met, all costs of the joint activity should be reported
as fund-raising costs, including costs that otherwise might be considered
program or management and general costs if they had been incurred in a
different activity, subject to the exception in the following sentence. Costs of
goods or services provided in exchange transactions that are part of joint
activities, such as costs of direct donor benefits of a special event (for example,
a meal), should not be reported as fund raising.

joint activity

Purpose

8. The purpose criterion is met if the purpose of the joint activity includes
accomplishing program or management and general functions. (Paragraphs 9
and 10 provide guidance that should be considered in determining whether the
purpose criterion is met. Paragraph 9 provides guidance pertaining to program
functions only. Paragraph 10 provides guidance pertaining to both program
and management and general functions.)
9. Program functions. To accomplish program functions, the activity
should call for specific action by the audience that will help accomplish
the entity’s mission. For purposes of applying the guidance in this SOP, the
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following are examples of activities that do and do not call for specific action by
the audience that will help accomplish the entity’s mission:
• An entity’s mission includes improving individuals’ physical health.
For that entity, motivating the audience to take specific action that
will improve their physical health is a call for specific action by the
audience that will help accomplish the entity’s mission. An example
of an activity that motivates the audience to take specific action that
will improve their physical health is sending the audience a brochure
that urges them to stop smoking and suggests specific methods,
instructions, references, and resources that may be used to stop
smoking.
• An entity’s mission includes educating individuals in areas other than
the causes, conditions, needs, or concerns that the entity’s programs
are designed to address (referred to hereafter in this SOP as “causes”).
For that entity, educating the audience in areas other than causes or
motivating the audience to otherwise engage in specific activities that
will educate them in areas other than causes is a call for specific action
by the audience that will help accomplish the entity’s mission. Exam
ples of entities whose mission includes educating individuals in
areas other than causes are universities and possibly other entities.
An example of an activity motivating individuals to engage in educa
tion in areas other than causes is a university inviting individuals to
attend a lecture or class in which the individuals will learn about the
solar system.
• Educating the audience about causes or motivating the audience to
otherwise engage in specific activities that will educate them about
causes is not a call for specific action by the audience that will help
accomplish the entity’s mission. Such activities are considered in
support of fund raising. (However, some educational activities that
might otherwise be considered as educating the audience about causes
may implicitly call for specific action by the audience that will help
accomplish the entity’s mission. For example, activities that educate
the audience about environmental problems caused by not recycling
implicitly call for that audience to increase recycling. If the need for
and benefits of the specific action are clearly evident from the educa
tional message, the message is considered to include an implicit call
for specific action by the audience that will help accomplish the entity’s
mission.)
• Asking the audience to make contributions is not a call for specific
action by the audience that will help accomplish the entity’s mission.
If the activity calls for specific action by the audience that will help accomplish
the entity’s mission, the guidance in paragraph 10 should also be considered in
determining whether the purpose criterion is met.
10.
Program and management and general functions. The following fac
tors should be considered, in the order in which they are listed,5 to determine
whether the purpose criterion is met:
a. Whether compensation or fees for performing the activity are based
on contributions raised. The purpose criterion is not met if a majority
5
In considering the guidance in paragraph 10, the factor in paragraph 10a (the compensation
or fees test) is the preeminent guidance. If the factor in paragraph 10a is not determinative, the factor
in paragraph 10b (whether a similar program or management and general activity is conducted
separately and on a similar or greater scale) should be considered. If the factor in paragraph 10b is
not determinative, the factor in paragraph 10c (other evidence) should be considered.
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of compensation or fees for any party’s performance of any compo
nent of the discrete joint activity varies based on contributions
raised for that discrete joint activity.6,7
b. Whether a similar program or management and general activity is
conducted separately and on a similar or greater scale. The pur
pose criterion is met if either of the following two conditions is met:
(1) Condition 1:
— The program component of the joint activity calls for
specific action by the recipient that will help accomplish
the entity’s mission and
— A similar program component is conducted without the
fund-raising component using the same medium and on
a scale that is similar to or greater than the scale on which
it is conducted with the fund raising.678
(2) Condition 2:
A management and general activity that is similar to the man
agement and general component of the joint activity being ac
counted for is conducted without the fund-raising component
using the same medium and on a scale that is similar to or
greater than the scale on which it is conducted with the fund
raising.
If the purpose criterion is met based on the factor in paragraph 10b,
the factor in paragraph 10c should not be considered.
c. Other evidence. If the factors in paragraph 10a or 10b do not deter
mine whether the purpose criterion is met, other evidence may
determine whether the criterion is met. All available evidence, both
positive and negative, should be considered to determine whether,
based on the weight of that evidence, the purpose criterion is met.
11.
The following are examples of indicators that provide evidence for
determining whether the purpose criterion is met:
a. Evidence that the purpose criterion may be met includes—
• Measuring program results and accomplishments of the activity.
The facts may indicate that the purpose criterion is met if the
6 Some compensation contracts provide that compensation for performing the activity is based
on a factor other than contributions raised, but not to exceed a specified portion of contributions
raised. For example, a contract may provide that compensation for performing the activity is $10 per
contact hour, but not to exceed 60 percent of contributions raised. In such circumstances, compensa
tion is not considered based on amounts raised, unless the stated maximum percentage is met. In
circumstances in which it is not yet known whether the stated maximum percentage is met,
compensation is not considered based on amounts raised, unless it is probable that the stated
maximum percentage will be met.
7 The compensation or fees test is a negative test in that it either (a) results in failing the
purpose criterion or (b) is not determinative of whether the purpose criterion is met. Therefore, if the
activity fails the purpose criterion based on this factor (the compensation or fees test), the activity
fails the purpose criterion and the factor in paragraph 10b should not be considered. If the purpose
criterion is not failed based on this factor, this factor is not determinative of whether the purpose
criterion is met and the factor in paragraph 106 should be considered.
8 Determining the scale on which an activity is conducted may be a subjective determination.
Factors to consider in determining the scale on which an activity is conducted may include dollars
spent, the size of the audience reached, and the degree to which the characteristics of the audience
are similar to the characteristics of the audience of the activity being evaluated.
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entity measures program results and accomplishments of the
activity (other than measuring the extent to which the public
was educated about causes).
• Medium. The facts may indicate that the purpose criterion is
met if the program component of the joint activity calls for
specific action by the recipient that will help accomplish the
entity’s mission and if the entity conducts the program compo
nent without a significant fund-raising component in a different
medium. Also, the facts may indicate that the purpose criterion
is met if the entity conducts the management and general
component of the joint activity without a significant fund-raising
component in a different medium.
b. Evidence that the purpose criterion may not be met includes—
• Evaluation or compensation. The facts may indicate that the
purpose criterion is not met if (a) the evaluation of any party’s
performance of any component of the discrete joint activity
varies based on contributions raised for that discrete joint activ
ity or (b) some, but less than a majority, of compensation or fees
for any party’s performance of any component of the discrete
joint activity varies based on contributions raised for that dis
crete joint activity.
c. Evidence that the purpose criterion may be either met or not met
includes—
• Evaluation of measured results of the activity. The entity may
have a process to evaluate measured program results and accom
plishments of the activity (other than measuring the extent to
which the public was educated about causes). If the entity has
such a process, in evaluating the effectiveness of the joint activ
ity, the entity may place significantly greater weight on the
activity’s effectiveness in accomplishing program goals or may
place significantly greater weight on the activity’s effectiveness
in raising contributions. The former may indicate that the pur
pose criterion is met. The latter may indicate that the purpose
criterion is not met.
• Qualifications. The qualifications and duties of those perform
ing the joint activity should be considered.
— If a third party, such as a consultant or contractor, per
forms part or all of the joint activity, such as producing
brochures or making telephone calls, the third party’s
experience and the range of services provided to the entity
should be considered in determining whether the third
party is performing fund-raising, program (other than
educating the public about causes), or management and
general activities on behalf of the entity.
— If the entity’s employees perform part or all of the joint
activity, the full range of their job duties should be consid
ered in determining whether those employees are perform
ing fund-raising, program (other than educating the public
about causes), or management and general activities on
behalf of the entity. For example, (a) employees who are
not members of the fund-raising department and (b) em
ployees who are members ofthe fund-raising department but
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who perform non-fund-raising activities are more likely to
perform activities that include program or management
and general functions than are employees who otherwise
devote significant time to fund raising.
• Tangible evidence of intent. Tangible evidence indicating the
intended purpose of the joint activity should be considered.
Examples of such tangible evidence include
— The entity’s written mission statement, as stated in its
fund-raising activities, bylaws, or annual report.
— Minutes ofboard of directors’, committees’, or other meetings.
— Restrictions imposed by donors (who are not related par
ties) on gifts intended to fund the joint activity.
— Long-range plans or operating policies.
— Written instructions to other entities, such as script writ
ers, consultants, or list brokers, concerning the purpose of
the joint activity, audience to be targeted, or method of
conducting the joint activity.
— Internal management memoranda.
Audience

12. A rebuttable presumption exists that the audience criterion is not met
if the audience includes prior donors or is otherwise selected based on its ability
or likelihood to contribute to the entity. That presumption can be overcome if
the audience is also selected for one or more of the reasons in paragraph 13a,
13b, or 13c. In determining whether that presumption is overcome, entities
should consider the extent to which the audience is selected based on its ability
or likelihood to contribute to the entity and contrast that with the extent to
which it is selected for one or more of the reasons in paragraph 13a, 13b, or 13c.
For example, if the audience’s ability or likelihood to contribute is a significant
factor in its selection and it has a need for the action related to the program
component of the joint activity, but having that need is an insignificant factor
in its selection, the presumption would not be overcome.
13. In circumstances in which the audience includes no prior donors and
is not otherwise selected based on its ability or likelihood to contribute to the
entity, the audience criterion is met if the audience is selected for one or more
of the following reasons:
a. The audience’s need to use or reasonable potential for use of the
specific action called for by the program component of the joint activity
b. The audience’s ability to take specific action to assist the entity in
meeting the goals of the program component of the joint activity
c. The entity is required to direct the management and general compo
nent of the joint activity to the particular audience or the audience
has reasonable potential for use of the management and general
component
Content

14. The content criterion is met if the joint activity supports program or
management and general functions, as follows:
a. Program. The joint activity calls for specific action by the recipient
that will help accomplish the entity’s mission. If the need for and
benefits of the action are not clearly evident, information describing
the action and explaining the need for and benefits of the action is
provided.
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b. Management and general. The joint activity fulfills one or more of
the entity’s management and general responsibilities through a
component of the joint activity.9
15. Information identifying and describing the entity, causes, or how the
contributions provided will be used is considered in support of fund raising.
Allocation Methods

16. The cost allocation methodology used should be rational and system
atic, it should result in an allocation of joint costs that is reasonable, and it
should be applied consistently given similar facts and circumstances.

Incidental Activities

17. Some fund-raising activities conducted in conjunction with program
or management and general activities are incidental to such program or
management and general activities. For example, an entity may conduct a
fund-raising activity by including a generic message, “Contributions to Organi
zation X may be sent to [address]” on a small area of a message that would
otherwise be considered a program or management and general activity based
on its purpose, audience, and content. That fund-raising activity likely would
be considered incidental to the program or management and general activity
being conducted. Similarly, entities may conduct program or management and
general activities in conjunction with fund-raising activities that are incidental
to such fund-raising activities. For example, an entity may conduct a program
activity by including a generic program message such as “Continue to pray for
[a particular cause]” on a small area of a message that would otherwise be
considered fund raising based on its purpose, audience, and content. That
program activity would likely be considered incidental to the fund-raising
activity being conducted. Similarly, an entity may conduct a management and
general activity by including a brief management and general message—“We
recently changed our phone number. Our new number is 123-4567”—on a
small area of a message that would otherwise be considered a program or
fund-raising activity based on its purpose, audience, and content. That man
agement and general activity would likely be considered incidental to the
program or fund-raising activity being conducted. In circumstances in which a
fund-raising, program, or management and general activity is conducted in
conjunction with another activity and is incidental to that other activity, and
the conditions in this SOP for allocation are met, joint costs are permitted but
not required to be allocated and may therefore be charged to the functional
classification related to the activity that is not the incidental activity. However,
in circumstances in which the program or management and general activities
are incidental to the fund-raising activities, it is unlikely that the conditions
required by this SOP to permit allocation of joint costs would be met.
Disclosures

18. Entities that allocate joint costs should disclose the following in the
notes to their financial statements:
a. The types of activities for which joint costs have been incurred
b. A statement that such costs have been allocated
9
Some states or other regulatory bodies require that certain disclosures be included when
soliciting contributions. For purposes of applying the guidance in this SOP, communications that
include such required disclosures are considered fund-raising activities and are not considered
management and general activities.
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c. The total amount allocated during the period and the portion allo
cated to each functional expense category
19.
This SOP encourages, but does not require, that the amount of joint
costs for each kind of joint activity be disclosed, if practical.
Effective Date

20.
This SOP is effective for financial statements for years beginning on
or after December 15, 1998. Earlier application is encouraged in fiscal years for
which financial statements have not been issued. If comparative financial
statements are presented, retroactive application is permitted but not required.
The provisions of this Statement of Position need
_______not be applied to immaterial items._______
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APPENDIX A
Accounting for Joint Activities10

10 Note: This flowchart summarizes certain guidance in this SOP and is not intended as a
substitute for the SOP.
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APPENDIX B
Background
B.l. As stated in paragraph 4, the provisions of Statement of Position
(SOP) 87-2, Accounting for Joint Costs of Informational Materials and Activities
of Not-for-profit Organizations That Include a Fund-Raising Appeal, have been
difficult to implement and applied inconsistently in practice. That difficulty has
been due in part to the following:
• The second sentence of paragraph 1 of SOP 87-2 stated that “some
of the costs incurred by such organizations are clearly identifiable
with fundraising, such as the cost of fund-raising consulting serv
ices.” It is unclear whether activities that would otherwise be
considered program activities should be characterized as program
activities if they are performed or overseen by professional fund
raisers. Also, it is unclear whether activities would be reported
differently (for example, as program rather than fund raising)
depending on whether the fund-raising consultant is compensated
by a predetermined fee or by some other method, such as a percent
age of contributions raised.
• SOP 87-2 was unclear about whether allocation of costs to fund
raising expense is required if the activity for which the costs were
incurred would not have been undertaken without the fund-raising
component.
• SOP 87-2 defined joint costs through examples, and it is therefore
unclear what kinds of costs were covered by SOP 87-2. For example,
it is unclear whether salaries and indirect costs can be joint costs.
• Some believe the guidance in SOP 87-2 was inadequate to determine
whether joint activities, such as those that request contributions and
also list the warning signs of a disease, are designed to motivate their
audiences to action other than to provide contributions to the entity.
It is unclear what attributes the targeted audience should possess in
order to conclude that a program function is being conducted.
B.2. In 1992, the Accounting Standards Executive Committee (AcSEC)
undertook a project to supersede SOP 87-2, to provide clearer guidance than
that provided by SOP 87-2, as well as to provide guidance that would improve
on the guidance in SOP 87-2. In September 1993, AcSEC released an exposure
draft of a proposed SOP, Accounting for Costs of Materials and Activities of
Not-for-Profit Organizations and State and Local Governmental Entities That
Include a Fund-Raising Appeal, for public comment. AcSEC received more than
300 comment letters on the exposure draft. AcSEC redeliberated the issues
based on the comments received.
B.3. In 1996, after redeliberating the issues based on the comments re
ceived and making certain revisions to the draft SOP, AcSEC conducted a field
test of the draft SOP. The objectives of the field test were to determine whether
the provisions of the draft SOP were sufficiently clear and definitive to generate
consistent and comparable application of the SOP. Based on the field test
results, AcSEC concluded that the provisions of the draft SOP, with certain
revisions, were sufficiently clear and definitive to generate consistent and
comparable application of the SOP.
B.4. Some respondents who commented on the exposure draft, as well as
some interested parties who followed the project through its due process sub
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sequent to the exposure draft, commented that the SOP should be reexposed
for public comment. Reasons cited include:
• Approximately three years had passed between the end of the com
ment period and AcSEC’s decision to issue the SOP.
• AcSEC made significant revisions to the SOP subsequent to releasing
the exposure draft for comment.
Considering whether a proposed standard should be reexposed for public
comment is inherently a subjective process. Factors that AcSEC considered
include—
• The significance of changes made to the exposure draft and whether
those changes result in guidance that the public did not have an
opportunity to consider.
• Whether the scope was revised in such a way that affected entities did
not have an opportunity to comment.
• New information about or changes in the nature of the transactions
being considered, practice, or other factors.
AcSEC believes that the length of time between exposure and final issuance is
not pertinent to whether the SOP should be reexposed for public comment.
B.5. Based on consideration of the factors identified, AcSEC believes that
the SOP should not be reexposed for public comment. AcSEC notes that
although the SOP has been revised based on comments received on the expo
sure draft, those revisions do not change the overall model in the SOP. Those
revisions were made primarily to clarify the SOP and improve its operational
ity. Further, AcSEC believes that the project received a high level of attention
from interested parties. AcSEC provided working drafts to interested parties
and those parties provided input throughout the process, up to and including
the Financial Accounting Standard Board’s and the Governmental Accounting
Standards Board’s clearance of the SOP for issuance.
B.6. Appendix C discusses the key issues in the exposure draft and com
ments received on those issues, as well as the basis for AcSEC’s conclusions on
those and certain other issues.
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APPENDIX C
Basis for Conclusions

C.1. This section discusses considerations that were deemed significant by
members of the Accounting Standards Executive Committee (AcSEC) in reach
ing the conclusions in this Statement of Position (SOP). It includes reasons for
accepting certain views and rejecting others. Individual AcSEC members gave
greater weight to some factors than to others.
Overall Framework

C.2. This SOP uses the model in SOP 87-2, Accounting for Joint Costs of
Informational Materials and Activities of Not-for-Profit Organizations That
Include a Fund-Raising Appeal, as a starting point and clarifies guidance that
was unclear, provides more detailed guidance, revises some guidance, and
expands the scope of costs covered to include all costs of joint activities. The
model established by SOP 87-2 was to account for joint costs as fund raising
unless an entity could demonstrate that a program or management and general
function had been conducted. SOP 87-2 used verifiable indications of the
reasons for conducting the activity, such as content, audience, the action
requested, if any, and other corroborating evidence as a basis for determining
whether a program or management and general function had been conducted.
C.3. On an overall basis, the majority of respondents who commented on
the September 1993 exposure draft of a proposed SOP, Accounting for Costs of
Materials and Activities of Not-for-Profit Organizations and State and Local
Governmental Entities That Include a Fund-Raising Appeal, opposed it, for
various reasons, including the following:
• The guidance in SOP 87-2 is operational, results in sound financial
reporting, and should be retained.
• The guidance in SOP 87-2 should be retained but clarified.
• The guidance proposed in the exposure draft should be revised. (Some
commented that it overstates fund raising; others commented that it
understates fund raising.)
C.4. AcSEC concluded that it supports the model in the exposure draft,
subject to certain revisions. AcSEC believes that this SOP provides clear,
detailed accounting guidance that, when applied, will increase comparability
of financial statements. Those statements will also include more meaningful
disclosures without incurring increased costs.
C.5. Some respondents commented that the model in the exposure draft
would adversely affect entities both financially and operationally. Various
reasons were given, including the following:
• It would inhibit the ability of entities, particularly small entities and
entities that raise contributions through direct solicitations, to gener
ate the necessary revenue to perform their program services.
• Most entities would not meet the criteria in this SOP for reporting
costs of joint activities as program or management and general,
because they must combine their mission statements, public informa
tion and education, and fund-raising appeals due to a lack of resources.
Some noted that this may result in unsatisfactory ratings from public
watchdog groups.
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AcSEC did not find these arguments compelling. This SOP provides accounting
guidance; it provides no guidance concerning how entities should undertake
their activities. Also, this SOP does not prohibit allocation merely because
activities carrying out different functions are combined. In fact, this SOP
provides guidance for reporting costs as program or management and general
in circumstances in which those activities are combined with fund-raising.
Moreover, actions taken by financial statement users are not the direct result
of the requirements of this SOP. Rather, those actions may result from more
relevant and useful information on which to base decisions.
C.6. Some respondents commented that the exposure draft is biased to
ward reporting expenses as fund raising. AcSEC believes that determining
whether the costs of joint activities should be classified as program, manage
ment and general, or fund raising sometimes is difficult, and such distinctions
sometimes are subject to a high degree of judgment. AcSEC believes that
external financial statement users focus on and have perceptions about
amounts reported as program, management and general, and fund raising.
That focus and those perceptions provide incentives for entities to report
expenses as program or management and general rather than fund raising.
Therefore, in circumstances in which joint activities are conducted, a presump
tion exists that expenses should be reported as fund raising rather than as
program or management and general. The criteria in this SOP provide guidance
for entities to overcome that presumption.
Accounting for Joint Activities

C.7. This SOP requires that if any of the criteria of purpose, audience, and
content are not met, all costs of the activity should be reported as fund raising,
including costs that otherwise might be considered program or management
and general costs if they had been incurred in a different activity, subject to the
exception in the following sentence. Costs of goods or services provided in
exchange transactions that are part of joint activities, such as costs of direct
donor benefits of a special event (for example, a meal), should not be reported
as fund raising. (This SOP expands on the model established by SOP 87-2 by
including all costs of joint activities other than costs of goods or services
provided in exchange transactions, rather than merely joint costs.) AcSEC
believes that the criteria of purpose, audience, and content are each relevant
in determining whether a joint activity should be reported as fund raising,
program, or management and general because each provides significant evi
dence about the benefits expected to be obtained by undertaking the activity.
C.8. Some respondents commented that reporting costs that otherwise
might be considered program or management and general costs if they had been
incurred in a different activity as fund raising is misleading and that the scope
of the SOP should include only joint costs of joint activities. Some commented
that reporting costs that otherwise might be considered program or manage
ment and general costs if they had been incurred in a different activity as fund
raising conflicts with Financial Accounting Standards Board (FASB) State
ment of Financial Accounting Standards No. 117, Financial Statements of
Not-for-Profit Organizations, which defines fund raising, program, and man
agement and general and requires not-for-profit organizations (NPOs) to report
information about expenses using those functional classifications.
C.9. AcSEC believes that the purpose for which costs other than joint
costs are incurred may be fund raising, program, or management and general,
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depending on the context in which they are used in the activity undertaken.
For example, a program-related pamphlet may be sent to an audience in need
of the program. In that context, the pamphlet is used for program purposes.
However, in order to demonstrate to potential donors that the entity’s programs
are worthwhile, that same pamphlet may be sent to an audience that is likely
to contribute, but that has no need or reasonable potential for use of the
program. In that context, the pamphlet is used for fund raising. AcSEC believes
this broader scope will result in more comparability and more meaningful
financial reporting by covering all costs of activities that include fund raising
and by assigning those costs to the function for which they are incurred,
consistent with the guidance in Statement No. 117.
C.10. AcSEC believes that costs of goods or services provided in exchange
transactions should not be charged to fund raising because those costs are
incurred in exchange for revenues other than contributions.
Criteria of Purpose, Audience, and Content
Call For Action

C.11. The definition of program in FASB Statement No. 117 includes
public education. As noted in paragraph C.6, AcSEC believes that in circum
stances in which joint activities are conducted, a presumption exists that
expenses should be reported as fund raising rather than as program or man
agement and general. AcSEC believes that in order to overcome that presump
tion, it is not enough that (a) the purpose of the activity include educating the
public about causes, (b) the audience has a need or reasonable potential for use
of any educational component of the activity pertaining to causes, or (c) the
audience has the ability to assist the entity in meeting the goals of the program
component of the activity by becoming educated about causes. Therefore,
AcSEC concluded that for purposes of this SOP, in order to conclude that the
criteria of purpose, audience, and content are met program activities are
required to call for specific action by the recipient (other than becoming
educated about causes) that will help accomplish the entity’s mission. As
discussed in paragraph 9, in certain circumstances educational activities may
call for specific action by the recipient that will help accomplish the entity’s
mission.
Purpose

C.12. AcSEC believes meeting the purpose criterion demonstrates that the
purpose of the activity includes accomplishing program or management and
general functions. Inherent in the notion of a joint activity is that the activity
has elements of more than one function. Accordingly, the purpose criterion
provides guidance for determining whether the purpose of the activity includes
accomplishing program or management and general functions in addition to
fund raising.
Compensation and Evaluation Tests

C.13. The exposure draft proposed that all costs of the joint activity should
be charged to fund raising if (a) substantially all compensation or fees for
performing the activity are based on amounts raised or (b) the evaluation of the
party performing the activity is based on amounts raised. Some respondents
commented that basing the method ofcompensation or evaluating the performance
AAG-HCO APP C

298

Health Care Organizations

of the party performing the activity based on contributions raised should
not lead to the conclusion that all costs of the activity should be charged to
fund raising. Others commented that the method of compensation is unre
lated to whether the purpose criterion is met. The reasons given included
the following:
• It is counterintuitive to imply that those performing multipurpose
activities that include fund raising would not be compensated or
evaluated based on amounts raised.
• Such guidance would create a bias toward entities that use employees
to raise contributions and against entities that hire professional fund
raisers and public relations firms and is therefore not neutral.
Some respondents gave examples of circumstances in which substantially all
compensation is based on contributions raised and asserted that the activity
was nevertheless a program activity. In each of those examples, AcSEC consid
ered all the facts presented and concluded that the activity was fund raising.
C.14. AcSEC continues to support the spirit of the proposed guidance,
because AcSEC believes that basing a majority of compensation on funds raised
is persuasive evidence that the activity is a fund-raising activity. Nevertheless,
AcSEC believes that the proposed guidance was unclear and would be difficult
to implement, primarily because of the broad definition of “based on contribu
tions raised” included in the glossary of the exposure draft. In connection with
that issue, AcSEC was concerned that any joint activities performed by a
fund-raising department or by individuals whose duties include fund raising,
such as executive officers of small NPOs who are employed based on their
ability to raise contributions, would be required to be reported as fund raising
because the compensation of the parties performing those activities is based on
amounts raised. Also, AcSEC had concerns that it would be difficult to deter
mine whether fixed contract amounts were negotiated based on expected
contributions. Therefore, AcSEC concluded that the compensation test should
be revised to provide that the purpose criterion is not met if a majority of
compensation or fees for any party’s performance of any component of the
discrete joint activity varies based on contributions raised for that discrete joint
activity. AcSEC believes that guidance is sound and is operational.
C.15. AcSEC believes that the guidance in paragraph 10a is not biased
against entities that hire professional fund raisers, because it applies to the
entity’s employees as well as professional fund raisers. For example, if a
majority of an employee’s compensation or fees for performing a component of
a discrete joint activity varies based on contributions raised for that discrete
joint activity, the purpose criterion is not met.
Similar Function-Similar Medium Test

C.16. Some respondents misinterpreted the exposure draft as providing
that, in order to meet the purpose criterion, the program or management and
general activity must be conducted without the fund-raising component, using
the same medium and on a scale that is similar to or greater than the program
or management and general component of the activity being accounted for. That
was not a requirement proposed by the exposure draft. The exposure draft
proposed that meeting that condition would result in meeting the purpose
criterion. Failing the criterion merely leads to consideration of other evidence,
such as the indicators in paragraph 11. AcSEC has revised the SOP to state
this more clearly.
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Other Evidence

C.17. The compensation test and the similar function-similar medium
test may not always be determinative because the attributes that they con
sider may not be present. Therefore, this SOP includes indicators that should
be considered in circumstances in which the compensation test and the similar
function-similar medium test are not determinative. The nature of those
indicators is such that they may be present in varying degrees. Therefore, all
available evidence, both positive and negative, should be considered to deter
mine whether, based on the weight of that evidence, the purpose criterion is
met.
Audience

C.18. The exposure draft proposed that if the audience for the materials or
activities is selected principally on its ability or likelihood to contribute, the
audience criterion is not met and all the costs of the activity should be charged
to fund raising. Further, the exposure draft proposed that if the audience is
selected principally based on its need for the program or because it can assist
the entity in meeting its program goals other than by financial support provided
to the entity, the audience criterion is met. Some respondents commented that
that audience criterion is too narrow, because it is based on the principal reason
for selecting the audience. They asserted that for some activities no principal
reason exists for selecting an audience; entities select the audience for those
activities for multiple reasons, such as both the audience’s ability to contribute
and its ability to help meet program goals. Some commented that for some
activities, entities select audiences that have provided past financial support
because, by providing financial support, those audiences have expressed an
interest in the program.
C.19. AcSEC believes that meeting the audience criterion should demon
strate that the audience is selected because it is a suitable audience for
accomplishing the activity’s program or management and general functions.
Therefore, the reasons for selecting the audience should be consistent with the
program or management and general content of the activity. However, AcSEC
believes it is inherent in the notion of joint activities that the activity has
elements of more than one function, including fund raising, and acknowledges
that it may be difficult to determine the principal reason for selecting the
audience. Accordingly, AcSEC concluded that if the audience includes prior
donors or is otherwise selected based on its ability or likelihood to contribute,
a rebuttable presumption should exist that the audience was selected to raise
funds. AcSEC believes that the reasons for selecting the audience that can
overcome that presumption, which are included in paragraph 13 of this SOP,
demonstrate that the audience is selected because it is a suitable audience for
accomplishing the activity’s program or management and general functions
based on the program or management and general content of the activity.
Content

C.20. AcSEC believes that meeting the content criterion demonstrates that
the content of the activity supports program or management and general
functions. AcSEC believes that accounting guidance should not impose value
judgments about whether the entity’s mission, programs, and responsibilities
are worthwhile. Therefore, whether the content criterion is met depends on the
relationship of the content to the entity’s mission, programs, and management
and general responsibilities.
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C.21. Paragraph 14 provides that, to meet the content criterion, program
activities should call for specific action by the recipient that will help accom
plish the entity’s mission. The exposure draft proposed that slogans, general
calls to prayer, and general calls to protest do not meet the content criterion;
some respondents disagreed. AcSEC concluded that this SOP should be silent
concerning whether slogans, general calls to prayer, and general calls to protest
are calls to action that meet the content criterion. AcSEC believes that deter
mining whether those items are calls to action that meet the content criterion
requires judgments based on the particular facts and circumstances.
C.22. Some respondents commented that educating the public about
causes without calling for specific action should satisfy the content criterion.
They noted that this is particularly relevant for NPOs subject to Internal
Revenue Code (IRC) Section 501(c)4, because those NPOs are involved in
legislative reform. Also, some noted that it may be the entity’s mission or goal
to educate the public about causes. They believe that, in those cases, the NPO’s
program is to educate the public about causes without necessarily calling for
specific action by the recipient.
C.23. As discussed in paragraph C.11, AcSEC concluded that education
that does not motivate the audience to action is in fact done in support of fund
raising. However, this SOP acknowledges that some educational messages
motivate the audience to specific action, and those messages meet the content
criterion. AcSEC believes that that provision will result in the activities of some
NPOs subject to IRC Section 501(c)4 (and some other entities, whose mission
or goal is to educate the public) meeting the content criterion.
C.24. Paragraph 13c provides that one way that the audience criterion is
met is if the entity is required to direct the management and general component
of the activity to the particular audience. Further, as discussed in paragraph
D.13, in Discussion of Conclusions, an audience that includes prior donors and
is selected because the entity is required to send them certain information to
comply with requirements of the Internal Revenue Service (IRS) is an example
of an audience that is selected because the entity is required to direct the
management and general component of the activity to that audience. Para
graph 146 provides that one way that the content criterion is met is if the
activity fulfills one or more of the entity’s management and general responsi
bilities through a component of the joint activity. However, footnote 9 to
paragraph 146 provides that disclosures made when soliciting contributions to
comply with requirements of states or other regulatory bodies are considered
fund-raising activities, and are not considered management and general activi
ties. AcSEC considered whether it is inconsistent to conclude both that (a)
activities conducted to comply with requirements of regulatory bodies concern
ing contributions that have been received are management and general activi
ties, and that (b) activities conducted to comply with requirements of regulatory
bodies concerning soliciting contributions are fund-raising activities. AcSEC
believes that those provisions are not inconsistent. AcSEC believes there is a
distinction between (a) requirements that must be met as a result of receiving
contributions and (b) requirements that must be met in order to solicit contri
butions. AcSEC believes that activities that are undertaken as a result of
receiving contributions are management and general activities while activities
that are undertaken in order to solicit contributions are fund-raising activities.
Incidental Activities

C.25. Many entities conduct fund-raising activities in conjunction with
program or management and general activities that are incidental to such program
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or management and general activities. Similarly, entities may conduct program
or management and general activities in conjunction with fund-raising activi
ties that are incidental to such fund-raising activities. Such efforts may be a
practical and efficient means for entities to conduct activities, although the
principal purpose of the activity may be to fulfill either fund-raising, program,
or management and general functions. The exposure draft proposed that
incidental activities need not be considered in applying this SOP. Some respon
dents disagreed with that guidance, while others commented that it was
confusing. AcSEC continues to support that guidance. AcSEC believes that
guidance is necessary to avoid requiring complex allocations in circumstances
in which the criteria of purpose, audience, and content are met but the activity
is overwhelmingly either fund raising, program, or management and general.
Allocation Methods

C.26. Respondents had various comments concerning allocation methods,
including the following:
• The SOP should focus on allocation methods rather than on circum
stances in which entities should allocate.
• The SOP should prescribe allocation methods.
• The approach taken in the SOP—discussing, rather than requiring or
prohibiting allocation methods—is sound.
• Certain allocation methods should be prohibited.
• The SOP should set maximum allocation percentages.
AcSEC believes that no particular allocation method or methods are necessarily
more desirable than other methods in all circumstances. Therefore, this SOP
neither prescribes nor prohibits any particular allocation methods. AcSEC
believes entities should apply the allocation methods that result in the most
reasonable cost allocations for their activities. Appendix F of this SOP illus
trates several allocation methods, any one of which may result in a reasonable
or unreasonable allocation of costs in particular circumstances. The methods
illustrated are not the only acceptable methods. However, AcSEC believes that
the methods illustrated in this SOP are among those most likely to result in
meaningful cost allocations.
C.27. Accounting Principles Board (APB) Opinion No. 20, Accounting
Changes, states in paragraph 7 that “the term accounting principle includes
‘not only accounting principles and practices but also the methods of applying
them.”’ APB Opinion 20 also states in paragraphs 15 and 16 that
. . . In the preparation of financial statements there is a presumption that an
accounting principle once adopted should not be changed in accounting for
events and transactions of a similar type . . . . The presumption that an entity
should not change an accounting principle may be overcome only if the enter
prise justifies the use of an alternative acceptable accounting principle [alloca
tion method] on the basis that it is preferable.

A change in cost allocation methodology may be a change in accounting
principle for entities covered by this SOP. Accordingly, paragraph 16 of this
SOP provides that the cost allocation methodology used should be applied
consistently, given similar facts and circumstances.
Disclosures

C.28. Respondents made various comments concerning the required and
encouraged disclosures, including recommendations for additional disclosures
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and recommendations that certain disclosures be deleted. AcSEC was not
persuaded that the costs of the other disclosures recommended by respondents
are justified by their benefits. AcSEC believes that, with the exception of one
disclosure, the disclosures prescribed by the exposure draft provide relevant
information about the kinds of activities for which joint costs have been
incurred and the manner in which those costs are reported in the financial
statements. In considering disclosures proposed by the exposure draft about
the allocation method, AcSEC observed that there are no requirements to
disclose methods of allocating other expenses and questioned the utility of
disclosing the allocation method in this circumstance. AcSEC concluded that
the requirement to disclose the allocation method should be deleted.
C.29. Paragraph 19 encourages, but does not require, certain disclosures.
AcSEC believes those disclosures provide useful information but that they
should be encouraged rather than required because the costs of making them
may not be justified by the benefits in all cases.
Effective Date

C.30. Some respondents commented that the effective date should be
deferred. AcSEC believes that the accounting systems required to implement
this SOP are already in place and that implementation should be relatively
straightforward. However, AcSEC acknowledges that some entities may
change their operations based on the reporting that would result from this SOP.
Therefore, AcSEC concluded that this SOP should be effective for financial
statements for years beginning on or after December 15, 1998.
Cost-Benefit

C.31. Some respondents commented that the guidance would increase
record keeping costs. AcSEC believes that implementing this SOP will not
significantly increase record keeping costs, which are primarily the costs of
documenting reasons for undertaking joint activities. Further, AcSEC believes
that the costs of making the disclosures required by this SOP should be
minimal, because entities should already have the information that is required
to be disclosed. AcSEC believes that implementing this SOP will result in more
relevant, meaningful, and comparable financial reporting and that the cost of
implementing this SOP will be justified by its benefits.
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APPENDIX D
Discussion of Conclusions
Scope

D.1. This Statement of Position (SOP) applies only to costs of joint activi
ties. It does not address allocations of costs in other circumstances.
Reporting Models and Related Requirements

D.2. Paragraph 26 of Financial Accounting Standards Board (FASB)
Statement of Financial Accounting Standards No. 117, Financial Statements
of Not-for-Profit Organizations, specifies that a statement of activities or notes
to the financial statements should provide information about expenses reported
by their functional classification, such as major classes of program services
and supporting activities. Paragraph 13.34 of the AICPA Audit and Account
ing Guide Not-for-Profit Organizations provides that the financial statements
of not-for-profit organizations (NPOs) should disclose the total fund-raising
expenses. [Revised, June 2004, to reflect conforming changes necessary due
to conforming changes made to the AICPA Audit and Accounting Guide
Not-for-Profit Organizations.]
D.3. Governmental Accounting Standards Board (GASB) Statement No.
29, The Use of Not-for-Profit Accounting and Financial Reporting Principles by
Governmental Entities, provides that governmental entities should not change
their accounting and financial reporting to apply the provisions of FASB
Statements No. 116, Accounting for Contributions Received and Contributions
Made, and No. 117. GASB Statement No. 29 permits governmental entities that
have applied the accounting and financial reporting principles in SOP 78-10,
Accounting Principles and Reporting Practices for Certain Nonprofit Organiza
tions, or in the AICPA Industry Audit Guide Audits of Voluntary Health and
Welfare Organizations (modified by all applicable FASB pronouncements is
sued through November 30, 1989, and by most applicable GASB pronounce
ments) to continue to do so, pending GASB pronouncements on the accounting
and financial reporting model for governmental entities. Alternatively, those
governmental entities are permitted to change to the current governmental
financial reporting model.||
D.4. GASB Statement No. 15, Governmental College and University Ac
counting and Financial Reporting Models, requires governmental colleges and
universities to use one of two accounting and financial reporting models. One
model, referred to as the “AICPA College Guide Model,” encompasses the account
ing and financial reporting guidance in the 1973 AICPA Industry Audit Guide
Audits of Colleges and Universities, as amended by SOP 74-8, Financial Account
ing and Reporting by Colleges and Universities, and as modified by applicable
FASB pronouncements issued through November 30, 1989, and all applicable
GASB pronouncements. (The other model, referred to as the “Governmental1
|| GASB Statement No. 34, Basic Financial Statements—and Management’s Discussion and
Analysis—for State and Local Governments, supersedes the provisions of GASB Statement No. 29,
The Use of Not-for-Profit Accounting and Financial Reporting Principles by Governmental Entities,
relating to the use of the AICPA Not-for-Profit model. See GASB Statement No. 34, including
paragraph 147. The AICPA Audit and Accounting Guide State and Local Governments, provides
guidance on the application of this SOP to state and local governments.
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Model,” is based on the pronouncements of the National Council on Govern
mental Accounting [NCGA] and the GASB.)#
D.5. For state and local governmental entities, some are required to report
expenses by function using the functional classifications of program, manage
ment and general, and fund raising. Other state and local governmental
entities that report expenses or expenditures by function have a functional
structure that does not include fund raising, program, or management and
general. Still other state and local governmental entities do not report expenses
or expenditures by function. Examples of those various reporting requirements
are as follows:**
• Entities applying the accounting and financial reporting principles in
the AICPA Industry Audit Guide Audits of Voluntary Health and
Welfare Organizations, as well as those that follow SOP 78-10 and that
receive significant amounts of contributions from the public, are re
quired to report separately the costs of the fund-raising, program, and
management and general functions.
• Entities applying the accounting and financial reporting principles in
the AICPA Industry Audit Guide Audits of Colleges and Universities,
as amended by SOP 74-8, are required to report fund raising as part
of the “institutional support” function.
D.6. As discussed in footnote 3 to paragraph 1 of this SOP, this SOP is not
intended to require reporting the functional classifications of fund raising,
program, and management and general. Rather, those functional classifica
tions are discussed throughout this SOP for purposes of illustrating how the
guidance in this SOP would be applied by entities that use those functional
classifications. Entities that do not use the functional classifications of fund
raising, program, and management and general should apply the guidance in
this SOP for purposes of accounting for joint activities, using their reporting
model. For example, some entities may conduct membership-development
activities. As discussed in the Glossary of this SOP, if there are no significant
benefits or duties connected with membership, the substance of the member
ship-development activities may, in fact, be fund raising. In such circum
stances, the costs of those activities should be charged to fund raising. To the
extent that member benefits are received, membership is an exchange trans
action. In circumstances in which membership development is in part soliciting
revenues from exchange transactions and in part soliciting contributions and
the purpose, audience, and content of the activity are appropriate for achieving
membership development, joint costs should be allocated between fund raising
and the exchange transaction.
Assigning Costs of Joint Activities

D.7. Paragraph 7 provides: “If the criteria of purpose, audience, and con
tent are met, the costs of a joint activity that are identifiable with a particular
function should be charged to that function and joint costs should be allocated
between fund raising and the appropriate program or management and general

# GASB Statement No. 35, Basic Financial Statements—and Management’s Discussion and
Analysis—for Public Colleges and Universities, supersedes GASB Statement No. 15, Governmental
College and University Accounting and Financial Reporting Models. See GASB Statements No. 34
and 35. The AICPA Audit and Accounting Guide State and Local Governments, provides guidance on
the application of this SOP to governmental (public) colleges and universities. [Footnote revised,
June 2004, to reflect conforming changes necessary due to the issuance of GASB Statement No. 35.]
** This discussion is no longer applicable. See footnotes || a n d ** to paragraphs D.3 and D.4.
[Footnote added, June 2004, to reflect conforming changes necessary due to the issuance of GASB
Statements No. 34 and No. 35.]
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function. If any of the criteria are not met, all costs of the joint activity should
be reported as fund-raising costs, including costs that otherwise might be
considered program or management and general costs if they had been incurred
in a different activity. . ..” For example, if the criteria are met, the costs of
materials that accomplish program goals and that are unrelated to fund
raising, such as the costs of a program-related pamphlet included in a joint
activity, should be charged to program, while joint costs, such as postage, should
be allocated between fund raising and program. However, if the pamphlet is
used in fund-raising packets and the criteria are not met, the costs of the
pamphlets used in the fund-raising packets, as well as the joint costs, should
be charged to fund raising. (If some pamphlets are used in program activities
that include no fund raising, the cost of the pamphlets used in those separate
program activities that include no fund raising should be charged to program.)
Educational Activities

D.8. Some entities have missions that include educating the public (stu
dents) in areas other than causes. Paragraph 9 provides that, for those entities,
educating the audience in areas other than causes or motivating the audience
to engage in specific activities, such as attending a lecture or class, that will
educate them in areas other than causes is considered a call for specific action
by the recipients that will help accomplish the entity’s mission. Educating the
audience about causes or motivating the audience to engage in specific activi
ties that will educate them about causes without educating them in other
subjects is not considered a call for specific action by the audience that will help
accomplish the entity’s mission. An example of a lecture or class that will
educate students in an area other than causes is a lecture on the nesting habits
of the bald eagle, given by the Save the Bald Eagle Society, an NPO whose
mission is to save the bald eagle from extinction and educate the public about
the bald eagle. An example of a lecture or class that will address particular
causes is a lecture by the Bald Eagle Society on the potential extinction of bald
eagles and the need to raise contributions to prevent their extinction. For
purposes of applying the guidance in this SOP, motivating the audience to
attend a lecture on the nesting habits of the bald eagle is a call for specific action
that will help accomplish the entity’s mission. If the lecture merely addresses
the potential extinction of bald eagles and the need to raise contributions to
prevent their extinction, without addressing the nesting habits of the bald
eagle, motivating the audience to attend the lecture is not considered a call for
specific action by the recipient that will help accomplish the entity’s mission.
D.9. AcSEC notes that most transactions in which a student attends a
lecture or class are exchange transactions and are not joint activities. Such
transactions are joint activities only if the activity includes fund raising.
Audience

D.10. Paragraph 12 provides that a rebuttable presumption exists that the
audience criterion is not met if the audience includes prior donors or is
otherwise selected based on its ability or likelihood to contribute to the entity.
That presumption can be overcome if the audience is also selected for the
program or management and general reasons specified in paragraph 13.
Further, paragraph 12 provides that in determining whether that presumption
is overcome, entities should consider the extent to which the audience is
selected based on its ability or likelihood to contribute to the entity and contrast
that with the extent to which it is selected for the reasons that may overcome
that presumption. Some organizations conduct joint activities that are special
events, such as symposia, dinners, dances, and theater parties, in which the
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attendee receives a direct benefit (for example, a meal or theater ticket) and
for which the admission price includes a contribution. For example, it may cost
$500 to attend a dinner with a fair value of $50. In that case, the audience is
required to make a $450 contribution in order to attend. In circumstances in
which the audience is required to make a contribution to participate in a joint
activity, such as attending a special event, the audience’s ability or likelihood
to contribute is a significant factor in its selection. Therefore, in circumstances
in which the audience is required to make a contribution to participate in a joint
activity, the extent to which the audience is selected for the program or manage
ment and general reasons in paragraph 13 must be overwhelmingly signifi
cant in order to rebut the presumption that the audience criterion is not met.
D.11. The source of the names and the characteristics of the audience
should be considered in determining the reason for selecting the audience.
Some entities use lists compiled by others to reach new audiences. The source
of such lists may indicate the purpose or purposes for which they were selected.
For example, lists acquired from entities with similar or related programs are
more likely to meet the audience criterion than are lists acquired from entities
with dissimilar or unrelated programs. Also, the characteristics of those on the
lists may indicate the purpose or purposes for which they were selected. For
example, a list based on a consumer profile of those who buy environmentally
friendly products may be useful to an entity whose mission addresses environ
mental concerns and could therefore indicate that the audience was selected
for its ability to take action to assist the entity in meeting program goals.
However, a list based on net worth would indicate that the audience was
selected based on its ability or likelihood to contribute, unless there was a
correlation between net worth and the program or management and general
components of the activity.
D.12. Some audiences may be selected because they have an interest in or
affinity to the program. For example, homeowners may have an interest in the
homeless because they are sympathetic to the plight of the homeless. Never
theless, including homeowners in the audience of a program activity to provide
services to the homeless would not meet the audience criterion, because they
do not have a need or reasonable potential for use of services to the homeless.
D.13. Paragraph 13c provides that the audience criterion is met if the
entity is required to direct the management and general component of the joint
activity to the particular audience or the audience has reasonable potential for
use of the management and general component. An example of a joint activity
in which the audience is selected because the entity is required to direct the
management and general component of the joint activity to the particular
audience is an activity in which the entity sends a written acknowledgment or
other information to comply with requirements of the Internal Revenue Service
to prior donors and includes a request for contributions. An example of a joint
activity in which the audience is selected because the audience has reasonable
potential for use of the management and general component is an activity in
which the entity sends its annual report to prior donors and includes a request
for contributions.
Content

D.14. Paragraph 14 provides that, to meet the content criterion, program
activities should call for specific action by the recipient that will help accom
plish the entity’s mission. As discussed in the Glossary, the action should benefit
the recipient or society. Examples of actions that benefit the recipient (such as by
improving the recipient’s physical, mental, emotional, or spiritual health and

AAG-HCO APP C

Statement of Position 98-2

307

well-being) or society (such as by addressing societal problems) include the
following:
a. Actions that benefit the recipient:
• Stop smoking. Specific methods, instructions, references, and
resources should be suggested.
• Do not use alcohol or drugs. Specific methods, instructions,
references, and resources should be suggested.
b. Actions that benefit society:
• Write or call. The party to communicate with and the subject
matter to be communicated should be specified.
• Complete and return the enclosed questionnaire. The results of
the questionnaire should help the entity achieve its mission. For
example, if the entity discards the questionnaire, it does not help
the entity achieve its mission.
• Boycott. The particular product or company to be boycotted
should be specified.
D.15. Paragraph 14b provides that to meet the content criterion, manage
ment and general functions are required to fulfill one or more of the entity’s
management and general responsibilities through a component of the joint
activity. Some states or other regulatory bodies require that certain disclosures
be included when soliciting contributions. Paragraph 14, footnote 9, of this SOP
provides that for purposes of applying the guidance in this SOP, communica
tions that include such required disclosures are considered fund-raising activi
ties and are not considered management and general activities. Some examples
of such disclosures include the following:
• Information filed with the attorney general concerning this charitable
solicitation may be obtained from the attorney general of [the state] by
calling 123-4567. Registration with the attorney general does not
imply endorsement.
• A copy of the registration and financial information may be obtained
from the Division of Consumer Services by calling toll-free, within [the
state], 1-800-123-4567. Registration does not imply endorsement, ap
proval, or recommendation by [the state].
• Information about the cost of postage and copying, and other informa
tion required to be filed under [the state] law, can be obtained by calling
123-4567.
• The organization’s latest annual report can be obtained by calling
123-4567.
Allocation Methods

D.16. Paragraph 16 of this SOP states, “The cost allocation methodology
used should be rational and systematic, it should result in an allocation ofjoint
costs that is reasonable, and it should be applied consistently given similar facts
and circumstances.” The allocation ofjoint costs should be based on the degree
to which costs were incurred for the functions to which the costs are allocated
(that is, program, management and general, or fund raising). For purposes of
determining whether the allocation methodology for a particular joint activity
should be consistent with methodologies used for other particular joint activi
ties, facts and circumstances that may be considered include factors related to
the content and relative costs of the components of the activity. The audience
should not be considered in determining whether the facts and circumstances are
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similar for purposes of determining whether the allocation methodology for a
particular joint activity should be consistent with methodologies used for other
particular joint activities.
Practicability of Measuring Joint Costs

D.17. The Glossary of this SOP includes a definition of joint costs. Some
costs, such as utilities, rent, and insurance, commonly referred to as indirect
costs, may be joint costs. For example, the telephone bill for a department that,
among other things, prepares materials that include both fund-raising and
program components may commonly be referred to as an indirect cost. Such
telephone bills may also be joint costs. However, for some entities, it is
impracticable to measure and allocate the portion of the costs that are joint
costs. Considerations about which joint costs should be measured and allocated,
such as considerations about materiality and the costs and benefits of develop
ing and providing the information, are the same as considerations about cost
allocations in other circumstances.
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APPENDIX E
Illustrations of Applying the Criteria of Purpose,
Audience, and Content to Determine Whether a
Program or Management and General Activity
Has Been Conducted
Illustration 1
Facts

E.1. Entity A’s mission is to prevent drug abuse. Entity A’s annual report
states that one of its objectives in fulfilling that mission is to assist parents in
preventing their children from abusing drugs.
E.2. Entity A mails informational materials to the parents of all junior high
school students explaining the prevalence and dangers of drug abuse. The
materials encourage parents to counsel children about the dangers of drug
abuse and inform them about how to detect drug abuse. The mailing includes
a request for contributions. Entity A conducts other activities informing the
public about the dangers of drug abuse and encouraging parents to counsel
their children about drug abuse that do not include requests for contributions
and that are conducted in different media. Entity A’s executive director is
involved in the development of the informational materials as well as the
request for contributions. The executive director’s annual compensation in
cludes a significant bonus if total annual contributions exceed a predetermined
amount.
Conclusion

E.3. The purpose, audience, and content criteria are met, and the joint costs
should be allocated.
E.4. The activity calls for specific action by the recipient (encouraging parents
to counsel children about the dangers of drug abuse and informing them about
how to detect drug abuse) that will help accomplish the entity’s mission. There
fore, the guidance in paragraph 10 should be considered. Neither of the factors
in paragraph 10a or 10b is determinative of whether the purpose criterion is
met. (Although Entity A’s executive director’s annual compensation varies
based on annual contributions, the executive director’s compensation does not
vary based on contributions raised for this discrete joint activity.) Therefore,
other evidence, such as the indicators in paragraph 11, should be considered.
The purpose criterion is met based on the other evidence, because (a) the
program component of this activity calls for specific action by the recipient
(encouraging parents to counsel children about the dangers of drug abuse) that
will help accomplish the entity’s mission, and it otherwise conducts the program
activity in this illustration without a request for contributions, and (b) perform
ing such programs helps accomplish Entity A’s mission. (Note that had Entity
A conducted the activity using the same medium on a scale that is similar to
or greater than the scale on which it is conducted with the request for contri
butions, the purpose criterion would have been met under paragraph 106.)
E.5. The audience criterion is met because the audience (parents of junior
high school students) is selected based on its need to use or reasonable potential
for use of the action called for by the program component.
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E.6. The content criterion is met because the activity calls for specific
action by the recipient (encouraging parents to counsel children about the
dangers of drug abuse and informing them about how to detect drug abuse) that
will help accomplish the entity’s mission (assisting parents in preventing their
children from abusing drugs), and it explains the need for and benefits of the
action (the prevalence and dangers of drug abuse).
Illustration 2
Facts

E.7. Entity B’s mission is to reduce the incidence of illness from ABC
disease, which afflicts a broad segment of the population. One of Entity B’s
objectives in fulfilling that mission is to inform the public about the effects and
early warning signs of the disease and specific action that should be taken to
prevent the disease.
E.8. Entity B maintains a list of its prior donors and sends them donor
renewal mailings. The mailings include messages about the effects and early
warning signs of the disease and specific action that should be taken to prevent
it. That information is also sent to a similar-sized audience but without the
request for contributions. Also, Entity B believes that recent donors are more
likely to contribute than nondonors or donors who have not contributed re
cently. Prior donors are deleted from the mailing list if they have not contrib
uted to Entity B recently, and new donors are added to the list. There is no
evidence of a correlation between recent contributions and participation in the
program component of the activity. Also, the prior donors’ need to use or
reasonable potential for use of the messages about the effects and early warning
signs of the disease and specific action that should be taken to prevent it is an
insignificant factor in their selection.
Conclusion

E.9. The purpose and content criteria are met. The audience criterion is
not met.11 All costs, including those that might otherwise be considered
program or management and general costs if they had been incurred in a
different activity, should be charged to fund raising.
E.10. The activity calls for specific action by the recipient (action that
should be taken to prevent ABC disease) that will help accomplish the entity’s
mission. Therefore, the guidance in paragraph 10 should be considered. The
purpose criterion is met because (a) the program component of the activity
calls for specific action by the recipient that will help accomplish the entity’s
mission (to reduce the incidence of illness from the disease), and (b) the program
is also conducted using the same medium on a scale that is similar to or
greater than the scale on which it is conducted with the request for contri
butions (a similar mailing is done without the request for contributions, to a
similar-sized audience).
11 Paragraph 7 of this SOP provides that all costs of joint activities, except for costs of goods or
services provided in exchange transactions that are part of joint activities, such as costs of direct
donor benefits of a special event (for example, a meal), should be charged to fund raising if any of the
criteria of purpose, audience, or content are not met. Accordingly, if one or more criteria are not met,
the other criteria need not be considered. However, the illustrations in this Appendix provide
conclusions about whether each of the criteria would be met in circumstances in which one or more
criteria are not met in order to provide further guidance.
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E.11. The audience criterion is not met. The rebuttable presumption that
the audience criterion is not met because the audience includes prior donors is
not overcome in this illustration. Although the audience has a need to use or
reasonable potential for use of the program component, that was an insignifi
cant factor in its selection.
E.12. The content criterion is met because the activity calls for specific
action by the recipient (actions to prevent ABC disease) that will help accom
plish the entity’s mission (to reduce the incidence of ABC disease), and it
explains the need for and benefits of the action (to prevent ABC disease).
Illustration 3
Facts

E.13. Entity C’s mission is to reduce the incidence of illness from ABC
disease, which afflicts a broad segment of the population. One of Entity C’s
objectives in fulfilling that mission is to increase governmental funding for
research about ABC disease.
E.14. Entity C maintains a list of its prior donors and its employees call
them on the telephone reminding them of the effects of ABC disease, asking for
contributions, and encouraging them to contact their elected officials to urge
increased governmental funding for research about ABC disease. The callers
are educated about ABC, do not otherwise perform fund-raising functions, and
are not compensated or evaluated based on contributions raised. Entity C’s
research indicates that recent donors are likely to contact their elected officials
about such funding while nonrecent donors are not. Prior donors are deleted
from the calling list if they have not contributed to Entity C recently, and new
donors are added to the list.
Conclusion

E.15. The purpose, audience, and content criteria are met, and the joint
costs should be allocated.
E.16. The activity calls for specific action by the recipient (contacting
elected officials concerning funding for research about ABC disease) that will
help accomplish the entity’s mission. Therefore, the guidance in paragraph 10
should be considered. Neither of the factors in paragraph 10a or 10b is
determinative of whether the purpose criterion is met. Therefore, other evi
dence, such as the indicators in paragraph 11, should be considered. The
purpose criterion is met based on the other evidence, because (a) the qualifica
tions and duties of the personnel performing the activity indicate that it is a
program activity (the callers are educated about ABC and do not otherwise
perform fund-raising functions), (b) the method of compensation for performing
the activity does not indicate that it is a fund-raising activity (the employees
are not compensated or evaluated based on contributions raised), and (c)
performing such programs helps accomplish Entity C’s mission.
E.17. The audience criterion is met because the audience (recent donors)
is selected based on its ability to assist Entity C in meeting the goals of the
program component of the activity (recent donors are likely to contact their
elected officials about such funding while nonrecent donors are not).
E.18. The content criterion is met because the activity calls for specific
action by the recipient (contacting elected officials concerning funding for re
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search about ABC disease) that will help accomplish the entity’s mission (to
reduce the incidence of ABC disease), and it explains the need for and benefits
of the action (to prevent ABC disease).
Illustration 4
Facts

E.19. Entity D’s mission is to improve the quality of life for senior citizens.
One of Entity D’s objectives included in that mission is to increase the physical
activity of senior citizens. One of Entity D’s programs to attain that objective
is to send representatives to speak to groups about the importance of exercise
and to conduct exercise classes.
E.20. Entity D mails a brochure on the importance of exercise that
encourages exercise in later years to residents over the age of sixty-five in three
zip code areas. The last two pages of the four-page brochure include a perforated
contribution remittance form on which Entity D explains its program and
makes an appeal for contributions. The content of the first two pages of the
brochure is primarily educational; it explains how seniors can undertake a
self-supervised exercise program and encourages them to undertake such a
program. In addition, Entity D includes a second brochure on various exercise
techniques that can be used by those undertaking an exercise program.
E.21. The brochures are distributed to educate people in this age group
about the importance of exercising, to help them exercise properly, and to raise
contributions for Entity D. These objectives are documented in a letter to the
public relations firm that developed the brochures. The audience is selected
based on age, without regard to ability to contribute. Entity D believes that
most of the recipients would benefit from the information about exercise.
Conclusion

E.22. The purpose, audience, and content criteria are met, and the joint
costs should be allocated. (Note that the costs of the second brochure should be
charged to program because all the costs of the brochure are identifiable with
the program function.)
E.23. The activity calls for specific action by the recipient (exercising) that
will help accomplish the entity’s mission. Therefore, the guidance in paragraph
10 should be considered. Neither of the factors in paragraph 10a or 106 is
determinative of whether the purpose criterion is met. Therefore, other evi
dence, such as the indicators in paragraph 11, should be considered. The
purpose criterion is met based on the other evidence, because (a) performing
such programs helps accomplish Entity D’s mission, and (b) the objectives of
the program are documented in a letter to the public relations firm that
developed the brochure.
E.24. The audience criterion is met because the audience (residents over
sixty-five in certain zip codes) is selected based on its need to use or reasonable
potential for use of the action called for by the program component.
E.25. The content criterion is met because the activity calls for specific
action by the recipient (exercising) that will help accomplish the entity’s mission
(increasing the physical activity of senior citizens), and the need for and benefits
of the action are clearly evident (explains the importance of exercising).
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Illustration 5

Facts
E.26. The facts are the same as those in Illustration 4, except that Entity
E employs a fund-raising consultant to develop the first brochure and pays that
consultant 30 percent of contributions raised.
Conclusion

E.27. The content and audience criteria are met. The purpose criterion
is not met, however, because a majority of compensation or fees for the fund
raising consultant varies based on contributions raised for this discrete joint
activity (the fund-raising consultant is paid 30 percent of contributions
raised). All costs should be charged to fund raising, including the costs of
the second brochure and any other costs that otherwise might be considered
program or management and general costs if they had been incurred in a
different activity.
Illustration 6
Facts

E.28. Entity F’s mission is to protect the environment. One of Entity F’s
objectives included in that mission is to take action that will increase the
portion of waste recycled by the public.
E.29. Entity F conducts a door-to-door canvass of a community that recy
cles a low portion of its waste. The purpose of the activity is to help increase
recycling by educating the community about environmental problems created
by not recycling, and to raise contributions. Based on the information commu
nicated by the canvassers, the need for and benefits of the action are clearly
evident. The ability or likelihood of the residents to contribute is not a basis for
communities selected, and all neighborhoods in the geographic area are covered
if their recycling falls below a predetermined rate. The canvassers are selected
from individuals who are well-informed about the organization’s environ
mental concerns and programs and who previously participated as volunteers
in program activities such as answering environmental questions directed to
the organization and developing program activities designed to influence leg
islators to take actions addressing those concerns. The canvassers have not
previously participated in fund-raising activities.
Conclusion

E.30. The purpose, audience, and content criteria are met, and the joint
costs should be allocated.
E.31. The activity calls for specific action by the recipient (implicitly—to
help increase recycling) that will help accomplish the entity’s mission. There
fore, the guidance in paragraph 10 should be considered. Neither of the factors
in paragraph 10a or 10b is determinative of whether the purpose criterion is
met. Therefore, other evidence, such as the indicators in paragraph 11, should
be considered. The purpose criterion is met based on the other evidence, because
(a) the qualifications and duties of the personnel performing the activity
indicate that it is a program activity (the canvassers are selected from individu
als who are well-informed about the organization’s environmental concerns and
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programs and who previously participated as volunteers in program activities
such as answering environmental questions directed to the organization and
developing program activities designed to influence legislators to take actions
addressing those concerns), and (b) performing such programs helps accom
plish Entity F’s mission (to protect the environment).
E.32. The audience criterion is met because the audience (neighborhoods
whose recycling falls below a predetermined rate) is selected based on its need
to use or reasonable potential for use of the action called for by the program
component.
E.33. The content criterion is met because the activity calls for specific
action by the recipient (implicitly—to help increase recycling) that will help
accomplish the entity’s mission (to protect the environment), and the need for
and benefits of the action are clearly evident (increased recycling will help
alleviate environmental problems).
Illustration 7
Facts

E.34. Entity G’s mission is to provide summer camps for economically
disadvantaged youths. Educating the families of ineligible youths about the
camps is not one of the program objectives included in that mission.
E.35. Entity G conducts a door-to-door solicitation campaign for its camp
programs. In the campaign, volunteers with canisters visit homes in middleclass neighborhoods to collect contributions. Entity G believes that people in
those neighborhoods would not need the camp’s programs but may contribute.
The volunteers explain the camp’s programs, including why the disadvantaged
children benefit from the program, and distribute leaflets to the residents
regardless of whether they contribute to the camp. The leaflets describe the
camp, its activities, who can attend, and the benefits to attendees. Requests for
contributions are not included in the leaflets.
Conclusion

E.36. The purpose, audience, and content criteria are not met. All costs
should be charged to fund raising.
E.37. The activity does not include a call for specific action because it only
educates the audience about causes (describing the camp, its activities, who
can attend, and the benefits to attendees). Therefore, the purpose criterion is
not met.
E.38. The audience criterion is not met, because the audience is selected
based on its ability or likelihood to contribute, rather than based on (a) its need
to use or reasonable potential for use of the action called for by the program
component, or (b) its ability to take action to assist the entity in meeting the
goals of the program component of the activity. (Entity G believes that people
in those neighborhoods would not need the camp’s programs but may contribute.)
E.39. The content criterion is not met because the activity does not call for
specific action by the recipient. (The content educates the audience about
causes that the program is designed to address without calling for specific
action.)
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Illustration 8

Facts

E.40. Entity H’s mission is to educate the public about lifesaving tech
niques in order to increase the number of lives saved. One of Entity H’s
objectives in fulfilling that mission, as stated in the minutes of the board’s
meetings, is to produce and show television broadcasts including information
about lifesaving techniques.
E.41. Entity H conducts an annual national telethon to raise contributions
and to reach the American public with lifesaving educational messages, such
as summary instructions concerning dealing with certain life-threatening
situations. Based on the information communicated by the messages, the need
for and benefits of the action are clearly evident. The broadcast includes
segments describing Entity H’s services. Entity H broadcasts the telethon to
the entire country, not merely to areas selected on the basis of giving potential
or prior fund raising results. Also, Entity H uses national television broadcasts
devoted entirely to lifesaving educational messages to conduct program activi
ties without fund raising.
Conclusion

E.42. The purpose, audience, and content criteria are met, and the joint
costs should be allocated.
E.43. The activity calls for specific action by the recipient (implicitly—to
save lives) that will help accomplish the entity’s mission. Therefore, the
guidance in paragraph 10 should be considered. The purpose criterion is met
because (a) the program component of the activity calls for specific action by
the recipient that will help accomplish Entity H’s mission (to save lives by
educating the public), and (b) a similar program activity is conducted without
the fund raising using the same medium and on a scale that is similar to or
greater than the scale on which it is conducted with the appeal (Entity H uses
national television broadcasts devoted entirely to lifesaving educational mes
sages to conduct program activities without fund raising).
E.44. The audience criterion is met because the audience (a broad segment
of the population) is selected based on its need to use or reasonable potential
for use of the action called for by the program activity.
E.45. The content criterion is met because the activity calls for specific
action by the recipient (implicitly—to save lives) that will help accomplish the
entity’s mission (to save lives by educating the public), and the need for and
benefits of the action are clearly evident (saving lives is desirable).
Illustration 9
Facts

E.46. Entity I’s mission is to provide food, clothing, and medical care to
children in developing countries.
E.47. Entity I conducts television broadcasts in the United States that
describe its programs, show the needy children, and end with appeals for
contributions. Entity I’s operating policies and internal management memo
randa state that these programs are designed to educate the public about the
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needs of children in developing countries and to raise contributions. The
employees producing the programs are trained in audiovisual production and
are familiar with Entity I’s programs. Also, the executive producer is paid
$25,000 for this activity, with a $5,000 bonus if the activity raises over
$ 1, 000, 000.
Conclusion

E.48. The purpose, audience, and content criteria are not met. All costs
should be charged to fund raising.
E.49. The activity does not include a call for specific action because it only
educates the audience about causes (describing its programs and showing the
needy children). Therefore, the purpose criterion is not met. (Also, note that if
the factor in paragraph 10a were considered, it would not be determinative of
whether the purpose criterion is met. Although the executive producer will be
paid $5,000 if the activity raises over $1,000,000, that amount would not be a
majority of the executive producer’s total compensation for this activity, be
cause $5,000 would not be a majority of the executive producer’s total compen
sation of $30,000 for this activity. Also, note that if other evidence, such as the
indicators in paragraph 11, were considered, the purpose criterion would not
be met based on the other evidence. Although the qualifications and duties of
the personnel performing the activity indicate that the employees producing
the program are familiar with Entity I’s programs, the facts that some, but less
than a majority, of the executive producer’s compensation varies based on
contributions raised, and that the operating policies and internal management
memoranda state that these programs are designed to educate the public about
the needs of children in developing countries [with no call for specific action by
recipients] and to raise contributions, indicate that the purpose is fund raising.)
E.50. The audience criterion is not met because the audience is selected
based on its ability or likelihood to contribute, rather than based on (a) its need
to use or reasonable potential for use of the action called for by the program
component, or (b) its ability to take action to assist the entity in meeting the
goals of the program component of the activity. (The audience is a broad
segment of the population of a country that is not in need of or has no reasonable
potential for use of the program activity.)
E.51. The content criterion is not met because the activity does not call for
specific action by the recipient that will help accomplish the entity’s mission.
(The content educates the audience about the causes without calling for specific
action.)
Illustration 10
Facts

E.52. Entity J is a university that distributes its annual report, which
includes reports on mission accomplishments, to those who have made signifi
cant contributions over the previous year, its board of trustees, and its employ
ees. The annual report is primarily prepared by management and general
personnel, such as the accounting department and executive staff. The activity
is coordinated by the public relations department. Internal management
memoranda indicate that the purpose of the annual report is to report on how
management discharged its stewardship responsibilities, including the univer
sity’s overall performance, goals, financial position, cash flows, and results of
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operations. Included in the package containing the annual report are requests
for contributions and donor reply cards.
Conclusion

E.53. The purpose, audience, and content criteria are met, and the joint
costs should be allocated.
E.54. The activity has elements of management and general functions.
Therefore, no call for specific action is required. Neither of the factors in
paragraph 10a or 106 is determinative of whether the purpose criterion is met.
Therefore, other evidence, such as the indicators in paragraph 11, should be
considered. The purpose criterion is met based on the other evidence, because
(a) the employees performing the activity are not members of the fund-raising
department and perform other non-fund-raising activities and (b) internal
management memoranda indicate that the purpose of the annual report is to
fulfill one of the university’s management and general responsibilities.
E.55. The audience criterion is met because the audience is selected based
on its reasonable potential for use of the management and general component.
Although the activity is directed primarily at those who have previously made
significant contributions, the audience was selected based on its presumed
interest in Entity J ’s annual report (prior donors who have made significant
contributions are likely to have an interest in matters discussed in the annual
report).
E.56. The content criterion is met because the activity (distributing annual
reports) fulfills one of the entity’s management and general responsibilities
(reporting concerning management’s fulfillment of its stewardship function).
Illustration 11
Facts

E.57. Entity K is an NPO. In accordance with internal management
memoranda documenting its policies requiring it to comply with Internal
Revenue Service (IRS) regulations, it mails prior donors who have made quid
pro quo payments in excess of $75 documentation required by the IRS. The
documentation is included on a perforated piece of paper. The information
above the perforation line pertains to the documentation required by the IRS.
The information below the perforation line includes a request for contributions
and may be used as a donor reply card.
Conclusion

E.58. The purpose, audience, and content criteria are met, and the joint
costs should be allocated. (Note that the costs of the information below the
perforation line are identifiable with fund raising and therefore should be
charged to fund raising.)
E.59. The activity has elements of management and general functions.
Therefore, no call for specific action is required. Neither of the factors in
paragraph 10a or 106 is determinative of whether the purpose criterion is met.
Therefore, other evidence, such as the indicators in paragraph 11, should be
considered. The purpose criterion is met based on the other evidence, because
internal management memoranda indicate that the purpose of the activity is
to fulfill one of Entity K’s management and general responsibilities.
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E.60. The audience criterion is met because the entity is required to direct
the management and general component of the activity to the particular
audience. Although the activity is directed at those who have previously
contributed, the audience was selected based on its need for the documentation.
E.61. The content criterion is met because the activity (sending documen
tation required by the IRS) fulfills one of the entity’s management and general
responsibilities (complying with IRS regulations).
Illustration 12
Facts

E.62. Entity L is an animal rights organization. It mails a package of
material to individuals included in lists rented from various environmental and
other organizations that support causes that Entity L believes are congruent
with its own. In addition to donor response cards and return envelopes, the
package includes (a) materials urging recipients to contact their legislators and
urge the legislators to support legislation to protect those rights, and (b)
postcards addressed to legislators urging support for legislation restricting the
use of animal testing for cosmetic products. The mail campaign is part of an
overall strategy that includes magazine advertisements and the distribution of
similar materials at various community events, some of which are undertaken
without fund-raising appeals. The advertising and community events reach
audiences similar in size and demographics to the audience reached by the
mailing.
Conclusion

E.63. The purpose, audience, and content criteria are met, and the joint
costs should be allocated.
E.64. The activity calls for specific action by the recipient (mailing post
cards to legislators urging support for legislation restricting the use of animal
testing for cosmetic products) that will help accomplish the entity’s mission.
Therefore, the guidance in paragraph 10 should be considered. Neither of the
factors in paragraph 10a or 106 is determinative of whether the purpose
criterion is met. Therefore, other evidence, such as the indicators in paragraph
11, should be considered. The purpose criterion is met based on the other
evidence, because (a) the program component of this activity calls for specific
action by the recipient that will help accomplish the entity’s mission, and it
otherwise conducts the program activity in this illustration without a request
for contributions, and (b) performing such programs helps accomplish Entity
L’s mission.
E.65. The audience criterion is met because the audience (individuals
included in lists rented from various environmental and other organizations
that support causes that Entity L believes are congruent with its own) is
selected based on its ability to take action to assist the entity in meeting the
goals of the program component of the activity.
E.66. The content criterion is met because the activity calls for specific
action by the recipient (mailing postcards to legislators urging support for
legislation restricting the use of animal testing for cosmetic products) that will
help accomplish the entity’s mission (to protect animal rights), and the need
for and benefits of the action are clearly evident (to protect animal rights).
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Illustration 13

Facts

E.67. Entity M is a performing arts organization whose mission is to make
the arts available to residents in its area. Entity M charges a fee for attending
performances and sends advertisements, including subscription forms, for the
performances to residents in its area. These advertisements include a return
envelope with a request for contributions. Entity M evaluates the effectiveness
of the advertising based on the number of subscriptions sold as well as
contributions received. In performing that evaluation, Entity M places more
weight on the number of subscriptions sold than on the contributions received.
Also, Entity M advertises the performances on local television and radio without
a request for contributions but on a smaller scale than the mail advertising.
Conclusion

E.68. The purpose, audience, and content criteria are met, and the joint
costs should be allocated.
E.69. The activity calls for specific action by the recipient (attending the
performances) that will help accomplish the entity’s mission. Therefore, the
guidance in paragraph 10 should be considered. Neither of the factors in
paragraph 10a or 10b is determinative of whether the purpose criterion is met.
Therefore, other evidence, such as the indicators in paragraph 11, should be
considered. The purpose criterion is met based on the other evidence, because
(a) the entity measures program results and accomplishments of the joint
activity and in evaluating the effectiveness of the activity, the entity places
significantly greater weight on the activity’s effectiveness in accomplishing
program goals than on the activity’s effectiveness in raising contributions
(Entity M evaluates the effectiveness of the advertising based on the number
of subscriptions sold as well as contributions received and places more weight
on the number of subscriptions sold than on the contributions received), (b) it
otherwise conducts the program activity without a request for contributions,
and (c) performing such programs helps accomplish Entity M’s mission (to
make the arts available to residents in its area).
E.70. The audience criterion is met because the audience (a broad segment
of the population in Entity M’s area) is selected based on its need to use or
reasonable potential for use of the action called for by the program component.
E.71. The content criterion is met because the activity calls for specific
action by the recipient (attending the performances) that will help accomplish
the entity’s mission (making the arts available to area residents), and the need
for and benefits of the action are clearly evident (attending the performance is
a positive cultural experience). (Note that the purchase of subscriptions is an
exchange transaction and, therefore, is not a contribution.)
Illustration 14
Facts

E.72. Entity N is a university whose mission is to educate the public
(students) in various academic pursuits. Entity N’s political science department
holds a special lecture series in which prominent world leaders speak about
current events. The speakers command relatively high fees and, in order to
cover costs and make a modest profit, the university sets a relatively expensive
fee to attend. However, the tickets are priced at the fair value of the lecture
AAG-HCO APP C

320

Health Care Organizations

and no portion of the ticket purchase price is a contribution. Entity N advertises
the lectures by sending invitations to prior attendees and to prior donors who
have contributed significant amounts, and by placing advertisements in local
newspapers read by the general public. At some of the lectures, including the
lecture being considered in this illustration, deans and other faculty members
of Entity N solicit significant contributions from attendees. Other lectures in
the series are conducted on a scale similar to the scale of the lecture in this
illustration without requesting contributions. Entity N’s records indicate that
historically 75 percent of the attendees have attended prior lectures. Of the 75
percent who have attended prior lectures, 15 percent have made prior contri
butions to Entity N. Of the 15 percent who have made prior contributions to
Entity N, 5 percent have made contributions in response to solicitations made
at the events. (Therefore, one-half of one percent of attendees make contribu
tions in response to solicitations made at the events. However, those contribu
tions are significant.) Overall, the audience’s ability or likelihood to contribute
is an insignificant factor in its selection. Entity N evaluates the effectiveness
of the activity based on the number of tickets sold, as well as contributions
received. In performing that evaluation, Entity N places more weight on the
number of tickets sold than on the contributions received.
Conclusion

E.73. The purpose, audience, and content criteria are met, and the joint
costs should be allocated.
E.74. The activity calls for specific action by the recipient (attending the
lecture) that will help accomplish the entity’s mission. Therefore, the guidance
in paragraph 10 should be considered. The purpose criterion is met because (a)
the program component of the activity calls for specific action by the recipient
that will help accomplish the entity’s mission (educating the public [students]
in various academic pursuits), and (b) the program is also conducted using the
same medium on a scale that is similar to or greater than the scale on which it
is conducted with the request for contributions (other lectures in the series are
conducted on a scale similar to the scale of the lecture in this illustration
without requesting contributions).
E.75. The audience criterion is met. The rebuttable presumption that the
audience criterion is not met because the audience includes prior donors is
overcome in this illustration because the audience (those who have shown prior
interest in the lecture series, prior donors, a broad segment of the population
in Entity N’s area, and those attending the lecture) is also selected for its
reasonable potential for use of the program component (attending the lecture).
Although the audience may make significant contributions, that was an insig
nificant factor in its selection.
E.76. The content criterion is met because the activity calls for specific
action by the recipient (attending the lecture) that will help accomplish the
entity’s mission (educating the public [students] in various academic pursuits),
and the need for and benefits of the action are clearly evident (attending the
lecture is a positive educational experience). (Note that the purchase of the
tickets is an exchange transaction and, therefore, is not a contribution. As
discussed in paragraph 7 of this SOP, costs of goods or services provided in
exchange transactions that are part of joint activities, such as costs of direct
donor benefits of a special event, should not be reported as fund raising.12)
12 Paragraphs 13.21 to 13.26 of the Audit and Accounting Guide Not-for-Profit Organizations
provide guidance concerning reporting special events. [Footnote revised, June 2004, to reflect con
forming changes due to conforming changes made to the AICPA Audit and Accounting Guide
Not-for-Profit Organizations.]
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Illustration 15

Facts

E.77. Entity O is a university whose mission is to educate the public
(students) in various academic pursuits. Entity O’s political science department
holds a special lecture series in which prominent world leaders speak about
current events. Admission is priced at $250, which is above the $50 fair value
of the lecture and, therefore, $200 of the admission price is a contribution.
Therefore, the audience’s likelihood to contribute to the entity is a significant
factor in its selection. Entity O advertises the lectures by sending invitations
to prior attendees and to prior donors who have contributed significant
amounts, and by placing advertisements in local newspapers read by the
general public. Entity O presents similar lectures that are priced at the fair
value of those lectures.
Conclusion

E.78. The purpose and content criteria are met. The audience criterion is
not met. All costs, including those that might otherwise be considered program
or management and general costs if they had been incurred in a different
activity, except for the costs of the direct donor benefit (the lecture), should be
charged to fund raising.
E.79. The activity calls for specific action by the recipient (attending the
lecture) that will help accomplish the entity’s mission. Therefore, the guidance
in paragraph 10 should be considered. The purpose criterion is met because (a)
the program component of the activity calls for specific action by the recipient
that will help accomplish the entity’s mission (educating the public [students]
in various academic pursuits), and (b) the program is also conducted using the
same medium on a scale that is similar to or greater than the scale on which it
is conducted with the request for contributions (other lectures in the series are
conducted on a scale similar to the scale of the lecture in this illustration
without including a contribution in the admission price.)
E.80. The audience criterion is not met. The rebuttable presumption that
the audience criterion is not met because the audience is selected based on its
likelihood to contribute to the entity is not overcome in this illustration. The
fact that the $250 admission price includes a $200 contribution leads to the
conclusion that the audience’s ability or likelihood to contribute is an over
whelmingly significant factor in its selection, whereas there is no evidence that
the extent to which the audience is selected for its need to use or reasonable
potential for use of the action called for by the program component (attending
the lecture) is overwhelmingly significant.
E.81. The content criterion is met because the activity calls for specific
action by the recipient (attending the lecture) that will help accomplish the
entity’s mission (educating the public [students] in various academic pursuits),
and the need for and benefits of the action are clearly evident (attending the
lecture is a positive educational experience). (Note that the purchase of the
tickets is an exchange transaction and, therefore, is not a contribution. As
discussed in paragraph 7 of this SOP, costs of goods or services provided in
exchange transactions that are part of joint activities, such as costs of direct
donor benefits of a special event, should not be reported as fund raising.13)
13 Paragraphs 13.21 to 13.26 of the Audit and Accounting Guide Not-for-Profit Organizations
provide guidance concerning reporting special events. [Footnote revised, June 2004, to reflect con
forming changes due to conforming changes made to the AICPA Audit and Accounting Guide
Not-for-Profit Organizations.]
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Illustration 16

Facts

E.82. Entity P’s mission is to reduce the incidence of illness from ABC
disease, which primarily afflicts people over sixty-five years of age. One of
Entity P’s objectives in fulfilling that mission is to have all persons over
sixty-five screened for ABC disease.
E.83. Entity P rents space at events attended primarily by people over
sixty-five years of age and conducts free screening for ABC disease. Entity P’s
employees, who are educated about ABC disease and screening procedures and
do not otherwise perform fund-raising functions, educate interested parties
about the effects of ABC disease and the ease and benefits of screening for it.
Entity P also solicits contributions at the events. The effectiveness of the
activity is evaluated primarily based on how many screening tests are per
formed, and only minimally based on contributions raised. The employees are
not compensated or evaluated based on contributions raised.
Conclusion

E.84. The purpose, audience, and content criteria are met, and the joint
costs should be allocated.
E.85. The activity calls for specific action by the recipient (being screened
for ABC disease) that will help accomplish the entity’s mission. Therefore, the
guidance in paragraph 10 should be considered. Neither of the factors in
paragraph 10a or 10b is determinative of whether the purpose criterion is met.
Therefore, other evidence, such as the indicators in paragraph 11, should be
considered. The purpose criterion is met based on the other evidence, because
(a ) a process exists to evaluate measured program results and accomplishments
and in evaluating the effectiveness of the joint activity, the entity places
significantly greater weight on the activity’s effectiveness in accomplishing
program goals than on the activity’s effectiveness in raising contributions
(Entity P evaluates the effectiveness of the activity based on the number of
screening tests conducted as well as contributions received and places more
weight on the number of tests conducted than on the contributions received);
(b) the qualifications and duties of the personnel performing the activity
indicate that it is a program activity (the employees are educated about ABC
disease and the testing procedures and do not otherwise perform fund-raising
functions); (c) the method of compensation for performing the activity does not
indicate that it is a fund-raising activity (the employees are not compensated
or evaluated based on contributions raised); and (d) performing such programs
helps accomplish Entity P’s mission (to prevent ABC disease).
E.86. The audience criterion is met because the audience (people over
sixty-five years of age) is selected based on its need to use or reasonable
potential for use of the action called for by the program component.
E.87. The content criterion is met because the activity calls for specific
action by the recipient (being screened for ABC disease) that will help accom
plish the entity’s mission (to reduce the incidence of ABC disease), and it
explains the need for and benefits of the action (to prevent ABC disease).
Illustration 17
Facts

E.88. Entity Q’s mission is to provide cultural and educational television
programming to residents in its area. Entity Q owns a public television station
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and holds a membership drive in which it solicits new members. The drive is
conducted by station employees and consists of solicitations that are shown
during long breaks between the station’s regularly scheduled programs. Entity
Q’s internal management memoranda state that these drives are designed to
raise contributions. Entity Q evaluates the effectiveness of the activity based
on the amount of contributions received. Entity Q shows the programs on a
similar scale, without the request for contributions. The audience is members
of the general public who watch the programs shown during the drive. Station
member benefits are given to those who contribute and consist of tokens of
appreciation with a nominal value.
Conclusion

E.89. The purpose, audience, and content criteria are met, and the joint
costs should be allocated. (Note that there would be few, if any, joint costs. Costs
associated with the fund-raising activities, such as costs of airtime, would be
separately identifiable from costs of the program activities, such as licensing
costs for a particular television program. Also, note that because no significant
benefits or duties are associated with membership, member dues are contribu
tions. Therefore, the substance of the membership-development activities is, in
fact, fund raising.)
E.90. The activity calls for specific action by the recipient (watching the
television program) that will help accomplish the entity’s mission. Therefore,
the guidance in paragraph 10 should be considered. The purpose criterion is
met because (a) the program component of the activity calls for specific action
by the recipient that will help accomplish the entity’s mission, and (b) the
program is also conducted using the same medium on a scale that is similar to
or greater than the scale on which it is conducted with the request for contri
butions (Entity Q shows the television programs on a similar scale, without the
request for contributions).
E.91. The audience criterion is met. The rebuttable presumption that the
audience criterion is not met because the audience is selected based on its
likelihood to contribute is overcome in this illustration because the audience
(members of the general public who watch the television programs shown
during the drive) is also selected for its reasonable potential for use of the
program component (watching the television programs). Although the audience
may make contributions, that was an insignificant factor in its selection.
E.92. The content criterion is met because the activity calls for specific
action by the recipient (watching the television programs) that will help
accomplish the entity’s mission (providing cultural and educational television
programming to residents in its area), and the need for and benefits of the action
are clearly evident (watching the programs is a positive cultural and educa
tional experience).
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APPENDIX F
Illustrations of Allocation Methods

F.1. Some commonly used cost allocation methods follow.
Physical Units Method

F.2. Joint costs are allocated to materials and activities in proportion to
the number of units of output that can be attributed to each of the materials
and activities. Examples of units of output are lines, square inches, and physical
content measures. This method assumes that the benefits received by the
fund-raising, program, or management and general component of the materials
or activity from the joint costs incurred are directly proportional to the lines,
square inches, or other physical output measures attributed to each component
of the activity. This method may result in an unreasonable allocation of joint
costs if the units of output, for example, line counts, do not reflect the degree
to which costs are incurred for the joint activity. Use of the physical units
method may also result in an unreasonable allocation if the physical units
cannot be clearly ascribed to fund raising, program, or management and
general. For example, direct mail and telephone solicitations sometimes in
clude content that is not identifiable with fund raising, program, or manage
ment and general; or the physical units of such content are inseparable.
Illustration

F.3. Assume a direct mail campaign is used to conduct programs of the
entity and to solicit contributions to support the entity and its programs.
Further, assume that the appeal meets the criteria for allocation of joint costs
to more than one function.
F.4. The letter and reply card include a total of one hundred lines. Fortyfive lines pertain to program because they include a call for action by the
recipient that will help accomplish the entity’s mission, while fifty-five lines
pertain to the fund-raising appeal. Accordingly, 45 percent of the costs are
allocated to program and 55 percent to fund-raising.
Relative Direct Cost Method

F.5. Joint costs are allocated to each of the components on the basis of
their respective direct costs. Direct costs are those costs that are incurred in
connection with the multipurpose materials or activity and that are specifi
cally identifiable with a function (program, fund raising, or management and
general). This method may result in an unreasonable allocation of joint costs
if the joint costs of the materials and activity are not incurred in approximately
the same proportion and for the same reasons as the direct costs of the
materials and activity. For example, if a relatively costly booklet informing
the reader about the entity’s mission (including a call for action by the
recipient that will help accomplish the entity’s mission) is included with a
relatively inexpensive fund-raising letter, the allocation of joint costs based
on the cost of these pieces may be unreasonable, particularly if the booklet
and letter weigh approximately the same and therefore contribute equally to
the postage costs.
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Illustration

F.6. The costs of a direct mail campaign that can be specifically identified
with program services are the costs of separate program materials and a
postcard which calls for specific action by the recipient that will help accomplish
the entity’s mission. They total $20,000. The direct costs of the fund-raising
component of the direct mail campaign consist of the costs to develop and
produce the fund-raising letter. They total $80,000. Joint costs associated with
the direct mail campaign total $40,000 and would be allocated as follows under
the relative direct cost method:
Program
$20,000/$100,000 X $40,000 = $8,000
Fund raising $80,000/$100,000 X $40,000 = $32,000
Stand-Alone Joint-Cost-Allocation Method

F.7. Joint costs are allocated to each component of the activity based on a
ratio that uses estimates of costs of items included in joint costs that would
have been incurred had the components been conducted independently. The
numerator of the ratio is the cost (of items included in joint costs) of conducting
a single component independently; the denominator is the cost (of items
included in joint costs) of conducting all components independently. This
method assumes that efforts for each component in the stand-alone situation
are proportionate to the efforts actually undertaken in the joint cost situation.
This method may result in an unreasonable allocation because it ignores the
effect of each function, which is performed jointly with other functions, on other
such functions. For example, the programmatic impact of a direct mail cam
paign or a telemarketing phone message may be significantly lessened when
performed in conjunction with a fund-raising appeal.
Illustration

F.8. Assume that the joint costs associated with a direct mail campaign
including both program and fund-raising components are the costs of station
ery, postage, and envelopes at a total of $100,000. The costs of stationery,
postage, and envelopes to produce and distribute each component separately
would have been $90,000 for the program component and $70,000 for the
fund-raising component. Under the stand-alone joint-cost-allocation method,
the $100,000 in joint costs would be allocated as follows: $90,000/$160,000 X
$100,000 = $56,250 to program services and $70,000/$160,000 X $100,000 =
$43,750 to fund raising.
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APPENDIX G
Illustrations of Disclosures

G.1. The disclosures discussed in paragraphs 18 and 19 are illustrated
below. Alternative 1 reports the required and encouraged information in
narrative format. Alternative 2 reports that information in tabular format, as
well as information concerning joint costs incurred for each kind of activity by
functional classification, which is neither required nor encouraged, but which
is not prohibited.
Alternative 1

Note X. Allocation of Joint Costs
In 19XX, the organization conducted activities that included requests for
contributions, as well as program and management and general components.
Those activities included direct mail campaigns, special events, and a telethon.
The costs of conducting those activities included a total of $310,000 of joint
costs, which are not specifically attributable to particular components of the
activities (joint costs). [Note to reader: The following sentence is encouraged
hut not required.] Joint costs for each kind of activity were $50,000, $150,000,
and $110,000 respectively. These joint costs were allocated as follows:
Fund raising
$180,000
Program A
80,000
Program B
40,000
Management and general
10,000
Total
$310,000
Alternative 2

Note X. Allocation of Joint Costs
In 19XX, the organization conducted activities that included appeals for con
tributions and incurred joint costs of $310,000. These activities included direct
mail campaigns, special events, and a telethon. Joint costs were allocated as
follows:
Special
Direct
Telethon
Total
Events
Mail
$180,000
Fund raising
80,000
Program A
40,000
Program B
Management and
_________
10,000 __________
10,000
general
$50,000 $150,000 $110,000 $310,000
Total
[Note to reader: Shading is used to highlight information that is neither
required nor encouraged, but which is not prohibited. However, entities may
prefer to disclose it. Disclosing the total joint costs for each kind of activity
($50,000, $150,000, and $110,000) is encouraged but not required.]
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APPENDIX H
Contrast of Guidance in This SOP With the Guidance
in SOP 87-214 ††

This SOP
Applies to all entities that solicit
contributions, including state and
local governments.

Covers all costs of joint activities.
(Costs that otherwise might be con
sidered program or management
and general costs if they had been
incurred in a different activity, ex
cept for costs of goods or services
provided in exchange transactions
that are part of joint activities,
such as costs of direct donor bene
fits of a special event [for example,
a meal], should be charged to fund
raising unless the criteria in the
SOP are met.)
Criteria of purpose, audience, and
content should all be met in order to
charge costs of the activity to pro
gram or management and general.

SOP 87-2
Applied to entities that follow the
AICPA Industry Audit Guide Audits
of Voluntary Health and Welfare
Organizations or SOP 78-10. (SOP
87-2 was not applicable to entities
that are within the scope of Govern
mental Accounting Standards Board
Statement No. 29, The Use of Notfor-Profit Accounting and Financial
Reporting Principles by Governmen
tal Entities.)
Covers only joint costs of joint
activities.

Unclear concerning whether all
criteria should be met in order to
charge costs of the activity to pro
gram or management and general.
(continued)

14 In August 1996, the AICPA issued the Audit and Accounting Guide Not-for-Profit
Organizations, which superseded SOP 87-2, Accounting for Joint Costs of Informational Materials
and Activities of Not-for-Profit Organizations That Include a Fund-Raising Appeal, because the
guidance in SOP 87-2 is incorporated into paragraphs 13.36 to 13.45 of the Guide. Also, Not-for-Profit
Organizations superseded the AICPA Industry Audit Guide Audits of Voluntary Health and Welfare
Organizations and SOP 78-10. Not-for-Profit Organizations applies to all nongovernmental not-forprofit organizations other than those required to follow the Audit and Accounting Guide Health Care
Organizations. Therefore, incorporating the guidance in SOP 87-2 into Not-for-Profit Organizations
broadened the scope of the guidance previously included in SOP 87-2 to all not-for-profit
organizations other than those required to follow Health Care Organizations. The discussion in this
SOP of SOP 87-2 refers to both SOP 87-2 and the guidance included in paragraphs 13.36 to 13.45 of
Not-for-Profit Organizations, except that the guidance in Not-for-Profit Organizations applies to all
not-for-profit organizations other than those required to follow Health Care Organizations.
†† See footnotes || and # to paragraphs D.3 and D.4 of this SOP. [Footnote revised, June 2004,
to reflect conforming changes necessary due to the issuance of GASB Statement No. 35.]
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This SOP
Neither prescribes nor prohibits any
allocation methods. Includes a dis
cussion to help users determine
whether an allocation is reasonable,
and provides some illustrations.
Requires note disclosures about the
types of activities for which joint
costs have been incurred, amounts
allocated during the period, and
amounts allocated to each functional
expense or expenditure category.

AAG-HCO APP C

SOP 87-2
Neither prescribes nor prohibits any
allocation methods. No illustrations
are provided.
Requires less extensive note disclo
sures: total amount allocated during
the period and amounts allocated to
each functional expense category.
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APPENDIX I
Effects on Other Guidance

I.1. For nongovernmental organizations, this Statement of Position (SOP)
amends the AICPA Audit and Accounting Guide Health Care Organizations
and paragraphs 13.35 to 13.44 of the AICPA Audit and Accounting Guide
Not-for-Profit Organizations. [Revised, June 2004, to reflect conforming
changes due to conforming changes made to the AICPA Audit and Accounting
Guide Not-for-Profit Organizations.]
I.2. Also, this SOP amends the AICPA Audit and Accounting Guide Notfor-Profit Organizations to clarify that costs of goods or services provided in
exchange transactions that are part of joint activities, such as costs of direct
donor benefits of a special event (for example, a meal), should not be reported
as fund-raising. In particular, paragraphs 13.21, 13.23, and 13.24 of Not-forProfit Organizations are amended as follows:
13.21 Some organizations conduct joint activities* that are special events,
including special social and educational events (such as symposia, dinners,
dances, and theater parties) in which the attendee receives a direct benefit (for
example, a meal or theater ticket). FASB Statement No. 117 requires the
reporting of the gross amounts of revenues and expenses from special events
and other fund-raising activities that are ongoing major or central activities,
but permits (but does not require) reporting net amounts if the receipts and
related costs result from special events that are peripheral or incidental
activities.
9 See footnote 1.
13.23 For example, assume that an organization has a special event that is
an ongoing and major activity with a ticket price of $100. Assume that the
activity does not meet the audience criterion in SOP 98-2, Accounting for Costs
of Activities of Not-for-Profit Organizations and State and Local Governmental
Entities That Include Fund Raising, and, therefore, all costs of the activity,
other than the direct donor benefits, should be reported as fund raising. The
event includes a dinner that costs the organization $25 and that has a fair value
of $30. (Chapter 5, “Contributions Received and Agency Transactions,” of this
Guide, discusses the appropriate reporting if the meal or other items of value
are donated to the organization for resale.) In addition, the organization incurs
other direct costs of the event in connection with promoting and conducting the
event, including incremental direct costs incurred in transactions with inde
pendent third parties and the payroll and payroll-related costs for the activities
of employees who are directly associated with, and devote time to, the event.
Those other direct costs, which include (a) $5 that otherwise might be consid
ered management and general costs if they had been incurred in a different
activity, and (b) fund-raising costs of $10, are unrelated to the direct benefits
to donors and, accordingly, should not be included as costs of benefits to donors.
In addition, the organization has the following transactions, which are unre
lated to the special event: unrestricted contributions of $200, program expenses
of $60, management and general expenses of $20, and fund-raising expenses
of $20.
13.24 Some ways in which the organization could display the results of the
special event as part of its statement of activities are illustrated as follows:
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Illustration 1
Changes in unrestricted net assets:
Contributions
Special event revenue
Less: Costs of direct benefits to donors
Net revenues from special events
Contributions and net revenues from
special events
Other expenses:
Program
Management and general
Fund raising
Total other expenses
Increase in unrestricted net assets
Illustration 2
Changes in unrestricted net assets:
Revenues:
Contributions
Special event revenue
Total revenues
Expenses:
Program
Costs of direct benefits to donors
Management and general
Fund raising
Total expenses
Increase in unrestricted net assets
Illustration 3
Changes in unrestricted net asset:
Contributions
Dinner sales
Less: Costs of direct benefits to donors
Gross profit on special events
Contributions and net revenues from
special events
Other expenses:
Program
Management and general
Fund raising
Total other expenses
Increase in unrestricted net assets

100
(25)

$200
75
275
60
20
35
115
$160

$200
100
300
60
25
20
35
140
$160

$270
30
(25)
5
275
60
20
35
115
$160

[Revised, June 2004, to reflect conforming changes due to conforming changes
made to the AICPA Audit and Accounting Guide Not-for-Proftt Organizations.]
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I.3. For governmental entities that have applied the accounting and finan
cial reporting principles in SOP 78-10, Accounting Principles and Reporting
Practices for Certain Nonprofit Organizations, or the AICPA Industry Audit
Guide Audits of Voluntary Health and Welfare Organizations (modified by all
applicable Financial Accounting Standards Board [FASB] pronouncements
issued through November 30, 1989, and by most applicable Governmental
Accounting Standards Board [GASB] pronouncements) in conformity with
GASB Statement No. 29, The Use of Not-for-Profit Accounting and Financial
Reporting Principles by Governmental Entities, this SOP amends the principles—
based on SOP 78-10 and Audits of Voluntary Health and Welfare Organizations,
as modified—that those entities apply. For governmental entities that have
applied the accounting and financial reporting principles in the 1973 AICPA
Industry Audit Guide Audits of Colleges and Universities, as amended by SOP
74-8, Financial Accounting and Reporting by Colleges and Universities, and as
modified by applicable FASB pronouncements issued through November 30,
1989, and all applicable GASB pronouncements in conformity with GASB
Statement No. 15, Governmental College and University Accounting and Fi
nancial Reporting Models, this SOP amends the principles—based on Audits
of Colleges and Universities, as amended and modified—that those entities
apply. For other governmental organizations, this SOP amends the Audit and
Accounting Guide Audits of State and Local Governmental Units.‡

‡‡See footnotes || and # to paragraphs D.3 and D.4 of this SOP. Also, the AICPA Audit and
Accounting Guide Audits of State and Local Governments, supersedes the 1994 AICPA Audit and
Accounting Guide Audits of State and Local Governmental Units, and subsequent editions of that
Guide with conforming changes made by the AICPA staff. AICPA Audit and Accounting Guide State
and Local Governments, provides guidance on the application of this SOP to state and local govern
ments. [Footnote added, June 2004, to reflect conforming changes necessary due to the issuance of
GASB Statements No. 34, No. 35, and the AICPA Audit and Accounting Guide State and Local
Governments.]
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G lossary
Activities. Activities are efforts to accomplish specific objectives. Some activi
ties include producing and distributing materials. For example, if an entity
undertakes a mass mailing that includes a letter and a pamphlet, produc
ing and distributing the letter and pamphlet are part of the activity. Other
activities may include no materials, such as an annual dinner or a radio
commercial.
Compensation or fees. Reciprocal transfers of cash or other assets in ex
change for services performed.
Contributions. Contributions are unconditional transfers of cash or other
assets to an entity or a settlement or cancellation of its liabilities in a
voluntary nonreciprocal transfer by another entity acting other than as an
owner.
Costs of joint activities. Costs of joint activities are costs incurred for a joint
activity. Costs of joint activities may include joint costs and costs other
than joint costs. Costs other than joint costs are costs that are identifiable
with a particular function, such as fund raising, program, management
and general, and cost of sales. For example, some costs incurred for
printing, paper, professional fees, and salaries to produce donor cards are
not joint costs, although they may be incurred in connection with conduct
ing joint activities.
Fund-raising activities. Fund-raising activities are activities undertaken to
induce potential donors to contribute money, securities, services, materi
als, facilities, other assets, or time. They include publicizing and conduct
ing fund-raising campaigns; maintaining donor mailing lists; conducting
special fund-raising events; preparing and distributing fund-raising manu
als, instructions, and other materials; and conducting other activities
involved with soliciting contributions from individuals, foundations, gov
ernments, and others.
Help accomplish the entity’s mission. Actions that help accomplish the en
tity’s mission are actions that either benefit the recipient (such as by
improving the recipient’s physical, mental, emotional, or spiritual health
and well-being) or benefit society (by addressing societal problems).
Joint activity. A joint activity is an activity that is part of the fund-raising
function and has elements of one or more other functions, such as program,
management and general, membership development, or any other func
tional category used by the entity.
Joint costs. Joint costs are the costs of conducting joint activities that are not
identifiable with a particular component of the activity. For example, the
cost of postage for a letter that includes both fund-raising and program
components is a joint cost. Joint costs may include the costs of salaries,
contract labor, consultants, professional fees, paper, printing, postage,
event advertising, telephones, airtime, and facility rentals.
Management and general activities. Management and general activities
are those that are not identifiable with a single program, fund-raising
activity, or membership-development activity but that are indispensable
to the conduct of those activities and to an organization’s existence. They
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include oversight, business management, general recordkeeping, budget
ing, financing, soliciting revenue from exchange transactions, such as
government contracts and related administrative activities, and all man
agement and administration except for direct conduct of program services
or fund-raising activities. Disseminating information to inform the public
of the organization’s “stewardship” of contributed funds, announcements
concerning appointments, and the annual report, among other activities,
are management and general activities, as are soliciting funds other than
contributions, including exchange transactions (whether program-related
or not).
Medium. A medium is a means of mass communication, such as direct mail,
direct response advertising, or television.
Membership-development activities. Membership-development activities
include soliciting for prospective members and membership dues, member
ship relations, and similar activities. If there are no significant benefits or
duties connected with membership, however, the substance of member
ship-development activities may, in fact, be fund-raising.
Program activities. Program activities are the activities that result in goods
or services being distributed to beneficiaries, customers, or members that
fulfill the purposes or mission for which the organization exists. Those
services are the major purpose for and the major output of the organization
and often relate to several major programs. For example, a large university
may have programs for student instruction, research, and patient care,
among others. Similarly, a health and welfare organization may have
programs for health and family services, research, disaster relief, and
public education, among others.
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NOTE

This Statement of Position presents the recommendations of the
AICPA Health Care Pilot Task Force regarding the application of
Statements on Standards for Attestation Engagements to agreedupon procedures attestation engagements performed to assist a
health care provider in evaluating the effectiveness of its corporate
compliance program consistent with the requirements of a Corporate
Integrity Agreement entered into with the Office of Inspector General
of the U.S. Department of Health and Human Services. The Auditing
Standards Board has found the recommendations in this Statement
of Position to be consistent with existing standards covered by Rule
202 of the AICPA Code of Professional Conduct. AICPA members
should be prepared to justify departures from the recommendations
in this Statement of Position.
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SUMMARY

This Statement of Position (SOP) provides guidance to practitioners in conduct
ing and reporting on an agreed-upon procedures engagement performed pur
suant to the AICPA Statements on Standards for Attestation Engagements to
assist a health care provider in evaluating the effectiveness of its corporate
compliance program consistent with the requirements of a Corporate Integrity
Agreement (CIA) entered into with the Office of Inspector General (OIG) of the
U.S. Department of Health and Human Services. CIAs are specific to the entity
involved; consequently, users of this SOP should be familiar with the specific
requirements of the entity’s CIA.
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Guidance to Practitioners in Conducting and
Reporting on an Agreed-Upon Procedures
Engagement to Assist Management in
Evaluating the Effectiveness of Its
Corporate Compliance Program
Introduction and Background

1. Within the past several years, the health care industry has experienced
a significant increase in the number and magnitude of allegations of fraud and
abuse involving federal health care programs (for example, Medicare and
Medicaid) and private health care insurance. These allegations have triggered
regulatory scrutiny, litigation, significant monetary settlements, and negative
publicity related to—among other things—coding and billing practices, patient
referrals, cost reporting, quality of care, and clinical practices. Typically, as
part of the global resolution of these allegations, the entity enters into a
Corporate Integrity Agreement (CIA) with the Office of Inspector General
(OIG) of the U.S. Department of Health and Human Services. Such agreements
require that management annually report on its compliance with the terms of
the CIA and that there be an assessment of the entity’s compliance with the
CIA. This assessment includes a billing analysis, which may be performed
by an independent review organization (such as a practitioner or consult
ant) or the provider (if permitted by the OIG), and an agreed-upon proce
dures engagement.
2. This SOP provides guidance to practitioners in conducting and report
ing on an agreed-upon procedures engagement performed pursuant to the
American Institute of Certified Public Accountants (AICPA) Statements on
Standards for Attestation Engagements (SSAEs) to assist an entity in evalu
ating the effectiveness of its corporate compliance program consistent with the
requirements of a CIA.1 The terms of a CIA are unique to the entity;
consequently, users of this SOP need to be familiar with the actual CIA and
its requirements.
3. This SOP applies to agreed-upon procedures engagements to assist in
evaluating an entity’s compliance for a specified period. Such engagements
should follow the AICPA attestation standards, including SSAE No. 1, Attesta
tion Standards (AICPA, Professional Standards, vol. 1, AT sec. 100); SSAE No.
3, Compliance Attestation (AICPA, Professional Standards, vol. 1, AT sec. 500);
and SSAE No. 4, Agreed-Upon Procedures Engagements (AICPA, Professional
Standards, vol. 1, AT sec. 600). The engagement should be conducted in
accordance with standards established by the AICPA, including the criteria set
forth in this SOP. However, this SOP is not intended to provide all the required
1
The practitioner also might be engaged to assist in other areas beyond an agreed-upon
procedures engagement such as providing consulting services in connection with evaluating the
company’s billing practices, policies, and procedures as required by the CIA or in implementing,
assessing, and reporting on voluntarily adopted compliance programs. In addition, the practitioner
may assist in preparing an entity’s self-disclosure reports to federal health agencies related to billing
errors and other compliance matters. Similarly, practitioners may be involved in an entity’s prepara
tion of government-required (but not CIA-imposed) compliance reporting (for example, contract
requirements for Medicare part C) beyond an agreed-upon procedures engagement.
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criteria set forth in individual CIAs, nor all the applicable standards estab
lished by the AICPA. Additionally, the SOP contains some guidance that may
be applied in evaluating an organization’s corporate compliance program, even
though the program was not imposed by a CIA.
Overview of a Typical Corporate Integrity Agreement

4. A CIA is an agreement between a health care provider and the OIG in
conjunction with a global settlement of a fraud investigation. Such an agree
ment typically seeks to establish a compliance program within the health care
provider (for example, hospital, clinical lab, physician group) that will promote
compliance with the requirements of Medicare, Medicaid, and all other federal
health care programs.
5. CIAs are case-specific. Their terms are tailored to address the organ
izational and operating deficiencies related to providing and billing for health
care services that have been identified by the OIG, the entity, or others. Detailed
compliance requirements are imposed as a condition for continued participa
tion in federal health care programs. A sample CIA, provided by the OIG and
intended to identify potential requirements, is included in appendix A, “Sam
ple Corporate Integrity Agreement.” Typical agreements cover five years and
require the entity to address the following areas:
• Appointment of a compliance officer and establishment of a compli
ance committee
• Establishment of a code of conduct
• Establishment of policies and procedures regarding the compliance
program
• Development of an information and education program as to CIA
requirements, compliance program and code of conduct
• Annual assessment of billing policies, procedures, and practices
• Establishment of a confidential disclosure program
• Prohibition of employment of excluded or convicted persons
• Notification to OIG of investigation or legal proceedings
• Reporting of credible evidence of misconduct
• Notifications to OIG of new provider locations
• Provision of implementation and annual reports
• Proper notification and submission of required reports
• Granting of OIG access to documents and individuals to conduct
assessments
• Documentation of record retention requirements
• Awareness of disclosure criteria
• Agreement to comply with certain default provisions, penalties, and
remedies
• Review of rights as to dispute resolution
• Review of effective and binding agreement clauses
Conditions for Engagement Performance

6. A practitioner may perform an agreed-upon procedures engagement
related to management’s compliance with a CIA if all of the conditions specified
in SSAE No. 4 (AT sec. 600.10) and SSAE No. 3 (AT sec. 500.09-.11) are met.
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7. As discussed more fully in the SSAEs noted in paragraph 6, manage
ment’s assertions as to its compliance must be capable of evaluation against
reasonable criteria that either have been established by a recognized body or
are stated in or attached to the practitioner’s report in a sufficiently clear and
comprehensive manner. Generally, to avoid confusion, management’s asser
tions, which are based on the specific terms of its CIA, should be attached to
the practitioner’s report. If the entity is not subject to a CIA, management may
develop its assertions using the model CIA. A sample based on the model CIA,
which is not meant to be all-inclusive, is included as appendix B, “Sample
Statement of Management’s Assertions.”
Establishing an Understanding With the Client

8. The practitioner should document the understanding in the working
papers, preferably through a written communication with the client, such as
an engagement letter. Appendix C, “Sample Engagement Letter,” contains a
sample engagement letter that may be used for this kind of engagement.
Users' Responsibilities

9. Users typically would be the management of the health care provider
and the OIG. Management is responsible for ensuring that the entity complies
with the requirements of the CIA. That responsibility encompasses (a) identi
fying applicable compliance requirements, (b) establishing and maintaining
internal control policies and procedures to provide reasonable assurance that
the entity complies with those requirements, (c) evaluating and monitoring the
entity’s compliance, and (d) preparing reports that satisfy legal, regulatory, or
contractual requirements. Management’s evaluation may include documenta
tion such as accounting or statistical data, policy manuals, accounting manu
als, narrative memoranda, procedural write-ups, flowcharts, completed
questionnaires, internal auditors’ reports, and other special studies or analy
ses. The form and extent of documentation will vary depending on the nature
of the compliance requirements and the size and complexity of the entity.
Management may engage the practitioner to gather information to assist it in
evaluating the entity’s compliance. Regardless of the procedures performed by
the practitioner, management must accept responsibility for its assertions and
must not base such assertions solely on the practitioner’s procedures.
10. Specified users are responsible for the sufficiency (nature, timing, and
extent) of the agreed-upon procedures because they best understand their own
needs. The specified users assume the risk that such procedures might be
insufficient for their purposes. In addition, the specified users assume the risk
that they might misunderstand or otherwise inappropriately use findings
properly reported by the practitioner.
Practitioner's Responsibilities

11. The objective of the practitioner’s agreed-upon procedures is to pre
sent specific findings to assist users in evaluating an entity’s compliance with
the requirements specified in the CIA. (See appendix D, “Sample Procedures.”)
12. The practitioner’s procedures generally may be as limited or extensive
as the specified users desire, as long as the specified users agree upon the
procedures performed or to be performed and take responsibility for the
sufficiency of the agreed-upon procedures for their purposes.
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13. To satisfy the requirements that the practitioner and the specified
users agree upon the procedures performed or to be performed and that the
specified users take responsibility for the sufficiency of the agreed-upon proce
dures for their purposes, ordinarily the practitioner should communicate di
rectly with and obtain affirmative acknowledgment from each of the specified
users. For the purposes of these engagements, an effective way to obtain this
agreement ordinarily is to distribute a draft of the report, detailing the proce
dures, that is expected to be issued to the OIG with a request for any comments
it may have.
14. To avoid possible misunderstandings, the practitioner should circu
late the draft with a legend stating that these are the procedures expected to
be performed, and unless informed otherwise, the practitioner assumes that
there are no additional procedures that he or she is expected to perform. A
legend such as the following might be used.
This draft is furnished solely for the purpose of indicating the form of report that
we would expect to be able to furnish pursuant to the request by Management of
[Provider] for our performance of limited procedures relating to [Provider’s]
compliance with the Corporate Integrity Agreement with the Office of Inspector
General (OIG) of the U.S. Department of Heath and Human Services. Based on
our discussions with [Provider], it is our understanding that the procedures
outlined in this draft report are those we are expected to follow. Unless informed
otherwise within ninety (90) days of this transmittal, we shall assume that there
are no additional procedures that we are expected to follow. The text of the
definitive report will depend, of course, on the results of the procedures.
Involvement of a Specialist2

15. The practitioner’s education and experience enable him or her to be
knowledgeable about business matters in general, but he or she is not expected
to have the expertise of a person trained for or qualified to engage in the
practice of another profession or occupation. In certain circumstances, it may
be appropriate to involve a specialist to assist the practitioner in the perform
ance of one or more procedures. The following are examples:
• An attorney might provide assistance concerning the application of
laws, regulations, or rules to a client’s situation.
• A medical specialist might provide assistance in understanding the
characteristics of diagnosis codes documented in patient medical records.
16. The practitioner and the specified users should agree to the involve
ment of a specialist in assisting a practitioner in the performance of an
agreed-upon procedures engagement. This agreement may be reached when
obtaining agreement on the procedures performed or to be performed and
acknowledgment of responsibility for the sufficiency of the procedures, as
discussed previously. The practitioner’s report should describe the nature of
the assistance provided by the specialist.
17. A practitioner may agree to apply procedures to the report or work
product of a specialist that does not constitute assistance by the specialist to
the practitioner in an agreed-upon procedures engagement. For example, the
practitioner may make reference to information contained in a report of a
specialist in describing an agreed-upon procedure. However, it is inappropriate
2
A specialist is a person (or firm) possessing special skill or knowledge in a particular field other
than the attest function. As used herein, a specialist does not include a person employed by the
practitioner’s firm who participates in the attestation engagement.
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for the practitioner to agree to merely read the specialist’s report solely to
describe or repeat the findings, or to take responsibility for all or a portion of
any procedures performed by a specialist or the specialist’s work product.
Internal Auditors and Other Personnel3

18. The agreed-upon procedures to be enumerated or referred to in the
practitioner’s report are to be performed entirely by the practitioner except as
discussed in paragraphs 15-17 of this SOP. However, internal auditors or
other personnel may prepare schedules, accumulate data, perform an internal
assessment of management’s compliance, or provide other information for the
practitioner’s use in performing the agreed-upon procedures.
19. A practitioner may agree to perform procedures on information docu
mented in the working papers of internal auditors. For example, the practi
tioner may agree to—
• Repeat all or some of the procedures.
• Determine whether the internal auditors’ working papers contain
documentation of procedures performed and whether the findings
documented in the working papers are presented in a report by the
internal auditors.
20. However, it is inappropriate for the practitioner to—
• Agree to merely read the internal auditor’s report solely to describe or
repeat its findings.
• Take responsibility for all or a portion of any procedures performed by
internal auditors by reporting those findings as the practitioner’s own.
• Report in any manner that implies shared responsibility for the
procedures with the internal auditors.
Planning the Engagement

21. Planning an agreed-upon procedures engagement involves working
with the users to develop an overall strategy for the expected conduct and scope
of the engagement. To develop such a strategy, practitioners should have
adequate technical training and proficiency in the attestation standards and
have adequate knowledge in health care regulatory matters to enable them to
sufficiently understand the events, transactions, and practices that, in their
judgment, have a significant effect on the presentation of the assertions.
Working Papers

22. The practitioner should prepare and maintain working papers in
connection with an engagement under the attestation standards; such working
papers should be appropriate to the circumstances and the practitioner’s needs
on the engagement to which they apply.
23. Concern over access to the practitioner’s working papers might cause
some clients to inquire about working paper requirements. In situations where
the practitioner is requested to not maintain copies of certain client documen
tation, or to not prepare and maintain documentation similar to client documents,

3
SAS No. 65, The Auditor’s Consideration of the Internal Audit Function in an Audit of
Financial Statements (AICPA, Professional Standards, vol. 1, AU sec. 322), does not apply to
agreed-upon procedures engagements.
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the practitioner may refer to the Auditing Interpretation, “The Auditor’s
Consideration of the Completeness Assertion” (AICPA, Professional Stand
ards, vol. 1, AU sec. 9326.06-.17), for guidance. See the Attest Interpretation,
“Providing Access to or Photocopies of Working Papers to a Regulator” (AICPA,
Professional Standards, vol. 1, AT sec. 9100.58), for guidance related to provid
ing access to or photocopies of working papers to a regulator in connection with
work performed on an attestation engagement.
Management's Representations

24.
The practitioner should obtain written representation from manage
ment on various matters including the following:
a. Acknowledging management’s responsibility for complying with the
CIA
b. Acknowledging management’s responsibility for establishing and
maintaining effective internal control over compliance
c. Stating that management has performed an evaluation of the entity’s
compliance with CIA-specified requirements
d. Stating management’s assertions about the entity’s compliance with
all aspects of the CIA, including the specific issues that gave rise to
the CIA4
e. Stating that management has disclosed to the practitioner all known
noncompliance with the CIA
f. Stating that management has made available all documentation
relating to compliance with the CIA
g. Stating management’s interpretation of any compliance require
ments that have varying interpretations
h. Stating that management has disclosed any communication from
regulatory agencies, internal auditors, legal counsel, and other par
ties concerning matters regarding the design, implementation, and
monitoring of the policies and procedures in place, including commu
nication received between the end of the reporting period and the
date of the practitioner’s report (the date of signature)
i. Stating that management has disclosed any known noncompliance
occurring subsequent to the end of the reporting period
j. Describing any related material fraud or abuse, other fraud, abuse
or illegal acts that, whether or not material, involve management or
other employees who have a significant role in the entity’s design,
implementation, and monitoring of the policies and procedures in
place upon which compliance is based
4 Depending on the circumstances, representations in the following areas might be appropriate.
• Violations or possible violations of laws or regulations, such as those related to the Medicare
and Medicaid antifraud and abuse statutes
• Compliance of third-party billings with applicable coding guidelines (for example, ICD-9-CM,
CPT) and laws and regulations (including medical necessity, proper approvals, and proper
rendering of care)
• Proper filing of all required Medicare, Medicaid, and similar reports under the applicable
reimbursement rules and regulations (including nature of costs—allowable, patient-related,
properly allocated, in accordance with applicable rules and regulations, properly adjusted to
reflect prior audit adjustments) and adequacy of disclosures (including disputed costs)
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Stating that management has disclosed to the practitioners, orally
or in writing, information about past noncompliance issues covered
in the settlement agreement that gave rise to the CIA and the related
corrective measures taken to support compliance in those areas
Management’s refusal to furnish all appropriate written representations con
stitutes a limitation on the scope of the engagement sufficient to require
withdrawal from the engagement.
k.

Reporting Considerations

25. A practitioner should present the results of applying agreed-upon
procedures to the specific subject matter in the form of findings. The practi
tioner should not provide negative assurance about whether the assertion is
fairly stated in accordance with established or stated criteria. For example, the
practitioner should not include a statement that “nothing came to my attention
that caused me to believe that the assertion is not fairly stated in accordance
with (established or stated) criteria.”
26. The practitioner should report all findings from the application of the
agreed-upon procedures. The concept of materiality does not apply to findings
to be reported in an agreed-upon procedures engagement unless the definition
of materiality is agreed to by the specified users. Any agreed-upon materiality
limits should be described in the practitioner’s report.
27. The practitioner has no obligation to perform procedures beyond the
agreed-upon procedures. However, if noncompliance related to management’s
assertion comes to the practitioner’s attention by other means, such informa
tion ordinarily should be included in his or her report.
28. The practitioner may become aware of noncompliance related to
management’s assertion that occurs subsequent to the reporting period but
before the date of the practitioner’s report. The practitioner should consider
including information regarding such noncompliance in his or her report.
However, the practitioner has no responsibility to perform procedures to detect
such noncompliance other than obtaining management’s representation about
noncompliance in the subsequent period.
29. The practitioner should follow the reporting guidance in SSAE No. 4
(AT sec. 600.33-.38). A sample report is included in appendix E, “Sample
Report.”
30. Evaluating compliance with certain requirements may require inter
pretation of the laws, regulations, rules, contracts, or other agreements that
establish those requirements. In such situations, the practitioner should con
sider whether he or she is provided with the reasonable criteria required to
evaluate an assertion under the third general attestation standard. If these
interpretations are significant, the practitioner may include a paragraph stat
ing the description and the source of interpretations made by the entity’s
management. An example of such a paragraph, which should precede the
procedures and findings paragraph(s), follows:
We have been informed that, under [name of entity’s] interpretation of [identify
the compliance requirement], [explain the nature and source of the relevant
interpretation].

31. The date of completion of the agreed-upon procedures should be used
as the date of the practitioner’s report.
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Appendix A

Sample Corporate Integrity Agreement
Between the Office of Inspector General
of the Department of Health and
Human Services and [Provider]

I. Pream ble

[Provider] (“[Provider]”) hereby enters into this Corporate Integrity Agree
ment (“CIA”) with the Office of Inspector General (“OIG”) of the United States
Department of Health and Human Services (“HHS”) to ensure compliance by
its employees with the requirements of Medicare, Medicaid and all other
Federal health care programs (as defined in 42 U.S.C. 1320a-7b(f)) (hereinafter
collectively referred to as the “Federal health care programs”). [Provider's]
compliance with the terms and conditions in this CIA shall constitute an
element of [Provider’s] present responsibility with regard to participation in
the Federal health care programs. Contemporaneously with this CIA,
[Provider] is entering into a Settlement Agreement with the United States, and
this CIA is incorporated by reference into the Settlement Agreement.
II. Term of the CIA

The period of the compliance obligations assumed by [Provider] under this
CIA shall be 5 years from the effective date of this CIA (unless otherwise
specified). The effective date of this CIA will be the date on which the final
signatory of this CIA executes this CIA (the “effective date”).*
III. Corporate Integrity O bligations

[Provider] shall establish a compliance program that includes the following
elements:
A. Compliance Officer
Within ninety (90) days after the effective date of this CIA, [Provider]
shall appoint an individual to serve as Compliance Officer, who shall
be responsible for developing and implementing policies, procedures,
and practices designed to ensure compliance with the requirements
set forth in this CIA and with the requirements of the Federal health
care programs. The Compliance Officer shall be a member of senior
management of [Provider], shall make regular (at least quarterly)
reports regarding compliance matters directly to the CEO and/or to
the Board of Directors of [Provider] and shall be authorized to report
to the Board of Directors at any time. The Compliance Officer shall
be responsible for monitoring the day-to-day activities engaged in by
[Provider] to further its compliance objectives as well as any report
ing obligations created under this CIA. In the event a new Compli
ance Officer is appointed during the term of this CIA, [Provider] shall
notify the OIG, in writing, within fifteen (15) days of such a change.
*Source: Office of the Inspector General of the United States Department of Health and
Human Services.
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[Provider] shall also appoint a Compliance Committee within ninety
(90) days after the effective date of this CIA. The Compliance Com
mittee shall, at a minimum, include the Compliance Officer and any
other appropriate officers as necessary to meet the requirements of
this CIA within the provider’s corporate structure (e.g., senior execu
tives of each major department, such as billing, clinical, human
resources, audit, and operations). The Compliance Officer shall chair
the Compliance Committee and the Committee shall support the
Compliance Officer in fulfilling his/her responsibilities.
B. Written Standards
1. Code of Conduct. Within ninety (90) days of the effective date of
this CIA, [Provider] shall establish a Code of Conduct. The Code of
Conduct shall be distributed to all employees within ninety (90) days
of the effective date of this CIA. [Provider] shall make the promotion
of, and adherence to, the Code of Conduct an element in evaluating
the performance of managers, supervisors, and all other employees.
The Code of Conduct shall, at a minimum, set forth:
a. [Provider’s] commitment to full compliance with all stat
utes, regulations, and guidelines applicable to Federal
health care programs, including its commitment to pre
pare and submit accurate billings consistent with Federal
health care program regulations and procedures or in
structions otherwise communicated by the Health Care
Financing Administration (“HCFA”) (or other appropriate
regulatory agencies) and/or its agents;
b. [Provider’s] requirement that all of its employees shall be
expected to comply with all statutes, regulations, and
guidelines applicable to Federal health care programs and
with [Provider’s] own policies and procedures (including
the requirements of this CIA);
c. the requirement that all of [Provider’s] employees shall be
expected to report suspected violations of any statute,
regulation, or guideline applicable to Federal health care
programs or with [Provider’s] own policies and procedures;
d. the possible consequences to both [Provider] and to any
employee of failure to comply with all statutes, regula
tions, and guidelines applicable to Federal health care
programs and with [Provider’s] own policies and proce
dures or of failure to report such non-compliance; and
e. the right of all employees to use the confidential disclosure
program, as well as [Provider’s] commitment to confiden
tiality and non-retaliation with respect to disclosures.
Within ninety (90) days of the effective date of the CIA, each
employee shall certify, in writing, that he or she has received,
read, understands, and will abide by [Provider’s] Code of Conduct.
New employees shall receive the Code of Conduct and shall
complete the required certification within two (2) weeks after the
commencement of their employment or within ninety (90) days of
the effective date of the CIA, whichever is later.
[Provider] will annually review the Code of Conduct and will make
any necessary revisions. These revisions shall be distributed within
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thirty (30) days of initiating such a change. Employees shall
certify on an annual basis that they have received, read, under
stand and will abide by the Code of Conduct.
2. Policies and Procedures. Within ninety (90) days of the effective
date of this CIA, [Provider] shall develop and initiate implemen
tation of written Policies and Procedures regarding the operation
of [Provider’s] compliance program and its compliance with all
federal and state health care statutes, regulations, and guide
lines, including the requirements of the Federal health care pro
grams. At a minimum, the Policies and Procedures shall
specifically address [insert language relevant to allegations in the
case]. In addition, the Policies and Procedures shall include disci
plinary guidelines and methods for employees to make disclosures
or otherwise report on compliance issues to [Provider] manage
ment through the Confidential Disclosure Program required by
section III.E. [Provider] shall assess and update as necessary the
Policies and Procedures at least annually and more frequently, as
appropriate. A summary of the Policies and Procedures will be
provided to OIG in the Implementation Report. The Policies and
Procedures will be available to OIG upon request.
Within ninety (90) days of the effective date of the CIA, the
relevant portions of the Policies and Procedures shall be distrib
uted to all appropriate employees. Compliance staff or supervisors
should be available to explain any and all policies and procedures.
C. Training and Education
1. General Training. Within ninety (90) days of the effective date
of this CIA, [Provider] shall provide at least two (2) hours of
training to each employee. This general training shall explain
[Provider’s]:
a. Corporate Integrity Agreement requirements;
b. Compliance Program (including the Policies and Proce
dures as they pertain to general compliance issues); and
c. Code of Conduct.
These training materials shall be made available to the OIG, upon
request.
New employees shall receive the general training described above
within thirty (30) days of the beginning of their employment or
within ninety (90) days after the effective date of this CIA, which
ever is later. Each year, every employee shall receive such general
training on an annual basis.
2. Specific Training. Within ninety (90) days of the effective date of
this CIA, each employee who is involved directly or indirectly in
the delivery of patient care and/or in the preparation or submis
sion of claims for reimbursement for such care (including, but not
limited to, coding and billing) for any Federal health care pro
grams shall receive at least [insert number of training hours]
hours of training in addition to the general training required
above. This training shall include a discussion of:
a. the submission of accurate bills for services rendered to
Medicare and/or Medicaid patients;
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b.

policies, procedures and other requirements applicable to
the documentation of medical records;
c. the personal obligation of each individual involved in the
billing process to ensure that such billings are accurate;
d. applicable reimbursement rules and statutes;
e. the legal sanctions for improper billings; and
f. examples of proper and improper billing practices.
These training materials shall be made available to OIG, upon
request. Persons providing the training must be knowledgeable
about the subject area.
Affected new employees shall receive this training within thirty
(30) days of the beginning of their employment or within ninety
(90) days of the effective date of this CIA, whichever is later. If a
new employee has any responsibility for the delivery of patient
care, the preparation or submission of claims and/or the assign
ment of procedure codes prior to completing this specific training,
a [Provider] employee who has completed the substantive training
shall review all of the untrained person’s work regarding the
assignment of billing codes.
Each year, every employee shall receive such specific training on
an annual basis.
3. Certification. Each employee shall certify, in writing, that he or
she has attended the required training. The certification shall
specify the type of training received and the date received. The
Compliance Officer shall retain the certifications, along with
specific course materials. These shall be made available to OIG
upon request.
D. Review Procedures
[Provider] shall retain an entity, such as an accounting, auditing or
consulting firm (hereinafter “Independent Review Organization”), to
perform review procedures to assist [Provider] in assessing the
adequacy of its billing and compliance practices pursuant to this CIA.
This shall be an annual requirement and shall cover a twelve (12)
month period. The Independent Review Organization must have
expertise in the billing, coding, reporting and other requirements of
the Federal health care programs from which [Provider] seeks reim
bursement. The Independent Review Organization must be retained
to conduct the assessment of the first year within ninety (90) days of
the effective date of this CIA. For purposes of complying with this
review procedures requirement, the OIG at its discretion, may per
mit the [Provider] to utilize internal auditors to perform the review(s). In such case, the [Provider] will engage the Independent
Review Organization to verify the propriety of the internal auditors’
methods and accuracy of their results. The [Provider] will request
the Independent Review Organization to produce a report on its
findings which report shall be included in the Annual Report to the
OIG.
The Independent Review Organization (or the [Provider], if permit
ted by the OIG, as set forth above) will conduct two separate engage
ments. One will be an analysis of [Provider’s] billing to the Federal
health care programs to assist the [Provider] and OIG in determining
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compliance with all applicable statutes, regulations, and directives/guidance (“billing engagement”). The second engagement will
assist the [Provider] and OIG in determining whether [Provider] is
in compliance with this CIA (“compliance engagement”).
1. Billing Engagement. The billing engagement shall consist of a
review of a statistically valid sample of claims for the relevant
period. The sample size shall be determined through the use of a
probe sample.1 At a minimum, the full sample must be within a
ninety (90) percent confidence level and a precision of twenty-five
(25) percent. The probe sample must contain at least thirty (30)
sample units and cannot be used as part of the full sample. Both
the probe sample and the sample must be selected through ran
dom numbers. [Provider] shall use OIG’s Office of Audit Services
Statistical Sampling Software, also known as “RAT-STATS”,
which is available through the Internet at www.hhs.gov/progorg
/ratstat.html.
Each annual billing engagement analysis shall include the follow
ing components in its methodology:
a. Billing Engagement Objective: Provide a statement stat
ing clearly the objective intended to be achieved by the
billing engagement and the procedure or combination of
procedures that will be applied to achieve the objective.
b. Billing Engagement Population: Identify the population,
which is the group about which information is needed.
Explain the methodology used to develop the population
and provide the basis for this determination.
c. Sources of Data: Provide a full description of the source of
the information upon which the billing engagement con
clusions will be based, including the legal or other stand
ards applied, documents relied upon, payment data,
and/or any contractual obligations.
d. Sampling Unit: Define the sampling unit, which is any of
the designated elements that comprise the population of
interest.
e. Sampling Frame: Identify the sampling frame, which is
the totality of the sampling units from which the sample
will be selected.
As part of the billing engagement:
a. Inquire of management as to the procedures and controls
affecting the billing process subject to the annual assess
ment as specified in the CIA. Document that aspect of the
billing process (e.g., flow of documents, processing activi
ties), and those controls that will be tested in the sample.
The documentation may consist of flow charts, excerpts
from policies and procedures manuals, control question
naires, etc.
b. Report the sample results, including the overall error rate
and the nature of the errors found (e.g., no documentation,
inadequate documentation, assignment of incorrect code).
1 Probe sample is defined as a small, random preliminary sample.
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c.

Document findings related to [Provider’s ] procedures to
correct inaccurate billings and codings to the Federal
health care programs and findings regarding the steps
[Provider] is taking to bring its operations into compliance
or to correct problems identified by the audit.
2. Agreed-upon Procedures or Compliance Engagement. An Inde
pendent Review Organization (or the [Provider], if permitted by
the OIG) shall also conduct an agreed-upon procedures or compli
ance engagement, which shall assist the users in determining
whether [Provider’s] program, policies, procedures, and opera
tions comply with the terms of this CIA. This engagement shall
include a section by section analysis of the requirements of this
CIA.
A complete copy of the Independent Review Organization’s billing
and agreed-upon procedures or compliance engagement shall be
included in each of [Provider’s] Annual Reports to OIG.
3. Disclosure of Overpayments and Material Deficiencies. If, as a
result of these engagements, [Provider] or the Independent Re
view Organization identifies any billing, coding or other policies,
procedures and/or practices that result in an overpayment,
[Provider] shall notify the payor (e.g., Medicare fiscal intermedi
ary or carrier) within 30 days of discovering the deficiency or
overpayment and take remedial steps within 60 days of discovery
(or such additional time as may be agreed to by the payor) to
correct the problem, including preventing the deficiency from
recurring. The notice to the payor shall include:
a. a statement that the refund is being made pursuant to this
CIA;
b. a description of the complete circumstances surrounding
the overpayment;
c. the methodology by which the overpayment was determined;
d. the amount of the overpayment;
e. any claim-specific information used to determine the over
payment (e.g., beneficiary health insurance number, claim
number, service date, and payment date);
f. the cost reporting period; and
g. the provider identification number under which the repay
ment is being made.
If [Provider] determines an overpayment represents a material
deficiency, contemporaneous with [Provider’s] notification to the
payor as provided above, [Provider] shall also notify OIG of:
a. a complete description of the material deficiency;
b. amount of overpayment due to the material deficiency;
c. [Provider’s] action(s) to correct and prevent such material
deficiency from recurring;
d. the payor’s name, address, and contact person where the
overpayment was sent;
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e.

the date of the check and identification number (or elec
tronic transaction number) on which the overpayment was
repaid.
For purposes of this CIA, an “overpayment” shall mean the
amount of money the provider has received in excess of the
amount due and payable under the Federal health care programs’
statutes, regulations or program directives, including carrier and
intermediary instructions.
For purposes of this CIA, a “material deficiency” shall mean
anything that involves: (i) a substantial overpayment or improper
payment relating to the Medicare and/or Medicaid programs; (ii)
conduct or policies that clearly violate the Medicare and/or Medi
caid statute, regulations or directives issued by HCFA and/or its
agents; or (iii) serious quality of care implications for federal
health care beneficiaries or recipients. A material deficiency may
be the result of an isolated event or a series of occurrences.
4. Verification/Validation. In the event that the OIG determines
that it is necessary to conduct an independent review to determine
whether or the extent to which [Provider] is complying with its
obligations under this CIA, [Provider] agrees to pay for the rea
sonable cost of any such review or engagement by the OIG or any
of its designated agents.
E. Confidential Disclosure Program
Within ninety (90) days after the effective date of this CIA, [Provider]
shall establish a Confidential Disclosure Program, which must include
measures (e.g., a toll-free compliance telephone line) to enable employ
ees, contractors, agents or other individuals to disclose, to the Compli
ance Officer or some other person who is not in the reporting individual’s
chain of command, any identified issues or questions associated with
[Provider’s] policies, practices or procedures with respect to the Federal
health care program, believed by the individual to be inappropriate.
[Provider] shall publicize the existence of the hotline (e.g., e-mail to
employees or post hotline number in prominent common areas).
The Confidential Disclosure Program shall emphasize a non-retribu
tion, non-retaliation policy, and shall include a reporting mechanism
for anonymous, confidential communication. Upon receipt of a com
plaint, the Compliance Officer (or designee) shall gather the infor
mation in such a way as to elicit all relevant information from the
individual reporting the alleged misconduct. The Compliance Officer
(or designee) shall make a preliminary good faith inquiry into the
allegations set forth in every disclosure to ensure that he or she has
obtained all of the information necessary to determine whether a
further review should be conducted. For any disclosure that is suffi
ciently specific so that it reasonably: (1) permits a determination of
the appropriateness of the alleged improper practice, and (2) pro
vides an opportunity for taking corrective action, [Provider] shall
conduct an internal review of the allegations set forth in such a
disclosure and ensure that proper follow-up is conducted.
The Compliance Officer shall maintain a confidential disclosure log,
which shall include a record and summary of each allegation re
ceived, the status of the respective investigations, and any corrective
action taken in response to the investigation.
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F. Ineligible Persons
[Provider] shall not hire or engage as contractors any “Ineligible
Person.” For purposes of this CIA, an “Ineligible Person” shall be any
individual or entity who: (i) is currently excluded, suspended, de
barred or otherwise ineligible to participate in the Federal health
care programs; or (ii) has been convicted of a criminal offense related
to the provision of health care items or services and has not been
reinstated in the Federal health care programs after a period of
exclusion, suspension, debarment, or ineligibility.
Within ninety (90) days of the effective date of this CIA, [Provider]
will review its list of current employees and contractors against the
General Services Administration’s List of Parties Excluded from
Federal Programs (available through the Internet at
http://www.amet.gov/ epls) and the HHS/OIG Cumulative Sanction
Report (available through the Internet at http://www.dhhs.gov/progorg/oig) to ensure that it is not currently employing or contracting
with any Ineligible Person. Thereafter, [Provider] will review the list
once semi-annually to ensure that no current employees or contrac
tors are or have become Ineligible Persons.
To prevent hiring or contracting with any Ineligible Person,
[Provider] shall screen all prospective employees and prospective
contractors prior to engaging their services by (i) requiring appli
cants to disclose whether they are Ineligible Persons, and (ii)
reviewing the General Services Administration’s List of Parties
Excluded from Federal Programs (available through the Internet at
http://www.arnet.gov/epls) and the HHS/OIG Cumulative Sanction
Report (available through the Internet at http://www.dhhs.gov/
progorg/oig).
If [Provider] has notice that an employee or agent is charged with a
criminal offense related to any Federal health care program, or is
suspended or proposed for exclusion during his or her employment
or contract with [Provider], within 10 days of receiving such notice
[Provider] will remove such employee from responsibility for, or
involvement with, [Provider’s] business operations related to the
Federal health care programs until the resolution of such criminal
action, suspension, or proposed exclusion. If [Provider] has notice
that an employee or agent has become an Ineligible Person,
[Provider] will remove such person from responsibility for, or involve
ment with, [Provider’s] business operations related to the Federal
health care programs and shall remove such person from any position
for which the person’s salary or the items or services rendered,
ordered, or prescribed by the person are paid in whole or in part,
directly or indirectly, by Federal health care programs or otherwise
with Federal funds at least until such time as the person is reinstated
into participation in the Federal health care programs.
G. Notification of Proceedings
Within thirty (30) days of discovery, [Provider] shall notify OIG, in
writing, of any ongoing investigation or legal proceeding conducted
or brought by a governmental entity or its agents involving an
allegation that [Provider] has committed a crime or has engaged in
fraudulent activities or any other knowing misconduct. This notifi
cation shall include a description of the allegation, the identity of the
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investigating or prosecuting agency, and the status of such investi
gation or legal proceeding. [Provider] shall also provide written
notice to OIG within thirty (30) days of the resolution of the matter,
and shall provide OIG with a description of the findings and/or
results of the proceedings, if any.
H. Reporting
1. Credible evidence of misconduct. If [Provider] discovers credible
evidence of misconduct from any source and, after reasonable in
quiry, has reason to believe that the misconduct may violate criminal,
civil, or administrative law concerning [Provider’s] practices relating
to the Federal health care programs, then [Provider] shall
promptly report the probable violation of law to OIG. Defendants
shall make this disclosure as soon as practicable, but, not later
than thirty (30) days after becoming aware of the existence of the
probable violation. The [Provider’s ] report to OIG shall include:
a. the findings concerning the probable violation, including
the nature and extent of the probable violation;
b. [Provider’s] actions to correct such probable violation; and
c. any further steps it plans to take to address such probable
violation and prevent it from recurring.
To the extent the misconduct involves an overpayment, the report
shall include the information listed in section III.D.3 regarding
material deficiencies.
2. Inappropriate Billing. If [Provider] discovers inappropriate or
incorrect billing through means other than the Independent Re
view Organization’s engagement, the provider shall follow proce
dures in section III.D.3 regarding overpayments and material
deficiencies.

IV. New Locations

In the event that [Provider] purchases or establishes new business units
after the effective date of this CIA, [Provider] shall notify OIG of this fact within
thirty (30) days of the date of purchase or establishment. This notification shall
include the location of the new operation(s), phone number, fax number,
Federal health care program provider number(s) (if any), and the corresponding
payor(s) (contractor specific) that has issued each provider number. All employ
ees at such locations shall be subject to the requirements in this CIA that apply
to new employees (e.g., completing certifications and undergoing training).

V. Im plem entation and Annual Reports
A. Implementation Report

Within one hundred and twenty (120) days after the effective date of
this CIA, [Provider] shall submit a written report to OIG summariz
ing the status of its implementation of the requirements of this CIA.
This Implementation Report shall include:
1. the name, address, phone number and position description of the
Compliance Officer required by section III.A;
2. the names and positions of the members of the Compliance Com
mittee required by section III.A;
3. a copy of [Provider’s] Code of Conduct required by section III.B.1;

AAG-HCO APP D

Statement of Position 99-1

355

4. the summary of the Policies and Procedures required by section
III.B.2;
5. a description of the training programs required by section III.C
including a description of the targeted audiences and a schedule
of when the training sessions were held;
6. a certification by the Compliance Officer that:
a. the Policies and Procedures required by section III.B have
been developed, are being implemented, and have been
distributed to all pertinent employees;
b. all employees have completed the Code of Conduct certifi
cation required by section III.B.1; and;
c. all employees have completed the training and executed
the certification required by section III.C;
7. a description of the confidential disclosure program required by
section III.E;
8. the identity of the Independent Review Organization(s) and the
proposed start and completion date of the first audit; and
9. a summary of personnel actions taken pursuant to section III.F.
B. Annual Reports
[Provider] shall submit to OIG an Annual Report with respect to the
status and findings of [Provider’s] compliance activities. The Annual
Reports shall include:
1. any change in the identity or position description of the Compli
ance Officer and/or members of the Compliance Committee de
scribed in section III.A;
2. a certification by the Compliance Officer that:
a. all employees have completed the annual Code of Conduct
certification required by section III.B.1; and
b. all employees have completed the training and executed
the certification required by section III.C;
3. notification of any changes or amendments to the Policies and
Procedures required by section III.B and the reasons for such
changes (e.g., change in contractor policy);
4. a complete copy of the report prepared pursuant to the Inde
pendent Review Organization’s billing and compliance engage
ment, including a copy of the methodology used;
5. [Provider’s ] response/corrective action plan to any issues raised
by the Independent Review Organization;
6. a summary of material deficiencies reported throughout the
course of the previous twelve (12) months pursuant to III.D.3 and
III.H;
7. a report of the aggregate overpayments that have been returned
to the Federal health care programs that were discovered as a
direct or indirect result of implementing this CIA. Overpayment
amounts should be broken down into the following categories:
Medicare, Medicaid (report each applicable state separately) and
other Federal health care programs;
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8. a copy of the confidential disclosure log required by section III.E;
9. a description of any personnel action (other than hiring) taken by
[.Provider] as a result of the obligations in section III.F;
10. a summary describing any ongoing investigation or legal proceed
ing conducted or brought by a government entity involving an
allegation that [Provider] has committed a crime or has engaged
in fraudulent activities, which have been reported pursuant to
section III.G. The statement shall include a description of the
allegation, the identity of the investigating or prosecuting agency,
and the status of such investigation, legal proceeding or requests
for information;
11. a corrective action plan to address the probable violations of law
identified in section III.H; and
12. a listing of all of the [Provider’s ] locations (including locations and
mailing addresses), the corresponding name under which each
location is doing business, the corresponding phone numbers and
fax numbers, each location’s Federal health care program
provider identification number(s) and the payor (specific contrac
tor) that issued each provider identification number.
The first Annual Report shall be received by the OIG no later than
one year and thirty (30) days after the effective date of this CIA.
Subsequent Annual Reports shall be submitted no later than the
anniversary date of the due date of the first Annual Report.
C. Certifications
The Implementation Report and Annual Reports shall include a certi
fication by the Compliance Officer under penalty of perjury, that: (1)
[Provider] is in compliance with all of the requirements of this CIA, to
the best of his or her knowledge; and (2) the Compliance Officer has
reviewed the Report and has made reasonable inquiry regarding its
content and believes that, upon such inquiry, the information is accurate
and truthful.

VI. N otifications and Subm ission of Reports

Unless otherwise stated in writing subsequent to the effective date of this
CIA, all notifications and reports required under this CIA shall be submitted
to the entities listed below:
OIG: Civil Recoveries Branch—Compliance Unit
Office of Counsel to the Inspector General
Office of Inspector General
U.S. Department of Health and Human Services
Cohen Building, Room 5527
330 Independence Avenue, SW
Washington, DC 20201
Phone 202-619-2078; Fax 202-205-0604
[Provider]:
[Address and Telephone number of Provider’s Compliance Contact]

VII. OIG Inspection, Audit and Review Rights

In addition to any other rights OIG may have by statute, regulation, or
contract, OIG or its duly authorized representative(s), may examine
[Provider’s] books, records, and other documents and supporting materials for
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the purpose of verifying and evaluating: (a) [Provider’s] compliance with the
terms of this CIA; and (b) [Provider’s] compliance with the requirements of the
Federal health care programs in which it participates. The documentation
described above shall be made available by [Provider] to OIG or its duly authorized
representative(s) at all reasonable times for inspection, audit or reproduction.
Furthermore, for purposes of this provision, OIG or its duly authorized repre
sentative(s) may interview any of [Provider’s] employees who consent to be inter
viewed at the employee’s place of business during normal business hours or at
such other place and time as may be mutually agreed upon between the
employee and OIG. [Provider] agrees to assist OIG in contacting and arranging
interviews with such employees upon OIG’s request. [Provider’s] employees
may elect to be interviewed with or without a representative of [Provider] present.
VIII. Docum ent and Record R etention

[Provider] shall maintain for inspection all documents and records relating
to reimbursement from the Federal health care programs or to compliance with
this CIA one year longer than the term of this CIA (or longer if otherwise
required by law).
IX. D isclosures

Subject to HHS’s Freedom of Information Act (“FOIA”) procedures, set forth
in 45 C.F.R. Part 5, the OIG shall make a reasonable effort to notify [Provider]
prior to any release by OIG of information submitted by [Provider] pursuant to
its obligations under this CIA and identified upon submission by [Provider] as
trade secrets, commercial or financial information and privileged and confidential
under the FOIA rules. [Provider] shall refrain from identifying any information
as trade secrets, commercial or financial information and privileged and confi
dential that does not meet the criteria for exemption from disclosure under FOIA.
X. Breach and Default Provisions

[Provider] is expected to fully and timely comply with all of the obligations
herein throughout the term of this CIA or other time frames herein agreed to.
A. Stipulated Penalties for Failure to Comply with Certain Obligations
As a contractual remedy, [Provider] and OIG hereby agree that failure
to comply with certain obligations set forth in this CIA may lead to the
imposition of the following monetary penalties (hereinafter referred to
as “Stipulated Penalties”) in accordance with the following provisions.
1. A Stipulated Penalty of $2,500 (which shall begin to accrue on the
day after the date the obligation became due) for each day,
beginning 120 days after the effective date of this CIA and con
cluding at the end of the term of this CIA, [Provider] fails to have
in place any of the following:
a. a Compliance Officer;
b. a Compliance Committee;
c. a written Code of Conduct;
d. written Policies and Procedures;
e. a training program; and
f. a Confidential Disclosure Program;
AAG-HCO APP D

358

Health Care Organizations

2. A Stipulated Penalty of $2,500 (which shall begin to accrue on the
day after the date the obligation became due) for each day
[Provider] fails to meet any of the deadlines to submit the Imple
mentation Report or the Annual Reports to the OIG.
3. A Stipulated Penalty of $2,000 (which shall begin to accrue on the
date the failure to comply began) for each day [Provider]:
a. hires or contracts with an Ineligible Person after that
person has been listed by a federal agency as excluded,
debarred, suspended or otherwise ineligible for participa
tion in the Medicare, Medicaid or any other Federal health
care program (as defined in 42 U.S.C. 1320a7b(f)). This
Stipulated Penalty shall not be demanded for any time
period if [Provider] can demonstrate that it did not dis
cover the person’s exclusion or other ineligibility after
making a reasonable inquiry (as described in section III.F)
as to the status of the person;
b. employs or contracts with an Ineligible Person and that
person: (i) has responsibility for, or involvement with,
[Provider’s] business operations related to the Federal
health care programs or (ii) is in a position for which the
person’s salary or the items or services rendered, ordered,
or prescribed by the person are paid in whole or in part,
directly or indirectly, by the Federal health care programs
or otherwise with Federal funds (this Stipulated Penalty
shall not be demanded for any time period during which
[Provider] can demonstrate that it did not discover the
person’s exclusion or other ineligibility after making a
reasonable inquiry (as described in III.F) as to the status
of the person);
c. employs or contracts with a person who: (i) has been
charged with a criminal offense related to any Federal
health care program, or (ii) is suspended or proposed for
exclusion, and that person has responsibility for, or in
volvement with, [Provider’s] business operations related
to the Federal health care programs (this Stipulated Pen
alty shall not be demanded for any time period before 10
days after [Provider] received notice of the relevant matter
or after the resolution of the matter).
4. A Stipulated Penalty of $1,500 (which shall begin to accrue on the
date the [Provider] fails to grant access) for each day [Provider]
fails to grant access to the information or documentation as
required in section V of this CIA.
5. A Stipulated Penalty of $1,000 (which shall begin to accrue ten
(10) days after the date that OIG provides notice to [Provider] of
the failure to comply) for each day [Provider] fails to comply fully
and adequately with any obligation of this CIA. In its notice to
[Provider], the OIG shall state the specific grounds for its deter
mination that the [Provider] has failed to comply fully and ade
quately with the CIA obligation(s) at issue.
B. Payment of Stipulated Penalties
1. Demand Letter. Upon a finding that [Provider] has failed to
comply with any of the obligations described in section X.A and
AAG-HCO APP D

Statement of Position 99-1

359

determining that Stipulated Penalties are appropriate, OIG shall
notify [Provider] by personal service or certified mail of (a)
[Provider’s] failure to comply; and (b) the OIG’s exercise of its
contractual right to demand payment of the Stipulated Penalties
(this notification is hereinafter referred to as the “Demand Letter”).
Within fifteen (15) days of the date of the Demand Letter,
[Provider] shall either (a) cure the breach to the OIG’s satisfaction
and pay the applicable stipulated penalties, or (b) request a
hearing before an HHS administrative law judge (“ALJ”) to dis
pute the OIG’s determination of noncompliance, pursuant to the
agreed-upon provisions set forth below in section X.D. In the event
[Provider] elects to request an ALJ hearing, the Stipulated Pen
alties shall continue to accrue until [Provider] cures, to the OIG’s
satisfaction, the alleged breach in dispute. Failure to respond to
the Demand Letter in one of these two manners within the allowed
time period shall be considered a material breach of this CIA and
shall be grounds for exclusion under section X.C.
2. Timely Written Requests for Extensions. [Provider] may submit a
timely written request for an extension of time to perform any act
or file any notification or report required by this CIA. Notwith
standing any other provision in this section, if OIG grants the
timely written request with respect to an act, notification, or
report, Stipulated Penalties for failure to perform the act or file
the notification or report shall not begin to accrue until one day
after [Provider] fails to meet the revised deadline as agreed to by
the OIG-approved extension. Notwithstanding any other provi
sion in this section, if OIG denies such a timely written request,
Stipulated Penalties for failure to perform the act or file the
notification or report shall not begin to accrue until two (2)
business days after [Provider] receives OIG’s written denial of
such request. A “timely written request” is defined as a request in
writing received by OIG at least five (5) business days prior to the
date by which any act is due to be performed or any notification
or report is due to be filed.
3. Form of Payment. Payment of the Stipulated Penalties shall be
made by certified or cashier’s check, payable to “Secretary of the
Department of Health and Human Services,” and submitted to
OIG at the address set forth in section VI.
4. Independence from Material Breach Determination. Except as
otherwise noted, these provisions for payment of Stipulated Pen
alties shall not affect or otherwise set a standard for the OIG’s
determination that [Provider] has materially breached this CIA,
which decision shall be made at the OIG’s discretion and governed
by the provisions in section X.C, below.
C. Exclusion for M aterial Breach of this CIA
1. Notice of Material Breach and Intent to Exclude. The parties
agree that a material breach of this CIA by [Provider] constitutes
an independent basis for [Provider’s] exclusion from participation
in the Federal health care programs (as defined in 42 U.S.C.
1320a7b(f)). Upon a determination by OIG that [Provider] has
materially breached this CIA and that exclusion should be im
posed, the OIG shall notify [Provider] by certified mail of (a)
[Provider’s] material breach; and (b) OIG’s intent to exercise its
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contractual right to impose exclusion (this notification is herein
after referred to as the “Notice of Material Breach and Intent to
Exclude”).
2. Opportunity to Cure. [Provider] shall have thirty-five (35) days
from the date of the Notice of Material Breach and Intent to
Exclude Letter to demonstrate to the OIG’s satisfaction that:
a. [Provider] is in full compliance with this CIA;
b. the alleged material breach has been cured; or
c. the alleged material breach cannot be cured within the
35-day period, but that: (i) [Provider] has begun to take
action to cure the material breach, (ii) [Provider] is pursu
ing such action with due diligence, and (iii) [Provider] has
provided to OIG a reasonable timetable for curing the
material breach.
3. Exclusion Letter. If at the conclusion of the thirty-five (35) day
period, [Provider] fails to satisfy the requirements of section
X.C.2, OIG may exclude [Provider] from participation in the
Federal health care programs. OIG will notify [Provider] in writ
ing of its determination to exclude [Provider] (this letter shall be
referred to hereinafter as the “Exclusion Letter”). Subject to the
Dispute Resolution provisions in section X.D, below, the exclusion
shall go into effect thirty (30) days after the date of the Exclusion
Letter. The exclusion shall have national effect and will also apply
to all other federal procurement and non-procurement programs.
If [Provider] is excluded under the provisions of this CIA,
[Provider] may seek reinstatement pursuant to the provisions at
42 C.F.R. §§1001.3001-.3004.
4. Material Breach. A material breach of this CIA means:
a. a failure by [Provider] to report a material deficiency, take
corrective action and pay the appropriate refunds, as pro
vided in section III.D;
b. repeated or flagrant violations of the obligations under
this CIA, including, but not limited to, the obligations
addressed in section X.A of this CIA;
c. a failure to respond to a Demand Letter concerning the
payment of Stipulated Penalties in accordance with sec
tion X.B above; or
d. a failure to retain and use an Independent Review Organi
zation for review purposes in accordance with section III.D.
D. Dispute Resolution
1. Review Rights. Upon the OIG’s delivery to [Provider] of its De
mand Letter or of its Exclusion Letter, and as an agreed-upon
contractual remedy for the resolution of disputes arising under
the obligation of this CIA, [Provider] shall be afforded certain
review rights comparable to the ones that are provided in 42
U.S.C. §§1320a7(f) and 42 C.F.R. §1005 as if they applied to the
Stipulated Penalties or exclusion sought pursuant to this CIA.
Specifically, the OIG’s determination to demand payment of
Stipulated Penalties or to seek exclusion shall be subject to review
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by an ALJ and, in the event of an appeal, the Departmental Appeals
Board (“DAB”), in a manner consistent with the provisions in 42
C.F.R. §§1005.2-.21. Notwithstanding the language in 42 C.F.R.
§1005.2(c), the request for a hearing involving stipulated penalties
shall be made within fifteen (15) days of the date of the Demand
Letter and the request for a hearing involving exclusion shall be
made within thirty (30) days of the date of the Exclusion Letter.
2. Stipulated Penalties Review. Notwithstanding any provision of
Title 42 of the United States Code or Chapter 42 of the Code of
Federal Regulations, the only issues in a proceeding for stipulated
penalties under this CIA shall be (a) whether [Provider] was in full
and timely compliance with the obligations of this CIA for which the
OIG demands payment; and (b) the period of noncompliance.
[Provider] shall have the burden of proving its full and timely
compliance and the steps taken to cure the noncompliance, if any. If
the ALJ finds for the OIG with regard to a finding of a breach of this
CIA and orders [Provider] to pay Stipulated Penalties, such Stipu
lated Penalties shall become due and payable twenty (20) days after
the ALJ issues such a decision notwithstanding that [Provider] may
request review of the ALJ decision by the DAB.
3. Exclusion Review. Notwithstanding any provision of Title 42 of
the United States Code or Chapter 42 of the Code of Federal
Regulations, the only issues in a proceeding for exclusion based
on a material breach of this CIA shall be (a) whether [Provider]
was in material breach of this CIA; (b) whether such breach was
continuing on the date of the Exclusion Letter; and (c) the alleged
material breach cannot be cured within the 35-day period, but that
(i) [Provider] has begun to take action to cure the material breach,
(ii) [Provider] is pursuing such action with due diligence, and (iii)
[Provider] has provided to OIG a reasonable timetable for curing
the material breach.
For purposes of the exclusion herein, exclusion shall take effect
only after an ALJ decision that is favorable to the OIG. [Provider’s]
election of its contractual right to appeal to the DAB shall not
abrogate the OIG’s authority to exclude [Provider] upon the issu
ance of the ALJ’s decision. If the ALJ sustains the determination
of the OIG and determines that exclusion is authorized, such
exclusion shall take effect twenty (20) days after the ALJ issues
such a decision, notwithstanding that [Provider] may request
review of the ALJ decision by the DAB.
4. Finality of Decision. The review by an ALJ or DAB provided for
above shall not be considered to be an appeal right arising under
any statutes or regulations. Consequently, the parties to this CIA
agree that the DAB’s decision (or the ALJ’s decision if not ap
pealed) shall be considered final for all purposes under this CIA
and [Provider] agrees to waive any right it may have to appeal the
decision administratively, judicially or otherwise seek review by
any court or other adjudicative forum.

XI. Effective and Binding Agreem ent

Consistent with the provisions in the Settlement Agreement pursuant to
which this CIA is entered, and into which this CIA is incorporated, [Provider]
and OIG agree as follows:
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a. This CIA shall be binding on the successors, assigns and transferees
of [Provider];
b. This CIA shall become final and binding on the date the final
signature is obtained on the CIA;
c. Any modifications to this CIA shall be made with the prior written
consent of the parties to this CIA; and
d. The undersigned [Provider] signatories represent and warrant that
they are authorized to execute this CIA. The undersigned OIG
signatory represents that he is signing this CIA in his official capac
ity and that he is authorized to execute this CIA.
On Behalf of [P r o v id e r ]

[Please identify all signatories]

[Date]
[Date]
[Date]

ON BEHALF OF THE OFFICE OF INSPECTOR GENERAL
OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES

Lewis Moris

[Date]

Assistant Inspector General for Legal Affairs
Office of Inspector General
U.S. Department of Health and Human Services
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Appendix B
Sample Statement of Management's Assertions

[Date]
In connection with the Corporate Integrity Agreement (CIA) entered into with
the Office of the Inspector General of the United States Department of Health
and Human Services dated [date], we make the following assertions, which are
true to the best of our knowledge and belief.
Governance

Within 90 days of the date of the CIA, we—
1. Established a Compliance Committee, which meets at least monthly
and requires a quorum to meet.
2. Appointed to our Compliance Committee members who include at a
minimum those individuals specified in the CIA.
3. Delegated to the Compliance Committee the authority to implement
and monitor the CIA, as evidenced by the organization chart or the
Compliance Committee’s charter.
4. Appointed a compliance officer, who reports directly to the individual
specified in the CIA.
We appointed a compliance officer who—
1. Has sufficient staff and resources to carry out his or her responsibilities.
2. Actively participates in compliance training.
3. Has authority to conduct full and complete internal investigations
without restriction.
4. Periodically revises the compliance program to meet changing cir
cumstances and risks.
Billing Practices, Policies, and Procedures

Although no system of internal controls can provide absolute assurance that
all bills comply in all respects with Medicare, Medicaid, and other federal
health care program guidelines, we are not aware of any material weaknesses
in our billing practices, policies, and procedures. Billings to third-party payors
comply in all material respects with applicable coding principles and laws and
regulations (including those dealing with Medicare and Medicaid antifraud and
abuse) and only reflect charges for goods and services that were medically
necessary, properly approved by regulatory bodies (e.g., the Food and Drug
Administration), if required and properly rendered. [Insert other assertions as
necessary to address matters covered in the CIA.] Any Medicare, Medicaid, and
other federal health program billing deficiencies that we identified have been
properly reported to the applicable payor within 60 days of discovery of the
deficiency.
Corporate Integrity Policy

1. Our policy was developed and implemented within [number] days of
execution of the CIA.
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2. The policy addresses the Company’s commitment to preparation and
submission of accurate billings consistent with the standards set
forth in federal health care program statutes, regulations, proce
dures and guidelines or as otherwise communicated by Health Care
Financing Administration (HCFA), its agents or any other agency
engaged in the administration of the applicable federal health care
program.
3. The policy addressed the specific issues that gave rise to the settle
ment, as well as other risk areas identified by the OIG in published
Fraud Alerts issued through [date].
4. Further details on the development and implementation of our policy
were provided to the OIG in our letter dated [date].
5. Our policy was distributed to all employees, physicians and inde
pendent contractors involved in submitting or preparing requests for
reimbursement.
6. We have prominently displayed a copy of our policy on the Company’s
premises.
Information and Education Program

As discussed more fully in our letter to the OIG dated [date], we conducted an
Information and Education Program within [number] days of the CIA. The
Information and Education Program requires that each officer, employee, agent
and contractor charged with administering federal health care programs (in
cluding, but not limited to billers, coders, nurses, physicians, medical records,
hospital administration and other individuals directly involved in billing fed
eral health care programs) receive at least [number] hours of training.
The training provided to employees involved in billing, coding, and/or charge
capture consisted of instructions on submitting accurate bills, the personal
obligations of each individual to ensure billings are accurate, the nature of
company-imposed disciplinary actions on individuals who violate company
policies and/or laws and regulations, applicable federal health care program
rules, legal sanctions against the company for submission of false or fraudulent
information, and how to report potential abuses or fraud. The training material
addresses those issues underlying our settlement with the OIG.
The experience of the trainers is consistent with the topics presented.
Confidential Disclosure Program

Our Confidential Disclosure Program—
1. Was established within [number] days of the CIA.
2. Enables any employee to disclose any practices or billing procedures
relating to federal health care programs.
3. Provides a toll-free telephone line maintained by the Company,
which Company representatives have indicated is maintained
twenty-four hours a day, seven days a week, for the purpose of
making any disclosures regarding compliance with the Company’s
Compliance Program, the obligations in the CIA, and Company’s
overall compliance with federal and state standards.
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4. Includes policies requiring the review of any disclosures to permit a
determination of the appropriateness of the billing practice alleged
to be involved and any corrective action to be taken to ensure that
proper follow-up is conducted.
5. A detailed summary of the communications (including the number
of disclosures by employees and the dates of such disclosures) con
cerning billing practices reported as, and found to be, inappropriate
under the Confidential Disclosure Program, and the results of any
internal review and the follow-up on such disclosures are summa
rized in Attachment [title] to our Annual Report.
Excluded Individuals or Entities

Company policy—
1. Prohibits the employment of or contracting with an individual or
entity that is listed by a federal agency as convicted of abuse or
excluded, suspended or otherwise ineligible for participation in fed
eral health care programs.
2. Includes a process to make an inquiry into the status of any potential
employee or independent contractor.
3. Provides for an annual review of the status of all existing employees
and contractors to verify whether any individual had been suspended
or excluded or charged with a criminal offense relating to the provi
sion of federal health care services.
We are not aware of any individuals employed in contravention of the prohibi
tions in the CIA.
Record Retention

Our record retention policy is consistent with the requirements of the CIA.
Signed by:
[Chief Executive Officer]
[Chief Financial Officer]
[Corporate Compliance Officer]
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Appendix C
Sample Engagement Letter

The following is an illustration of a sample engagement letter that may be used
for this kind of engagement.
[CPA Firm Letterhead]
[Client’s Name and Address]
Dear___________________ :
This will confirm our understanding of the arrangements for our performance
of certain agreed-upon procedures in connection with management’s compli
ance with the terms of the Corporate Integrity Agreement (CIA) with the Office
of Inspector General (OIG) of the U.S. Department of Health and Human
Services (HHS) dated [date of CIA] for the period ending [date].
We will perform those procedures enumerated in the attachment to this letter.
Our responsibility is to carry out these procedures and report our findings. We
will conduct our engagement in accordance with standards established by the
American Institute of Certified Public Accountants. Our planned procedures
were agreed to by management and will be communicated to the OIG for its
review and are based on the terms specified in the CIA. The sufficiency of these
procedures is solely the responsibility of the specified users of the report.
Consequently, it is understood that we make no representation regarding the
sufficiency of the procedures described in the attachment for the purpose for
which this report has been requested or for any other purpose.
Management is responsible for the Company’s compliance with all applicable
laws, regulations, and contracts and agreements, including the CIA. Manage
ment also is responsible for the design, implementation, and monitoring of the
policies and procedures upon which compliance is based.
Our engagement to perform agreed-upon procedures is substantially less in
scope than an examination, the objective of which is the expression of an opinion
on management’s compliance with the CIA. Accordingly, we will not express
such an opinion or any other form of assurance thereon.1
Working papers that are prepared in connection with this engagement are the
property of the independent accountant. The working papers are prepared for
the purpose of providing the principal support for the independent accountant’s
report. At the completion of our work, we expect to issue an agreed-upon
procedures report in the attached form.
1 The independent accountant may wish to include an understanding with the client about any
limitation or other arrangements regarding liability of the practitioner or the client in the engage
ment letter. For example, the following might be included in the letter:
Our maximum liability relating to services rendered under this letter (regardless of form of
action, whether in contract, negligence or otherwise) shall be limited to the charges paid to us
for the portion of the services or work products giving rise to liability. We will not be liable for
consequential or punitive damages (including lost profits or savings) even if aware of their
possible existence.
You will indemnify us against any damage or expense that may result from any third-party
claim relating to our services or any use by you of any work product, and you will reimburse
us for all expenses (including counsel fees) as incurred by us in connection with any such claim,
except to the extent such claim (i) is finally determined to have resulted from our gross negli
gence or willful misconduct or (ii) is covered by any of the preceding indemnities.
AAG-HCO APP D

Statement of Position 99-1

367

If, however, we are not able to complete all of the specified procedures, we will
so advise you. At that time, we will discuss with you the form of communication,
if any, that you desire for our findings. We will ask you to confirm your request
in writing at that time. If you request that we delay issuance of our report until
corrective action is taken that will result in compliance with all aspects of the
CIA, we will do so only at your written request. Our working papers will be
retained in accordance with our firm’s working paper retention policy.
The distribution of the independent accountant’s report will be restricted to the
governing board and management of the Company and the OIG.
Our fees will be billed as work progresses and are based on the amount of time
required at various levels of responsibility plus actual out-of-pocket expenses.
Invoices are payable upon presentation. We will notify you immediately of any
circumstances we encounter that could significantly affect our initial estimate
of total fees.
We agree that to the extent required by law, we will allow the Comptroller General
ofthe United States, HHS, and their duly authorized representatives to have access
to this engagement letter and our documents and records to the extent necessary
to verify the nature and amount of costs of the services provided to the Company,
until the expiration of four years after we have concluded providing services to the
Company that are performed pursuant to this Engagement Letter. In the event
the Comptroller General, HHS, or their duly authorized representatives request
such records, we agree to notify the Company of such request as soon as practicable.
In the event we are requested or authorized by the Company or are required by
government regulation, subpoena, or other legal process to produce our documents
or our personnel as witnesses with respect to our engagements for the Company,
the Company will, so long as we are not a party to the proceeding in which the
information is sought, reimburse us for our professional time and expenses, as well
as the fees and expenses of our counsel, incurred in responding to such requests.
If this letter correctly expresses your understanding of this engagement, please
sign the enclosed copy where indicated and return it to us. We appreciate the
opportunity to serve you.
Sincerely,___________________________
[Partner’s Signature]
[Firm Name or Firm Representative]
Accepted and agreed to:_______________
[Client Representative’s Signature]
[Title]______________________________
[Date]______________________________
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Appendix D
Sample Procedures

Procedure
Governance

1. We read the Company’s corporate minutes and
organization chart and ascertained that, within
[number] days of the date of the Corporate Integ
rity Agreement (CIA), the Company—
a. Established a Compliance Committee, which
is to meet meets at least monthly and requires
a quorum to meet.
b. Appointed to its Compliance Committee
members who include, at a minimum, those
individuals specified in the CIA.
c. Delegated to the Compliance Committee the
authority to implement and monitor the CIA,
as evidenced by the organization chart or the
Compliance Committee’s charter.
d. Appointed a compliance officer who reports
directly to the individual specified in the CIA.
2. We interviewed the compliance officer and were
informed that, in his or her opinion, the Compli
ance Officer—
a. Has sufficient staff and resources to carry out
his or her responsibilities.
b. Actively participates in compliance training.
c. Has the authority to conduct full and complete
internal investigations without restriction.
d. Periodically revises the compliance program
to meet changing circumstances and risks.
3. We read the OIG notification letter as specified in
the CIA and noted that the appropriate official
signed the letter, that it was addressed to the OIG,
that it covered items (a) through (d) in Step 1, and
that it was dated within [number of] days of the
execution of the CIA.
Billing Practices, Policies, and Procedures

The practitioner might be engaged to provide consulting
services in connection with the evaluation of the Com
pany’s billing practices, policies, and procedures. If so,
generally no agreed-upon procedures would be per
formed relating to this area.
Alternatively, if the procedures relating to the Com
pany’s billing practices, policies, and procedures are
performed by others such as the Company’s internal
audit staff, the practitioner performs Steps 4 through 9.
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Procedure_____________________________________Findings
4. We read the compliance work plan and noted the
following:
a. The work plan’s stated objectives include the
determination that billings are accurate and
complete, for services rendered that have been
deemed by medical specialists as being
necessary, and are submitted in accordance
with federal program guidelines.
b. The work plan sampling methodology sets
confidence levels consistent with those defined
in the CIA.
c. The work plan identifies risk areas, as defined
in the CIA (if applicable), and specifies testing
procedures by risk area.
d. The work plan specifies that samples are
taken in risk areas (if applicable) identified by
the CIA.
e. The work plan includes testing procedures,
which the practitioner should modify as
required by the CIA, for the following risks
areas (if applicable) identified in the CIA:
(1) Clinical documentation, as follows:
(i) No documentation of service
(ii) Insufficient documentation of service
(iii) Improper diagnosis or treatm ent
plan giving rise to the provision of a
medically unnecessary service or
treatment
(iv) Service or treatment does not conform
medically with the documented
diagnosis or treatment plan
(v) Services incorrectly coded
(2) Billing and coding, as follows:
(i) Noncovered or unallowable service
(ii) Duplicate payment
(iii) DRG window error
(iv) Unbundling
(v) Utilization
(vi) Medicare credit balances
[Note to Practitioner: Modify the preceding list as
required by the CIA.]
5. We selected [quantity] probe samples performed by
the independent review organization for the
following risk areas [list risk areas tested]. For the
probe samples selected, we noted that the—
a. Sample patient billing files were randomly
selected.
b. Sample size reflected confidence levels
specified in the CIA.
c. Sample plan describes how missing items (if
any) would be treated.
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6.

7.

8.

9.

d. Patient billing files tested were pulled per the
listing of random numbers and all patient
billing files were accounted for in the working
papers.
e. Work plans for the specific sample described
the risk areas (if applicable) being tested and
the testing approach/procedures.
f. Working papers noted the completion of each
work plan step.
g. Working papers contained a summary of
findings for the sample.
We reperformed the work plan steps [list of specific
steps performed] for the sample patient billing
files. The reperformance of work plan steps related
to the medical review of the sample patient billing
files was performed by the following individuals
[note the professional qualifications of individuals
without listing names]. Any exceptions between
our findings and the Company’s are summarized
in the Attachment to this report.
We read the summary findings of all internal
compliance reviews that the Company’s Internal
Audit department indicated it had performed for
the Company and noted that all material billing
deficiencies [specify material threshold as defined
by the Company] noted therein were discussed in
written communications addressed to the appro
priate payor (for example, Medicare Part B carrier)
and were dated within 60 days from the time the
deficiency occurred.1
We inquired of [individual] as to whether the
Company took remedial steps within [number of]
days (or such additional time as agreed to by the
payor) to correct all material billing deficiencies
noted in Step 7. We were informed that such
remedial steps had been taken.
By reading applicable correspondence, we noted
that any material billing deficiencies noted in Step
7 were communicated to the OIG, including
specific findings relative to the deficiency, the
Company’s actions taken to correct the deficiency,
and any further steps the Company plans to take
to prevent any similar deficiencies from recurring.

1 The CIA provides its own legal definition of a “material deficiency.” Determination of whether
a billing or other act meets this definition is normally beyond the auditor’s professional competence
and may have to await final determination by a court of law. Accordingly, to avoid confusion, a
working definition different from that provided in the CIA (e.g., a specified dollar threshold) may be
necessary.
AAG-HCO APP D

371

Statement of Position 99-1

Procedure_____________________________________Findings
Corporate Integrity Policy

10. We read the Company’s Corporate Integrity Policy
and noted the following.
a. The policy was developed and implemented
within [number of] days of execution of the
CIA.
b. The policy addressed the Company’s commit
ment to preparation and submission of ac
curate billings consistent with the standards
set forth in federal health care program
statutes, regulations, procedures, and
guidelines or as otherwise communicated by
HCFA, its agents, or any other agency
engaged in the adm inistration of the
applicable federal health care program.
c. The policy addressed the specific issues that
gave rise to the settlement, as well as other
risk areas identified by the OIG in published
Fraud Alerts issued through [agency].
d. Correspondence addressed to the OIG covered
the development and implementation of the
policy.
e. Documentation indicating that the policy was
distributed to all employees, physicians, and
independent contractors involved in submit
ting or preparing requests for reimbursement.
f. The prominent display of a copy of the policy
on the Company’s premises.
11. We selected a sample of ten employees (involved in
submitting and preparing requests for reimburse
ment) and examined written confirmation in the
employee’s personnel file indicating receipt of a
copy of the Corporate Integrity Policy.

Information and Education Program

12. We read the Company’s Information and Educa
tion Program and noted the following.
a. The Information and Education Program
agenda was dated within [number of] days of
execution of the CIA.
b. Correspondence covering the development
and implementation of the Information and
Education Program was addressed to the OIG.
c. The Information and Education Program re
quires that each officer, employee, agent, and
contractor charged with administering federal
health care programs (including, but not
limited to billers, coders, nurses, physicians,
medical records, hospital administration and
other individuals directly involved in billing
federal health care programs) receive at least
[number of] hours of training.
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13. We selected a sample of ten employees involved in
billing, coding and/or charge capture and ex
amined sign-in logs of the training classes and
noted that each had signed indicating that they
had received at least [number of\ hours of training
as specified in the Information and Education Pro
gram. We also reviewed tests and surveys com
pleted by each of the ten trained employees noting
evidence that they were completed.
14. We inquired as to the training of individuals not
present during the regularly scheduled training
programs and were informed that each such indi
vidual is trained either individually or in a separ
ate make-up session. We inquired as to the names
of individuals not initially present and selected one
such individual and examined that individual’s
post-training test and survey for completion.
15. We read the course agenda and noted that the
training provided to employees involved in billing,
coding, and/or charge capture consisted of
instructions on submitting accurate bills, the
personal obligations of each individual to ensure
billings are accurate, the nature of companyimposed disciplinary actions on individuals who
violate company policies and/or laws and regula
tions applicable to federal health care program
rules, legal sanctions against the company for sub
mission of false or fraudulent information, and
how to report potential abuses or fraud. We also
noted that the training material addressed the
following issues which gave rise to the settlement
[practitioner list].
16. We inquired of the Corporate Compliance Officer
as to the qualifications and experience of the train
ers and were informed that, in the Corporate Com
pliance Officer’s opinion, they were consistent with
the topics presented.
17. We noted that the Company’s draft Annual Report
to the OIG dated [date] addresses certification of
training.
Confidential Disclosure Program

18. We read documentation of the Company’s Confi
dential Disclosure Program and noted that it—
a. Includes the printed effective date that was
within [number of] days of execution of the CIA.
b. Consists of a confidential disclosure program
enabling any employee to disclose any prac
tices or billing procedures relating to federal
health care programs.

AAG-HCO APP D

373

Statement of Position 99-1

Procedure________________________________

c. Provides a toll-free telephone line maintained
by the Company, which Company representa
tives have indicated is maintained twentyfour hours a day, seven days a week, for the
purpose of making any disclosures regarding
compliance with the Company’s Compliance
Program, the obligations in the CIA, and
Company’s overall compliance with federal
and state standards.
d. Includes policies requiring the review of any
disclosures to permit a determination of the
appropriateness of the billing practice alleged to
be involved and any corrective action to be taken
to ensure that proper follow-up is conducted.
19. We made five test calls to the toll-free telephone
line (hotline) and noted the following.
a. Each call was captured in the hotline logs and
reported with all other incoming calls.
b. Anonymity is not discouraged.
20. We noted that the Company included in its draft
Annual Report addressed to OIG dated [date] a
detailed summary of the communications (includ
ing the number of disclosures by employees and the
dates of such disclosures) concerning billing prac
tices reported as, and found to be, inappropriate
under the Confidential Disclosure Program, and
the results of any internal review and the follow-up
on such disclosures.
21. We observed the display of the Company’s Confiden
tial Disclosure Program, including notice of the
availability ofits hotline, on the Companys premises.

Findings

Excluded Individuals or Entities

22. We read the Company’s written policy relating to
dealing with excluded or convicted persons or
entities and noted that the policy—
a. Prohibits the hiring of or contracting with an
individual or entity that is listed by a federal
agency as convicted of abuse or excluded, sus
pended, or otherwise ineligible for participa
tion in federal health care programs.
b. Includes a process to make an inquiry into the
status of any potential employee or indepen
dent contractor.
c. Provides for a semi-annual review of the
status of all existing employees and contrac
tors to verify whether any individual had been
suspended or excluded or charged with a cri
minal offense relating to the provision of
federal health care services.
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23. We selected a sample of ten employees hired over
the course of the test period as defined in the CIA
and examined support in the employee’s personnel
file documenting inquiries made into the status of
the employee, including documentation of com
parison to the [source specified in the CIA].
24. We performed the following procedures related to
the Company’s semi-annual review of employee
status.
a. Read documentation of the semi-annual re
view as evidence that a review was performed.
b. Selected and reviewed the lesser of ten or all
exceptions and determined that such employees
were removed from responsibility for or involve
ment with Provider business operations related
to the Federal health care programs.
c. Examined a notification letter addressed to
the OIG and dated within 30 days of the em
ployee’s removal from employment.
d. Inquired of [officer] as to whether he or she
was aware of any individuals employed in
contravention of the prohibitions in the CIA.
If so, we further noted that [indicate specific
procedures] to confirm that such situation was
cured within 30 days by [indicate how situa
tion was cured].

Annual Report

25. We read the Company’s draft Annual Report dated
[date] and determined that it included the follow
ing items, to be modified as appropriate, by the
practitioner:
a. Compliance Program Charter and organiza
tion chart
b. Amendments to policies
c. Detailed descriptions of reviews and audits
d. Summary of hotline communications
e. Summary of annual review of employees
f. Cross-referencing to items noted in the CIA
Record Retention

26. We read the Company’s record retention policy and
noted that it was consistent with the requirements
as outlined in the CIA.
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Appendix E
Sample Report
Independent Accountant’s Report

[Date]
[Sample Health Care Provider]
Office of Inspector General of the U.S. Department of Health and Human
Services
We have performed the procedures enumerated in the Attachment, which were
agreed to by Sample Health Care Provider (Company) and the Office of
Inspector General (OIG) of the U.S. Department of Health and Human Serv
ices, solely to assist the users in evaluating management’s assertion about
[name of entity’s] compliance with the Corporate Integrity Agreement (CIA)
with the OIG dated [date of CIA] for the [period] ending [date], which is included
as Attachment A to this report. This agreed-upon procedures engagement was
performed in accordance with standards established by the American Institute
of Certified Public Accountants. The sufficiency of these procedures is solely
the responsibility of the specified users of the report. Consequently, we make
no representation regarding the sufficiency of the procedures described in
Attachment B either for the purpose for which this report has been requested
or for any other purpose.
We were not engaged to and did not perform an examination, the objective of
which would be the expression of an opinion on management’s compliance with
the CIA. Accordingly, we do not express such an opinion. Had we performed
additional procedures, other matters might have come to our attention that
would have been reported to you.
This report is intended solely for the information and use of the Compliance
Committee and management of the Company and the OIG, and is not intended
to be and should not be used by anyone other than those specified parties.
[Include as Attachments the CIA and the summary that enumerates procedures
and findings. ]
[Signature]
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NOTE

This Statement of Position presents the recommendations of the
AICPA Health Care Third-Party Revenue Recognition Task Force
with regard to auditing financial statement assertions about thirdparty revenues and related receivables of health care entities. The
Auditing Standards Board has found the recommendations in this
Statement of Position to be consistent with existing standards cov
ered by rule 202 of the AICPA Code of Professional Conduct. AICPA
members should be prepared to justify departures from the recom
mendations in this Statement of Position.
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SUMMARY

This Statement of Position (SOP) provides guidance to auditors regarding
uncertainties inherent in health care third-party revenue recognition. It dis
cusses auditing matters to consider in testing third-party revenues and related
receivables, and provides guidance regarding the sufficiency of evidential
matter and reporting on financial statements of health care entities exposed to
material uncertainties.
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Auditing Health Care Third-Party
Revenues and Related Receivables
Introduction and Background

1. Most health care providers participate in payment programs that pay
less than full charges for services rendered. For example, some cost-based
programs retrospectively determine the final amounts reimbursable for serv
ices rendered to their beneficiaries based on allowable costs. With increasing
frequency, even non-cost-based programs (such as the Medicare Prospective
Payment System) have become subject to retrospective adjustments (for exam
ple, billing denials and coding changes). Often, such adjustments are not known
for a considerable period of time after the related services were rendered.
2. The lengthy period of time between rendering services and reaching
final settlement, compounded further by the complexities and ambiguities of
reimbursement regulations, makes it difficult to estimate the net patient
service revenue associated with these programs. This situation has been
compounded due to the frequency of changes in federal program guidelines.
3. The AICPA Audit and Accounting Guide Health Care Organizations
(the Guide) requires that patient revenues be reported net of provisions for
contractual and other adjustments (paragraph 10.20). As a result, patient
receivables, including amounts due from third-party payors, are also reported
net of expected contractual and other adjustments. However, amounts ulti
mately realizable will not be known until some future date, which may be
several years after the period in which the services were rendered.
4. This SOP provides guidance to auditors regarding uncertainties inher
ent in health care third-party revenue recognition. It discusses auditing mat
ters to consider in testing third-party revenue and related receivables,
including the effects of settlements (both cost-based and non-cost-based thirdparty payment programs), and provides guidance regarding the sufficiency of
evidential matter and reporting on financial statements of health care entities
exposed to material uncertainties.
Scope and Applicability

5.
This SOP applies to audits of health care organizations falling within
the scope of the Guide. Its provisions are effective for audits of periods ending
on or after June 30, 2000. Early application of the provisions of this SOP is
permitted.
Third-Party Revenues and Related Receivables—
Inherent Uncertainties

6.
Health care entities need to estimate amounts that ultimately will be
realizable in order for revenues to be fairly stated in accordance with generally
accepted accounting principles (GAAP). The basis for such estimates may
range from relatively straightforward calculations using information that is
readily available to highly complex judgments based on assumptions about
future decisions.
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7. Entities doing business with governmental payors (for example, Medicare
and Medicaid) are subject to risks unique to the government-contracting
environment that are hard to anticipate and quantify and that may vary from
entity to entity. For example—
• A health care entity’s revenues may be subject to adjustment as a result
of examination by government agencies or contractors. The audit proc
ess and the resolution of significant related matters (including disputes
based on differing interpretations of the regulations) often are not
finalized until several years after the services were rendered.
• Different fiscal intermediaries (entities that contract with the federal
government to assist in the administration of the Medicare program)
may interpret governmental regulations differently.
• Differing opinions on a patient’s principal medical diagnosis, including
the appropriate sequencing of codes used to submit claims for pay
ment, can have a significant effect on the payment amount.1
• Otherwise valid claims may be determined to be nonallowable after
the fact due to differing opinions on medical necessity.
• Claims for services rendered may be nonallowable if they are
later determined to have been based on inappropriate referrals.12
• Governmental agencies may make changes in program interpreta
tions, requirements, or “conditions of participation,” some of which
may have implications for amounts previously estimated.
8. Such factors often result in retrospective adjustments to interim pay
ments. Reasonable estimates of such adjustments are central to the third-party
revenue recognition process in health care, in order to avoid recognizing
revenue that the provider will not ultimately realize. The delay between
rendering services and reaching final settlement, as well as the complexities
and ambiguities of billing and reimbursement regulations, makes it difficult to
estimate net realizable third-party revenues.
Management's Responsibilities

9.
Management is responsible for the fair presentation of its financial
statements in conformity with GAAP. Management also is responsible for
adopting sound accounting policies and for establishing and maintaining inter
nal control that will, among other things, record, process, summarize, and
report transactions (as well as events and conditions) consistent with manage
ment’s assertions embodied in the financial statements. Despite the inherent
uncertainties, management is responsible for estimating the amounts recorded
in the financial statements and making the required disclosures in accordance
with GAAP, based on management’s analysis of existing conditions.
1 Historically, the Health Care Financing Administration (HCFA) contracted with Peer Review
Organizations (PROs) to validate the appropriateness of admissions and the clinical coding from
which reimbursement was determined. Such reviews were typically performed within ninety days of
the claim submission date. However, the government has modified its policies with respect to such
reviews and now analyzes coding errors through other means, including in conjunction with investi
gations conducted by the Office of the Inspector General (OIG) of the U. S. Department of Health and
Human Services.
2 Effective January 1, 1995, the Limitation on Certain Physician Referrals law prohibited
physicians from referring Medicare and Medicaid patients to health care organizations with which
they had a financial relationship for the furnishing of designated health services. Implementing
regulations have not yet been adopted as of the date of this publication.
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10. Management’s assertions regarding proper valuation of its revenues
and receivables are embodied in the financial statements. Management is
responsible for assuring that revenues are not recognized until their realiza
tion is reasonably assured. As a result, management makes a reasonable
estimate of amounts that ultimately will be realized, considering—among
other things—adjustments associated with regulatory reviews, audits, billing
reviews, investigations, or other proceedings. Estimates that are significant to
management’s assertions about revenue include the provision for third-party
payor contractual adjustments and allowances.
11. Management also is responsible for preparing and certifying cost
reports submitted to federal and state government agencies in support of
claims for payment for services rendered to government program beneficiaries.
The Auditor's Responsibilities

12. The auditor’s responsibility is to express an opinion on the financial
statements taken as a whole. In reaching this opinion, the auditor considers
the evidence in support of recorded amounts. If amounts are not known with
certainty, the auditor considers the reasonableness of management’s estimates
in the present circumstances. The auditor also considers the fairness of the
presentation and adequacy of the disclosures made by management.
13. In planning the audit, the auditor considers current industry condi
tions, as well as specific matters affecting the entity.3 Among a number of
things, the auditor’s procedures typically include an analysis of historical
results (for example, prior fiscal intermediary audit adjustments and compari
sons with industry benchmarks and norms) that enable the auditor to better
assess the risk of material misstatements in the current period. When there
are heightened risks, the auditor performs more extensive tests covering the
current period. Exhibit 5-1 of the Guide includes a number of examples of
procedures that auditors may consider.
14. With respect to auditing third-party revenues, in addition to the usual
revenue recognition considerations, the auditor considers whether amounts
ultimately realizable are or should be presently known or are uncertain be
cause they are dependent on some other future, prospective actions or confirm
ing events. For example, under a typical fee-for-service contract with a
commercial payor, if the provider has performed a service for a covered indi
vidual, the revenue to which the provider is entitled should be determinable at
the time the service is rendered. On the other hand, if the service was provided
under a cost-based government contract, the revenue ultimately collectible
may not be known until certain future events occur (for example, a cost report
has been submitted and finalized after desk review or audit). In this case,
management estimates the effect of such potential future adjustments.
15. As stated previously, management is responsible for preparing the
estimates contained in the financial statements. The auditor evaluates the
adequacy of the evidence supporting those estimates, reviews the facts sup
porting management’s judgments, and evaluates the judgments made based on
conditions existing at the time of the audit. The fact that net revenues recorded
at the time services are rendered differ materially from amounts that ultimately
3
Risk factors, including ones related to legislative and regulatory matters, are discussed
annually in the AICPA Audit Risk Alert Health Care Industry Developments.
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are realized does not necessarily mean the audit was not properly planned or
carried out. Similarly, the fact that future events may differ materially from
management’s assumptions or estimates does not necessarily mean that man
agement’s estimates were not valid or the auditor did not follow generally
accepted auditing standards (GAAS) as described in this SOP with respect to
auditing estimates.
Evidential Matter

16. The measurement of estimates is inherently uncertain and depends
on the outcome of future events. Statement on Auditing Standards (SAS) No.
57, Auditing Accounting Estimates (AICPA, Professional Standards, vol. 1, AU
sec. 342), and SAS No. 79, Amendment to SAS No. 58, Reports on Audited
Financial Statements (AICPA, Professional Standards, vol. 1, AU sec. 508)
provide guidance to the auditor when the valuation of revenues is uncertain,
pending the outcome of future events. In the current health care environment,
conclusive evidence concerning amounts ultimately realizable cannot be ex
pected to exist at the time of the financial statement audit because the
uncertainty associated with future program audits, administrative reviews,
billing reviews, regulatory investigations, or other actions will not be resolved
until sometime in the future.
17. The fact that information related to the effects of future program
audits, administrative reviews, regulatory investigations, or other actions does
not exist does not lead to a conclusion that the evidential matter supporting
management’s assertions is not sufficient to support management’s estimates.
Rather, the auditor’s judgment regarding the sufficiency of the evidential
matter is based on the evidential matter that is available or can reasonably be
expected to be available in the circumstances. If, after considering the existing
conditions and available evidence, the auditor concludes that sufficient eviden
tial matter supports management’s assertions about the valuation of revenues
and receivables, and their presentation and disclosure in the financial state
ments, an unqualified opinion ordinarily is appropriate.
18. If relevant evidential matter exists that the auditor needs and is
unable to obtain, the auditor should consider the need to express a qualified
opinion or to disclaim an opinion because of a scope limitation. For example, if
an entity has conducted an internal evaluation (for example, of coding or other
billing matters) under attorney—client privilege and management and its
legal counsel refuse to respond to the auditor’s inquiries and the auditor
determines the information is necessary, ordinarily the auditor qualifies his or
her opinion for a scope limitation.
19. The auditor considers the reasonableness of management’s assump
tions in light of the entity’s historical experience and the auditor’s knowledge
of general industry conditions, because the accuracy of management’s assump
tions will not be known until future events occur. For certain matters, the best
evidential matter available to the auditor (particularly as it relates to clinical
and legal interpretations) may be the representations of management and its
legal counsel, as well as information obtained through reviewing correspon
dence from regulatory agencies.
20. Pursuant to SAS No. 85, Management Representations (AICPA,
Professional Standards, vol. 1, AU sec. 333), the auditor should obtain written
representations from management concerning the absence of violations or
possible violations of laws or regulations whose effects should be considered for
disclosure in the financial statements or as a basis for recording a loss contin
gency. Examples of specific representations include the following:
AAG-HCO APP E

Statement of Position 00-1

385

• Receivables
— Adequate consideration has been given to, and appropriate provi
sion made for, estimated adjustments to revenue, such as for
denied claims and changes to diagnosis-related group (DRG)
assignments.
— Recorded valuation allowances are necessary, appropriate, and
properly supported.
— All peer review organizations, fiscal intermediary, and thirdparty payor reports and information have been made available.
• Cost reports filed with third parties
— All required Medicare, Medicaid, and similar reports have been
properly filed.
— Management is responsible for the accuracy and propriety of all
cost reports filed.
— All costs reflected on such reports are appropriate and allowable
under applicable reimbursement rules and regulations and are
patient-related and properly allocated to applicable payors.
— The reimbursement methodologies and principles employed are
in accordance with applicable rules and regulations.
— Adequate consideration has been given to, and appropriate provi
sion made for, audit adjustments by intermediaries, third-party
payors, or other regulatory agencies.
— All items required to be disclosed, including disputed costs that
are being claimed to establish a basis for a subsequent appeal,
have been fully disclosed in the cost report.
— Recorded third-party settlements include differences between
filed (and to be filed) cost reports and calculated settlements,
which are necessary based on historical experience or new or
ambiguous regulations that may be subject to differing interpre
tations. While management believes the entity is entitled to all
amounts claimed on the cost reports, management also believes
the amounts of these differences are appropriate.
• Contingencies
— There are no violations or possible violations of laws or regula
tions, such as those related to the Medicare and Medicaid antifraud and abuse statutes, including but not limited to the
Medicare and Medicaid Anti-Kickback Statute, Limitations on
Certain Physician Referrals (the Stark law), and the False Claims
Act, in any jurisdiction, whose effects should be considered for
disclosure in the financial statements or as a basis for recording
a loss contingency other than those disclosed or accrued in the
financial statements.
— Billings to third-party payors comply in all material respects with
applicable coding guidelines (for example, ICD-9-CM and CPT-4)
and laws and regulations (including those dealing with Medicare
and Medicaid antifraud and abuse), and billings reflect only
charges for goods and services that were medically necessary;
properly approved by regulatory bodies (for example, the Food and
Drug Administration), if required; and properly rendered.
— There have been no communications (oral or written) from regulatory
agencies, governmental representatives, employees, or others con
cerning investigations or allegations of noncompliance with laws
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and regulations in any jurisdiction (including those related to the
Medicare and Medicaid antifraud and abuse statutes), deficien
cies in financial reporting practices, or other matters that could
have a material adverse effect on the financial statements.
21.
Management’s refusal to furnish written representations constitutes
a limitation on the scope of the audit sufficient to preclude an unqualified
opinion and is ordinarily sufficient to cause an auditor to disclaim an opinion
or withdraw from the engagement. However, based on the nature of the
representations not obtained or the circumstances of the refusal, the auditor
may conclude that a qualified opinion is appropriate.
Potential Departures From GAAP Related to Estimates
and Uncertainties

22. In addition to examining the evidence in support of management’s
estimates, the auditor determines that there has not been a departure from
GAAP with respect to the reporting of those estimates in the financial state
ments. Such departures generally fall into one of the following categories:
• Unreasonable accounting estimates
• Inappropriate accounting principles
• Inadequate disclosure
Therefore, in order to render an opinion, the auditor’s responsibility is to
evaluate the reasonableness of management’s estimates based on present
circumstances and to determine that estimates are reported in accordance with
GAAP and adequately disclosed.
23. As discussed in SAS No. 31, Evidential Matter (AICPA, Professional
Standards, vol. 1, AU sec. 326), the auditor’s objective is to obtain sufficient
competent evidential matter to provide him or her with a reasonable basis for
forming an opinion. As discussed previously, exhibit 5-1 of the Guide provides
a number of sample procedures that the auditor might consider in auditing an
entity’s patient revenues and accounts receivable, including those derived from
third-party payors. For example, the Guide notes that the auditor might “test
the reasonableness of settlement amounts, including specific and unallocated
reserves, in light of the payors involved, the nature of the payment mechanism,
the risks associated with future audits, and other relevant factors.”4
Unreasonable Accounting Estimates

24. In evaluating the reasonableness of management’s estimates, the
auditor considers the basis for management’s assumptions regarding the na
ture of future adjustments and management’s calculations as to the effects of
such adjustments.5 The auditor cannot determine with certainty whether such
estimates are right or wrong, because the accuracy of management’s assump
tions cannot be confirmed until future events occur.
25. Though difficult to predict, it is reasonable for the auditor to expect
that management has made certain assumptions (either in detail or in the
aggregate) in developing its estimates regarding conditions likely to result in
adjustments. The auditor gathers evidence regarding the reasonableness of the
4 See paragraphs 25-28.
5 The lack of such analyses may call into question the reasonableness of recorded amounts.
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estimates (for example, consistency with historical experience and basis of
management’s underlying assumptions). In evaluating reasonableness, the
auditor should obtain an understanding of how management developed the
estimate. Based on that understanding, the auditor should use one or a
combination of the following approaches:
a. Review and test the process used by management to develop the
estimate.
b. Develop an independent expectation of the estimate to corroborate
the reasonableness of management’s estimates.
c. Review subsequent events or transactions occurring prior to comple
tion of fieldwork (AU sec. 342.10).
26. Since no one accounting estimate can be considered accurate with
certainty, the auditor recognizes that a difference between an estimated
amount best supported by the audit evidence and the estimated amount
included in the financial statements may be reasonable, and such difference
would not be considered to be a likely misstatement. However, if the auditor
believes the estimated amount included in the financial statements is unrea
sonable, he or she should treat the difference between that estimate and the
closest reasonable estimate in the range as a likely misstatement and aggre
gate it with other likely misstatements. The auditor also should consider
whether the difference between estimates best supported by the audit evidence
and the estimates included in the financial statements, which are individually
reasonable, indicate a possible bias on the part of the entity’s management. For
example, if each accounting estimate included in the financial statements was
individually reasonable, but the effect of the difference between each estimate
and the estimate best supported by the audit evidence was to increase income,
the auditor should reconsider the reasonableness of the estimates taken as a
whole (SAS No. 47, Audit Risk and Materiality in Conducting an Audit
[AICPA, Professional Standards, vol. 1, AU sec. 312.36]).
27. The auditor recognizes that approaches and estimates will vary from
entity to entity. Some entities with significant prior experience may attempt
to quantify the effects of individual potential intermediary or other govern
mental (for example, the Office of Inspector General and the Department of
Justice) or private payor adjustments, basing their estimates on very detailed
calculations and assumptions regarding potential future adjustments. Some
may prepare cost report6 analyses to estimate the effect of potential adjust
ments. Others may base their estimates on an analysis of potential adjustments
in the aggregate, in light of the payors involved; the nature of the payment
mechanism; the risks associated with future audits; and other relevant factors.
28. Normally, the auditor considers the historical experience of the entity
(for example, the aggregate amount of prior cost-report adjustments and previous
regulatory settlements) as well as the risk of potential future adjustments. The
6
Medicare cost reimbursement is based on the application of highly complex technical rules,
some of which are ambiguous and subject to different interpretations even among Medicare’s fiscal
intermediaries. It is not uncommon for fiscal intermediaries to reduce claims for reimbursement that
were based on management’s good faith interpretations of pertinent laws and regulations. Addition
ally, the Provider Reimbursement Review Board (PRRB) or the courts may be required to resolve
controversies regarding the application of certain rules. To avoid recognizing revenues before their
realization is reasonably assured, providers estimate the effects of such potential adjustments. This
is occasionally done by preparing a cost report based on alternative assumptions to help estimate
contractual allowances required by generally accepted accounting principles. The existence of re
serves or a reserve cost report does not by itself mean that a cost report was incorrectly or
fraudulently filed.
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fact that an entity currently is not subject to a governmental investigation does
not mean that a recorded valuation allowance for potential billing adjustments
is not warranted. Nor do these emerging industry trends necessarily indicate
that an accrual for a specific entity is warranted.
29. In evaluating valuation allowances, the auditor may consider the entity’s
historical experience and potential future adjustments in the aggregate. For
example, assume that over the past few years after final cost report audits were
completed, a hospital’s adjustments averaged 3 percent to 5 percent of total filed
reimbursable costs. Additionally, the hospital is subject to potential billing adjust
ments, including errors (for example, violations of the three-day window, dis
charge and transfer issues, and coding errors). Even though specific incidents are
not known, it may be reasonable for the hospital to estimate and accrue a valuation
allowance for such potential future retrospective adjustments, both cost-based and
non-cost-based. Based on this and other information obtained, the auditor may
conclude that a valuation allowance for the year under audit of 3 percent to 5
percent of reimbursable costs plus additional amounts for potential non-cost-based
program billing errors is reasonable.
30. Amounts that ultimately will be realized by an entity are dependent
on a number of factors, many of which may be unknown at the time the
estimate is first made. Further, even if two entities had exactly the same
clinical and coding experience, amounts that each might realize could vary
materially due to factors outside of their control (for example, differing appli
cation of payment rules by fiscal intermediaries, legal interpretations of courts,
local enforcement initiatives, timeliness of reviews, and quality of documenta
tion). As a result, because estimates are a matter of judgment and their
ultimate accuracy depends on the outcome of future events, different entities
in seemingly similar circumstances may develop materially different esti
mates. The auditor may conclude that both estimates are reasonable in light
of the differing assumptions.
Inappropriate Accounting Principles

31. The auditor also determines that estimates are presented in the
financial statements in accordance with GAAP. If the auditor believes that the
accounting principles have not been applied correctly, causing the financial
statements to be materially misstated, the auditor expresses a qualified or
adverse opinion.
32. Valuation allowances are recorded so that revenues are not recog
nized until the revenues are realizable. Valuation allowances are not estab
lished based on the provisions of Financial Accounting Standards Board
(FASB) Statement of Financial Accounting Standards No. 5, Accounting for
Contingencies.
33. The auditor should be alert for valuation allowances not associated
with any particular program, issue, or time period (for example, cost-report
year or year the service was rendered). Such a reserve may indicate measure
ment bias. The auditor also considers the possibility of bias resulting in
distorted earnings trends over time (for example, building up specific or
unallocated valuation allowances in profitable years and drawing them down
in unprofitable years).
Inadequate Disclosure

34. If the auditor concludes that a matter involving a risk or an uncer
tainty is not adequately disclosed in the financial statements in conformity
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with GAAP, the auditor should express a qualified or adverse opinion. SOP
94-6, Disclosure of Certain Significant Risks and Uncertainties, provides guid
ance on the information that reporting entities should disclose regarding risks
and uncertainties existing as of the date of the financial statements.
35. In the health care environment, it is almost always at least reason
ably possible that estimates regarding third-party payments could change in
the near term as a result of one or more future confirming events (for example,
regulatory actions reflecting local or national audit or enforcement initiatives).
For most entities with significant third-party revenues, the effect of the change
could be material to the financial statements. Where material exposure exists,
the uncertainty regarding revenue realization is disclosed in the notes to the
financial statements. Because representations from legal counsel are often key
audit evidence in evaluating the reasonableness of management’s estimates of
potential future adjustments, the inability of an attorney to form an opinion on
matters about which he or she has been consulted may be indicative of an
uncertainty that should be specifically disclosed in the financial statements.
36. Differences between original estimates and subsequent revisions
might arise due to final settlements, ongoing audits and investigations, or
passage of time in relation to the statute of limitations. The Guide (paragraph
5.07) requires that these differences be included in the statement of operations
in the period in which the revisions are made and disclosed, if material. Such
differences are not treated as prior period adjustments unless they meet the
criteria for prior period adjustments as set forth in FASB Statement No. 16,
Prior Period Adjustments.
37. Disclosures such as the following may be appropriate:
General Hospital (the Hospital) is a (not-for-profit, for-profit, or governmental
hospital or health care system) located in (City, State). The Hospital provides
health care services primarily to residents of the region.
Net patient service revenue is reported at estimated net realizable amounts
from patients, third-party payors, and others for services rendered and includes
estimated retroactive revenue adjustments due to future audits, reviews, and
investigations. Retroactive adjustments are considered in the recognition of
revenue on an estimated basis in the period the related services are rendered,
and such amounts are adjusted in future periods as adjustments become known
or as years are no longer subject to such audits, reviews, and investigations.
Revenue from the Medicare and Medicaid programs accounted for approxi
mately 40 percent and 10 percent, respectively, of the Hospital’s net patient
revenue for the year ended 1999. Laws and regulations governing the Medicare
and Medicaid programs are extremely complex and subject to interpretation.
As a result, there is at least a reasonable possibility that recorded estimates
will change by a material amount in the near term. The 1999 net patient service
revenue increased approximately $10,000,000 due to removal of allowances
previously estimated that are no longer necessary as a result of final settle
ments and years that are no longer subject to audits, reviews, and investiga
tions. The 1998 net patient service revenue decreased approximately
$8,000,000 due to prior-year retroactive adjustments in excess of amounts
previously estimated.
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Appendix
Other Considerations Related to
Government Investigations

In recent years, the federal government and many states have aggressively
increased enforcement efforts under Medicare and Medicaid anti-fraud and
abuse legislation. Broadening regulatory and legal interpretations have signifi
cantly increased the risk of penalties for providers; for example, broad inter
pretations of “false claims” laws are exposing ordinary billing mistakes to
scrutiny and penalty consideration. In such circumstances, evaluating the
adequacy of accruals for or disclosure of the potential effects of illegal acts in
the financial statements of health care organizations is a matter that is likely
to require a high level of professional judgment.
As previously discussed in this SOP, the far-reaching nature of alleged fraud
and abuse violations creates an uncertainty with respect to the valuation of
revenues, because future allegations of illegal acts could, if proven, result in a
subsequent reduction of revenues. In addition, management makes provisions
in the financial statements and disclosures for any contingent liabilities asso
ciated with fines and penalties due to violations of such laws. FASB Statement
No. 5, Accounting for Contingencies, provides guidance in evaluating contingent
liabilities, such as fines and penalties under applicable laws and regulations.
Estimates of potential fines and penalties are not accrued unless their payment
is probable and reasonably estimable.
The auditor’s expertise is in accounting and auditing matters rather than
operational, clinical, or legal matters. Accordingly, the auditor’s procedures
focus on areas that normally are subject to internal controls relevant to
financial reporting. However, the further that potential illegal acts are removed
from the events and transactions ordinarily reflected in the financial state
ments, the less likely the auditor is to become aware of the act, to recognize its
possible illegality, and to evaluate the effect on the financial statements. For
example, determining whether a service was medically necessary, obtained
through a legally appropriate referral, properly performed (including using
only approved devices, rendered in a quality manner), adequately supervised,
accurately documented and classified, or rendered and billed by nonsanctioned
individuals typically is not within the auditor’s professional expertise. As a
result, an audit in accordance with generally accepted auditing standards
(GAAS) is not designed to detect such matters.
Further, an audit conducted in accordance with GAAS does not include render
ing an opinion or any form of assurance on an entity’s compliance with laws
and regulations.1 Nor does an audit under GAAS include providing any
assurance on an entity’s billings or cost report. In fact, cost reports typically
are not prepared and submitted until after the financial statement audit has
been completed.
Certain audit procedures, although not specifically designed to detect illegal
acts, may bring possible illegal acts to an auditor’s attention. When a poten
tially illegal act is detected, the auditor’s responsibilities are addressed in SAS
1 Even when auditors undertake a special engagement designed to attest to compliance with
certain provisions of laws, regulations, contracts, and grants (for example, an audit in accordance
with OMB Circular A-133), the auditor’s procedures do not extend to testing compliance with laws
and regulations related to Medicare and Medicaid fraud and abuse.
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No. 54, Illegal Acts by Clients (AICPA, Professional Standards, vol. 1, AU sec.
317). Disclosure of an illegal act to parties other than the client’s senior
management and its audit committee or board of directors is not ordinarily part
of the auditor’s responsibility, and such disclosure would be precluded by the
auditor’s ethical or legal obligation of confidentiality, unless the matter affects
the auditor’s opinion on the financial statements.2

2 Statement on Auditing Standards No. 54, Illegal Acts by Clients (AICPA, Professional Stand
ards, vol. 1, AU sec. 317.23), discusses circumstances in which a duty to notify parties outside the
client of detected illegal acts may exist.
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NOTE

Statements of Position on accounting issues present the conclusions
of at least two-thirds of the Accounting Standards Executive Com
mittee, which is the senior technical body of the Institute authorized
to speak for the Institute in the areas of financial accounting and
reporting. Statement on Auditing Standards No. 69, The Meaning of
Present Fairly in Conformity With Generally Accepted Accounting
Principles, identifies AICPA Statements of Position that have been
cleared by the Financial Accounting Standards Board as sources of
established accounting principles in category b of the hierarchy of
generally accepted accounting principles that it establishes. AICPA
members should consider the accounting principles in this Statement
of Position if a different accounting treatment of a transaction or
event is not specified by a pronouncement covered by Rule 203 of the
AICPA Code of Professional Conduct. In such circumstances, the
accounting treatment specified by the Statement of Position should
be used, or the member should be prepared to justify a conclusion
that another treatment better presents the substance of the transac
tion in the circumstances.
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SUMMARY

This Statement of Position (SOP) amends the AICPA Audit and Accounting
Guide Health Care Organizations (Guide) to address how nongovernmental
not-for-profit health care organizations should report gains or losses on hedging
and nonhedging derivative instruments under Financial Accounting Standards
Board (FASB) Statement of Financial Accounting Standards No. 133, Account
ing for Derivative Instruments and Hedging Activities, as amended. This SOP
requires the following:
• Not-for-profit health care organizations should apply the provisions of
FASB Statement No. 133 (including the provisions pertaining to cash
flow hedge accounting) in the same manner as for-profit enterprises.
• Not-for-profit health care organizations should provide all the disclo
sures required by paragraph 45 of FASB Statement No. 133, including
disclosures related to reclassifications into earnings of gains and losses
that are reported in accumulated other comprehensive income. Al
though those organizations are not otherwise required to report
changes in the components of comprehensive income pursuant to
paragraph 26 of FASB Statement No. 130, Reporting Comprehensive
Income, such organizations should separately disclose the beginning
and ending accumulated derivative gain or loss that has been excluded
from the performance indicator (earnings measure), the related net
change associated with current period hedging transactions, and the
net amount of any reclassifications into the performance indicator in
a manner similar to that described in paragraph 47 of FASB State
ment No. 133.
The SOP also amends the Guide to clarify that the performance indicator
(earnings measure) reported by not-for-profit health care organizations is
analogous to income from continuing operations of a for-profit enterprise.
The provisions of the SOP are effective for fiscal years beginning after June 15,
2003. Earlier application of this SOP is encouraged but is permitted only as of
the beginning of any fiscal quarter that begins after issuance of this SOP. The
provisions of the SOP should be applied prospectively. Not-for-profit health
care organizations that reported derivative gains or losses in a manner incon
sistent with the conclusions of the SOP in financial statements issued prior to
adoption of the SOP are not permitted to reclassify those gains or losses upon
adoption.
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FOREWORD
The accounting guidance contained in this document has been cleared by the
Financial Accounting Standards Board (FASB). The procedure for clearing
accounting guidance in documents issued by the Accounting Standards Execu
tive Committee (AcSEC) involves the FASB reviewing and discussing in public
board meetings (1) a prospectus for a project to develop a document, (2) a
proposed exposure draft that has been approved by at least 10 of AcSEC’s 15
members, and (3) a final document that has been approved by at least 10 of
AcSEC’s 15 members. The document is cleared if at least four of the seven FASB
members do not object to AcSEC undertaking the project, issuing the proposed
exposure draft or, after considering the input received by AcSEC as a result of
the issuance of the exposure draft, issuing the final document.
The criteria applied by the FASB in its review of proposed projects and proposed
documents include the following:
1. The proposal does not conflict with current or proposed accounting
requirements, unless it is a limited circumstance, usually in special
ized industry accounting, and the proposal adequately justifies the
departure.
2. The proposal will result in an improvement in practice.
3. The AICPA demonstrates the need for the proposal.
4. The benefits of the proposal are expected to exceed the costs of
applying it.
In many situations, prior to clearance, the FASB will propose suggestions,
many of which are included in the document.
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Accounting for Derivative Instruments and
Hedging Activities by Not-for-Profit
Health Care Organizations, and
Clarification of the Performance Indicator
Introduction

1. Financial Accounting Standards Board (FASB) Statement of Financial
Accounting Standards No. 133, Accounting for Derivative Instruments and
Hedging Activities, as amended, establishes accounting and reporting stand
ards for derivative instruments and hedging activities. If certain conditions are
met, a derivative may be specifically designated as a hedge of the exposure to
changes in the fair value of a recognized asset or liability or an unrecognized
firm commitment (fair value hedge), a hedge of the exposure to variable cash
flows of an existing recognized asset or liability or a forecasted transaction
(cash flow hedge), or a hedge of foreign currency exposure.1
2. The accounting for derivative gains and losses depends on the intended
use of the derivative and the resulting designation.
• For a fair value hedge, the gain or loss on the derivative is recognized
in earnings in the period of change together with the offsetting loss or
gain on the hedged item attributable to the risk being hedged.
• For a cash flow hedge, the effective portion of the derivative’s gain or
loss is initially reported as a component of other comprehensive income
(outside earnings) and subsequently reclassified into earnings when
the forecasted transaction affects earnings. Any ineffective portion of
the gain or loss is reported in earnings immediately.
• For a derivative not designated as a hedging instrument, the gain or
loss is recognized in earnings in the period of change.
3. The application of FASB Statement No. 133 to entities that do not
report earnings as a separate caption in a statement of financial performance
(for example, a not-for-profit organization) is described in paragraph 43 of that
Statement. Paragraph 43 indicates that such organizations shall recognize the
gain or loss on hedging and nonhedging derivative instruments, and changes
in the carrying amount of the hedged item in a fair value hedge, as a change in
net assets in the period of change. Paragraph 43 also indicates that cash flow
hedge accounting is not available to a not-for-profit or other entity that does
not report earnings as a separate caption in a statement of financial perform
ance. Consistent with the provisions of FASB Statement No. 117, Financial
Statements of Not-for-Profit Organizations, FASB Statement No. 133 does not
prescribe how a not-for-profit organization should determine the components
of an operating measure, if one is presented.
4. Many health care entities are organized as not-for-profit organizations,
and thus would appear to be subject to the provisions of paragraph 43 of FASB
Statement No. 133. The thrust of the guidance in paragraph 43 appears to be
directed at the fact that FASB Statement No. 117 does not require not-forprofit entities to report earnings. However, not-for-profit health care organiza
tions must report a defined measure of earnings (performance indicator) as a
1
Not-for-profit health care organizations do not frequently enter into foreign currency hedges.
Therefore, this SOP focuses on matters pertaining to fair value and cash flow hedges.
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separate caption in the statement of operations, based on requirements con
tained in paragraph 10.17 and 10.18 of the AICPA Audit and Accounting Guide
Health Care Organizations (the Guide). Consequently, some not-for-profit
health care organizations believed that paragraph 43 of FASB Statement No.
133 (including its provisions related to cash flow hedge accounting) did not
affect them. Those entities applied the provisions of FASB Statement No. 133
in the same manner as for-profit enterprises. Other not-for-profit health care
organizations believed they were subject to the guidance in paragraph 43, but
interpreted that guidance in different ways. As a result, diversity in practice
arose among not-for-profit health care organizations with respect to their
accounting for derivatives.
5. This SOP addresses how not-for-profit health care organizations
should report gains or losses on hedging and nonhedging derivative instru
ments under FASB Statement No. 133 and clarifies certain matters with
respect to the performance indicator (earnings measure) reported by such
organizations.
Scope

6. This SOP applies to not-for-profit health care organizations that are
within the scope of the Guide. It does not apply to governmental entities that
are within the scope of the Guide.
Conclusions
Application of FASB Statement No. 133

7. Except as provided in paragraph 8 of this SOP, not-for-profit health
care organizations should apply the provisions of FASB Statement No. 133
(including the provisions pertaining to cash flow hedge accounting) in the same
manner as for-profit enterprises. That is, the gain or loss items that affect a
for-profit enterprise’s income from continuing operations similarly should
affect the not-for-profit health care organization’s performance indicator, and
the gain or loss items that are excluded from a for-profit enterprise’s income
from continuing operations (such as items reported in other comprehensive
income) similarly should be excluded from the performance indicator by the
not-for-profit health care organization.
8. Paragraph 47 of FASB Statement No. 133 discusses requirements to
report changes in the components of comprehensive income pursuant to para
graph 26 of FASB Statement No. 130, Reporting Comprehensive Income.
Although not-for-profit health care organizations are not subject to the require
ments of FASB Statement No. 130, this SOP requires those organizations to
separately disclose the beginning and ending accumulated derivative gain or
loss that has been excluded from the performance indicator (also see paragraph
10 of this SOP), the related net change associated with current period hedging
transactions, and the net amount of any reclassifications into the performance
indicator in a manner similar to that described in paragraph 47 of FASB
Statement No. 133. Similarly, this SOP requires not-for-profit health care
organizations to provide disclosures that are analogous to those required by
paragraph 45 of FASB Statement No. 133 for for-profit enterprises, including
the disclosure of anticipated reclassifications into the performance indicator of
gains and losses that have been excluded from that measure and reported in
accumulated derivative gain or loss as of the reporting date.
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Performance Indicator

9. Paragraph 10.17 and 10.18 of the Guide are amended as follows. The
following text is added after the first sentence of paragraph 10.17:
This performance indicator and the income from continuing operations re
ported by for-profit health care enterprises generally are consistent, except for
transactions that clearly are not applicable to one kind of entity (for example,
for-profit health care enterprises typically would not receive contributions, and
not-for-profit health care organizations would not award stock compensation).
That is, the performance indicator is analogous to income from continuing
operations of a for-profit enterprise.

In paragraph 10.18, item e is eliminated, item f is renumbered e, and item g is
deleted and replaced with the following two subpoints:
f. Items that are required to be reported in or reclassified from other
comprehensive income, such as minimum pension liabilities in ac
cordance with paragraph 37 of FASB Statement No. 87, Employers’
Accounting for Pensions; foreign currency translation adjustments;
and the effective portion of the gain or loss on derivative instruments
designated and qualifying as cash flow hedging instruments.
g. Items that are required to be reported separately under specialized
not-for-profit standards. These include extraordinary items, the ef
fect of discontinued operations, and the cumulative effect of account
ing changes pursuant to the provisions of FASB Statement No. 117;
and unrealized gains and losses on investments not restricted by
donors or by law (except for those investments classified as trading
securities) and investment returns restricted by donors or by law, as
required by paragraphs 4.07 through 4.10 of this Guide.
Effective Date and Transition

10. The provisions of this SOP are effective for fiscal years beginning after
June 15, 2003. Earlier application of this SOP is encouraged but is permitted
only as of the beginning of any fiscal quarter that begins after issuance of this
SOP. This SOP should be applied prospectively for all contracts existing on the
initial date of application of this SOP and for transactions after that date.
Derivative gains or losses reported in a manner inconsistent with the provi
sions of this SOP in financial statements for periods prior to the initial date of
application of this SOP should not be reclassified upon adoption. Any deriva
tive gains and losses excluded from the performance indicator in the financial
statements issued for periods ended before the initial date of application of this
SOP that did not meet the cash flow hedging criteria of FASB Statement No.
133 should not be reclassified and included as a component of the performance
indicator in any period subsequent to the initial date of application of this SOP.
In addition, the derivative gains and losses referred to in the preceding
sentence should not be included in the disclosure of the accumulated derivative
gain or loss (as described in paragraph 8 of this SOP). However, to the extent
that derivative gains or losses on cash flow hedges qualifying under FASB
Statement No. 133 had been reported in a manner consistent with the provi
sions of this SOP in financial statements for periods prior to the initial date of
application of this SOP, such amounts should be included in that disclosure
and should be reclassified and included in the performance indicator when the
hedged transaction affects the performance indicator. When the financial
statements of the year of adoption are presented separately or included in
comparative financial statements, the notes to the financial statements should
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disclose (a) the fact that this SOP has been adopted and the effective date of
adoption, and (b) the nature of any differences in accounting principles or
financial statement presentation applicable to the financial statements pre
sented that resulted from adoption of the SOP. Disclosure of pro forma
amounts is not required.
11.
Entities initially applying hedge accounting upon adoption of this
SOP are reminded that all the hedge accounting criteria in FASB Statement
No. 133 must be met for the entire period to which hedge accounting is being
applied. Derivative instruments should not be retroactively designated as
hedges if appropriate contemporaneous documentation of the election and
periodic assessment of effectiveness2 did not occur in conformity with FASB
Statement No. 133.
The provisions of this SOP need not
be applied to im m aterial item s.
Background

12. Issues surrounding the reporting of derivatives by not-for-profit
health care organizations and the resulting diversity in practice were brought
to the attention of the planning subcommittee of the AICPA’s Accounting
Standards Executive Committee (AcSEC) in December 2000. Specifically,
questions had been raised about whether the guidance in paragraph 43 of
FASB Statement No. 133, Accounting for Derivative Instruments and Hedging
Activities, as amended, applied to not-for-profit health care organizations that
are required under industry-specific generally accepted accounting principles
(GAAP) to report a performance indicator.
13. The planning subcommittee discussed the paragraph 43 issue and
concluded that, because not-for-profit health care organizations are required
to report a standardized performance indicator that is considered analogous to
income from continuing operations reported by for-profit enterprises, they
should apply the provisions of FASB Statement No. 133 in the same manner
as do for-profit enterprises. Because that conclusion was not considered contro
versial, the planning subcommittee directed the AICPA staff to draft clarifying
guidance in the form of a proposed AICPA Technical Practice Aid (TPA).
14. The planning subcommittee also discussed a footnote that had been
added as a conforming change to paragraph 10.18 of the Guide in May 2000.
That footnote contained the following statement:
Not-for-profit health care organizations that have early-adopted FASB State
ment No. 133, Accounting for Derivative Instruments and Hedging Activities,
should also report unrealized gains and losses on derivatives that do not qualify
as a fair value hedge under FASB Statement No. 133, except for the effect of
changes in interest accruals, separate from the performance indicator.

In light of the planning subcommittee’s conclusion that the provisions of FASB
Statement No. 133 should be applied to not-for-profit health care organizations
2
FASB Statement No. 133, Accounting for Derivative Instruments and Hedging Activities, as
amended, establishes the general requirement that, to use hedge accounting, an entity should assess
a hedge’s effectiveness at the time it enters into a hedge and at least every three months thereafter,
unless the hedge qualifies for use of the short-cut method. The requirement to assess hedge effective
ness at least every three months applies to entities that issue financial statements only on an annual
basis as well as to entities that issue quarterly financial statements.
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in the same manner as for-profit enterprises, it was decided that the May 2000
conforming change should be deleted from future editions of the Guide.
15. In January 2001, the planning subcommittee discussed a letter re
ceived by AcSEC’s Chair from The Bond Market Association (TBMA). The
letter indicated TBMA’s awareness of the planning subcommittee’s discussions
and expressed concern that the proposed guidance would be issued in the form
of a nonauthoritative TPA. TBMA was concerned that not-for-profit health
care organizations and their independent auditors would not be aware of such
guidance, resulting in the inconsistent application of derivative accounting
among organizations in the sector. TBMA also wanted to ensure that all
affected parties would have an opportunity to review and comment on the
proposed guidance, because it could represent a significant change in reporting
for some not-for-profit health care organizations.
16. In March 2001, after further discussing the draft TPA and considering
input received from various sources, the planning subcommittee and AcSEC
decided that an SOP should be issued to amend the Guide to address these
issues. Although the planning subcommittee and AcSEC did not disagree with
the conclusions in the draft TPA, it was concluded that an SOP subject to due
process would be the most appropriate vehicle for communicating the guid
ance. AcSEC issued an exposure draft of a proposed SOP on June 14, 2002 and
received four comment letters.
Views on the Issue

17. Some believed that because not-for-profit health care organizations
are required by the AICPA Audit and Accounting Guide Health Care Organi
zations to report a performance indicator that is analogous to income from
continuing operations of a for-profit enterprise, they should apply the provi
sions of FASB Statement No. 133 (including the cash flow hedge accounting
provisions) in the same manner as for-profit enterprises. That is, the gain or
loss items that under FASB Statement No. 133 would affect a for-profit
enterprise’s earnings similarly should affect the not-for-profit health care
organization’s performance indicator, and the gain or loss items that under
FASB Statement No. 133 are reported in other comprehensive income by the
for-profit enterprise similarly should be excluded from the performance indica
tor by the not-for-profit health care organization. They interpreted paragraph
43 of FASB Statement No. 133 as applying only to organizations that are not
required to report an earnings measure.
18. Others believed that paragraph 43 precludes the use of cash flow
hedge accounting by not-for-profit health care organizations because the FASB
has not defined the performance indicator to be used by those organizations.
They cited the following sentence in paragraph 501 of FASB Statement No. 133
as support for their position:
For this Statement to permit a not-for-profit entity, for example, to apply cash
flow hedge accounting, the Board would first have to define a subcomponent of
the total change in net assets during a period that would be analogous to
earnings for a business enterprise.

They believed that the definition ofperformance indicator used by not-for-profit
health care organizations does not qualify as earnings for FASB Statement No.
133 purposes because it was promulgated by AcSEC, rather than the FASB.
Opponents of that view pointed to paragraph 49 of FASB Statement No. 117,
Financial Statements of Not-for-Profit Organizations, which allows AICPA
industry Audit and Accounting Guides to provide implementing guidance with
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respect to that Statement that, if cleared by the FASB, should be adopted by
users of those guides. The FASB did not object to the definition ofperformance
indicator promulgated in the Guide.
19. Others acknowledged that not-for-profit health care organizations
report a performance indicator that is analogous to income from continuing
operations of a for-profit enterprise, but believed that the cash flow hedge
accounting prohibitions in paragraph 43 should apply because the concept of
other comprehensive income is limited to for-profit enterprises that are subject
to FASB Statement No. 130, Reporting Comprehensive Income. Opponents of
that view responded that not-for-profit health care organizations employ other
comprehensive income reporting concepts in their statement of operations and
their definition of a performance indicator. They pointed to the fact that among
the exclusions from the performance indicator listed in paragraph 10.18 of the
Guide are the items that for-profit organizations are required to include in
other comprehensive income under FASB Statement No. 130 (foreign currency
items, minimum pension liability adjustments, and unrealized gains and
losses on certain investments in debt and equity securities). Further, they
pointed to paragraphs 500 and 501 of FASB Statement No. 133, which indicate
that the total change in net assets of a not-for-profit organization is analogous
to the total comprehensive income of a for-profit enterprise.
20. Still others believed that, although not-for-profit health care organi
zations conceptually are capable of applying the mechanics of cash flow hedge
accounting in their financial statements, they are precluded from doing so
because the list in paragraph 10.18 of the Guide of items to be excluded from
the performance indicator does not explicitly include “the effective portion of
the gain or loss on derivative instruments designated and qualifying as cash
flow hedging instruments.” They believed that all transactions except those
explicitly listed in paragraph 10.18 should be included in the performance
indicator.
21. Among those who believed that paragraph 43 prohibits not-for-profit
health care organizations from applying cash flow hedge accounting, some
believed that all hedging and nonhedging derivative gains and losses should be
included in the performance indicator. Others interpreted paragraph 43 as
requiring all hedging and nonhedging derivative gains and losses to be ex
cluded from the performance indicator and reported in “other changes in net
assets.” Still others employed a hybrid approach to reporting derivative gains
and losses based on guidance provided in a conforming change (that sub
sequently was rescinded3 contained in a footnote to paragraph 10.18 of the
May 2000 edition of the Guide.
Basis for Conclusions
Scope
Other Not-for-Profit Organizations

22. AcSEC discussed whether the scope of the SOP should extend to other
types of not-for-profit organizations (that is, not-for-profit organizations other
than health care organizations) in situations in which those organizations
voluntarily choose to provide a performance indicator. Those organizations are
subject to the AICPA Audit and Accounting Guide Not-for-Profit Organiza
tions, rather than the Audit and Accounting Guide Health Care Organizations.
3 See paragraph 14 of this SOP.
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AcSEC chose not to address similar issues for those organizations in the
context of this SOP because, unlike health care organizations, other types of
not-for-profit organizations are not subject to a standardized or prescribed
performance measure.
Governmental Health Care Enterprises

23. Because the concept of reporting “other comprehensive income” con
flicts with the reporting requirements of Governmental Accounting Standards
Board (GASB) Statement No. 34, Basic Financial Statements—and Manage
ment’s Discussion and Analysis—for State and Local Governments, cash flow
hedge accounting is not available to governmental health care enterprises that
are within the scope of the Guide. Therefore, governmental health care enter
prises are excluded from the scope of the SOP. FASB Statement No. 133
applies to governmental enterprises only to the extent that provisions in that
Statement do not conflict with the provisions of GASB pronouncements (see
paragraph 94 of GASB Statement No. 34).
Reporting a Separate Component of Equity

24. Pursuant to paragraph 26 of FASB Statement No. 130, for-profit
entities report accumulated other comprehensive income as a component of
equity that is displayed separately from retained earnings and additional
paid-in capital in a statement of financial position. When FASB Statement No.
130 was issued, the FASB considered whether not-for-profit organizations
should also be included within the scope of that Statement. The FASB decided
to exclude those organizations, noting that not-for-profit organizations’ finan
cial statements already were displaying the equivalent of comprehensive in
come as a result of the requirements of FASB Statement No. 117. Thus,
not-for-profit organizations are not required to report accumulated other com
prehensive income as a separate component of equity.
25. AcSEC discussed whether the absence of a requirement to report
accumulated other comprehensive income as a separate component of equity
was a significant enough difference to preclude not-for-profit health care
organizations from being able to use cash flow hedge accounting under FASB
Statement No. 133. AcSEC determined that the concept of reporting accumu
lated other comprehensive income as a separate component of equity is unique
to for-profit enterprises that report retained earnings and additional paid-in
capital and that, further, the concept primarily appears to be a carryforward
of the reporting practices followed by such entities before the issuance of FASB
Statement No. 130. Moreover, AcSEC was concerned that such reporting may
conflict with the provisions of FASB Statement No. 117 requiring not-for-profit
organizations to report three classes of net assets (unrestricted, temporarily
restricted, and permanently restricted). Therefore, AcSEC concluded that the
absence of a requirement to report a separate component of equity in the
balance sheet of not-for-profit health care organizations should not preclude
those organizations from using comprehensive income reporting for qualifying
gains and losses on cash flow hedges. Although accumulated other comprehen
sive income will inherently be carried forward in a not-for-profit health care
organization’s net assets, there is no compelling need for it to be reported
separately in the balance sheet.
Income Statement Classification of Derivative Gains and Losses

26. Although FASB Statement No. 133 provides comprehensive disclo
sure guidance for derivatives, it does not explicitly address or prescribe the
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income statement classification for derivative gains and losses that are in
cluded in earnings.
27. Paragraph 45 of FASB Statement No. 133 requires an entity to
disclose where in the income statement it has chosen to report the net gain or
loss on fair value and cash flow hedges (and the related hedged transaction or
item), but the paragraph does not specify where or in what captions such gains
and losses should be displayed. That allows for flexibility in reporting based on
an entity’s economic rationale for entering into the hedge. For derivatives that
are not designated as hedges, FASB Statement No. 133 does not require
disclosure of where gains and losses are reported in the income statement, nor
does it specify where within the income statement those gains and losses
should be reported. AcSEC decided not to provide more specific guidance
regarding income statement classification in this SOP because it did not want
to prescribe more restrictive guidance for not-for-profit health care organiza
tions than that applicable to other organizations subject to FASB Statement
No. 133.
Definition of Performance Indicator

28. The term performance indicator was introduced in 1996 when the AICPA
issued the Audit and Accounting Guide Health Care Organizations.4 The 1996
revision of the industry Guide was necessitated largely by the issuance of
FASB Statements No. 116, Accounting for Contributions Received and Contri
butions Made, and No. 117, which (among other things) changed the financial
statement display requirements for not-for-profit organizations. The 1995
exposure draft of the Guide had referred to the earnings measure using terms
such as net income and operating income. The FASB subsequently objected to
that terminology, deeming it inappropriate for describing an earnings measure
of a not-for-profit organization. Accordingly, the final Guide used the generic
term performance indicator to denote the earnings measure.
29. Paragraph 1.04 of the Guide states, in part:
The financial reporting for not-for-profit, business-oriented organizations and
investor-owned health care enterprises generally is consistent except for trans
actions that clearly are not applicable. For example, not-for-profit business
organizations would have nothing to report for shareholders’ equity. On the
other hand, investor-owned health care enterprises typically would not have
anything to report for contributions.

Consequently, in developing the definition ofperformance indicator (paragraph
10.17 and 10.18 of the Guide), AcSEC intended that the linkage between the
new performance indicator measure and the earnings measure previously
reported by not-for-profit health care organizations be preserved to the greatest
extent possible, due to its importance to users of health care organizations’
financial statements. The phrase “other items that are required by GAAP to be
reported separately” was included in paragraph 10.18g of the Guide to enable
the performance indicator to remain “evergreen,” that is, to permit it to be
updated by conforming changes to incorporate the issuance of future accounting
standards.
30. Subsequent to issuance of the Guide, AcSEC determined that the
provisions of paragraph 10.17 and 10.18 were not being interpreted by some
readers of the Guide in the manner intended by AcSEC. In addition, when new
accounting standards have been issued, some readers of the Guide have been
4
Health Care Organizations replaced the AICPA Industry Audit Guide Audits of Providers of
Health Care Services.
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uncertain how to apply them with respect to the performance indicator. Con
sequently, paragraph 9 of this SOP revises the definition of performance
indicator to state explicitly that the performance indicator should be regarded
as the functional equivalent of income from continuing operations of a forprofit enterprise. Additionally, this SOP amends paragraph 10.18 of the Guide
to clarify that the reference to “other items that are required by GAAP to be
reported separately” refers to GAAP applicable to for-profit enterprises (for
example, items that are required under existing accounting standards to be
reported in other comprehensive income5 as well as GAAP specific to not-forprofit organizations, and that additional items may result from issuance of
future accounting standards.
Transition

31. Paragraph 515 of FASB Statement No. 133 states, in part:

Because hedge accounting is based on an entity’s intent at the time a hedging
relationship is established, the Board decided that retroactive application of
the provisions of this Statement was not appropriate.

Similarly, Derivatives Implementation Group (DIG) Issue No. K5, Transition
Provisions for Applying the Guidance in Statement 133 Implementation Issues,
indicates that when an entity has applied “the recognition and measurement
of derivatives differently than required by subsequently issued cleared imple
mentation guidance, [the entity] should account for the effects of initially
complying with that implementation guidance prospectively for all existing
contracts and future transactions, as of the effective date for that guidance.”
Consequently, AcSEC determined that the effects of initially complying with
the guidance in this SOP should also be accounted for prospectively.
32. AcSEC also considered whether to allow an alternative for retroactive
application of this SOP. Although this SOP does not change the “recognition
and measurement of derivatives,” it may change an entity’s accounting policy
and thus may affect certain actions taken by an entity. For example, based on
their interpretation of authoritative literature, certain health care entities
may have had economic hedges that they did not designate as cash flow hedges
because they did not believe that cash flow hedging derivatives were accounted
for differently from non-hedging derivatives. AcSEC recognized that the his
torical actions undertaken to document, designate, or assess effectiveness by
entities that, in prior periods, had adopted accounting policies inconsistent
with those set forth in this SOP may have differed had this SOP been effective
during those prior periods. In recognition of this fact, and because hedging
relationships cannot be documented retroactively under FASB Statement No.
133, AcSEC decided that retroactive application of the provisions of this SOP
was not appropriate.
33. Because the effect of an entity’s hedging activities on its financial
statements in the initial year of adoption of this SOP may not be comparable
to the preceding year, AcSEC discussed whether pro forma disclosures in the
year of adoption would address concerns related to consistency and compara
bility of financial information. Disclosure of the pro forma effects of retroactive
application of hedge accounting for prior periods (in a manner similar to the
requirements of paragraph 19(d) of Accounting Principles Board Opinion No.
5
For example, in June 1997 the phrase “minimum pension liabilities in accordance with
paragraph 37 of FASB Statement No. 87, Employers’ Accounting for Pensions, or foreign currency
translation adjustments” was added to paragraph 10.18(g) as a conforming change necessitated by
the issuance of FASB Statement No. 130, Reporting Comprehensive Income.
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20, Accounting Changes) was considered and rejected for the same reasons that
AcSEC rejected retroactive restatement as a transition option, as described in
paragraph 32. The exposure draft solicited comments on an alternative pro
forma measure that would require entities to disclose the effect on their
performance indicator for the year of adoption of continuing to apply their prior
year’s reporting practices, if such practices differed from those required by the
SOP. One commenter stated that such a requirement was inappropriate and
would not provide users of the financial statements with meaningful compara
tive information. For example, for an entity that prior to adoption of the SOP
believed that paragraph 43 of Statement No. 133 prohibited cash flow hedge
accounting but that upon adoption of the SOP adopted cash flow hedge ac
counting, the information derived from disclosing what the performance indi
cator would have been had the entity continued to not take advantage of hedge
accounting has little (if any) meaning for users of financial statements. Simi
larly, for an entity that prior to adoption of the SOP was excluding gains and
losses from the performance indicator in a manner other than that allowed by
this SOP, disclosing what the performance indicator would have been had the
entity continued to exclude those derivative gains/losses from the performance
indicator subsequent to its adoption of the SOP does not provide meaningful
information and, further, results in comparing a performance indicator derived
in accordance with GAAP with a measure that is no longer considered to be in
accordance with GAAP. Therefore, although acknowledging that the useful
ness of financial information about an entity increases if that information can
be compared with similar information in prior periods, AcSEC concluded that
the potential usefulness of that information is diminished or eliminated if the
information has no comparative value. Additionally, AcSEC considered this
SOP’s guidance as similar in nature to the guidance provided in Statement No.
133 and DIG Issue No. K5. Neither Statement No. 133 nor Issue No. K5
requires disclosure of any pro forma information. Consequently, AcSEC con
cluded that pro forma disclosures of any type would not be appropriate for the
year of adoption of this SOP. However, when the financial statements of the
year of adoption are presented separately or included in comparative financial
statements, the entity should disclose in the notes to the financial statements
(a) the fact that the SOP has been adopted and the effective date of adoption
(for example, beginning of a year or beginning of a quarter), and (b) the nature
of any differences in accounting principles or financial statement presentation
applicable to the financial statements presented that resulted from adoption of
the SOP (for example, “The effective portion of unrealized gains and losses on
cash flow hedges, which prior to adoption of SOP 02-2 were included in the
performance indicator, are now reported below the performance indicator”).
34. The exposure draft would have required entities to adopt the SOP as
of the beginning of a fiscal year. Several respondents to the exposure draft
objected to precluding entities from early adopting this SOP, based on their
understanding that a number of entities had already been applying the provi
sions of FASB Statement No. 133 pertaining to cash flow hedge accounting
prior to issuance of the exposure draft. They also were concerned about
allowing diversity in practice to continue over the extended period that would
result from requiring adoption as of the beginning of a fiscal year. AcSEC
concluded that in the interest of remedying diversity in practice as quickly as
possible, entities should be allowed to early adopt the SOP.
35. AcSEC observed that some not-for-profit health care organizations
may have employed a methodology that excluded derivative gains and losses
from the performance indicator until those gains or losses were realized. Upon
realization, those organizations would have recognized the derivative’s gain or
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loss in the performance indicator. Consistent with its decision to require
prospective application of this SOP, AcSEC decided that upon initial applica
tion of this SOP, any prior gains or losses on derivative instruments recognized
by those not-for-profit health care organizations that had been excluded from
the performance indicator in years before adoption and that did not meet the
hedging criteria of FASB Statement No. 133 (including the requirements of
contemporaneous documentation and testing of effectiveness) should not sub
sequently be reclassified and included as a component of the performance
indicator. Rather, any such derivative gains and losses should be permanently
excluded from the performance indicator.
36. AcSEC did agree, however, that to the extent that a not-for-profit
health care organization had reported derivative gains or losses in a manner
consistent with the provisions of this SOP (including compliance with the
documentation and designation requirements of FASB Statement No. 133) in
financial statements for periods prior to the initial application of this SOP,
such amounts should be reclassified and included in the performance indicator
when the hedged item affects the performance indicator.
37. For entities that initially apply hedge accounting upon adoption of
this SOP or thereafter, paragraph 11 states that all the hedge accounting
criteria in FASB Statement No. 133 must be met for the entire period to which
hedge accounting is being applied in order for hedge accounting to be used.
AcSEC noted that when an organization designates an existing derivative as a
hedging instrument upon adoption of the SOP or thereafter, the fair value of
the derivative instrument typically will not be zero at the inception of the
hedging relationship. Because paragraph 68(b) of FASB Statement No. 133
requires that the fair value of the hedging instrument at the inception of the
hedging relationship be zero in order for the short-cut method to be used,
application of the short-cut method will not be possible and hedge ineffective
ness for cash flow hedges must be measured under either the hypothetical
derivative method or the change in fair value method as described in DIG Issue
No. G7, Cash Flow Hedges: Measuring the Ineffectiveness of a Cash Flow Hedge
under Paragraph 30(b) When the Shortcut Method is Not Applied. For cash flow
hedging relationships that were designated and accounted for pursuant to the
hedge accounting criteria in FASB Statement No. 133 prior to the adoption of
this SOP, the adoption of this SOP will not affect how hedge effectiveness is
assessed or hedge ineffectiveness is measured for such relationships.
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Appendix G
Information Sources

Further information on matters addressed in this Guide is available through
various publications and services listed in the table that follows. Many non
government and some government publications and services involve a charge
or membership requirement.
Fax services allow users to follow voice cues and request that selected
documents be sent by fax machine. Some fax services require the user to call
from the handset of the fax machine, others allow the user to call from any
phone. Most fax services offer an index document, which lists titles and other
information describing available documents.
Recorded announcements allow users to listen to announcements about a
variety of recent or scheduled actions or meetings.
All telephone numbers listed are voice lines, unless otherwise designated as
fax (f) or data (d) lines.
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Health Care Financial
Management Association
(HFMA)

Medical Group
Management Association

American Medical
Association (AMA)

Interstudy Publications

Group Health Association
of America, Inc. (GHAA)

American Hospital
Association (AHA)

Center for Health Care
Industry Performance
Studies (CHIPS)

American Association of
Homes and Services for
the Aging (AAHSA)

Baltimore, MD 21200
Attn: Customer Service
(800) 568-3282__________________________
Order Department
AAHSA Publications Dept. 5119
Washington, DC 20061-5119
(301) 490-0677__________________________
Order Department
1550 Old Henderson Road, Suite S277
Columbus, OH 43220-3626
(800) 859-2447__________________________
Order Department
P.O. Box 92683
Chicago, IL 90673-2683
(800) AHA-2626________________________
Order Department
1129 20th Street, NW, Suite 600
Washington, DC 20036
(202) 778-3200__________________________
Order Department
2901 Metro Drive, Fourth Floor
Minneapolis, MN 55425
(612) 858-9291_________________________
Order Department
515 N. State Street
Chicago, IL 60610
(800) 621-8335__________________________
Order Department
Denver, CO 80256-0444
(303) 397-7888__________________________
Order Department
Two Westbrook Corporate Center, Suite 700
Westchester, IL 60154
(202) 296-2920__________________________
HMO Industry Profile
Competitive Edge Industry Report for HMOs
Socioeconomics of the Medical Practice

Cost Survey
Academic Practice Management Survey__________________
Health Care Financial Management (monthly publication)
Issue Analysis 98-1, Compliance with Laws and
Regulations for Health Care Organizations

Fax-on-Demand
(202) 331-7487
Fax-on-Demand
(612) 854-5698
Information-on-Request
Fax Line
(800) 621-8335
Fax-on-Demand
(800) FAX-4MED
Fax-on-Demand
(800) 839-HFMA

Hospital Statistics
National Hospital Panel Survey Report

Almanac of Hospital Financial & Operating Indicators

Comparative Performance o f U.S. Hospitals: The Sourcebook
Profile o f U.S. Hospitals
Guide to the Managed Care Industry
Guide to the Nursing Home Industry
Continuing Care Retirement Communities:
An Industry in Action

_____________ Available Publications_____________

Fax-on-Demand
(312) 422-2020

.......................... Fax Services
______ Organization______ ________ General Information_______
Health Care Investment
Order Department
Analysts, Inc. (HCIA)
300 East Lombard Street
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U.S. Office of
Management
and Budget

U.S. Securities and
Exchange Commission

U.S. Government
Accountability Office

Governmental
Accounting
Standards Board

Financial Accounting
Standards Board

American Institute
of Certified Public
Accountants

Order Department
Harborside Financial Center
201 Plaza Three
Jersey City, NJ 07311-3881
(888) 777-7077___________________
Order Department
401 Merritt 7
P.O. Box 5116
Norwalk, CT 06856-5116
(203) 847-0700, ext. 10
(800) 748-0659___________________
Order Department
401 Merritt 7
P.O. Box 5116
Norwalk, CT 06856-5116
(203) 847-0700, ext. 10
(800) 748-0659___________________
GAO Document Distribution Center
(202) 512-6000
Superintendent of Documents
U.S. Government Printing Office
(202) 512-1800___________________
Publications Unit
450 Fifth Street, NW
Washington, DC 20549-0001
(202) 942-4040
SEC Public Reference Room
(202) 942-8090___________________
725 17th Street NW
Washington, DC 20503
(202) 395-3080
OMB Information Line
(202) 395-3080___________________

____ Organization____ _____ General Information_____

www.aicpa.org

_________Web Site Address_______

Information Line
(202) 942-8088, ext. 4
TTY (202) 942-7114

www.omb.gov

www.sec.gov

www.gao.gov

24 Hour Fax on Demand www.gasb.org
(203) 847-0700
menu item 14

24 Hour Fax on Demand www.fasb.org
(203) 847-0700
menu item 14

Fax Services

24 Hour Fax Hotline
(201) 938-3787
Action Alert Telephone Line
(203) 847-0700 (ext. 444)

Recorded Announcements

Information Sources
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Appendix H
Schedule o f Changes M ade to Health
Care Organizations
As of May 2004

Beginning May 2001, all schedules of changes reflect only current year activity
for improved clarity.
Reference
Change
Deleted “Audits of’’in all references to all applicable
General
Guide titles.
Revised to reflect the issuance of GASB Statement
Preface
No. 34 and related pronouncements, the Audit and
Accounting Guide State and Local Governments, and
the Audit Guide Government Auditing Standards and
Circular A-133 Audits and to clarify guidance; Up
dated to reflect the applicability and requirements of
the Sarbanes-Oxley Act, related SEC regulations, and
Standards of the PCAOB; Footnotes 1, 3, and 4 added;
Former footnote 4 deleted; Subsequent footnotes re
numbered.
Chapter 1 (title)
Note deleted.
Paragraph 1.01
Revised to reflect the issuance of GASB Statement
No. 34.
(footnote 1)
Revised since guidance for governmental health care
Paragraph 1.03
(heading)
organizations formerly contained under this heading
has been transferred to a new section in the chapter
entitled “Financial Reporting of Governmental Health
Care Organizations.”
Paragraphs 1.04
Revised to delete guidance for governmental healthcare
organizations.
and 1.05
Paragraph 1.06
Deleted; Subsequent footnotes renumbered.
(footnote 4)
Paragraphs 1.07
Revised to delete guidance for governmental healthcare
and 1.08
organizations.
Former paragraphs Deleted; Subsequent paragraphs renumbered.
1.09 (and heading),
1.10, and 1.11
Paragraphs 1.09,
Added to include new section entitled “Financial
1. 10, 1. 11, 1. 12,
Reporting of Governmental Health Care Organizations”
1.13, 1.14, 1.15,
with guidance for governm ental healthcare
1.16, 1.17, 1.18,
organizations transferred from paragraphs 1.03
1.19, 1.20, 1.21,
through 1.08 as well as to reflect the issuance of GASB
1.22, 1.23, and
Statement No. 34 and related pronouncements, GASB
1.24
Staff document Comprehensive Implementation Guide—
2003, and Audit and Accounting Guide State and Local
Governments;Footnotes 4 and 5 added; Subsequent para
graphs and footnotes further renumbered.
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Reference

Renumbered
paragraph 1.51
Renumbered
paragraph 1.52
(heading)
Renumbered
paragraphs 1.52
and 1.53
Renumbered
paragraphs 1.55,
1.56, 1.57, 1.58,
1.59, and 1.60
Chapter 2 (title)
Paragraph 2.01
Paragraph 2.02
Renumbered
paragraphs 2.03
and 2.09
Renumbered
paragraph 2.14
Former paragraphs
2.13 and 2.14
Paragraphs 2.15,
2.16, 2.17, 2.18,
2.19, 2.20, 2.21,
2.22, 2.23, 2.24,
2.25, 2.26, and 2.27
Paragraph 2.27
(heading)
Paragraphs 2.28,
2.29, 2.30, 2.31,
2.32, 2.33 (and
footnotes 1 and 2),
2.34, 2.35, 2.36
Paragraph 2.37
Renumbered
paragraph 2.38
(heading)
Renumbered
paragraphs 2.41
and 2.51
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Change
Revised to delete reference to FASB Statement No. 4;
Footnotes * and ** deleted.
Footnote *** deleted.
Revised to reflect the issuance of GASB Statement No.
34 and to clarify guidance by adding a cross-reference
to paragraph 1.16.
Revised to reflect the issuance of recent authoritative
or proposed guidance; Footnotes CON, footnote **, and
footnotes * deleted.
Footnote * and note deleted.
Added to reflect the issuance of the Audit and
Accounting Guide State and Local Governments.
Added discussion of regulatory developments for reg
istered public accounting firms; Subsequent para
graphs renumbered.
Revised to reflect the issuance of SAS No. 96 and the
Audit and Accounting Guide State and Local Govern
ments; Footnotes ** and *, respectively, deleted.
Revised to reflect the issuance of SAS No. 99; Footnote
* deleted.
Deleted; Subsequent paragraphs further renumbered.
Added to reflect the issuance of SAS No. 99; Subse
quent paragraphs further renumbered.
Footnote * added to reflect the issuance of PCAOB Audit
ing Standard No. 2.
Added to reflect the issuance of SAS No. 99; Subse
quent paragraphs and footnotes further renumbered;
Footnotes 1 and 2 added.
Added to reflect the release of the Practice Aid, Fraud
Detection in a GAAS Audit—Revised Edition; Subse
quent paragraphs further renumbered.
Footnote †added to reflect the issuance of PCAOB
Auditing Standard No. 2 and release of proposed PCAOB
auditing standard; Subsequent footnotes redesignated.
Revised to reflect the issuance of SAS No. 96; Footnotes
* deleted.

Schedule of Changes

Reference
Paragraph 2.52

Renumbered
paragraph 2.53
(footnote **)
Renumbered
paragraph 2.72
Renumbered
paragraph 2.74
Renumbered
paragraph 2.75
Renumbered
paragraph 2.76
Renumbered
paragraph 2.79
Renumbered
paragraph 2.83
Chapter 3 (title)
Paragraph 3.01
Paragraph 3.04
(footnote *)
Chapter 4 (title)
Paragraph 4.02
(footnote *)
Paragraphs 4.04,
4.05, 4.07, and
4.11
Paragraph 4.12
Paragraph 4.13
(footnote *)
Paragraph 4.18
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Change
Added to reflect the issuance of SAS No. 96; Subse
quent paragraphs further renumbered; Footnote ‡
added to reflect the issuance of PCAOB Auditing
Standard No. 2 and release of proposed PCAOB audit
ing standard; Subsequent footnotes further redesig
nated.
Deleted.
Revised to reflect the issuance of SAS No. 96; Footnote
* deleted.
Revised to reflect the issuance of SAS No. 96; Footnote
** deleted; Footnote || added to reflect the issuance of
PCAOB Auditing Standard No. 2, release of proposed
PCAOB auditing standard, and release of ASB expo
sure draft; Subsequent footnotes further redesignated.
Revised to reflect the issuance of SAS No. 99; Former
footnote * deleted.
Revised to reflect the issuance of SAS No. 99 and to
discuss guidance in SAS No. 52; Footnote ** deleted.
Revised to reflect recent regulatory developments;
Footnote # added; Subsequent footnotes further re
designated.
Revised to reflect the issuance of the Audit Guide
Government Auditing Standards and Circular A-133
Audits; Footnote 4 deleted.
Note deleted.
Revised to reflect the issuance of GASB Statement
No. 34.
Added to reflect the issuance of GASB Statement No.
40; Subsequent footnotes redesignated.
Note deleted.
Deleted.
Footnotes 2, 3, 5, and 7 added, respectively, to reflect
the issuance of EITF Issue No. 03-1; Subsequent
footnotes renumbered.
Revised to reflect the issuance of GASB Statement
No. 34.
Added to reflect the issuance of GASB Statement No.
40; Subsequent footnotes redesignated.
Revised to reflect the issuance of FASB Statement No.
149, SOP 02-2, and GASB Technical Bulletin 2003-1;
Renumbered footnote 11 revised to reflect the issuance
of FASB Statement No. 149; Footnotes * deleted;
Footnote * added to reflect the issuance of GASB State
ment No. 40; Footnote ** added to reflect the issuance
of GASB Technical Bulletin 2003-1; Subsequent foot
notes further redesignated.
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Reference
Exhibit 4-1
(renumbered
footnote 13)
Chapter 5 (title)
Paragraphs 5.04
and 5.22
(footnotes *)
Paragraph 5.23
Renumbered
paragraph 5.25
(footnote *)
Renumbered
paragraph 5.26
Renumbered
paragraph 5.27
Chapter 6 (title)
Paragraph 6.05
Paragraph 6.09
Renumbered
paragraph 6.14
Exhibit 6-1
(footnote 3)
Chapter 7 (title)
Paragraph 7.04
(footnote *)
Paragraph 7.13
Renumbered
paragraph 7.20
Chapter 8 (title)
Paragraph 8.02
Paragraph 8.16
(footnote *)
Paragraphs 8.21
and 8.23
Chapter 9 (title)
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Change
Revised to reflect the issuance of SAS No. 101.
Note deleted.
Deleted.
Added to reflect the issuance of GASB Statement No.
38; Subsequent paragraphs renumbered.
Deleted.
Revised to reflect the issuance of SOP 02-2 and GASB
Technical Bulletin 2003-1; Footnote ** deleted; Foot
note †added; Subsequent footnotes redesignated.
Revised to reflect the issuance of GASB Statement No.
34; Footnote 14 added.
Note deleted.
Footnote * revised to reflect the issuance of GASB
Statement No. 42; Footnote ** deleted.
Added to reflect the issuance of GASB Statement No.
34; Subsequent paragraphs renumbered.
Footnote * deleted; Footnote †added to reflect the
issuance of GASB Statement No. 42; Subsequent
footnotes redesignated.
Added to reflect the issuance of SAS No. 101.
Note deleted.
Added to reflect release of GASB exposure draft and
issuance of GASB Statement No. 45; Subsequent
footnotes redesignated.
Added to reflect the issuance of GASB Statement No.
34 and related pronouncements; Subsequent para
graphs renumbered.
Revised to reflect the issuance of FASB Statement No.
145; Footnote * deleted.
Note deleted.
Revised to reflect the issuance of FASB Interpretation
No. 45; Footnote * deleted.
Revised to reflect the issuance of FASB Interpretation
No. 46 and FASB Interpretation No. 46 (revised Decem
ber 2003).
Revised to reflect the issuance of GASB Statement
No. 34.
Note deleted.

Schedule of Changes
Reference

Paragraph 9.02
(heading)
Paragraph 9.06
Paragraphs 9.07
(and heading),
9.08, 9.09, 9.10,
and 9.11

Chapter 10 (title)
Paragraph 10.03
(heading)
Paragraphs 10.03
and 10.09
Paragraph 10.12
Paragraphs 10.15
and 10.16
Renumbered
paragraphs 10.19
and 10.20
Paragraphs 10.22,
10.23, 10.24, and
10.26
Renumbered
paragraph 10.28
Paragraphs 10.29,
10.30, and 10.31
Chapter 11 (title)
Paragraph 11.01

Paragraph 11.03
and heading
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Change

Revised since guidance for governmental health care
entities formerly contained under this heading has been
transferred to a new section in the chapter entitled
“Governmental Health Care Organizations.”
Deleted; Subsequent paragraphs renumbered.
Added to include new section entitled “Governmental
H ealth Care Organizations” with guidance for
governmental healthcare organizations transferred
from paragraphs 9.02 through 9.07, and to reflect the
issuance of GASB Statement No. 34 and related
pronouncements; Footnote * added; Subsequent foot
notes renumbered; Subsequent paragraphs further
renumbered.
Note deleted.
Revised to reflect the issuance of GASB Statement No.
34.
Revised to reflect the issuance of GASB Statement No.
34; Footnote 2 added; Subsequent footnotes renumbered.
Revised to reflect the issuance of GASB Statements
No. 33 and No. 34.
Added to reflect the issuance of GASB Statement No.
34 and GASB Staff Document Comprehensive Implemen
tation Guide—2003; Subsequent paragraphs renum
bered.
Revised to reflect the issuance of SOP 02-2; Foot
notes * and 5 deleted; Subsequent footnotes redesig
nated and renumbered.
Added to reflect the issuance of GASB Statement No.
34; Subsequent paragraphs further renumbered.
Revised to reflect the issuance of GASB Statement No.
34 and related pronouncements; Footnote 6 deleted;
Subsequent footnote renumbered.
Added to reflect the issuance of GASB Statement No.
34 and related pronouncements; Subsequent para
graphs renumbered.
Note deleted.
Deleted; Discussion of GASB Statement No. 14 trans
ferred to paragraph 11.03 (a new section in the chapter
entitled “Financial Reporting of Governmental Health
Care Entities”); Footnotes * and ** deleted; Subse
quent paragraphs and footnotes renumbered.
Added; Discussion of GASB Statement No. 14 trans
ferred from former paragraph 11.01 and revised to
reflect the issuance of GASB Statement No. 39.
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Reference

Paragraph 11.04
(heading)
Paragraph 11.05
(heading)
Paragraphs 11.07
and 11.08
(footnote 2)
Paragraph 11.10
Paragraph 11.14

Renumbered
paragraph 11.17
(footnote | | )
Renumbered
paragraph 11.20
(footnote 13)
Renumbered
paragraph 11.37
Chapter 12 (title)
Paragraph 12.01
Paragraph 12.02
Paragraphs 12.07,
12.08, and 12.09
Renumbered
paragraph 12.10
AAG-HCO APP H

Change
Added “Financial Reporting of Nongovernmental
Health Care Entities;” Footnote * from paragraph 11.05
moved to the new heading and revised to reflect the
issuance of FASB Interpretation No. 46 and FASB
Interpretation No. 46 (revised December 2003).
Deleted; Footnote * moved to new heading at para
graph 11.04.
Revised to reflect the issuance of FASB Interpretation
No. 46 and FASB Interpretation No. 46 (revised
December 2003).
Footnote 5 revised to clarify guidance; Footnote †
added to reflect the release of AcSEC exposure draft;
Subsequent footnotes redesignated.
Added to reflect the issuance of FASB Interpretation
No. 46 and FASB Interpretation No. 46 (revised Decem
ber 2003); Footnote ‡ added; Subsequent footnotes
further redesignated; Subsequent paragraphs renum
bered.
Added to reflect the release of AcSEC exposure draft;
Subsequent footnotes further redesignated.
Revised to reflect the issuance of GASB Statement No.
34 and add cross-reference to paragraphs 1.12 and 10.12.
Revised to reflect the issuance of FASB Interpretation
No. 46 and FASB Interpretation No. 46 (revised Decem
ber 2003); Footnote * added; Subsequent footnotes
further redesignated.
Note deleted.
Revised to reflect the issuance of the Audit and
Accounting Guide State and Local Governments; Foot
note * added to discuss proposed Audit Interpretations.
Added discussion of regulatory developments for reg
istered public accounting firms and PCAOB Auditing
Standard No. 1; Subsequent paragraphs renumbered.
Added to reflect the issuance of GASB Statement No.
34 and to discuss guidance in SAS No. 8, SAS No. 29,
and SAS No. 52; Footnote 2 added to clarify guidance;
Subsequent footnotes renumbered; Subsequent para
graphs further renumbered.
Revised to reflect the issuance of the Audit Guide
Government Auditing Standards and Circular A-133
Audits.

Schedule of Changes

Reference
Paragraph 13.02
Paragraph 13.08
(footnote *)
Appendix A

Appendix F
Appendix G
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Change
Revised to reflect the issuance of FASB Statement No.
146; Footnote * deleted; Footnote 1 added; Subsequent
footnotes renumbered.
Added to reflect the issuance of GASB Statement
No. 42.
Introductory paragraphs revised to reflect the issuance
of GASB pronouncements and EITF Issue No. 03-1;
Illustrative Financial Statements for Sample Not-forProfit Hospital: Revised to reflect the release of
Technical Practice Aids 6400.36 through 6400.42, the
issuance of FASB Statements No. 145, No. 132 (revised
2003), and FASB Staff Positions No. FAS 106-1 and
No. FAS 106-2, and delete effective date information
for SOP 01-6; Illustrative Financial Statements for
Sample Governmental Hospital Authority: Replaced
with Illustrative Management’s Discussion and Ana
lysis and Financial Statements from former Appendix
F that have been revised to reflect the issuance of
recent authoritative and proposed guidance; Illustra
tive Financial Statements for Sample Ambulatory Care
Organization: Revised to reflect the issuance of FASB
Interpretation No. 45, and delete effective date
information for SOP 01-6. Illustrative financial
statements for Sample For-Profit Nursing Home, Inc.,
Sample Not-for-Profit Continuing Care Retirement
Community, Sample Not-for-Profit Home Health
Agency, and Sample Not-for-Profit H ealth
Maintenance Organization revised to delete effective
date information for SOP 01-6.
Deleted (transferred Illustrative Management’s
Discussion and Analysis and Financial Statements to
Appendix A); SOP 02-2 added.
Updated.
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Marketing costs that are (a) directly related to the acquisi
tion of specific subscriber contracts and member enrollment and (b) incre
mental to general marketing activities.
acute care. Inpatient general routine care provided to patients who are in a
phase of illness that does not require the concentrated and continuous
observation and treatment provided in intensive-care units.
advance fee. A payment required to be made by a continuing care retirement
community (CCRC) resident prior to, or at the time of, admission to the
CCRC for future services and the use of facilities specified in a contract
that remains in effect for as long as the resident resides in the CCRC.
advance refunding. A transaction in which refunding debt is issued to pay
the refunded debt at a specified future date(s), with the proceeds placed in
trust or otherwise restricted to pay the refunded debt.
affiliate. A party that, directly or indirectly through one or more intermediar
ies, controls, is controlled by, or is under common control with an enterprise
(FASB Statement No. 57, Related Party Disclosures, paragraph 24(a))
agent. An entity that acts for and on behalf of another. A recipient organization
acts as an agent for and on behalf of a donor if it receives assets from the
donor and agrees to use those assets on behalf of or transfer those assets,
the return on investment of those assets, or both to a specified beneficiary.
A recipient organization acts as an agent for and on behalf of a beneficiary
if it agrees to solicit assets from potential donors specifically for the
beneficiary’s use and to distribute those assets to the beneficiary. A
recipient organization also acts as an agent if a beneficiary can compel the
organization to make distributions on its behalf. (FASB Statement No. 136,
Transfers of Assets to a Not-for-Profit Organization or Charitable Trust
That Raises or Holds Contributions for Others, paragraph 10)
allocated loss adjustment expense (ALAE). Claim expense that can be as
signed to individual claims (for example, attorney’s fees, claim adjusting
service fees, or court costs).
ambulatory care organization. A partnership, association, corporation, or
other legal entity organized to deliver health care services to patients that
come or are brought to a health care facility for a purpose other than
admission as an inpatient (for example, emergency room services, clinic
services, or outpatient surgery).
ancillary services. Services performed for diagnostic or therapeutic purposes.
Ancillary services generally are those special services for which charges in
addition to routine charges customarily are made (for example, laboratory,
radiology, surgical, or other services).
anticipated revenues. Amounts including third-party payments (for exam
ple, those from Blue Cross), contractually or statutorily committed invest
ment income from sources related to the activities of a continuing care
retirement community (CCRC), contributions pledged by donors to support
CCRC activities, periodic fees expected to be collected, or the balance of
deferred nonrefundable advance fees.
asserted claim. A claim made against a health care organization by or on
behalf of a patient alleging improper professional service.
acquisition costs.
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Assets that are segregated and limited either by the
Board or management (for example, designated for expenditure in the
acquisition of property and equipment or for the liquidation of long-term
debt) or by outside third parties other than a donor or grantor (for example,
funds under bond agreements or malpractice arrangements) as to how the
assets may be used.
associated entity. An individual practice association, hospital, medical group,
or similar health care organization that contracts with a prepaid health
care provider to provide health care services.
bad-debt expense. The current period charge for actual or expected doubtful
accounts resulting from the extension of credit.
capitation fee. A fixed amount per individual that is paid periodically (usually
monthly) to a provider as compensation for providing comprehensive
health care services for the period. The fee is set by contract between a
prepaid health care plan and the provider. These contracts are generally
with medical groups, independent practice associations (IPAs), hospitals,
and other similar providers. Capitation fees may be determined actuarially
or negotiated based on expected costs to be incurred.
charity care. Health care services that never were expected to result in cash
inflows. Charity care results from a provider’s policy to provide health care
services free of charge to individuals who meet certain financial criteria.
claims-made insurance policy. A policy that covers only malpractice claims
reported to the insurance carrier during the policy term, regardless of the
date of the incident giving rise to the claim.
clinic. A freestanding facility or part of another health care organization used
for diagnosis and treatment of outpatients.
commercial paper. Short-term, unsecured promissory notes that represent a
flexible and low-cost form of short-term financing. Taxable commercial
paper is sold on a discount basis, rather than on an interest-bearing basis,
with the discount determined by the maturity of the notes, the creditwor
thiness of the issuer or its credit support, and general market demand. The
primary risk is the variable interest rate exposure. Issuance often requires
some form of credit enhancement or liquidity support.
comprehensive medical plan (CMP). A health plan option that may be avail
able to Medicare beneficiaries and provides a more limited range of services
than health maintenance organizations but includes physician services,
laboratory, radiology, emergency, preventive, and inpatient services. A
CMP assumes the financial risk for the provision of services and for
out-of-area coverage.
conditional promise to give. A promise to give that depends on the occur
rence of a specified future or uncertain event to bind the promisor.
continuing-care contract. An agreement between a resident and a CCRC
specifying the services and facilities to be provided by the CCRC to a
resident over an established period of time (usually the remaining life of
the resident).
continuing care retirement community (CCRC). A legal entity sponsoring
or guaranteeing residential facilities, meals, and health care services for a
community of retired persons who may reside in apartments, other living
units, or in some cases a nursing center. (Also referred to as a residential
care facility or a life-care retirement community.)
contract period. The period (typically one year) for which premium rates are
fixed by contract.
assets limited as to use.
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The differences between revenue at established
rates and the amounts realizable from third-party payors under contrac
tual agreements.
contribution. An unconditional transfer of cash or other assets to an entity or
a settlement or cancellation of its liabilities in a voluntary nonreciprocal
transfer by another entity acting other than as an owner.
costs of acquiring initial continuing-care contracts. Costs incurred to origi
nate a contract that result from and are essential to the acquisition of the
initial contracts and are incurred through the date of substantial occupancy
but no later than one year from the date of completion of construction.
These costs include—
• The costs of processing the contract, such as evaluating the prospective
resident’s financial condition; evaluating and recording guarantees, collat
eral, and other security arrangements; negotiating contract terms; prepar
ing and processing contract documents; and closing the transaction.
• The costs from activities in connection with soliciting potential initial
residents (such as model units and their furnishings, sales brochures,
semipermanent signs, tours, grand openings, and sales salaries).
These costs do not include advertising, interest, administrative costs,
rent, depreciation, or any other occupancy or equipment costs.
• The portion of an employee’s compensation and benefits that relates
to the initial contract acquisitions.
courtesy and policy discounts. The differences between revenue recorded at
established rates and amounts realizable for services provided to specific
individuals such as employees, medical staff, and clergy.
credibility. A measure of the statistical significance of a provider’s own data,
dependent on its stability and volume in relation to the stability and
volume of the industry data. Actuaries use credibility to blend an estimate
from a provider’s own experience with a broader estimate based on the
experience of similar institutions. A provider’s own experience may be
assigned a credibility weight less than 100 percent due to year-to-year
volatility. Such volatility is often a function of the size of the provider.
Large providers generally have less volatility than small providers. In such
an instance, a broader and more stable body of experience of similar
providers would be used to supplement the specific provider’s experience.
credit enhancement. Typically, a bank letter of credit that guarantees investors
will receive principal and interest in the event of an issuer default. A line of
credit provides liquidity support to an issuer but does not provide a guarantee
of the repayment of principal and interest in the event of issuer default. The
liquidity support provides a loan to issuers in the event the issuer is unable to
place large amounts of maturing commercial paper with investors.
crossover refunding (also called a delayed defeasance). A type of advance
refunding in which the old debt is not immediately replaced. The proceeds
from the new debt, additional cash deposits (if any), and the income earned
on the related investments are sufficient to pay the principal and any call
premium of the old debt and the interest on the new debt until the date of
crossover. Until the crossover, the proceeds from the new debt serve as
collateral for that debt. The old debt is serviced by the entity until the date
of crossover, at which time the proceeds from the new debt are used to retire
the old debt and the entity becomes obligated to service the new debt. The
old debt remains as a liability on the issuer’s books until the crossover,
when it is called in accordance with the call provisions of its indenture.
contractual adjustments.
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Reductions in gross revenue arising from contrac
tual adjustments, courtesy and policy discounts, or other adjustments and
deductions.
defeasance. Legal satisfaction of refunded debt without the debt necessarily
being retired.
development factor. A computed factor used to project future changes in
estimated losses from the date of the occurrence of the incident to the
date-of-claim payment resulting from inflation, claimed cost growth, in
dustry trends, and court awards. The development factor can be applied to
incurred losses, paid losses, claim counts, and average values.
diagnosis-related group (DRG). A patient classification scheme that catego
rizes patients who are related medically with respect to primary and
secondary diagnosis, age, or complications.
donor-imposed condition. A donor stipulation that specifies a future and
uncertain event whose occurrence or failure to occur gives the promisor a
right of return of the assets it has transferred or releases the promisor from
its obligation to transfer its assets.
donor-imposed restriction. A donor stipulation that specifies the use for a
contributed asset that is more specific than broad limits resulting from the
nature of the organization, the environment in which it operates, and the
purposes specified in its articles of incorporation or bylaws of comparable
documents for an unincorporated association. A restriction on an organi
zation’s use of the asset contributed may be temporary or permanent.
endowment fund. An established fund of cash, securities, or other assets used
to provide income for the maintenance of a not-for-profit organization. The
use of the assets of the fund may be permanently restricted, temporarily
restricted, or unrestricted. Endowment funds generally are established by
donor-restricted gifts and bequests to provide a permanent endowment (to
provide a permanent source of income) or a term endowment (to provide
income for a specific period). The principal of a permanent endowment
must be maintained permanently, that is, not used up, expended, or
otherwise exhausted—and is classified as permanently restricted net
assets. The principal of a term endowment must be maintained for a
specified term and is classified as temporarily restricted net assets. An
organization’s governing board may earmark a portion of its unrestricted
net assets as a board-designated endowment (sometimes called funds
functioning as endowment or quasi-endowment funds) to be invested to
provide income for a long but unspecified period. The principal of a
board-designated endowment, which results from an internal designation,
is not donor restricted and is classified as unrestricted net assets.
enrollee. An individual who is a subscriber or an eligible dependent of a
subscriber in a prepaid health care plan.
estimated costs of future services. Amounts that are expected to be incurred
to provide services and the use of facilities to individuals over their
remaining lives under continuing-care contracts. Examples include resi
dent care, dietary, health care, facility, general and administrative, inter
est, depreciation, and amortization costs.
exposure. The amount of potential claim risk. The basis for reflecting differ
ences in the claim potential among providers’bases for charging insurance
premiums or allocating member contributions to a captive. Exposure bases
for hospital professional liability include number of occupied beds, outpa
tient visits, emergency room visits, and number of residents by specialty.
deductions from revenue.
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A debt instrument that allows issuers to borrow at
a floating short-term rate with a long-term stated maturity without some
of the risks traditionally associated with commercial paper. The investor
is subject to principal risk to the degree the issuer’s credit deteriorates or
investor demand for FRNs decreases. Most health care issuers of FRNs
require credit enhancement and a bank liquidity facility in conjunction
with an FRN program.
functional classification. A method of grouping expenses according to the
purpose for which costs are incurred. The primary functional classifica
tions are program services and supporting activities.
fund. A self-contained accounting entity set up to account for a specific activity
or project.
gross service revenues. All revenues from the provision of health care serv
ices excluding charity care.
health care services. Services provided to individuals related to the diagnosis
or treatment of physical or mental illness.
health maintenance organization (HMO). A generic group of medical care
entities organized to provide defined health care services to members in
return for fixed, periodic premiums (usually paid monthly) that are paid
in advance.
home health agency. An agency organized to provide health and supportive
services in a person’s home. These services may include nursing, nutri
tional, and therapeutic aid (such as physical therapy and dialysis) and the
rental, as well as sale of medical equipment.
increased limit factor. The relationship between losses limited to a peroccurrence limit at which the provider’s own experience is meaningful to
losses limited to the provider’s total retained limit per occurrence.
incremental costs. Costs that vary with and are directly attributable to
changes in business, such as an additional employer or HMO contract.
Fixed costs such as building depreciation or general overhead that do not
change with the addition or loss of a contract are not incremental costs.
incurred but not reported (IBNR) costs. Costs associated with health care
services incurred during a financial reporting period but not reported to
the health care organization until after the financial reporting date.
indenture. An agreement between two or more persons specifying the recip
rocal rights and duties of the parties under a contract (such as a lease,
mortgage, or contract between bondholders and the issuer of the bond).
individual practice association (IPA). A partnership, association, corpora
tion, or other legal entity organized to provide or arrange for the delivery
of health care services to members of a prepaid health care plan and
nonmember patients. In return, the IPA receives either a capitation fee or
a specified fee for services rendered.
inpatient. Under most circumstances, a patient who is provided with room,
board, and general nursing service and is expected to remain in the health
care facility at least overnight and occupy a bed.
in-substance defeasance. A form of advance refunding in which the debtor
places into an irrevocable trust an amount of assets estimated to be
sufficient to satisfy all future principal and interest payments of a specific
obligation. In such cases, the debt is not considered extinguished because
the debtor is not legally released from being the primary obligor.

floating rate note (FRN).
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A provider or group of providers that is organ
ized to deliver and finance acute and preventive health care services. An
integrated delivery system generally will provide (or arrange to provide) a
complete continuum of health care services (inpatient acute care, ambula
tory care, outpatient surgery, home health care, including long-term care)
to an enrolled population, generally for fixed prepaid fees called premiums.
interest rate swaps. An agreement to exchange interest payments without
actually exchanging the underlying principal. The two parties each agree
to make interest payments based on the calculation formula for the other’s
debt. Swaps can be used for a variety of purposes, such as to reduce the
overall cost of borrowing, lock in forward rates, reduce interest rate risk,
or adjust the ratio of variable and fixed-rate debt liabilities. Interest rate
swaps do not change the amount or type of debt outstanding, but they do
affect the issuer’s debt portfolio and risk profile.
intermediary. An entity that acts as a facilitator for the transfer of assets
between a potential donor and a potential beneficiary (donee) but is neither
an agent or trustee nor a donee and donor as contemplated by FASB Statement
No. 116, Accounting for Contributions Received and Contributions Made.
(FASB Statement No. 136, Transfers of Assets to a Not-for-Profit Organi
zation or Charitable Trust That Raises or Holds Contributions for Others,
paragraph 8)
intermediate care facility (ICF). A facility that provides care to individuals
whose mental or physical conditions require services that are above the
level of room and board and that can be made available only through
institutional facilities. The care provided at an ICF does not require
hospitals or skilled nursing facilities.
maintenance costs. Costs associated with maintaining enrollment records
and processing premium collections and payments.
margin for risk of adverse deviation. Actuarially determined estimate of
the additional funding requirement to obtain a specific confidence level
that losses will not exceed the amount paid into the self-insurance fund.
Margins are determined using statistical simulation techniques.
medical group. An association of physicians and other licensed health care
professionals organized on a group basis to practice medicine.
medium-term notes. An intermediate-term security offered on a continuous
basis providing flexibility for an issuer to vary the amount of outstanding
notes as its funding requirements change. The broad range of possible
maturities enables an issuer to borrow at the most attractive yield at the
time of each issuance. They can be issued domestically or abroad.
member. An individual who is enrolled as a subscriber or as an eligible
dependent of a subscriber in a prepaid health care plan.
multiprovider captive. An insurance company owned by two or more health
care organizations that underwrites malpractice insurance for its owners.
natural classification. A method of classifying expenditures according to the
nature of the expense such as salaries and wages, employee benefits,
supplies, and purchased services.
integrated delivery system.
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A type of advance refunding in which the proceeds
from the new debt, additional cash deposits (if any) and the income earned
on the related investments are sufficient to pay the interest, principal, and
call premium on the old debt. After the advance refunding, the old debt is
serviced by the investments in trust and the new debt is serviced by the
entity.
net service revenue. Gross service revenue less provisions for contractual
adjustments with third-party payors.
nonexchange transaction. An external transaction in which a government
gives (or receives) value without directly receiving (or giving) equal value
in exchange.
nonfinancial assets. Nonmonetary assets such as inventories or property,
plant, and equipment.
not-for-profit organization. An entity that possesses the following charac
teristics that distinguish it from a business enterprise: (a) contributions of
significant amounts of resources from resource providers that do not expect
commensurate or proportionate pecuniary return, (b) operating purposes
other than to provide goods or services at a profit, and (c) absence of
ownership interests like those of business enterprises. Not-for-profit or
ganizations possess these characteristics in varying degrees.
nursing center. A facility that provides nursing care to residents with a
variety of needs or medical conditions. A nursing center may be a compo
nent of a continuing care retirement community. (Also called a health
center, skilled-nursing facility, intermediate-care facility, continuing-care
facility, or basic-care home.)
occurrence-basis policy. A policy that covers claims resulting from incidents
that occur during the policy term, regardless of when the claims are
reported to the insurance carrier.
outliers. In referring to the Medicare Prospective Payment System, additional
payments that are made for cases that either have unusually long lengths
of stay or have charges in excess of the cost outlier threshold.
outpatient. A patient who is not confined overnight in a health care institu
tion.
peer review organization (PRO). Under federal statutory provision, PROs
are required in each state to monitor hospital activity under the prospec
tive payment system. Each hospital must contract with a PRO, which will
review (a) the validity of diagnostic information, which establishes the
diagnosis-related group; (b) the appropriateness of admissions; (c) the
appropriateness of care to outliers; and (d) the adequacy of care provided.
periodic fees. Amounts paid to a continuing care retirement community by a
resident at periodic intervals for continuing-care services. Such fees may
be fixed or adjustable. (Also called maintenance fees or monthly fees.)
periodic interim payment (PIP). A plan under which the health care organi
zation receives cash payments from a third-party payor (usually Medicare)
in constant amounts periodically.
permanent restriction. A donor-imposed restriction that stipulates that re
sources be maintained permanently but permits the organization to use up
or expend part or all of the income (or other economic benefits) derived
from the donated assets.
net advance refunding.
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The part of the net assets of a not-forprofit organization resulting from (a) contributions and other inflows of
assets whose use by the organization is limited by donor-imposed stipula
tions that neither expire by the passage of time nor can be fulfilled or
otherwise removed by the actions of the organization, (b) other asset
enhancements and diminishments subject to the same kind of stipulations,
and (c) reclassification from (or to) other classes of net assets as a conse
quence of donor-imposed stipulations.
premium. The consideration paid for providing contract coverage. (Also called
a subscriber fee.)
premium period. The period to which a premium payment applies (generally
one month) that entitles a member to health care services according to the
contract provisions.
prepaid health care plan. A plan in which the provider is compensated in
advance by the sponsoring organization. The sponsoring organization pays
or compensates the provider based on either a fixed sum or a per-enrollee
amount. Prepaid health care plans include health maintenance organiza
tions, preferred provider organizations, eye care plans, dental care plans,
and similar plans. Under such plans, the financial risk of delivering the
health care is transferred to the provider of services.
prepaid health care services. Any form of health care service provided to a
member in exchange for a scheduled payment (or payments) established
before care is provided, regardless of the level of service subsequently
provided.
prevailing charge. A charge that falls within the range of charges most
frequently used in a locality for a particular service or procedure.
primary care. Care that is rendered in an ambulatory fashion, such as in an
emergency room, an outpatient clinic, or other outpatient department.
prospective payment system (PPS). Medicare payment made at a predeter
mined, specific rate for each Medicare discharge, based on the patient’s
diagnosis. Each discharge is classified according to a series of diagnosisrelated groups. (See also diagnosis-related group.)
provider. A person or entity that undertakes to provide health care services.
permanently restricted net assets.

providers of prepaid health care services (prepaid health care providers).

Organizations that provide or arrange for the delivery of health care
services in accordance with the terms and provisions of a prepaid health
care plan. Providers assume the financial risk of the cost of delivering
health care services in excess of preestablished fixed premiums. However,
some or all of the financial risk may be contractually transferred to other
providers (affiliated entities) or by purchasing stop-loss insurance. Other
providers of prepaid health care services may include comprehensive
medical plans, physicians groups (for example, independent practice asso
ciations), and hospitals.
refundable advance fees. The portion of an advance fee that is payable to a
resident of a continuing care retirement community or the resident’s
estate.
refunded debt. Debt for which payment at a specified future date has been
provided by the issuance of refunding debt.
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Debt issued to provide funds to pay for refunded debt at a
specified future date.
reported incident. An occurrence identified by a health care organization as
one in which improper professional service may be alleged at a future time
that would result in a malpractice claim.
retrospectively rated insurance policy. An insurance policy with a premium
that is adjustable based on the experience of the insured health care
organization or group of health care organizations during the policy term.
risk contract. A contract between a provider of health care services and a
prepaid health care plan that exposes the provider to the uncertainty of
financial gain or loss by obligating the provider to provide specified health
care services to enrollees of the plan for a negotiated price, which may be
an amount per case, service, or day. The price may vary based on the
volume of services furnished during the contract period.
secondary care. Care that is rendered to inpatients in hospitals that offer
short-term, acute-care services of either a general or a specialized nature.
self-insurance. That portion of risk or loss assumed by a health care organi
zation. There is no external insurance coverage.
skilled nursing facilities (SNF). These facilities provide services on a daily,
inpatient basis. The services provided by an SNF are ordered by a physi
cian and require the skilled services of technical or professional personnel.
stop-loss (or reinsurance) insurance. A contract in which a company agrees
to indemnify providers for certain health care costs incurred by members.
subscriber. The person who is responsible for the payment of premiums or
whose employment is the basis for eligibility for membership in a prepaid
health care plan.
tail coverage. Insurance designed to cover malpractice claims incurred before,
but reported after, cancellation or expiration of a claims-made insurance
policy.
taxable variable rate demand notes. Issuers may call the notes on any
monthly interest payment date, which provides issuers the opportunity to
refinance short-term obligations with long-term bonds if market conditions
make this alternative attractive.
temporarily restricted net assets. The part of the net assets of a not-forprofit organization resulting (a) from contributions and other inflows of
assets whose use by the organization is limited by donor-imposed stipula
tions that either expire with the passage of time or can be fulfilled and
removed by actions of the organization pursuant to those stipulations, (b)
from other asset enhancements and diminishments subject to the same
kinds of stipulations, or (c) from reclassification to (or from) other classes
of net assets as a consequence of donor-imposed stipulations, their expira
tion by passage of time, or their fulfillment and removal by actions of the
organization pursuant to those stipulations.
tertiary care. Care that is rendered in hospitals that possess the personnel,
equipment, and expertise to handle complex cases.
refunding debt.
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Any agency (such as Blue Cross, Medicare, or commercial
insurance companies) that contracts with health care organizations and
patients to pay for the care of covered patients.
trend factor. A factor used in actuarial methodology to adjust ultimate losses
from historical experience periods to the loss cost levels of the projection
period, due to the impact of economic, jurisdictional, and social changes
affecting hospital professional liability loss costs.
trust fund. A fund established with an outside entity to be used for a specific
purpose, such as to pay malpractice claims and related expenses as they
arise.
trustee. An entity that has a duty to hold and manage assets for the benefit
of a specified beneficiary in accordance with a charitable trust agreement.
(FASB Statement No. 136, Transfers of Assets to a Not-for-Profit Organi
zation or Charitable Trust That Raises or Holds Contributions for Others,
paragraph 9)
ultimate cost. Total claims payments, including costs associated with litigat
ing or setting claims.
unasserted claim. A medical malpractice claim that has not been asserted
formally against a health care provider by or on behalf of a patient alleging
improper professional service. It may relate to either reported incidents or
to unreported incidents.
unreported incident. An occurrence in which improper professional service
may have been administered by a health care provider, which may result
in a malpractice claim of which the provider is not yet aware.
unrestricted net assets. The part of net assets of a not-for-profit organization
that is neither permanently restricted nor temporarily restricted by donorimposed stipulations.
voluntary health and welfare organizations. Organizations formed for the
purpose of performing voluntary services for various segments of society.
They are tax-exempt (organized for the benefit of the public), supported by
the public, and operated on a not-for-profit basis. Most voluntary health
and welfare organizations concentrate their efforts and expend their re
sources in an attempt to solve health and welfare problems of society and,
in many cases, those of specific individuals. As a group, voluntary health
and welfare organizations include not-for-profit organizations that derive
their revenue primarily from voluntary contributions from the general
public to be used for general or specific purposes connected with health,
welfare, or community services.
wholly owned captive. An insurance company subsidiary of a health care
organization that provides malpractice insurance primarily to its parent
corporation.
third-party payor.
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